<SEC-DOCUMENT>0001099800-23-000039.txt : 20231027
<SEC-HEADER>0001099800-23-000039.hdr.sgml : 20231027
<ACCEPTANCE-DATETIME>20231027164916
ACCESSION NUMBER:		0001099800-23-000039
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		100
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231027
DATE AS OF CHANGE:		20231027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Edwards Lifesciences Corp
		CENTRAL INDEX KEY:			0001099800
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				364316614
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15525
		FILM NUMBER:		231356131

	BUSINESS ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9492502500

	MAIL ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP.
		DATE OF NAME CHANGE:	20090225

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP
		DATE OF NAME CHANGE:	20000203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVG CONTROLLED INC
		DATE OF NAME CHANGE:	19991126
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ew-20230930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:eaa870a0-ed84-4111-a2ce-17bb0f4c4328,g:a046b429-8038-45a1-a20d-74cf9c7f6b8d,d:a0551ad7b75a442cb2396ea8bed8f718--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2023" xmlns:ew="http://www.edwards.com/20230930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ew-20230930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0001099800</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-26">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q3</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-29">false</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="f-870">http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="f-871">http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-876">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20230930#AccruedAndOtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-877">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20230930#AccruedAndOtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-423" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1460">60</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ew-20230930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-12</xbrli:startDate><xbrli:endDate>2023-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-12</xbrli:startDate><xbrli:endDate>2023-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ew:SpecialChargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:NewMarketsTaxCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ew:ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-28</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ew:MeasurementInputProbabilityOfMilestoneAchievementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ew:AccruedAndOtherLiabilitiesCurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ew:AccruedAndOtherLiabilitiesCurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:MarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:MarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:MarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:MarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledJanuary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledJanuary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:January2022StockRepurchaseProgramSharesSoldInFebruary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>ew:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>ew:agreement</xbrli:measure></xbrli:unit><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:JeanLucLemercierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:JeanLucLemercierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001099800</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:JeanLucLemercierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">September&#160;30, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">1-15525</ix:nonNumeric> </span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">EDWARDS LIFESCIENCES CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></div></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">36-4316614</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">One Edwards Way</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Irvine</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">92614</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">949</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">250-2500</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(Registrant's telephone number, including area code)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $1.00 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">EW</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:16.030%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares outstanding of the registrant's common stock, $1.00 par value, as of October&#160;25, 2023 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-24">606.5</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended September&#160;30, 2023 </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_13">Part&#160;I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_16">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_19">Consolidated Condensed Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_22">Consolidated Condensed Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_22">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_25">Consolidated Condensed Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_25">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_28">Consolidated Condensed Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_28">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_31">Consolidated Condensed Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_31">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_34">Notes to Consolidated Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_82">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_82">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_82">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_100">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_100">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_100">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_103">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_103">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_103">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_106">Part&#160;II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_106">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_109">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_109">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_109">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_112">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_112">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_112">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_115">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_115">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_115">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_118">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_118">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_118">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item&#160;6.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_124">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_124">41</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_127">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia0551ad7b75a442cb2396ea8bed8f718_127">42</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOTE REGARDING FORWARD-LOOKING STATEMENTS </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This report contains forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934. We intend the forward-looking statements contained in this report to be covered by the safe harbor provisions of such Acts. Statements other than statements of historical or current fact in this report or referred to or incorporated by reference into this report are "forward-looking statements" for purposes of these safe harbor provisions. These statements include, among other things, the expected impact of COVID-19 on our business, the expected impact of macroeconomic conditions on our business, any predictions, opinions, expectations, plans, strategies, objectives and any statements of assumptions underlying any of the foregoing relating to our current and future business and operations, including, but not limited to, financial matters, development activities, clinical trials and regulatory matters, manufacturing and supply operations, and product sales and demand.  These statements can sometimes be identified by the use of the forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "goal," "continue," "seek," "pro forma," "forecast," "intend," "guidance," "optimistic," "aspire," "confident," other forms of these words or similar words or expressions or the negative thereof. Statements regarding past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "preliminary," "initial," diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negative thereof.  These forward-looking statements are subject to substantial risks and uncertainties that could cause our results or future business, financial condition, results of operations or performance to differ materially from our historical results or experiences or those expressed or implied in any forward-looking statements contained in this report.  These risks and uncertainties include, but are not limited to: our success in developing new products and avoiding manufacturing and quality issues; clinical trial or commercial results or new product approvals and therapy adoption; the impact of domestic and global conditions; competitive dynamics in the markets in which we operate; our reliance on vendors, suppliers, and other third parties; damage, failure or interruption of our information technology systems; the impact of public health crises, including the COVID-19 pandemic; consolidation in the healthcare industry; our ability to protect our intellectual property; our compliance with applicable regulations; our exposure to product liability claims; use of our products in unapproved circumstances; changes to reimbursement for our products; the impact of currency exchange rates; unanticipated actions by the United States Food and Drug Administration and other regulatory agencies; changes to tax laws; unexpected impacts or expenses of litigation or internal or government investigations; and other risks detailed under &#8220;Risk Factors&#8221; in our annual report on Form&#160;10-K for the year ended December&#160;31, 2022, as such risks and uncertainties may be amended, supplemented or superseded from time to time by our subsequent reports on Forms&#160;10-Q and 8-K we file with the United States Securities and Exchange Commission. These forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated or otherwise required by the context, the terms "we," "our," "it," "its," "Company," "Edwards," and "Edwards Lifesciences" refer to Edwards Lifesciences Corporation and its subsidiaries.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:11pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part&#160;I. Financial Information</span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_16"></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements</span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_19"></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED BALANCE SHEETS</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions, except par value; unaudited)</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-30">1,410.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-31">769.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments (Note&#160;5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ShortTermInvestments" scale="6" id="f-32">453.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ShortTermInvestments" scale="6" id="f-33">446.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-34">7.9</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="f-35">7.9</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-36">739.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-37">643.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherReceivables" scale="6" id="f-38">62.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherReceivables" scale="6" id="f-39">56.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories (Note&#160;2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-40">1,032.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-41">875.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-42">133.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-43">110.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-44">235.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-45">195.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-46">4,067.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-47">3,095.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments (Note&#160;5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-48">704.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-49">1,239.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-50">1,681.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="f-51">1,632.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-52">90.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-53">92.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-54">1,297.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-55">1,164.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net (Note 7) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-56">429.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-57">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-58">651.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-59">484.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-60">447.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-61">299.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-62">9,370.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-63">8,292.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-64">190.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-65">201.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued and other liabilities (Note 2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-66">1,024.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedAndOtherLiabilitiesCurrent" scale="6" id="f-67">795.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-68">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-69">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-70">1,238.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-71">1,022.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-72">596.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-73">596.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration liabilities (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="6" id="f-74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="f-75">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="6" id="f-76">81.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="6" id="f-77">143.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-78">70.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-79">69.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="f-80">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="f-81">267.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement accrual</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="f-82">104.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="f-83">143.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-84">240.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-85">217.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-86">2,643.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-87">2,485.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note&#160;12)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-88"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-89"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-90"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-91">0.01</ix:nonFraction></ix:nonFraction> par value, authorized <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-92"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-93">50.0</ix:nonFraction></ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-94"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="f-95">no</ix:nonFraction></ix:nonFraction> shares outstanding&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-98"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-99">1.00</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-100"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-101">1,050.0</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-102">649.9</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-103">646.3</ix:nonFraction> shares issued, and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-104">606.5</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-105">608.3</ix:nonFraction> shares outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-106">649.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-107">646.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-108">2,211.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-109">1,969.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-110">8,622.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-111">7,590.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-112">250.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-113">254.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-114">43.4</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-115">38.0</ix:nonFraction> shares, respectively </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-116">4,576.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-117">4,144.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Edwards Lifesciences Corporation stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-118">6,657.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-119">5,806.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest (Note 7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="f-120">69.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:MinorityInterest" format="ixt:fixed-zero" scale="6" id="f-121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-122">6,727.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-123">5,806.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-124">9,370.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-125">8,292.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions, except per share information; unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-126">1,480.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-127">1,319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-128">4,470.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-129">4,034.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-130">350.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-131">253.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-132">1,022.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-133">822.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-134">1,130.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-135">1,065.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-136">3,447.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-137">3,211.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-138">439.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-139">377.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-140">1,344.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-141">1,156.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-142">270.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-143">233.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-144">801.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-145">713.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and litigation expense (income), net (Note 3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-146">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-147">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-148">193.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-149">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities (Note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="f-150">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-151">12.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-152">26.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-153">36.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charge (Note&#160;4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="f-155">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-156">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="f-157">66.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-158">418.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-159">402.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-160">1,134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-161">1,300.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-162">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-163">6.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-164">32.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-165">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-166">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-167">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-168">9.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-169">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-170">439.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-171">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-172">1,176.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-173">1,308.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-174">55.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-175">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-176">146.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-177">184.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-178">383.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-179">343.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-180">1,029.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-181">1,123.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest (Note 7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-182">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-183">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="f-184">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-186">384.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-187">343.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-188">1,032.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-189">1,123.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Note 14)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-190">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-191">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-192">1.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-193">1.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-194">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-195">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-196">1.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-197">1.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-198">607.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-199">619.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-200">607.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-201">621.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-202">609.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-203">624.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-204">610.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-205">626.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions; unaudited)</span></div><div style="margin-bottom:4pt;margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-206">383.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-207">343.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-208">1,029.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-209">1,123.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax (Note&#160;13):</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-210">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-211">41.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-212">31.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="f-213">94.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on hedges</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-214">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-215">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-216">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="f-217">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension (costs) credits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="f-218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-219">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-220">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="f-221">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on available-for-sale investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-222">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-223">10.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-224">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-225">68.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-226">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-227">31.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-228">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-229">98.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-230">389.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-231">311.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-232">1,034.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-233">1,025.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interest</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="f-234">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="f-236">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-237">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Edwards Lifesciences Corporation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-238">390.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-239">311.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-240">1,037.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="f-241">1,025.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_28"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions; unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-242">1,029.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="f-243">1,123.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-244">108.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-245">104.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-246">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-247">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation (Note&#160;10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-248">108.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-249">98.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charge (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="f-250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-251">55.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-252">26.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-253">36.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="f-254">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="f-255">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-256">180.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="f-257">148.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-258">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-259">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and other receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="f-260">123.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="6" id="f-261">83.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-262">189.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-263">151.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-264">112.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-265">55.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-266">106.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="f-267">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-268">63.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-269">20.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement accrual</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="ew:IncreaseDecreaseInLegalSettlementAccrual" scale="6" id="f-270">26.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="ew:IncreaseDecreaseInLegalSettlementAccrual" scale="6" id="f-271">36.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepaid royalties (Note 3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidRoyalties" scale="6" id="f-272">111.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidRoyalties" format="ixt:fixed-zero" scale="6" id="f-273">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-274">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="f-275">39.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-276">759.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-277">935.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-278">164.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-279">175.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of held-to-maturity investments (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="6" id="f-280">23.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" scale="6" id="f-281">285.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from held-to-maturity investments (Note 5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="6" id="f-282">91.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="6" id="f-283">324.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of available-for-sale investments (Note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="f-284">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="f-285">302.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from available-for-sale investments (Note 5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="f-286">486.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="f-287">761.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combination, net of cash (Note 7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" scale="6" id="f-288">141.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" format="ixt:fixed-zero" scale="6" id="f-289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition options (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" scale="6" id="f-290">15.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" scale="6" id="f-291">107.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances of notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireReceivables" scale="6" id="f-292">47.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireReceivables" scale="6" id="f-293">51.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collections of notes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="6" id="f-294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" scale="6" id="f-295">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-296">18.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-297">22.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-298">159.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-299">157.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-300">431.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-301">861.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="f-302">136.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="f-303">118.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-304">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-305">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-306">297.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-307">746.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-308">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-309">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-310">641.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-311">384.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-312">772.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-313">867.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period (Note 2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-314">1,413.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-315">1,251.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions; unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.134%"><tr><td style="width:1.0%"></td><td style="width:26.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.013%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.904%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Edwards Lifesciences Corporation Stockholders' Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-316">646.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-317">646.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-318">38.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-319">4,144.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-320">1,969.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-321">7,590.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-322">254.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-323">5,806.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="f-324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-325">5,806.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-326">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-327">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-328">340.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-329">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-330">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-331">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-332">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-333">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-334">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-335">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-336">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-337">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-338">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-339">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-340">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-341">249.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-342">249.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-343">249.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-344">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-345">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-346">647.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-347">647.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-348">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-349">4,393.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-350">2,049.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-351">7,930.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-352">255.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-353">5,978.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-354">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-355">6,062.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-356">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-357">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-358">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-359">305.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-360">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-361">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-362">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under equity plans</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-363">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-364">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-365">58.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-366">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-367">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-368">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-369">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-370">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-371">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-372">7.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-373">7.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-374">7.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-375">11.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="f-376">11.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-377">649.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-378">649.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-379">41.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-380">4,401.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-381">2,145.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-382">8,237.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-383">255.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-384">6,375.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-385">70.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-386">6,446.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-387">384.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-388">384.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="f-389">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-390">383.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-391">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-392">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-393">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under equity plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-394">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-395">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-396">33.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-397">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-398">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-399">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-400">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-401">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-402">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-403">175.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-404">175.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-405">175.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-406">649.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-407">649.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-408">43.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-409">4,576.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-410">2,211.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-411">8,622.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-412">250.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-413">6,657.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-414">69.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-415">6,727.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in millions; unaudited)</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.043%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.068%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.510%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-416">642.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-417">642.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-64" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-418">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-419">2,416.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-420">1,700.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-421">6,068.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-422">157.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-423">5,835.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-424">373.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-425">373.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-426">28.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-427">28.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-71" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-428">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-429">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-430">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-431">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-432">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-433">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-73" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-434">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-435">405.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-436">405.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-74" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-437">642.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-438">642.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-75" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-439">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-440">2,822.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-441">1,769.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-442">6,441.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-443">186.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-444">5,844.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-445">406.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-446">406.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-447">37.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-448">37.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under equity plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-83" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-449">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-450">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-451">46.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-452">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-453">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-454">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-85" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-455">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-456">355.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-457">355.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-86" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-458">645.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-459">645.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-87" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-460">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-461">3,177.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-462">1,852.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-463">6,848.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-464">224.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-465">5,943.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-466">343.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="f-467">343.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-468">31.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-469">31.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under equity plans</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-94" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-470">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-471">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-472">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-473">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-474">30.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-475">30.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-476">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-477">100.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-478">100.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-97" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-479">645.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-480">645.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-98" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-481">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-482">3,278.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-483">1,914.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-484">7,191.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="f-485">256.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-486">6,217.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">consolidated condensed financial statements.</span></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_37"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="f-487" continuedAt="f-487-1" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-487-1"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-488" escape="true">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</ix:nonNumeric></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-489" escape="true">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.</ix:nonNumeric></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-490" escape="true">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.</ix:nonNumeric>  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-491" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_40"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-492" continuedAt="f-492-1" escape="true">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-492-1" continuedAt="f-492-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-493" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-494">204.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-495">156.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-496">223.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-497">177.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-498">603.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-499">541.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="f-500">1,032.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-501">875.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2023 and December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" format="ixt:num-dot-decimal" scale="6" id="f-502">142.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" format="ixt:num-dot-decimal" scale="6" id="f-503">128.6</ix:nonFraction> million, respectively, of the Company's finished products inventories were held on consignment. </span></div></ix:continuation><div style="padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-492-2"><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-504" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-505">340.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-506">268.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-507">172.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-508">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" scale="6" id="f-509">57.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" scale="6" id="f-510">45.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:ResearchAndDevelopmentAccruals" scale="6" id="f-511">70.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:ResearchAndDevelopmentAccruals" scale="6" id="f-512">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedRebates" scale="6" id="f-513">139.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedRebates" scale="6" id="f-514">116.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="f-515">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DerivativeLiabilitiesCurrent" scale="6" id="f-516">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="f-517">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="f-518">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedLitigationAndInsuranceReserves" scale="6" id="f-519">30.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedLitigationAndInsuranceReserves" scale="6" id="f-520">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="f-521">65.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LitigationReserveCurrent" scale="6" id="f-522">53.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedRelocationCostsCurrent" scale="6" id="f-523">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedRelocationCostsCurrent" scale="6" id="f-524">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="f-525">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="f-526">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="f-527">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="f-528">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-529">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-530">80.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ew:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-531">1,024.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ew:AccruedAndOtherLiabilitiesCurrent" scale="6" id="f-532">795.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="f-533" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-534">219.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-535">315.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-536">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-537">22.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-538">21.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-539">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-540">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-541">25.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-542" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-543" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-544">1,410.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-545">769.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-546">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-547">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-548">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-549">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-550">1,413.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-551">772.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_43"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="f-552" continuedAt="f-552-1" escape="true">INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET</ix:nonNumeric></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:18pt"><ix:continuation id="f-552-1" continuedAt="f-552-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a <ix:nonNumeric contextRef="c-102" name="ew:IntellectualPropertyAgreementTerm" format="ixt-sec:durwordsen" id="f-553">15-year</ix:nonNumeric> global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="f-554">300.0</ix:nonFraction>&#160;million and will pay annual royalty payments that are tied to net sales of certain Edwards products.  Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="f-555">300.0</ix:nonFraction>&#160;million upfront payment based on their respective fair values.  The Company recorded a $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="f-556">37.0</ix:nonFraction>&#160;million pre-tax charge in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Litigation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in March 2023 related primarily to prior commercial sales incurred through March 31, 2023.  The Company recorded a prepaid royalty asset of $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:PrepaidRoyalties" format="ixt:num-dot-decimal" scale="6" id="f-557">124.0</ix:nonFraction>&#160;million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property </span></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><ix:continuation id="f-552-2" continuedAt="f-552-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement.  Separately, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="f-558">139.0</ix:nonFraction>&#160;million pre-tax charge in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Litigation Expense</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-552-3">" in April 2023 related to products currently in development.</ix:continuation>  </span></div><div><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_549755814846"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock" id="f-559" continuedAt="f-559-1" escape="true">SPECIAL CHARGE</ix:nonNumeric></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:18pt"><ix:continuation id="f-559-1"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Company decided to exit its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HARPOON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> surgical mitral repair system program. As a result, the Company recorded a charge to its United States segment of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-560">68.4</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-561">66.8</ix:nonFraction>&#160;million was included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Special Charge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-562">1.6</ix:nonFraction>&#160;million was included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed statements of operations. The charge primarily related to the full impairment of intangible assets associated with the technology and other related exit costs. The Company believes that no additional contingent consideration is due and, in September 2022, recorded an $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="ew:RestructuringContingentConsiderationGainLoss" format="ixt:num-dot-decimal" scale="6" id="f-563">11.7</ix:nonFraction>&#160;million contingent consideration gain associated with the exit.</span></ix:continuation></div><div><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_46"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="f-564" continuedAt="f-564-1" escape="true">INVESTMENTS</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-564-1" continuedAt="f-564-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="f-565" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:HeldToMaturitySecurities" scale="6" id="f-566">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="f-567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="f-568">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="f-569">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:HeldToMaturitySecurities" scale="6" id="f-570">96.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" format="ixt:fixed-zero" scale="6" id="f-571">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" format="ixt:fixed-zero" scale="6" id="f-572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="f-573">96.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-574">83.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-576">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-577">79.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-578">137.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-580">6.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-581">131.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-582">227.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-584">7.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-585">219.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-586">380.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-588">14.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-589">366.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-590">745.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-591">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-592">26.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-593">718.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-594">1,028.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-596">47.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-597">980.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-598">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-600">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-601">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-602">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-603">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-604">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-605">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-606">1,059.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-607">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-608">38.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-609">1,020.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-610">1,549.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-611">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-612">68.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-613">1,481.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-614" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of September&#160;30, 2023, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1&#160;year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" scale="6" id="f-615">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="6" id="f-616">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" scale="6" id="f-617">435.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="6" id="f-618">425.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1&#160;year through 5&#160;years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" format="ixt:fixed-zero" scale="6" id="f-619">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" format="ixt:fixed-zero" scale="6" id="f-620">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="6" id="f-621">365.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="6" id="f-622">347.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 5&#160;years through 10&#160;years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost" format="ixt:fixed-zero" scale="6" id="f-623">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" format="ixt:fixed-zero" scale="6" id="f-624">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" format="ixt:fixed-zero" scale="6" id="f-625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" format="ixt:fixed-zero" scale="6" id="f-626">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" format="ixt:fixed-zero" scale="6" id="f-627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:fixed-zero" scale="6" id="f-628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" scale="6" id="f-629">258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="f-630">247.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="6" id="f-631">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="f-632">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-633">1,059.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-634">1,020.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  &#160;&#160;&#160;&#160;Consists of mortgage- and asset-backed securities.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-564-2" continuedAt="f-564-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="f-635" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September&#160;30, 2023 and December&#160;31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-636">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-637">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-638">76.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-639">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-640">79.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-641">4.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-642">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-643">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-644">200.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-645">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-646">218.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-647">7.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-648">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-649">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-650">674.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-651">26.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-652">674.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-653">26.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-656">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-657">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-658">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-659">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-660">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-661">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-662">953.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-663">38.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-664">974.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-665">38.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.411%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-666">61.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-667">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-668">69.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-669">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-670">131.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-671">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-672">103.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-673">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-674">254.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-675">12.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-676">357.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-677">14.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-678">189.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-679">5.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-680">784.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-681">42.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-682">973.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-683">47.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="f-684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="f-685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="f-686">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-687">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="f-688">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-689">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="f-690">353.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="f-691">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="f-692">1,111.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="f-693">60.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="f-694">1,465.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="f-695">68.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value.  Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of September&#160;30, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Unconsolidated Entities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities.  <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" id="f-696" continuedAt="f-696-1" escape="true">These investments are recorded in "</ix:nonNumeric></span><ix:continuation id="f-696-1" continuedAt="f-696-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets, and are as follows:</span></ix:continuation></div><div style="margin-top:5pt"><ix:continuation id="f-696-2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-697">22.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-698">21.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-699">86.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-700">86.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="f-701">109.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="f-702">108.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023, the Company made $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-703">1.7</ix:nonFraction> million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program.  The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities.  The NMTC is equal to <ix:nonFraction unitRef="number" contextRef="c-120" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-704">39</ix:nonFraction>% of the qualified investment and is taken over <ix:nonNumeric contextRef="c-121" name="ew:EquityMethodInvestmentsInvestmentPeriod" format="ixt-sec:durwordsen" id="f-705">seven years</ix:nonNumeric>.  These limited liability companies are variable interest entities ("VIEs").  The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-564-3" continuedAt="f-564-4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company does not consolidate these entities.  Instead, the NMTC investments are accounted for as equity method investments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.  As of September&#160;30, 2023, the Company had recorded cumulative upward adjustments of $<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="f-706">8.8</ix:nonFraction> million based on observable price changes, and cumulative downward adjustments of $<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="f-707">3.1</ix:nonFraction> million due to impairments and observable price changes.   </span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-564-4">During the three and nine months ended September 30, 2023, the gross realized gains or losses from sales of available-for-sale investments were not material.</ix:continuation> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_49"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="f-708" continuedAt="f-708-1" escape="true">INVESTMENTS IN VARIABLE INTEREST ENTITIES </ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-708-1" continuedAt="f-708-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE.  The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest.  Edwards concluded that it is the primary beneficiary and consolidated the VIE.  See Note 7 for additional information. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unconsolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company agreed to pay a medical device company up to $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="ew:LoansReceivablesMaximumLendingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-709">45.0</ix:nonFraction>&#160;million as consideration for an option to acquire the medical device company, of which $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-710">15.0</ix:nonFraction>&#160;million had been paid as of September&#160;30, 2023. Also, in March 2023, Edwards advanced $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="6" id="f-711">5.0</ix:nonFraction>&#160;million to the medical device company under a convertible promissory note. The option and the note are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet as of September&#160;30, 2023.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="ew:EquitySecuritiesFVNIMaximumSecuredPromissoryNote" format="ixt:num-dot-decimal" scale="6" id="f-712">45.0</ix:nonFraction>&#160;million secured promissory note agreement with a privately-held medical device company (the "Investee"), of which $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="ew:EquitySecuritiesFVNIPromissoryNoteOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-713">25.0</ix:nonFraction>&#160;million had been advanced as of September&#160;30, 2023.  Also in 2021, the Company invested $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-714">39.3</ix:nonFraction>&#160;million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in the Investee's preferred equity securities and paid $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="ew:EquitySecuritiesFVNIOptionToAcquireInvestment" format="ixt:num-dot-decimal" scale="6" id="f-715">13.1</ix:nonFraction>&#160;million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for an option to acquire the Investee.  Pursuant to the agreement, the Company may be required to invest up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="ew:EquitySecuritiesFVNIMaximumAdditionalRequired" format="ixt:num-dot-decimal" scale="6" id="f-716">6.5</ix:nonFraction>&#160;million in the Investee's preferred equity securities and up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="ew:EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" format="ixt:num-dot-decimal" scale="6" id="f-717">14.4</ix:nonFraction>&#160;million for the option to acquire the Investee.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into an option agreement with a medical device company.  Under the option agreement, Edwards paid $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-718">47.1</ix:nonFraction>&#160;million for an option to acquire the medical device company.  The $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="ew:OptionToAcquireInvestmentAmount" format="ixt:num-dot-decimal" scale="6" id="f-719">47.1</ix:nonFraction>&#160;million option is included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company.  Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="ew:LoansReceivablesMaximumLendingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-720">47.5</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="6" id="f-721">32.5</ix:nonFraction>&#160;million had been advanced as of September&#160;30, 2023.  In addition, in 2019 the Company paid $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-722">35.0</ix:nonFraction>&#160;million for an option to acquire the medical device company. The $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="ew:OptionToAcquireInvestmentAmount" format="ixt:num-dot-decimal" scale="6" id="f-723">35.0</ix:nonFraction>&#160;million option and the $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:NotesReceivableGross" format="ixt:num-dot-decimal" scale="6" id="f-724">32.5</ix:nonFraction>&#160;million note receivable are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an option agreement with a medical technology company.  Under the option agreement, Edwards paid $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-725">60.0</ix:nonFraction>&#160;million for an option to acquire the medical technology company, of which $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-726">10.0</ix:nonFraction>&#160;million was paid in 2021. The $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="ew:OptionToAcquireInvestmentAmount" format="ixt:num-dot-decimal" scale="6" id="f-727">60.0</ix:nonFraction>&#160;million option is included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet. In addition, in August 2023, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-6" name="ew:EquitySecuritiesFVNIMaximumPromissoryNote" format="ixt:num-dot-decimal" scale="6" id="f-728">15</ix:nonFraction>&#160;million promissory note with the medical technology company.  </span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-708-2">In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs.  For more information, see Note 5.</ix:continuation></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_52"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-729" continuedAt="f-729-1" escape="true">BUSINESS COMBINATION</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-729-1"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2023, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-139" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-730">61</ix:nonFraction>% of the then outstanding shares of a medical technology company in an all cash transaction.  The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated condensed financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination.  Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date.  The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill.  <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="f-731" continuedAt="f-731-1" escape="true">The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):</ix:nonNumeric></span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:continuation id="f-731-1"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="f-732">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-733">133.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-734">136.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="f-735">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="f-736">28.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="f-737">248.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="ew:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" scale="6" id="f-738">72.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" scale="6" id="f-739">175.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="f-740">6.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-741">169.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  Includes the fair value of the noncontrolling interest of $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="6" id="f-742">94.4</ix:nonFraction>&#160;million, offset by the purchase consideration allocated to the option of $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="ew:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" format="ixt:num-dot-decimal" scale="6" id="f-743">22.0</ix:nonFraction>&#160;million, which was ascribed to the noncontrolling interest.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Includes $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:OtherPaymentsToAcquireBusinesses" format="ixt:num-dot-decimal" scale="6" id="f-744">22.5</ix:nonFraction>&#160;million paid in a previous year under option agreements and $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-745">5.3</ix:nonFraction>&#160;million for the settlement of a pre-existing note.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition.  Goodwill was assigned to the Company&#8217;s Rest of World segment and is not deductible for tax purposes.     </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.</span></div></ix:continuation><div style="padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_55"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-746" continuedAt="f-746-1" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-746-1" continuedAt="f-746-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-746-2" continuedAt="f-746-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable.  As of September&#160;30, 2023, the fair value of the notes payable, based on Level 2 inputs, was $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-747">565.7</ix:nonFraction> million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:20.25pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-748" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-749">554.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-750">266.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-751">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-752">820.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-754">718.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-756">718.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-758">219.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-760">219.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-762">79.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-764">79.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-766">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-767">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-768">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-769">123.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-772">123.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-774">89.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-776">89.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-777">677.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-778">1,376.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-779">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-780">2,053.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-782">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-783">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-784">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="f-787">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="f-788">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-790">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-791">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-792">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-793">280.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-794">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-796">280.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-797">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-798">980.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-800">980.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-801">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-802">366.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-804">366.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-805">37.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-806">94.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-807">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-808">131.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-809">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-810">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-811">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-812">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-813">112.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-814">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" format="ixt:fixed-zero" scale="6" id="f-815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DeferredCompensationPlanAssets" scale="6" id="f-816">112.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-817">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-818">65.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="f-819">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-820">65.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-821">429.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-822">1,509.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-823">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-824">1,939.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-826">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-827">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-828">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="f-829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="f-830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="f-831">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="f-832">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-833">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="f-835">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="6" id="f-836">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-838">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-839">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="f-840">67.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents included money market funds for the periods presented above.  The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets.  The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs.  The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source.  The Company&#8217;s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.  </span></div></ix:continuation><div style="text-indent:20.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-746-3"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in trading securities related to its deferred compensation plans.  The investments are in a variety of stock, bond and money market mutual funds.  The fair values of these investments are based on quoted market prices.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures.  All derivatives contracts are recognized on the balance sheet at their fair value.  The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates.  Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange.  The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements.  Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals.  These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs.  As of September&#160;30, 2023, the probability of milestone achievement was determined to be <ix:nonFraction unitRef="number" contextRef="c-182" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="f-841">0</ix:nonFraction>% and, accordingly, the contingent consideration liability was <ix:nonFraction unitRef="usd" contextRef="c-183" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="0" id="f-842">zero</ix:nonFraction>.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-843" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-844">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-845">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-846">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-847">26.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-848">3.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-849">29.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:fixed-zero" scale="6" id="f-850">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-851">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-852">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-853">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-854">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-855">76.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-856">36.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="f-857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="f-858">36.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-859">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-860">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="f-861">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_58"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-862" continuedAt="f-862-1" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-862-1" continuedAt="f-862-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="f-863" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-864">1,686.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-865">1,678.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-866">300.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-867">300.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default.  It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy.  The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities.  The Company also uses International Swap Dealers Association master-netting agreements.  The master-netting </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-862-2" continuedAt="f-862-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge" format="ixt-sec:duryear" id="f-868">1</ix:nonNumeric> year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges).  The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets.  For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item.  The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges.  The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings.  Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated.  The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative.  The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument.  Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" id="f-869" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-870"><span style="-sec-ix-hidden:f-871">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-872">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-873">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-874">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-875">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-876"><span style="-sec-ix-hidden:f-877">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-878">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-879">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-881">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-862-3" continuedAt="f-862-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:OffsettingAssetsTableTextBlock" id="f-882" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:OffsettingLiabilitiesTableTextBlock" id="f-883" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-884">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="f-885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-886">53.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="f-887">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeCollateralObligationToReturnCash" format="ixt:fixed-zero" scale="6" id="f-888">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="f-889">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-890">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="f-891">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-892">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" format="ixt:fixed-zero" scale="6" id="f-893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:DerivativeCollateralObligationToReturnCash" format="ixt:fixed-zero" scale="6" id="f-894">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="f-895">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-896">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" format="ixt:fixed-zero" scale="6" id="f-897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-898">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="f-899">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeCollateralRightToReclaimCash" format="ixt:fixed-zero" scale="6" id="f-900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" format="ixt:fixed-zero" scale="6" id="f-901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-902">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="f-903">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-904">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="f-905">12.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeCollateralObligationToReturnCash" format="ixt:fixed-zero" scale="6" id="f-906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="f-907">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-908">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:DerivativeAssetFairValueGrossLiability" format="ixt:fixed-zero" scale="6" id="f-909">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:DerivativeAssets" scale="6" id="f-910">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" format="ixt:fixed-zero" scale="6" id="f-911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:DerivativeCollateralObligationToReturnCash" format="ixt:fixed-zero" scale="6" id="f-912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="f-913">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="f-914">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" format="ixt:fixed-zero" scale="6" id="f-915">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="f-916">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="f-917">12.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeCollateralRightToReclaimCash" format="ixt:fixed-zero" scale="6" id="f-918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="f-919">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="f-920" continuedAt="f-920-1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-921">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-922">55.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-923">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-924">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-925">60.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-926">138.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-927">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="f-928">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.891%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from <br/>Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-929">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-930">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="f-931">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="f-932">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-862-4" continuedAt="f-862-5"><div style="text-align:center"><ix:continuation id="f-920-1" continuedAt="f-920-2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.998%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from<br/>&#160;Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-933">5.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-934">40.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="f-935">5.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="f-936">5.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cross currency swap contracts have an expiration date of June 15, 2028.  At maturity of the cross currency swap contracts, the Company will deliver the notional amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="c-232" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-937">257.2</ix:nonFraction> million and will receive $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-938">300.0</ix:nonFraction> million from the counterparties.  The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><ix:continuation id="f-920-2"><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-939">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-940">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-941">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-942">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-943">14.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-944">24.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-945">19.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="f-946">66.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-862-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-947" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-948">350.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-949">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-950">1,022.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-951">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" format="ixt:fixed-zero" scale="6" id="f-952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-953">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" format="ixt:fixed-zero" scale="6" id="f-954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-955">12.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="6" id="f-956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-957">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="6" id="f-958">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-959">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="f-960">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="f-961">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="f-962">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="f-963">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-964">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="f-965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-966">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="f-967">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-968">253.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-969">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-970">822.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-971">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" format="ixt:fixed-zero" scale="6" id="f-972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-973">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" format="ixt:fixed-zero" scale="6" id="f-974">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="f-975">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="6" id="f-976">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-977">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" format="ixt:fixed-zero" scale="6" id="f-978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" scale="6" id="f-979">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="f-980">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="f-981">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" format="ixt:fixed-zero" scale="6" id="f-982">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="f-983">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-984">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="f-985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="f-986">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="6" id="f-987">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during the next twelve months it will reclassify to earnings a $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="f-988">5.5</ix:nonFraction> million gain currently recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-989" continuedAt="f-989-1" escape="true">STOCK-BASED COMPENSATION  </ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-989-1" continuedAt="f-989-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-990" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2023 and 2022 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-991">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-992">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-993">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-994">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-995">19.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-996">18.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-997">63.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-998">57.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-999">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1000">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1001">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1002">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1003">32.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1004">30.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1005">108.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1006">98.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1007">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1008">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1009">17.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1010">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1011">26.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1012">25.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1013">91.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="f-1014">83.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2023, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1015">254.5</ix:nonFraction> million, which will be amortized on a straight-line basis over each award's requisite service period.  The weighted-average remaining requisite service period is <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durmonth" id="f-1016">33</ix:nonNumeric> months.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023, the Company granted <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="6" id="f-1017">2.0</ix:nonFraction> million stock options at a weighted-average</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1018">88.45</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="c-269" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1019">1.0</ix:nonFraction> million restricted stock units at a weighted-average grant-date fair value per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-269" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1020">87.36</ix:nonFraction>. During the nine months ended September 30, 2023, the Company also granted <ix:nonFraction unitRef="shares" contextRef="c-270" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1021">0.1</ix:nonFraction> million market-based restricted stock units at a weighted-average grant-date fair value per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-270" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1022">110.10</ix:nonFraction>.  The market-based restricted stock units granted during the nine months ended September 30, 2023 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a <ix:nonNumeric contextRef="c-1" name="ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" format="ixt-sec:durwordsen" id="f-1023">three-year</ix:nonNumeric> performance period and may range from <ix:nonFraction unitRef="number" contextRef="c-271" decimals="INF" name="ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" scale="-2" id="f-1024">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-272" decimals="INF" name="ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" scale="-2" id="f-1025">175</ix:nonFraction>% of the target number of shares granted.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Disclosures</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements.  The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the nine months ended September 30, 2023 and 2022 included a risk-free interest rate of <ix:nonFraction unitRef="number" contextRef="c-270" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1026">3.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-273" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1027">2.9</ix:nonFraction>%, respectively, and an expected volatility rate of <ix:nonFraction unitRef="number" contextRef="c-270" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1028">32.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-273" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1029">33.9</ix:nonFraction>%, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-1030" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1031">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1032">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-276" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1033">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1034">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1035">None</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1036">None</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-276" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1037">None</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1038">None</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1039">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1040">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-276" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1041">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1042">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-274" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1043">5.2</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-275" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1044">4.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-276" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1045">5.1</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-277" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1046">5.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-274" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1047">31.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-275" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1048">32.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-276" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1049">31.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-277" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1050">34.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-989-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="f-1051" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-278" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1052">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1053">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-280" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1054">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-281" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1055">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-278" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1056">None</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1057">None</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-280" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1058">None</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-281" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1059">None</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-278" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1060">34.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1061">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-280" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1062">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-281" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1063">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-278" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1064">0.6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-279" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1065">0.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-280" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1066">0.6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-281" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1067">0.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-278" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1068">18.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-279" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1069">21.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-280" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1070">19.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1071">28.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_64"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-1072" continuedAt="f-1072-1" escape="true">ACCELERATED SHARE REPURCHASE</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-1072-1"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023 and 2022, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreement, less a discount.  <ix:nonNumeric contextRef="c-1" name="us-gaap:AcceleratedShareRepurchasesTextBlock" id="f-1073" continuedAt="f-1073-1" escape="true">The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="f-1073-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-1074">250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1075">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-283" decimals="2" name="us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare" scale="0" id="f-1076">104.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-283" decimals="2" name="ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" scale="-2" id="f-1077">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1078">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-284" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="f-1079">110.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-1080">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-286" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1081">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-286" decimals="2" name="us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare" scale="0" id="f-1082">80.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-286" decimals="2" name="ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" scale="-2" id="f-1083">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-287" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1084">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-287" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="f-1085">79.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreements were each accounted for as two separate transactions: (1)&#160;the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2)&#160;the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and subsequently, upon settlement, was transferred to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_67"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1086" continuedAt="f-1086-1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-1086-1" continuedAt="f-1086-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act ("FCPA").  The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company&#8217;s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> product infringes certain of its patents.  The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued.  The Company intends to vigorously defend itself in this litigation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1086-2">operations or cash flows. However, the resolution of <ix:nonFraction unitRef="lawsuit" contextRef="c-1" decimals="INF" name="ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" format="ixt-sec:numwordsen" scale="0" id="f-1087">one</ix:nonFraction> or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-1088" continuedAt="f-1088-1" escape="true">ACCUMULATED OTHER COMPREHENSIVE LOSS</ix:nonNumeric></span></div><div style="text-indent:18pt"><span><br/></span></div><ix:continuation id="f-1088-1" continuedAt="f-1088-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-1089" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credits</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1090">218.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1091">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1092">65.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1093">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1094">254.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1095">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1096">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1097">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1098">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1099">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1100">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1101">29.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1102">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1104">27.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1105">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1106">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1109">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1110">215.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1111">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1112">52.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1113">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1114">255.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1115">11.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1116">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1117">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1118">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1119">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1120">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1121">25.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1122">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1124">23.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1125">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1126">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1129">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1130">226.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1131">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1132">46.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1133">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1134">255.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1135">20.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1136">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1137">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1139">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1140">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1141">14.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1142">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1143">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1144">14.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1145">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1146">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1148">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1149">7.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1150">249.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1151">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1152">36.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1153">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1154">250.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1155">172.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1156">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1157">6.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1158">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1159">157.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1160">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1161">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1162">47.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1164">30.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1165">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1166">7.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1167">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1169">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1170">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1171">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1172">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1174">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1175">182.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1176">43.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1177">39.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1178">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1179">186.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1180">36.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1181">57.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1182">20.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1183">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1184">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1185">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1186">16.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1187">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1188">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1189">13.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1190">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1191">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1192">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1193">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1194">25.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1195">225.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1196">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-334" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1197">65.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1198">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1199">224.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1200">35.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1201">59.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1202">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1203">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="f-1204">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1205">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1206">31.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1207">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-1208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="6" id="f-1209">28.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1210">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-337" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1211">7.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-338" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="6" id="f-1212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1213">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="6" id="f-1214">11.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1215">267.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-1216">95.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1217">75.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1218">8.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-1219">256.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-1088-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="f-1220" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.387%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1221">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1222">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1223">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1224">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1225">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1226">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1227">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1228">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-344" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1229">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1230">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1231">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1232">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on hedges</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1233">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1234">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1235">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-1236">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1237">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1238">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1239">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1240">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1241">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1242">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1243">69.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1244">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1245">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1246">7.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1247">14.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1248">13.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-348" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1249">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1250">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-350" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1251">54.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1252">41.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-1253">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-1254">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-1255">9.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="f-1256">14.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1257">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1258">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1259">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1260">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1261">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1262">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1263">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1264">11.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_73"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1265" continuedAt="f-1265-1" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-1265-1" continuedAt="f-1265-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. </span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1266" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1267">384.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-1268">343.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="f-1269">1,032.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="f-1270">1,123.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1271">607.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1272">619.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1273">607.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1274">621.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1275">0.63</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1276">0.55</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1277">1.70</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1278">1.81</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="f-1279">384.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="f-1280">343.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="f-1281">1,032.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="f-1282">1,123.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1283">607.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1284">619.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1285">607.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-1286">621.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-1287">2.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-1288">4.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-1289">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-1290">5.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1291">609.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1292">624.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1293">610.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-1294">626.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1295">0.63</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1296">0.55</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1297">1.69</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1298">1.79</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1265-2">Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-356" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1299">6.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-357" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1300">4.0</ix:nonFraction> million common shares for the three months ended September 30, 2023 and 2022, respectively, and <ix:nonFraction unitRef="shares" contextRef="c-358" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1301">6.1</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-359" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1302">3.1</ix:nonFraction>&#160;million shares for the nine months ended September 30, 2023 and 2022, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.</ix:continuation> </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1303" continuedAt="f-1303-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:continuation id="f-1303-1" continuedAt="f-1303-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective income tax rates were <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1304">12.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1305">15.7</ix:nonFraction>% for the three months ended September 30, 2023 and 2022, respectively, and <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1306">12.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1307">14.1</ix:nonFraction>% for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022, respectively.  The decrease in the effective rate between the nine months ended September 30, 2023 and 2022 is primarily due </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the impact of temporary relief provided by the Internal Revenue Service ("IRS") relating to U.S. foreign tax credit regulations.  On July 21, 2023, the IRS issued Notice 2023-55 which delayed the application of certain U.S. foreign tax credit regulations that had previously limited the Company's ability to claim credits on certain foreign taxes for tax years 2022 and 2023.  In addition, there was an increase in the benefit from the federal research and development credit and the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation.   The effective rates for the nine months ended September 30, 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective rates include a tax benefit from employee share-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compensation of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-1308">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-1309">3.4</ix:nonFraction> million for the three months ended September 30, 2023 and 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-1310">14.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-1311">36.7</ix:nonFraction> million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2022, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the IRS and other taxing authorities are in different stages of examining various years of the Company's tax filings.  During these audits the Company may receive proposed audit adjustments that could be material.  Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition.  The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time.  While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements.  Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the gross liability recorded for income taxes associated with uncertain tax positions was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="f-1312">542.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="f-1313">475.3</ix:nonFraction> million, respectively. The Company estimates that these liabilities would be reduced by $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="f-1314">226.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="f-1315">182.1</ix:nonFraction> million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1316">316.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1317">293.2</ix:nonFraction> million, respectively, if not required, would favorably affect the Company's effective tax rate.   </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.  The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively &#8220;Surgical/TAVR&#8221;) intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits.  In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all <ix:nonFraction unitRef="agreement" contextRef="c-360" decimals="INF" name="ew:NumberOfAdvancePricingAgreementsRenewed" format="ixt-sec:numwordsen" scale="0" id="f-1318">three</ix:nonFraction> of the APAs with Japan for the years 2020 and forward.  An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021.  The execution of some or all of these APA renewals depends on many variables outside of the Company's control. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company&#8217;s United States federal income tax returns through 2014 have been closed.  The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters.  The IRS began its examination of the 2018 through 2020 tax years during the first quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015.  While not material, the Company continues to address matters in India for years from 2010 and on. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company received a Notice of Proposed Adjustment (&#8220;NOPA&#8221;) from the IRS for the 2015-2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries.  The NOPA proposed an increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $<ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-6" name="us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="f-1319">220</ix:nonFraction> million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS.  The Company disagreed with the NOPA and submitted a formal protest on the matter during the fourth quarter of 2021.  During the second quarter of 2022, the Company received the IRS's rebuttal to the Company's protest and was notified that the case had been transferred to the IRS Independent Office of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><ix:continuation id="f-1303-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Appeals ("Appeals").  The opening conference was held with Appeals during March 2023 and discussions with Appeals continued into the third quarter of 2023.  While Appeals still maintains jurisdiction over the matter as of September&#160;30, 2023, the Company and Appeals have concluded that a satisfactory resolution of this matter at the administrative level is not possible.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company plans to vigorously contest the proposed adjustments through the judicial process.  Final resolution of this matter is not likely within the next 12 months.  The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOPA received or as a result of the Appeals proceedings to date.  Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements.  As noted below, similar material tax disputes may arise for the 2018-2023 tax years. While no payment of any amount related to the NOPA has yet been required, the Company made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any potential deficiency that may be ultimately sustained.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018-2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of September&#160;30, 2023.  The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions.  The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company&#8217;s consolidated financial statements.  Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_79"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;  <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1320" continuedAt="f-1320-1" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><ix:continuation id="f-1320-1" continuedAt="f-1320-2"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:18pt"><span><br/></span></div><ix:continuation id="f-1320-2" continuedAt="f-1320-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1321" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1322">869.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1323">786.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1324">2,614.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1325">2,337.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1326">317.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1327">291.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1328">989.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1329">901.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1330">107.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1331">130.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1332">321.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1333">416.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1334">181.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1335">160.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1336">529.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1337">449.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1338">1,476.1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1339">1,370.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1340">4,453.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1341">4,104.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1342">571.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1343">535.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1344">1,727.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1345">1,596.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1346">168.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1347">156.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1348">527.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1349">487.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1350">63.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1351">87.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1352">190.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1353">282.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1354">80.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1355">63.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1356">230.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1357">178.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1358">884.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-1359">842.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1360">2,677.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-1361">2,543.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1362">1,476.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1363">1,370.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1364">4,453.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1365">4,104.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1366">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1367">51.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1368">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1369">70.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1370">1,480.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1371">1,319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1372">4,470.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1373">4,034.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1374">884.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1375">842.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1376">2,677.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1377">2,543.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="f-1378">473.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-5" name="us-gaap:CostsAndExpenses" scale="6" id="f-1379">415.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-5" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="f-1380">1,435.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-5" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="f-1381">1,285.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charge (Note&#160;4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-1382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="f-1383">66.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-1384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="f-1385">66.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and litigation (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-1386">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-5" sign="-" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-1387">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-1388">193.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" name="us-gaap:LitigationSettlementExpense" scale="6" id="f-1389">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="6" id="f-1390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-1391">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-1392">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="f-1393">36.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-1394">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-1395">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-1396">59.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="f-1397">83.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1398">418.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1399">402.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1400">1,134.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-1401">1,300.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1402">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1403">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1404">42.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-1405">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1406">439.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1407">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1408">1,176.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-1409">1,308.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="f-1320-3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enterprise-wide Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="f-1410" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1411">869.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1412">786.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1413">2,614.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1414">2,337.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1415">322.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1416">270.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1417">989.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1418">884.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1419">108.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1420">104.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1421">340.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1422">362.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1423">180.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1424">158.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1425">526.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1426">450.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1427">1,480.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1428">1,319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1429">4,470.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1430">4,034.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1431">960.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1432">862.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1433">2,900.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1434">2,650.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1435">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1436">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1437">141.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1438">84.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1439">246.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1440">219.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1441">751.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1442">669.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1443">221.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1444">207.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1445">677.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1446">630.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1447">1,480.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1448">1,319.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1449">4,470.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1450">4,034.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis contains forward-looking statements within the meaning of the federal securities laws, and should be read in conjunction with the disclosures we make concerning risks and other factors that may affect our business and operating results. See &#8220;Note Regarding Forward-Looking Statements&#8221; preceding Part I, Item 1 in this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care.  We conduct operations worldwide and are managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Our products are categorized into the following groups: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Highlights and Market Update</span></div><div><img src="ew-20230930_g1.jpg" alt="1201" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:342px"/><img src="ew-20230930_g2.jpg" alt="1202" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:341px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">COVID-19 and Macroeconomic Uncertainties</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While conditions related to the COVID-19 pandemic have improved compared to 2022, we have continued to experience the impacts of the COVID-19 pandemic in 2023, particularly in Japan and disruptions related to staffing shortages in the United States and Europe.  The COVID-19 pandemic adversely impacted, and may further adversely impact, aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. Our priority has been to maintain access for patients to our life-saving technologies while providing continuous front-line support to our clinician partners, and protecting the well-being of our employees. Our manufacturing operations have continued to respond to impacts related to COVID-19, and we have been able to supply our technologies around the world. Across our organization, we are proactively managing inventory, assessing alternative logistics options, and closely monitoring the supply of components to address potential supply constraints. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the impacts described above, the global economy, including the financial and credit markets, continues to experience extreme volatility and disruptions, including inflationary conditions, rising interest rates, declines in consumer confidence, and uncertainty about economic growth and stability. The severity and duration of the impact of these conditions on our business cannot be predicted.  See Item 1A, "Risk Factors," of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022 for additional information.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial Highlights</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the challenges to our business due to COVID-19 and macroeconomic factors, our net sales for the first nine months of 2023 were $4.5 billion, representing an increase of $436.6 million over the first nine months of 2022, driven primarily by sales of our TAVR products. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit increased in the nine months ended September 30, 2023, driven by our sales growth.  Gross profit as a percentage of sales decreased primarily due to the impact of foreign currency exchange rate fluctuations.  The decrease in our diluted earnings per share in the nine months ended September 30, 2023 was driven by an after-tax charge of $138.7 million related to an intellectual property agreement.  See Note 3 to the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for further information.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Healthcare Environment, Opportunities, and Challenges</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The medical technology industry is highly competitive and continues to evolve. Our success is measured both by the development of innovative products and the value we bring to our stakeholders. We are committed to developing new technologies and providing innovative patient care, and we are committed to defending our intellectual property in support of those developments.  In the first nine months of 2023, we invested 17.9% of our net sales in research and development. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We are dedicated to generating robust clinical, economic, and quality-of-life evidence increasingly expected by patients, clinicians, and payors in the current healthcare environment, with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes.  </span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_88"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on new accounting standards is included in Note 1 to the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales by Region</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.661%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,856.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,470.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales outside of the United States include the impact of foreign currency exchange rate fluctuations.  The impact of foreign currency exchange rate fluctuations on net sales is not necessarily indicative of the impact on net income due to the corresponding effect of foreign currency exchange rate fluctuations on international manufacturing and operating costs, and our hedging activities. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Sales by Product Group</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars in millions)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.661%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,470.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transcatheter Aortic Valve Replacement Sales</span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><img src="ew-20230930_g3.jpg" alt="566" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:469px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of TAVR products increased for the three and nine months ended September 30, 2023 driven by:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.65pt">higher sales of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edwards SAPIEN </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">platform in 2023, primarily the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edwards SAPIEN 3 Ultra RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> valve in the United States; </span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">foreign currency exchange rate fluctuations, which increased net sales outside of the United States by $11.4 million for the three months ended September 30, 2023, primarily due to the strengthening of the Euro against the United States dollar, and decreased net sales outside of the United States by $17.1 million for the nine months ended September 30, 2023, primarily due the weakening of the Japanese yen against the United States dollar.</span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2023, we continued to enroll our PROGRESS pivotal trial, studying moderate aortic stenosis patients.  In March 2023, we launched the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edwards SAPIEN 3 Ultra RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> valve in Japan.  In July 2023, we announced the restart of enrollment in our pivotal trial, ALLIANCE, designed to study our next generation TAVR technology, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SAPIEN X4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transcatheter Mitral and Tricuspid Therapies Sales</span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><img src="ew-20230930_g4.jpg" alt="1477" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:469px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of TMTT products increased for the three and nine months ended September 30, 2023 primarily due to the  launch of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">system in the United States and its continued adoption in Europe.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2023, we continued to enroll the CLASP IIF pivotal trial with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for patients with functional mitral regurgitation.  In mitral replacement, we completed enrollment in the ENCIRCLE pivotal trial for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SAPIEN M3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In tricuspid, we completed the enrollment of the full cohort of the TRISCEND II pivotal trial of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EVOQUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> replacement system.  In the United States, in December 2022, the Food and Drug Administration approved continued access allowing hospitals that were involved in the clinical trial to continue to have </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EVOQUE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a therapy option.  In October 2023, we received CE Mark approval in Europe for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EVOQUE </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and we received approval in Japan for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL Precision </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to treat patients with degenerative mitral regurgitation.  In addition, enrollment continued in the CLASP IITR pivotal trial with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> repair system in patients with symptomatic, severe tricuspid regurgitation.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Surgical Structural Heart Sales</span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><img src="ew-20230930_g5.jpg" alt="2408" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:469px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of Surgical products increased for the three and nine months ended September 30, 2023 primarily due to increased sales of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> INSPIRIS RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aortic valve in the United States and Europe, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MITRIS RESILIA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valve in the United States.  These increases were partially offset by the impact of foreign currency exchange rate fluctuations, which increased net sales outside of the United States by $2.4 million for the three months ended September 30, 2023, primarily due to the strengthening of the Euro against the United States dollar, and decreased net sales outside of the United States by $8.1 million for the nine months ended September 30, 2023, primarily due to the weakening of the Japanese yen against the United States dollar.  </span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to enroll patients in our MOMENTIS clinical study to demonstrate the durability of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tissue in the mitral position.  In October 2023, we received CE Mark approval for our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MITRIS RESILIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mitral valve.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:13.5pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Care Sales</span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><img src="ew-20230930_g6.jpg" alt="3158" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:469px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales of Critical Care products increased for the three and nine months ended September 30, 2023 primarily due to:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">increased demand for our enhanced surgical recovery products and pressure monitoring products, primarily in the United States; </span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:13.5pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">foreign currency exchange rate fluctuations, which increased net sales outside of the United States by $0.5 million for the three months ended September 30, 2023, primarily due to the strengthening of the Euro against the United States dollar, and decreased net sales outside of the United States by $10.8 million for the nine months ended September 30, 2023, primarily due to the weakening of the Japanese yen against the United States dollar.</span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="text-indent:18pt"><img src="ew-20230930_g7.jpg" alt="3616" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:506px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross profit as a percentage of net sales for the three and nine months ended September 30, 2023 was driven by a 4.1 percentage point and 2.3 percentage point decrease, respectively, from the impact of foreign currency exchange rate fluctuations, primarily the weakening of the United States dollar against the Euro.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General, and Administrative ("SG&amp;A") Expenses</span></div><div style="text-indent:18pt"><img src="ew-20230930_g8.jpg" alt="3967" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:506px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses increased for the three and nine months ended September 30, 2023 primarily due to higher performance-based compensation and higher field-based personnel-related costs, primarily TAVR and TMTT in the United States. Foreign currency exchange rate fluctuations increased expenses by $5.3 million in the three months ended September 30, 2023 due to the weakening of the United States dollar against the Euro, and decreased expenses by $4.6 million for the nine months ended September 30, 2023 due to the strengthening of the United States dollar against multiple foreign currencies, primarily the Japanese yen.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development ("R&amp;D") Expenses</span></div><div style="text-indent:18pt"><img src="ew-20230930_g9.jpg" alt="4409" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:506px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses increased for the three and nine months ended September 30, 2023 primarily due to continued investments in our transcatheter aortic valve innovations, including increased clinical trial activity. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Agreement and Litigation Expense (Income), net</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred intellectual property agreement and litigation expenses of $2.2 million and income of $2.4 million during the three months ended September 30, 2023 and 2022, respectively, and expenses of $193.6 million and $10.8 million during the nine months ended September 30, 2023 and 2022, respectively. On April 12, 2023, we entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") and recorded a $37.0 million charge in March 2023 and a $139.0 million charge in April 2023.  For more information, see Note 3 to the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Fair Value of Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in fair value of contingent consideration liabilities resulted in gains of $26.2 million and $36.3 million during the nine months ended September 30, 2023 and 2022.  The gains in 2023 were primarily due to changes in projected probabilities of milestone achievement.  The gains in 2022 were due to changes in projected probabilities of milestone achievement and our decision in the third quarter of 2022 to exit our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HARPOON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> surgical mitral repair system program.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special Charge</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, we decided to exit our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HARPOON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> surgical mitral repair system program. As a result, we recorded a</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charge of $68.4 million, of which $66.8 million was included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Special Charge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and $1.6 million was included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed statements of operations. The charge primarily related to the full impairment of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intangible assets associated with the technology and other related exit costs. We believe that no additional contingent</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consideration is due and, in September 2022, recorded an $11.7 million contingent consideration gain associated with the exit.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of provisions for federal, state, and foreign income taxes. We operate in an international environment with significant operations in various locations outside the United States which have statutory tax rates typically lower than the United States tax rate. Accordingly, the consolidated income tax rate is a composite rate reflecting the earnings in the various locations and the applicable rates. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was 12.7% and 15.7% for the three months ended September 30, 2023 and 2022, respectively, and 12.5% and 14.1% for the nine months ended September 30, 2023 and 2022, respectively.  The decrease in the effective rate between the nine months ended September 30, 2023 and 2022 is primarily due to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the impact of temporary relief provided by the Internal Revenue Service ("IRS") relating to U.S. foreign tax credit regulations.  On July 21, 2023, the IRS </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued Notice 2023-55 which delayed the application of certain U.S. foreign tax credit regulations that had previously limited our ability to claim credits on certain foreign taxes for tax years 2022 and 2023.  In addition, there is an increase in the benefit from the Federal research and development credit and the Intellectual Property Agreement with Medtronic (see Note 3 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a reduced tax benefit from employee share-based compensation.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The effective rates for the nine months ended September 30, 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the IRS and other taxing authorities are in different stages of examining various years of our tax filings.  During these audits we may receive proposed audit adjustments that could be material.  Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on our results of operations and financial condition.  We strive to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time.  While we have accrued for matters we believe are more likely than not to require settlement, the eventual outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements.  Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.  The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, we executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. We have filed to renew all three of the APAs with Japan for the years 2020 and forward.  An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021.  The execution of some or all these APA renewals depends on many variables outside of our control. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audits of our United States federal income tax returns through 2014 have been closed.  The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters.  The IRS began its examination of the 2018 through 2020 tax years during the first quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audits of our material state, local, and foreign income tax matters have been concluded for years through 2015.  While not material, we continue to address matters in India for years from 2010 and on.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we received a Notice of Proposed Adjustment (&#8220;NOPA&#8221;) from the IRS for the 2015-2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between our United States and Switzerland subsidiaries.  The NOPA proposed an increase to our United States taxable income, which could result in additional tax expense for this period of approximately $220 million and reflects a departure from a transfer pricing method we had previously agreed upon with the IRS.  We have disagreed with the NOPA and submitted a formal protest on the matter during the fourth quarter of 2021.  During the second quarter of 2022, we received the IRS's rebuttal to our protest and were notified that the case had been transferred to the IRS Independent Office of Appeals ("Appeals"). The opening conference was held with Appeals during March 2023 and discussions with Appeals continued into the third quarter of 2023.  While Appeals still maintains jurisdiction over the matter as of September&#160;30, 2023, we and Appeals have concluded that a satisfactory resolution of this matter at the administrative level is not possible.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to vigorously contest the proposed adjustments through the judicial process.  Final resolution of this matter is not likely within the next 12 months.  We believe the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to our facts and, accordingly, have not accrued any additional amount based on the NOPA received or as a result of the Appeals proceedings to date.  Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on our consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018-2023 tax years. While no payment of any amount related to the NOPA has yet been required, we made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any potential deficiency that may ultimately be sustained. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018-2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of September&#160;30, 2023.  We have considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in our evaluation of our uncertain tax positions.  The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to our consolidated financial statements.  Based on the information currently available and numerous possible outcomes, we cannot reasonably estimate what, if any, changes in our existing uncertain tax positions may occur in the next 12 months and, therefore, have continued to record the uncertain tax positions as a long-term liability.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 16, 2022, the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;) was signed into law.  The IRA includes, among other provisions, changes to the U.S. corporate income tax system, including a 15% minimum tax based on &#8220;adjusted financial statement income,&#8221; which is effective for tax years beginning after December 31, 2022, and a one percent excise tax on net repurchases of stock after December 31, 2022.  Based upon our analysis to date, we do not expect the IRA will have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sources of cash liquidity include cash and cash equivalents, short-term investments, cash from operations, and amounts available under credit facilities. We believe that these sources are sufficient to fund the current and long-term requirements of working capital, capital expenditures, and other financial commitments. However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023, cash and cash equivalents and short-term investments held in the United States and outside of the United States were $1.3 billion and $523.9 million, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a Five-year Credit Agreement (the "Credit Agreement") which provides for a $750.0 million multi-currency unsecured revolving credit facility and matures on July 15, 2027.  We may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate and extend the maturity date for an additional year, subject to agreement of the lenders.  As of September&#160;30, 2023, no amounts were outstanding under the Credit Agreement.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we issued $600.0 million of 4.3% fixed-rate unsecured senior notes (the "2018 Notes") due June 15, 2028.  As of September&#160;30, 2023, the carrying value of the 2018 Notes was $596.8 million. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we repurchase shares of our common stock under share repurchase programs authorized by the Board of Directors.  We consider several factors in determining when to execute share repurchases, including, among other things, expected dilution from stock plans, cash capacity, and the market price of our common stock. During the nine months ended September 30, 2023, under the Board authorized repurchase program, we repurchased a total of 5.4 million shares at an aggregate cost of $422.8 million. See Part II, Item 2, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Unregistered Sales of Equity Securities and Use of Proceeds,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; for additional information about our share repurchase program.  As of September&#160;30, 2023, we had remaining authority to purchase $492.8 million of our common stock under the share repurchase program.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 12, 2023, we entered into the Intellectual Property Agreement with Medtronic pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS, we paid Medtronic a one-time, lump sum payment of $300.0&#160;million and will pay annual royalty payments that are tied to net sales of certain Edwards products.   For more information, see Note 3 to the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">."</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 28, 2023, we acquired a majority equity interest in a medical technology company.  In addition, we amended and restated our previous option agreement with the medical technology company.  The option agreement gives us the option to acquire the remaining equity interest in the medical technology company.  For more information, see Note 7 to the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">."</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2023, there had been no material changes in our cash requirements from known contractual and other obligations, including commitments for capital expenditures, as disclosed in Item 7, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Cash Flows - For the nine months ended September 30, 2023 and 2022: </span></div><div style="margin-bottom:8pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><img src="ew-20230930_g10.jpg" alt="3362" style="height:200px;margin-bottom:5pt;vertical-align:text-bottom;width:213px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><img src="ew-20230930_g11.jpg" alt="3366" style="height:200px;margin-bottom:5pt;vertical-align:text-bottom;width:213px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><img src="ew-20230930_g12.jpg" alt="3369" style="height:200px;margin-bottom:5pt;vertical-align:text-bottom;width:213px"/></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash flows provided by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">operating activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $759.2 million for the nine months ended September 30, 2023 decreased $176.2 million&#160;over the same period last year primarily due to a $300.0 million payment in 2023 under the Intellectual Property Agreement, partially offset by a higher bonus payout in 2022 associated with 2021 performance.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">investing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $159.7 million for the nine months ended September 30, 2023 consisted primarily of net proceeds from investments of $541.1 million, partially offset by a payment of $141.2 million to acquire a majority interest in another company (see Note 7 to the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">") and capital expenditures of $164.7 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities of $157.6 million for the nine months ended September 30, 2022 consisted primarily of net proceeds from investments of $474.7 million, partially offset by capital expenditures of $175.7 million and payments of 107.6 million for options to acquire other companies.  For further information, see Note 6 to the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $297.8 million for the nine months ended September 30, 2023 consisted primarily of purchases of treasury stock of $431.2 million, partially offset by proceeds from stock plans of $136.7 million. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities of $746.1 million for the nine months ended September 30, 2022 consisted primarily of purchases of treasury stock of $861.1 million, partially offset by proceeds from stock plans of $118.9 million.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated condensed financial statements and sales and expenses during the periods reported. Actual results could differ from those estimates. Information with respect to our critical accounting policies and estimates which we believe could have the most significant effect on our reported results and require subjective or complex judgments by management is contained on pages&#160;34-36 in Item&#160;7, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022. There have been no significant changes from the information discussed therein.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk, Foreign Currency Risk, Credit Risk, and Concentrations of Risk</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a complete discussion of our exposure to interest rate risk, foreign currency risk, credit risk, and concentrations of risk, refer to Item&#160;7A "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022. There have been no material changes from the information discussed therein.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Risk</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to investment risks related to changes in the underlying financial condition and credit capacity of certain of our investments.  As of September&#160;30, 2023, we had $1.0 billion&#160;of investments in debt securities, of which $0.6 billion were long-term. In addition, we had $109.8 million of investments in equity instruments of public and private companies.  Should these companies experience a decline in financial performance, financial condition or credit capacity, or fail to meet certain development milestones, a decline in the investments' value may occur, resulting in unrealized or realized losses.  See Note 5 to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Consolidated Condensed Financial Statements"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-indent:18pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our management, including the Chief Executive Officer and the Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of September&#160;30, 2023. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded as of September&#160;30, 2023 that our disclosure controls and procedures are designed at a reasonable assurance level and effective in providing reasonable assurance that the information we are required to disclose in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  There have been no changes in our internal control over financial reporting during the quarter ended September&#160;30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part&#160;II. Other Information</span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_109"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2021, we initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act ("FCPA").  We voluntarily notified the United States Securities and Exchange Commission ("SEC") and the United States Department of Justice ("DOJ") during 2021 that we engaged outside counsel to conduct this review and investigation.   We have provided status updates to the SEC and DOJ since that time.  Any determination that our operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. We cannot currently predict the final outcome of the investigation or any potential impact on our financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (&#8220;Edwards&#8221;) in the United States District Court for the District of Delaware alleging that Edwards&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> product infringes certain of its patents.  We are unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amount has been accrued. We intend to vigorously defend ourselves in this litigation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to various environmental laws and regulations both within and outside of the United States. Our operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on our financial results. Our threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million.  </span></div><div><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_112"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of the risk factors associated with our business is contained in the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; section of our&#160;Annual Report on Form 10-K for our fiscal year ended&#160;December 31, 2022.&#160; There have been no material changes to our risk factors as previously reported.</span></div><div><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_115"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Purchases of Equity Securities</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.828%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total&#160;Number<br/>&#160;of Shares&#160;<br/>(or Units)&#160;<br/>Purchased (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average<br/>Price&#160;Paid<br/>per&#160;Share<br/>(or&#160;Unit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of&#160;<br/>Shares (or Units)&#160;<br/>Purchased as&#160;Part&#160;of&#160;Publicly Announced&#160;Plans or&#160;Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate&#160;<br/>Dollar Value&#160;of&#160;<br/>Shares&#160;that<br/>May&#160;Yet&#160;Be&#160;<br/>Purchased<br/>Under&#160;the&#160;Plans<br/>or Programs <br/>(in millions) (b)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2023 through July 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2023 through August 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2023 through September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,190,978&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The difference between the total number of shares (or units) purchased and the total number of shares (or units) purchased as part of publicly announced plans or programs is due to shares withheld by us to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In July 2022, the Board of Directors approved a stock repurchase program providing for up to $1.5 billion of repurchases of our common stock, effective July 28, 2022.  Repurchases under the program may be made on the open market, including pursuant to a Rule 10b5-1 plan, and in privately negotiated transactions.  The repurchase program does not have an expiration date.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;Other Information</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rule 10b5-1 <ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1451"><ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1452"><ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1453">Trading Plans</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-422" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1454" escape="true">On <ix:nonNumeric contextRef="c-423" name="ecd:TrdArrAdoptionDate" id="f-1455">August 31, 2023</ix:nonNumeric>, <ix:nonNumeric contextRef="c-423" name="ecd:TrdArrIndName" id="f-1456">Jean-Luc Lemercier</ix:nonNumeric>, <ix:nonNumeric contextRef="c-423" name="ecd:TrdArrIndTitle" id="f-1457">Corporate Vice President of EMEA, Canada, Latin America, and JAPAC</ix:nonNumeric>, <ix:nonNumeric contextRef="c-423" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1458">entered into a 10b5-1 trading plan</ix:nonNumeric> (the &#8220;Plan&#8221;) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the potential sale of <ix:nonFraction unitRef="shares" contextRef="c-424" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-1459">43,200</ix:nonFraction> shares of the Company&#8217;s stock commencing March 11, 2024.  The Plan terminates on the earlier of May 10, 2024 or the date all shares are sold.</ix:nonNumeric></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_124"></div><div style="-sec-extract:summary;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;Exhibits</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in the Exhibit Index below are filed, furnished, or incorporated by reference as part of this report on Form 10-Q.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.494%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1099800/000110465913042912/a13-12753_1ex3d1.htm">Amended and Restated Certificate of Incorporation of Edwards Lifesciences Corporation, dated May&#160;16, 2013 (incorporated by reference to Exhibit&#160;3.1 in Edwards Lifesciences' report on Form&#160;8-K filed on May&#160;17, 2013)</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1099800/000119312520137597/d923809dex31.htm">Certificate of Amendment of Amended and Restated Certificate of Incorporation of Edwards Lifesciences Corporation, dated May 7, 2020 (incorporated by reference to Exhibit 3.1 in Edwards Lifesciences&#8217; report on Form 8-K filed on May 8, 2020)</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1099800/000119312523144564/d427364dex31.htm">Certificate of Amendment of Amended and Restated Certificate of Incorporation of Edwards Lifesciences Corporation, dated May 11, 2023 (incorporated by reference to Exhibit 3.1 in Edwards Lifesciences' report on Form 8-K filed on May 15, 2023)</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1099800/000119312523043538/d452156dex31.htm">Bylaws of Edwards Lifesciences Corporation, as amended and restated as of February 16, 2023 (incorporated by reference to Exhibit 3.1 in Edwards Lifesciences' report on Form 8-K filed on February 21, 2023)</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31110xqq32023.htm">Certification Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31110xqq32023.htm">2002</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31210xqq32023.htm">Certification Pursuant to Section&#160;302 of the Sarbanes-Oxley </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31210xqq32023.htm">Act of 2002</a></span></div></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-3210xqq32023.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Inline Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ia0551ad7b75a442cb2396ea8bed8f718_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EDWARDS LIFESCIENCES CORPORATION</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;SCOTT B. ULLEM</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott B. Ullem</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer; Duly Authorized Officer)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;ROBERT W.A. SELLERS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert W.A. Sellers</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Corporate Controller</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex-31110xqq32023.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifc91573b19d24802b1e5fa28e08c0eea_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF&#160;2002</font></div><div><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Bernard J. Zovighian, certify that&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;I have reviewed this quarterly report on Form&#160;10-Q of Edwards Lifesciences Corporation&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;&#160;&#160;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;BERNARD J. ZOVIGHIAN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernard J. Zovighian</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex-31210xqq32023.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i84e2c0d2780642d482c3a3afba2b124e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF&#160;2002</font></div><div><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:8pt;margin-top:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Scott B. Ullem, certify that&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;&#160;I have reviewed this quarterly report on Form&#160;10-Q of Edwards Lifesciences Corporation&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">&#160;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:31.5pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;SCOTT B. ULLEM</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott B. Ullem</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>ex-3210xqq32023.htm
<DESCRIPTION>EX-32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if8a88838e4fb486f893adcbcd34365c6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EDWARDS LIFESCIENCES CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF&#160;2002</font></div><div><font><br></font></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Edwards Lifesciences Corporation (the &#34;Company&#34;) on Form&#160;10-Q for the period ended September&#160;30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), we, Bernard J. Zovighian, Chief Executive Officer of the Company, and Scott B. Ullem, Corporate Vice President, Chief Financial Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:56.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;BERNARD J. ZOVIGHIAN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernard J. Zovighian</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;SCOTT B. ULLEM</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott B. Ullem</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>ew-20230930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:eaa870a0-ed84-4111-a2ce-17bb0f4c4328,g:a046b429-8038-45a1-a20d-74cf9c7f6b8d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ew="http://www.edwards.com/20230930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.edwards.com/20230930">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ew-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ew-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ew-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ew-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVER" roleURI="http://www.edwards.com/role/COVER">
        <link:definition>0000001 - Document - COVER</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDBALANCESHEETS" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATION" roleURI="http://www.edwards.com/role/BASISOFPRESENTATION">
        <link:definition>0000008 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS">
        <link:definition>0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET" roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET">
        <link:definition>0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SPECIALCHARGE" roleURI="http://www.edwards.com/role/SPECIALCHARGE">
        <link:definition>0000011 - Disclosure - SPECIAL CHARGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTS" roleURI="http://www.edwards.com/role/INVESTMENTS">
        <link:definition>0000012 - Disclosure - INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSINVARIABLEINTERESTENTITIES" roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES">
        <link:definition>0000013 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATION" roleURI="http://www.edwards.com/role/BUSINESSCOMBINATION">
        <link:definition>0000014 - Disclosure - BUSINESS COMBINATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000015 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES">
        <link:definition>0000016 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000017 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASE" roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE">
        <link:definition>0000018 - Disclosure - ACCELERATED SHARE REPURCHASE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000019 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSS" roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS">
        <link:definition>0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.edwards.com/role/EARNINGSPERSHARE">
        <link:definition>0000021 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.edwards.com/role/INCOMETAXES">
        <link:definition>0000022 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.edwards.com/role/SEGMENTINFORMATION">
        <link:definition>0000023 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONPolicies" roleURI="http://www.edwards.com/role/BASISOFPRESENTATIONPolicies">
        <link:definition>9954471 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables">
        <link:definition>9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSTables" roleURI="http://www.edwards.com/role/INVESTMENTSTables">
        <link:definition>9954473 - Disclosure - INVESTMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONTables" roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONTables">
        <link:definition>9954474 - Disclosure - BUSINESS COMBINATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>9954475 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables">
        <link:definition>9954476 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>9954477 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASETables" roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables">
        <link:definition>9954478 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables">
        <link:definition>9954479 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.edwards.com/role/EARNINGSPERSHARETables">
        <link:definition>9954480 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONTables">
        <link:definition>9954481 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails">
        <link:definition>9954482 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails">
        <link:definition>9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails">
        <link:definition>9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>9954485 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails" roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails">
        <link:definition>9954486 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SPECIALCHARGEDetails" roleURI="http://www.edwards.com/role/SPECIALCHARGEDetails">
        <link:definition>9954487 - Disclosure - SPECIAL CHARGE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails">
        <link:definition>9954488 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>9954489 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails">
        <link:definition>9954490 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails">
        <link:definition>9954491 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSNarrativeDetails" roleURI="http://www.edwards.com/role/INVESTMENTSNarrativeDetails">
        <link:definition>9954492 - Disclosure - INVESTMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSINVARIABLEINTERESTENTITIESDetails" roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails">
        <link:definition>9954493 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONNarrativeDetails" roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails">
        <link:definition>9954494 - Disclosure - BUSINESS COMBINATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>9954495 - Disclosure - BUSINESS COMBINATION - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>9954496 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>9954497 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails">
        <link:definition>9954498 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails">
        <link:definition>9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails">
        <link:definition>9954500 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails">
        <link:definition>9954501 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails">
        <link:definition>9954502 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails">
        <link:definition>9954503 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails">
        <link:definition>9954504 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9954505 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>9954506 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails">
        <link:definition>9954507 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCELERATEDSHAREREPURCHASEDetails" roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails">
        <link:definition>9954508 - Disclosure - ACCELERATED SHARE REPURCHASE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>9954509 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails">
        <link:definition>9954510 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails">
        <link:definition>9954511 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" roleURI="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails">
        <link:definition>9954512 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARENarrativeDetails" roleURI="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails">
        <link:definition>9954513 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.edwards.com/role/INCOMETAXESDetails">
        <link:definition>9954514 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails">
        <link:definition>9954515 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails">
        <link:definition>9954516 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails">
        <link:definition>9954517 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ew_CriticalCareMember" abstract="true" name="CriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_TranscatheterAorticValveReplacementMember" abstract="true" name="TranscatheterAorticValveReplacementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_JapanSegmentMember" abstract="true" name="JapanSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" abstract="false" name="EquitySecuritiesFVNIPromissoryNoteOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" abstract="false" name="EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_OptionToAcquireInvestmentAmount" abstract="false" name="OptionToAcquireInvestmentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_ShareInformationAbstract" abstract="true" name="ShareInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ew_RestructuringContingentConsiderationGainLoss" abstract="false" name="RestructuringContingentConsiderationGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" abstract="false" name="AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_ConvertiblePromissoryNoteMember" abstract="true" name="ConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_MedicalDeviceCompanyMember" abstract="true" name="MedicalDeviceCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIOptionToAcquireInvestment" abstract="false" name="EquitySecuritiesFVNIOptionToAcquireInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_TranscatheterMitralAndTricuspidTherapiesMember" abstract="true" name="TranscatheterMitralAndTricuspidTherapiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_RestOfWorldSegmentMember" abstract="true" name="RestOfWorldSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_LoansReceivablesMaximumLendingCapacity" abstract="false" name="LoansReceivablesMaximumLendingCapacity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_NumberOfAdvancePricingAgreementsRenewed" abstract="false" name="NumberOfAdvancePricingAgreementsRenewed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ew_IntellectualPropertyAgreementTerm" abstract="false" name="IntellectualPropertyAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ew_MarketBasedRestrictedStockUnitsMember" abstract="true" name="MarketBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_IncreaseDecreaseInLegalSettlementAccrual" abstract="false" name="IncreaseDecreaseInLegalSettlementAccrual" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" abstract="true" name="DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" abstract="true" name="February2023StockRepurchaseProgramSharesSoldInMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_EmployeeAndNonemployeeStockOptionsMember" abstract="true" name="EmployeeAndNonemployeeStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_MedtronicIncMember" abstract="true" name="MedtronicIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_AccruedAndOtherLiabilitiesCurrentMember" abstract="true" name="AccruedAndOtherLiabilitiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" abstract="false" name="EquitySecuritiesFVNIMaximumSecuredPromissoryNote" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_AccruedRebates" abstract="false" name="AccruedRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_MedicalTechnologyCompanyMember" abstract="true" name="MedicalTechnologyCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_EquityMethodInvestmentsInvestmentPeriod" abstract="false" name="EquityMethodInvestmentsInvestmentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" abstract="false" name="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_ContingentConsiderationLiabilityMember" abstract="true" name="ContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" abstract="false" name="AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ew_AccruedLitigationAndInsuranceReserves" abstract="false" name="AccruedLitigationAndInsuranceReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_AccruedAndOtherLiabilitiesCurrent" abstract="false" name="AccruedAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_UnitedStatesSegmentMember" abstract="true" name="UnitedStatesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_InitialDeliveryOfSharesSettledJanuary2022Member" abstract="true" name="InitialDeliveryOfSharesSettledJanuary2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIMaximumPromissoryNote" abstract="false" name="EquitySecuritiesFVNIMaximumPromissoryNote" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_ResearchAndDevelopmentAccruals" abstract="false" name="ResearchAndDevelopmentAccruals" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_EquitySecuritiesFVNIMaximumAdditionalRequired" abstract="false" name="EquitySecuritiesFVNIMaximumAdditionalRequired" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_SurgicalHeartValveTherapyMember" abstract="true" name="SurgicalHeartValveTherapyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_MeasurementInputProbabilityOfMilestoneAchievementMember" abstract="true" name="MeasurementInputProbabilityOfMilestoneAchievementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_InitialDeliveryOfSharesSettledFebruary2023Member" abstract="true" name="InitialDeliveryOfSharesSettledFebruary2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" abstract="false" name="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_NewMarketsTaxCreditMember" abstract="true" name="NewMarketsTaxCreditMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_SpecialChargeMember" abstract="true" name="SpecialChargeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member" abstract="true" name="January2022StockRepurchaseProgramSharesSoldInFebruary2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_AccruedRelocationCostsCurrent" abstract="false" name="AccruedRelocationCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_EuropeSegmentMember" abstract="true" name="EuropeSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ew_VariableInterestEntitiesAbstract" abstract="true" name="VariableInterestEntitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" abstract="false" name="LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" abstract="false" name="PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ew_JeanLucLemercierMember" abstract="true" name="JeanLucLemercierMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>ew-20230930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:eaa870a0-ed84-4111-a2ce-17bb0f4c4328,g:a046b429-8038-45a1-a20d-74cf9c7f6b8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_34955e08-db78-4496-affe-ae29a92af73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cfca375b-99c8-4c0b-86f1-7744b9689753" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_34955e08-db78-4496-affe-ae29a92af73d" xlink:to="loc_us-gaap_Liabilities_cfca375b-99c8-4c0b-86f1-7744b9689753" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2c4546bd-0768-4d8c-adce-43f91ceabe9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_34955e08-db78-4496-affe-ae29a92af73d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2c4546bd-0768-4d8c-adce-43f91ceabe9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_864e7021-28bb-4c1c-a4f9-61adf02275ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_34955e08-db78-4496-affe-ae29a92af73d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_864e7021-28bb-4c1c-a4f9-61adf02275ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a9f503b-25f0-41d2-950a-2b27426cbf5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5a035b35-aff1-4e39-9487-0c0a41f2fa05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a9f503b-25f0-41d2-950a-2b27426cbf5f" xlink:to="loc_us-gaap_StockholdersEquity_5a035b35-aff1-4e39-9487-0c0a41f2fa05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_5adee4be-9d9d-4b8c-87db-8144794a1d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a9f503b-25f0-41d2-950a-2b27426cbf5f" xlink:to="loc_us-gaap_MinorityInterest_5adee4be-9d9d-4b8c-87db-8144794a1d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_67b0983b-b0e5-44df-9b2c-463b65432d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7cfa5e2d-3340-41ae-8e6f-86e77ced0eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67b0983b-b0e5-44df-9b2c-463b65432d43" xlink:to="loc_us-gaap_InventoryNet_7cfa5e2d-3340-41ae-8e6f-86e77ced0eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b10db7d2-04f6-4e10-9e4a-3ee822f71e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67b0983b-b0e5-44df-9b2c-463b65432d43" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b10db7d2-04f6-4e10-9e4a-3ee822f71e0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c67b57da-6ca7-46d2-ade1-6248857182ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67b0983b-b0e5-44df-9b2c-463b65432d43" xlink:to="loc_us-gaap_OtherAssetsCurrent_c67b57da-6ca7-46d2-ade1-6248857182ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_f9f0c24e-c330-406d-a2e0-aa47eaa6ea25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67b0983b-b0e5-44df-9b2c-463b65432d43" xlink:to="loc_us-gaap_OtherReceivables_f9f0c24e-c330-406d-a2e0-aa47eaa6ea25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e5a0fca6-9590-4587-af1d-9f0b906ed90b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67b0983b-b0e5-44df-9b2c-463b65432d43" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e5a0fca6-9590-4587-af1d-9f0b906ed90b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_e4debe1b-d5bd-4e5a-abe7-ad8771ba080e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67b0983b-b0e5-44df-9b2c-463b65432d43" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_e4debe1b-d5bd-4e5a-abe7-ad8771ba080e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7dbb71ef-8264-4624-aed7-0a6e808010b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67b0983b-b0e5-44df-9b2c-463b65432d43" xlink:to="loc_us-gaap_ShortTermInvestments_7dbb71ef-8264-4624-aed7-0a6e808010b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a660de1f-ccdc-4b8c-9e0a-b32c08aed1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2718b227-4a99-4d1d-a63e-7012ffe138a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a660de1f-ccdc-4b8c-9e0a-b32c08aed1b7" xlink:to="loc_us-gaap_AccountsPayableCurrent_2718b227-4a99-4d1d-a63e-7012ffe138a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_a329d45c-8c98-4fdc-a250-c5dd23b3dd60" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a660de1f-ccdc-4b8c-9e0a-b32c08aed1b7" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrent_a329d45c-8c98-4fdc-a250-c5dd23b3dd60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8c68abd8-59e5-4419-94d1-f924f2d00b49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a660de1f-ccdc-4b8c-9e0a-b32c08aed1b7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8c68abd8-59e5-4419-94d1-f924f2d00b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ef7fb715-083c-48a4-93b5-8b2228e29863" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:to="loc_us-gaap_AssetsCurrent_ef7fb715-083c-48a4-93b5-8b2228e29863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_9172d908-ea03-4b09-9ce0-b915c1029da2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:to="loc_us-gaap_LongTermInvestments_9172d908-ea03-4b09-9ce0-b915c1029da2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b7a639f4-41f9-4578-b18f-75e20e4e70ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b7a639f4-41f9-4578-b18f-75e20e4e70ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_065211a9-f551-4396-95ed-0b3c15f69dba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_065211a9-f551-4396-95ed-0b3c15f69dba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6bc2cd5e-6e43-4b15-b06b-1c856dc81973" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:to="loc_us-gaap_Goodwill_6bc2cd5e-6e43-4b15-b06b-1c856dc81973" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1838fe05-e54d-4c9b-acd9-8efb7aee3c02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1838fe05-e54d-4c9b-acd9-8efb7aee3c02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8daca6ac-d2cd-4815-ac5d-90df1508d163" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8daca6ac-d2cd-4815-ac5d-90df1508d163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ea0060f3-79d0-4c48-b803-d23b8213c603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9df0ce6c-6900-480f-9f7f-32cf23fd7edb" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ea0060f3-79d0-4c48-b803-d23b8213c603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b260bfd7-5c9e-4d9d-b478-15355a68aa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:to="loc_us-gaap_LiabilitiesCurrent_b260bfd7-5c9e-4d9d-b478-15355a68aa6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c70fd698-7522-4e56-ba31-7823ecb0412a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c70fd698-7522-4e56-ba31-7823ecb0412a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e0de67ef-25ce-4ccf-81d2-11a25eaefd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e0de67ef-25ce-4ccf-81d2-11a25eaefd0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_810ce6b9-3688-418d-a46c-df1701e54f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_810ce6b9-3688-418d-a46c-df1701e54f6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_68253045-4f18-46ee-97ec-7f3f187835a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_68253045-4f18-46ee-97ec-7f3f187835a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_482555ff-28d0-4114-a545-8d40cdae1aac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_482555ff-28d0-4114-a545-8d40cdae1aac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_fd7d59fa-f76d-4552-881e-ba4ff6629dae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_fd7d59fa-f76d-4552-881e-ba4ff6629dae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5b16ef9e-70ab-45cb-b0f8-cf5322d59ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ffa6b88c-a612-4c5e-b1db-ff30b91ed8a2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5b16ef9e-70ab-45cb-b0f8-cf5322d59ac7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6a5b49d4-78d3-4c3a-a784-8e343cd5b816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_bb4d1e34-6ffa-420c-ac94-041ed8b20ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6a5b49d4-78d3-4c3a-a784-8e343cd5b816" xlink:to="loc_us-gaap_PreferredStockValue_bb4d1e34-6ffa-420c-ac94-041ed8b20ddd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4d88eb01-8a02-437c-b7c6-fe192ffdbffd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6a5b49d4-78d3-4c3a-a784-8e343cd5b816" xlink:to="loc_us-gaap_CommonStockValue_4d88eb01-8a02-437c-b7c6-fe192ffdbffd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2d8babd4-a4ec-435d-abde-52d614cc1ced" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6a5b49d4-78d3-4c3a-a784-8e343cd5b816" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2d8babd4-a4ec-435d-abde-52d614cc1ced" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5c1e5fa9-187e-432e-bfb5-4d38a9815424" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6a5b49d4-78d3-4c3a-a784-8e343cd5b816" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5c1e5fa9-187e-432e-bfb5-4d38a9815424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6726155d-ef8c-4644-98b0-da8b87ea19ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6a5b49d4-78d3-4c3a-a784-8e343cd5b816" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6726155d-ef8c-4644-98b0-da8b87ea19ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_15e9c513-0c41-4ee8-bef3-b937f1fd7bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6a5b49d4-78d3-4c3a-a784-8e343cd5b816" xlink:to="loc_us-gaap_TreasuryStockCommonValue_15e9c513-0c41-4ee8-bef3-b937f1fd7bb6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_143dec3f-eb06-4cec-800d-6e15ff76ecac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_dcf2f897-0e28-4f71-a4c4-20e4e335243c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_143dec3f-eb06-4cec-800d-6e15ff76ecac" xlink:to="loc_us-gaap_GrossProfit_dcf2f897-0e28-4f71-a4c4-20e4e335243c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6ee1e6df-48c4-49b9-ab38-232995b0e0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_143dec3f-eb06-4cec-800d-6e15ff76ecac" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6ee1e6df-48c4-49b9-ab38-232995b0e0f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_16cf57c7-0e2e-46d6-8649-f1b017ccad8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_143dec3f-eb06-4cec-800d-6e15ff76ecac" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_16cf57c7-0e2e-46d6-8649-f1b017ccad8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_512db7c9-e970-49ac-b202-a5b668ea70c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_143dec3f-eb06-4cec-800d-6e15ff76ecac" xlink:to="loc_us-gaap_LitigationSettlementExpense_512db7c9-e970-49ac-b202-a5b668ea70c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_033bd797-10b8-4927-b0ad-6d31cb850df5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_143dec3f-eb06-4cec-800d-6e15ff76ecac" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_033bd797-10b8-4927-b0ad-6d31cb850df5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_eadb99ab-c58d-4c95-96c6-5afffc736b35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_143dec3f-eb06-4cec-800d-6e15ff76ecac" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_eadb99ab-c58d-4c95-96c6-5afffc736b35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0c527d28-b1b3-4c24-abe2-387210f5db00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4fbf13cb-ed69-411a-8047-9633b5e00484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0c527d28-b1b3-4c24-abe2-387210f5db00" xlink:to="loc_us-gaap_OperatingIncomeLoss_4fbf13cb-ed69-411a-8047-9633b5e00484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_98c374eb-0fd4-4b2f-b05d-49f366c2426d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0c527d28-b1b3-4c24-abe2-387210f5db00" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_98c374eb-0fd4-4b2f-b05d-49f366c2426d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a0a2b6d0-aa60-4eda-b42c-705f58d6051a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0c527d28-b1b3-4c24-abe2-387210f5db00" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a0a2b6d0-aa60-4eda-b42c-705f58d6051a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5fb1c9fe-5967-4b5f-86f4-9d4cbb932ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c14486c9-3293-4c1c-bb93-c3636405cda2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5fb1c9fe-5967-4b5f-86f4-9d4cbb932ae2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c14486c9-3293-4c1c-bb93-c3636405cda2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1434bbda-bf08-4bcf-b2fd-d882c514981e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_5fb1c9fe-5967-4b5f-86f4-9d4cbb932ae2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1434bbda-bf08-4bcf-b2fd-d882c514981e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bc9064de-61c2-471d-b3b7-f3965bebfc63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6ae588ca-3897-41a5-8fa4-0b615b8a2ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bc9064de-61c2-471d-b3b7-f3965bebfc63" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6ae588ca-3897-41a5-8fa4-0b615b8a2ab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e0e1b6b9-66e0-4ccc-a961-8d8300ccfc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bc9064de-61c2-471d-b3b7-f3965bebfc63" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e0e1b6b9-66e0-4ccc-a961-8d8300ccfc5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9b20af21-c27e-411d-b4f8-0f4e851d5a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8e35bf2d-3448-490b-943b-f45c4843b5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9b20af21-c27e-411d-b4f8-0f4e851d5a6b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8e35bf2d-3448-490b-943b-f45c4843b5c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_68542662-8ffa-4f68-b2be-7a0b89db7102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9b20af21-c27e-411d-b4f8-0f4e851d5a6b" xlink:to="loc_us-gaap_ProfitLoss_68542662-8ffa-4f68-b2be-7a0b89db7102" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_449c0cbd-58ea-4a04-8749-78d0b783b404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9dbb1839-8f84-4424-b16b-56e68e10cbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_449c0cbd-58ea-4a04-8749-78d0b783b404" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_9dbb1839-8f84-4424-b16b-56e68e10cbb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e89f1f8b-b063-4986-ac05-c23177cb8cad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_449c0cbd-58ea-4a04-8749-78d0b783b404" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e89f1f8b-b063-4986-ac05-c23177cb8cad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d02a4b2c-cb7a-4811-bb97-1b18b2258f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4ce01a68-0026-4bf5-a9f0-e79209e00f44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d02a4b2c-cb7a-4811-bb97-1b18b2258f9e" xlink:to="loc_us-gaap_ProfitLoss_4ce01a68-0026-4bf5-a9f0-e79209e00f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_edb44bf6-3b64-42c8-9000-5dc68fc2dfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d02a4b2c-cb7a-4811-bb97-1b18b2258f9e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_edb44bf6-3b64-42c8-9000-5dc68fc2dfcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_971e8300-3997-4d6e-bdcf-d730c7482f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_40965ee2-ac43-4bf2-8b33-5036442c6b79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_971e8300-3997-4d6e-bdcf-d730c7482f3c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_40965ee2-ac43-4bf2-8b33-5036442c6b79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3b22aa0b-5e19-4e76-a3e3-c9c581ed24ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_971e8300-3997-4d6e-bdcf-d730c7482f3c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3b22aa0b-5e19-4e76-a3e3-c9c581ed24ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4cbfd735-e68c-44f1-a060-d3edb519097d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_971e8300-3997-4d6e-bdcf-d730c7482f3c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4cbfd735-e68c-44f1-a060-d3edb519097d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d76a60aa-d40f-44f4-b198-49cbfd5cf14a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_971e8300-3997-4d6e-bdcf-d730c7482f3c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d76a60aa-d40f-44f4-b198-49cbfd5cf14a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6a0199a-ac3a-4474-b261-bf74e68e1a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_face80c1-37d5-45af-941a-7dee0d37cc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6a0199a-ac3a-4474-b261-bf74e68e1a13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_face80c1-37d5-45af-941a-7dee0d37cc7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7f9d83c-9aca-4840-ba7f-1a31354ca7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6a0199a-ac3a-4474-b261-bf74e68e1a13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7f9d83c-9aca-4840-ba7f-1a31354ca7ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eceabf79-8163-469e-9e33-dfeabe5eb44e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6a0199a-ac3a-4474-b261-bf74e68e1a13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eceabf79-8163-469e-9e33-dfeabe5eb44e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5e4e5dc-694e-4389-908b-cc2889cd18a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6a0199a-ac3a-4474-b261-bf74e68e1a13" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5e4e5dc-694e-4389-908b-cc2889cd18a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_dd919bbe-279b-4ae4-8937-e7da8e4bcc22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_dd919bbe-279b-4ae4-8937-e7da8e4bcc22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1e7dfc74-9818-4f1c-8c17-ecb41a5fedb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1e7dfc74-9818-4f1c-8c17-ecb41a5fedb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncreaseDecreaseInLegalSettlementAccrual_6d6f9ebc-ebd2-4ea6-9f02-c3c617fe6224" xlink:href="ew-20230930.xsd#ew_IncreaseDecreaseInLegalSettlementAccrual"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_ew_IncreaseDecreaseInLegalSettlementAccrual_6d6f9ebc-ebd2-4ea6-9f02-c3c617fe6224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_649a967c-9bbd-483d-af6d-3f073914158d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_649a967c-9bbd-483d-af6d-3f073914158d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_023f5ecb-c68f-461d-b61d-1fb250f154bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_023f5ecb-c68f-461d-b61d-1fb250f154bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7dbe8ad5-7108-4277-af7a-848b027af46e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7dbe8ad5-7108-4277-af7a-848b027af46e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_dfdb3039-8744-4efd-a9a8-fc91beb0d5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_dfdb3039-8744-4efd-a9a8-fc91beb0d5e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_14d565ae-902f-4b14-9007-4dbe89896c63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_14d565ae-902f-4b14-9007-4dbe89896c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_fbd0dc2d-dc12-47c9-8a7d-3f3c472c2313" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_ShareBasedCompensation_fbd0dc2d-dc12-47c9-8a7d-3f3c472c2313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7ce2214a-35dc-433d-83f9-32076d817e20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7ce2214a-35dc-433d-83f9-32076d817e20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c4eb56f7-d576-40b3-8930-793dbed418c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_ProfitLoss_c4eb56f7-d576-40b3-8930-793dbed418c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7b178e14-334a-492b-8f71-51fe1fd85c21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7b178e14-334a-492b-8f71-51fe1fd85c21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7f104b2e-f791-452c-940a-12eccf38e575" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7f104b2e-f791-452c-940a-12eccf38e575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c026ea77-9c98-4a9b-8715-37e0ab3e0afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c026ea77-9c98-4a9b-8715-37e0ab3e0afc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_268fc648-732e-4171-88a7-9a79c0b71eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_GainLossOnInvestments_268fc648-732e-4171-88a7-9a79c0b71eb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidRoyalties_cd6b3105-7217-4639-aca5-a2bf53106ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidRoyalties"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidRoyalties_cd6b3105-7217-4639-aca5-a2bf53106ea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_15d79111-06c6-4391-823d-da518dcf92ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9ece15c7-27ac-4df6-8326-9cab605facc6" xlink:to="loc_us-gaap_AssetImpairmentCharges_15d79111-06c6-4391-823d-da518dcf92ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c37b898c-8f73-4371-9d7d-9cf9c8e9bb83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_000351db-8412-41a8-ba66-665dc0b7b41e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c37b898c-8f73-4371-9d7d-9cf9c8e9bb83" xlink:to="loc_us-gaap_ProceedsFromStockPlans_000351db-8412-41a8-ba66-665dc0b7b41e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a0926144-6b73-4d70-af26-9af77fac52d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c37b898c-8f73-4371-9d7d-9cf9c8e9bb83" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a0926144-6b73-4d70-af26-9af77fac52d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c1c69717-8d96-4b31-a654-5f33d9cd4efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c37b898c-8f73-4371-9d7d-9cf9c8e9bb83" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c1c69717-8d96-4b31-a654-5f33d9cd4efe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_d6e685b5-dbe2-4e8e-bead-a3d025b80e27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_d6e685b5-dbe2-4e8e-bead-a3d025b80e27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_f814f59a-e101-4e2a-82a8-8e1f9ddc7627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_f814f59a-e101-4e2a-82a8-8e1f9ddc7627" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireReceivables_06ce2c50-ab5a-42d3-8325-511daaba24aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_PaymentsToAcquireReceivables_06ce2c50-ab5a-42d3-8325-511daaba24aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4b1fb107-cac8-4052-910b-0e3f7d954fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4b1fb107-cac8-4052-910b-0e3f7d954fcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b44b9591-f3ad-4bbd-93a4-4d44fb7f86f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b44b9591-f3ad-4bbd-93a4-4d44fb7f86f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_42306954-7e7c-4d29-9807-aab9dad5975f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_42306954-7e7c-4d29-9807-aab9dad5975f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_af5207b7-00d6-46cc-9391-77ffb0a627b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_af5207b7-00d6-46cc-9391-77ffb0a627b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_bc2d6696-4823-4075-90b3-565c88e5b152" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_bc2d6696-4823-4075-90b3-565c88e5b152" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_864ed947-1df0-420a-af09-fa307391382b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_864ed947-1df0-420a-af09-fa307391382b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_3cb8ee39-f9fb-4f44-976b-900412ee439d" xlink:href="ew-20230930.xsd#ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0b966bde-b9b5-4367-836c-972df8be95c3" xlink:to="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_3cb8ee39-f9fb-4f44-976b-900412ee439d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f87ae8f2-6909-4ec3-89b6-db4f24b2dd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_62122418-52cb-4fc8-8ee4-a7e2a514ae10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f87ae8f2-6909-4ec3-89b6-db4f24b2dd4e" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_62122418-52cb-4fc8-8ee4-a7e2a514ae10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_710e6085-346d-4105-9695-afee38d6b553" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f87ae8f2-6909-4ec3-89b6-db4f24b2dd4e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_710e6085-346d-4105-9695-afee38d6b553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_66a28c4a-d784-4a9f-b741-284c42995336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f87ae8f2-6909-4ec3-89b6-db4f24b2dd4e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_66a28c4a-d784-4a9f-b741-284c42995336" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bc4f8d6b-8f10-4a08-8743-23dd0497c3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bc4f8d6b-8f10-4a08-8743-23dd0497c3bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7013f335-01ed-4d26-b240-aa9d40fe3bab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7013f335-01ed-4d26-b240-aa9d40fe3bab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_5a6555c0-554a-4f58-9f5f-a7cdb91b051d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_5a6555c0-554a-4f58-9f5f-a7cdb91b051d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_95531c59-c5b9-4ca8-8520-05d6dddc136f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_95531c59-c5b9-4ca8-8520-05d6dddc136f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ResearchAndDevelopmentAccruals_74ee921f-1b06-4885-b9c5-4c1628cb3a10" xlink:href="ew-20230930.xsd#ew_ResearchAndDevelopmentAccruals"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_ew_ResearchAndDevelopmentAccruals_74ee921f-1b06-4885-b9c5-4c1628cb3a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedLitigationAndInsuranceReserves_002ff112-9abb-4ee0-a070-627baf6f30a9" xlink:href="ew-20230930.xsd#ew_AccruedLitigationAndInsuranceReserves"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_ew_AccruedLitigationAndInsuranceReserves_002ff112-9abb-4ee0-a070-627baf6f30a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRebates_9127f506-24a0-4425-a8b9-d68174936c6a" xlink:href="ew-20230930.xsd#ew_AccruedRebates"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_ew_AccruedRebates_9127f506-24a0-4425-a8b9-d68174936c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_86b9336f-fc0d-4d01-8a0a-0a4f7252eee0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_86b9336f-fc0d-4d01-8a0a-0a4f7252eee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRelocationCostsCurrent_d4fc63d3-2141-4d87-95f5-d64b65095b3b" xlink:href="ew-20230930.xsd#ew_AccruedRelocationCostsCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_ew_AccruedRelocationCostsCurrent_d4fc63d3-2141-4d87-95f5-d64b65095b3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_0e0f8464-e527-4c49-a765-6743971e159c" xlink:href="ew-20230930.xsd#ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_0e0f8464-e527-4c49-a765-6743971e159c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_60deb3ea-275f-453d-a5da-449e61b5397e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_us-gaap_RestructuringReserveCurrent_60deb3ea-275f-453d-a5da-449e61b5397e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_b723ea55-ffc8-4461-a367-af5db5ec18c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_b723ea55-ffc8-4461-a367-af5db5ec18c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_29d6e3e1-6a65-4876-9b3c-c70d69da0c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent_296f0c47-3967-4b8f-8355-3ff585e1d78c" xlink:to="loc_us-gaap_LitigationReserveCurrent_29d6e3e1-6a65-4876-9b3c-c70d69da0c3f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3bafbb19-9383-435b-b064-caee56bc1705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_36dae3fd-ee27-415a-8389-d167c7c742ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3bafbb19-9383-435b-b064-caee56bc1705" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_36dae3fd-ee27-415a-8389-d167c7c742ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_702a96ec-00cb-4b71-a67f-3b68b9a7af74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3bafbb19-9383-435b-b064-caee56bc1705" xlink:to="loc_us-gaap_RestrictedCashCurrent_702a96ec-00cb-4b71-a67f-3b68b9a7af74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_5bc0c3e6-5ffe-4349-9875-c03fb88fa405" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3bafbb19-9383-435b-b064-caee56bc1705" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_5bc0c3e6-5ffe-4349-9875-c03fb88fa405" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_79158d07-754b-4a3b-b201-ef3f395836ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bb7b4e25-e1f9-4a47-8b11-fccad31f94fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_79158d07-754b-4a3b-b201-ef3f395836ad" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bb7b4e25-e1f9-4a47-8b11-fccad31f94fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7daaa1d1-9e85-4006-9ef4-f4d5464fb6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_79158d07-754b-4a3b-b201-ef3f395836ad" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7daaa1d1-9e85-4006-9ef4-f4d5464fb6ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_92c22afa-b9dc-4ccc-ba46-37037ba449ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_79158d07-754b-4a3b-b201-ef3f395836ad" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_92c22afa-b9dc-4ccc-ba46-37037ba449ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_7703aa3d-088f-4cc1-b6f3-c93b367991a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_27aa794e-2c72-49f9-a22d-d6ce031dbcee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_7703aa3d-088f-4cc1-b6f3-c93b367991a6" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_27aa794e-2c72-49f9-a22d-d6ce031dbcee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_ccb7777f-e41b-4e74-a010-5dc95c9085fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_7703aa3d-088f-4cc1-b6f3-c93b367991a6" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_ccb7777f-e41b-4e74-a010-5dc95c9085fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2be46189-413d-4a14-b20c-bee7c7205f02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_7703aa3d-088f-4cc1-b6f3-c93b367991a6" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_2be46189-413d-4a14-b20c-bee7c7205f02" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f1cb66a-092a-4300-aa0f-a62db7de6d22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_fdc41f98-d7d9-487f-b45a-931ef39c11ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f1cb66a-092a-4300-aa0f-a62db7de6d22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_fdc41f98-d7d9-487f-b45a-931ef39c11ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_9bb81e18-e54f-4e50-a2ba-0536413f0856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f1cb66a-092a-4300-aa0f-a62db7de6d22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_9bb81e18-e54f-4e50-a2ba-0536413f0856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_39919a09-5236-4604-88ea-f57dfec01173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f1cb66a-092a-4300-aa0f-a62db7de6d22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_39919a09-5236-4604-88ea-f57dfec01173" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_cd81a33f-d4e8-4628-9a41-d165b1dee7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f1cb66a-092a-4300-aa0f-a62db7de6d22" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_cd81a33f-d4e8-4628-9a41-d165b1dee7ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_9c29ed0a-b907-4c0c-9457-51e95d94fa53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_ae30ce59-21b3-4b1b-9dd4-ad428215ef0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_9c29ed0a-b907-4c0c-9457-51e95d94fa53" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_ae30ce59-21b3-4b1b-9dd4-ad428215ef0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_c8359b5a-fdfa-4a3b-8d91-d6a0d868b90f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_9c29ed0a-b907-4c0c-9457-51e95d94fa53" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_c8359b5a-fdfa-4a3b-8d91-d6a0d868b90f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_1baab4e2-9d52-4dc8-b924-ccce9498d26e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_9c29ed0a-b907-4c0c-9457-51e95d94fa53" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_1baab4e2-9d52-4dc8-b924-ccce9498d26e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_0e1ebe7c-48fb-433c-af33-b6515c1f5957" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_9c29ed0a-b907-4c0c-9457-51e95d94fa53" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_0e1ebe7c-48fb-433c-af33-b6515c1f5957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bf7b5e32-9138-40fd-bc1a-e1740b25b461" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_75875fd0-01f9-469b-891e-3c95c5b019ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bf7b5e32-9138-40fd-bc1a-e1740b25b461" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_75875fd0-01f9-469b-891e-3c95c5b019ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_b5252b46-cc1f-4560-ab48-fe4ee4cae72d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bf7b5e32-9138-40fd-bc1a-e1740b25b461" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_b5252b46-cc1f-4560-ab48-fe4ee4cae72d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_2fc9f766-0531-41bf-afbb-959bf4e2a307" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bf7b5e32-9138-40fd-bc1a-e1740b25b461" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_2fc9f766-0531-41bf-afbb-959bf4e2a307" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_cda8b701-1f45-4adf-b3e5-0f2e03cf7b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bf7b5e32-9138-40fd-bc1a-e1740b25b461" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_cda8b701-1f45-4adf-b3e5-0f2e03cf7b0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_e3b7ddfc-1dd6-4a45-9651-2de5268bf23f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_7ccfbf8f-0500-4272-95a7-16b6e8f404b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_e3b7ddfc-1dd6-4a45-9651-2de5268bf23f" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_7ccfbf8f-0500-4272-95a7-16b6e8f404b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_dd09a7a1-d6e2-4f54-bf46-b9b249c6c23f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_e3b7ddfc-1dd6-4a45-9651-2de5268bf23f" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_dd09a7a1-d6e2-4f54-bf46-b9b249c6c23f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost_80aa781b-0624-46f4-9610-80dcb72521bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_e3b7ddfc-1dd6-4a45-9651-2de5268bf23f" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost_80aa781b-0624-46f4-9610-80dcb72521bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_b674269b-fe23-4dca-80a7-445576c38529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_e3b7ddfc-1dd6-4a45-9651-2de5268bf23f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_b674269b-fe23-4dca-80a7-445576c38529" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f3656573-f399-4028-aae0-aa8a254bb080" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_d09641a7-363a-46e6-aaa6-7a0f16de9c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f3656573-f399-4028-aae0-aa8a254bb080" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_d09641a7-363a-46e6-aaa6-7a0f16de9c0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2329a37f-1039-405b-b531-e6e4854cb893" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f3656573-f399-4028-aae0-aa8a254bb080" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2329a37f-1039-405b-b531-e6e4854cb893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_655ed4b6-c760-4aa1-a5bc-95bd566c1959" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_eee36500-339d-4394-b133-2e4a97a972d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_655ed4b6-c760-4aa1-a5bc-95bd566c1959" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_eee36500-339d-4394-b133-2e4a97a972d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_2c0e8274-5b2d-4d69-84b3-429599c945bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_655ed4b6-c760-4aa1-a5bc-95bd566c1959" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_2c0e8274-5b2d-4d69-84b3-429599c945bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a05efd80-19c7-4dfd-a52c-1aa3743f23cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_217905a1-ceb8-4f9a-b5ef-6a3bcdd306a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a05efd80-19c7-4dfd-a52c-1aa3743f23cc" xlink:to="loc_us-gaap_EquityMethodInvestments_217905a1-ceb8-4f9a-b5ef-6a3bcdd306a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2b93163a-e133-49a9-942d-e1264cc0e4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a05efd80-19c7-4dfd-a52c-1aa3743f23cc" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2b93163a-e133-49a9-942d-e1264cc0e4ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_7cd65ec1-cb83-4e8f-a12e-eca3a8c399b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_eefb315d-9976-414b-bd00-f59a44003e55" xlink:href="ew-20230930.xsd#ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_7cd65ec1-cb83-4e8f-a12e-eca3a8c399b7" xlink:to="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_eefb315d-9976-414b-bd00-f59a44003e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_647de7a7-ea57-4cd2-8589-ed3a3917eca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_7cd65ec1-cb83-4e8f-a12e-eca3a8c399b7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_647de7a7-ea57-4cd2-8589-ed3a3917eca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d350335e-5b82-4bc8-8e07-74380e9bfb63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5ddcdc5c-562e-461d-9abd-0f7685402030" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d350335e-5b82-4bc8-8e07-74380e9bfb63" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5ddcdc5c-562e-461d-9abd-0f7685402030" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c61ee60c-3601-437c-a1b4-c2af2f8e9c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d350335e-5b82-4bc8-8e07-74380e9bfb63" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c61ee60c-3601-437c-a1b4-c2af2f8e9c06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_26590940-ae98-44b1-bc40-bade0d9d90e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d350335e-5b82-4bc8-8e07-74380e9bfb63" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_26590940-ae98-44b1-bc40-bade0d9d90e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_15355d3f-bbf4-4b5b-b6d6-58c4ba79076a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d350335e-5b82-4bc8-8e07-74380e9bfb63" xlink:to="loc_us-gaap_Goodwill_15355d3f-bbf4-4b5b-b6d6-58c4ba79076a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_ea866385-9007-4fac-94b5-7dcdcada8572" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d350335e-5b82-4bc8-8e07-74380e9bfb63" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_ea866385-9007-4fac-94b5-7dcdcada8572" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9b3e98c1-5750-4fa2-a1a0-63deca6c8b59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4963a1b6-b46a-4790-a9ca-83d7de3c3b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9b3e98c1-5750-4fa2-a1a0-63deca6c8b59" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4963a1b6-b46a-4790-a9ca-83d7de3c3b17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_235c6a89-879a-4436-8057-fef78e55de39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9b3e98c1-5750-4fa2-a1a0-63deca6c8b59" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_235c6a89-879a-4436-8057-fef78e55de39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_cba42201-c7e4-42d1-996b-5521f581be56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9b3e98c1-5750-4fa2-a1a0-63deca6c8b59" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_cba42201-c7e4-42d1-996b-5521f581be56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_ff0042ed-92d4-42c6-b4f2-5161b8c15129" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_9b3e98c1-5750-4fa2-a1a0-63deca6c8b59" xlink:to="loc_us-gaap_DerivativeAssets_ff0042ed-92d4-42c6-b4f2-5161b8c15129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_36c35c47-36a0-41e7-ace4-4aa384c0f042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0193e1dc-2b3f-4ed4-8329-14b7593f9c12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_36c35c47-36a0-41e7-ace4-4aa384c0f042" xlink:to="loc_us-gaap_DerivativeLiabilities_0193e1dc-2b3f-4ed4-8329-14b7593f9c12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_4f2ac215-97b6-4608-9bec-41cf39567825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_36c35c47-36a0-41e7-ace4-4aa384c0f042" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_4f2ac215-97b6-4608-9bec-41cf39567825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_c64bfe4f-7da5-4b6e-96ed-2fb815b08898" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_36c35c47-36a0-41e7-ace4-4aa384c0f042" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_c64bfe4f-7da5-4b6e-96ed-2fb815b08898" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_302833f7-c2c3-4341-b7c9-2d9f3061b651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fcf56bef-6c04-4c73-af1d-af37e608aaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_302833f7-c2c3-4341-b7c9-2d9f3061b651" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fcf56bef-6c04-4c73-af1d-af37e608aaa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_7cd46497-cdf8-44aa-a0bf-8d674d7f0ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_302833f7-c2c3-4341-b7c9-2d9f3061b651" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_7cd46497-cdf8-44aa-a0bf-8d674d7f0ebc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_20369c19-de7d-4590-b5bb-3d5eea323432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_ed2ddf9a-1c2f-41b4-b6af-e19f1dbb89bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_20369c19-de7d-4590-b5bb-3d5eea323432" xlink:to="loc_us-gaap_DerivativeAssets_ed2ddf9a-1c2f-41b4-b6af-e19f1dbb89bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_b477e380-0a75-40b5-8819-d5333d4b3a18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_20369c19-de7d-4590-b5bb-3d5eea323432" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_b477e380-0a75-40b5-8819-d5333d4b3a18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_4344337e-4d6f-49c6-9453-a456fc0db807" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_20369c19-de7d-4590-b5bb-3d5eea323432" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_4344337e-4d6f-49c6-9453-a456fc0db807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_03d30acf-d894-4a00-b57c-739fbec96260" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ed8db831-1fe0-45be-8802-d2cf855f62b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_03d30acf-d894-4a00-b57c-739fbec96260" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ed8db831-1fe0-45be-8802-d2cf855f62b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_886eb9fb-1593-48b1-aa19-e11afef9c65b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_03d30acf-d894-4a00-b57c-739fbec96260" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_886eb9fb-1593-48b1-aa19-e11afef9c65b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_9837d365-7597-4707-a8d7-caa05f791086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_7b59b1e1-d30b-4241-a111-3dc69ad52b10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_9837d365-7597-4707-a8d7-caa05f791086" xlink:to="loc_us-gaap_DerivativeLiabilities_7b59b1e1-d30b-4241-a111-3dc69ad52b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_9fd07237-e8ef-44c2-906f-b4d310d27ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_9837d365-7597-4707-a8d7-caa05f791086" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_9fd07237-e8ef-44c2-906f-b4d310d27ddb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_f8fdff11-c0bb-4f3f-a0ca-05cf0bbd09b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_9837d365-7597-4707-a8d7-caa05f791086" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_f8fdff11-c0bb-4f3f-a0ca-05cf0bbd09b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_47aeeb35-de90-4c88-8cce-f65f848d189c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_69c119d7-873d-4658-aebd-c64011dc7ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_47aeeb35-de90-4c88-8cce-f65f848d189c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_69c119d7-873d-4658-aebd-c64011dc7ba2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a078f3bb-452e-4c33-96a4-b4b5c69cf833" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_47aeeb35-de90-4c88-8cce-f65f848d189c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a078f3bb-452e-4c33-96a4-b4b5c69cf833" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdeff891-cfd2-4fb5-a684-8ea14dc0e0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_004a03dc-aaa5-4253-a2f1-eccab767e8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdeff891-cfd2-4fb5-a684-8ea14dc0e0a5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_004a03dc-aaa5-4253-a2f1-eccab767e8e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2f180571-2047-456d-9ca5-75897a91281b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fdeff891-cfd2-4fb5-a684-8ea14dc0e0a5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2f180571-2047-456d-9ca5-75897a91281b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ew-20230930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:eaa870a0-ed84-4111-a2ce-17bb0f4c4328,g:a046b429-8038-45a1-a20d-74cf9c7f6b8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a96c50b4-038a-480f-8be2-f5fdc78e9196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a96c50b4-038a-480f-8be2-f5fdc78e9196" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_71eb1b77-da29-4b90-ac83-50f2068fbee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_71eb1b77-da29-4b90-ac83-50f2068fbee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7024a8e8-22f2-4143-bed1-6cf594c7431c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7024a8e8-22f2-4143-bed1-6cf594c7431c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_5a70cc51-6c17-442c-b95a-a9e029aaab3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_TreasuryStockCommonShares_5a70cc51-6c17-442c-b95a-a9e029aaab3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9869d06f-f3d9-4240-8b64-ec53262b9bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_ProfitLoss_9869d06f-f3d9-4240-8b64-ec53262b9bdb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ae6b428c-e97a-4300-9094-8a18c067932a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ae6b428c-e97a-4300-9094-8a18c067932a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_57c6ac2b-c3b7-424c-baad-47377ead370e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_57c6ac2b-c3b7-424c-baad-47377ead370e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9fbafde4-e7e8-4448-bd85-503e5cb776b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9fbafde4-e7e8-4448-bd85-503e5cb776b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a8b16aa6-d39e-45f6-939e-e679a5539070" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a8b16aa6-d39e-45f6-939e-e679a5539070" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9939fd36-47eb-4dd3-b6f6-3c39b44432da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9939fd36-47eb-4dd3-b6f6-3c39b44432da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bdf54492-84af-4143-b5f1-3fa3ff5b6d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bdf54492-84af-4143-b5f1-3fa3ff5b6d0c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_f1fe21fa-088a-4265-b636-c96bc082ffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_f1fe21fa-088a-4265-b636-c96bc082ffd0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_05bce0ac-101f-4151-a78d-05cd82623b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4a75ebd4-eded-487f-b0bc-4a313ab17a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_c91bc6c2-f336-4d1b-ae7b-0c83fae57fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e2a06cc9-3596-49de-aa7c-1c8a2276d166" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a96c50b4-038a-480f-8be2-f5fdc78e9196" xlink:to="loc_us-gaap_StatementTable_e2a06cc9-3596-49de-aa7c-1c8a2276d166" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e2a06cc9-3596-49de-aa7c-1c8a2276d166" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c" xlink:to="loc_us-gaap_EquityComponentDomain_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f2782bb-25f4-4628-af20-62447e72ba98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c" xlink:to="loc_us-gaap_EquityComponentDomain_9f2782bb-25f4-4628-af20-62447e72ba98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f2782bb-25f4-4628-af20-62447e72ba98" xlink:to="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_06cd5645-e70a-40e8-8f7b-8a64aed8f5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_CommonStockMember_06cd5645-e70a-40e8-8f7b-8a64aed8f5cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_45371b24-caa1-45e6-a6be-cfb25a4ee12b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_TreasuryStockCommonMember_45371b24-caa1-45e6-a6be-cfb25a4ee12b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b3334a48-d6cb-4e63-bf07-827aae36a4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b3334a48-d6cb-4e63-bf07-827aae36a4c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9c789719-c6d4-40eb-ab16-2342835b6142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_RetainedEarningsMember_9c789719-c6d4-40eb-ab16-2342835b6142" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f249cd7e-ec07-4a00-8af9-99a2558196bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f249cd7e-ec07-4a00-8af9-99a2558196bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_1e60f8d3-ed04-44fa-8bb4-274952219730" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f2782bb-25f4-4628-af20-62447e72ba98" xlink:to="loc_us-gaap_NoncontrollingInterestMember_1e60f8d3-ed04-44fa-8bb4-274952219730" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IntellectualPropertyAgreementTerm_4fd6855a-d121-470b-ae2e-029746c27630" xlink:href="ew-20230930.xsd#ew_IntellectualPropertyAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_ew_IntellectualPropertyAgreementTerm_4fd6855a-d121-470b-ae2e-029746c27630" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_176da43d-3703-4c78-8415-f589561ef9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_176da43d-3703-4c78-8415-f589561ef9d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_eb4bfa58-b5ad-46da-b66f-78894890d737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_us-gaap_LitigationSettlementExpense_eb4bfa58-b5ad-46da-b66f-78894890d737" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRoyalties_755ce066-83f9-46ae-8308-29a64ef8e78c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_us-gaap_PrepaidRoyalties_755ce066-83f9-46ae-8308-29a64ef8e78c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c2e37739-74e0-431b-b19d-385778ac91a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_us-gaap_LossContingenciesTable_c2e37739-74e0-431b-b19d-385778ac91a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e719c0f4-dc07-4922-b19d-7bf99cbee420" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c2e37739-74e0-431b-b19d-385778ac91a1" xlink:to="loc_srt_LitigationCaseAxis_e719c0f4-dc07-4922-b19d-7bf99cbee420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e719c0f4-dc07-4922-b19d-7bf99cbee420_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_e719c0f4-dc07-4922-b19d-7bf99cbee420" xlink:to="loc_srt_LitigationCaseTypeDomain_e719c0f4-dc07-4922-b19d-7bf99cbee420_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b91f3964-c005-49b8-ae66-7df6c8a41f39" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_e719c0f4-dc07-4922-b19d-7bf99cbee420" xlink:to="loc_srt_LitigationCaseTypeDomain_b91f3964-c005-49b8-ae66-7df6c8a41f39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedtronicIncMember_d169a2cf-95f9-4ee7-9b9c-93913d526657" xlink:href="ew-20230930.xsd#ew_MedtronicIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b91f3964-c005-49b8-ae66-7df6c8a41f39" xlink:to="loc_ew_MedtronicIncMember_d169a2cf-95f9-4ee7-9b9c-93913d526657" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SPECIALCHARGEDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#SPECIALCHARGEDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/SPECIALCHARGEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_52b3930c-3765-43fa-8dbd-cbb768749a31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_58c9a384-246f-44ae-b54b-4b9afe478958" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_52b3930c-3765-43fa-8dbd-cbb768749a31" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_58c9a384-246f-44ae-b54b-4b9afe478958" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestructuringContingentConsiderationGainLoss_a1e2b225-b626-446d-9de8-abd135b80717" xlink:href="ew-20230930.xsd#ew_RestructuringContingentConsiderationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_52b3930c-3765-43fa-8dbd-cbb768749a31" xlink:to="loc_ew_RestructuringContingentConsiderationGainLoss_a1e2b225-b626-446d-9de8-abd135b80717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e3d5c4f6-4665-4c2d-9b89-c4ee83e26a99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_52b3930c-3765-43fa-8dbd-cbb768749a31" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e3d5c4f6-4665-4c2d-9b89-c4ee83e26a99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_44242050-d49f-4ec2-86d6-987818b32c73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e3d5c4f6-4665-4c2d-9b89-c4ee83e26a99" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_44242050-d49f-4ec2-86d6-987818b32c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_44242050-d49f-4ec2-86d6-987818b32c73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44242050-d49f-4ec2-86d6-987818b32c73" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_44242050-d49f-4ec2-86d6-987818b32c73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cb9873ae-2e4d-47a5-bb42-dc451656d649" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44242050-d49f-4ec2-86d6-987818b32c73" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cb9873ae-2e4d-47a5-bb42-dc451656d649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SpecialChargeMember_2eacf452-ae44-41d6-9e11-90e75d57b254" xlink:href="ew-20230930.xsd#ew_SpecialChargeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cb9873ae-2e4d-47a5-bb42-dc451656d649" xlink:to="loc_ew_SpecialChargeMember_2eacf452-ae44-41d6-9e11-90e75d57b254" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_29da2dd1-415a-40bf-8511-4425c6fb02ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cb9873ae-2e4d-47a5-bb42-dc451656d649" xlink:to="loc_us-gaap_CostOfSalesMember_29da2dd1-415a-40bf-8511-4425c6fb02ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_41a120f4-cdf9-4a14-881c-75e9485044b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_41a120f4-cdf9-4a14-881c-75e9485044b5" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_e7534364-656d-434e-b675-7e90951585fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:to="loc_us-gaap_HeldToMaturitySecurities_e7534364-656d-434e-b675-7e90951585fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_80d74435-7660-4d24-9d6a-836435763791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_80d74435-7660-4d24-9d6a-836435763791" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_a9b1a991-938e-45e5-bc7a-c14c3994acfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_a9b1a991-938e-45e5-bc7a-c14c3994acfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d913d4be-fa0a-452c-aa3b-a1f0cc26796b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d913d4be-fa0a-452c-aa3b-a1f0cc26796b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_41a120f4-cdf9-4a14-881c-75e9485044b5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3444ad72-e2c4-4c39-92fb-ffd575809ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3444ad72-e2c4-4c39-92fb-ffd575809ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e124945-f5b9-413b-a4d3-f187b5a96964" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e124945-f5b9-413b-a4d3-f187b5a96964" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a37acaf4-6920-404c-b8db-d40e242c8bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a37acaf4-6920-404c-b8db-d40e242c8bc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_57c3c6d5-7a2a-4aee-8c50-3175f4f7c2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_57c3c6d5-7a2a-4aee-8c50-3175f4f7c2ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_a900d44b-75e9-4713-8895-ac21ce4aba8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_41a120f4-cdf9-4a14-881c-75e9485044b5" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_a900d44b-75e9-4713-8895-ac21ce4aba8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_bc778ab7-659d-418d-a644-fea07baec739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_a900d44b-75e9-4713-8895-ac21ce4aba8c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_bc778ab7-659d-418d-a644-fea07baec739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc778ab7-659d-418d-a644-fea07baec739_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bc778ab7-659d-418d-a644-fea07baec739" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc778ab7-659d-418d-a644-fea07baec739_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bc778ab7-659d-418d-a644-fea07baec739" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_8b795bff-5a1a-4fbf-a4fa-2d1c13fe6189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_BankTimeDepositsMember_8b795bff-5a1a-4fbf-a4fa-2d1c13fe6189" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_985caaf0-c508-4867-8cd7-3d1268b18391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_985caaf0-c508-4867-8cd7-3d1268b18391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e84647d0-f6df-41c5-a0f7-a7f4a4a69194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e84647d0-f6df-41c5-a0f7-a7f4a4a69194" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6adfbcfb-0273-4513-9a34-83037cac7de6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6adfbcfb-0273-4513-9a34-83037cac7de6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_bd4807f3-1f8d-4d19-92ad-098c7ae1864c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_MunicipalBondsMember_bd4807f3-1f8d-4d19-92ad-098c7ae1864c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_502521a2-cccd-44ac-801e-58b6457a97e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_502521a2-cccd-44ac-801e-58b6457a97e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c37ae703-5ec8-4bc2-aa7a-728653b8fe3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c37ae703-5ec8-4bc2-aa7a-728653b8fe3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_62392743-76e9-4cb3-ac65-a38fc9e15538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_62392743-76e9-4cb3-ac65-a38fc9e15538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_75f95eee-b8a3-4d3c-9fd6-81e71bc12967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_75f95eee-b8a3-4d3c-9fd6-81e71bc12967" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_61431ca6-54bf-40c0-b554-13a87b6f26b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_61431ca6-54bf-40c0-b554-13a87b6f26b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5beb2578-4450-40cf-a889-2df123c10664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5beb2578-4450-40cf-a889-2df123c10664" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6896a461-bc4b-4e3c-92cf-17f08952be9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6896a461-bc4b-4e3c-92cf-17f08952be9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1342fb52-ef52-4703-b6c0-d97088f32087" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6896a461-bc4b-4e3c-92cf-17f08952be9c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1342fb52-ef52-4703-b6c0-d97088f32087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1342fb52-ef52-4703-b6c0-d97088f32087_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1342fb52-ef52-4703-b6c0-d97088f32087" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1342fb52-ef52-4703-b6c0-d97088f32087_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1342fb52-ef52-4703-b6c0-d97088f32087" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_12c315fc-2bf8-47c3-a1e5-8ad183dcf125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_12c315fc-2bf8-47c3-a1e5-8ad183dcf125" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_5e5492ee-157e-4e60-9e8c-5195e22b9faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_5e5492ee-157e-4e60-9e8c-5195e22b9faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_4ae0cb5a-3518-4014-84a4-85faf877ede8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_4ae0cb5a-3518-4014-84a4-85faf877ede8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_2096da9b-44b8-4b1a-ba6e-084b0c97b3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:to="loc_us-gaap_MunicipalBondsMember_2096da9b-44b8-4b1a-ba6e-084b0c97b3c3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INVESTMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d56fdcce-af83-405c-9c85-51bc4d9879c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_EquityMethodInvestments_d56fdcce-af83-405c-9c85-51bc4d9879c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_32c7f3ee-e05a-4b1e-b0e6-f29706c25895" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_32c7f3ee-e05a-4b1e-b0e6-f29706c25895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquityMethodInvestmentsInvestmentPeriod_1a7e6fc0-bbbb-49f7-86b7-ebeadffe866f" xlink:href="ew-20230930.xsd#ew_EquityMethodInvestmentsInvestmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_ew_EquityMethodInvestmentsInvestmentPeriod_1a7e6fc0-bbbb-49f7-86b7-ebeadffe866f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_3762d519-9108-4ed7-8b84-1918dd87f115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_3762d519-9108-4ed7-8b84-1918dd87f115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_a4278374-2b2e-4485-9ac9-16d1443fc636" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_a4278374-2b2e-4485-9ac9-16d1443fc636" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40bee3d9-6f11-4383-b572-294465278e28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40bee3d9-6f11-4383-b572-294465278e28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_40bee3d9-6f11-4383-b572-294465278e28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40bee3d9-6f11-4383-b572-294465278e28" xlink:to="loc_us-gaap_RelatedPartyDomain_40bee3d9-6f11-4383-b572-294465278e28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f8d51f03-e336-4e89-81eb-f1fe2a0d4b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40bee3d9-6f11-4383-b572-294465278e28" xlink:to="loc_us-gaap_RelatedPartyDomain_f8d51f03-e336-4e89-81eb-f1fe2a0d4b81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember_26828572-2657-4fda-b469-6920d7500f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_f8d51f03-e336-4e89-81eb-f1fe2a0d4b81" xlink:to="loc_us-gaap_LimitedLiabilityCompanyMember_26828572-2657-4fda-b469-6920d7500f9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d9518313-35bf-4abb-82c4-48addc17b94c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d9518313-35bf-4abb-82c4-48addc17b94c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d9518313-35bf-4abb-82c4-48addc17b94c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9518313-35bf-4abb-82c4-48addc17b94c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d9518313-35bf-4abb-82c4-48addc17b94c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_949749b6-8406-4ca4-9f79-58a9f8a55851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9518313-35bf-4abb-82c4-48addc17b94c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_949749b6-8406-4ca4-9f79-58a9f8a55851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5a69ab45-1704-4765-bba9-4dd53387dfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_949749b6-8406-4ca4-9f79-58a9f8a55851" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5a69ab45-1704-4765-bba9-4dd53387dfbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4488146-42bd-4275-8394-4b9d149060a1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4488146-42bd-4275-8394-4b9d149060a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b4488146-42bd-4275-8394-4b9d149060a1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4488146-42bd-4275-8394-4b9d149060a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b4488146-42bd-4275-8394-4b9d149060a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bfde26e5-9aff-4a72-b7d7-a722103db3b2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4488146-42bd-4275-8394-4b9d149060a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bfde26e5-9aff-4a72-b7d7-a722103db3b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NewMarketsTaxCreditMember_585ffbf6-301d-4628-b5c4-3ccf66fe94d5" xlink:href="ew-20230930.xsd#ew_NewMarketsTaxCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bfde26e5-9aff-4a72-b7d7-a722103db3b2" xlink:to="loc_ew_NewMarketsTaxCreditMember_585ffbf6-301d-4628-b5c4-3ccf66fe94d5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSINVARIABLEINTERESTENTITIESDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LoansReceivablesMaximumLendingCapacity_2c1c26dc-f8d4-4a3d-a4f6-e4ddb6c8fbfe" xlink:href="ew-20230930.xsd#ew_LoansReceivablesMaximumLendingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_LoansReceivablesMaximumLendingCapacity_2c1c26dc-f8d4-4a3d-a4f6-e4ddb6c8fbfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_79f363aa-0023-4054-9e7e-1247e2fd3fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_79f363aa-0023-4054-9e7e-1247e2fd3fb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross_72aee1d8-59ad-4ee6-88ed-2ef41f87b566" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_us-gaap_NotesReceivableGross_72aee1d8-59ad-4ee6-88ed-2ef41f87b566" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_3dca40cb-b67f-4829-a13f-83c332e83094" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_3dca40cb-b67f-4829-a13f-83c332e83094" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_df3b0524-2f80-4a4e-8196-e22aada9dd7d" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIPromissoryNoteOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_df3b0524-2f80-4a4e-8196-e22aada9dd7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_69a1f274-6bc5-48a4-be6b-cbe2c4e4f7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_69a1f274-6bc5-48a4-be6b-cbe2c4e4f7ef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_e038c168-2ed2-4250-86fd-7b20b8c0fb48" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIOptionToAcquireInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_e038c168-2ed2-4250-86fd-7b20b8c0fb48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_fea3fa46-3663-4182-a19f-23db634e6bae" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_fea3fa46-3663-4182-a19f-23db634e6bae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_562a036a-c123-4fc7-a007-16ea5dfca471" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_562a036a-c123-4fc7-a007-16ea5dfca471" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_OptionToAcquireInvestmentAmount_42569d33-d0ce-4404-a6d2-d99eb2b27c15" xlink:href="ew-20230930.xsd#ew_OptionToAcquireInvestmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_OptionToAcquireInvestmentAmount_42569d33-d0ce-4404-a6d2-d99eb2b27c15" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumPromissoryNote_58a715fa-48d3-4d34-8ce9-0527cebc38c0" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumPromissoryNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumPromissoryNote_58a715fa-48d3-4d34-8ce9-0527cebc38c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_44d722ef-59fd-4f91-b7f1-df4d54c9bac8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_srt_CounterpartyNameAxis_44d722ef-59fd-4f91-b7f1-df4d54c9bac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_44d722ef-59fd-4f91-b7f1-df4d54c9bac8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_44d722ef-59fd-4f91-b7f1-df4d54c9bac8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_44d722ef-59fd-4f91-b7f1-df4d54c9bac8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b360c67-3f77-4ba3-9d94-0775e1ed8249" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_44d722ef-59fd-4f91-b7f1-df4d54c9bac8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b360c67-3f77-4ba3-9d94-0775e1ed8249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember_aca5aa43-87ff-4b28-b0a5-4e6022a5056c" xlink:href="ew-20230930.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b360c67-3f77-4ba3-9d94-0775e1ed8249" xlink:to="loc_ew_MedicalDeviceCompanyMember_aca5aa43-87ff-4b28-b0a5-4e6022a5056c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalTechnologyCompanyMember_647a5e77-3af8-45e1-9ef8-37d3e0e34744" xlink:href="ew-20230930.xsd#ew_MedicalTechnologyCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b360c67-3f77-4ba3-9d94-0775e1ed8249" xlink:to="loc_ew_MedicalTechnologyCompanyMember_647a5e77-3af8-45e1-9ef8-37d3e0e34744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_adf7d322-e49a-47f4-98d5-bdd64918fa0e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_srt_ConsolidatedEntitiesAxis_adf7d322-e49a-47f4-98d5-bdd64918fa0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_adf7d322-e49a-47f4-98d5-bdd64918fa0e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_adf7d322-e49a-47f4-98d5-bdd64918fa0e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_adf7d322-e49a-47f4-98d5-bdd64918fa0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c93bbb3f-5d45-4f08-9e2b-e17ebf13ab81" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_adf7d322-e49a-47f4-98d5-bdd64918fa0e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c93bbb3f-5d45-4f08-9e2b-e17ebf13ab81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cf78e585-19a6-4a42-97f1-4e6fbe106a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c93bbb3f-5d45-4f08-9e2b-e17ebf13ab81" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cf78e585-19a6-4a42-97f1-4e6fbe106a90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_27eb188b-74fc-40ea-abba-a2c28bfaf413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_us-gaap_DebtInstrumentAxis_27eb188b-74fc-40ea-abba-a2c28bfaf413" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_27eb188b-74fc-40ea-abba-a2c28bfaf413_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_27eb188b-74fc-40ea-abba-a2c28bfaf413" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_27eb188b-74fc-40ea-abba-a2c28bfaf413_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_afdfe18e-2dca-404b-9acb-dcfc2a1a5b57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_27eb188b-74fc-40ea-abba-a2c28bfaf413" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_afdfe18e-2dca-404b-9acb-dcfc2a1a5b57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ConvertiblePromissoryNoteMember_eb2e3ea5-fe7d-4d40-8235-2b02a61a9e91" xlink:href="ew-20230930.xsd#ew_ConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afdfe18e-2dca-404b-9acb-dcfc2a1a5b57" xlink:to="loc_ew_ConvertiblePromissoryNoteMember_eb2e3ea5-fe7d-4d40-8235-2b02a61a9e91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_045eb1ca-2d1a-43ac-aa5e-d2834904ddca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_045eb1ca-2d1a-43ac-aa5e-d2834904ddca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_045eb1ca-2d1a-43ac-aa5e-d2834904ddca_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_045eb1ca-2d1a-43ac-aa5e-d2834904ddca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_045eb1ca-2d1a-43ac-aa5e-d2834904ddca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9c457adc-adf6-409a-86c2-9dc68f3f3ef0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_045eb1ca-2d1a-43ac-aa5e-d2834904ddca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9c457adc-adf6-409a-86c2-9dc68f3f3ef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember_b4fc0a2c-0c79-4f89-80a1-991d6390a4ec" xlink:href="ew-20230930.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9c457adc-adf6-409a-86c2-9dc68f3f3ef0" xlink:to="loc_ew_MedicalDeviceCompanyMember_b4fc0a2c-0c79-4f89-80a1-991d6390a4ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_76e56c48-827c-4aa9-890b-cea1e7452f75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_us-gaap_InvestmentTypeAxis_76e56c48-827c-4aa9-890b-cea1e7452f75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_76e56c48-827c-4aa9-890b-cea1e7452f75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_76e56c48-827c-4aa9-890b-cea1e7452f75" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_76e56c48-827c-4aa9-890b-cea1e7452f75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_5c946e22-7848-4034-9910-b75e8430571e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_76e56c48-827c-4aa9-890b-cea1e7452f75" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_5c946e22-7848-4034-9910-b75e8430571e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_053bfc19-27de-447b-984e-ed6dae4b589a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5c946e22-7848-4034-9910-b75e8430571e" xlink:to="loc_us-gaap_EquitySecuritiesMember_053bfc19-27de-447b-984e-ed6dae4b589a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#BUSINESSCOMBINATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ea8d4d55-4949-4bd3-9977-3a46932daf92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_82e21ce6-d4ea-44da-a70d-b3d52ca915f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea8d4d55-4949-4bd3-9977-3a46932daf92" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_82e21ce6-d4ea-44da-a70d-b3d52ca915f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea8d4d55-4949-4bd3-9977-3a46932daf92" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_aa14b108-d7fa-4339-9d62-9b73db29beef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_aa14b108-d7fa-4339-9d62-9b73db29beef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aa14b108-d7fa-4339-9d62-9b73db29beef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aa14b108-d7fa-4339-9d62-9b73db29beef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aa14b108-d7fa-4339-9d62-9b73db29beef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f8db21d-3c23-4c0f-85c7-70cd0d99e228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aa14b108-d7fa-4339-9d62-9b73db29beef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f8db21d-3c23-4c0f-85c7-70cd0d99e228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalTechnologyCompanyMember_bed8ae75-b1e8-4e97-9ba4-7ec1d9912b02" xlink:href="ew-20230930.xsd#ew_MedicalTechnologyCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f8db21d-3c23-4c0f-85c7-70cd0d99e228" xlink:to="loc_ew_MedicalTechnologyCompanyMember_bed8ae75-b1e8-4e97-9ba4-7ec1d9912b02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_068b949f-8985-402a-b6d3-a0312acd375b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_068b949f-8985-402a-b6d3-a0312acd375b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_068b949f-8985-402a-b6d3-a0312acd375b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_068b949f-8985-402a-b6d3-a0312acd375b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_068b949f-8985-402a-b6d3-a0312acd375b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_bd0b779c-b25e-49e6-b48b-7a51d08057d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_068b949f-8985-402a-b6d3-a0312acd375b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_bd0b779c-b25e-49e6-b48b-7a51d08057d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_528187d0-b877-4315-be3d-fa487ab5d806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_bd0b779c-b25e-49e6-b48b-7a51d08057d1" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_528187d0-b877-4315-be3d-fa487ab5d806" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2df543ea-6971-4aa2-adf0-81f636a4a1df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2df543ea-6971-4aa2-adf0-81f636a4a1df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_93f47b35-4911-4d6b-aa19-6fcbad058849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_Goodwill_93f47b35-4911-4d6b-aa19-6fcbad058849" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1ff6f558-87ca-4453-81e0-b46cd5b57905" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1ff6f558-87ca-4453-81e0-b46cd5b57905" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3ce6ff2f-5e1e-42a3-a0bc-4f2552de3bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3ce6ff2f-5e1e-42a3-a0bc-4f2552de3bac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0015bb16-7d8d-4923-a6d6-cf107da323b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0015bb16-7d8d-4923-a6d6-cf107da323b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f145fd60-098c-4b91-9596-46afffaea69a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f145fd60-098c-4b91-9596-46afffaea69a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_08629f06-fbb0-4a67-b525-8ca7d469bdda" xlink:href="ew-20230930.xsd#ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_08629f06-fbb0-4a67-b525-8ca7d469bdda" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_312788f9-2403-4fdb-b38a-daacd5d3d168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_312788f9-2403-4fdb-b38a-daacd5d3d168" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_939dbecc-6b2e-4e51-84ad-d73924362706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_939dbecc-6b2e-4e51-84ad-d73924362706" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_25b755d8-526a-456a-92d1-b59c4bf9bdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_25b755d8-526a-456a-92d1-b59c4bf9bdf0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_553fb5a1-8caa-4e29-8484-54401c749d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_553fb5a1-8caa-4e29-8484-54401c749d2d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment_147d02d4-5b96-4ff3-a2c8-96bd1b620ccc" xlink:href="ew-20230930.xsd#ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment_147d02d4-5b96-4ff3-a2c8-96bd1b620ccc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_2c04688c-33ee-4e37-8817-9095edd4d527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_2c04688c-33ee-4e37-8817-9095edd4d527" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_7fff5786-c4c4-420d-a2be-c553ae25980b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_7fff5786-c4c4-420d-a2be-c553ae25980b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8814f231-387e-4409-8afd-32b9d5ee0b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8814f231-387e-4409-8afd-32b9d5ee0b5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8814f231-387e-4409-8afd-32b9d5ee0b5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8814f231-387e-4409-8afd-32b9d5ee0b5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8814f231-387e-4409-8afd-32b9d5ee0b5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381d2043-dde8-4db0-8ced-ee69f2ca4002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8814f231-387e-4409-8afd-32b9d5ee0b5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381d2043-dde8-4db0-8ced-ee69f2ca4002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalTechnologyCompanyMember_caa55c5e-e859-4a5e-83dd-a6d1e1144526" xlink:href="ew-20230930.xsd#ew_MedicalTechnologyCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381d2043-dde8-4db0-8ced-ee69f2ca4002" xlink:to="loc_ew_MedicalTechnologyCompanyMember_caa55c5e-e859-4a5e-83dd-a6d1e1144526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_821be66f-64ad-420a-bb9d-d357b84d4f0a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:to="loc_srt_ConsolidatedEntitiesAxis_821be66f-64ad-420a-bb9d-d357b84d4f0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_821be66f-64ad-420a-bb9d-d357b84d4f0a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_821be66f-64ad-420a-bb9d-d357b84d4f0a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_821be66f-64ad-420a-bb9d-d357b84d4f0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f72b76e7-2c4e-4484-9b75-e32dcebf2665" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_821be66f-64ad-420a-bb9d-d357b84d4f0a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f72b76e7-2c4e-4484-9b75-e32dcebf2665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_e37db47d-5139-4c5b-9b1d-18ef32f64308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f72b76e7-2c4e-4484-9b75-e32dcebf2665" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_e37db47d-5139-4c5b-9b1d-18ef32f64308" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_da29f12e-47c5-47e8-b1e1-7e9c0b3c7c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_da29f12e-47c5-47e8-b1e1-7e9c0b3c7c1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_65daa9d3-224c-4538-a977-6477da6e3ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_65daa9d3-224c-4538-a977-6477da6e3ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6fbeb798-12d7-47da-a7de-3760f2bf414f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6fbeb798-12d7-47da-a7de-3760f2bf414f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b17f06d0-36a7-4f50-9825-5587608c007d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b17f06d0-36a7-4f50-9825-5587608c007d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b17f06d0-36a7-4f50-9825-5587608c007d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b17f06d0-36a7-4f50-9825-5587608c007d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b17f06d0-36a7-4f50-9825-5587608c007d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2da1a3f-47e7-4828-99b5-204e2ff200e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b17f06d0-36a7-4f50-9825-5587608c007d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2da1a3f-47e7-4828-99b5-204e2ff200e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_644edb69-ecd6-4980-9223-f2dc674e3aca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2da1a3f-47e7-4828-99b5-204e2ff200e7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_644edb69-ecd6-4980-9223-f2dc674e3aca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_c34941a1-f73b-4560-8d8b-5ecc6b210eea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_c34941a1-f73b-4560-8d8b-5ecc6b210eea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c34941a1-f73b-4560-8d8b-5ecc6b210eea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_c34941a1-f73b-4560-8d8b-5ecc6b210eea" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c34941a1-f73b-4560-8d8b-5ecc6b210eea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_dc622b32-6e17-4183-ba3e-36c52e319fda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_c34941a1-f73b-4560-8d8b-5ecc6b210eea" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_dc622b32-6e17-4183-ba3e-36c52e319fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_4ffcbfe5-792a-4c3a-aef7-7d5f508b5154" xlink:href="ew-20230930.xsd#ew_MeasurementInputProbabilityOfMilestoneAchievementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dc622b32-6e17-4183-ba3e-36c52e319fda" xlink:to="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_4ffcbfe5-792a-4c3a-aef7-7d5f508b5154" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d97fdb69-fd07-4e65-8e31-9e30f2ba6242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d97fdb69-fd07-4e65-8e31-9e30f2ba6242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember_21de3ddf-1dc6-4142-988d-8d7665344edf" xlink:href="ew-20230930.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d97fdb69-fd07-4e65-8e31-9e30f2ba6242" xlink:to="loc_ew_ContingentConsiderationLiabilityMember_21de3ddf-1dc6-4142-988d-8d7665344edf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03cfefe9-6d4f-4008-b4d8-f5f6c8e8941c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03cfefe9-6d4f-4008-b4d8-f5f6c8e8941c" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d2010ff1-88f4-41b8-a0e8-9335a19f715f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d2010ff1-88f4-41b8-a0e8-9335a19f715f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dacbe2af-5d31-4d97-a8bf-438884b9a4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dacbe2af-5d31-4d97-a8bf-438884b9a4ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_17afd0a6-f734-4b7e-94c6-19051f054a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_17afd0a6-f734-4b7e-94c6-19051f054a7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9107ba8e-6e66-48ee-8c48-f2274a7ea015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_DerivativeAssets_9107ba8e-6e66-48ee-8c48-f2274a7ea015" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7618f26d-f19d-4504-8dd6-105da08bacf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7618f26d-f19d-4504-8dd6-105da08bacf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03cfefe9-6d4f-4008-b4d8-f5f6c8e8941c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ca296f1c-f865-4d80-b47f-eb725a9e1280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:to="loc_us-gaap_DerivativeLiabilities_ca296f1c-f865-4d80-b47f-eb725a9e1280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b761d75f-cc66-4a27-9866-2080e5aa939f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b761d75f-cc66-4a27-9866-2080e5aa939f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_2bff80fe-093e-4f21-9f20-08d383a44a56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_2bff80fe-093e-4f21-9f20-08d383a44a56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_565beab8-b7ea-420c-9391-0016ae3eb3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_565beab8-b7ea-420c-9391-0016ae3eb3c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03cfefe9-6d4f-4008-b4d8-f5f6c8e8941c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_a751cbde-3a45-44e7-a31c-5d6dd957c69d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_a751cbde-3a45-44e7-a31c-5d6dd957c69d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a751cbde-3a45-44e7-a31c-5d6dd957c69d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a751cbde-3a45-44e7-a31c-5d6dd957c69d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a751cbde-3a45-44e7-a31c-5d6dd957c69d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_28e45fea-c104-4c01-9f68-386e9d15eae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a751cbde-3a45-44e7-a31c-5d6dd957c69d" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_28e45fea-c104-4c01-9f68-386e9d15eae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b1ab5b62-a688-4720-bf31-3dc1b3cbe8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_28e45fea-c104-4c01-9f68-386e9d15eae7" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b1ab5b62-a688-4720-bf31-3dc1b3cbe8e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0488a204-974f-4bec-bfb7-9df8f68295cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b1ab5b62-a688-4720-bf31-3dc1b3cbe8e6" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0488a204-974f-4bec-bfb7-9df8f68295cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b971aa42-1a29-4426-835e-556f50c4c6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b971aa42-1a29-4426-835e-556f50c4c6a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_cad0bdb8-6073-4dc9-825d-1d4d802db8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b971aa42-1a29-4426-835e-556f50c4c6a6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_cad0bdb8-6073-4dc9-825d-1d4d802db8f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2af7fc74-aec1-45b6-bd5e-830815c121e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2af7fc74-aec1-45b6-bd5e-830815c121e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2bc3dfe2-178b-40b0-954b-5132be57b3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2bc3dfe2-178b-40b0-954b-5132be57b3d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3eb1ab19-c762-4f2a-b0a1-a90f3a3b4f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3eb1ab19-c762-4f2a-b0a1-a90f3a3b4f2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6afb4588-7f3d-4c73-88a5-c129458e976f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6afb4588-7f3d-4c73-88a5-c129458e976f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_7e48d151-2f87-46aa-a705-20b6e8b8f769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_7e48d151-2f87-46aa-a705-20b6e8b8f769" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_6b702a76-958e-4b8f-9434-bc0c440b5af3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_6b702a76-958e-4b8f-9434-bc0c440b5af3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_b6088e78-6a47-4113-a92c-c2a1523ed25b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:to="loc_us-gaap_MunicipalBondsMember_b6088e78-6a47-4113-a92c-c2a1523ed25b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a8f13035-102a-4325-9094-fe6c6f1520b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a8f13035-102a-4325-9094-fe6c6f1520b9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3e665964-5784-4287-b01f-5ce6fe6be44e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3e665964-5784-4287-b01f-5ce6fe6be44e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9879c0c0-dcba-4249-b20a-28910440e066" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9879c0c0-dcba-4249-b20a-28910440e066" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_21491717-7128-42d4-9443-09aa24bc2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a8f13035-102a-4325-9094-fe6c6f1520b9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df1edc5f-6f83-4c90-a9e8-6487670d7b67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df1edc5f-6f83-4c90-a9e8-6487670d7b67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember_36c264fb-a016-40ad-ac4e-499e482a5ab7" xlink:href="ew-20230930.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df1edc5f-6f83-4c90-a9e8-6487670d7b67" xlink:to="loc_ew_ContingentConsiderationLiabilityMember_36c264fb-a016-40ad-ac4e-499e482a5ab7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_8a4ad148-dfe2-4945-b3b6-d407a9848235" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df1edc5f-6f83-4c90-a9e8-6487670d7b67" xlink:to="loc_us-gaap_OtherLiabilitiesMember_8a4ad148-dfe2-4945-b3b6-d407a9848235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_696e4be2-78dd-4885-aba6-3c4288d424d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_696e4be2-78dd-4885-aba6-3c4288d424d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_274fc2db-a79a-4d0d-bf00-14ec0979bc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_696e4be2-78dd-4885-aba6-3c4288d424d2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_274fc2db-a79a-4d0d-bf00-14ec0979bc6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_243b7163-0cea-45d5-9474-720b367a9f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_243b7163-0cea-45d5-9474-720b367a9f8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_243b7163-0cea-45d5-9474-720b367a9f8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_243b7163-0cea-45d5-9474-720b367a9f8f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_243b7163-0cea-45d5-9474-720b367a9f8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd1bdad8-745a-47cf-b602-0b1bf8c633a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_243b7163-0cea-45d5-9474-720b367a9f8f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd1bdad8-745a-47cf-b602-0b1bf8c633a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_73d5b6f8-1d7a-4dde-9aa2-a611d591d996" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd1bdad8-745a-47cf-b602-0b1bf8c633a4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_73d5b6f8-1d7a-4dde-9aa2-a611d591d996" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_020e1b1d-aaed-44dd-ad05-35cfb2142366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_20c60f54-9a0e-4577-b4e4-131220796fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_020e1b1d-aaed-44dd-ad05-35cfb2142366" xlink:to="loc_us-gaap_DerivativeNotionalAmount_20c60f54-9a0e-4577-b4e4-131220796fb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_020e1b1d-aaed-44dd-ad05-35cfb2142366" xlink:to="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e09a3bf9-04af-4792-8d07-469808057866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:to="loc_us-gaap_HedgingDesignationAxis_e09a3bf9-04af-4792-8d07-469808057866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e09a3bf9-04af-4792-8d07-469808057866_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e09a3bf9-04af-4792-8d07-469808057866" xlink:to="loc_us-gaap_HedgingDesignationDomain_e09a3bf9-04af-4792-8d07-469808057866_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9070bdb7-4fff-48fa-a498-bdf66b846d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e09a3bf9-04af-4792-8d07-469808057866" xlink:to="loc_us-gaap_HedgingDesignationDomain_9070bdb7-4fff-48fa-a498-bdf66b846d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_add8996d-0434-460a-9b3e-256133ab80d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9070bdb7-4fff-48fa-a498-bdf66b846d40" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_add8996d-0434-460a-9b3e-256133ab80d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_27fd087f-0522-454e-82fb-9b70309b9738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_27fd087f-0522-454e-82fb-9b70309b9738" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_27fd087f-0522-454e-82fb-9b70309b9738_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_27fd087f-0522-454e-82fb-9b70309b9738" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_27fd087f-0522-454e-82fb-9b70309b9738_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8e5bcb4d-7af1-4c69-ad27-662bfa551565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_27fd087f-0522-454e-82fb-9b70309b9738" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8e5bcb4d-7af1-4c69-ad27-662bfa551565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_5ce14589-20e3-410a-8934-aa805de7c989" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e5bcb4d-7af1-4c69-ad27-662bfa551565" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_5ce14589-20e3-410a-8934-aa805de7c989" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_d6bebaed-7370-4455-93c6-85432e206534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e5bcb4d-7af1-4c69-ad27-662bfa551565" xlink:to="loc_us-gaap_CurrencySwapMember_d6bebaed-7370-4455-93c6-85432e206534" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_85bbae3d-7fd9-47c1-ba92-2c1ce9677fde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_85bbae3d-7fd9-47c1-ba92-2c1ce9677fde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2c1ee728-850d-4e1a-9a11-964b57ad1aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2c1ee728-850d-4e1a-9a11-964b57ad1aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_71be027e-040a-4006-bd1f-cc7b11aaf5de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_71be027e-040a-4006-bd1f-cc7b11aaf5de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:to="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd304a82-2bcd-445c-b825-56ff974f34af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd304a82-2bcd-445c-b825-56ff974f34af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dd304a82-2bcd-445c-b825-56ff974f34af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd304a82-2bcd-445c-b825-56ff974f34af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dd304a82-2bcd-445c-b825-56ff974f34af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d1772477-9bcf-4141-9e8d-8ab646da9e36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd304a82-2bcd-445c-b825-56ff974f34af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d1772477-9bcf-4141-9e8d-8ab646da9e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_dd2860c4-f6b6-49fb-935c-9f17a42b79d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d1772477-9bcf-4141-9e8d-8ab646da9e36" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_dd2860c4-f6b6-49fb-935c-9f17a42b79d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_cac3a5df-b4c8-425e-a6d1-4c136b10f28d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:to="loc_us-gaap_HedgingDesignationAxis_cac3a5df-b4c8-425e-a6d1-4c136b10f28d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cac3a5df-b4c8-425e-a6d1-4c136b10f28d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_cac3a5df-b4c8-425e-a6d1-4c136b10f28d" xlink:to="loc_us-gaap_HedgingDesignationDomain_cac3a5df-b4c8-425e-a6d1-4c136b10f28d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3de72a21-55ee-49bf-958b-de03354eded2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_cac3a5df-b4c8-425e-a6d1-4c136b10f28d" xlink:to="loc_us-gaap_HedgingDesignationDomain_3de72a21-55ee-49bf-958b-de03354eded2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f109cfe8-991f-44d4-a82e-2df4a0f54dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3de72a21-55ee-49bf-958b-de03354eded2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f109cfe8-991f-44d4-a82e-2df4a0f54dcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b5046deb-4807-45e2-b775-356bcad02d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b5046deb-4807-45e2-b775-356bcad02d7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_17a4d16d-26fa-4a60-8d77-aecdd64ec984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b5046deb-4807-45e2-b775-356bcad02d7a" xlink:to="loc_us-gaap_CurrencySwapMember_17a4d16d-26fa-4a60-8d77-aecdd64ec984" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_f90a7efc-a5b3-4c2c-a9fd-84e59f27819f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_b0285d9a-cdb9-4694-bc6e-bc78558ee78f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f90a7efc-a5b3-4c2c-a9fd-84e59f27819f" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_b0285d9a-cdb9-4694-bc6e-bc78558ee78f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_85268b0f-ff93-454a-8551-d1c61130f82f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_b0285d9a-cdb9-4694-bc6e-bc78558ee78f" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_85268b0f-ff93-454a-8551-d1c61130f82f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_0c0973ea-247e-458a-ab91-c8fb520263c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_b0285d9a-cdb9-4694-bc6e-bc78558ee78f" xlink:to="loc_us-gaap_DerivativeAssets_0c0973ea-247e-458a-ab91-c8fb520263c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_cbd21a1a-2fb6-4e33-98bf-1471110f6d77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f90a7efc-a5b3-4c2c-a9fd-84e59f27819f" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_cbd21a1a-2fb6-4e33-98bf-1471110f6d77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b01a2ce6-fdd9-4d94-8db7-9a3437a16dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_cbd21a1a-2fb6-4e33-98bf-1471110f6d77" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b01a2ce6-fdd9-4d94-8db7-9a3437a16dc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_03b86ca0-da74-416b-8c6d-f86c0a51b33b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_cbd21a1a-2fb6-4e33-98bf-1471110f6d77" xlink:to="loc_us-gaap_DerivativeLiabilities_03b86ca0-da74-416b-8c6d-f86c0a51b33b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f90a7efc-a5b3-4c2c-a9fd-84e59f27819f" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_efc99291-bdb2-4b62-a84d-2a92beae5f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:to="loc_us-gaap_HedgingDesignationAxis_efc99291-bdb2-4b62-a84d-2a92beae5f2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_efc99291-bdb2-4b62-a84d-2a92beae5f2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_efc99291-bdb2-4b62-a84d-2a92beae5f2e" xlink:to="loc_us-gaap_HedgingDesignationDomain_efc99291-bdb2-4b62-a84d-2a92beae5f2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5e060a33-91d7-4555-a2d8-b28c3d1e48e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_efc99291-bdb2-4b62-a84d-2a92beae5f2e" xlink:to="loc_us-gaap_HedgingDesignationDomain_5e060a33-91d7-4555-a2d8-b28c3d1e48e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_14e4aee9-6b1f-4d06-9420-ff010a62b3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5e060a33-91d7-4555-a2d8-b28c3d1e48e3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_14e4aee9-6b1f-4d06-9420-ff010a62b3eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f058b46e-3789-48aa-bdf2-5092ef55d115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f058b46e-3789-48aa-bdf2-5092ef55d115" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f058b46e-3789-48aa-bdf2-5092ef55d115_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f058b46e-3789-48aa-bdf2-5092ef55d115" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f058b46e-3789-48aa-bdf2-5092ef55d115_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d6cd3e8e-5045-4a1b-aee6-2cb26322684c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f058b46e-3789-48aa-bdf2-5092ef55d115" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d6cd3e8e-5045-4a1b-aee6-2cb26322684c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8a8f729b-71ff-4483-870b-aead0be64b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d6cd3e8e-5045-4a1b-aee6-2cb26322684c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8a8f729b-71ff-4483-870b-aead0be64b8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b5669b71-691d-409c-9452-89569d4f6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignExchangeContractMember_8a8f729b-71ff-4483-870b-aead0be64b8c" xlink:to="loc_us-gaap_CurrencySwapMember_b5669b71-691d-409c-9452-89569d4f6e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bf0eff9c-2710-43e5-8403-4f2af019b892" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bf0eff9c-2710-43e5-8403-4f2af019b892" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bf0eff9c-2710-43e5-8403-4f2af019b892_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bf0eff9c-2710-43e5-8403-4f2af019b892" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bf0eff9c-2710-43e5-8403-4f2af019b892_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9ad0a26f-3b8f-4d1e-9a65-4ae9e2fd3a06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bf0eff9c-2710-43e5-8403-4f2af019b892" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9ad0a26f-3b8f-4d1e-9a65-4ae9e2fd3a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrentMember_c56e6140-6990-4105-aac9-ee106212fb5c" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ad0a26f-3b8f-4d1e-9a65-4ae9e2fd3a06" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrentMember_c56e6140-6990-4105-aac9-ee106212fb5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_db634778-53df-426f-8881-7e99be2c9bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ad0a26f-3b8f-4d1e-9a65-4ae9e2fd3a06" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_db634778-53df-426f-8881-7e99be2c9bb5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_1e553c76-4ad3-4d4a-9d3a-a000873e600d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_1e553c76-4ad3-4d4a-9d3a-a000873e600d" xlink:to="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cb69fede-c9d7-46ef-9562-e4fd01675d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cb69fede-c9d7-46ef-9562-e4fd01675d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_870adb45-3810-47e5-a910-c2d91e0806eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_870adb45-3810-47e5-a910-c2d91e0806eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_2ba4109d-5d33-4706-aa47-d41f403a922f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeAssets_2ba4109d-5d33-4706-aa47-d41f403a922f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueNetAbstract_5d621775-a458-451a-aacd-b0b5734eeafa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeAssetFairValueNetAbstract_5d621775-a458-451a-aacd-b0b5734eeafa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_178a17e4-11cf-452a-ad0a-e56547cb315e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_5d621775-a458-451a-aacd-b0b5734eeafa" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_178a17e4-11cf-452a-ad0a-e56547cb315e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_5fe1de95-1b86-46e6-97d1-24ed3fae8f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_5d621775-a458-451a-aacd-b0b5734eeafa" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_5fe1de95-1b86-46e6-97d1-24ed3fae8f33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_ab755b29-2bda-4c38-ab7b-ff913bb20406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_ab755b29-2bda-4c38-ab7b-ff913bb20406" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_1e553c76-4ad3-4d4a-9d3a-a000873e600d" xlink:to="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a6a8291e-e8d4-454a-9ea8-4a1df62298d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a6a8291e-e8d4-454a-9ea8-4a1df62298d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_26aeaeb7-edde-48cd-8149-e48440f88d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_26aeaeb7-edde-48cd-8149-e48440f88d6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_45371b46-02d2-4660-9dfb-417e17042582" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_us-gaap_DerivativeLiabilities_45371b46-02d2-4660-9dfb-417e17042582" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_2c580cbb-860f-4535-8f49-c5a682dbb36a" xlink:href="ew-20230930.xsd#ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_2c580cbb-860f-4535-8f49-c5a682dbb36a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4c68e2b3-d63c-4190-bc90-1da552c65938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_2c580cbb-860f-4535-8f49-c5a682dbb36a" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4c68e2b3-d63c-4190-bc90-1da552c65938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_430085fb-cda4-407c-8e08-69162454a4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_2c580cbb-860f-4535-8f49-c5a682dbb36a" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_430085fb-cda4-407c-8e08-69162454a4aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_a487f373-8a5c-4427-ac59-7f2a6df1e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_a487f373-8a5c-4427-ac59-7f2a6df1e1c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_e2ac3863-f59a-46fb-92eb-d507c2ea108e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_1e553c76-4ad3-4d4a-9d3a-a000873e600d" xlink:to="loc_us-gaap_OffsettingAssetsTable_e2ac3863-f59a-46fb-92eb-d507c2ea108e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c6b28139-23f0-4311-8283-99b28be9eace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_e2ac3863-f59a-46fb-92eb-d507c2ea108e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c6b28139-23f0-4311-8283-99b28be9eace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c6b28139-23f0-4311-8283-99b28be9eace_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c6b28139-23f0-4311-8283-99b28be9eace" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c6b28139-23f0-4311-8283-99b28be9eace_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd2e46ff-3ac3-421a-8e13-6a58060d0036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c6b28139-23f0-4311-8283-99b28be9eace" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd2e46ff-3ac3-421a-8e13-6a58060d0036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_be65e096-0aa7-4e4e-944c-b2c7119fcdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2e46ff-3ac3-421a-8e13-6a58060d0036" xlink:to="loc_us-gaap_ForeignExchangeContractMember_be65e096-0aa7-4e4e-944c-b2c7119fcdbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_8a994651-0f48-4376-855e-575e45301cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2e46ff-3ac3-421a-8e13-6a58060d0036" xlink:to="loc_us-gaap_CurrencySwapMember_8a994651-0f48-4376-855e-575e45301cdc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fc036e83-c1bf-4742-a566-1e8be4553afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fc036e83-c1bf-4742-a566-1e8be4553afc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_93e3a8a6-358c-4222-8b0d-085622f3f0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_93e3a8a6-358c-4222-8b0d-085622f3f0ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_1f08ce60-f192-4556-9138-7c3094cdd3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_1f08ce60-f192-4556-9138-7c3094cdd3cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_cff742e0-c8c4-407d-9d43-f3a53aa4c861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_cff742e0-c8c4-407d-9d43-f3a53aa4c861" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3c4192e0-b364-445b-ad57-0f888e63cdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3c4192e0-b364-445b-ad57-0f888e63cdfd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_602f7c94-3639-446c-a0da-40bfe585eebf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_602f7c94-3639-446c-a0da-40bfe585eebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_602f7c94-3639-446c-a0da-40bfe585eebf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_602f7c94-3639-446c-a0da-40bfe585eebf" xlink:to="loc_us-gaap_HedgingRelationshipDomain_602f7c94-3639-446c-a0da-40bfe585eebf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_602f7c94-3639-446c-a0da-40bfe585eebf" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_8ce96da8-0383-427a-9044-d2b5b6ea36c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_8ce96da8-0383-427a-9044-d2b5b6ea36c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f7f22087-1b1a-4b9d-9465-3edc0dfd46d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f7f22087-1b1a-4b9d-9465-3edc0dfd46d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_f8809d4d-affe-4616-9fea-5f9aa9087cda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:to="loc_us-gaap_FairValueHedgingMember_f8809d4d-affe-4616-9fea-5f9aa9087cda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_99a60b4c-da2f-4765-aae6-83e43739e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_99a60b4c-da2f-4765-aae6-83e43739e29d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_99a60b4c-da2f-4765-aae6-83e43739e29d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99a60b4c-da2f-4765-aae6-83e43739e29d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_99a60b4c-da2f-4765-aae6-83e43739e29d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_224143fe-343e-48ef-81a9-b40fc42172b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99a60b4c-da2f-4765-aae6-83e43739e29d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_224143fe-343e-48ef-81a9-b40fc42172b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a8b32e85-6dff-4d9c-b2d6-d2560b053113" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_224143fe-343e-48ef-81a9-b40fc42172b1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a8b32e85-6dff-4d9c-b2d6-d2560b053113" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_a4b7a20d-2f00-4dc6-9021-534307b1e3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignExchangeContractMember_a8b32e85-6dff-4d9c-b2d6-d2560b053113" xlink:to="loc_us-gaap_CurrencySwapMember_a4b7a20d-2f00-4dc6-9021-534307b1e3c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c777334a-ccb5-4c22-981b-a827097ce7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_HedgingDesignationAxis_c777334a-ccb5-4c22-981b-a827097ce7a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c777334a-ccb5-4c22-981b-a827097ce7a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c777334a-ccb5-4c22-981b-a827097ce7a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_c777334a-ccb5-4c22-981b-a827097ce7a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_096a3731-424c-4058-89d5-3f3a327b20ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c777334a-ccb5-4c22-981b-a827097ce7a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_096a3731-424c-4058-89d5-3f3a327b20ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ab9d9f02-6906-4fca-a013-0d6e75d6ed0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_096a3731-424c-4058-89d5-3f3a327b20ea" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ab9d9f02-6906-4fca-a013-0d6e75d6ed0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_25564bc6-c4a6-4d36-bfcc-d1fbdca05042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_096a3731-424c-4058-89d5-3f3a327b20ea" xlink:to="loc_us-gaap_NondesignatedMember_25564bc6-c4a6-4d36-bfcc-d1fbdca05042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_88ac7f65-a09a-44a0-a8df-c19fc51943d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_88ac7f65-a09a-44a0-a8df-c19fc51943d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_88ac7f65-a09a-44a0-a8df-c19fc51943d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_88ac7f65-a09a-44a0-a8df-c19fc51943d2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_88ac7f65-a09a-44a0-a8df-c19fc51943d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_36b07121-6dd2-4688-8014-45dd9208c7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_88ac7f65-a09a-44a0-a8df-c19fc51943d2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_36b07121-6dd2-4688-8014-45dd9208c7f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3f570c41-9550-4f96-b976-b3057e87cfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_36b07121-6dd2-4688-8014-45dd9208c7f9" xlink:to="loc_us-gaap_CostOfSalesMember_3f570c41-9550-4f96-b976-b3057e87cfb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_9f06c640-bf9a-43f5-ac76-99205eb630d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_36b07121-6dd2-4688-8014-45dd9208c7f9" xlink:to="loc_us-gaap_InterestIncomeMember_9f06c640-bf9a-43f5-ac76-99205eb630d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bb5e4afb-4076-4abb-b2ab-c6a857f10eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bb5e4afb-4076-4abb-b2ab-c6a857f10eb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_21eeac42-e600-48dd-a101-2da4c2884097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_21eeac42-e600-48dd-a101-2da4c2884097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_284816e9-fc1b-425e-a0a2-cb19cb0a92ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_284816e9-fc1b-425e-a0a2-cb19cb0a92ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_7f20a621-7ba3-469e-8fd1-e879846cd049" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_7f20a621-7ba3-469e-8fd1-e879846cd049" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_cff16991-8b36-4308-b9bc-8b02be9fe1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_cff16991-8b36-4308-b9bc-8b02be9fe1ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_085857e8-c4c6-454f-9df2-157f8463deb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_085857e8-c4c6-454f-9df2-157f8463deb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05e9531d-7113-49ef-b020-cfb178502aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_085857e8-c4c6-454f-9df2-157f8463deb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05e9531d-7113-49ef-b020-cfb178502aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_35e8981b-67bd-49f6-9b1d-4151de24066c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_35e8981b-67bd-49f6-9b1d-4151de24066c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_35e8981b-67bd-49f6-9b1d-4151de24066c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_35e8981b-67bd-49f6-9b1d-4151de24066c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_35e8981b-67bd-49f6-9b1d-4151de24066c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bf10e5b4-a6dc-43a5-8a8f-a4616d8e6ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_35e8981b-67bd-49f6-9b1d-4151de24066c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bf10e5b4-a6dc-43a5-8a8f-a4616d8e6ddf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0c3c2130-ff0c-4589-9a85-2d5b457aa1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf10e5b4-a6dc-43a5-8a8f-a4616d8e6ddf" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0c3c2130-ff0c-4589-9a85-2d5b457aa1c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_33a08f30-be8b-4b34-8a24-48bf62d558a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_33a08f30-be8b-4b34-8a24-48bf62d558a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_33a08f30-be8b-4b34-8a24-48bf62d558a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_33a08f30-be8b-4b34-8a24-48bf62d558a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_33a08f30-be8b-4b34-8a24-48bf62d558a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4faeb4da-b3bc-4dff-a299-586fefc74cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_33a08f30-be8b-4b34-8a24-48bf62d558a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4faeb4da-b3bc-4dff-a299-586fefc74cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a75df2a4-42b9-40dc-a746-def64b17943d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4faeb4da-b3bc-4dff-a299-586fefc74cb3" xlink:to="loc_us-gaap_CostOfSalesMember_a75df2a4-42b9-40dc-a746-def64b17943d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9b3d9e5e-3613-4268-9296-288ce066b8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4faeb4da-b3bc-4dff-a299-586fefc74cb3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9b3d9e5e-3613-4268-9296-288ce066b8a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_9612b266-32e8-433b-9ee7-792147353d23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:to="loc_us-gaap_HedgingDesignationAxis_9612b266-32e8-433b-9ee7-792147353d23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9612b266-32e8-433b-9ee7-792147353d23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_9612b266-32e8-433b-9ee7-792147353d23" xlink:to="loc_us-gaap_HedgingDesignationDomain_9612b266-32e8-433b-9ee7-792147353d23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_720ffec4-26bd-4527-8d9e-af26f700960c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_9612b266-32e8-433b-9ee7-792147353d23" xlink:to="loc_us-gaap_HedgingDesignationDomain_720ffec4-26bd-4527-8d9e-af26f700960c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_37f4c644-94cb-4cca-8fa6-870ab0ea3219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_720ffec4-26bd-4527-8d9e-af26f700960c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_37f4c644-94cb-4cca-8fa6-870ab0ea3219" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3eacf91-b3f3-46b2-8f07-cfd333f38670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3eacf91-b3f3-46b2-8f07-cfd333f38670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b9bd0d99-7bad-49dd-b832-edd675a8d94b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b9bd0d99-7bad-49dd-b832-edd675a8d94b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_8fdb2310-5720-4284-b3d7-cd23b72c0f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_8fdb2310-5720-4284-b3d7-cd23b72c0f0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2d19dac3-5a17-4415-baa4-012a1d7b315f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2d19dac3-5a17-4415-baa4-012a1d7b315f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2d19dac3-5a17-4415-baa4-012a1d7b315f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_23d9dd52-dce1-42af-9283-8160c7c4f092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:to="loc_us-gaap_CostOfSalesMember_23d9dd52-dce1-42af-9283-8160c7c4f092" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_64073977-242e-42f1-8d34-89dce6c34ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_64073977-242e-42f1-8d34-89dce6c34ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3c57e376-4c14-4aed-8a60-f2f81b1e72ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3c57e376-4c14-4aed-8a60-f2f81b1e72ed" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_83233517-dfd4-434b-ae45-115657429491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_83233517-dfd4-434b-ae45-115657429491" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d101f238-2503-40ac-ad59-d73a22b6b4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d101f238-2503-40ac-ad59-d73a22b6b4d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b467a285-040b-4b7d-9a1b-0f3a9d7a5fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b467a285-040b-4b7d-9a1b-0f3a9d7a5fbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fe3abc60-55cd-4d2d-9044-ef99a10247d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fe3abc60-55cd-4d2d-9044-ef99a10247d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d1d7edcc-cb27-4d84-aa89-fee1faa72884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d1d7edcc-cb27-4d84-aa89-fee1faa72884" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_950137a7-0da8-4794-9327-596ba0695efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_950137a7-0da8-4794-9327-596ba0695efe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod_18a8bbf1-5aa7-487a-94d0-287643cf6a95" xlink:href="ew-20230930.xsd#ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod_18a8bbf1-5aa7-487a-94d0-287643cf6a95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget_bee4a353-95f1-4e42-a2b4-e849dc508406" xlink:href="ew-20230930.xsd#ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget_bee4a353-95f1-4e42-a2b4-e849dc508406" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3eb9ed58-99fa-47f1-8481-ce086528c3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3eb9ed58-99fa-47f1-8481-ce086528c3bb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ef2d59bb-613b-4353-a190-1ee2ac9c60ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ef2d59bb-613b-4353-a190-1ee2ac9c60ea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:to="loc_us-gaap_AwardTypeAxis_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32d5273d-c3b2-437b-b0bb-4b09864aea8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32d5273d-c3b2-437b-b0bb-4b09864aea8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4a9bed20-4e4d-4a5b-9806-3b18e52f10f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32d5273d-c3b2-437b-b0bb-4b09864aea8d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4a9bed20-4e4d-4a5b-9806-3b18e52f10f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MarketBasedRestrictedStockUnitsMember_001cd3a3-93d8-4b69-8032-24a23b3074e8" xlink:href="ew-20230930.xsd#ew_MarketBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32d5273d-c3b2-437b-b0bb-4b09864aea8d" xlink:to="loc_ew_MarketBasedRestrictedStockUnitsMember_001cd3a3-93d8-4b69-8032-24a23b3074e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_eaf6e918-6fc1-4db0-b848-62d409bad609" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:to="loc_srt_RangeAxis_eaf6e918-6fc1-4db0-b848-62d409bad609" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eaf6e918-6fc1-4db0-b848-62d409bad609_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_eaf6e918-6fc1-4db0-b848-62d409bad609" xlink:to="loc_srt_RangeMember_eaf6e918-6fc1-4db0-b848-62d409bad609_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8cc326cb-20ea-45cc-a49d-7319029323d8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_eaf6e918-6fc1-4db0-b848-62d409bad609" xlink:to="loc_srt_RangeMember_8cc326cb-20ea-45cc-a49d-7319029323d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_592b3d50-1c97-4bf5-b47c-318a4ddde860" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8cc326cb-20ea-45cc-a49d-7319029323d8" xlink:to="loc_srt_MinimumMember_592b3d50-1c97-4bf5-b47c-318a4ddde860" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0e866504-6dea-4d5a-90ff-7c3d53c0ad20" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8cc326cb-20ea-45cc-a49d-7319029323d8" xlink:to="loc_srt_MaximumMember_0e866504-6dea-4d5a-90ff-7c3d53c0ad20" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_de293fd4-fa49-4575-bc19-06a21943a929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_de293fd4-fa49-4575-bc19-06a21943a929" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_56c5a12a-b7a9-486e-a5eb-719739857447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_56c5a12a-b7a9-486e-a5eb-719739857447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ff60c936-def8-47b7-8d87-74c7507b05fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ff60c936-def8-47b7-8d87-74c7507b05fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5f8f7f44-0d56-46fb-b5a4-ce0b704fce12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5f8f7f44-0d56-46fb-b5a4-ce0b704fce12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_151ef924-4239-43c8-828d-bbc781c9cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_151ef924-4239-43c8-828d-bbc781c9cf5d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_931aaedd-101a-4a7b-8d3d-6786e64d8db0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_931aaedd-101a-4a7b-8d3d-6786e64d8db0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ae7870ee-662a-40dc-97a6-57a4ae37886a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_931aaedd-101a-4a7b-8d3d-6786e64d8db0" xlink:to="loc_us-gaap_AwardTypeAxis_ae7870ee-662a-40dc-97a6-57a4ae37886a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae7870ee-662a-40dc-97a6-57a4ae37886a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ae7870ee-662a-40dc-97a6-57a4ae37886a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae7870ee-662a-40dc-97a6-57a4ae37886a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81996e57-80dd-4aab-8731-1b11b7636eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ae7870ee-662a-40dc-97a6-57a4ae37886a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81996e57-80dd-4aab-8731-1b11b7636eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember_53508be6-ed00-4f7c-9ccc-f6a6cf457060" xlink:href="ew-20230930.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81996e57-80dd-4aab-8731-1b11b7636eb4" xlink:to="loc_ew_EmployeeAndNonemployeeStockOptionsMember_53508be6-ed00-4f7c-9ccc-f6a6cf457060" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b5a2cab6-811b-4a48-a160-c90aa0805d80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81996e57-80dd-4aab-8731-1b11b7636eb4" xlink:to="loc_us-gaap_EmployeeStockMember_b5a2cab6-811b-4a48-a160-c90aa0805d80" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCELERATEDSHAREREPURCHASEDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1de94e0a-398e-47fe-a568-8447a9b8ca61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1de94e0a-398e-47fe-a568-8447a9b8ca61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_a82e4d79-d3ec-4e08-a809-4c37a770b23f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_a82e4d79-d3ec-4e08-a809-4c37a770b23f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_6d6fb6e8-0c96-46e4-a65a-8e7555b90456" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_6d6fb6e8-0c96-46e4-a65a-8e7555b90456" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_da146e81-8e39-4668-ba11-611697e3ef55" xlink:href="ew-20230930.xsd#ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_da146e81-8e39-4668-ba11-611697e3ef55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_97d29d18-3241-49d4-b2be-ec191290372e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_97d29d18-3241-49d4-b2be-ec191290372e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_3ce6e90a-2834-4582-bc4f-04342f99153f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_3ce6e90a-2834-4582-bc4f-04342f99153f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_199b7e87-473b-4aa7-a0dd-6506399e3d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3ce6e90a-2834-4582-bc4f-04342f99153f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_199b7e87-473b-4aa7-a0dd-6506399e3d4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_199b7e87-473b-4aa7-a0dd-6506399e3d4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_199b7e87-473b-4aa7-a0dd-6506399e3d4a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_199b7e87-473b-4aa7-a0dd-6506399e3d4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_199b7e87-473b-4aa7-a0dd-6506399e3d4a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledJanuary2022Member_4b9544d2-915a-44cf-8005-7aa2cd3c52a2" xlink:href="ew-20230930.xsd#ew_InitialDeliveryOfSharesSettledJanuary2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:to="loc_ew_InitialDeliveryOfSharesSettledJanuary2022Member_4b9544d2-915a-44cf-8005-7aa2cd3c52a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member_ef5162a9-d381-4112-981c-ee962a938492" xlink:href="ew-20230930.xsd#ew_InitialDeliveryOfSharesSettledFebruary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:to="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member_ef5162a9-d381-4112-981c-ee962a938492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member_0ebf10f9-da1b-4b1d-b60d-5e69478ac7c6" xlink:href="ew-20230930.xsd#ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:to="loc_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member_0ebf10f9-da1b-4b1d-b60d-5e69478ac7c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_5b7da496-c3de-41e0-b1c1-3331cbc6793a" xlink:href="ew-20230930.xsd#ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:to="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_5b7da496-c3de-41e0-b1c1-3331cbc6793a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d3ab1f6b-3739-47b4-a7ca-0f9942dba97a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d3ab1f6b-3739-47b4-a7ca-0f9942dba97a" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e475accc-5b69-46ba-a562-d13dd7320370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_StockholdersEquity_e475accc-5b69-46ba-a562-d13dd7320370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f59c8990-b476-4038-bbca-0795c4cf8740" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f59c8990-b476-4038-bbca-0795c4cf8740" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_81d2f96a-77a8-4693-b557-24fec80fccca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_81d2f96a-77a8-4693-b557-24fec80fccca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_4d7c638b-bcef-4c31-9c0c-a193f6539c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_4d7c638b-bcef-4c31-9c0c-a193f6539c3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0312b2f1-a5a6-457d-984e-e114bc4a6969" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b3d7c1f6-63f1-4846-97b4-aebc1bd14d60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d3ab1f6b-3739-47b4-a7ca-0f9942dba97a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b3d7c1f6-63f1-4846-97b4-aebc1bd14d60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8d8aefee-08d7-4281-969e-60005e5d8666" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b3d7c1f6-63f1-4846-97b4-aebc1bd14d60" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8d8aefee-08d7-4281-969e-60005e5d8666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8d8aefee-08d7-4281-969e-60005e5d8666_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8d8aefee-08d7-4281-969e-60005e5d8666" xlink:to="loc_us-gaap_EquityComponentDomain_8d8aefee-08d7-4281-969e-60005e5d8666_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f88f2e1e-4495-4ff8-8064-e579c5ad7aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8d8aefee-08d7-4281-969e-60005e5d8666" xlink:to="loc_us-gaap_EquityComponentDomain_f88f2e1e-4495-4ff8-8064-e579c5ad7aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f88f2e1e-4495-4ff8-8064-e579c5ad7aa6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_71fa6981-79d5-4c47-8f4d-b4f7afa9168c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_71fa6981-79d5-4c47-8f4d-b4f7afa9168c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9a156ee3-fb0c-4b3f-8324-c892470c2b66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9a156ee3-fb0c-4b3f-8324-c892470c2b66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_81ae1b31-4298-4a5e-b1d2-0ae9b9db5f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_81ae1b31-4298-4a5e-b1d2-0ae9b9db5f4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f8016683-e0ca-4181-a3f7-fad511b227cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f8016683-e0ca-4181-a3f7-fad511b227cd" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0b87e22c-b9b2-48f3-8ac5-58339541bb59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0b87e22c-b9b2-48f3-8ac5-58339541bb59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f27b45b4-5b71-49ff-9816-8711f77104c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f27b45b4-5b71-49ff-9816-8711f77104c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a494ef1b-3cbf-466a-851c-f1f3fd39683d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a494ef1b-3cbf-466a-851c-f1f3fd39683d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7f5edfde-71fd-4eb6-97ac-f609d7aedbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7f5edfde-71fd-4eb6-97ac-f609d7aedbd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_37d0cc2e-6ff5-40a9-b09f-c65669738fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_37d0cc2e-6ff5-40a9-b09f-c65669738fa4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_901e5b66-fb47-466d-9e06-e753775c3261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_901e5b66-fb47-466d-9e06-e753775c3261" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e06962dc-0a82-4b67-987f-f800585326a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e06962dc-0a82-4b67-987f-f800585326a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e06962dc-0a82-4b67-987f-f800585326a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e06962dc-0a82-4b67-987f-f800585326a4" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e06962dc-0a82-4b67-987f-f800585326a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b3fb03ac-d1fc-4b4f-ae06-ba687f78a460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e06962dc-0a82-4b67-987f-f800585326a4" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b3fb03ac-d1fc-4b4f-ae06-ba687f78a460" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_83b08a8b-8409-4c76-b9a3-012dfe457bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b3fb03ac-d1fc-4b4f-ae06-ba687f78a460" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_83b08a8b-8409-4c76-b9a3-012dfe457bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c73558a3-9a6b-4a70-96a0-95744552f07c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c73558a3-9a6b-4a70-96a0-95744552f07c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c73558a3-9a6b-4a70-96a0-95744552f07c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c73558a3-9a6b-4a70-96a0-95744552f07c" xlink:to="loc_us-gaap_EquityComponentDomain_c73558a3-9a6b-4a70-96a0-95744552f07c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c73558a3-9a6b-4a70-96a0-95744552f07c" xlink:to="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d94e662c-6836-45e6-b061-27491855cbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d94e662c-6836-45e6-b061-27491855cbe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_428a9d3d-ebc8-47dc-bcb4-633c1bff58f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_428a9d3d-ebc8-47dc-bcb4-633c1bff58f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c2b13924-0d86-45be-a31f-ea98dd3e26e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c2b13924-0d86-45be-a31f-ea98dd3e26e3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_adced6e3-cea4-4657-b479-34a983a11208" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ee5b6574-f7d6-471f-a54c-5b27cbcbf2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_adced6e3-cea4-4657-b479-34a983a11208" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ee5b6574-f7d6-471f-a54c-5b27cbcbf2fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8dca74f2-617a-4929-90e7-947c6f679dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_adced6e3-cea4-4657-b479-34a983a11208" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8dca74f2-617a-4929-90e7-947c6f679dd5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dbfa9f09-dc3c-420e-ada4-342f9fdd2878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8dca74f2-617a-4929-90e7-947c6f679dd5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dbfa9f09-dc3c-420e-ada4-342f9fdd2878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_dbfa9f09-dc3c-420e-ada4-342f9fdd2878_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dbfa9f09-dc3c-420e-ada4-342f9fdd2878" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_dbfa9f09-dc3c-420e-ada4-342f9fdd2878_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d7e363f5-2f65-442b-9afd-a8c85b52ab9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dbfa9f09-dc3c-420e-ada4-342f9fdd2878" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d7e363f5-2f65-442b-9afd-a8c85b52ab9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_2483951e-e3a8-47a3-ab2e-16571b257725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d7e363f5-2f65-442b-9afd-a8c85b52ab9e" xlink:to="loc_us-gaap_StockCompensationPlanMember_2483951e-e3a8-47a3-ab2e-16571b257725" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_701fe460-fc0f-4ddc-9d3b-86321a226100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_1154b49b-74a8-4126-a4e6-be0ecd4d9d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_701fe460-fc0f-4ddc-9d3b-86321a226100" xlink:to="loc_us-gaap_RevenuesAbstract_1154b49b-74a8-4126-a4e6-be0ecd4d9d2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c97f3de4-6328-4725-a75b-231e74b41719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_1154b49b-74a8-4126-a4e6-be0ecd4d9d2c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c97f3de4-6328-4725-a75b-231e74b41719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_4411d5c7-d437-48ee-b06e-36470b7c76f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_701fe460-fc0f-4ddc-9d3b-86321a226100" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_4411d5c7-d437-48ee-b06e-36470b7c76f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1905292b-df05-4e94-82ab-fa59cfee812c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_4411d5c7-d437-48ee-b06e-36470b7c76f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1905292b-df05-4e94-82ab-fa59cfee812c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_701fe460-fc0f-4ddc-9d3b-86321a226100" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d9613b51-7403-4338-a380-a1f8d639f79d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d9613b51-7403-4338-a380-a1f8d639f79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d9613b51-7403-4338-a380-a1f8d639f79d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9613b51-7403-4338-a380-a1f8d639f79d" xlink:to="loc_us-gaap_SegmentDomain_d9613b51-7403-4338-a380-a1f8d639f79d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9613b51-7403-4338-a380-a1f8d639f79d" xlink:to="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_UnitedStatesSegmentMember_0ffc409f-0da0-4872-a9d2-dbdac563dfac" xlink:href="ew-20230930.xsd#ew_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:to="loc_ew_UnitedStatesSegmentMember_0ffc409f-0da0-4872-a9d2-dbdac563dfac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EuropeSegmentMember_58b81082-7384-4d15-a7dc-eaf144982786" xlink:href="ew-20230930.xsd#ew_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:to="loc_ew_EuropeSegmentMember_58b81082-7384-4d15-a7dc-eaf144982786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JapanSegmentMember_9cf672fa-b342-4b43-b7d7-85bc7dbd89f2" xlink:href="ew-20230930.xsd#ew_JapanSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:to="loc_ew_JapanSegmentMember_9cf672fa-b342-4b43-b7d7-85bc7dbd89f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldSegmentMember_32134b86-8b0b-467a-a0aa-d391596a4666" xlink:href="ew-20230930.xsd#ew_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:to="loc_ew_RestOfWorldSegmentMember_32134b86-8b0b-467a-a0aa-d391596a4666" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4b8c008d-c54d-43dd-a1be-d5a33fabd721" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:to="loc_srt_ConsolidationItemsAxis_4b8c008d-c54d-43dd-a1be-d5a33fabd721" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4b8c008d-c54d-43dd-a1be-d5a33fabd721_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_4b8c008d-c54d-43dd-a1be-d5a33fabd721" xlink:to="loc_srt_ConsolidationItemsDomain_4b8c008d-c54d-43dd-a1be-d5a33fabd721_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fb65049b-2f10-4a5d-934b-4a939dedc372" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_4b8c008d-c54d-43dd-a1be-d5a33fabd721" xlink:to="loc_srt_ConsolidationItemsDomain_fb65049b-2f10-4a5d-934b-4a939dedc372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_0a0053b2-0006-421a-9341-2b393be8afc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_fb65049b-2f10-4a5d-934b-4a939dedc372" xlink:to="loc_us-gaap_OperatingSegmentsMember_0a0053b2-0006-421a-9341-2b393be8afc8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2dfca248-bf1e-4527-83f5-c70e6835cfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_f5ed13b8-f84c-4993-97b3-1f5104f2ea99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2dfca248-bf1e-4527-83f5-c70e6835cfa3" xlink:to="loc_us-gaap_RevenuesAbstract_f5ed13b8-f84c-4993-97b3-1f5104f2ea99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_633efc92-4622-4a06-ac20-34b6bd6b9167" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_f5ed13b8-f84c-4993-97b3-1f5104f2ea99" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_633efc92-4622-4a06-ac20-34b6bd6b9167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2dfca248-bf1e-4527-83f5-c70e6835cfa3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_76d45c9a-2055-4181-b892-e632bef07861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:to="loc_us-gaap_OperatingIncomeLoss_76d45c9a-2055-4181-b892-e632bef07861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8e5157f8-8196-4165-acc3-abdee856a3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_CostsAndExpenses_8e5157f8-8196-4165-acc3-abdee856a3cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_e19deb89-a221-4729-97d0-2bf2dacf2fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_e19deb89-a221-4729-97d0-2bf2dacf2fe5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_a03560e9-8cda-400d-a67f-1d412c104724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_LitigationSettlementExpense_a03560e9-8cda-400d-a67f-1d412c104724" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc240925-a435-4c3d-9727-c35860229ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc240925-a435-4c3d-9727-c35860229ec8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_c470da75-08be-4ec5-bfcf-3ff566c58574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_c470da75-08be-4ec5-bfcf-3ff566c58574" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2376f629-9b59-4c80-a66d-ad3d4fff95c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2376f629-9b59-4c80-a66d-ad3d4fff95c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e2d64b-8447-4f4a-a289-0dc8243e573c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e2d64b-8447-4f4a-a289-0dc8243e573c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c624f90b-163a-4a2b-9186-8e4aa70571ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2dfca248-bf1e-4527-83f5-c70e6835cfa3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c624f90b-163a-4a2b-9186-8e4aa70571ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_adba5e09-d296-4e28-9f31-15e8aed3b578" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c624f90b-163a-4a2b-9186-8e4aa70571ee" xlink:to="loc_srt_ConsolidationItemsAxis_adba5e09-d296-4e28-9f31-15e8aed3b578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_adba5e09-d296-4e28-9f31-15e8aed3b578_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_adba5e09-d296-4e28-9f31-15e8aed3b578" xlink:to="loc_srt_ConsolidationItemsDomain_adba5e09-d296-4e28-9f31-15e8aed3b578_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_adba5e09-d296-4e28-9f31-15e8aed3b578" xlink:to="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1a2de6d3-78ac-4c3e-8424-7ad117d1f12a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:to="loc_us-gaap_OperatingSegmentsMember_1a2de6d3-78ac-4c3e-8424-7ad117d1f12a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_b662e287-75f8-42ad-890e-e71ed3db05b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_b662e287-75f8-42ad-890e-e71ed3db05b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_74dfc498-48c8-4d56-9a4d-447a3087720f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_74dfc498-48c8-4d56-9a4d-447a3087720f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"/>
  <link:definitionLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_f3398a90-843c-4193-88cb-8d77f5aceba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_042b8315-89d3-4081-a11b-d76f2ac128db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_f3398a90-843c-4193-88cb-8d77f5aceba9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_042b8315-89d3-4081-a11b-d76f2ac128db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_f3398a90-843c-4193-88cb-8d77f5aceba9" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_43273c13-09ca-481d-bef1-9b4379e0761d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:to="loc_srt_StatementGeographicalAxis_43273c13-09ca-481d-bef1-9b4379e0761d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_43273c13-09ca-481d-bef1-9b4379e0761d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_43273c13-09ca-481d-bef1-9b4379e0761d" xlink:to="loc_srt_SegmentGeographicalDomain_43273c13-09ca-481d-bef1-9b4379e0761d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_43273c13-09ca-481d-bef1-9b4379e0761d" xlink:to="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ac993e82-13a2-4252-8a0a-16e5317c52c7" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:to="loc_country_US_ac993e82-13a2-4252-8a0a-16e5317c52c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_2c233072-8775-44fe-b8d0-10684eed9820" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:to="loc_srt_EuropeMember_2c233072-8775-44fe-b8d0-10684eed9820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_ed815ae8-c44e-4c20-9e30-fd7fc7613b9b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:to="loc_country_JP_ed815ae8-c44e-4c20-9e30-fd7fc7613b9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldMember_f155eed7-6f4e-41f8-8ed3-73b50ab93bee" xlink:href="ew-20230930.xsd#ew_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:to="loc_ew_RestOfWorldMember_f155eed7-6f4e-41f8-8ed3-73b50ab93bee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_82249aa6-aa1b-40b9-90ca-851b95325dc0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:to="loc_srt_ProductOrServiceAxis_82249aa6-aa1b-40b9-90ca-851b95325dc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_82249aa6-aa1b-40b9-90ca-851b95325dc0_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_82249aa6-aa1b-40b9-90ca-851b95325dc0" xlink:to="loc_srt_ProductsAndServicesDomain_82249aa6-aa1b-40b9-90ca-851b95325dc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_82249aa6-aa1b-40b9-90ca-851b95325dc0" xlink:to="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterAorticValveReplacementMember_858ff5ee-aea0-41da-a0c1-f3e6ff591d93" xlink:href="ew-20230930.xsd#ew_TranscatheterAorticValveReplacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:to="loc_ew_TranscatheterAorticValveReplacementMember_858ff5ee-aea0-41da-a0c1-f3e6ff591d93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember_4a5ab5be-5b5c-4718-a2c3-4271dce9d34d" xlink:href="ew-20230930.xsd#ew_TranscatheterMitralAndTricuspidTherapiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:to="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember_4a5ab5be-5b5c-4718-a2c3-4271dce9d34d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SurgicalHeartValveTherapyMember_de135ffe-592e-48cf-a5f5-73c0a7cd9f28" xlink:href="ew-20230930.xsd#ew_SurgicalHeartValveTherapyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:to="loc_ew_SurgicalHeartValveTherapyMember_de135ffe-592e-48cf-a5f5-73c0a7cd9f28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_CriticalCareMember_04839ced-7709-4876-95f0-237863aa3775" xlink:href="ew-20230930.xsd#ew_CriticalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:to="loc_ew_CriticalCareMember_04839ced-7709-4876-95f0-237863aa3775" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_deebf98b-c8fb-47f0-862b-15a85460648f" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrent_deebf98b-c8fb-47f0-862b-15a85460648f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MarketBasedRestrictedStockUnitsMember_d1956a3f-494e-4bfb-a26c-8679134be5e1" xlink:href="ew-20230930.xsd#ew_MarketBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ew_MarketBasedRestrictedStockUnitsMember_d1956a3f-494e-4bfb-a26c-8679134be5e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember_7e086b98-dfa8-4dc1-82a9-47c74710939c" xlink:href="ew-20230930.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ew_EmployeeAndNonemployeeStockOptionsMember_7e086b98-dfa8-4dc1-82a9-47c74710939c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JeanLucLemercierMember_b193c1a8-7b35-4efc-82fa-53eb95e88969" xlink:href="ew-20230930.xsd#ew_JeanLucLemercierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ew_JeanLucLemercierMember_b193c1a8-7b35-4efc-82fa-53eb95e88969" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ew-20230930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:eaa870a0-ed84-4111-a2ce-17bb0f4c4328,g:a046b429-8038-45a1-a20d-74cf9c7f6b8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_e7a86e6c-61ec-46d5-9120-ce89b084b62a_negatedTerseLabel_en-US" xlink:label="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, net of cash (Note 7)</link:label>
    <link:label id="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_label_en-US" xlink:label="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options</link:label>
    <link:label id="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_documentation_en-US" xlink:label="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:href="ew-20230930.xsd#ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:to="lab_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_ee5c3b96-758e-467b-b673-017301e9a250_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_fbbb4671-5b69-4d48-b64c-889d23b3287f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c682d676-a90a-41d2-8410-a63ad84ef65f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest (Note 7)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_9f65986a-f616-4b9b-b7b2-d759acf51974_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_a94582f8-52f3-4bb6-a0eb-5908d4b06bd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7c60b9b6-d00e-4987-bd25-bed768291e25_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_2a10af27-103a-4980-b068-17a808a4f8ac_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_64afaefd-d98e-4204-b3ae-233f69cdeb54_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional federal tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:to="lab_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_73a4d103-2e54-4a7c-a3e8-8e33040aa18a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5af43c7d-34dc-492e-88a4-f83cff7fe3bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_f50c597a-08a8-454b-b7c5-1c26dd4ea7fe_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedRelocationCostsCurrent_cce2be32-2654-40b7-9c07-32e6ed7cd7bf_terseLabel_en-US" xlink:label="lab_ew_AccruedRelocationCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued relocation costs</link:label>
    <link:label id="lab_ew_AccruedRelocationCostsCurrent_label_en-US" xlink:label="lab_ew_AccruedRelocationCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Relocation Costs, Current</link:label>
    <link:label id="lab_ew_AccruedRelocationCostsCurrent_documentation_en-US" xlink:label="lab_ew_AccruedRelocationCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Relocation Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRelocationCostsCurrent" xlink:href="ew-20230930.xsd#ew_AccruedRelocationCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedRelocationCostsCurrent" xlink:to="lab_ew_AccruedRelocationCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_9690cf5e-05a9-4473-895b-d549d145d02e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_358fadfb-ac37-4608-8125-60f256c5a0a6_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement accrual</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a37323ec-2179-480e-b78f-f58bd9c3365e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_32e2c26e-f09f-49d7-a414-600fa675f23c_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_e86086ee-9afe-4b72-bbcc-2cff679cf7c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Values of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b993cbc-6632-403f-bf25-711219a44b37_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_29c4838e-b0dc-4b1e-ac1c-b112d2bd7704_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_70fb052c-fdf8-40b4-b132-7df944002a81_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_562b5cf3-1cea-4d3f-980e-4d75554c9e22_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-Maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrentMember_41d385e7-6841-4d06-b414-cc81803d2e17_terseLabel_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other liabilities</link:label>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrentMember_label_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued And Other Liabilities, Current [Member]</link:label>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrentMember_documentation_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued And Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrentMember" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrentMember" xlink:to="lab_ew_AccruedAndOtherLiabilitiesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_3780b3de-2796-4cf3-ad35-a9504f99bc89_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ef9e839b-fa7c-413f-9fd5-543e95ccec5f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_18a3278b-338a-4997-9b9d-2bc540584a81_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments not due at a single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bf60dcd6-004c-46d4-81ea-425fa32a1580_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_29130e1f-3a64-4616-8e3c-5d9fcfab82f3_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_388f4fe2-2ab5-4964-a721-fe3cc759b1f7_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_4c95ec95-60e7-45c7-8bf1-2bbe374cf746_netLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_457f5a1b-2c9a-4d03-a393-775098ec7921_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EmployeeAndNonemployeeStockOptionsMember_3fc8ba9c-c502-439f-bedc-577ab19e7606_verboseLabel_en-US" xlink:label="lab_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Option Awards</link:label>
    <link:label id="lab_ew_EmployeeAndNonemployeeStockOptionsMember_label_en-US" xlink:label="lab_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee and Nonemployee Stock Options [Member]</link:label>
    <link:label id="lab_ew_EmployeeAndNonemployeeStockOptionsMember_documentation_en-US" xlink:label="lab_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:href="ew-20230930.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:to="lab_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_0ef70365-e18b-40ee-8cf8-a7cbd3f7a74b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note&#160;12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_NumberOfAdvancePricingAgreementsRenewed_a28b0677-a154-4a53-9f5e-366b9013c2f1_terseLabel_en-US" xlink:label="lab_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of APAs renewed</link:label>
    <link:label id="lab_ew_NumberOfAdvancePricingAgreementsRenewed_label_en-US" xlink:label="lab_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Advance Pricing Agreements Renewed</link:label>
    <link:label id="lab_ew_NumberOfAdvancePricingAgreementsRenewed_documentation_en-US" xlink:label="lab_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Advance Pricing Agreements Renewed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:href="ew-20230930.xsd#ew_NumberOfAdvancePricingAgreementsRenewed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:to="lab_ew_NumberOfAdvancePricingAgreementsRenewed" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_33d045e2-98f0-4fe0-b2c6-004a9cb5d940_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCELERATED SHARE REPURCHASE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_f034338a-c184-4453-88a6-b82bb9ecda3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Enterprise-Wide Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3a488f13-5f9d-4176-81d9-b76d615b77d0_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_c36ec746-fca8-48cf-b37b-96f4827247c3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_0fd978db-d6a1-4ea1-831d-f4a87ece958a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_f39690ce-3136-41b9-8d65-58b196b00091_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_24c4b248-6897-4a21-b9bc-aacaf6fc8467_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_8d934768-3443-4841-a969-b18f75517cb4_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPECIAL CHARGE</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Items, or Both, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:to="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_33e4af81-3d76-496d-8475-604a826f4205_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget_1c87a64b-4441-41e2-bd9a-d9e733582248_terseLabel_en-US" xlink:label="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares expected to be granted as percentage of target (as a percent)</link:label>
    <link:label id="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget_label_en-US" xlink:label="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target</link:label>
    <link:label id="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget_documentation_en-US" xlink:label="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" xlink:href="ew-20230930.xsd#ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" xlink:to="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_f33b37f0-04b1-47fe-b885-6ed9689da2b6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on fair value hedging relationships:</link:label>
    <link:label id="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Fair Value Hedges on Results of Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:to="lab_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_9fb987dc-29b7-4e0b-8766-0309643bd832_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_b337db58-fc1a-4466-b533-91eeaf41bb6a_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_6d898071-aaa0-4ace-961c-9fc5b977e077_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_db6ecfd8-689f-40fb-b304-f54d235cea48_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_7a60d713-6f93-4445-b9c0-5e401ed77a36_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_6834434c-0a59-4aee-957e-2b762e39f333_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireReceivables_6d689b16-797a-4823-82ef-15c68324dca1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of notes receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireReceivables_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireReceivables" xlink:to="lab_us-gaap_PaymentsToAcquireReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2459d60f-71db-4935-a638-d03dd7ab0b48_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_3b88f851-62a2-447a-8c36-8628a3ed80fe_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_d9879297-1d66-4287-9761-4e201cd38081_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_58838cbc-23b6-4b42-9f08-22de4eb7894f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a73d70cb-aef7-4060-aeb3-80879573a640_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $7.9 and $7.9, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e984977e-2d7d-45e1-a2a9-08e567031011_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_8d434ad0-fd37-4a54-9e76-cc173ff09889_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_a68d7226-e15a-4704-9a46-c69274ee12f4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_241b8aec-2c9c-48ac-8a2b-ac3655c6491c_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_dcd9b1bd-59fc-4ca8-8cd5-a776cbf93b51_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_d681c5d6-f87f-46de-bf07-95347c61f401_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_6dac0102-a712-477e-80a7-8c64be5e98a7_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cd13d9f7-6c93-4072-80ab-47b5368cd644_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6631a97c-a108-4a2d-b23f-178b92c93b5b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bc8ff3fa-917e-4154-8055-1c798813ef90_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, per option/share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_c621225d-9d47-432c-ae9b-0098ca0d0e80_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Edwards Lifesciences Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_d021d94a-38f5-43a5-b717-e53e80205d61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_c3c02490-fd5b-4d0e-bba3-7a218378850f_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in 1&#160;year or less</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2311b13d-3b7a-4e30-a307-1374f0c9976d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c6e60f7b-b7cf-436b-8210-1271e35a84b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_849abb92-6eec-41b7-99b6-ac9cd812854d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1b6755df-cb41-4d10-a609-f80f07d22caa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_b73db7ad-299b-4424-bb39-923c8f18e18c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ac4de104-6eb8-4665-bf80-6851ac7a4707_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_1f67ee18-2e9d-415f-9bde-49641d436ab9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e68323d0-e85a-45ca-8c76-5784dbb060bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_bb02600a-16af-4f3e-bd8c-59666a0a5a44_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_996e1a8e-da9e-4d8a-9faa-5679555370c0_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_36cd802f-d8a7-4525-a587-e51574c565a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_9ecc167a-6ab8-4a8c-a9bf-5c2174fc7a2d_terseLabel_en-US" xlink:label="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability of Milestone Achievement</link:label>
    <link:label id="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_label_en-US" xlink:label="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Milestone Achievement [Member]</link:label>
    <link:label id="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_documentation_en-US" xlink:label="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Milestone Achievement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:href="ew-20230930.xsd#ew_MeasurementInputProbabilityOfMilestoneAchievementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:to="lab_ew_MeasurementInputProbabilityOfMilestoneAchievementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_93f0a99d-989f-476d-bfa0-ba0a6eb90bf3_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affected Line on Consolidated Condensed Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_88692462-0862-4ad3-a990-d58dbdbff47f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_17d6baea-9eb5-4927-b51c-c48d607d1661_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_8554f024-db47-41cc-9b41-37dd63c68312_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_2d32db15-a05e-449e-90e8-93d7f08acdfc_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_60fe9a7e-14f5-4fa2-b0fe-b492a09de75c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_51dbe16c-eaf9-462a-a0cb-7509c09cd2b5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_495a1891-0409-48a1-8d36-1932821407e9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c463a842-db7b-4c2a-931e-24ebfcfac2fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_IncreaseDecreaseInLegalSettlementAccrual_ffd37e4b-5e18-4d99-af12-29bf5c4d2da6_terseLabel_en-US" xlink:label="lab_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property agreement accrual</link:label>
    <link:label id="lab_ew_IncreaseDecreaseInLegalSettlementAccrual_label_en-US" xlink:label="lab_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Legal Settlement Accrual</link:label>
    <link:label id="lab_ew_IncreaseDecreaseInLegalSettlementAccrual_documentation_en-US" xlink:label="lab_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Legal Settlement Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:href="ew-20230930.xsd#ew_IncreaseDecreaseInLegalSettlementAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:to="lab_ew_IncreaseDecreaseInLegalSettlementAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_e553a3c6-00b5-4406-99e6-bc47219ca7df_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ccb20008-fd1e-4891-9c4d-d39949de77e1_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_455b3701-b42c-4a13-bc6d-da4783eb8540_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f16486e-9b52-484b-8006-5ca96220d08b_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_4b14d5b7-232c-4cbd-9490-14d1af799757_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_a634747b-3050-434f-8846-70549b73a1ba_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_276c3503-269b-476f-9453-adea7b738fb8_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional required investment</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Additional Required</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Additional Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:to="lab_ew_EquitySecuritiesFVNIMaximumAdditionalRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_18d58da8-e2cd-45d9-8844-8366e759f325_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9ef8fa0b-6630-4d8b-abea-4a3707bccd3f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_fa1f1c09-6d28-4b1e-a2ca-29f48f0b4a77_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_b2428bfb-aedf-455a-82a4-2ad041cedacc_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MedicalTechnologyCompanyMember_bbd2a3c2-9997-4375-85a9-53b5c50e8238_terseLabel_en-US" xlink:label="lab_ew_MedicalTechnologyCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Technology Company</link:label>
    <link:label id="lab_ew_MedicalTechnologyCompanyMember_label_en-US" xlink:label="lab_ew_MedicalTechnologyCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Technology Company [Member]</link:label>
    <link:label id="lab_ew_MedicalTechnologyCompanyMember_documentation_en-US" xlink:label="lab_ew_MedicalTechnologyCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Technology Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalTechnologyCompanyMember" xlink:href="ew-20230930.xsd#ew_MedicalTechnologyCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MedicalTechnologyCompanyMember" xlink:to="lab_ew_MedicalTechnologyCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_6947b380-3741-4464-87f2-c434c9648bf0_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE LOSS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_54ae1343-6cbb-4c8a-9ff3-ebbef2607979_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_c9a6c4f1-a7a0-43ce-ad75-706d13ed2abf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_OptionToAcquireInvestmentAmount_e2455ac8-d770-4917-b72d-b514bdd2d6b5_terseLabel_en-US" xlink:label="lab_ew_OptionToAcquireInvestmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to acquire investment amount</link:label>
    <link:label id="lab_ew_OptionToAcquireInvestmentAmount_label_en-US" xlink:label="lab_ew_OptionToAcquireInvestmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option To Acquire Investment, Amount</link:label>
    <link:label id="lab_ew_OptionToAcquireInvestmentAmount_documentation_en-US" xlink:label="lab_ew_OptionToAcquireInvestmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option To Acquire Investment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_OptionToAcquireInvestmentAmount" xlink:href="ew-20230930.xsd#ew_OptionToAcquireInvestmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_OptionToAcquireInvestmentAmount" xlink:to="lab_ew_OptionToAcquireInvestmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e58f17eb-7605-49b3-a855-71a28bbc8a28_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_869ca0df-3af1-4c9f-b987-62167f26cabf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_d5c18504-8ee1-41da-96c0-1eb281f969fa_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_b4bb405b-803f-465c-96e8-8d175a647952_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_f1db1aaf-cb8a-4d6f-9986-48d94f54fd1f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_307a5c85-f518-4f2d-b49b-fc02c4a13660_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_305cd7ff-7819-4068-b38c-ff88b1c3f138_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_3f2fbc4d-a6a0-4802-8081-e55fe5a3e2de_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_e3c29db4-1e5a-40d8-aaed-fd6b5405228a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_901de2fd-1f3b-4831-a81a-e210e21357bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_f54b9a11-24cb-4e5c-856c-2db7fe238767_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from employee share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_a5f790f3-5746-46f6-bb7e-9872702496dc_terseLabel_en-US" xlink:label="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts Not Offset in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_label_en-US" xlink:label="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:href="ew-20230930.xsd#ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:to="lab_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_4729f374-3a79-49d1-85fc-5f4891f52aee_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_RestOfWorldSegmentMember_f8188852-0037-40a5-88a7-2ba929c5ce8a_terseLabel_en-US" xlink:label="lab_ew_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_ew_RestOfWorldSegmentMember_label_en-US" xlink:label="lab_ew_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World Segment [Member]</link:label>
    <link:label id="lab_ew_RestOfWorldSegmentMember_documentation_en-US" xlink:label="lab_ew_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldSegmentMember" xlink:href="ew-20230930.xsd#ew_RestOfWorldSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_RestOfWorldSegmentMember" xlink:to="lab_ew_RestOfWorldSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_3b6c2d04-bad8-4526-93c3-03961cc3d877_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_171b4e19-a734-4acc-927c-2d16f4abc9cc_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_948b2e1c-8ca4-4d4c-9bcf-fd95f826f2f8_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_6ac9db05-f8e5-4978-a05d-911eccaba49e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_39a83206-eb00-4a65-95c9-2cce168c6778_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_fddbfc97-f9e0-4ee3-9279-ca21b6101e56_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_e0f82b3d-5cdb-4ca7-9b60-908d57be55c4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember_d6c21242-78ed-4c98-a663-bd0c324e567d_terseLabel_en-US" xlink:label="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transcatheter Mitral and Tricuspid Therapies</link:label>
    <link:label id="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember_label_en-US" xlink:label="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transcatheter Mitral And Tricuspid Therapies [Member]</link:label>
    <link:label id="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember_documentation_en-US" xlink:label="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transcatheter Mitral And Tricuspid Therapies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:href="ew-20230930.xsd#ew_TranscatheterMitralAndTricuspidTherapiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:to="lab_ew_TranscatheterMitralAndTricuspidTherapiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_24824b04-09ba-4fb4-8aa9-627219fecd48_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_9eb2ebba-80c6-4c6a-872b-bb4965ab433f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_3e255fef-d18a-40aa-bc7e-ba721537c6bf_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other liabilities</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_bf518a16-6fca-4cbb-8d87-7886c6069d3d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_bb63ec6e-d269-44be-8e35-1cb4f444e757_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_de5d3b63-bdae-4dc8-a294-39c34cced9b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_450c6cf3-8628-4d97-97e3-10d14722b80e_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Collateral Received</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:to="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_0da24d88-e935-4043-899f-c43bb65a2db3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_f417971f-5f7b-4fb6-98c7-ade87d55f3f6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_SpecialChargeMember_24492222-a664-42f4-84b4-a55f99006472_terseLabel_en-US" xlink:label="lab_ew_SpecialChargeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charge</link:label>
    <link:label id="lab_ew_SpecialChargeMember_label_en-US" xlink:label="lab_ew_SpecialChargeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charge [Member]</link:label>
    <link:label id="lab_ew_SpecialChargeMember_documentation_en-US" xlink:label="lab_ew_SpecialChargeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SpecialChargeMember" xlink:href="ew-20230930.xsd#ew_SpecialChargeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_SpecialChargeMember" xlink:to="lab_ew_SpecialChargeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_1ae98937-17f7-4b26-b9b1-211e5288ff51_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable fair value disclosure</link:label>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:to="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1026aa57-3d19-4d6f-a967-9c15252fb804_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_4b662319-0b69-4d62-85a2-09c35b804fc6_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d9d1022-16cd-4646-9d41-fd05526e7a2a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_460c6d4a-8cee-492b-bf51-a384dba25902_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_b0cc3170-f89b-462a-8db3-0fc4ede28d41_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_eee8800f-b3ac-4e34-a271-f17aea7f2024_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures accruals</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ec58461e-f1a3-4f47-b310-47ad651c04a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_f6539494-0dee-40c3-b264-7276dfaa2b0f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1cf4254e-2c7d-4590-a227-b9480c341ec4_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_1b7d4814-fea5-4369-b250-25422c1501b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_cab74abb-73f6-405f-af9f-bb68599a2526_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_ed8b6d0d-1222-47d6-bd03-c9d1054ca29d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_34222db0-5a80-4903-b91d-1199ad84d0e1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_f87f34f4-156b-42a5-b879-0e0867beb408_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_cd734b16-2dc6-4dd3-bc9f-183e3d1c969d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_dc71b8f5-89bb-496e-9056-a6c1831ab288_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3e6b7f44-20ab-499a-8948-b5a6f8e73605_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract_3271e000-86e3-4caf-85a8-8fc10fb86e3a_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Derivative Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_OffsettingDerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_643fb542-07a2-4c0a-ad81-8664264e94f6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_7fb2ea88-657a-40e1-a81d-345520d51af2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_f163fe1e-3266-47e0-b2d2-559e830391e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss on Available-for-sale Investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9f07247a-1ddf-4ccb-af6d-cedc3cb83113_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b368ca23-5a52-4ad2-8f6e-da183dbdadd4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_c5cb3b75-f5d1-4bea-940c-44ea2f3dd279_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_5a65d7b9-0aad-41f0-a44a-3c1760bc70b1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from available-for-sale investments (Note 5)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e9b89cd1-322f-4769-8507-293cebfa9358_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_1ddc9100-8183-400c-bdf5-f8fc5570a050_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, gross</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_32b1db04-8509-48ea-a6de-e0c1d882cff0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments (Note&#160;5)</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_d7d0cbf1-9d47-48c0-8f9a-898d88e2c960_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1cf258fe-5a41-4246-86ff-2d3473e0c39b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingLiabilitiesTableTextBlock_fd4715be-9689-4a0a-a56f-196794df2095_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_OffsettingLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_af30cedc-9acb-4952-83a0-1b84714964e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueNetAbstract_246beb2e-403e-42fe-918b-1b020cc0a1b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts Not Offset in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueNetAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract" xlink:to="lab_us-gaap_DerivativeAssetFairValueNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_0ecf0c65-b2b6-41c9-9b15-dc9120ec411a_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e43576a2-f040-4d6b-87ef-8c298166bde2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8d7a9fef-7bdc-4989-bd50-1b5309901ffb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c89851cb-c830-44fa-9d0a-c18bde0170a7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period (Note 2)</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ae19f28-f03d-4b1f-bc9c-254e0cc6454c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_3ce11984-3113-4832-9d9a-e134ee99a7ff_negatedTerseLabel_en-US" xlink:label="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Noncontrolling interest</link:label>
    <link:label id="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_label_en-US" xlink:label="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net</link:label>
    <link:label id="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_documentation_en-US" xlink:label="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" xlink:href="ew-20230930.xsd#ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" xlink:to="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_730c7126-5b6b-49cd-b7a3-8ebf6700d392_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, 12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_00e623f6-ad17-484e-a221-18629f24b143_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_f78b2ac3-363f-47ed-8233-f29b048c7e7b_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_7e520c03-07a3-4a06-86dc-0d2089c39373_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments in Debt Securities</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_5442187f-3af8-46a5-8663-6da608170f9b_negatedLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_5b568ddb-55f1-4b4b-ab44-80b30eba36c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted-Average Assumptions for Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_3523b55a-34a1-4de4-b462-bfb881ceff07_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost, 43.4 and 38.0 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6e379bdb-9efe-408a-96a0-4ee9d45c36ab_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_a5c945bc-8e26-4ffe-86b4-667fbd46713b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_a07edf3d-f176-42e7-afd8-b01f7476c1e8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses, total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_23630efd-d2a8-4375-a120-eb8852355c76_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment_ed2dfd9e-cd8d-48ca-af49-7718416f4699_terseLabel_en-US" xlink:label="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, option adjustment</link:label>
    <link:label id="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment_label_en-US" xlink:label="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment</link:label>
    <link:label id="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment_documentation_en-US" xlink:label="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" xlink:href="ew-20230930.xsd#ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" xlink:to="lab_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_24327755-f75f-47a7-b93a-fe3ba002eb99_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss (Note 13)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_272af124-b43c-4342-80f2-9b504f71a145_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_19015e8e-ca74-4d44-a365-b95af57848bc_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_50fa2d6c-7f30-4570-a6c8-d40a6732cc4b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_8b2e35d9-29ab-4784-adc1-c87bb9254f81_terseLabel_en-US" xlink:label="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Shares as % of Contract Value</link:label>
    <link:label id="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_label_en-US" xlink:label="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount</link:label>
    <link:label id="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_documentation_en-US" xlink:label="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:href="ew-20230930.xsd#ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:to="lab_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_6c158a22-0364-4f5e-bcf4-816355a403ab_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_7040a40e-70e3-4b0b-b8e5-b861c7b55c6a_negatedLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate items</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9879df6c-407f-4c39-bcce-3b54ddf1da0e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost, recognition period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9d56b3d4-86aa-4c6e-8d3c-bce78ea4bfb5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_044ad389-3c62-4010-856c-a6ab0ff38260_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_23c55ebc-009c-4f31-a9e2-24cc71d08383_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Edwards Lifesciences Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1cba89bf-74da-4fe5-9315-98988b3c1add_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total remaining unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ae9e4000-c52f-4bfc-ae1a-86585397eaf9_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_89e9d903-59d2-4c7b-8d62-36bde9749e1e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_150a1a29-dbab-41c8-8506-502eca8ab991_terseLabel_en-US" xlink:label="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lawsuits that if settled could have a material adverse impact on net income or cash flows</link:label>
    <link:label id="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_label_en-US" xlink:label="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number</link:label>
    <link:label id="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_documentation_en-US" xlink:label="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:href="ew-20230930.xsd#ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:to="lab_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_f8386dac-ddbf-4c60-9acb-70826f74149a_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap contracts</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_b3ab507b-2409-46d1-a1e6-3e51f551231c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap contracts</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_75aa226c-6094-4ae7-95e8-82f7f68d29ac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_d8dad817-ef07-4a91-a606-967e8da54780_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_cfc958df-b0c1-4f65-87cd-314785fef8cd_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_daafc058-0ce1-4bd3-8aaf-f8afbce2474c_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_c6876432-38cf-49d3-91a0-8853a40945a4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f90503d2-8bee-46ad-8c94-91f015f0bb24_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_17359dfd-c3e8-44ba-a500-a1d85a3bff7a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_b19829b7-954a-40e5-ade7-dd072af23bf3_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d0febb3c-504f-4ecd-8d1c-fd8652978cae_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of available-for-sale investments (Note 5)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_24ad8c0d-4bfe-43e5-93f5-b0297df38a35_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0f47035a-70c3-4687-9fa6-bef795480bfd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_051c80c4-d7f7-4d3a-b9ea-e69e9a9e355d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_NewMarketsTaxCreditMember_a968af5e-ead9-48e5-b91a-954c62b46219_terseLabel_en-US" xlink:label="lab_ew_NewMarketsTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Markets Tax Credit</link:label>
    <link:label id="lab_ew_NewMarketsTaxCreditMember_label_en-US" xlink:label="lab_ew_NewMarketsTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Markets Tax Credit [Member]</link:label>
    <link:label id="lab_ew_NewMarketsTaxCreditMember_documentation_en-US" xlink:label="lab_ew_NewMarketsTaxCreditMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Markets Tax Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NewMarketsTaxCreditMember" xlink:href="ew-20230930.xsd#ew_NewMarketsTaxCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_NewMarketsTaxCreditMember" xlink:to="lab_ew_NewMarketsTaxCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e91edee9-264d-498f-a865-0c82da596643_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_717361c5-a338-4415-a2eb-7f926ee87537_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_54a875db-c534-422d-a3e5-f9478c321a4c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_1ff052b9-fb90-4125-9490-91bcf24e7c8e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from held-to-maturity investments (Note 5)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0af9de64-acbb-417a-859b-0d43df87179a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_4ae5f355-137d-4254-a163-ef4a80b0d0d7_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final settlement per share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Final Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_f2770103-8a07-47f1-b02d-3348bf08a37e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special charge (Note&#160;4)</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_71c09c68-4caf-41ab-82a1-2f9a15fb463d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special charge (Note&#160;4)</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonrecurring (Income) Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:to="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1ba25222-5a79-4c19-8ebf-90819d4b5112_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_608967d4-466f-483d-af7e-61bc0dcc5271_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cc4ea314-157c-419c-a82f-671c2a50883a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_15d48d1b-0e66-40bd-818a-d1afe0d81966_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8a35a7bb-dcee-4844-b7c7-96fc8703d96f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_a55e0181-f09b-4f27-a86d-6d9f258a4faf_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_97210d29-bba9-45ef-a3b3-e2932a0f0464_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_f0bbdd72-c437-4d66-a42d-f2c3da056957_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_7e16739a-a6f7-4d0b-8950-b9584aee2be3_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_1a27b142-d91c-4ab8-a6d8-22ba0f128332_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amounts Presented in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ee053a59-fb87-4fa3-9fe8-ef0a74cab10c_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments not due at a single maturity date</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_bbed56b5-37b7-4fab-8c25-5a02d2aba403_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_add88ff5-17df-4687-8077-5d0bec39fb20_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under stock/equity plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_af49d095-0a51-4f93-ba3d-756a89a9b4ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_9c7367c4-6edb-4dd1-8d0e-6f6c2eb88fde_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_2d04f5c7-48b4-4fd1-82c9-53010f18c06d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_d41a5c9a-c538-4833-8a81-d960853a68fa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_abd1063d-ee8a-402c-8fc7-4a40f3a07fdf_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9333b305-ef6a-4c78-9523-c5a8407a56db_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_4cdc1af6-a829-4150-8f4d-b7d64e9816bf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_c95e007f-2475-43d4-9e09-02a94555ffdb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories (Note&#160;2)</link:label>
    <link:label id="lab_us-gaap_InventoryNet_a62d3e94-e521-4cca-82b1-abe220bf77ac_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EuropeSegmentMember_cb4c51ec-ffcb-48d1-a848-d3e0c598fa5d_terseLabel_en-US" xlink:label="lab_ew_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_ew_EuropeSegmentMember_label_en-US" xlink:label="lab_ew_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:label id="lab_ew_EuropeSegmentMember_documentation_en-US" xlink:label="lab_ew_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the Europe reportable segment of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EuropeSegmentMember" xlink:href="ew-20230930.xsd#ew_EuropeSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EuropeSegmentMember" xlink:to="lab_ew_EuropeSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_0fb72566-3897-449b-9c2c-e52afc647e49_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MarketBasedRestrictedStockUnitsMember_0b8ff0b8-a539-4b32-a9a8-8261b63208e4_terseLabel_en-US" xlink:label="lab_ew_MarketBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Restricted Stock Units</link:label>
    <link:label id="lab_ew_MarketBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_ew_MarketBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_ew_MarketBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_ew_MarketBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MarketBasedRestrictedStockUnitsMember" xlink:href="ew-20230930.xsd#ew_MarketBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MarketBasedRestrictedStockUnitsMember" xlink:to="lab_ew_MarketBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_3a224744-4840-4c9f-acf4-578f9ddeb235_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments not due at a single maturity date</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_66b47528-60d5-4f4c-977a-4360e3be5a5b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_bb2408e7-fa0a-479f-88a9-766750b7cdbc_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_23795926-7d04-4177-bb16-ce764a3607c8_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_e64504bf-27a1-4e6c-86ef-d8fa463c35fa_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_7924b0a8-030c-420d-baaa-bf5101bfd7ae_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquityMethodInvestmentsInvestmentPeriod_9cee937e-e729-4dcc-9d7e-85612a1f078a_terseLabel_en-US" xlink:label="lab_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments taken period</link:label>
    <link:label id="lab_ew_EquityMethodInvestmentsInvestmentPeriod_label_en-US" xlink:label="lab_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Investment Period</link:label>
    <link:label id="lab_ew_EquityMethodInvestmentsInvestmentPeriod_documentation_en-US" xlink:label="lab_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Investment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:href="ew-20230930.xsd#ew_EquityMethodInvestmentsInvestmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:to="lab_ew_EquityMethodInvestmentsInvestmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f297ee6d-3ad2-4638-87ca-a3c7c934be80_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_UnitedStatesSegmentMember_4e92130f-d860-4b40-9155-bca81e54be25_terseLabel_en-US" xlink:label="lab_ew_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_ew_UnitedStatesSegmentMember_label_en-US" xlink:label="lab_ew_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Segment [Member]</link:label>
    <link:label id="lab_ew_UnitedStatesSegmentMember_documentation_en-US" xlink:label="lab_ew_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the United States reportable segment of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_UnitedStatesSegmentMember" xlink:href="ew-20230930.xsd#ew_UnitedStatesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_UnitedStatesSegmentMember" xlink:to="lab_ew_UnitedStatesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_d9ff91da-9f91-466f-827d-98b660ec4dd3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_25754f03-25d4-4baf-abe6-84346aaf2cb4_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_06cf6510-75a6-446e-aa5c-6542a9834554_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 1&#160;year through 5&#160;years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_f7244301-a801-486b-b25f-96443857fe40_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special charge</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_SurgicalHeartValveTherapyMember_921c0a59-26bf-4d7b-9ed1-6e59bb5a6544_terseLabel_en-US" xlink:label="lab_ew_SurgicalHeartValveTherapyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Structural Heart</link:label>
    <link:label id="lab_ew_SurgicalHeartValveTherapyMember_label_en-US" xlink:label="lab_ew_SurgicalHeartValveTherapyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Heart Valve Therapy [Member]</link:label>
    <link:label id="lab_ew_SurgicalHeartValveTherapyMember_documentation_en-US" xlink:label="lab_ew_SurgicalHeartValveTherapyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the surgical heart valve therapy product line.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SurgicalHeartValveTherapyMember" xlink:href="ew-20230930.xsd#ew_SurgicalHeartValveTherapyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_SurgicalHeartValveTherapyMember" xlink:to="lab_ew_SurgicalHeartValveTherapyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_f09bdcf4-7868-4145-990b-0d8592a8a657_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in 1&#160;year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_32394dee-dd88-484a-9027-3c7f8d31dcc8_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing transactions:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_1bce261c-68a7-4a86-b2c6-d58b314b0e8a_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Edwards Lifesciences Corporation Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_fa7c1c01-415d-4de4-b771-9f3e87c39247_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_88ef3dce-319f-44fa-aaf7-b1dc1deddd3a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments held for deferred compensation plans</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_42cdc1df-a12b-4294-b3bc-4a0f345d941a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1e5209df-fce6-4bab-b019-5ea40696f493_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_89375730-5964-46d8-8dac-d44c8386c6a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_33cb04fa-9343-484f-bdd0-91a5f3419c1c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_af24ab7e-592b-445d-862f-8814187463ae_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8013af73-b53b-4413-bf68-ae0a78f7e1e1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_6b805607-018d-4d2e-a7ef-c30932c0bd44_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_aa0e31e8-5138-4fa1-829f-4efd474204d0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_643910c4-30b4-4996-9efb-dd395a6dc01a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_JapanSegmentMember_d8989a82-8d56-4ba0-b3a3-fc39e788d535_terseLabel_en-US" xlink:label="lab_ew_JapanSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_ew_JapanSegmentMember_label_en-US" xlink:label="lab_ew_JapanSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan Segment [Member]</link:label>
    <link:label id="lab_ew_JapanSegmentMember_documentation_en-US" xlink:label="lab_ew_JapanSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the Japan reportable segment of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JapanSegmentMember" xlink:href="ew-20230930.xsd#ew_JapanSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_JapanSegmentMember" xlink:to="lab_ew_JapanSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_42a86248-c4b5-434e-ba8c-fb8c72b2969d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_82006b4a-43b3-4473-8377-867b569a66b0_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_fb63ccdd-f04b-473c-b3a1-fedae71b0c9d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ef192351-04c7-4f06-88e8-536356e97c3a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_7e33f096-015b-44ec-b4c2-6920783631b4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c243d062-5f27-498d-9d79-5b57531a2c73_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2acfa790-791e-4447-9a1b-8dda83fdbdc1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0113da05-0d0a-4dd8-a2a6-cb153f1fe57d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_1695190c-13ae-45a2-bad1-02a7b0f2fe37_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_bf9a60ae-d3ec-4d35-b072-e5a16e9d0887_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional option to acquire investment</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:to="lab_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_22a7e3ae-16fe-40b9-b59d-05b669e4b7e3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and other receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAbstract_d0b63721-2516-4c7e-98bd-8717f7ef3b04_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_8a0c2a86-d13b-4e99-9064-2a27ce4909e4_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accelerated Share Repurchases</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_4617d9bd-2a5a-4961-b5f1-833290046ed3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_9447deee-4cc3-4057-a96e-07398c0b58af_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_TranscatheterAorticValveReplacementMember_a1dc0295-da95-466b-a33f-cc47418cfbf7_terseLabel_en-US" xlink:label="lab_ew_TranscatheterAorticValveReplacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transcatheter Aortic Valve Replacement</link:label>
    <link:label id="lab_ew_TranscatheterAorticValveReplacementMember_label_en-US" xlink:label="lab_ew_TranscatheterAorticValveReplacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transcatheter Aortic Valve Replacement [Member]</link:label>
    <link:label id="lab_ew_TranscatheterAorticValveReplacementMember_documentation_en-US" xlink:label="lab_ew_TranscatheterAorticValveReplacementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transcatheter Aortic Valve Replacement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterAorticValveReplacementMember" xlink:href="ew-20230930.xsd#ew_TranscatheterAorticValveReplacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_TranscatheterAorticValveReplacementMember" xlink:to="lab_ew_TranscatheterAorticValveReplacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_2b491b0f-ad27-4e1d-a5f7-e9e40bed1a10_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain or (Loss) Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ad3a75e0-e966-40a9-89e4-7d0bf06ecf41_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_d3208cc6-26c2-4cc5-907b-a090959b81f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_c6779d6d-7a5d-44c1-960c-40eb54f567ae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7c71195a-1572-4526-9854-908708e65e22_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_e028cb65-df7e-454d-8c67-f46f17992d4f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_54be6d69-5d70-4030-8b89-529d8d3fd90d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_a3895809-27fe-446f-9131-d1f6ddd47c7d_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of non-marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_16aec862-442c-4a2f-8de0-bfc2a2460328_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1af7f726-cd6d-41f6-8c21-49c81fb6aec3_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net of tax</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e2b7e723-1ae9-4d61-a34c-04ecda5ace8b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Edwards Lifesciences Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_59c67454-ff96-4bd9-9c0f-e2aeb600699d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_8aefb026-e61e-49af-a36f-2fa02306fc12_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 1&#160;year through 5&#160;years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_36fe4d73-b422-44ab-aad6-80cd8620fcc7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9d4cb1cd-b445-42dc-ab80-f619c29c865b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_dca665de-4149-4dd1-9ee8-34f9525b026d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise-Wide Information</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_4a2c1cee-9f85-46d0-af2a-50530aaa8e3a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_6c6da5ea-bbce-404e-a40e-5939dba1e5a2_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property agreement and litigation expense (income), net (Note 3)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_49798dd1-ed12-4ade-9fa4-35b18c120588_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_0d9fded2-9d00-49aa-a6dd-277bbfc542c5_negatedLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property agreement and litigation (expense) income, net</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7595431a-fda8-4710-b0c1-fcec82c5898c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_5fda0e4e-31cf-4e4c-bb13-d5e9734bcc51_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_47e0e9fd-f657-402e-9de6-dc8f5a27024a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_37a2b5c2-9916-4f06-b099-143fc4dc39d8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidRoyalties_d7ccd09e-36c7-475a-b209-057c830f05ce_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid royalty asset</link:label>
    <link:label id="lab_us-gaap_PrepaidRoyalties_label_en-US" xlink:label="lab_us-gaap_PrepaidRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidRoyalties" xlink:to="lab_us-gaap_PrepaidRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_df1369e2-36f1-40e7-9f3b-7f97c9c0d8a3_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_89460820-9be0-4816-bde1-1a9c86744c54_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c4fa8799-f364-4e4d-8ddd-5d9c8a8b2f5c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7d42b6c2-10c8-4514-ba5b-bb364a059225_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04f91426-bf8b-4c72-88bf-1c0297492956_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b4acfe71-4cf4-40d3-a0c2-68e050b01e36_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_cc501d68-13e5-4a2d-8501-20eea7650976_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_b43a72ac-ae28-4471-9265-bcc1a39b1838_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on cash flow hedging relationships:</link:label>
    <link:label id="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Cash Flow Hedges on Results of Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:to="lab_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_da290483-eaf5-4286-b16d-2684be2b4c51_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_31b79b67-f318-4319-8284-daf4f3f8ec1e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 5&#160;years through 10&#160;years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_b2070028-b0a8-4c11-8663-574314c21733_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_2d2a8fa3-24c0-4700-9ec4-d7a0a07246b3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_310ede5e-0141-491e-8599-15b08f392a9e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Pension Credits</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_IntellectualPropertyAgreementTerm_5c103895-8b19-4b71-b353-95a30343bb8e_terseLabel_en-US" xlink:label="lab_ew_IntellectualPropertyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property agreement term</link:label>
    <link:label id="lab_ew_IntellectualPropertyAgreementTerm_label_en-US" xlink:label="lab_ew_IntellectualPropertyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property Agreement Term</link:label>
    <link:label id="lab_ew_IntellectualPropertyAgreementTerm_documentation_en-US" xlink:label="lab_ew_IntellectualPropertyAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IntellectualPropertyAgreementTerm" xlink:href="ew-20230930.xsd#ew_IntellectualPropertyAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_IntellectualPropertyAgreementTerm" xlink:to="lab_ew_IntellectualPropertyAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b856a032-d200-4650-b974-07b0373d2e47_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f177b271-c905-4114-aa43-c42691c0f45d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_54b37821-90e9-4996-9853-257920c8b05d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_3755b953-9a49-4f33-91e8-1dab1929f27d_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_9ada6e45-4d00-48cc-acbb-33a176358465_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in unrecognized tax benefits is reasonably possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_06574db4-235a-43f3-8c72-92bd899d466c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $1.00 par value, 1,050.0 shares authorized, 649.9 and 646.3 shares issued, and 606.5 and 608.3 shares outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_edc1511f-79fb-4d80-89e3-b3d3fa3ddbe4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_a7357bef-bb36-4049-8920-e8bec291014b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_438d97c0-a46b-463c-bc2d-3e706e584589_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_a7042b16-2d82-4390-b369-1b47fec859fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c3557f9c-8c56-4a67-af96-cf9440678a25_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_9ee6ea41-8ca3-482b-94bd-65a84dea5f3a_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_29b17f2a-c4c3-432d-8bf8-c2edeb2f0548_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyMember_0aacc166-40d3-43c8-aada-f1dc783920ba_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyMember_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyMember" xlink:to="lab_us-gaap_LimitedLiabilityCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_64817c04-f630-4789-9e34-6d94bc43f679_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments in unconsolidated entities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_2bd0fb52-387d-4e63-8673-641d92e75528_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge (Note 4)</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_50892f18-56fb-4cf7-9db9-16549e586a69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_1a154f4e-e5eb-4cbc-9198-a080d372ca5b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_cd22b171-5f1d-4271-ae8b-51354a94814a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the year for:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidRoyalties_95f1b9fc-df3a-4d20-8f07-631f1c514d51_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term prepaid royalties (Note 3)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidRoyalties_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_7b9266d0-f9f4-4b2b-9475-8eae74675d1e_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_568d5479-da94-454c-a4a8-210698a77579_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_f90625e6-fc7d-4bff-986e-d1b9cf52147d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5a1f8f8c-642b-4f4c-87a4-8778f24b914a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c18080a8-1b87-45c2-beca-5d1d98323700_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_c27528da-6652-457d-a65d-40fea03223f6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of held-to-maturity investments (Note 5)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e428696f-eda1-418b-9c8c-e6589582dd4a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_24f8d536-07b8-41dc-adbe-fc7e7f333291_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1fef8596-931f-4c8a-aa78-4328027a63d2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liabilities (Note 8)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_527974a1-035f-4264-8234-eb7b8f029c3c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9bc4de2d-6b70-47a3-8691-e29ce5c199a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Paid</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_150e3c99-6351-46cc-a7a3-023b69460f10_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_fc366ac3-a3df-4120-99dc-72364e5e7fa8_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_c4c70932-054e-4a01-a90b-c66f3287aed2_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7c18ba39-2ac8-4156-aed6-7482e05bebb1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_47a5f6a5-648d-4662-a99c-110f7fd81dee_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for income taxes associated with uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_78c6e783-243d-48e8-96fb-2a7737cc0c3d_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7af06880-568d-435c-b186-60e550883a3a_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_b802fd17-d364-4e01-aaac-41dc4b8aafbb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_345c2d95-8cad-44cc-9810-bca122af553d_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 1&#160;year through 5&#160;years</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost_24df0c9c-e448-4031-b451-3fae9965591a_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 5&#160;years through 10&#160;years</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_360e218f-1fbb-47c0-9c35-60501e0ac32e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_e3f66c19-172a-497d-a23d-ef8ce6850684_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b527ba60-e3e9-45b4-9ca7-f5bf46fc59a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_512fc68c-5935-4429-a9eb-356eded815f0_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_4fcbb439-1f2b-4657-b248-8803549f6287_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_e064500d-9a3f-45a6-b355-897620abfb90_netLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States government and agency securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_d460b92a-dedf-4f32-851d-8002de2ad060_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MedicalDeviceCompanyMember_b4f99b0b-624e-4b49-a798-7495dc29607d_terseLabel_en-US" xlink:label="lab_ew_MedicalDeviceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Company</link:label>
    <link:label id="lab_ew_MedicalDeviceCompanyMember_18397939-5ba1-4d16-8448-8d0961f66abe_verboseLabel_en-US" xlink:label="lab_ew_MedicalDeviceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investee</link:label>
    <link:label id="lab_ew_MedicalDeviceCompanyMember_label_en-US" xlink:label="lab_ew_MedicalDeviceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Company [Member]</link:label>
    <link:label id="lab_ew_MedicalDeviceCompanyMember_documentation_en-US" xlink:label="lab_ew_MedicalDeviceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember" xlink:href="ew-20230930.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MedicalDeviceCompanyMember" xlink:to="lab_ew_MedicalDeviceCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_f4b3ce47-808f-47fc-967c-3aec022dd0ed_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_37f5dd69-747a-4f2d-be77-682e3a83a646_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7aca0ed1-cd24-4830-bd32-02ab8043b392_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_MedtronicIncMember_0080e24f-eec6-4914-b3f6-5636a24edaaf_terseLabel_en-US" xlink:label="lab_ew_MedtronicIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc</link:label>
    <link:label id="lab_ew_MedtronicIncMember_label_en-US" xlink:label="lab_ew_MedtronicIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc [Member]</link:label>
    <link:label id="lab_ew_MedtronicIncMember_documentation_en-US" xlink:label="lab_ew_MedtronicIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedtronicIncMember" xlink:href="ew-20230930.xsd#ew_MedtronicIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_MedtronicIncMember" xlink:to="lab_ew_MedtronicIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_b8fac15e-b220-4882-9e33-dafdee3ca202_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_6b7c353a-998b-4d9a-b241-5d370fcce415_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_f956d958-ce30-45c8-a89f-febe2f93ac89_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate items</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_bb3ec00f-0ee2-4f99-bcc6-a7de0e854270_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_22e5cf36-c970-4b6a-88ce-060dd8355c2a_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investee drew additional amount</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI Promissory Note Outstanding</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI Promissory Note Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIPromissoryNoteOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:to="lab_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_dfda1fca-ab57-40b7-8cca-000fbd5ac5b2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_15d5f821-c373-4400-b7ab-e1cace494bc8_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_7214ce59-2f34-4451-816b-9dd5ce8fb762_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in 1&#160;year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_120c924c-70ae-468f-8953-2b481598db6c_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6391ddeb-4af6-4b93-a636-22cf45ba7d37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_49e8841e-4460-4217-a174-b307d98e1d1c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Edwards Lifesciences Corporation stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_63f0d3d8-996b-4aab-af9b-1cdb24c1ceee_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_18b91c36-82be-458d-bdbb-b24139427685_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_eeed12f9-9a77-4d84-b3a0-c56804a6b7b6_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_f4fe9be3-c2aa-4ebe-9b5b-2b47c16a00e6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amounts that would favorably affect effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_518fccaf-59ae-418e-ab3a-fef0941a5e68_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_112cac94-e2bb-4b12-9121-c4f7195856ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_2e9ff2f1-738e-4863-918e-0d042dbd96b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0a21db77-a133-4c33-836e-0f07de52c4c9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain on Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_28e8c80c-8a83-46da-8d45-6d87c8eb7086_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4855cf98-786c-4e72-970f-ad61241d41f6_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15140329-a84e-4772-8179-ae82c18b838d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_41ea3aa0-b65a-4014-a4ad-f20c428f1a07_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENTS IN VARIABLE INTEREST ENTITIES</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_cec6c273-ff5e-4775-9f18-ea57dc4b289e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_ec331dd1-c30d-4b81-aab5-1a2fb7032c14_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_ad5cf7ab-8ca2-43e4-abcf-ec18b45e082e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in non-marketable equity securities due to observable price changes</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_a70f9dea-7ca6-44ce-84d0-ac80600e8ef5_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_1f9d990d-d53d-4775-8e88-5bb47b78bc9e_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_e5df893f-f07b-4991-8f91-014e73760d03_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_528ef4b5-f364-4ecf-b8b6-0d12db0da2f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_a905fbe1-19fc-4226-9abe-dde249360440_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_725eacd8-fa54-4f35-bdbe-d36510fcea20_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member_d5912826-de48-40c5-921c-2d69f952a46b_terseLabel_en-US" xlink:label="lab_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2022 Stock Repurchase Program Shares Sold in February 2022</link:label>
    <link:label id="lab_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member_label_en-US" xlink:label="lab_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2022 Stock Repurchase Program Shares Sold In February 2022 [Member]</link:label>
    <link:label id="lab_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member_documentation_en-US" xlink:label="lab_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2022 Stock Repurchase Program Shares Sold In February 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member" xlink:href="ew-20230930.xsd#ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member" xlink:to="lab_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a3141df6-1243-46ad-89ed-90d7026eb4e0_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net (Note 7)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_873108a4-cc92-4e78-ac9d-b9efa098559b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0cd69fd7-9f16-4716-8f0f-6e943d856ad6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9b085662-623d-4f50-94c2-7c9a91314cde_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b9bfed74-94c2-4e5c-b3ef-4c3e3af54a1b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7777e518-6a62-44d0-be50-af693ddf8fc0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_efc989fb-5dfa-44bb-b959-c0afd308955d_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Plan</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_9b6d1b8e-3e9a-4858-995b-a09767c756b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (Note&#160;10)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumPromissoryNote_9bc0f732-80dc-49b9-bb71-f2e2c474648b_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory note</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumPromissoryNote_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Promissory Note</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumPromissoryNote_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumPromissoryNote" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumPromissoryNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIMaximumPromissoryNote" xlink:to="lab_ew_EquitySecuritiesFVNIMaximumPromissoryNote" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_91cdca80-5e8f-4040-adfc-863e98f22f1d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d6a531f4-e857-4957-b7a0-d67be3f42b6d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized pension (costs) credits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1dee9e71-79a2-43b8-a8d0-18aae3669786_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9caebfe5-d48e-43a5-9532-02b6fd3cccd0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_dfb9fd42-8baf-4f22-8d50-cea361048028_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_1b5a8aef-d5b4-45ac-b8ff-a12bea3f089e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_15c47e2e-2305-475e-9aff-733d19e0c4b9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_91418c1c-ae40-4880-8c8d-0880c01c9208_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_d6ce1fba-0757-455d-bdee-623d0b65feb9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment percentage (in percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_faa22033-56bc-447c-bd4c-769d34119f77_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Contingent Consideration and Other Liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8712c422-7967-4d68-8236-b164b6935899_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_726fe901-13e2-47dd-a608-b7e90a666c36_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f65011d4-377e-4ae0-876f-fc489197c4b8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ec9a5ad-cd27-4c88-b365-d5d13ff714de_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a36ecd3b-aae6-427c-b9f8-bdfe8eff5e8b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_555c8edd-e674-4903-beb5-85873498bdd8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued marketing expenses</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3495c4d7-c678-40f4-b542-3531cede54ce_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_715eab25-302e-4cfd-b6d4-cd542cbb77ba_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_19a64531-0912-4be2-8cef-1af1e5dda86c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_326fe434-bc5e-44c5-952e-9ede93876370_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 5&#160;years through 10&#160;years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_17f0ea7e-2121-451c-9e1a-9a53c167cb83_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ac95d671-d43b-45ba-9103-f2f8a9849b0a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_c4871528-44bc-40e0-bb55-1aa6ace9cf34_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_d00fdfa4-372d-42ac-b86a-5dee520f7f62_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow gain to be reclassified in the next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7735f0e1-3064-4cfc-b1b6-b43f105e5e9c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6d2d6be2-30a9-42fe-8b40-5fc7cfcf062d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_68440503-4686-48d7-aaf6-b19008e46ec0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_fdb09162-6564-439b-85a0-29946bbc42bf_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_f45517eb-8340-4d5a-b7cd-3a90a34d3731_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale Securities, Debt Maturities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_af18d2b8-094e-4eda-94c2-fbe6362e227c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_064dde48-0106-4964-964f-a257cdbfed73_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_2e741966-9e92-44f4-aae0-41989c6c58f8_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_dd074fd3-0f9a-4970-9e0d-c864de7353fe_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_1f6958ec-e621-43b1-a2ff-1382fb404368_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_17dbe6da-9189-4e73-b0fe-d52ac01d145a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_e5ca1531-c295-441e-9659-af90694ed1e9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_9e76fc82-3e56-49e9-abdc-005a12307dab_terseLabel_en-US" xlink:label="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, payroll, and other taxes</link:label>
    <link:label id="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_label_en-US" xlink:label="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Property Payroll and Other Taxes Other than Income Taxes Current</link:label>
    <link:label id="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_documentation_en-US" xlink:label="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:href="ew-20230930.xsd#ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:to="lab_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f4bd577a-b435-43c2-a8bd-fdff790da22d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f768d3cd-3677-4c69-9e38-b6399e7260b9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b3dbfaff-79e1-471e-9615-34f0ecfd5567_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7f5a9241-f1c7-4a35-84d8-6f98eb5e5d9a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c47bd064-536a-465a-8a3c-68978d6da3d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e133e8e1-75f3-4caf-8d99-01bc6dafdccc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_44aacd26-59d5-43af-9904-53cbb54cd904_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_dfa26270-6e32-4bde-8f17-0612f267a476_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets (Note 6)</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_58e4896a-d0e9-4e63-aeaa-04b28e378739_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_808d1a98-60f8-4c0b-aab6-036be511e1e9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a2881832-c33a-4d17-b737-9ddc32d0f895_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_98c1a616-6057-4d8e-8c73-a716699d9747_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_db3eb9de-155b-4faa-accd-133c14b15291_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f50ada01-6cd4-4b67-b36c-a40cac578d57_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_46521184-7c22-4f97-b9db-1fc8862435f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_70baf890-90f4-421d-8cf7-50fc72e3fb95_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated amounts:</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_d138fea4-c189-4f13-ad8d-ce36cfe14116_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Edwards Lifesciences Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledJanuary2022Member_a0f96c83-2129-4252-bf34-5ce5f8b8801b_terseLabel_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledJanuary2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Delivery of Shares Settled January 2022</link:label>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledJanuary2022Member_label_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledJanuary2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Delivery Of Shares Settled January 2022 [Member]</link:label>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledJanuary2022Member_documentation_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledJanuary2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Delivery Of Shares Settled January 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledJanuary2022Member" xlink:href="ew-20230930.xsd#ew_InitialDeliveryOfSharesSettledJanuary2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_InitialDeliveryOfSharesSettledJanuary2022Member" xlink:to="lab_ew_InitialDeliveryOfSharesSettledJanuary2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_423e4b7a-c453-4352-b3f1-036232918ad9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_cc5f0301-2b75-417f-b27a-2abb436cfd4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_193e149c-46cb-47b0-815f-3d585346067f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7f84e7ab-8297-4f43-8e61-4a22e1774e6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_c9f1afb2-da44-4ee0-b24d-7c686f9b54b4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments not due at a single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ShareInformationAbstract_0d176b38-17a6-4e7c-9163-78fc4dc5261c_terseLabel_en-US" xlink:label="lab_ew_ShareInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share information (Note 14)</link:label>
    <link:label id="lab_ew_ShareInformationAbstract_label_en-US" xlink:label="lab_ew_ShareInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareInformationAbstract" xlink:href="ew-20230930.xsd#ew_ShareInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ShareInformationAbstract" xlink:to="lab_ew_ShareInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_4487f99e-4856-44d8-b922-da8ea55dec67_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in 1&#160;year or less</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_b5dada9c-cafd-47b2-b69a-0bbf739af5fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_ade89b1a-b1ab-4dee-b207-4e53b4ca0172_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_04dd4922-f00c-4c7a-8880-a82271c2cc6f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a8b7cd3b-ca78-4b58-bf23-6a2258907317_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_89e2e031-1d02-4b2c-84ad-efd8e8f3941c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b2590a25-666e-4a83-ae64-ef3939ff4532_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_0ec5ee40-3017-4f57-a72f-14daf6faed35_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished products inventories held on consignment</link:label>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_label_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:to="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedRebates_af388664-d349-4f8a-8c7e-daf94a910767_terseLabel_en-US" xlink:label="lab_ew_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_ew_AccruedRebates_label_en-US" xlink:label="lab_ew_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates</link:label>
    <link:label id="lab_ew_AccruedRebates_documentation_en-US" xlink:label="lab_ew_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRebates" xlink:href="ew-20230930.xsd#ew_AccruedRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedRebates" xlink:to="lab_ew_AccruedRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_bcb9f84c-5487-4749-99ef-006ce9c5b49c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_1d81b6aa-2a3f-404c-bb15-166be8ba0c11_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 1&#160;year through 5&#160;years</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_f7fd927c-088d-4361-b3e2-f0a2620f16aa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collections of notes receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6a850efe-83f9-4576-bfd1-059065e7a392_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_595ff665-0357-473e-8ba6-72612ef79e55_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_74cf623e-91be-4659-88e3-5aa12d5d1bba_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale investments:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_18751acf-073c-437d-a2fc-ebb64a8e9ab7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments measured on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_34e67cc9-2370-4fb3-b7f9-2e0df09c95e7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedLitigationAndInsuranceReserves_4a3f0e8c-22c4-4ab6-9141-526aa69be310_terseLabel_en-US" xlink:label="lab_ew_AccruedLitigationAndInsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal and insurance</link:label>
    <link:label id="lab_ew_AccruedLitigationAndInsuranceReserves_label_en-US" xlink:label="lab_ew_AccruedLitigationAndInsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Litigation And Insurance Reserves</link:label>
    <link:label id="lab_ew_AccruedLitigationAndInsuranceReserves_documentation_en-US" xlink:label="lab_ew_AccruedLitigationAndInsuranceReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Litigation And Insurance Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedLitigationAndInsuranceReserves" xlink:href="ew-20230930.xsd#ew_AccruedLitigationAndInsuranceReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedLitigationAndInsuranceReserves" xlink:to="lab_ew_AccruedLitigationAndInsuranceReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_d11acdce-7717-425e-b783-b912e9b1314a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_51ec4f25-99a5-4b81-842f-bed1eb67771b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_52da6626-d4d8-41c2-ba89-32fe21043012_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_79d6a317-bc5d-457e-ae52-82645e1b1719_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_cfa84211-a34b-42fd-9b45-ea576e9bbcf8_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum secured promissory note</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Secured Promissory Note</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Maximum Secured Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:to="lab_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_67d88ac9-1e53-480b-bad9-b270530186d0_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes due to currency rate movements and expenses expected to occur, maximum term</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time, Foreign Currency Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:to="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1e861f26-067e-485f-86dc-1239402dd42d_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_de29a7fe-d0fc-4f1a-8d0e-7742d26cac3a_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Collateral Received</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:to="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_3aaa5ae2-35e6-4661-a885-4369c012046b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on investments, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6e2d4632-3a0d-4c15-8105-82147b9bb66b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax (Note&#160;13):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b2999eaa-06ab-49d0-9ff7-fd93536519eb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_ff3ac278-86ed-4c05-a1a5-75934509bc4a_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_0ed3274c-5b1a-4c44-8544-1adad512568b_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amounts Presented in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ccba6bb3-b190-4275-93f4-4b8061ef1285_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock_65fff8b6-7453-424a-bb3a-d367216d7015_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments in Unconsolidated Affiliates</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_291ac14a-c3f8-42b5-aad8-7f4e69822476_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableGross_7da04b92-d926-4225-a771-b187327227cf_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableGross_label_en-US" xlink:label="lab_us-gaap_NotesReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableGross" xlink:to="lab_us-gaap_NotesReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_4aad70cb-a795-47be-a750-4b4e247d8366_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_dcb4e65c-d9ba-4f4e-8fe3-4601aaa91f99_verboseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_d428e048-d746-4d13-94cc-73618d38a90d_netLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_cfc7bf69-ccb6-4260-865c-5d02f8f54d47_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ResearchAndDevelopmentAccruals_b02a09aa-5bd1-41d0-81a3-565628e208b7_terseLabel_en-US" xlink:label="lab_ew_ResearchAndDevelopmentAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development accruals</link:label>
    <link:label id="lab_ew_ResearchAndDevelopmentAccruals_label_en-US" xlink:label="lab_ew_ResearchAndDevelopmentAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Accruals</link:label>
    <link:label id="lab_ew_ResearchAndDevelopmentAccruals_documentation_en-US" xlink:label="lab_ew_ResearchAndDevelopmentAccruals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ResearchAndDevelopmentAccruals" xlink:href="ew-20230930.xsd#ew_ResearchAndDevelopmentAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ResearchAndDevelopmentAccruals" xlink:to="lab_ew_ResearchAndDevelopmentAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_aa78cdb4-90a3-4901-a59c-2108c983e1c0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued realignment reserves</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7e2d1ffd-ecfe-4598-8e10-fb207a306c8e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7a05f460-8652-4491-a544-3c535a683567_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5406dd95-ee33-492b-b960-209e0fbc9140_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under stock/equity plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cf982eee-6ab5-48b2-bab0-4f91b3b291fa_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7e48a8bc-f9be-4f50-ae4d-7721003082e5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_a221b76b-b324-4157-bb1a-11a9a09265f3_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_2043d4f2-0cf9-4b01-8278-18fc47bef97a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1337f0c0-6143-43d8-8781-3ef45d2dffdf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration liabilities (Note 8)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_88b32caa-6994-4064-8719-9a8159fc1380_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration liabilities (Note 8)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3642f8d3-83f9-4557-be87-85e7875fdcfd_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_ae9205aa-f90f-45d0-80ff-5018970163a9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest (Note 7)</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_cc3156e6-556b-43d0-83a8-b0093f0954f3_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e3d46e6c-b7bb-4688-ba6b-813e683b907a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_d74b0175-8315-4da2-bf85-9977572eb96e_terseLabel_en-US" xlink:label="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2023 Stock Repurchase Program Shares Sold in March 2023</link:label>
    <link:label id="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_label_en-US" xlink:label="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2023 Stock Repurchase Program Shares Sold In March 2023 [Member]</link:label>
    <link:label id="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_documentation_en-US" xlink:label="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2023 Stock Repurchase Program Shares Sold In March 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:href="ew-20230930.xsd#ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:to="lab_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod_bba6f4b9-b1e8-4a1a-9823-379a40258849_terseLabel_en-US" xlink:label="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period (years)</link:label>
    <link:label id="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod_label_en-US" xlink:label="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</link:label>
    <link:label id="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod_documentation_en-US" xlink:label="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" xlink:href="ew-20230930.xsd#ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" xlink:to="lab_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_19e2b84c-a71f-4d88-b3a0-51c69903871a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4b9a56de-5422-41e3-afa8-97ac7b0685ef_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_23fd0276-7dde-4422-953f-a68e876ad679_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Reclassified from Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_54c9708a-2035-4e60-9718-592c2d8aec49_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_afda0390-30de-4bf5-9dd6-970714ddf696_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_b243b52c-4cfd-4d2a-a50d-0643224d8d5b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain or (Loss) Recognized in Income on Derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a11bffc7-185c-44df-830b-09d22d4811a3_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6e6c77be-bd44-4545-ae1e-2909c500bda7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_49c13d52-1487-4b01-ba7f-08e18d68620b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_LoansReceivablesMaximumLendingCapacity_064024df-df60-4c72-bd15-822e8a1c212e_terseLabel_en-US" xlink:label="lab_ew_LoansReceivablesMaximumLendingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivables, maximum lending amount</link:label>
    <link:label id="lab_ew_LoansReceivablesMaximumLendingCapacity_label_en-US" xlink:label="lab_ew_LoansReceivablesMaximumLendingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivables, Maximum Lending Capacity</link:label>
    <link:label id="lab_ew_LoansReceivablesMaximumLendingCapacity_documentation_en-US" xlink:label="lab_ew_LoansReceivablesMaximumLendingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivables, Maximum Lending Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LoansReceivablesMaximumLendingCapacity" xlink:href="ew-20230930.xsd#ew_LoansReceivablesMaximumLendingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_LoansReceivablesMaximumLendingCapacity" xlink:to="lab_ew_LoansReceivablesMaximumLendingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_a1b32361-08b8-42b0-98a4-a868d10ab5c9_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished products</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_34793452-efdc-491d-9c81-0017df306afa_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_109d5b63-a49b-4dc9-b360-7019f55277f5_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_418c96ef-aac6-40d7-b484-8afcd5b2aff2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and withholdings</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_e1605649-322e-4d39-8ef1-a542c0d3552f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0151b34f-7bfe-45e1-8d39-6c8842a1295d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_4cf486d5-2710-44c7-bcaf-1440d319ba45_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a66b0e06-3caa-4479-8a2f-51a99b212ce1_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses, 12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_afae6872-dae8-4ba9-9a06-efee9c9a2c7d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8abdec1c-8bb9-4c0b-ba49-bee2437da89a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_26fe49fb-3e02-4d2a-8dd7-8a660ea99edb_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_afde16f4-fc1a-4267-8f7a-6fdfb509942e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_CriticalCareMember_8111da3b-c976-4191-9925-fbd0ad33bd16_terseLabel_en-US" xlink:label="lab_ew_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care</link:label>
    <link:label id="lab_ew_CriticalCareMember_label_en-US" xlink:label="lab_ew_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:label id="lab_ew_CriticalCareMember_documentation_en-US" xlink:label="lab_ew_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the critical care product line.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_CriticalCareMember" xlink:href="ew-20230930.xsd#ew_CriticalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_CriticalCareMember" xlink:to="lab_ew_CriticalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_557eff08-12a0-4e23-ae03-2f48cc440391_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_b8a8b8fc-d713-451f-aa3f-96fb29000b82_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_ffca23b2-e013-4935-85ae-1050c331e88f_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts Offset in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, Asset Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_f80ff50c-ba83-4c03-868c-35caf9b31f92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9b510124-7506-4f96-add0-eab9ddc4606e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_a74a6e6f-140d-4fcd-b99a-422e694e42f3_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses, less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_579f42b8-225e-4b8d-94cd-9ae0c7843259_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_bff0475b-4abb-43ea-91cd-0c9d6488f37d_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_e02528ec-8bb3-4c17-9df1-c2f3e8cc531f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of pre-existing notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b744e38a-5b30-4c1e-90e3-30c52261a167_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_31333383-a5c8-45b2-b0d4-a481c895e6de_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_603471cb-add7-4d98-8ee6-7ccde3267d85_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_a40a32eb-60b7-4f0e-bd1b-159c1b34fa1e_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_648ecfc2-9374-4e19-a009-7800bc8c8ef5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Financial Statement, Reported Amounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_1ff2924e-b5a4-473a-bc86-06de18fdc9d8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_2354c76a-e75b-4ca5-a752-d28f2200278d_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after 5&#160;years through 10&#160;years</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_0f8eb952-b214-447b-9110-5cf2f302fbe0_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank time deposits</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_42f2c057-7066-4c97-8fa5-367db97052b3_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_66c0ccca-f1d5-4a39-96e5-0edd825bb630_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Received (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_73ca60c5-4fdf-4817-b55e-02a073d8aa9d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_7a55eaf3-bc3c-4f3d-8911-919f3c553268_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_fcd7fb92-7ae6-44a7-bd47-1bcd4df25a5c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ContingentConsiderationLiabilityMember_58906583-f0a1-490d-b89a-a0e367d44df9_terseLabel_en-US" xlink:label="lab_ew_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_ew_ContingentConsiderationLiabilityMember_label_en-US" xlink:label="lab_ew_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_ew_ContingentConsiderationLiabilityMember_documentation_en-US" xlink:label="lab_ew_ContingentConsiderationLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember" xlink:href="ew-20230930.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ContingentConsiderationLiabilityMember" xlink:to="lab_ew_ContingentConsiderationLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_32eefb9a-928e-4225-8261-d1d0fbe634c9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7fdb374c-e098-4b0d-8646-4649f2d3e39f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_0edbce77-474b-433a-b254-3b975424d599_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsAbstract" xlink:to="lab_us-gaap_DerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_VariableInterestEntitiesAbstract_label_en-US" xlink:label="lab_ew_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities [Abstract]</link:label>
    <link:label id="lab_ew_VariableInterestEntitiesAbstract_documentation_en-US" xlink:label="lab_ew_VariableInterestEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Variable Interest Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_VariableInterestEntitiesAbstract" xlink:href="ew-20230930.xsd#ew_VariableInterestEntitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_VariableInterestEntitiesAbstract" xlink:to="lab_ew_VariableInterestEntitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_c9d721a9-cc94-49a4-b9cc-89953669abeb_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingDerivativeAssetsAbstract_91ffa962-bbbe-409c-b2b1-1ae15961a1c4_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_OffsettingDerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Derivative Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:to="lab_us-gaap_OffsettingDerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_947d1921-10b5-4a02-b0ed-5a86c6e18f7a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_9014a0ff-d8b0-4358-af50-424a07e29b99_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeMember_7a9cd988-c331-49e5-977d-acc04270734c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeMember_label_en-US" xlink:label="lab_us-gaap_InterestIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeMember" xlink:to="lab_us-gaap_InterestIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0e28f4e3-cb34-4bd9-aa37-1194a34de641_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d38f2dee-c98d-4f1d-8baa-5952f687a499_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e9af14b1-736b-4296-9235-32528bde7ed1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrent_85f5e336-c96c-4725-924c-103eeb3d72c9_terseLabel_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other liabilities (Note 2)</link:label>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrent_14d209c2-bc01-40c2-bb8f-596d295e29e0_totalLabel_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued and other liabilities</link:label>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued And Other Liabilities, Current</link:label>
    <link:label id="lab_ew_AccruedAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued And Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_AccruedAndOtherLiabilitiesCurrent" xlink:to="lab_ew_AccruedAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_ac1b4ff1-6235-4948-934f-b68454485758_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_6ec9baef-80ac-4df7-ac8f-fabc316de775_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6d6e84b5-dfb6-46fc-bbdd-812b987a4ffc_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2cc5b212-82ac-4b90-9e6f-8776d1ecd5bd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_80019549-3a6d-4579-b22d-71d4ab95443f_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_f6fa325e-282a-4cfc-8147-c3564b9a90c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_15127faa-6be8-4c5b-adec-a2d7219cb68b_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciling items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_0d381d93-a038-4cdb-8f2a-04b99cc56551_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_137bef06-2b87-426c-aaea-6904037132df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_bd896502-0c66-4ed2-8eaf-3a09df60eb90_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments (Note&#160;5)</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_ce0749ef-2c19-4b83-9a11-9b823e4260c4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_ed979978-b20d-40ef-84a3-78b9cd545251_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_JeanLucLemercierMember_label_en-US" xlink:label="lab_ew_JeanLucLemercierMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jean-Luc Lemercier [Member]</link:label>
    <link:label id="lab_ew_JeanLucLemercierMember_documentation_en-US" xlink:label="lab_ew_JeanLucLemercierMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jean-Luc Lemercier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JeanLucLemercierMember" xlink:href="ew-20230930.xsd#ew_JeanLucLemercierMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_JeanLucLemercierMember" xlink:to="lab_ew_JeanLucLemercierMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_694b80d5-3ae6-4cd3-b411-0b08f26b653f_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_c55e2d8e-af23-4f8e-b6a5-64a4e551b499_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_205a6ae8-ea87-4dd7-879b-c2914b8a6cb5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_232249e4-b3a5-455e-9c66-26e25ead0463_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_RestOfWorldMember_63795a15-1a91-47ba-8269-a268ebc81906_terseLabel_en-US" xlink:label="lab_ew_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_ew_RestOfWorldMember_label_en-US" xlink:label="lab_ew_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:label id="lab_ew_RestOfWorldMember_documentation_en-US" xlink:label="lab_ew_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the geographic areas of the world other than the United States, Europe and Japan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldMember" xlink:href="ew-20230930.xsd#ew_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_RestOfWorldMember" xlink:to="lab_ew_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e45a047b-3177-4546-b278-d95fff0815c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total before tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_32b114d0-8e21-4593-aa41-286301afe238_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f0f7a9b4-0261-4004-a7df-01c80200222d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTableTextBlock_c3dc1603-0360-4a3d-b602-160dbfd6b4e9_verboseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTableTextBlock" xlink:to="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_9202a32d-17f1-4451-a391-7e9bc15aa48c_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_d2851ad8-5732-4925-98e0-5da97f99eb16_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_624a46e7-e49b-4ebe-a41e-e70858515f24_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amounts Offset in the Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, Liability Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:to="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_30b88844-e0de-493f-9175-1be58296cd1a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c1873755-d2d7-4300-8944-634f0b1f563b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_eb04831b-d1ab-438a-aa5d-1136a1ab6e71_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_773c2fab-085d-417f-b1ab-c0e1869e3777_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_2df7ebee-94b3-44a5-9544-aa895c1e45cc_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial delivery, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Initial Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_401e0f70-a3d7-4eb9-a055-b5b46154c912_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income, net</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4c61a2dc-931a-4594-a827-c703ce96448a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b96a6353-1d3a-40c0-8893-2f867948f268_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Net Sales</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_e21c46f6-7f27-424b-be5c-2db9b51873b6_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales Reconciliation</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_f51eafb6-f459-4876-82b2-c073549d99db_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_25043c71-4697-4d22-b667-574183bd5413_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_587aff61-4c4f-4950-8ba5-f6391ca74346_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_f9937bad-61ec-4f19-ba9a-b86c9b411a55_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in non-marketable equity securities due to observable price changes</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a7be371a-f539-461e-b8a9-7163a84a6123_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b02a85b2-daa4-4a9d-bc5d-fc4e9e068c63_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_eb4f4129-dd83-429e-93db-792f84ac2551_verboseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPaymentsToAcquireBusinesses_0a2edc16-9f4d-4be9-a5e1-02e733607e23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for acquisition options (Note 6)</link:label>
    <link:label id="lab_us-gaap_OtherPaymentsToAcquireBusinesses_b6ad4ee8-44f5-4911-8350-914611183255_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for option to acquire company</link:label>
    <link:label id="lab_us-gaap_OtherPaymentsToAcquireBusinesses_label_en-US" xlink:label="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Payments to Acquire Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="lab_us-gaap_OtherPaymentsToAcquireBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_RestructuringContingentConsiderationGainLoss_60b8cee0-24a7-4b2d-96e0-3f671204555d_terseLabel_en-US" xlink:label="lab_ew_RestructuringContingentConsiderationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring contingent consideration gain</link:label>
    <link:label id="lab_ew_RestructuringContingentConsiderationGainLoss_label_en-US" xlink:label="lab_ew_RestructuringContingentConsiderationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Contingent Consideration, Gain (Loss)</link:label>
    <link:label id="lab_ew_RestructuringContingentConsiderationGainLoss_documentation_en-US" xlink:label="lab_ew_RestructuringContingentConsiderationGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Contingent Consideration, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestructuringContingentConsiderationGainLoss" xlink:href="ew-20230930.xsd#ew_RestructuringContingentConsiderationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_RestructuringContingentConsiderationGainLoss" xlink:to="lab_ew_RestructuringContingentConsiderationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member_cb694f5c-45dc-4e65-8676-d820e3cc4a49_terseLabel_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Delivery of Shares Settled February2023</link:label>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member_label_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Delivery Of Shares Settled February 2023 [Member]</link:label>
    <link:label id="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member_documentation_en-US" xlink:label="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Delivery Of Shares Settled February 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:href="ew-20230930.xsd#ew_InitialDeliveryOfSharesSettledFebruary2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:to="lab_ew_InitialDeliveryOfSharesSettledFebruary2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_10fe95b4-ea35-4329-ae19-898b6e194c51_terseLabel_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment option to acquire</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_label_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Option To Acquire Investment</link:label>
    <link:label id="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_documentation_en-US" xlink:label="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Option To Acquire Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIOptionToAcquireInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:to="lab_ew_EquitySecuritiesFVNIOptionToAcquireInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_7cb3ec2d-7c25-4ec0-b4db-9a469f6a8705_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_71996450-afc1-486a-9784-732f08026a60_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax Income Reconciliation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ew_ConvertiblePromissoryNoteMember_6800ab20-da95-465f-b4b7-36c3f2bf1790_terseLabel_en-US" xlink:label="lab_ew_ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Promissory Note</link:label>
    <link:label id="lab_ew_ConvertiblePromissoryNoteMember_label_en-US" xlink:label="lab_ew_ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Promissory Note [Member]</link:label>
    <link:label id="lab_ew_ConvertiblePromissoryNoteMember_documentation_en-US" xlink:label="lab_ew_ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ConvertiblePromissoryNoteMember" xlink:href="ew-20230930.xsd#ew_ConvertiblePromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ew_ConvertiblePromissoryNoteMember" xlink:to="lab_ew_ConvertiblePromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a774d158-86e1-4f5e-a7db-47b57d6a3614_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_955ff92d-7fa1-4a92-9524-716de2810bae_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_5199f40a-8cb3-4288-ac9b-6f86e9071609_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ew-20230930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:eaa870a0-ed84-4111-a2ce-17bb0f4c4328,g:a046b429-8038-45a1-a20d-74cf9c7f6b8d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.edwards.com/role/COVER" xlink:type="simple" xlink:href="ew-20230930.xsd#COVER"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/COVER" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c1c796d4-82c7-459a-86b1-b3335e01b97a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_DocumentType_c1c796d4-82c7-459a-86b1-b3335e01b97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_b013b8ee-72f2-4f66-bb77-8912410fa7d8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_DocumentQuarterlyReport_b013b8ee-72f2-4f66-bb77-8912410fa7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3e03eea0-ae0c-42b5-a94e-81c1ca776d6f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_DocumentPeriodEndDate_3e03eea0-ae0c-42b5-a94e-81c1ca776d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_4a9a8760-7a19-477f-9c5a-32b91c06ca8e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_DocumentTransitionReport_4a9a8760-7a19-477f-9c5a-32b91c06ca8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9ab44691-627c-4cb4-8817-233bbe5ae59d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityFileNumber_9ab44691-627c-4cb4-8817-233bbe5ae59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7749a9ee-d3b2-4392-9796-a49cf5ae58d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityRegistrantName_7749a9ee-d3b2-4392-9796-a49cf5ae58d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_74cdb2ce-c9ee-4c57-9bd4-bf983be210c3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_74cdb2ce-c9ee-4c57-9bd4-bf983be210c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_61c1f68c-05e5-4a78-8aee-c80b11d7681a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityTaxIdentificationNumber_61c1f68c-05e5-4a78-8aee-c80b11d7681a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d998d9e8-8544-4959-a1ea-6db43f44ad98" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityAddressAddressLine1_d998d9e8-8544-4959-a1ea-6db43f44ad98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6e1feaf9-4189-4f77-a6ec-b96dace30134" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityAddressCityOrTown_6e1feaf9-4189-4f77-a6ec-b96dace30134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9868248e-db17-4fee-b864-793598a03edb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityAddressStateOrProvince_9868248e-db17-4fee-b864-793598a03edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5de589e4-20e8-40b2-b513-5dc9322a68d8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityAddressPostalZipCode_5de589e4-20e8-40b2-b513-5dc9322a68d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_400c9ba4-17b1-4790-898e-30d36b1087f3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_CityAreaCode_400c9ba4-17b1-4790-898e-30d36b1087f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_617c3c3b-a3a8-4d5e-b6d5-0636d2e871b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_LocalPhoneNumber_617c3c3b-a3a8-4d5e-b6d5-0636d2e871b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_191eadf6-7d8d-44d1-9da7-d862499371af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_Security12bTitle_191eadf6-7d8d-44d1-9da7-d862499371af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c99b7f24-07eb-4de4-9009-881424e17d29" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_TradingSymbol_c99b7f24-07eb-4de4-9009-881424e17d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_61a4f3f6-ad16-4c5b-8df7-9b778f9dd73a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_SecurityExchangeName_61a4f3f6-ad16-4c5b-8df7-9b778f9dd73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8cf66ec6-6363-45b2-9f6d-4a05bb74dd66" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityCurrentReportingStatus_8cf66ec6-6363-45b2-9f6d-4a05bb74dd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ba84dd5e-3a94-4f34-a237-93f7572f47ba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityInteractiveDataCurrent_ba84dd5e-3a94-4f34-a237-93f7572f47ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_942af5a5-9bdd-4fbc-b322-8ce409636caa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityFilerCategory_942af5a5-9bdd-4fbc-b322-8ce409636caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_e0612de0-90a6-4f61-96c3-03213afca366" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntitySmallBusiness_e0612de0-90a6-4f61-96c3-03213afca366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_428363cd-a8ed-4c69-bc6b-8caf4c90be2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityEmergingGrowthCompany_428363cd-a8ed-4c69-bc6b-8caf4c90be2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_340db3be-9aab-4fea-8d5f-181a5a7f7568" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityShellCompany_340db3be-9aab-4fea-8d5f-181a5a7f7568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c6a30862-952a-4d40-9bb5-6a8c5d8edbe9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c6a30862-952a-4d40-9bb5-6a8c5d8edbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fd869f5b-ef50-4e8a-badc-8d4eef996496" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_EntityCentralIndexKey_fd869f5b-ef50-4e8a-badc-8d4eef996496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ef14339f-0867-4fda-a62a-6df89062372b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_CurrentFiscalYearEndDate_ef14339f-0867-4fda-a62a-6df89062372b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_17f423ae-6d49-438b-a82d-a4d0c55cfc4c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_DocumentFiscalYearFocus_17f423ae-6d49-438b-a82d-a4d0c55cfc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f8b516df-af32-4069-94f5-02e6c78bd1e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f8b516df-af32-4069-94f5-02e6c78bd1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ce31b8c2-9be4-4261-bc52-522a2bb4b4fb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8f254bda-0364-4b55-92e6-a794d3ca711f" xlink:to="loc_dei_AmendmentFlag_ce31b8c2-9be4-4261-bc52-522a2bb4b4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3e09b263-521f-469b-adaa-468a945a3531" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3e09b263-521f-469b-adaa-468a945a3531" xlink:to="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_752e1cce-43da-4b9b-9e2e-7e063b4c3583" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_752e1cce-43da-4b9b-9e2e-7e063b4c3583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_66ab3d9a-2b32-4033-831c-bcbe1d0914e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:to="loc_us-gaap_ShortTermInvestments_66ab3d9a-2b32-4033-831c-bcbe1d0914e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_845821fc-45a2-4847-9c12-afefabf43046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_845821fc-45a2-4847-9c12-afefabf43046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_6e04f385-6205-4c27-88fe-bf55c988ce17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:to="loc_us-gaap_OtherReceivables_6e04f385-6205-4c27-88fe-bf55c988ce17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b34e5300-af38-4e30-8bf8-5b224ba17118" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:to="loc_us-gaap_InventoryNet_b34e5300-af38-4e30-8bf8-5b224ba17118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_cf9ebf61-40c6-4a70-9d0d-d2c272f37ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_cf9ebf61-40c6-4a70-9d0d-d2c272f37ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b97ffb7e-9be4-4dcf-ad52-8db10764c4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:to="loc_us-gaap_OtherAssetsCurrent_b97ffb7e-9be4-4dcf-ad52-8db10764c4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0b82a2b7-3646-4447-8523-3bb033138f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_718183c3-e687-4b38-a6bc-ff18928e8bd6" xlink:to="loc_us-gaap_AssetsCurrent_0b82a2b7-3646-4447-8523-3bb033138f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_276582ab-f4d3-4d94-b9ee-7981ba62ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_LongTermInvestments_276582ab-f4d3-4d94-b9ee-7981ba62ed2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a1a46e7f-83e1-4315-9123-94a912581c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a1a46e7f-83e1-4315-9123-94a912581c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0869ef6f-b739-4149-96a3-cca2550eac92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0869ef6f-b739-4149-96a3-cca2550eac92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_67441275-50ad-4e93-bd2c-fe9a09a59375" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_Goodwill_67441275-50ad-4e93-bd2c-fe9a09a59375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_73de9f8a-5601-48fd-ba6a-824825bebfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_73de9f8a-5601-48fd-ba6a-824825bebfe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_d03134bd-c7e7-496d-b81a-b61daa61fdc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_d03134bd-c7e7-496d-b81a-b61daa61fdc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e7d138b4-adf9-4c78-a3c3-f4cde3145ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e7d138b4-adf9-4c78-a3c3-f4cde3145ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_18c13f58-0846-411d-808b-ac6010d10aab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_82b48737-be4a-4110-820a-1874e01df626" xlink:to="loc_us-gaap_Assets_18c13f58-0846-411d-808b-ac6010d10aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3e09b263-521f-469b-adaa-468a945a3531" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_00cf9d2b-e96b-4f27-a47c-bb1f5622a4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_00cf9d2b-e96b-4f27-a47c-bb1f5622a4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_acdad3bb-fdbc-429f-807e-c96401dc5b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_00cf9d2b-e96b-4f27-a47c-bb1f5622a4a2" xlink:to="loc_us-gaap_AccountsPayableCurrent_acdad3bb-fdbc-429f-807e-c96401dc5b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_9bbc73be-2ec3-47ff-baf4-da97fa2252e5" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_00cf9d2b-e96b-4f27-a47c-bb1f5622a4a2" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrent_9bbc73be-2ec3-47ff-baf4-da97fa2252e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1385b86e-f1b2-440b-b20d-da9c6312dd50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_00cf9d2b-e96b-4f27-a47c-bb1f5622a4a2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1385b86e-f1b2-440b-b20d-da9c6312dd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_47488a1a-8526-4ab7-95b7-f9646cb3c7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_00cf9d2b-e96b-4f27-a47c-bb1f5622a4a2" xlink:to="loc_us-gaap_LiabilitiesCurrent_47488a1a-8526-4ab7-95b7-f9646cb3c7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c18fbee8-c767-4238-a6fe-3a91ff480c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c18fbee8-c767-4238-a6fe-3a91ff480c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e69335f2-099c-4aef-9ae9-cc7ed18228de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e69335f2-099c-4aef-9ae9-cc7ed18228de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_94362064-e240-485f-8f9e-da46cc5ff8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_94362064-e240-485f-8f9e-da46cc5ff8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3542825d-2962-4670-9f77-b3f5f61d2568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3542825d-2962-4670-9f77-b3f5f61d2568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_513cc22d-09c4-4f20-bece-b7ddc504283f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_513cc22d-09c4-4f20-bece-b7ddc504283f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_4ec686f4-2789-4fdd-88dd-e719c9964d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_4ec686f4-2789-4fdd-88dd-e719c9964d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_43b42dfe-dbca-4940-9a7c-5df79a97838a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_43b42dfe-dbca-4940-9a7c-5df79a97838a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4e4e4f67-ae91-4658-865b-65286e5c54b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_Liabilities_4e4e4f67-ae91-4658-865b-65286e5c54b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_51a8c333-4594-481f-912a-88e40c5efdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_CommitmentsAndContingencies_51a8c333-4594-481f-912a-88e40c5efdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_917eba0e-dd88-4e33-a620-064ea239eb96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_PreferredStockValue_917eba0e-dd88-4e33-a620-064ea239eb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3152a0d1-2070-448a-8674-27bbed261b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_CommonStockValue_3152a0d1-2070-448a-8674-27bbed261b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_130fe3c6-74fd-4581-a2b1-235fb5be0e60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_130fe3c6-74fd-4581-a2b1-235fb5be0e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8071445c-2c12-46c9-9f2b-e35ffe092f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8071445c-2c12-46c9-9f2b-e35ffe092f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_41b2bba5-0e87-4fcf-9048-b3db2dfa1036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_41b2bba5-0e87-4fcf-9048-b3db2dfa1036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_df014799-b023-4bcc-acb4-e10c74788114" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_TreasuryStockCommonValue_df014799-b023-4bcc-acb4-e10c74788114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7cd21402-37a2-49ed-b6ab-fcc8ebcbeded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_StockholdersEquity_7cd21402-37a2-49ed-b6ab-fcc8ebcbeded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_32a20345-e7e4-49c9-8a47-452130c1d67a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_MinorityInterest_32a20345-e7e4-49c9-8a47-452130c1d67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9d8adb48-adbb-4118-aa27-1136321e3477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d95b5d8b-4574-4d4d-b58a-7f2f2da74134" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9d8adb48-adbb-4118-aa27-1136321e3477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d18cf574-fbc6-4396-83f0-f8b946464db8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbae0e9d-9b8f-421d-b6b7-f8bae7633d05" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d18cf574-fbc6-4396-83f0-f8b946464db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bd3cca6c-f901-4881-9175-a2fc2ad53eed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bd3cca6c-f901-4881-9175-a2fc2ad53eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8b1d6ba2-050e-42bf-abe7-71ac15fd210d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8b1d6ba2-050e-42bf-abe7-71ac15fd210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_8b108d4b-30b9-401f-bf5f-453bdb10507b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_8b108d4b-30b9-401f-bf5f-453bdb10507b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_472531dc-3e6e-45c5-95b9-6fff8c383281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_472531dc-3e6e-45c5-95b9-6fff8c383281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2d0df561-293e-4776-ba8b-8d6254563697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2d0df561-293e-4776-ba8b-8d6254563697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b8078438-eaa9-4552-8fc4-08b4466b51d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b8078438-eaa9-4552-8fc4-08b4466b51d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2a6645ee-fe56-4d84-a0b5-ab002bd31a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_CommonStockSharesIssued_2a6645ee-fe56-4d84-a0b5-ab002bd31a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bf8af610-409e-401d-8e5d-03f58b6b2497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bf8af610-409e-401d-8e5d-03f58b6b2497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_e9c7ebc9-5311-47a4-a9e2-d63836664a34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3af46d6b-841a-4c09-a1c0-54b93d12f14c" xlink:to="loc_us-gaap_TreasuryStockCommonShares_e9c7ebc9-5311-47a4-a9e2-d63836664a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1adfcf0a-2b5f-442c-9a11-847afd06bf40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1adfcf0a-2b5f-442c-9a11-847afd06bf40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7efdc059-e8a1-4f94-9f8f-241d6adb952e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7efdc059-e8a1-4f94-9f8f-241d6adb952e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f148dfda-717c-46da-8a9b-f74fe1c250a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_GrossProfit_f148dfda-717c-46da-8a9b-f74fe1c250a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_135a59d6-b84e-4fff-b5da-586991530f39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_135a59d6-b84e-4fff-b5da-586991530f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ad8e6466-1179-4b89-b8c2-c4b37f64c32a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ad8e6466-1179-4b89-b8c2-c4b37f64c32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_2d721426-240c-4f88-857b-dbc35b1829de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_LitigationSettlementExpense_2d721426-240c-4f88-857b-dbc35b1829de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8eeec69d-3da9-49fd-aef9-f203233654eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8eeec69d-3da9-49fd-aef9-f203233654eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_3161f34e-8d75-4714-9144-78dfffced4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_3161f34e-8d75-4714-9144-78dfffced4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_99bb489e-3f39-4688-97ec-d31177716f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_OperatingIncomeLoss_99bb489e-3f39-4688-97ec-d31177716f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_98d9fa38-d9b4-4be1-856d-4ed1fe32db77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_98d9fa38-d9b4-4be1-856d-4ed1fe32db77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_67065e26-125b-49a7-91e0-dec6fa7209d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_67065e26-125b-49a7-91e0-dec6fa7209d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bd1c72d6-10ff-4919-b1a7-dee6e7cc9d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bd1c72d6-10ff-4919-b1a7-dee6e7cc9d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_897d489a-45d2-4425-b67a-59dfa0ea8d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_897d489a-45d2-4425-b67a-59dfa0ea8d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7fc5e89f-ce63-4f85-9ab9-e07a3a03d145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_ProfitLoss_7fc5e89f-ce63-4f85-9ab9-e07a3a03d145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_49e8061c-e871-42da-86f6-1e91cd91712c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_49e8061c-e871-42da-86f6-1e91cd91712c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fd979481-e7ce-4005-bbe3-11c43f4589e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_us-gaap_NetIncomeLoss_fd979481-e7ce-4005-bbe3-11c43f4589e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareInformationAbstract_6431c7e6-7149-4de8-b8ed-7be9d7c6a523" xlink:href="ew-20230930.xsd#ew_ShareInformationAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cbd9ca1e-8fe5-4604-b950-b860f14bf761" xlink:to="loc_ew_ShareInformationAbstract_6431c7e6-7149-4de8-b8ed-7be9d7c6a523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c9dfb8ac-dcb2-4805-909a-6af19198a03f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_ShareInformationAbstract_6431c7e6-7149-4de8-b8ed-7be9d7c6a523" xlink:to="loc_us-gaap_EarningsPerShareAbstract_c9dfb8ac-dcb2-4805-909a-6af19198a03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ddb86742-5009-44e8-8e4a-11b6f8df8f75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c9dfb8ac-dcb2-4805-909a-6af19198a03f" xlink:to="loc_us-gaap_EarningsPerShareBasic_ddb86742-5009-44e8-8e4a-11b6f8df8f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1edc1baa-666d-42fc-8e4e-524f3bdc7656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c9dfb8ac-dcb2-4805-909a-6af19198a03f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1edc1baa-666d-42fc-8e4e-524f3bdc7656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b72d3161-1b62-40ea-9543-40535f5dafe1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_ShareInformationAbstract_6431c7e6-7149-4de8-b8ed-7be9d7c6a523" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b72d3161-1b62-40ea-9543-40535f5dafe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9f9c0ea4-b763-4458-9941-545725531015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b72d3161-1b62-40ea-9543-40535f5dafe1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9f9c0ea4-b763-4458-9941-545725531015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bad2b2c6-540d-4660-902f-6d34a61f66a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b72d3161-1b62-40ea-9543-40535f5dafe1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bad2b2c6-540d-4660-902f-6d34a61f66a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3042cc61-7d75-4518-ba7c-b4941a5529e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6c2530fb-6008-41dd-b210-8249342b634a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3042cc61-7d75-4518-ba7c-b4941a5529e1" xlink:to="loc_us-gaap_ProfitLoss_6c2530fb-6008-41dd-b210-8249342b634a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8aa07325-ac0f-487d-8030-73bf82d49dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3042cc61-7d75-4518-ba7c-b4941a5529e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8aa07325-ac0f-487d-8030-73bf82d49dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4d8fd99a-1841-4b75-8f16-459c1a2fad3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8aa07325-ac0f-487d-8030-73bf82d49dd1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4d8fd99a-1841-4b75-8f16-459c1a2fad3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_00592879-c8d9-4695-b552-b56679cec307" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8aa07325-ac0f-487d-8030-73bf82d49dd1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_00592879-c8d9-4695-b552-b56679cec307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5b72d696-1363-4c98-8a3f-e3907ed047f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8aa07325-ac0f-487d-8030-73bf82d49dd1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_5b72d696-1363-4c98-8a3f-e3907ed047f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7bc5de94-ed97-4462-99fe-cee968497b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8aa07325-ac0f-487d-8030-73bf82d49dd1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7bc5de94-ed97-4462-99fe-cee968497b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_017edd8b-9163-48e5-8aa2-375b469b5cab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_8aa07325-ac0f-487d-8030-73bf82d49dd1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_017edd8b-9163-48e5-8aa2-375b469b5cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9ed5d844-0161-485e-8df9-d482e6967109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3042cc61-7d75-4518-ba7c-b4941a5529e1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9ed5d844-0161-485e-8df9-d482e6967109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_01048ee0-dc56-402a-bfaa-391fc0a1b15c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3042cc61-7d75-4518-ba7c-b4941a5529e1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_01048ee0-dc56-402a-bfaa-391fc0a1b15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d85857a5-da14-49d8-8357-26a803d47fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3042cc61-7d75-4518-ba7c-b4941a5529e1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d85857a5-da14-49d8-8357-26a803d47fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4254b77a-84b0-429d-b057-80d06f804376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_179d976e-0d1b-4ecb-8afa-2e07fa60b7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4254b77a-84b0-429d-b057-80d06f804376" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_179d976e-0d1b-4ecb-8afa-2e07fa60b7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_251cb9e8-5047-4059-afef-4040df40ae5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_179d976e-0d1b-4ecb-8afa-2e07fa60b7f0" xlink:to="loc_us-gaap_ProfitLoss_251cb9e8-5047-4059-afef-4040df40ae5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_179d976e-0d1b-4ecb-8afa-2e07fa60b7f0" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_95a79d91-2591-49bb-a1ed-0b60048c8cce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_95a79d91-2591-49bb-a1ed-0b60048c8cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8174da1a-2d3d-4ee0-a87e-198d27bc63a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8174da1a-2d3d-4ee0-a87e-198d27bc63a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d6941d7c-f2f0-4b98-aeb7-641091fcb4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_ShareBasedCompensation_d6941d7c-f2f0-4b98-aeb7-641091fcb4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_05b9bad9-1d2b-4c60-95c2-e5115e18d64f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_AssetImpairmentCharges_05b9bad9-1d2b-4c60-95c2-e5115e18d64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_af80ff02-5a40-4178-889a-ab684814e241" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_af80ff02-5a40-4178-889a-ab684814e241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_1ee9abdc-ee58-452a-8862-c019293d7512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_GainLossOnInvestments_1ee9abdc-ee58-452a-8862-c019293d7512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d249a8ec-a008-4027-ad1f-2565df137622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d249a8ec-a008-4027-ad1f-2565df137622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1594703d-ef78-4997-a7db-09310a5f8811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1594703d-ef78-4997-a7db-09310a5f8811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8cb709fb-6b10-4ac5-8de9-11c55e0c7d39" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_3772f95a-29dd-4118-b296-b0647d0ce4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_3772f95a-29dd-4118-b296-b0647d0ce4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_316bad83-a5bb-415e-87c2-e69b7923f2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_316bad83-a5bb-415e-87c2-e69b7923f2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ec05ebd7-49c5-43b0-aad5-5ef4c72e10e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ec05ebd7-49c5-43b0-aad5-5ef4c72e10e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_dc9f5a61-cd2e-42a0-b1f9-605b1240d15e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_dc9f5a61-cd2e-42a0-b1f9-605b1240d15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b0ca75a7-159e-448d-ae7f-0401b635f2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b0ca75a7-159e-448d-ae7f-0401b635f2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IncreaseDecreaseInLegalSettlementAccrual_ea3843d3-278e-4899-9c03-025767c38ddd" xlink:href="ew-20230930.xsd#ew_IncreaseDecreaseInLegalSettlementAccrual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:to="loc_ew_IncreaseDecreaseInLegalSettlementAccrual_ea3843d3-278e-4899-9c03-025767c38ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidRoyalties_5f041abc-b5af-4896-ab2a-5fe24a6b2310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidRoyalties"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidRoyalties_5f041abc-b5af-4896-ab2a-5fe24a6b2310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f0052d84-5710-46dd-a19f-203142ccc50e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e3eecf4f-9a08-4387-8761-4cf03ab34c25" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f0052d84-5710-46dd-a19f-203142ccc50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f151c2db-1072-4752-842c-7d7cc712a010" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_179d976e-0d1b-4ecb-8afa-2e07fa60b7f0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f151c2db-1072-4752-842c-7d7cc712a010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4254b77a-84b0-429d-b057-80d06f804376" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_31d0d993-2c0f-4e88-a43b-4b5c823300d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_31d0d993-2c0f-4e88-a43b-4b5c823300d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_bbfafcda-32c3-4b60-b2bb-62337e4b7f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_bbfafcda-32c3-4b60-b2bb-62337e4b7f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_c71f6ca1-0f12-4939-bb81-0dbe39175b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_c71f6ca1-0f12-4939-bb81-0dbe39175b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_c480f082-1ded-4e63-afc6-d764c28ed119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_c480f082-1ded-4e63-afc6-d764c28ed119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_01bd2680-1a2b-45f2-8d02-06b990e869c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_01bd2680-1a2b-45f2-8d02-06b990e869c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_9a40ee15-70a7-4d89-b2dc-a95f1aa25138" xlink:href="ew-20230930.xsd#ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions_9a40ee15-70a7-4d89-b2dc-a95f1aa25138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_8817faf6-7ed5-48ac-a559-8ef0cf8ea525" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_8817faf6-7ed5-48ac-a559-8ef0cf8ea525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireReceivables_918fded8-af20-4197-90d1-e1c11235cad2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireReceivables"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_PaymentsToAcquireReceivables_918fded8-af20-4197-90d1-e1c11235cad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_c7af4227-bedd-4a57-a2ee-5b5843af3be1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_c7af4227-bedd-4a57-a2ee-5b5843af3be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_52fb22f1-bafb-48a1-896a-0ffbcb9ed915" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_52fb22f1-bafb-48a1-896a-0ffbcb9ed915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_87e2ddae-5c12-4f74-af49-495b551fbce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_bad2e0ad-4984-4b7f-a752-e2ec2af06db7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_87e2ddae-5c12-4f74-af49-495b551fbce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_52a5fd56-a9aa-4df7-a55e-88b41ed71d12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4254b77a-84b0-429d-b057-80d06f804376" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_52a5fd56-a9aa-4df7-a55e-88b41ed71d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cfb8c271-ad81-4a07-9b61-7be6d3815218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_52a5fd56-a9aa-4df7-a55e-88b41ed71d12" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cfb8c271-ad81-4a07-9b61-7be6d3815218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_ba94b86b-7ced-4cbf-915b-ff89d80c2fda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_52a5fd56-a9aa-4df7-a55e-88b41ed71d12" xlink:to="loc_us-gaap_ProceedsFromStockPlans_ba94b86b-7ced-4cbf-915b-ff89d80c2fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ffe1480e-5f84-4dfa-9637-046a67db66fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_52a5fd56-a9aa-4df7-a55e-88b41ed71d12" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ffe1480e-5f84-4dfa-9637-046a67db66fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d0350bd-5d7e-4617-9568-ccdde47d00e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_52a5fd56-a9aa-4df7-a55e-88b41ed71d12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d0350bd-5d7e-4617-9568-ccdde47d00e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_176e8046-f95f-4ccf-b9b2-5cabfc4c63e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4254b77a-84b0-429d-b057-80d06f804376" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_176e8046-f95f-4ccf-b9b2-5cabfc4c63e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0b310c4e-c16c-484f-b92f-92f79e50d6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4254b77a-84b0-429d-b057-80d06f804376" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0b310c4e-c16c-484f-b92f-92f79e50d6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1b7a29cb-8aac-408f-a3cc-908fef6bb002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4254b77a-84b0-429d-b057-80d06f804376" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1b7a29cb-8aac-408f-a3cc-908fef6bb002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee46b9df-1e06-4c8c-a650-d58516c39f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4254b77a-84b0-429d-b057-80d06f804376" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee46b9df-1e06-4c8c-a650-d58516c39f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ew-20230930.xsd#CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b3df32e6-e0f7-4d26-9cf9-dfe0a63d0b87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e2a06cc9-3596-49de-aa7c-1c8a2276d166" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b3df32e6-e0f7-4d26-9cf9-dfe0a63d0b87" xlink:to="loc_us-gaap_StatementTable_e2a06cc9-3596-49de-aa7c-1c8a2276d166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e2a06cc9-3596-49de-aa7c-1c8a2276d166" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f2782bb-25f4-4628-af20-62447e72ba98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3c67c1e7-2e7c-4e39-be45-a62d5aecc02c" xlink:to="loc_us-gaap_EquityComponentDomain_9f2782bb-25f4-4628-af20-62447e72ba98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f2782bb-25f4-4628-af20-62447e72ba98" xlink:to="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_06cd5645-e70a-40e8-8f7b-8a64aed8f5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_CommonStockMember_06cd5645-e70a-40e8-8f7b-8a64aed8f5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_45371b24-caa1-45e6-a6be-cfb25a4ee12b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_TreasuryStockCommonMember_45371b24-caa1-45e6-a6be-cfb25a4ee12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b3334a48-d6cb-4e63-bf07-827aae36a4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b3334a48-d6cb-4e63-bf07-827aae36a4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9c789719-c6d4-40eb-ab16-2342835b6142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_RetainedEarningsMember_9c789719-c6d4-40eb-ab16-2342835b6142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f249cd7e-ec07-4a00-8af9-99a2558196bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_7d4ee25a-0b30-4c32-9730-41c666cee97d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f249cd7e-ec07-4a00-8af9-99a2558196bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_1e60f8d3-ed04-44fa-8bb4-274952219730" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f2782bb-25f4-4628-af20-62447e72ba98" xlink:to="loc_us-gaap_NoncontrollingInterestMember_1e60f8d3-ed04-44fa-8bb4-274952219730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a96c50b4-038a-480f-8be2-f5fdc78e9196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e2a06cc9-3596-49de-aa7c-1c8a2276d166" xlink:to="loc_us-gaap_StatementLineItems_a96c50b4-038a-480f-8be2-f5fdc78e9196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a96c50b4-038a-480f-8be2-f5fdc78e9196" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_71eb1b77-da29-4b90-ac83-50f2068fbee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_71eb1b77-da29-4b90-ac83-50f2068fbee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7024a8e8-22f2-4143-bed1-6cf594c7431c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7024a8e8-22f2-4143-bed1-6cf594c7431c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_5a70cc51-6c17-442c-b95a-a9e029aaab3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_TreasuryStockCommonShares_5a70cc51-6c17-442c-b95a-a9e029aaab3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9869d06f-f3d9-4240-8b64-ec53262b9bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_ProfitLoss_9869d06f-f3d9-4240-8b64-ec53262b9bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ae6b428c-e97a-4300-9094-8a18c067932a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ae6b428c-e97a-4300-9094-8a18c067932a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_57c6ac2b-c3b7-424c-baad-47377ead370e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_57c6ac2b-c3b7-424c-baad-47377ead370e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9fbafde4-e7e8-4448-bd85-503e5cb776b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9fbafde4-e7e8-4448-bd85-503e5cb776b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a8b16aa6-d39e-45f6-939e-e679a5539070" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a8b16aa6-d39e-45f6-939e-e679a5539070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9939fd36-47eb-4dd3-b6f6-3c39b44432da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9939fd36-47eb-4dd3-b6f6-3c39b44432da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bdf54492-84af-4143-b5f1-3fa3ff5b6d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_bdf54492-84af-4143-b5f1-3fa3ff5b6d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_f1fe21fa-088a-4265-b636-c96bc082ffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_f1fe21fa-088a-4265-b636-c96bc082ffd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_05bce0ac-101f-4151-a78d-05cd82623b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_05bce0ac-101f-4151-a78d-05cd82623b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4a75ebd4-eded-487f-b0bc-4a313ab17a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4a75ebd4-eded-487f-b0bc-4a313ab17a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_c91bc6c2-f336-4d1b-ae7b-0c83fae57fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7549346-31dd-4448-aa49-9cfeb1db74b8" xlink:to="loc_us-gaap_TreasuryStockCommonShares_c91bc6c2-f336-4d1b-ae7b-0c83fae57fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="ew-20230930.xsd#BASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/BASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4e2327c9-f407-427b-b186-463178ae114a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_51a650d5-aacd-44fd-8032-2af39e14e73f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4e2327c9-f407-427b-b186-463178ae114a" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_51a650d5-aacd-44fd-8032-2af39e14e73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5006e26f-3e0f-4eae-b864-24f4e55268fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_c64b2b62-f8b3-45ed-83e3-00dc1fdb8eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5006e26f-3e0f-4eae-b864-24f4e55268fc" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_c64b2b62-f8b3-45ed-83e3-00dc1fdb8eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET" xlink:type="simple" xlink:href="ew-20230930.xsd#INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_608d7d58-cd8e-43c6-b698-f1809389b734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_3ddbca3b-232b-4d44-96b4-980864b613cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_608d7d58-cd8e-43c6-b698-f1809389b734" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_3ddbca3b-232b-4d44-96b4-980864b613cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SPECIALCHARGE" xlink:type="simple" xlink:href="ew-20230930.xsd#SPECIALCHARGE"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SPECIALCHARGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_fe95c5be-254a-4b1e-adc7-62ec3d2e20ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_17ecafce-e11e-4562-8657-79dde5b5260b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_fe95c5be-254a-4b1e-adc7-62ec3d2e20ee" xlink:to="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_17ecafce-e11e-4562-8657-79dde5b5260b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTS" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_17845ea8-3286-4b0b-bd2f-be29b3a4bd70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_5b858bf5-a856-4d06-b1f9-7cff8a6d7c47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_17845ea8-3286-4b0b-bd2f-be29b3a4bd70" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_5b858bf5-a856-4d06-b1f9-7cff8a6d7c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSINVARIABLEINTERESTENTITIES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ew_VariableInterestEntitiesAbstract_711bbc06-1cc0-4689-85ae-0751228d66f8" xlink:href="ew-20230930.xsd#ew_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_a68aba94-a755-44c2-b267-256fbb81a99a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_VariableInterestEntitiesAbstract_711bbc06-1cc0-4689-85ae-0751228d66f8" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_a68aba94-a755-44c2-b267-256fbb81a99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BUSINESSCOMBINATION" xlink:type="simple" xlink:href="ew-20230930.xsd#BUSINESSCOMBINATION"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/BUSINESSCOMBINATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e5abb9d5-18c8-408a-bbc2-be54c93d9e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a9ab2230-dfba-4ca3-a032-b914661a01c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e5abb9d5-18c8-408a-bbc2-be54c93d9e7b" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a9ab2230-dfba-4ca3-a032-b914661a01c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_74c243f3-8fd0-4e37-9e6e-5c80a5ed1f17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_01757c20-645a-460b-82f2-0ddc316e2ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_74c243f3-8fd0-4e37-9e6e-5c80a5ed1f17" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_01757c20-645a-460b-82f2-0ddc316e2ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b5e2f34a-b71f-449f-822f-41de3afb5806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e72f9042-b48c-4f48-b3ef-8003ae830897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b5e2f34a-b71f-449f-822f-41de3afb5806" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e72f9042-b48c-4f48-b3ef-8003ae830897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eec5e7d1-bf3e-427d-a38b-2f4c19ef0ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_44d9cc07-d308-4425-8232-cdf2f7d87949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eec5e7d1-bf3e-427d-a38b-2f4c19ef0ff4" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_44d9cc07-d308-4425-8232-cdf2f7d87949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCELERATEDSHAREREPURCHASE"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9b80e185-6909-4ba3-a4ea-025cbb71b775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_162944ea-7180-49c0-81d8-94ad2011b913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9b80e185-6909-4ba3-a4ea-025cbb71b775" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_162944ea-7180-49c0-81d8-94ad2011b913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="ew-20230930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2ed21b26-f9a2-47f9-8d1d-08ca14677dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9b35436c-361b-4184-89b2-49e570985630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2ed21b26-f9a2-47f9-8d1d-08ca14677dfc" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9b35436c-361b-4184-89b2-49e570985630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_67573085-060b-4a6f-9a4c-c42f61a9f7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_8c86829d-1f8d-4c7a-9925-07b4f7167149" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_67573085-060b-4a6f-9a4c-c42f61a9f7b3" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_8c86829d-1f8d-4c7a-9925-07b4f7167149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="ew-20230930.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3f799733-f73c-425f-ac2b-2c08b28e7cea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a1a1fcec-97de-45c4-8c95-8fa1b37c2768" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3f799733-f73c-425f-ac2b-2c08b28e7cea" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a1a1fcec-97de-45c4-8c95-8fa1b37c2768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INCOMETAXES" xlink:type="simple" xlink:href="ew-20230930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4eca740a-b0a2-4abc-96a9-b479f99dd347" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ac930169-860a-4788-a418-8a9b9881f13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4eca740a-b0a2-4abc-96a9-b479f99dd347" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ac930169-860a-4788-a418-8a9b9881f13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="ew-20230930.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2ba8b261-c84a-4d2d-b645-8d24dbe237c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_da01fc71-d663-4326-be5a-88ec34be632f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2ba8b261-c84a-4d2d-b645-8d24dbe237c4" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_da01fc71-d663-4326-be5a-88ec34be632f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="ew-20230930.xsd#BASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7bfc22ca-0273-4360-b2ec-e844e5e77713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ac2dc336-93a2-4602-90f8-1699a02bca05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7bfc22ca-0273-4360-b2ec-e844e5e77713" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ac2dc336-93a2-4602-90f8-1699a02bca05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a9431911-0a59-40ae-8c50-5d7f680c17dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7bfc22ca-0273-4360-b2ec-e844e5e77713" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a9431911-0a59-40ae-8c50-5d7f680c17dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_aa8df6bf-65d5-4712-84f2-b460b859c03b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7bfc22ca-0273-4360-b2ec-e844e5e77713" xlink:to="loc_us-gaap_UseOfEstimates_aa8df6bf-65d5-4712-84f2-b460b859c03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a25831a6-90de-4b79-bb06-68b7ae2a9709" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7bfc22ca-0273-4360-b2ec-e844e5e77713" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a25831a6-90de-4b79-bb06-68b7ae2a9709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e1c9ec55-d512-4308-bfd6-861fa69c70b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f819f711-03cb-423a-a2f5-e6d25e099558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e1c9ec55-d512-4308-bfd6-861fa69c70b7" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f819f711-03cb-423a-a2f5-e6d25e099558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_b1778467-e970-4340-8ced-920763dca947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e1c9ec55-d512-4308-bfd6-861fa69c70b7" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_b1778467-e970-4340-8ced-920763dca947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_7d298f6f-9c07-4853-89c2-e317959c6344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e1c9ec55-d512-4308-bfd6-861fa69c70b7" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_7d298f6f-9c07-4853-89c2-e317959c6344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_f7d13b14-3006-4201-a2d8-6f136323709d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e1c9ec55-d512-4308-bfd6-861fa69c70b7" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_f7d13b14-3006-4201-a2d8-6f136323709d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_632074c8-cb62-4780-9aea-def539c0b1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e1c9ec55-d512-4308-bfd6-861fa69c70b7" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_632074c8-cb62-4780-9aea-def539c0b1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSTables" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b7a6ec9-0a5e-49ce-ac81-1093950a5e05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_f64d9b81-2ce9-4919-bcc9-2e5d94104384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b7a6ec9-0a5e-49ce-ac81-1093950a5e05" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_f64d9b81-2ce9-4919-bcc9-2e5d94104384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1e61a6a4-f4b5-4c23-939d-bcc2f9158d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b7a6ec9-0a5e-49ce-ac81-1093950a5e05" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1e61a6a4-f4b5-4c23-939d-bcc2f9158d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_f5ef1ff6-4a7d-45a8-879c-3546936b3935" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b7a6ec9-0a5e-49ce-ac81-1093950a5e05" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_f5ef1ff6-4a7d-45a8-879c-3546936b3935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock_772698ef-ce55-4d5b-a3ae-2527758de9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b7a6ec9-0a5e-49ce-ac81-1093950a5e05" xlink:to="loc_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock_772698ef-ce55-4d5b-a3ae-2527758de9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONTables" xlink:type="simple" xlink:href="ew-20230930.xsd#BUSINESSCOMBINATIONTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/BUSINESSCOMBINATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4212ef62-0a3f-4e59-9d2b-a2ad1c39cc26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_cc17fd84-713a-4f2d-95e6-e3633d5e8a62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4212ef62-0a3f-4e59-9d2b-a2ad1c39cc26" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_cc17fd84-713a-4f2d-95e6-e3633d5e8a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9794663d-49a4-45cf-8a77-43c70f924db7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_a93c20d6-1919-4dee-875d-aba8a8882b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9794663d-49a4-45cf-8a77-43c70f924db7" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_a93c20d6-1919-4dee-875d-aba8a8882b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_fadbfe38-18a6-48c3-9e25-f9bfce3fe1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9794663d-49a4-45cf-8a77-43c70f924db7" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_fadbfe38-18a6-48c3-9e25-f9bfce3fe1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4e6ee1dc-c6ee-429a-a955-435b1c12c6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_d7f2a8ae-b336-487c-99f9-a53cc411515a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4e6ee1dc-c6ee-429a-a955-435b1c12c6c2" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_d7f2a8ae-b336-487c-99f9-a53cc411515a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_b258cbfc-aa91-4cf0-b11f-a8f317851790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4e6ee1dc-c6ee-429a-a955-435b1c12c6c2" xlink:to="loc_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_b258cbfc-aa91-4cf0-b11f-a8f317851790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock_45c2934d-fdb7-4117-9576-c139c1a32cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4e6ee1dc-c6ee-429a-a955-435b1c12c6c2" xlink:to="loc_us-gaap_OffsettingAssetsTableTextBlock_45c2934d-fdb7-4117-9576-c139c1a32cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_a8cb4c76-ea1e-476e-b4b6-6a7f37c254b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4e6ee1dc-c6ee-429a-a955-435b1c12c6c2" xlink:to="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_a8cb4c76-ea1e-476e-b4b6-6a7f37c254b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8e6c0f2f-894a-4523-80be-ef24fc59d09a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4e6ee1dc-c6ee-429a-a955-435b1c12c6c2" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8e6c0f2f-894a-4523-80be-ef24fc59d09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8e7faf45-14a0-4a9c-ba01-789a4060b2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4e6ee1dc-c6ee-429a-a955-435b1c12c6c2" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8e7faf45-14a0-4a9c-ba01-789a4060b2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb3882e0-ad9c-4109-b460-95401ca2719c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_40f1b968-f64e-4aa3-8840-af27654ca4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb3882e0-ad9c-4109-b460-95401ca2719c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_40f1b968-f64e-4aa3-8840-af27654ca4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_279dee00-183f-40de-90f7-6198eac7a314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb3882e0-ad9c-4109-b460-95401ca2719c" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_279dee00-183f-40de-90f7-6198eac7a314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_54aed692-0396-4e78-94b4-d56fd4fb7c43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb3882e0-ad9c-4109-b460-95401ca2719c" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_54aed692-0396-4e78-94b4-d56fd4fb7c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCELERATEDSHAREREPURCHASETables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8059d59d-384a-4cbf-b52d-66336e6b87e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_44741d0f-781f-42dd-9c4c-18d5a4ba8f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8059d59d-384a-4cbf-b52d-66336e6b87e9" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_44741d0f-781f-42dd-9c4c-18d5a4ba8f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3b5a6103-5ff7-4d43-a6fb-50a0fdac5597" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_edd4d950-d2ec-4d26-8843-fde7e60ce3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3b5a6103-5ff7-4d43-a6fb-50a0fdac5597" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_edd4d950-d2ec-4d26-8843-fde7e60ce3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_12c48683-8a50-4ec9-8e31-a8b89b76f8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3b5a6103-5ff7-4d43-a6fb-50a0fdac5597" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_12c48683-8a50-4ec9-8e31-a8b89b76f8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="ew-20230930.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5535aefe-ec2a-431f-ad0f-67a30aaa7bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a2746295-08c0-4c91-b0b8-289193ae3365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5535aefe-ec2a-431f-ad0f-67a30aaa7bc3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a2746295-08c0-4c91-b0b8-289193ae3365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="ew-20230930.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dea85948-13f5-4b42-9153-d97016c8eb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_65b7bf2d-a62d-4879-b8a4-7506a4c6d656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dea85948-13f5-4b42-9153-d97016c8eb2e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_65b7bf2d-a62d-4879-b8a4-7506a4c6d656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_f0083f37-b198-44ff-8216-8ed0649f0c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dea85948-13f5-4b42-9153-d97016c8eb2e" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_f0083f37-b198-44ff-8216-8ed0649f0c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76c5bce4-aa81-46b3-9e9a-3f7ece55cb88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_ce089ac8-31c6-4abe-8819-32d5a36af3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76c5bce4-aa81-46b3-9e9a-3f7ece55cb88" xlink:to="loc_us-gaap_InventoryNetAbstract_ce089ac8-31c6-4abe-8819-32d5a36af3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1c586bd9-21b8-4ef0-a660-431537547fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_ce089ac8-31c6-4abe-8819-32d5a36af3ca" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1c586bd9-21b8-4ef0-a660-431537547fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a5feb2ac-5d75-43cf-88eb-b29d3c07dc80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_ce089ac8-31c6-4abe-8819-32d5a36af3ca" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a5feb2ac-5d75-43cf-88eb-b29d3c07dc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_77490b5a-1b6c-45ca-b81d-adce6d4c6778" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_ce089ac8-31c6-4abe-8819-32d5a36af3ca" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_77490b5a-1b6c-45ca-b81d-adce6d4c6778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b96418c9-a792-454b-9dd4-8d92620e15ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_ce089ac8-31c6-4abe-8819-32d5a36af3ca" xlink:to="loc_us-gaap_InventoryNet_b96418c9-a792-454b-9dd4-8d92620e15ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_b7f54e6e-240e-40aa-926a-afa70a7c2788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_76c5bce4-aa81-46b3-9e9a-3f7ece55cb88" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_b7f54e6e-240e-40aa-926a-afa70a7c2788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d2e01b1-35f2-4fde-9931-c08be4d145e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d2e01b1-35f2-4fde-9931-c08be4d145e4" xlink:to="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_753eda49-b3bd-45c4-8c21-7d164a4cf490" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_753eda49-b3bd-45c4-8c21-7d164a4cf490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_24441816-1fe6-4ea9-82b8-55fa7e943f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_24441816-1fe6-4ea9-82b8-55fa7e943f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_850e73a9-759e-46a4-9aef-5ef62377b19d" xlink:href="ew-20230930.xsd#ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent_850e73a9-759e-46a4-9aef-5ef62377b19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ResearchAndDevelopmentAccruals_cec730d1-7103-4225-b840-0df13400a4cc" xlink:href="ew-20230930.xsd#ew_ResearchAndDevelopmentAccruals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_ew_ResearchAndDevelopmentAccruals_cec730d1-7103-4225-b840-0df13400a4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRebates_c1974f84-07f2-43ba-852e-6d12ce012734" xlink:href="ew-20230930.xsd#ew_AccruedRebates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_ew_AccruedRebates_c1974f84-07f2-43ba-852e-6d12ce012734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_0981f489-ef4e-4ef4-9728-f63874098b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_0981f489-ef4e-4ef4-9728-f63874098b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_c9bd4adb-1d4e-4172-a6f9-7aba6136995b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_c9bd4adb-1d4e-4172-a6f9-7aba6136995b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedLitigationAndInsuranceReserves_592ae65a-9299-462f-b5c6-ecd1f82200bf" xlink:href="ew-20230930.xsd#ew_AccruedLitigationAndInsuranceReserves"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_ew_AccruedLitigationAndInsuranceReserves_592ae65a-9299-462f-b5c6-ecd1f82200bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_c3b21b64-452d-4da5-ac26-463ce4d4ac82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_us-gaap_LitigationReserveCurrent_c3b21b64-452d-4da5-ac26-463ce4d4ac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedRelocationCostsCurrent_38ebda59-206b-46e7-9d48-955a0936d8c6" xlink:href="ew-20230930.xsd#ew_AccruedRelocationCostsCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_ew_AccruedRelocationCostsCurrent_38ebda59-206b-46e7-9d48-955a0936d8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_09a77c31-1dc5-4f1d-80d7-f541712c3251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_09a77c31-1dc5-4f1d-80d7-f541712c3251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_25d65258-b1f2-4d5d-b8d0-1188990c470b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_us-gaap_RestructuringReserveCurrent_25d65258-b1f2-4d5d-b8d0-1188990c470b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f3fadf6f-c757-402d-9a6c-45cf9398a2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f3fadf6f-c757-402d-9a6c-45cf9398a2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrent_1553bc7d-ffd1-45d1-9eb4-94b37309a92c" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ff7f9d1f-e286-4d68-ba15-b226f173be31" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrent_1553bc7d-ffd1-45d1-9eb4-94b37309a92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c3d69bf6-67bf-49eb-9ceb-a6c2084d65d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_2761fde5-05ef-4c2b-920b-39a033677fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c3d69bf6-67bf-49eb-9ceb-a6c2084d65d0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_2761fde5-05ef-4c2b-920b-39a033677fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_8287401d-46d3-42f6-8b8f-3f8746f41f09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2761fde5-05ef-4c2b-920b-39a033677fe5" xlink:to="loc_us-gaap_IncomeTaxesPaid_8287401d-46d3-42f6-8b8f-3f8746f41f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_e85b5dfb-56bd-4d99-a883-b6e132b164a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2761fde5-05ef-4c2b-920b-39a033677fe5" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_e85b5dfb-56bd-4d99-a883-b6e132b164a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_7dc7ceb1-b18f-4701-a25e-21105d8ea01d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_e85b5dfb-56bd-4d99-a883-b6e132b164a5" xlink:to="loc_us-gaap_OperatingLeasePayments_7dc7ceb1-b18f-4701-a25e-21105d8ea01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c474e7e2-685d-4772-8e18-62aaf16ecf04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c3d69bf6-67bf-49eb-9ceb-a6c2084d65d0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c474e7e2-685d-4772-8e18-62aaf16ecf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_314db7fe-1c36-47b7-873a-217d8c690eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c474e7e2-685d-4772-8e18-62aaf16ecf04" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_314db7fe-1c36-47b7-873a-217d8c690eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ce6ebce3-cf1b-4997-b3e9-ceb077b41e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c474e7e2-685d-4772-8e18-62aaf16ecf04" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ce6ebce3-cf1b-4997-b3e9-ceb077b41e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0febb885-b740-481d-bfe4-903e8853660b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_43303148-4699-431a-86c8-2594886bfc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0febb885-b740-481d-bfe4-903e8853660b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_43303148-4699-431a-86c8-2594886bfc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_4eac4da3-324d-4b97-bcf1-7164ccebc6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0febb885-b740-481d-bfe4-903e8853660b" xlink:to="loc_us-gaap_RestrictedCashCurrent_4eac4da3-324d-4b97-bcf1-7164ccebc6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_522e76b3-6f04-46bb-bea6-a755e880aa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0febb885-b740-481d-bfe4-903e8853660b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_522e76b3-6f04-46bb-bea6-a755e880aa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7265945c-b7cd-4c77-945f-2bdf001880ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0febb885-b740-481d-bfe4-903e8853660b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7265945c-b7cd-4c77-945f-2bdf001880ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b967a715-d9e7-415a-bbb9-78286f2cfcac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c2e37739-74e0-431b-b19d-385778ac91a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b967a715-d9e7-415a-bbb9-78286f2cfcac" xlink:to="loc_us-gaap_LossContingenciesTable_c2e37739-74e0-431b-b19d-385778ac91a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e719c0f4-dc07-4922-b19d-7bf99cbee420" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c2e37739-74e0-431b-b19d-385778ac91a1" xlink:to="loc_srt_LitigationCaseAxis_e719c0f4-dc07-4922-b19d-7bf99cbee420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b91f3964-c005-49b8-ae66-7df6c8a41f39" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_e719c0f4-dc07-4922-b19d-7bf99cbee420" xlink:to="loc_srt_LitigationCaseTypeDomain_b91f3964-c005-49b8-ae66-7df6c8a41f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedtronicIncMember_d169a2cf-95f9-4ee7-9b9c-93913d526657" xlink:href="ew-20230930.xsd#ew_MedtronicIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b91f3964-c005-49b8-ae66-7df6c8a41f39" xlink:to="loc_ew_MedtronicIncMember_d169a2cf-95f9-4ee7-9b9c-93913d526657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c2e37739-74e0-431b-b19d-385778ac91a1" xlink:to="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_IntellectualPropertyAgreementTerm_4fd6855a-d121-470b-ae2e-029746c27630" xlink:href="ew-20230930.xsd#ew_IntellectualPropertyAgreementTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_ew_IntellectualPropertyAgreementTerm_4fd6855a-d121-470b-ae2e-029746c27630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_176da43d-3703-4c78-8415-f589561ef9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_176da43d-3703-4c78-8415-f589561ef9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_eb4bfa58-b5ad-46da-b66f-78894890d737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_us-gaap_LitigationSettlementExpense_eb4bfa58-b5ad-46da-b66f-78894890d737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRoyalties_755ce066-83f9-46ae-8308-29a64ef8e78c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRoyalties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cba41248-839e-4a83-94bb-ed00539a64d4" xlink:to="loc_us-gaap_PrepaidRoyalties_755ce066-83f9-46ae-8308-29a64ef8e78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SPECIALCHARGEDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#SPECIALCHARGEDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SPECIALCHARGEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_1ff663a4-7156-4af2-8545-6f4b1bb10de5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e3d5c4f6-4665-4c2d-9b89-c4ee83e26a99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1ff663a4-7156-4af2-8545-6f4b1bb10de5" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e3d5c4f6-4665-4c2d-9b89-c4ee83e26a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_44242050-d49f-4ec2-86d6-987818b32c73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e3d5c4f6-4665-4c2d-9b89-c4ee83e26a99" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_44242050-d49f-4ec2-86d6-987818b32c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cb9873ae-2e4d-47a5-bb42-dc451656d649" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44242050-d49f-4ec2-86d6-987818b32c73" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cb9873ae-2e4d-47a5-bb42-dc451656d649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SpecialChargeMember_2eacf452-ae44-41d6-9e11-90e75d57b254" xlink:href="ew-20230930.xsd#ew_SpecialChargeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cb9873ae-2e4d-47a5-bb42-dc451656d649" xlink:to="loc_ew_SpecialChargeMember_2eacf452-ae44-41d6-9e11-90e75d57b254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_29da2dd1-415a-40bf-8511-4425c6fb02ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cb9873ae-2e4d-47a5-bb42-dc451656d649" xlink:to="loc_us-gaap_CostOfSalesMember_29da2dd1-415a-40bf-8511-4425c6fb02ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_52b3930c-3765-43fa-8dbd-cbb768749a31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e3d5c4f6-4665-4c2d-9b89-c4ee83e26a99" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_52b3930c-3765-43fa-8dbd-cbb768749a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_58c9a384-246f-44ae-b54b-4b9afe478958" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_52b3930c-3765-43fa-8dbd-cbb768749a31" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_58c9a384-246f-44ae-b54b-4b9afe478958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestructuringContingentConsiderationGainLoss_a1e2b225-b626-446d-9de8-abd135b80717" xlink:href="ew-20230930.xsd#ew_RestructuringContingentConsiderationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_52b3930c-3765-43fa-8dbd-cbb768749a31" xlink:to="loc_ew_RestructuringContingentConsiderationGainLoss_a1e2b225-b626-446d-9de8-abd135b80717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_76a61941-b0ae-427a-b89d-14f09bc8096c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_a900d44b-75e9-4713-8895-ac21ce4aba8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_76a61941-b0ae-427a-b89d-14f09bc8096c" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_a900d44b-75e9-4713-8895-ac21ce4aba8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_bc778ab7-659d-418d-a644-fea07baec739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_a900d44b-75e9-4713-8895-ac21ce4aba8c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_bc778ab7-659d-418d-a644-fea07baec739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bc778ab7-659d-418d-a644-fea07baec739" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_8b795bff-5a1a-4fbf-a4fa-2d1c13fe6189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_BankTimeDepositsMember_8b795bff-5a1a-4fbf-a4fa-2d1c13fe6189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_985caaf0-c508-4867-8cd7-3d1268b18391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_985caaf0-c508-4867-8cd7-3d1268b18391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e84647d0-f6df-41c5-a0f7-a7f4a4a69194" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e84647d0-f6df-41c5-a0f7-a7f4a4a69194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6adfbcfb-0273-4513-9a34-83037cac7de6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6adfbcfb-0273-4513-9a34-83037cac7de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_bd4807f3-1f8d-4d19-92ad-098c7ae1864c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0fd9fd8c-0adc-447e-b0cb-9825818f8834" xlink:to="loc_us-gaap_MunicipalBondsMember_bd4807f3-1f8d-4d19-92ad-098c7ae1864c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_41a120f4-cdf9-4a14-881c-75e9485044b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_a900d44b-75e9-4713-8895-ac21ce4aba8c" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_41a120f4-cdf9-4a14-881c-75e9485044b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_41a120f4-cdf9-4a14-881c-75e9485044b5" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_e7534364-656d-434e-b675-7e90951585fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:to="loc_us-gaap_HeldToMaturitySecurities_e7534364-656d-434e-b675-7e90951585fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_80d74435-7660-4d24-9d6a-836435763791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_80d74435-7660-4d24-9d6a-836435763791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_a9b1a991-938e-45e5-bc7a-c14c3994acfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_a9b1a991-938e-45e5-bc7a-c14c3994acfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d913d4be-fa0a-452c-aa3b-a1f0cc26796b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAbstract_702dc8ac-6a43-4a4f-8059-ea67a7f2e876" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_d913d4be-fa0a-452c-aa3b-a1f0cc26796b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_41a120f4-cdf9-4a14-881c-75e9485044b5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3444ad72-e2c4-4c39-92fb-ffd575809ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3444ad72-e2c4-4c39-92fb-ffd575809ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e124945-f5b9-413b-a4d3-f187b5a96964" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e124945-f5b9-413b-a4d3-f187b5a96964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a37acaf4-6920-404c-b8db-d40e242c8bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a37acaf4-6920-404c-b8db-d40e242c8bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_57c3c6d5-7a2a-4aee-8c50-3175f4f7c2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_675cb85e-24b7-4a0b-aec5-bd91253fd785" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_57c3c6d5-7a2a-4aee-8c50-3175f4f7c2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3fc7ee95-8758-4726-9ed2-612e9e8e5431" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_466062a4-1c56-4970-8399-bc849763e576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3fc7ee95-8758-4726-9ed2-612e9e8e5431" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_466062a4-1c56-4970-8399-bc849763e576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_3bb9f5f6-7b9f-446a-808a-2e87ff64f90a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_466062a4-1c56-4970-8399-bc849763e576" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_3bb9f5f6-7b9f-446a-808a-2e87ff64f90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_b223eccc-c00e-4d08-8a8d-bb397079bf8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_3bb9f5f6-7b9f-446a-808a-2e87ff64f90a" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost_b223eccc-c00e-4d08-8a8d-bb397079bf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_3f67c71d-281c-417d-b04a-8a2a7bb2e780" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_3bb9f5f6-7b9f-446a-808a-2e87ff64f90a" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost_3f67c71d-281c-417d-b04a-8a2a7bb2e780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost_fa158fb4-0a26-4414-9656-caacdfde662c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_3bb9f5f6-7b9f-446a-808a-2e87ff64f90a" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost_fa158fb4-0a26-4414-9656-caacdfde662c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_dbe6c4ba-8aa2-4ccf-9f80-d2981a609fde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_3bb9f5f6-7b9f-446a-808a-2e87ff64f90a" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount_dbe6c4ba-8aa2-4ccf-9f80-d2981a609fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_1ca1a4c8-01ae-4cd1-8059-6c56bca00e98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract_3bb9f5f6-7b9f-446a-808a-2e87ff64f90a" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_1ca1a4c8-01ae-4cd1-8059-6c56bca00e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_a2c1db04-5deb-49bc-ae95-5c65b1bfdf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_466062a4-1c56-4970-8399-bc849763e576" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_a2c1db04-5deb-49bc-ae95-5c65b1bfdf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_7dce7080-7108-4414-89e6-d7a36a8665fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_a2c1db04-5deb-49bc-ae95-5c65b1bfdf0d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_7dce7080-7108-4414-89e6-d7a36a8665fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_62579001-bb0d-4dbb-acd7-bfd03ab8f10c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_a2c1db04-5deb-49bc-ae95-5c65b1bfdf0d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_62579001-bb0d-4dbb-acd7-bfd03ab8f10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_63fc6815-9496-4f76-8ca9-a7759ae6c178" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_a2c1db04-5deb-49bc-ae95-5c65b1bfdf0d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_63fc6815-9496-4f76-8ca9-a7759ae6c178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_c7d934ce-9eaa-4cab-b555-0997e6f6c6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_a2c1db04-5deb-49bc-ae95-5c65b1bfdf0d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_c7d934ce-9eaa-4cab-b555-0997e6f6c6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_b0bd93ce-2116-47ea-9414-0fa5d0c68f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_a2c1db04-5deb-49bc-ae95-5c65b1bfdf0d" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_b0bd93ce-2116-47ea-9414-0fa5d0c68f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_7a3f6626-a378-4488-94de-c2317b201102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3fc7ee95-8758-4726-9ed2-612e9e8e5431" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_7a3f6626-a378-4488-94de-c2317b201102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_63f74d22-4de0-4961-b550-f64fe759702c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_7a3f6626-a378-4488-94de-c2317b201102" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_63f74d22-4de0-4961-b550-f64fe759702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_b7a30385-40c8-4798-aec9-5dd0e6721d14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_63f74d22-4de0-4961-b550-f64fe759702c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_b7a30385-40c8-4798-aec9-5dd0e6721d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_160f4fa2-fdc1-4e93-9188-cacf2347a032" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_63f74d22-4de0-4961-b550-f64fe759702c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_160f4fa2-fdc1-4e93-9188-cacf2347a032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_fb50b407-4a4b-4d63-80ce-f73818090fce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_63f74d22-4de0-4961-b550-f64fe759702c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis_fb50b407-4a4b-4d63-80ce-f73818090fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_3856a4b3-ab1b-4272-a8ec-4d7c7beb98e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_63f74d22-4de0-4961-b550-f64fe759702c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_3856a4b3-ab1b-4272-a8ec-4d7c7beb98e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_80b50eb6-a473-4377-b274-71b4cea3989e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract_63f74d22-4de0-4961-b550-f64fe759702c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_80b50eb6-a473-4377-b274-71b4cea3989e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_04ad75f0-2f52-4eab-9973-5a288edb5eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_7a3f6626-a378-4488-94de-c2317b201102" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_04ad75f0-2f52-4eab-9973-5a288edb5eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_5f18d4c9-22f2-4ded-8c08-c3181896964c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_04ad75f0-2f52-4eab-9973-5a288edb5eaf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_5f18d4c9-22f2-4ded-8c08-c3181896964c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_7edeae3b-6ca5-4d23-8fe0-2f55359e8ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_04ad75f0-2f52-4eab-9973-5a288edb5eaf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_7edeae3b-6ca5-4d23-8fe0-2f55359e8ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_898aa2d2-571f-45df-ae63-87e610da70e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_04ad75f0-2f52-4eab-9973-5a288edb5eaf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue_898aa2d2-571f-45df-ae63-87e610da70e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a278fcb9-ffc3-454e-bafc-68b92b4a0a34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_04ad75f0-2f52-4eab-9973-5a288edb5eaf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a278fcb9-ffc3-454e-bafc-68b92b4a0a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_562ffd66-da7c-4df7-9ac4-b9807c63b551" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_04ad75f0-2f52-4eab-9973-5a288edb5eaf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_562ffd66-da7c-4df7-9ac4-b9807c63b551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3828ed9c-effa-4c29-8597-0255b570c6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6896a461-bc4b-4e3c-92cf-17f08952be9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3828ed9c-effa-4c29-8597-0255b570c6dd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6896a461-bc4b-4e3c-92cf-17f08952be9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1342fb52-ef52-4703-b6c0-d97088f32087" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6896a461-bc4b-4e3c-92cf-17f08952be9c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1342fb52-ef52-4703-b6c0-d97088f32087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1342fb52-ef52-4703-b6c0-d97088f32087" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_12c315fc-2bf8-47c3-a1e5-8ad183dcf125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_12c315fc-2bf8-47c3-a1e5-8ad183dcf125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_5e5492ee-157e-4e60-9e8c-5195e22b9faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_5e5492ee-157e-4e60-9e8c-5195e22b9faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_4ae0cb5a-3518-4014-84a4-85faf877ede8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_4ae0cb5a-3518-4014-84a4-85faf877ede8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_2096da9b-44b8-4b1a-ba6e-084b0c97b3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_46029c80-7643-44d9-89c0-988118144671" xlink:to="loc_us-gaap_MunicipalBondsMember_2096da9b-44b8-4b1a-ba6e-084b0c97b3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6896a461-bc4b-4e3c-92cf-17f08952be9c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_502521a2-cccd-44ac-801e-58b6457a97e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_502521a2-cccd-44ac-801e-58b6457a97e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c37ae703-5ec8-4bc2-aa7a-728653b8fe3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_c37ae703-5ec8-4bc2-aa7a-728653b8fe3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_62392743-76e9-4cb3-ac65-a38fc9e15538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_62392743-76e9-4cb3-ac65-a38fc9e15538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_75f95eee-b8a3-4d3c-9fd6-81e71bc12967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_75f95eee-b8a3-4d3c-9fd6-81e71bc12967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_61431ca6-54bf-40c0-b554-13a87b6f26b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_61431ca6-54bf-40c0-b554-13a87b6f26b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5beb2578-4450-40cf-a889-2df123c10664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f16a6d84-e618-48ed-9bfd-01c3f38244fa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5beb2578-4450-40cf-a889-2df123c10664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3c41ae4a-95bd-43f0-bb91-03d9d4d39198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_265a1697-204e-4db9-8742-69455f340db4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3c41ae4a-95bd-43f0-bb91-03d9d4d39198" xlink:to="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_265a1697-204e-4db9-8742-69455f340db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b3350169-d0ec-4b37-9183-b97d10fb6060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract_265a1697-204e-4db9-8742-69455f340db4" xlink:to="loc_us-gaap_EquityMethodInvestments_b3350169-d0ec-4b37-9183-b97d10fb6060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_d800f675-dc93-4804-87f4-65a8df809766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3c41ae4a-95bd-43f0-bb91-03d9d4d39198" xlink:to="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_d800f675-dc93-4804-87f4-65a8df809766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_b9d0b331-f46e-45ca-ab19-d4f8081bda71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_d800f675-dc93-4804-87f4-65a8df809766" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_b9d0b331-f46e-45ca-ab19-d4f8081bda71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0e072719-b772-4718-b1d0-7a09aeccbda2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3c41ae4a-95bd-43f0-bb91-03d9d4d39198" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0e072719-b772-4718-b1d0-7a09aeccbda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_390ee41d-c071-4f9b-8264-bafa29d96c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_390ee41d-c071-4f9b-8264-bafa29d96c53" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40bee3d9-6f11-4383-b572-294465278e28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40bee3d9-6f11-4383-b572-294465278e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f8d51f03-e336-4e89-81eb-f1fe2a0d4b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_40bee3d9-6f11-4383-b572-294465278e28" xlink:to="loc_us-gaap_RelatedPartyDomain_f8d51f03-e336-4e89-81eb-f1fe2a0d4b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember_26828572-2657-4fda-b469-6920d7500f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_f8d51f03-e336-4e89-81eb-f1fe2a0d4b81" xlink:to="loc_us-gaap_LimitedLiabilityCompanyMember_26828572-2657-4fda-b469-6920d7500f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d9518313-35bf-4abb-82c4-48addc17b94c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d9518313-35bf-4abb-82c4-48addc17b94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_949749b6-8406-4ca4-9f79-58a9f8a55851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9518313-35bf-4abb-82c4-48addc17b94c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_949749b6-8406-4ca4-9f79-58a9f8a55851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5a69ab45-1704-4765-bba9-4dd53387dfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_949749b6-8406-4ca4-9f79-58a9f8a55851" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_5a69ab45-1704-4765-bba9-4dd53387dfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4488146-42bd-4275-8394-4b9d149060a1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4488146-42bd-4275-8394-4b9d149060a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bfde26e5-9aff-4a72-b7d7-a722103db3b2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4488146-42bd-4275-8394-4b9d149060a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bfde26e5-9aff-4a72-b7d7-a722103db3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NewMarketsTaxCreditMember_585ffbf6-301d-4628-b5c4-3ccf66fe94d5" xlink:href="ew-20230930.xsd#ew_NewMarketsTaxCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_bfde26e5-9aff-4a72-b7d7-a722103db3b2" xlink:to="loc_ew_NewMarketsTaxCreditMember_585ffbf6-301d-4628-b5c4-3ccf66fe94d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_7fa91a64-7ec1-4cc1-8266-e3c3690d0449" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d56fdcce-af83-405c-9c85-51bc4d9879c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_EquityMethodInvestments_d56fdcce-af83-405c-9c85-51bc4d9879c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_32c7f3ee-e05a-4b1e-b0e6-f29706c25895" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_32c7f3ee-e05a-4b1e-b0e6-f29706c25895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquityMethodInvestmentsInvestmentPeriod_1a7e6fc0-bbbb-49f7-86b7-ebeadffe866f" xlink:href="ew-20230930.xsd#ew_EquityMethodInvestmentsInvestmentPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_ew_EquityMethodInvestmentsInvestmentPeriod_1a7e6fc0-bbbb-49f7-86b7-ebeadffe866f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_3762d519-9108-4ed7-8b84-1918dd87f115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_3762d519-9108-4ed7-8b84-1918dd87f115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_a4278374-2b2e-4485-9ac9-16d1443fc636" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_3ef1fcc6-2785-4ccb-8f7a-c0de72c5826c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_a4278374-2b2e-4485-9ac9-16d1443fc636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INVESTMENTSINVARIABLEINTERESTENTITIESDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ew_VariableInterestEntitiesAbstract_7a7f1492-2030-4aa5-9427-c196c1ef4e3d" xlink:href="ew-20230930.xsd#ew_VariableInterestEntitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_VariableInterestEntitiesAbstract_7a7f1492-2030-4aa5-9427-c196c1ef4e3d" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_44d722ef-59fd-4f91-b7f1-df4d54c9bac8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_srt_CounterpartyNameAxis_44d722ef-59fd-4f91-b7f1-df4d54c9bac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b360c67-3f77-4ba3-9d94-0775e1ed8249" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_44d722ef-59fd-4f91-b7f1-df4d54c9bac8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b360c67-3f77-4ba3-9d94-0775e1ed8249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember_aca5aa43-87ff-4b28-b0a5-4e6022a5056c" xlink:href="ew-20230930.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b360c67-3f77-4ba3-9d94-0775e1ed8249" xlink:to="loc_ew_MedicalDeviceCompanyMember_aca5aa43-87ff-4b28-b0a5-4e6022a5056c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalTechnologyCompanyMember_647a5e77-3af8-45e1-9ef8-37d3e0e34744" xlink:href="ew-20230930.xsd#ew_MedicalTechnologyCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b360c67-3f77-4ba3-9d94-0775e1ed8249" xlink:to="loc_ew_MedicalTechnologyCompanyMember_647a5e77-3af8-45e1-9ef8-37d3e0e34744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_adf7d322-e49a-47f4-98d5-bdd64918fa0e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_srt_ConsolidatedEntitiesAxis_adf7d322-e49a-47f4-98d5-bdd64918fa0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c93bbb3f-5d45-4f08-9e2b-e17ebf13ab81" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_adf7d322-e49a-47f4-98d5-bdd64918fa0e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c93bbb3f-5d45-4f08-9e2b-e17ebf13ab81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cf78e585-19a6-4a42-97f1-4e6fbe106a90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c93bbb3f-5d45-4f08-9e2b-e17ebf13ab81" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cf78e585-19a6-4a42-97f1-4e6fbe106a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_27eb188b-74fc-40ea-abba-a2c28bfaf413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_us-gaap_DebtInstrumentAxis_27eb188b-74fc-40ea-abba-a2c28bfaf413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_afdfe18e-2dca-404b-9acb-dcfc2a1a5b57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_27eb188b-74fc-40ea-abba-a2c28bfaf413" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_afdfe18e-2dca-404b-9acb-dcfc2a1a5b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ConvertiblePromissoryNoteMember_eb2e3ea5-fe7d-4d40-8235-2b02a61a9e91" xlink:href="ew-20230930.xsd#ew_ConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_afdfe18e-2dca-404b-9acb-dcfc2a1a5b57" xlink:to="loc_ew_ConvertiblePromissoryNoteMember_eb2e3ea5-fe7d-4d40-8235-2b02a61a9e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_045eb1ca-2d1a-43ac-aa5e-d2834904ddca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_045eb1ca-2d1a-43ac-aa5e-d2834904ddca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9c457adc-adf6-409a-86c2-9dc68f3f3ef0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_045eb1ca-2d1a-43ac-aa5e-d2834904ddca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9c457adc-adf6-409a-86c2-9dc68f3f3ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalDeviceCompanyMember_b4fc0a2c-0c79-4f89-80a1-991d6390a4ec" xlink:href="ew-20230930.xsd#ew_MedicalDeviceCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9c457adc-adf6-409a-86c2-9dc68f3f3ef0" xlink:to="loc_ew_MedicalDeviceCompanyMember_b4fc0a2c-0c79-4f89-80a1-991d6390a4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_76e56c48-827c-4aa9-890b-cea1e7452f75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_us-gaap_InvestmentTypeAxis_76e56c48-827c-4aa9-890b-cea1e7452f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_5c946e22-7848-4034-9910-b75e8430571e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_76e56c48-827c-4aa9-890b-cea1e7452f75" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_5c946e22-7848-4034-9910-b75e8430571e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_053bfc19-27de-447b-984e-ed6dae4b589a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_5c946e22-7848-4034-9910-b75e8430571e" xlink:to="loc_us-gaap_EquitySecuritiesMember_053bfc19-27de-447b-984e-ed6dae4b589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6338e58d-3961-489f-a67b-df6ae27c68cb" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LoansReceivablesMaximumLendingCapacity_2c1c26dc-f8d4-4a3d-a4f6-e4ddb6c8fbfe" xlink:href="ew-20230930.xsd#ew_LoansReceivablesMaximumLendingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_LoansReceivablesMaximumLendingCapacity_2c1c26dc-f8d4-4a3d-a4f6-e4ddb6c8fbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_79f363aa-0023-4054-9e7e-1247e2fd3fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_79f363aa-0023-4054-9e7e-1247e2fd3fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableGross_72aee1d8-59ad-4ee6-88ed-2ef41f87b566" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_us-gaap_NotesReceivableGross_72aee1d8-59ad-4ee6-88ed-2ef41f87b566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_3dca40cb-b67f-4829-a13f-83c332e83094" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote_3dca40cb-b67f-4829-a13f-83c332e83094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_df3b0524-2f80-4a4e-8196-e22aada9dd7d" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIPromissoryNoteOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding_df3b0524-2f80-4a4e-8196-e22aada9dd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_69a1f274-6bc5-48a4-be6b-cbe2c4e4f7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_69a1f274-6bc5-48a4-be6b-cbe2c4e4f7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_e038c168-2ed2-4250-86fd-7b20b8c0fb48" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIOptionToAcquireInvestment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIOptionToAcquireInvestment_e038c168-2ed2-4250-86fd-7b20b8c0fb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_fea3fa46-3663-4182-a19f-23db634e6bae" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalRequired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumAdditionalRequired_fea3fa46-3663-4182-a19f-23db634e6bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_562a036a-c123-4fc7-a007-16ea5dfca471" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment_562a036a-c123-4fc7-a007-16ea5dfca471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_OptionToAcquireInvestmentAmount_42569d33-d0ce-4404-a6d2-d99eb2b27c15" xlink:href="ew-20230930.xsd#ew_OptionToAcquireInvestmentAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_OptionToAcquireInvestmentAmount_42569d33-d0ce-4404-a6d2-d99eb2b27c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EquitySecuritiesFVNIMaximumPromissoryNote_58a715fa-48d3-4d34-8ce9-0527cebc38c0" xlink:href="ew-20230930.xsd#ew_EquitySecuritiesFVNIMaximumPromissoryNote"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_d9af5c0a-9779-4417-85df-85e77f9407ae" xlink:to="loc_ew_EquitySecuritiesFVNIMaximumPromissoryNote_58a715fa-48d3-4d34-8ce9-0527cebc38c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#BUSINESSCOMBINATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a8550ab6-0006-4595-a80e-9b10b2297ada" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a8550ab6-0006-4595-a80e-9b10b2297ada" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_aa14b108-d7fa-4339-9d62-9b73db29beef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_aa14b108-d7fa-4339-9d62-9b73db29beef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f8db21d-3c23-4c0f-85c7-70cd0d99e228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aa14b108-d7fa-4339-9d62-9b73db29beef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f8db21d-3c23-4c0f-85c7-70cd0d99e228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalTechnologyCompanyMember_bed8ae75-b1e8-4e97-9ba4-7ec1d9912b02" xlink:href="ew-20230930.xsd#ew_MedicalTechnologyCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f8db21d-3c23-4c0f-85c7-70cd0d99e228" xlink:to="loc_ew_MedicalTechnologyCompanyMember_bed8ae75-b1e8-4e97-9ba4-7ec1d9912b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_068b949f-8985-402a-b6d3-a0312acd375b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_068b949f-8985-402a-b6d3-a0312acd375b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_bd0b779c-b25e-49e6-b48b-7a51d08057d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_068b949f-8985-402a-b6d3-a0312acd375b" xlink:to="loc_srt_ConsolidatedEntitiesDomain_bd0b779c-b25e-49e6-b48b-7a51d08057d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_528187d0-b877-4315-be3d-fa487ab5d806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_bd0b779c-b25e-49e6-b48b-7a51d08057d1" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_528187d0-b877-4315-be3d-fa487ab5d806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ea8d4d55-4949-4bd3-9977-3a46932daf92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7869fa96-e010-49f3-ab16-7299f296db6b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ea8d4d55-4949-4bd3-9977-3a46932daf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_82e21ce6-d4ea-44da-a70d-b3d52ca915f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ea8d4d55-4949-4bd3-9977-3a46932daf92" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_82e21ce6-d4ea-44da-a70d-b3d52ca915f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7cc37be4-b7cf-4401-9b42-d6227cdbe439" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7cc37be4-b7cf-4401-9b42-d6227cdbe439" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8814f231-387e-4409-8afd-32b9d5ee0b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8814f231-387e-4409-8afd-32b9d5ee0b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381d2043-dde8-4db0-8ced-ee69f2ca4002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8814f231-387e-4409-8afd-32b9d5ee0b5a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381d2043-dde8-4db0-8ced-ee69f2ca4002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MedicalTechnologyCompanyMember_caa55c5e-e859-4a5e-83dd-a6d1e1144526" xlink:href="ew-20230930.xsd#ew_MedicalTechnologyCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_381d2043-dde8-4db0-8ced-ee69f2ca4002" xlink:to="loc_ew_MedicalTechnologyCompanyMember_caa55c5e-e859-4a5e-83dd-a6d1e1144526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_821be66f-64ad-420a-bb9d-d357b84d4f0a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:to="loc_srt_ConsolidatedEntitiesAxis_821be66f-64ad-420a-bb9d-d357b84d4f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f72b76e7-2c4e-4484-9b75-e32dcebf2665" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_821be66f-64ad-420a-bb9d-d357b84d4f0a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f72b76e7-2c4e-4484-9b75-e32dcebf2665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_e37db47d-5139-4c5b-9b1d-18ef32f64308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_f72b76e7-2c4e-4484-9b75-e32dcebf2665" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_e37db47d-5139-4c5b-9b1d-18ef32f64308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8214640e-f61f-4eab-b79f-f89df314d4c2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2df543ea-6971-4aa2-adf0-81f636a4a1df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2df543ea-6971-4aa2-adf0-81f636a4a1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_93f47b35-4911-4d6b-aa19-6fcbad058849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_Goodwill_93f47b35-4911-4d6b-aa19-6fcbad058849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1ff6f558-87ca-4453-81e0-b46cd5b57905" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1ff6f558-87ca-4453-81e0-b46cd5b57905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3ce6ff2f-5e1e-42a3-a0bc-4f2552de3bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3ce6ff2f-5e1e-42a3-a0bc-4f2552de3bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0015bb16-7d8d-4923-a6d6-cf107da323b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0015bb16-7d8d-4923-a6d6-cf107da323b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f145fd60-098c-4b91-9596-46afffaea69a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f145fd60-098c-4b91-9596-46afffaea69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_08629f06-fbb0-4a67-b525-8ca7d469bdda" xlink:href="ew-20230930.xsd#ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet_08629f06-fbb0-4a67-b525-8ca7d469bdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_312788f9-2403-4fdb-b38a-daacd5d3d168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_312788f9-2403-4fdb-b38a-daacd5d3d168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_939dbecc-6b2e-4e51-84ad-d73924362706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_939dbecc-6b2e-4e51-84ad-d73924362706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_25b755d8-526a-456a-92d1-b59c4bf9bdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_25b755d8-526a-456a-92d1-b59c4bf9bdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_553fb5a1-8caa-4e29-8484-54401c749d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_553fb5a1-8caa-4e29-8484-54401c749d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment_147d02d4-5b96-4ff3-a2c8-96bd1b620ccc" xlink:href="ew-20230930.xsd#ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment_147d02d4-5b96-4ff3-a2c8-96bd1b620ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPaymentsToAcquireBusinesses_2c04688c-33ee-4e37-8817-9095edd4d527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_OtherPaymentsToAcquireBusinesses_2c04688c-33ee-4e37-8817-9095edd4d527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_7fff5786-c4c4-420d-a2be-c553ae25980b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5bf89482-5f16-41e4-9960-221461768c71" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_7fff5786-c4c4-420d-a2be-c553ae25980b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_09c9b959-89ab-4694-8c11-3980ba1af28a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_09c9b959-89ab-4694-8c11-3980ba1af28a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b17f06d0-36a7-4f50-9825-5587608c007d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b17f06d0-36a7-4f50-9825-5587608c007d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2da1a3f-47e7-4828-99b5-204e2ff200e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b17f06d0-36a7-4f50-9825-5587608c007d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2da1a3f-47e7-4828-99b5-204e2ff200e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_644edb69-ecd6-4980-9223-f2dc674e3aca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2da1a3f-47e7-4828-99b5-204e2ff200e7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_644edb69-ecd6-4980-9223-f2dc674e3aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_c34941a1-f73b-4560-8d8b-5ecc6b210eea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_c34941a1-f73b-4560-8d8b-5ecc6b210eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_dc622b32-6e17-4183-ba3e-36c52e319fda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_c34941a1-f73b-4560-8d8b-5ecc6b210eea" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_dc622b32-6e17-4183-ba3e-36c52e319fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_4ffcbfe5-792a-4c3a-aef7-7d5f508b5154" xlink:href="ew-20230930.xsd#ew_MeasurementInputProbabilityOfMilestoneAchievementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dc622b32-6e17-4183-ba3e-36c52e319fda" xlink:to="loc_ew_MeasurementInputProbabilityOfMilestoneAchievementMember_4ffcbfe5-792a-4c3a-aef7-7d5f508b5154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d97fdb69-fd07-4e65-8e31-9e30f2ba6242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d249b3cd-e173-4fc9-b51d-f27ccf21e9ef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d97fdb69-fd07-4e65-8e31-9e30f2ba6242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember_21de3ddf-1dc6-4142-988d-8d7665344edf" xlink:href="ew-20230930.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d97fdb69-fd07-4e65-8e31-9e30f2ba6242" xlink:to="loc_ew_ContingentConsiderationLiabilityMember_21de3ddf-1dc6-4142-988d-8d7665344edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6c3f1cdd-13a9-4957-9b3f-a4b53d8ffdf0" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_da29f12e-47c5-47e8-b1e1-7e9c0b3c7c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_da29f12e-47c5-47e8-b1e1-7e9c0b3c7c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_65daa9d3-224c-4538-a977-6477da6e3ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_65daa9d3-224c-4538-a977-6477da6e3ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6fbeb798-12d7-47da-a7de-3760f2bf414f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_05140f00-731a-4e83-831f-c79fdc7a6084" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6fbeb798-12d7-47da-a7de-3760f2bf414f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_edad831f-e76d-4bf9-8c1d-1c9c0f89285e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_edad831f-e76d-4bf9-8c1d-1c9c0f89285e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_a751cbde-3a45-44e7-a31c-5d6dd957c69d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_a751cbde-3a45-44e7-a31c-5d6dd957c69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_28e45fea-c104-4c01-9f68-386e9d15eae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a751cbde-3a45-44e7-a31c-5d6dd957c69d" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_28e45fea-c104-4c01-9f68-386e9d15eae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b1ab5b62-a688-4720-bf31-3dc1b3cbe8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_28e45fea-c104-4c01-9f68-386e9d15eae7" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b1ab5b62-a688-4720-bf31-3dc1b3cbe8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0488a204-974f-4bec-bfb7-9df8f68295cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b1ab5b62-a688-4720-bf31-3dc1b3cbe8e6" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0488a204-974f-4bec-bfb7-9df8f68295cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b971aa42-1a29-4426-835e-556f50c4c6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b9bc5ed4-ca14-4ce7-8532-8188fbc9be79" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b971aa42-1a29-4426-835e-556f50c4c6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_cad0bdb8-6073-4dc9-825d-1d4d802db8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b971aa42-1a29-4426-835e-556f50c4c6a6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_cad0bdb8-6073-4dc9-825d-1d4d802db8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a8afbccb-1c51-4c24-8bf2-ec6f65a1f707" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2af7fc74-aec1-45b6-bd5e-830815c121e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2af7fc74-aec1-45b6-bd5e-830815c121e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2bc3dfe2-178b-40b0-954b-5132be57b3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2bc3dfe2-178b-40b0-954b-5132be57b3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3eb1ab19-c762-4f2a-b0a1-a90f3a3b4f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8b65f370-c9fc-491b-a593-f76d6274ace7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3eb1ab19-c762-4f2a-b0a1-a90f3a3b4f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9644bfbb-3eb2-4da7-9f8b-21fe72ae54bb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6afb4588-7f3d-4c73-88a5-c129458e976f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6afb4588-7f3d-4c73-88a5-c129458e976f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_7e48d151-2f87-46aa-a705-20b6e8b8f769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_7e48d151-2f87-46aa-a705-20b6e8b8f769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_6b702a76-958e-4b8f-9434-bc0c440b5af3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_6b702a76-958e-4b8f-9434-bc0c440b5af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_b6088e78-6a47-4113-a92c-c2a1523ed25b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e78a97b9-da68-428e-a770-3345213c1edb" xlink:to="loc_us-gaap_MunicipalBondsMember_b6088e78-6a47-4113-a92c-c2a1523ed25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03cfefe9-6d4f-4008-b4d8-f5f6c8e8941c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9badab0f-fde7-466e-b3fe-750394cc5f12" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03cfefe9-6d4f-4008-b4d8-f5f6c8e8941c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03cfefe9-6d4f-4008-b4d8-f5f6c8e8941c" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d2010ff1-88f4-41b8-a0e8-9335a19f715f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d2010ff1-88f4-41b8-a0e8-9335a19f715f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dacbe2af-5d31-4d97-a8bf-438884b9a4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dacbe2af-5d31-4d97-a8bf-438884b9a4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_17afd0a6-f734-4b7e-94c6-19051f054a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_17afd0a6-f734-4b7e-94c6-19051f054a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9107ba8e-6e66-48ee-8c48-f2274a7ea015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_DerivativeAssets_9107ba8e-6e66-48ee-8c48-f2274a7ea015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7618f26d-f19d-4504-8dd6-105da08bacf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_cf8e55a6-f74d-42a8-b2ff-299ede146f60" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7618f26d-f19d-4504-8dd6-105da08bacf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_03cfefe9-6d4f-4008-b4d8-f5f6c8e8941c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ca296f1c-f865-4d80-b47f-eb725a9e1280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:to="loc_us-gaap_DerivativeLiabilities_ca296f1c-f865-4d80-b47f-eb725a9e1280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b761d75f-cc66-4a27-9866-2080e5aa939f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b761d75f-cc66-4a27-9866-2080e5aa939f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_2bff80fe-093e-4f21-9f20-08d383a44a56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_2bff80fe-093e-4f21-9f20-08d383a44a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_565beab8-b7ea-420c-9391-0016ae3eb3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_93247955-f4dd-4646-8f64-359308efa1f1" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_565beab8-b7ea-420c-9391-0016ae3eb3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ec7c51d7-f44b-41e9-8bad-3d63184410f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ec7c51d7-f44b-41e9-8bad-3d63184410f3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df1edc5f-6f83-4c90-a9e8-6487670d7b67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_00b8c8ac-6017-4352-b0a3-7d2bbe6aceef" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df1edc5f-6f83-4c90-a9e8-6487670d7b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ContingentConsiderationLiabilityMember_36c264fb-a016-40ad-ac4e-499e482a5ab7" xlink:href="ew-20230930.xsd#ew_ContingentConsiderationLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df1edc5f-6f83-4c90-a9e8-6487670d7b67" xlink:to="loc_ew_ContingentConsiderationLiabilityMember_36c264fb-a016-40ad-ac4e-499e482a5ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_8a4ad148-dfe2-4945-b3b6-d407a9848235" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_df1edc5f-6f83-4c90-a9e8-6487670d7b67" xlink:to="loc_us-gaap_OtherLiabilitiesMember_8a4ad148-dfe2-4945-b3b6-d407a9848235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_696e4be2-78dd-4885-aba6-3c4288d424d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_34fea2cb-3e22-4c8d-b4b3-ff962fae95d2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_696e4be2-78dd-4885-aba6-3c4288d424d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_274fc2db-a79a-4d0d-bf00-14ec0979bc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_696e4be2-78dd-4885-aba6-3c4288d424d2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_274fc2db-a79a-4d0d-bf00-14ec0979bc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_243b7163-0cea-45d5-9474-720b367a9f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_243b7163-0cea-45d5-9474-720b367a9f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd1bdad8-745a-47cf-b602-0b1bf8c633a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_243b7163-0cea-45d5-9474-720b367a9f8f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd1bdad8-745a-47cf-b602-0b1bf8c633a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_73d5b6f8-1d7a-4dde-9aa2-a611d591d996" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd1bdad8-745a-47cf-b602-0b1bf8c633a4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_73d5b6f8-1d7a-4dde-9aa2-a611d591d996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a8f13035-102a-4325-9094-fe6c6f1520b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_dc0c5abc-bd1b-488b-8b65-023e9e9be286" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a8f13035-102a-4325-9094-fe6c6f1520b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a8f13035-102a-4325-9094-fe6c6f1520b9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3e665964-5784-4287-b01f-5ce6fe6be44e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3e665964-5784-4287-b01f-5ce6fe6be44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9879c0c0-dcba-4249-b20a-28910440e066" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9879c0c0-dcba-4249-b20a-28910440e066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_21491717-7128-42d4-9443-09aa24bc2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_0371ed35-8b9e-49a6-bb50-4ea0b71d70f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_21491717-7128-42d4-9443-09aa24bc2b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6054d95a-80fe-47b5-9888-71da77c98c43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6054d95a-80fe-47b5-9888-71da77c98c43" xlink:to="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e09a3bf9-04af-4792-8d07-469808057866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:to="loc_us-gaap_HedgingDesignationAxis_e09a3bf9-04af-4792-8d07-469808057866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9070bdb7-4fff-48fa-a498-bdf66b846d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e09a3bf9-04af-4792-8d07-469808057866" xlink:to="loc_us-gaap_HedgingDesignationDomain_9070bdb7-4fff-48fa-a498-bdf66b846d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_add8996d-0434-460a-9b3e-256133ab80d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9070bdb7-4fff-48fa-a498-bdf66b846d40" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_add8996d-0434-460a-9b3e-256133ab80d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_27fd087f-0522-454e-82fb-9b70309b9738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_27fd087f-0522-454e-82fb-9b70309b9738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8e5bcb4d-7af1-4c69-ad27-662bfa551565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_27fd087f-0522-454e-82fb-9b70309b9738" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8e5bcb4d-7af1-4c69-ad27-662bfa551565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_5ce14589-20e3-410a-8934-aa805de7c989" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e5bcb4d-7af1-4c69-ad27-662bfa551565" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_5ce14589-20e3-410a-8934-aa805de7c989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_d6bebaed-7370-4455-93c6-85432e206534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8e5bcb4d-7af1-4c69-ad27-662bfa551565" xlink:to="loc_us-gaap_CurrencySwapMember_d6bebaed-7370-4455-93c6-85432e206534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_020e1b1d-aaed-44dd-ad05-35cfb2142366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c644b875-745e-417c-9c55-1e415186354a" xlink:to="loc_us-gaap_DerivativeLineItems_020e1b1d-aaed-44dd-ad05-35cfb2142366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_20c60f54-9a0e-4577-b4e4-131220796fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_020e1b1d-aaed-44dd-ad05-35cfb2142366" xlink:to="loc_us-gaap_DerivativeNotionalAmount_20c60f54-9a0e-4577-b4e4-131220796fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2a3b3259-e9cd-4f9d-a68e-cae7c4dbc99e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2a3b3259-e9cd-4f9d-a68e-cae7c4dbc99e" xlink:to="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd304a82-2bcd-445c-b825-56ff974f34af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd304a82-2bcd-445c-b825-56ff974f34af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d1772477-9bcf-4141-9e8d-8ab646da9e36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dd304a82-2bcd-445c-b825-56ff974f34af" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d1772477-9bcf-4141-9e8d-8ab646da9e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_dd2860c4-f6b6-49fb-935c-9f17a42b79d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d1772477-9bcf-4141-9e8d-8ab646da9e36" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_dd2860c4-f6b6-49fb-935c-9f17a42b79d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_cac3a5df-b4c8-425e-a6d1-4c136b10f28d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:to="loc_us-gaap_HedgingDesignationAxis_cac3a5df-b4c8-425e-a6d1-4c136b10f28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3de72a21-55ee-49bf-958b-de03354eded2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_cac3a5df-b4c8-425e-a6d1-4c136b10f28d" xlink:to="loc_us-gaap_HedgingDesignationDomain_3de72a21-55ee-49bf-958b-de03354eded2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f109cfe8-991f-44d4-a82e-2df4a0f54dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3de72a21-55ee-49bf-958b-de03354eded2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f109cfe8-991f-44d4-a82e-2df4a0f54dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b5046deb-4807-45e2-b775-356bcad02d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_baacfe87-ea30-4f6f-aa67-cf2e7406ccf4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b5046deb-4807-45e2-b775-356bcad02d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_17a4d16d-26fa-4a60-8d77-aecdd64ec984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b5046deb-4807-45e2-b775-356bcad02d7a" xlink:to="loc_us-gaap_CurrencySwapMember_17a4d16d-26fa-4a60-8d77-aecdd64ec984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_443cbbe5-70f8-4141-8be4-3918afb02136" xlink:to="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_85bbae3d-7fd9-47c1-ba92-2c1ce9677fde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_85bbae3d-7fd9-47c1-ba92-2c1ce9677fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2c1ee728-850d-4e1a-9a11-964b57ad1aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2c1ee728-850d-4e1a-9a11-964b57ad1aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_71be027e-040a-4006-bd1f-cc7b11aaf5de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2b4fa288-be0a-4725-a566-af8eee292bd5" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_71be027e-040a-4006-bd1f-cc7b11aaf5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_77cc908f-0049-496e-93a4-ea348bc9da7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_77cc908f-0049-496e-93a4-ea348bc9da7a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_efc99291-bdb2-4b62-a84d-2a92beae5f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:to="loc_us-gaap_HedgingDesignationAxis_efc99291-bdb2-4b62-a84d-2a92beae5f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5e060a33-91d7-4555-a2d8-b28c3d1e48e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_efc99291-bdb2-4b62-a84d-2a92beae5f2e" xlink:to="loc_us-gaap_HedgingDesignationDomain_5e060a33-91d7-4555-a2d8-b28c3d1e48e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_14e4aee9-6b1f-4d06-9420-ff010a62b3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5e060a33-91d7-4555-a2d8-b28c3d1e48e3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_14e4aee9-6b1f-4d06-9420-ff010a62b3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f058b46e-3789-48aa-bdf2-5092ef55d115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f058b46e-3789-48aa-bdf2-5092ef55d115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d6cd3e8e-5045-4a1b-aee6-2cb26322684c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f058b46e-3789-48aa-bdf2-5092ef55d115" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d6cd3e8e-5045-4a1b-aee6-2cb26322684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8a8f729b-71ff-4483-870b-aead0be64b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d6cd3e8e-5045-4a1b-aee6-2cb26322684c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8a8f729b-71ff-4483-870b-aead0be64b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b5669b71-691d-409c-9452-89569d4f6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignExchangeContractMember_8a8f729b-71ff-4483-870b-aead0be64b8c" xlink:to="loc_us-gaap_CurrencySwapMember_b5669b71-691d-409c-9452-89569d4f6e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bf0eff9c-2710-43e5-8403-4f2af019b892" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bf0eff9c-2710-43e5-8403-4f2af019b892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9ad0a26f-3b8f-4d1e-9a65-4ae9e2fd3a06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bf0eff9c-2710-43e5-8403-4f2af019b892" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9ad0a26f-3b8f-4d1e-9a65-4ae9e2fd3a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AccruedAndOtherLiabilitiesCurrentMember_c56e6140-6990-4105-aac9-ee106212fb5c" xlink:href="ew-20230930.xsd#ew_AccruedAndOtherLiabilitiesCurrentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ad0a26f-3b8f-4d1e-9a65-4ae9e2fd3a06" xlink:to="loc_ew_AccruedAndOtherLiabilitiesCurrentMember_c56e6140-6990-4105-aac9-ee106212fb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_db634778-53df-426f-8881-7e99be2c9bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9ad0a26f-3b8f-4d1e-9a65-4ae9e2fd3a06" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_db634778-53df-426f-8881-7e99be2c9bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_f90a7efc-a5b3-4c2c-a9fd-84e59f27819f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d3586ad0-0b46-4636-91b4-12e8a8123c85" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_f90a7efc-a5b3-4c2c-a9fd-84e59f27819f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_b0285d9a-cdb9-4694-bc6e-bc78558ee78f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f90a7efc-a5b3-4c2c-a9fd-84e59f27819f" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_b0285d9a-cdb9-4694-bc6e-bc78558ee78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_85268b0f-ff93-454a-8551-d1c61130f82f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_b0285d9a-cdb9-4694-bc6e-bc78558ee78f" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_85268b0f-ff93-454a-8551-d1c61130f82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_0c0973ea-247e-458a-ab91-c8fb520263c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_b0285d9a-cdb9-4694-bc6e-bc78558ee78f" xlink:to="loc_us-gaap_DerivativeAssets_0c0973ea-247e-458a-ab91-c8fb520263c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_cbd21a1a-2fb6-4e33-98bf-1471110f6d77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f90a7efc-a5b3-4c2c-a9fd-84e59f27819f" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_cbd21a1a-2fb6-4e33-98bf-1471110f6d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b01a2ce6-fdd9-4d94-8db7-9a3437a16dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_cbd21a1a-2fb6-4e33-98bf-1471110f6d77" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_b01a2ce6-fdd9-4d94-8db7-9a3437a16dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_03b86ca0-da74-416b-8c6d-f86c0a51b33b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_cbd21a1a-2fb6-4e33-98bf-1471110f6d77" xlink:to="loc_us-gaap_DerivativeLiabilities_03b86ca0-da74-416b-8c6d-f86c0a51b33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_638e6e8e-14a4-4b11-9d9b-7e0d147b4c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_e2ac3863-f59a-46fb-92eb-d507c2ea108e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_638e6e8e-14a4-4b11-9d9b-7e0d147b4c2f" xlink:to="loc_us-gaap_OffsettingAssetsTable_e2ac3863-f59a-46fb-92eb-d507c2ea108e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c6b28139-23f0-4311-8283-99b28be9eace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_e2ac3863-f59a-46fb-92eb-d507c2ea108e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c6b28139-23f0-4311-8283-99b28be9eace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd2e46ff-3ac3-421a-8e13-6a58060d0036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c6b28139-23f0-4311-8283-99b28be9eace" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd2e46ff-3ac3-421a-8e13-6a58060d0036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_be65e096-0aa7-4e4e-944c-b2c7119fcdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2e46ff-3ac3-421a-8e13-6a58060d0036" xlink:to="loc_us-gaap_ForeignExchangeContractMember_be65e096-0aa7-4e4e-944c-b2c7119fcdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_8a994651-0f48-4376-855e-575e45301cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2e46ff-3ac3-421a-8e13-6a58060d0036" xlink:to="loc_us-gaap_CurrencySwapMember_8a994651-0f48-4376-855e-575e45301cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_1e553c76-4ad3-4d4a-9d3a-a000873e600d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_e2ac3863-f59a-46fb-92eb-d507c2ea108e" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_1e553c76-4ad3-4d4a-9d3a-a000873e600d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_1e553c76-4ad3-4d4a-9d3a-a000873e600d" xlink:to="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cb69fede-c9d7-46ef-9562-e4fd01675d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_cb69fede-c9d7-46ef-9562-e4fd01675d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_870adb45-3810-47e5-a910-c2d91e0806eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_870adb45-3810-47e5-a910-c2d91e0806eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_2ba4109d-5d33-4706-aa47-d41f403a922f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeAssets_2ba4109d-5d33-4706-aa47-d41f403a922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueNetAbstract_5d621775-a458-451a-aacd-b0b5734eeafa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetFairValueNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeAssetFairValueNetAbstract_5d621775-a458-451a-aacd-b0b5734eeafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_178a17e4-11cf-452a-ad0a-e56547cb315e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_5d621775-a458-451a-aacd-b0b5734eeafa" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_178a17e4-11cf-452a-ad0a-e56547cb315e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_5fe1de95-1b86-46e6-97d1-24ed3fae8f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueNetAbstract_5d621775-a458-451a-aacd-b0b5734eeafa" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_5fe1de95-1b86-46e6-97d1-24ed3fae8f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_ab755b29-2bda-4c38-ab7b-ff913bb20406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeAssetsAbstract_4b56b096-1575-4d7a-ac96-7b5d8d0bed2f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_ab755b29-2bda-4c38-ab7b-ff913bb20406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingDerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_1e553c76-4ad3-4d4a-9d3a-a000873e600d" xlink:to="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a6a8291e-e8d4-454a-9ea8-4a1df62298d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a6a8291e-e8d4-454a-9ea8-4a1df62298d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_26aeaeb7-edde-48cd-8149-e48440f88d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_26aeaeb7-edde-48cd-8149-e48440f88d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_45371b46-02d2-4660-9dfb-417e17042582" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_us-gaap_DerivativeLiabilities_45371b46-02d2-4660-9dfb-417e17042582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_2c580cbb-860f-4535-8f49-c5a682dbb36a" xlink:href="ew-20230930.xsd#ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_2c580cbb-860f-4535-8f49-c5a682dbb36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4c68e2b3-d63c-4190-bc90-1da552c65938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_2c580cbb-860f-4535-8f49-c5a682dbb36a" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_4c68e2b3-d63c-4190-bc90-1da552c65938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_430085fb-cda4-407c-8e08-69162454a4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract_2c580cbb-860f-4535-8f49-c5a682dbb36a" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_430085fb-cda4-407c-8e08-69162454a4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_a487f373-8a5c-4427-ac59-7f2a6df1e1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingDerivativeLiabilitiesAbstract_9bd0ef3f-68f4-4cb0-b3c7-ddbb12cd3b09" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_a487f373-8a5c-4427-ac59-7f2a6df1e1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a15545dd-c90a-49de-af36-80e265af5302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a15545dd-c90a-49de-af36-80e265af5302" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_602f7c94-3639-446c-a0da-40bfe585eebf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_602f7c94-3639-446c-a0da-40bfe585eebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_602f7c94-3639-446c-a0da-40bfe585eebf" xlink:to="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_8ce96da8-0383-427a-9044-d2b5b6ea36c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:to="loc_us-gaap_CashFlowHedgingMember_8ce96da8-0383-427a-9044-d2b5b6ea36c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f7f22087-1b1a-4b9d-9465-3edc0dfd46d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f7f22087-1b1a-4b9d-9465-3edc0dfd46d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_f8809d4d-affe-4616-9fea-5f9aa9087cda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_ee2b1496-dac1-4a61-83a6-711c9ea851d2" xlink:to="loc_us-gaap_FairValueHedgingMember_f8809d4d-affe-4616-9fea-5f9aa9087cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_99a60b4c-da2f-4765-aae6-83e43739e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_99a60b4c-da2f-4765-aae6-83e43739e29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_224143fe-343e-48ef-81a9-b40fc42172b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_99a60b4c-da2f-4765-aae6-83e43739e29d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_224143fe-343e-48ef-81a9-b40fc42172b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a8b32e85-6dff-4d9c-b2d6-d2560b053113" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_224143fe-343e-48ef-81a9-b40fc42172b1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a8b32e85-6dff-4d9c-b2d6-d2560b053113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_a4b7a20d-2f00-4dc6-9021-534307b1e3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignExchangeContractMember_a8b32e85-6dff-4d9c-b2d6-d2560b053113" xlink:to="loc_us-gaap_CurrencySwapMember_a4b7a20d-2f00-4dc6-9021-534307b1e3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c777334a-ccb5-4c22-981b-a827097ce7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_HedgingDesignationAxis_c777334a-ccb5-4c22-981b-a827097ce7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_096a3731-424c-4058-89d5-3f3a327b20ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c777334a-ccb5-4c22-981b-a827097ce7a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_096a3731-424c-4058-89d5-3f3a327b20ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ab9d9f02-6906-4fca-a013-0d6e75d6ed0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_096a3731-424c-4058-89d5-3f3a327b20ea" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_ab9d9f02-6906-4fca-a013-0d6e75d6ed0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_25564bc6-c4a6-4d36-bfcc-d1fbdca05042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_096a3731-424c-4058-89d5-3f3a327b20ea" xlink:to="loc_us-gaap_NondesignatedMember_25564bc6-c4a6-4d36-bfcc-d1fbdca05042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_88ac7f65-a09a-44a0-a8df-c19fc51943d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_88ac7f65-a09a-44a0-a8df-c19fc51943d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_36b07121-6dd2-4688-8014-45dd9208c7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_88ac7f65-a09a-44a0-a8df-c19fc51943d2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_36b07121-6dd2-4688-8014-45dd9208c7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3f570c41-9550-4f96-b976-b3057e87cfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_36b07121-6dd2-4688-8014-45dd9208c7f9" xlink:to="loc_us-gaap_CostOfSalesMember_3f570c41-9550-4f96-b976-b3057e87cfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeMember_9f06c640-bf9a-43f5-ac76-99205eb630d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_36b07121-6dd2-4688-8014-45dd9208c7f9" xlink:to="loc_us-gaap_InterestIncomeMember_9f06c640-bf9a-43f5-ac76-99205eb630d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_dbe06d65-3950-421a-980d-0e47c94ec41a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fc036e83-c1bf-4742-a566-1e8be4553afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fc036e83-c1bf-4742-a566-1e8be4553afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_93e3a8a6-358c-4222-8b0d-085622f3f0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_93e3a8a6-358c-4222-8b0d-085622f3f0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_1f08ce60-f192-4556-9138-7c3094cdd3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_1f08ce60-f192-4556-9138-7c3094cdd3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_cff742e0-c8c4-407d-9d43-f3a53aa4c861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_cff742e0-c8c4-407d-9d43-f3a53aa4c861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3c4192e0-b364-445b-ad57-0f888e63cdfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2e664fcb-98a4-49ee-a27f-8bdda353d1ef" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_3c4192e0-b364-445b-ad57-0f888e63cdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1051169e-b36e-4cc0-b06d-3cc7100f6651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1051169e-b36e-4cc0-b06d-3cc7100f6651" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_35e8981b-67bd-49f6-9b1d-4151de24066c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_35e8981b-67bd-49f6-9b1d-4151de24066c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bf10e5b4-a6dc-43a5-8a8f-a4616d8e6ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_35e8981b-67bd-49f6-9b1d-4151de24066c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bf10e5b4-a6dc-43a5-8a8f-a4616d8e6ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_0c3c2130-ff0c-4589-9a85-2d5b457aa1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bf10e5b4-a6dc-43a5-8a8f-a4616d8e6ddf" xlink:to="loc_us-gaap_ForeignExchangeContractMember_0c3c2130-ff0c-4589-9a85-2d5b457aa1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_33a08f30-be8b-4b34-8a24-48bf62d558a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_33a08f30-be8b-4b34-8a24-48bf62d558a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4faeb4da-b3bc-4dff-a299-586fefc74cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_33a08f30-be8b-4b34-8a24-48bf62d558a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4faeb4da-b3bc-4dff-a299-586fefc74cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a75df2a4-42b9-40dc-a746-def64b17943d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4faeb4da-b3bc-4dff-a299-586fefc74cb3" xlink:to="loc_us-gaap_CostOfSalesMember_a75df2a4-42b9-40dc-a746-def64b17943d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9b3d9e5e-3613-4268-9296-288ce066b8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4faeb4da-b3bc-4dff-a299-586fefc74cb3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9b3d9e5e-3613-4268-9296-288ce066b8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_9612b266-32e8-433b-9ee7-792147353d23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:to="loc_us-gaap_HedgingDesignationAxis_9612b266-32e8-433b-9ee7-792147353d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_720ffec4-26bd-4527-8d9e-af26f700960c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_9612b266-32e8-433b-9ee7-792147353d23" xlink:to="loc_us-gaap_HedgingDesignationDomain_720ffec4-26bd-4527-8d9e-af26f700960c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_37f4c644-94cb-4cca-8fa6-870ab0ea3219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_720ffec4-26bd-4527-8d9e-af26f700960c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_37f4c644-94cb-4cca-8fa6-870ab0ea3219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ae74019d-acda-43c1-a883-e8357685edd7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bb5e4afb-4076-4abb-b2ab-c6a857f10eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bb5e4afb-4076-4abb-b2ab-c6a857f10eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_21eeac42-e600-48dd-a101-2da4c2884097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_21eeac42-e600-48dd-a101-2da4c2884097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_284816e9-fc1b-425e-a0a2-cb19cb0a92ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_284816e9-fc1b-425e-a0a2-cb19cb0a92ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_7f20a621-7ba3-469e-8fd1-e879846cd049" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_7f20a621-7ba3-469e-8fd1-e879846cd049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_cff16991-8b36-4308-b9bc-8b02be9fe1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract_fe352391-31b1-4985-a3fb-db2fe65c5fcf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_cff16991-8b36-4308-b9bc-8b02be9fe1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_085857e8-c4c6-454f-9df2-157f8463deb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0db6f347-3df3-4f07-87b7-5cbaab13cffe" xlink:to="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_085857e8-c4c6-454f-9df2-157f8463deb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05e9531d-7113-49ef-b020-cfb178502aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract_085857e8-c4c6-454f-9df2-157f8463deb8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_05e9531d-7113-49ef-b020-cfb178502aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a3cd0e91-5a80-4f86-9081-aeab81865abb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2d19dac3-5a17-4415-baa4-012a1d7b315f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a3cd0e91-5a80-4f86-9081-aeab81865abb" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2d19dac3-5a17-4415-baa4-012a1d7b315f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2d19dac3-5a17-4415-baa4-012a1d7b315f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c7c17fe8-f7e7-41fc-8a4c-b87aeb025814" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_23d9dd52-dce1-42af-9283-8160c7c4f092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:to="loc_us-gaap_CostOfSalesMember_23d9dd52-dce1-42af-9283-8160c7c4f092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_64073977-242e-42f1-8d34-89dce6c34ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_64073977-242e-42f1-8d34-89dce6c34ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3c57e376-4c14-4aed-8a60-f2f81b1e72ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5d4e866f-663d-4c49-895b-95d2ac47b004" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3c57e376-4c14-4aed-8a60-f2f81b1e72ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2d19dac3-5a17-4415-baa4-012a1d7b315f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3eacf91-b3f3-46b2-8f07-cfd333f38670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3eacf91-b3f3-46b2-8f07-cfd333f38670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b9bd0d99-7bad-49dd-b832-edd675a8d94b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b9bd0d99-7bad-49dd-b832-edd675a8d94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_8fdb2310-5720-4284-b3d7-cd23b72c0f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfcdaea1-b892-40a0-8c8f-bfa55cfec6f7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_8fdb2310-5720-4284-b3d7-cd23b72c0f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c3e6fb61-1b04-49c8-8dbb-ba2713408200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c3e6fb61-1b04-49c8-8dbb-ba2713408200" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:to="loc_us-gaap_AwardTypeAxis_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32d5273d-c3b2-437b-b0bb-4b09864aea8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a1b43f18-6e72-4bc8-aaed-6022c0cb5a8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32d5273d-c3b2-437b-b0bb-4b09864aea8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4a9bed20-4e4d-4a5b-9806-3b18e52f10f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32d5273d-c3b2-437b-b0bb-4b09864aea8d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4a9bed20-4e4d-4a5b-9806-3b18e52f10f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MarketBasedRestrictedStockUnitsMember_001cd3a3-93d8-4b69-8032-24a23b3074e8" xlink:href="ew-20230930.xsd#ew_MarketBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32d5273d-c3b2-437b-b0bb-4b09864aea8d" xlink:to="loc_ew_MarketBasedRestrictedStockUnitsMember_001cd3a3-93d8-4b69-8032-24a23b3074e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_eaf6e918-6fc1-4db0-b848-62d409bad609" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:to="loc_srt_RangeAxis_eaf6e918-6fc1-4db0-b848-62d409bad609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8cc326cb-20ea-45cc-a49d-7319029323d8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_eaf6e918-6fc1-4db0-b848-62d409bad609" xlink:to="loc_srt_RangeMember_8cc326cb-20ea-45cc-a49d-7319029323d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_592b3d50-1c97-4bf5-b47c-318a4ddde860" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8cc326cb-20ea-45cc-a49d-7319029323d8" xlink:to="loc_srt_MinimumMember_592b3d50-1c97-4bf5-b47c-318a4ddde860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0e866504-6dea-4d5a-90ff-7c3d53c0ad20" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8cc326cb-20ea-45cc-a49d-7319029323d8" xlink:to="loc_srt_MaximumMember_0e866504-6dea-4d5a-90ff-7c3d53c0ad20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fc091856-29e9-445d-9618-0184c9db9707" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_83233517-dfd4-434b-ae45-115657429491" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_83233517-dfd4-434b-ae45-115657429491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d101f238-2503-40ac-ad59-d73a22b6b4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d101f238-2503-40ac-ad59-d73a22b6b4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b467a285-040b-4b7d-9a1b-0f3a9d7a5fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b467a285-040b-4b7d-9a1b-0f3a9d7a5fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fe3abc60-55cd-4d2d-9044-ef99a10247d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_fe3abc60-55cd-4d2d-9044-ef99a10247d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d1d7edcc-cb27-4d84-aa89-fee1faa72884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d1d7edcc-cb27-4d84-aa89-fee1faa72884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_950137a7-0da8-4794-9327-596ba0695efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_950137a7-0da8-4794-9327-596ba0695efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod_18a8bbf1-5aa7-487a-94d0-287643cf6a95" xlink:href="ew-20230930.xsd#ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod_18a8bbf1-5aa7-487a-94d0-287643cf6a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget_bee4a353-95f1-4e42-a2b4-e849dc508406" xlink:href="ew-20230930.xsd#ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget_bee4a353-95f1-4e42-a2b4-e849dc508406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3eb9ed58-99fa-47f1-8481-ce086528c3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3eb9ed58-99fa-47f1-8481-ce086528c3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ef2d59bb-613b-4353-a190-1ee2ac9c60ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_38aa1ce6-7b34-418e-84b1-799e8f45b48e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ef2d59bb-613b-4353-a190-1ee2ac9c60ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23fb91e5-d081-4198-8f2b-e6ac14a28a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_931aaedd-101a-4a7b-8d3d-6786e64d8db0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23fb91e5-d081-4198-8f2b-e6ac14a28a7a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_931aaedd-101a-4a7b-8d3d-6786e64d8db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ae7870ee-662a-40dc-97a6-57a4ae37886a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_931aaedd-101a-4a7b-8d3d-6786e64d8db0" xlink:to="loc_us-gaap_AwardTypeAxis_ae7870ee-662a-40dc-97a6-57a4ae37886a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81996e57-80dd-4aab-8731-1b11b7636eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ae7870ee-662a-40dc-97a6-57a4ae37886a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81996e57-80dd-4aab-8731-1b11b7636eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember_53508be6-ed00-4f7c-9ccc-f6a6cf457060" xlink:href="ew-20230930.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81996e57-80dd-4aab-8731-1b11b7636eb4" xlink:to="loc_ew_EmployeeAndNonemployeeStockOptionsMember_53508be6-ed00-4f7c-9ccc-f6a6cf457060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b5a2cab6-811b-4a48-a160-c90aa0805d80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81996e57-80dd-4aab-8731-1b11b7636eb4" xlink:to="loc_us-gaap_EmployeeStockMember_b5a2cab6-811b-4a48-a160-c90aa0805d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_931aaedd-101a-4a7b-8d3d-6786e64d8db0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_de293fd4-fa49-4575-bc19-06a21943a929" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_de293fd4-fa49-4575-bc19-06a21943a929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_56c5a12a-b7a9-486e-a5eb-719739857447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_56c5a12a-b7a9-486e-a5eb-719739857447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ff60c936-def8-47b7-8d87-74c7507b05fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ff60c936-def8-47b7-8d87-74c7507b05fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5f8f7f44-0d56-46fb-b5a4-ce0b704fce12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5f8f7f44-0d56-46fb-b5a4-ce0b704fce12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_151ef924-4239-43c8-828d-bbc781c9cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7e0fa64d-fa1b-43d2-ab1e-b60103910060" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_151ef924-4239-43c8-828d-bbc781c9cf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCELERATEDSHAREREPURCHASEDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_597d67ad-29d2-498a-91c0-a52aeb373df6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_3ce6e90a-2834-4582-bc4f-04342f99153f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_597d67ad-29d2-498a-91c0-a52aeb373df6" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_3ce6e90a-2834-4582-bc4f-04342f99153f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_199b7e87-473b-4aa7-a0dd-6506399e3d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3ce6e90a-2834-4582-bc4f-04342f99153f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_199b7e87-473b-4aa7-a0dd-6506399e3d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_199b7e87-473b-4aa7-a0dd-6506399e3d4a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledJanuary2022Member_4b9544d2-915a-44cf-8005-7aa2cd3c52a2" xlink:href="ew-20230930.xsd#ew_InitialDeliveryOfSharesSettledJanuary2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:to="loc_ew_InitialDeliveryOfSharesSettledJanuary2022Member_4b9544d2-915a-44cf-8005-7aa2cd3c52a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member_ef5162a9-d381-4112-981c-ee962a938492" xlink:href="ew-20230930.xsd#ew_InitialDeliveryOfSharesSettledFebruary2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:to="loc_ew_InitialDeliveryOfSharesSettledFebruary2023Member_ef5162a9-d381-4112-981c-ee962a938492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member_0ebf10f9-da1b-4b1d-b60d-5e69478ac7c6" xlink:href="ew-20230930.xsd#ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:to="loc_ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member_0ebf10f9-da1b-4b1d-b60d-5e69478ac7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_5b7da496-c3de-41e0-b1c1-3331cbc6793a" xlink:href="ew-20230930.xsd#ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_bdda764c-08e7-4933-be0e-9c3e6424b9ff" xlink:to="loc_ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member_5b7da496-c3de-41e0-b1c1-3331cbc6793a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_3ce6e90a-2834-4582-bc4f-04342f99153f" xlink:to="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1de94e0a-398e-47fe-a568-8447a9b8ca61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1de94e0a-398e-47fe-a568-8447a9b8ca61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_a82e4d79-d3ec-4e08-a809-4c37a770b23f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_a82e4d79-d3ec-4e08-a809-4c37a770b23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_6d6fb6e8-0c96-46e4-a65a-8e7555b90456" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_6d6fb6e8-0c96-46e4-a65a-8e7555b90456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_da146e81-8e39-4668-ba11-611697e3ef55" xlink:href="ew-20230930.xsd#ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount_da146e81-8e39-4668-ba11-611697e3ef55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_97d29d18-3241-49d4-b2be-ec191290372e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a4c051f6-e8a6-43a2-8e3a-a4a7aeb96b09" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_97d29d18-3241-49d4-b2be-ec191290372e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1edf9de5-0bb5-4adf-b77d-96b27b45e9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_c9fd321e-504b-457c-912e-4282e35a6861" xlink:href="ew-20230930.xsd#ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1edf9de5-0bb5-4adf-b77d-96b27b45e9bf" xlink:to="loc_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber_c9fd321e-504b-457c-912e-4282e35a6861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_86ed8378-69fc-41f0-bf91-b8b444f1d013" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b3d7c1f6-63f1-4846-97b4-aebc1bd14d60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_86ed8378-69fc-41f0-bf91-b8b444f1d013" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b3d7c1f6-63f1-4846-97b4-aebc1bd14d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8d8aefee-08d7-4281-969e-60005e5d8666" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b3d7c1f6-63f1-4846-97b4-aebc1bd14d60" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8d8aefee-08d7-4281-969e-60005e5d8666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f88f2e1e-4495-4ff8-8064-e579c5ad7aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8d8aefee-08d7-4281-969e-60005e5d8666" xlink:to="loc_us-gaap_EquityComponentDomain_f88f2e1e-4495-4ff8-8064-e579c5ad7aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f88f2e1e-4495-4ff8-8064-e579c5ad7aa6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_71fa6981-79d5-4c47-8f4d-b4f7afa9168c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_71fa6981-79d5-4c47-8f4d-b4f7afa9168c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9a156ee3-fb0c-4b3f-8324-c892470c2b66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_9a156ee3-fb0c-4b3f-8324-c892470c2b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_81ae1b31-4298-4a5e-b1d2-0ae9b9db5f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_81ae1b31-4298-4a5e-b1d2-0ae9b9db5f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f8016683-e0ca-4181-a3f7-fad511b227cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c32c535f-ebfb-496a-bb80-f78344566e57" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f8016683-e0ca-4181-a3f7-fad511b227cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d3ab1f6b-3739-47b4-a7ca-0f9942dba97a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b3d7c1f6-63f1-4846-97b4-aebc1bd14d60" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d3ab1f6b-3739-47b4-a7ca-0f9942dba97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d3ab1f6b-3739-47b4-a7ca-0f9942dba97a" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e475accc-5b69-46ba-a562-d13dd7320370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_StockholdersEquity_e475accc-5b69-46ba-a562-d13dd7320370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f59c8990-b476-4038-bbca-0795c4cf8740" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f59c8990-b476-4038-bbca-0795c4cf8740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_81d2f96a-77a8-4693-b557-24fec80fccca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_81d2f96a-77a8-4693-b557-24fec80fccca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_4d7c638b-bcef-4c31-9c0c-a193f6539c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_4d7c638b-bcef-4c31-9c0c-a193f6539c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0312b2f1-a5a6-457d-984e-e114bc4a6969" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a3f5cb1b-aa3f-474b-bc46-acb8c6dd72e1" xlink:to="loc_us-gaap_StockholdersEquity_0312b2f1-a5a6-457d-984e-e114bc4a6969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a1380910-c293-4f13-8e8a-d6d9e56ff880" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a1380910-c293-4f13-8e8a-d6d9e56ff880" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e06962dc-0a82-4b67-987f-f800585326a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e06962dc-0a82-4b67-987f-f800585326a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b3fb03ac-d1fc-4b4f-ae06-ba687f78a460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e06962dc-0a82-4b67-987f-f800585326a4" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b3fb03ac-d1fc-4b4f-ae06-ba687f78a460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_83b08a8b-8409-4c76-b9a3-012dfe457bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b3fb03ac-d1fc-4b4f-ae06-ba687f78a460" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_83b08a8b-8409-4c76-b9a3-012dfe457bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c73558a3-9a6b-4a70-96a0-95744552f07c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c73558a3-9a6b-4a70-96a0-95744552f07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c73558a3-9a6b-4a70-96a0-95744552f07c" xlink:to="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d94e662c-6836-45e6-b061-27491855cbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d94e662c-6836-45e6-b061-27491855cbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_428a9d3d-ebc8-47dc-bcb4-633c1bff58f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_428a9d3d-ebc8-47dc-bcb4-633c1bff58f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c2b13924-0d86-45be-a31f-ea98dd3e26e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ad3afbe9-ed34-4caf-ac1d-e438bf367479" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c2b13924-0d86-45be-a31f-ea98dd3e26e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_80385453-b6bb-400c-bdd2-552789567517" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0b87e22c-b9b2-48f3-8ac5-58339541bb59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0b87e22c-b9b2-48f3-8ac5-58339541bb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f27b45b4-5b71-49ff-9816-8711f77104c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f27b45b4-5b71-49ff-9816-8711f77104c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a494ef1b-3cbf-466a-851c-f1f3fd39683d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a494ef1b-3cbf-466a-851c-f1f3fd39683d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7f5edfde-71fd-4eb6-97ac-f609d7aedbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7f5edfde-71fd-4eb6-97ac-f609d7aedbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_37d0cc2e-6ff5-40a9-b09f-c65669738fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_37d0cc2e-6ff5-40a9-b09f-c65669738fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_901e5b66-fb47-466d-9e06-e753775c3261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_e8072e43-1c1b-4cc9-9602-32b46db12b38" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_901e5b66-fb47-466d-9e06-e753775c3261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2ce40d72-13bf-4f4b-92a6-410b60cab20d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_031eeb01-b64b-4d89-92a6-80535fafced0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2ce40d72-13bf-4f4b-92a6-410b60cab20d" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_031eeb01-b64b-4d89-92a6-80535fafced0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d910b9bd-795b-4c22-a21d-54adf1645a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_031eeb01-b64b-4d89-92a6-80535fafced0" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d910b9bd-795b-4c22-a21d-54adf1645a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b8a0067c-4679-4c66-9392-0986b0e68756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_031eeb01-b64b-4d89-92a6-80535fafced0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b8a0067c-4679-4c66-9392-0986b0e68756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3532143e-7dc6-4a79-a66f-c499b4c0d036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_031eeb01-b64b-4d89-92a6-80535fafced0" xlink:to="loc_us-gaap_EarningsPerShareBasic_3532143e-7dc6-4a79-a66f-c499b4c0d036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_e7a6e10c-43ec-4499-8617-6ca4b73dd877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2ce40d72-13bf-4f4b-92a6-410b60cab20d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_e7a6e10c-43ec-4499-8617-6ca4b73dd877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_95371d81-f9e6-49a2-a3c9-af24ab660724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e7a6e10c-43ec-4499-8617-6ca4b73dd877" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_95371d81-f9e6-49a2-a3c9-af24ab660724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b01aed58-d41e-499f-a323-95f60519df6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e7a6e10c-43ec-4499-8617-6ca4b73dd877" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b01aed58-d41e-499f-a323-95f60519df6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b0a81919-ee7b-4699-b619-649b436433e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e7a6e10c-43ec-4499-8617-6ca4b73dd877" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b0a81919-ee7b-4699-b619-649b436433e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9a4c7195-7e4b-4b58-90ab-e0b589485574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e7a6e10c-43ec-4499-8617-6ca4b73dd877" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9a4c7195-7e4b-4b58-90ab-e0b589485574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_77b3a120-59f3-4437-a3fb-e1acae166f38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_e7a6e10c-43ec-4499-8617-6ca4b73dd877" xlink:to="loc_us-gaap_EarningsPerShareDiluted_77b3a120-59f3-4437-a3fb-e1acae166f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_368eebbd-c95d-473c-8eb2-3a10342c3840" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8dca74f2-617a-4929-90e7-947c6f679dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_368eebbd-c95d-473c-8eb2-3a10342c3840" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8dca74f2-617a-4929-90e7-947c6f679dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dbfa9f09-dc3c-420e-ada4-342f9fdd2878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8dca74f2-617a-4929-90e7-947c6f679dd5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dbfa9f09-dc3c-420e-ada4-342f9fdd2878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d7e363f5-2f65-442b-9afd-a8c85b52ab9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dbfa9f09-dc3c-420e-ada4-342f9fdd2878" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d7e363f5-2f65-442b-9afd-a8c85b52ab9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_2483951e-e3a8-47a3-ab2e-16571b257725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d7e363f5-2f65-442b-9afd-a8c85b52ab9e" xlink:to="loc_us-gaap_StockCompensationPlanMember_2483951e-e3a8-47a3-ab2e-16571b257725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_adced6e3-cea4-4657-b479-34a983a11208" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8dca74f2-617a-4929-90e7-947c6f679dd5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_adced6e3-cea4-4657-b479-34a983a11208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ee5b6574-f7d6-471f-a54c-5b27cbcbf2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_adced6e3-cea4-4657-b479-34a983a11208" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ee5b6574-f7d6-471f-a54c-5b27cbcbf2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8e9b66f1-0810-4571-a144-321818e2c700" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3664a327-5f9f-4922-9dec-42ca8f132068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e9b66f1-0810-4571-a144-321818e2c700" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3664a327-5f9f-4922-9dec-42ca8f132068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_fabca933-77c5-4448-9ced-d22f5a3db740" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e9b66f1-0810-4571-a144-321818e2c700" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_fabca933-77c5-4448-9ced-d22f5a3db740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_98450403-7a72-4900-af0e-404a0b7e636d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e9b66f1-0810-4571-a144-321818e2c700" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_98450403-7a72-4900-af0e-404a0b7e636d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_79d3cbe4-4bc3-4e35-8dfe-0ebf92c3444f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e9b66f1-0810-4571-a144-321818e2c700" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_79d3cbe4-4bc3-4e35-8dfe-0ebf92c3444f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_16895f7e-ecb0-4f81-8061-b2d9c5c674ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e9b66f1-0810-4571-a144-321818e2c700" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_16895f7e-ecb0-4f81-8061-b2d9c5c674ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_NumberOfAdvancePricingAgreementsRenewed_16444711-6c5b-4522-ba9a-1d5e9c71a609" xlink:href="ew-20230930.xsd#ew_NumberOfAdvancePricingAgreementsRenewed"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e9b66f1-0810-4571-a144-321818e2c700" xlink:to="loc_ew_NumberOfAdvancePricingAgreementsRenewed_16444711-6c5b-4522-ba9a-1d5e9c71a609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_4e4da9bb-62d6-4229-a433-b28ec08eb26a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e9b66f1-0810-4571-a144-321818e2c700" xlink:to="loc_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss_4e4da9bb-62d6-4229-a433-b28ec08eb26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_533283a0-a5d0-41f9-8d34-b3ffb05adac1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_533283a0-a5d0-41f9-8d34-b3ffb05adac1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d9613b51-7403-4338-a380-a1f8d639f79d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d9613b51-7403-4338-a380-a1f8d639f79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9613b51-7403-4338-a380-a1f8d639f79d" xlink:to="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_UnitedStatesSegmentMember_0ffc409f-0da0-4872-a9d2-dbdac563dfac" xlink:href="ew-20230930.xsd#ew_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:to="loc_ew_UnitedStatesSegmentMember_0ffc409f-0da0-4872-a9d2-dbdac563dfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EuropeSegmentMember_58b81082-7384-4d15-a7dc-eaf144982786" xlink:href="ew-20230930.xsd#ew_EuropeSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:to="loc_ew_EuropeSegmentMember_58b81082-7384-4d15-a7dc-eaf144982786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JapanSegmentMember_9cf672fa-b342-4b43-b7d7-85bc7dbd89f2" xlink:href="ew-20230930.xsd#ew_JapanSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:to="loc_ew_JapanSegmentMember_9cf672fa-b342-4b43-b7d7-85bc7dbd89f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldSegmentMember_32134b86-8b0b-467a-a0aa-d391596a4666" xlink:href="ew-20230930.xsd#ew_RestOfWorldSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1f269b8a-9074-455d-8eeb-03e56f17c0e8" xlink:to="loc_ew_RestOfWorldSegmentMember_32134b86-8b0b-467a-a0aa-d391596a4666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4b8c008d-c54d-43dd-a1be-d5a33fabd721" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:to="loc_srt_ConsolidationItemsAxis_4b8c008d-c54d-43dd-a1be-d5a33fabd721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fb65049b-2f10-4a5d-934b-4a939dedc372" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_4b8c008d-c54d-43dd-a1be-d5a33fabd721" xlink:to="loc_srt_ConsolidationItemsDomain_fb65049b-2f10-4a5d-934b-4a939dedc372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_0a0053b2-0006-421a-9341-2b393be8afc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_fb65049b-2f10-4a5d-934b-4a939dedc372" xlink:to="loc_us-gaap_OperatingSegmentsMember_0a0053b2-0006-421a-9341-2b393be8afc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_701fe460-fc0f-4ddc-9d3b-86321a226100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f606a7ba-77e9-4d31-bbfd-a8cc164b965d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_701fe460-fc0f-4ddc-9d3b-86321a226100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_1154b49b-74a8-4126-a4e6-be0ecd4d9d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_701fe460-fc0f-4ddc-9d3b-86321a226100" xlink:to="loc_us-gaap_RevenuesAbstract_1154b49b-74a8-4126-a4e6-be0ecd4d9d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c97f3de4-6328-4725-a75b-231e74b41719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_1154b49b-74a8-4126-a4e6-be0ecd4d9d2c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c97f3de4-6328-4725-a75b-231e74b41719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_4411d5c7-d437-48ee-b06e-36470b7c76f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_701fe460-fc0f-4ddc-9d3b-86321a226100" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_4411d5c7-d437-48ee-b06e-36470b7c76f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1905292b-df05-4e94-82ab-fa59cfee812c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_4411d5c7-d437-48ee-b06e-36470b7c76f7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1905292b-df05-4e94-82ab-fa59cfee812c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ab45729c-eba6-4250-be0d-ae42b558b24b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c624f90b-163a-4a2b-9186-8e4aa70571ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ab45729c-eba6-4250-be0d-ae42b558b24b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c624f90b-163a-4a2b-9186-8e4aa70571ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_adba5e09-d296-4e28-9f31-15e8aed3b578" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c624f90b-163a-4a2b-9186-8e4aa70571ee" xlink:to="loc_srt_ConsolidationItemsAxis_adba5e09-d296-4e28-9f31-15e8aed3b578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_adba5e09-d296-4e28-9f31-15e8aed3b578" xlink:to="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1a2de6d3-78ac-4c3e-8424-7ad117d1f12a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:to="loc_us-gaap_OperatingSegmentsMember_1a2de6d3-78ac-4c3e-8424-7ad117d1f12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_b662e287-75f8-42ad-890e-e71ed3db05b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_b662e287-75f8-42ad-890e-e71ed3db05b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_74dfc498-48c8-4d56-9a4d-447a3087720f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0fee7b94-1904-475e-85b5-2b6ddb60d56d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_74dfc498-48c8-4d56-9a4d-447a3087720f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2dfca248-bf1e-4527-83f5-c70e6835cfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c624f90b-163a-4a2b-9186-8e4aa70571ee" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2dfca248-bf1e-4527-83f5-c70e6835cfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_f5ed13b8-f84c-4993-97b3-1f5104f2ea99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2dfca248-bf1e-4527-83f5-c70e6835cfa3" xlink:to="loc_us-gaap_RevenuesAbstract_f5ed13b8-f84c-4993-97b3-1f5104f2ea99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_633efc92-4622-4a06-ac20-34b6bd6b9167" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_f5ed13b8-f84c-4993-97b3-1f5104f2ea99" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_633efc92-4622-4a06-ac20-34b6bd6b9167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2dfca248-bf1e-4527-83f5-c70e6835cfa3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_76d45c9a-2055-4181-b892-e632bef07861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:to="loc_us-gaap_OperatingIncomeLoss_76d45c9a-2055-4181-b892-e632bef07861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8e5157f8-8196-4165-acc3-abdee856a3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_CostsAndExpenses_8e5157f8-8196-4165-acc3-abdee856a3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_e19deb89-a221-4729-97d0-2bf2dacf2fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_e19deb89-a221-4729-97d0-2bf2dacf2fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_a03560e9-8cda-400d-a67f-1d412c104724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_LitigationSettlementExpense_a03560e9-8cda-400d-a67f-1d412c104724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc240925-a435-4c3d-9727-c35860229ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_dc240925-a435-4c3d-9727-c35860229ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_c470da75-08be-4ec5-bfcf-3ff566c58574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_c470da75-08be-4ec5-bfcf-3ff566c58574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2376f629-9b59-4c80-a66d-ad3d4fff95c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_2d083329-ca8c-4e71-90f4-5dfe144d86f1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2376f629-9b59-4c80-a66d-ad3d4fff95c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e2d64b-8447-4f4a-a289-0dc8243e573c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_c3de7039-1768-4315-bc63-39e4ab8a2984" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e2d64b-8447-4f4a-a289-0dc8243e573c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" xlink:type="simple" xlink:href="ew-20230930.xsd#SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"/>
  <link:presentationLink xlink:role="http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bf6cfce7-2939-46c8-8e1b-c560a0e976bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bf6cfce7-2939-46c8-8e1b-c560a0e976bb" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_43273c13-09ca-481d-bef1-9b4379e0761d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:to="loc_srt_StatementGeographicalAxis_43273c13-09ca-481d-bef1-9b4379e0761d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_43273c13-09ca-481d-bef1-9b4379e0761d" xlink:to="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ac993e82-13a2-4252-8a0a-16e5317c52c7" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:to="loc_country_US_ac993e82-13a2-4252-8a0a-16e5317c52c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_2c233072-8775-44fe-b8d0-10684eed9820" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:to="loc_srt_EuropeMember_2c233072-8775-44fe-b8d0-10684eed9820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_ed815ae8-c44e-4c20-9e30-fd7fc7613b9b" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JP"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:to="loc_country_JP_ed815ae8-c44e-4c20-9e30-fd7fc7613b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_RestOfWorldMember_f155eed7-6f4e-41f8-8ed3-73b50ab93bee" xlink:href="ew-20230930.xsd#ew_RestOfWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d4b71570-8922-49be-9066-a6ec93016a0d" xlink:to="loc_ew_RestOfWorldMember_f155eed7-6f4e-41f8-8ed3-73b50ab93bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_82249aa6-aa1b-40b9-90ca-851b95325dc0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:to="loc_srt_ProductOrServiceAxis_82249aa6-aa1b-40b9-90ca-851b95325dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_82249aa6-aa1b-40b9-90ca-851b95325dc0" xlink:to="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterAorticValveReplacementMember_858ff5ee-aea0-41da-a0c1-f3e6ff591d93" xlink:href="ew-20230930.xsd#ew_TranscatheterAorticValveReplacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:to="loc_ew_TranscatheterAorticValveReplacementMember_858ff5ee-aea0-41da-a0c1-f3e6ff591d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember_4a5ab5be-5b5c-4718-a2c3-4271dce9d34d" xlink:href="ew-20230930.xsd#ew_TranscatheterMitralAndTricuspidTherapiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:to="loc_ew_TranscatheterMitralAndTricuspidTherapiesMember_4a5ab5be-5b5c-4718-a2c3-4271dce9d34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_SurgicalHeartValveTherapyMember_de135ffe-592e-48cf-a5f5-73c0a7cd9f28" xlink:href="ew-20230930.xsd#ew_SurgicalHeartValveTherapyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:to="loc_ew_SurgicalHeartValveTherapyMember_de135ffe-592e-48cf-a5f5-73c0a7cd9f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_CriticalCareMember_04839ced-7709-4876-95f0-237863aa3775" xlink:href="ew-20230930.xsd#ew_CriticalCareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ceff64ab-8dc9-4df5-968b-fb820dc09668" xlink:to="loc_ew_CriticalCareMember_04839ced-7709-4876-95f0-237863aa3775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_f3398a90-843c-4193-88cb-8d77f5aceba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8d11cd82-4ceb-4d4f-b6d0-b921911a7fce" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_f3398a90-843c-4193-88cb-8d77f5aceba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_042b8315-89d3-4081-a11b-d76f2ac128db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_f3398a90-843c-4193-88cb-8d77f5aceba9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_042b8315-89d3-4081-a11b-d76f2ac128db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_MarketBasedRestrictedStockUnitsMember" xlink:href="ew-20230930.xsd#ew_MarketBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ew_MarketBasedRestrictedStockUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:href="ew-20230930.xsd#ew_EmployeeAndNonemployeeStockOptionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ew_EmployeeAndNonemployeeStockOptionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_ew_JeanLucLemercierMember" xlink:href="ew-20230930.xsd#ew_JeanLucLemercierMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ew_JeanLucLemercierMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ew-20230930_g1.jpg
<TEXT>
begin 644 ew-20230930_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J
M-*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH
M TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q
M\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_
M $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J
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M=_R#X/\ KBO\A4U $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\
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MUM3\!?%?P)_PM2\U$-Y]G+?16)>[N\_=</;$2%L8EE X+"O9_P#@YI\)ZO\
M&GX-_LV_LO\ @N%[CQ'X^_:H\.0:?;1#+K;Q6U]]HN..B1"2-F;HJDDX K]
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MN0!ZU]>UX7^UA_R6SX'_ /8]R_\ I,U 'KGV+QO_ -!NR_\  8_XT?8O&_\
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MOO\ XU1_PV1\'/\ HLUE_P"$[??_ !JOAZB@#[A_X;(^#G_19K+_ ,)V^_\
MC5=E\.?B-%\6M'FU[X?>.++4+2WN3;S2_P!F31;9 JL5Q(JD\,IR!CFOSLK[
M*_X)S?\ )(=9_P"QDD_])X* /:OL7C?_ *#=E_X#'_&K6E0:_#(YUB_@F4K\
M@BBVD&KU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%?-O[&_\ P4\^!7[<?[3GQO\ V<?@AI]]=1_ ^]TBSU;Q2[H;
M+5Y[U;O<+4#YFCB:T=/,/RR9#)E,,P!])445\F:O_P %9/!5QX0\=_'GX7?
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M** "BBB@#F_C)_R2'Q5_V+=]_P"D[U^:]?I1\9/^20^*O^Q;OO\ TG>OS7H
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MP!S6A_9VG_\ /C#_ -^A5#Q5I]@/"^I$6,/_ !X3?\LA_<- ' _\-J_LS?\
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M\46NIQ/I\MCL+_:EN WEF'8"WF9V[><XKE?@G^V'^R_^T;K5QX;^"'QQ\/\
MB34+?3TU V6GWH,LUB[;4O(E8 SVS-\JW$>Z)CP&)H ]*HKC?C/^T+\$OV>-
M(L=;^-7Q+TOP]%JE[]CTB*^G_?ZC<[2WDVT*@RW$FT,Q2-68*I8C )K2^%WQ
M8^&?QN\$6?Q)^$/CS2O$F@W^\6FK:->I/"[(Q1TW*3AT=61D.&5E*L 010!T
M%%%% !7A?[6'_);/@?\ ]CW+_P"DS5[I7A?[6'_);/@?_P!CW+_Z3-0![I11
M10 4444 %%%% &/X'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%6Q0 4444
M%%%% !1110 4444 %%%% !6/X'_Y!$O_ %^S?^A5L5C^!_\ D$2_]?LW_H5
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M% !1110 4444 %8_@?\ Y!$O_7[-_P"A5L5C^!_^01+_ -?LW_H5 &Q1110
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M%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
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M44 %>%_M8?\ );/@?_V/<O\ Z3-7NE>%_M8?\EL^!_\ V/<O_I,U 'NE%%%
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M1^T'\/M"D:/2_%G[-NB:[K\,9PLM_93Z;:6\CCH66"XD4$\X8^] 'Z:4444
M%>%_M8?\EL^!_P#V/<O_ *3-7<?$']I[X ?"KQ&WA+XB?%32](U)(4E:SNY&
M#A&Y5N >#7B'QR_:0^!GQ3^./P;@^'OQ,TW5GL/&S27BVDC'RD: HI.0."Q
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MDU&^CA+W]N5#GK\CU]'_ /"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\
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M]!T:8W^O>,M0M%M;.SMX/+MK"RM[4\RM*\/+':L4<ORL2"OVK10!\G?LY_\
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M_L7?\%;_ !1_P4*\&_#O7_$_PY^-OP^M-#^)EMX2TB74=1T+7M-,:V.H?8X
MT]Q:RVJ&!A!'(\<H#L-C$C3_ & OV2?B/=_MV?'G_@J/\<_!-YX7U7XK+IGA
M[X>^$=5*?;])\,Z?;Q1B:[5&8137DT27!@W%H55 ^'+(GVC10 4444 9>K>"
M/!>O7AU#7/"&EWMP5"F>[T^.1R!T&YE)Q7AG[3G@WPAH7QM^";:)X4TVS,OC
MF02FUL8X]X%NQ .T#//-?0]>%_M8?\EL^!__ &/<O_I,U 'MW]G:?_SXP_\
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MV@),%NB$]2B 9I]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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M719&>[$A4&"2U61=J(4(!^L]%0:7/?76F6]SJ=@+6YD@1KBU$PD$+E063<
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MJ_\ T*%[_P!]+1X'_P"01+_U^S?^A5L4 8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2UYG)^W3
M\!8G:-]=G#*2"/L,_!_[]U[)7Y<W_P#Q_3_]=F_F: /N'_ANSX!_]!^?_P
M9_\ XW1_PW9\ _\ H/S_ /@#/_\ &Z^&** /N?\ X;L^ ?\ T'Y__ &?_P"-
MU1T#]M;X#Z/9/:R^))7+3O)E;"XZ,<X_U=?$U% 'W/\ \-V? /\ Z#\__@#/
M_P#&Z/\ ANSX!_\ 0?G_ / &?_XW7PQ10!]S_P##=GP#_P"@_/\ ^ ,__P ;
MKI?AU^T9X*^++W<?P]@N=2:P"&["0O'Y8?=M_P!8JYSM;IZ5^>=?4/\ P35_
MX_O&/_7&Q_G/0!])_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+6Q10!C_\
M)+J__0H7O_?2U0\4>)-6;PSJ*GPE> &QF!)9>/D-=/5#Q7_R*VI?]@^;_P!
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M_"2ZO_T*%[_WTM6M*U6]U"1TNM$GM0JY#2D8;VXJ]10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17'?'OXV^&?V=_A5K
M'Q=\7>'?$>JV&C6<MS/8^%/#MQJ=[*L<;2$)# K$?*A^9RJ XRPR*Y#]@?\
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MZ\_8H^/?Q9^+GC/6-)^(7BO^T+>UTM9K>/[#!%M<R*N<Q1J3P>_%?2%?'_\
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MG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\
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MT444 %4/%?\ R*VI?]@^;_T U?JAXK_Y%;4O^P?-_P"@&@#\PJ*** "BBB@
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MXIO=3BU:VU&"5K?693>2R$7MM);.[7"D23+(T<C,"NWP+_@H!H/QUM_V7O\
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MY/&A&G+I6B-;F&00DN7R3N!7( ]: /KVBL?[%XW_ .@W9?\ @,?\:/L7C?\
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MVE/W:T?CAU3[KO%]'\GJ/HHHKY$^P/HS_@G!_P E$\0?]@5?_1RU]@5\:_\
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M96'!%<'XK\*3:%-]HMP7M7/RMW0^A_QK^A?"_C#+ZF#ADU:*IU(_"UHI^O\
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MZ"HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#Y*^+'[9GQ4^+/_  41_P"':G[*OB+2M U#PMX#
M'B[XL>/=1TG^T'T>":5(K'2[.W9T0W<V\3M)+NCC@'".[C9J_L-_MM>,OBK^
MT'\8OV$_VATTM?BE\%-3LFNM4T6T:VL_$VA7\"W%AJD4#NYADV-Y5Q$'=4E
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M\$U?^/[QC_UQL?YSU\?>7^UE_P!&$?%/_P $P_QKU#]FK]H[]K+]GB?6)_\
MAVK\4]8_M9(%QY M_*\LR?[#[L[_ &QCOF@#]'**^.?^'E/[67_2)_XI_P#@
M6/\ Y'H_X>4_M9?](G_BG_X%C_Y'H ^QJH>*_P#D5M2_[!\W_H!KY(_X>4_M
M9?\ 2)_XI_\ @6/_ )'JOJW_  4;_:RU32[G3?\ AU)\4T^T6[Q;_M(.W<I&
M<>1SUH \!HKG_+_:R_Z,(^*?_@F'^-'E_M9?]&$?%/\ \$P_QH Z"BN?\O\
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M>Z:L<42_WF8G"CWJU8W/[5.HV4.H67["'Q0EAGB62*6+20RNK#((.>00<YH
MZ6BN?\O]K+_HPCXI_P#@F'^-'E_M9?\ 1A'Q3_\ !,/\: .@K[*_X)S?\DAU
MG_L9)/\ TG@KX5\O]K+_ *,(^*?_ ()A_C7LO[.7[6G[67P \(7GA3_AV1\4
M]6^UZDUW]HV"#9F-$V[?+?/W,YSWZ4 ?H/17QS_P\I_:R_Z1/_%/_P "Q_\
M(]>I_LJ?M6?&?]H#Q3J>@?$W]C+QC\,[:QT\7%MJ?B2<-%=R%PODI^[0[L$M
MWX!H ]SHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[ 5I_P"B4K=IL444$2P01JB(H5$08"@= !V%.H **** "BBB@ HHHH ****
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M/A_!VH>.?#FGS7\/A'QCX;N+Z/Q D8#&U@>"[@:"<J'\O(=7?:A";MZ^\44
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MN;B:?4BH9@(]L$8!(VD/(K_;<<<<,:Q1(%50 JJ,  = !2T4 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'S'^VC^T+\8/A-\4;#PY\/\ Q?\ V?93Z!%<RP_V
M?;R[I3/.I;,D;$<(HQG''UKR+_AM7]IG_HI?_E&LO_C-=5_P46_Y+;I?_8JP
M?^E-S7@5 'J?_#:O[3/_ $4O_P HUE_\9KUW]B[]H7XP?%GXHW_ASX@>+_[0
MLH- EN8H?[/MXMLHG@4-F.-2>'88SCGZ5\GU[[_P3I_Y+;JG_8JS_P#I3;4
M?9]%%% !39IHK:%[B>0*D:EG8]  ,DTZB@#S7X6_ME_LE?&[XD:G\'/@_P#M
M*^!_$WB[1;9KC5_"^B>)[:XU&RB5E5I);=',D:AG0$LH +J#U%=)\6?C/\)O
M@/X/G^(7QJ^(^C>%=!M03=:SK^H):VL  ))>60A4  )R2!7Y6_\ !7S]B?\
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MJ[]C^P/HR<=Y'E6$Q/#^.JQI5*E3VM-R:2FW&,90N].9<J<5]J[MJCX]K7\
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MTY7RYI8V>/!.1M(Q6[XU^'W@'XDZ5'H7Q%\$:/K]C%<">*SUK3(KJ))0K*)
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M39J5M-+TBQCMK> $EB$CC 5<DD\#J36E0 4444 %%%% !1110 4444 %%%%
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MM?VCM)^-OP"M[/2?#/QBD\+RFQ\:036WA"&QL0B6J1LH>\:24&1Y8PJEYV(
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M]Q_P6C^('@NW\46$FKQ_LU>%'DTU+M#.@37M?9LH#D86:%B,<"5#T89^$_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ew-20230930_g10.jpg
<TEXT>
begin 644 ew-20230930_g10.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:?\ \&P?[;=SX$;45T=_&&B169MMW^K:;3EUG;C^$V+0B3MY><T ?OI\./\
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M_%R!)?A?XF\9> ]1TO2/$RN8Q']FN;B)0N[SH2#*(QB:(Y_>)NQO^"N'PO\
M^":?P._X)R_''Q?^U1\&K/1? ?B^*RN?B"WP\TF#3M9\2:DEY"; ^="J&>Y^
MTB':\Q90-V_]WOK\,O\ @K%XK\1>+/V1OV O%NGQ^'_#?@6XDU3_ (59\/=,
MU:35-1T+18[C2HXIM2U&1P;JZF*$LL<,,4)B\M5)5B #];/^"^O_  6SN?\
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M_!W[!NGPZ'\8Y_A7J+_'GXJ^.->EFT32;"WAL1<6VEZ9YD8NKX[;-7EEE6"
MQR.(Y0CJ0#](_P!FK_@HU^QE^UM^R[J'[9/P2^.&F7WP]T6"[D\1:W?(]I_8
MOV6+SKE+N.95>!HXR'.X8*,KJ65E8\G\&?\ @K9^R-\<O$_P]\,>%8_'EA_P
MMJYFC^&&J>(?ASJEAI_B>.*UGNGGMKJ6$1!/)MW<+(R2,&0JA# U^0G_  ;,
M?#7X4?&K_@BK^UU\(?CO\0I/"G@_Q!J\MEKGB5%+?V/#+I4:F\*CJL9VNP.%
M(0AB!DU+^P/XQ_X*/?\ !%;_ (*&_!S_ ()5_M[>%;;XC?![QCXZCC^#7B$,
MUQ%I5[(6MH]0TJX.)(%0WFRXLY?]6ER[* )-TH!M^(_CUX(_9*_X._?&%SXT
M\?7GAOX?6.@&\N=%M'N9;:2]N_"<$A6"Q@#&>XGNIBRQ11M)+-+\JLS<_K=^
MP1_P5*_8S_X*3VOB@?LM?$.\OM1\%WZ6OBC0-;T6XT[4-/9RXC=X)U5MC&.0
M!AG#(RMM88K\L='L[.\_X/?]8:[M8I3#X6CDA,D8;RW'@B !EST.">1SR:F_
MX-XI&A_X."/V][.)ML1\7^)SY:\#*^*YP./8$_G0!^Y]%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %<?\ 'C]G[X)_M0?"_4O@M^T+\+]&\8>%=70+?Z)KEDLT,A!RKC/*2*>5
MD4AU(!4@C-=A10!\EW7_  1=_8[U+X3P?LYZYXE^+.H?"RV2.*'X7WWQCUR3
M11;QD&.U*&Y\Y[92%VP-*8QL7Y>*^@?#/A7X$?LF?!.'PWX1T+P[X!\ ^#]+
M;R;2SABL=/TRU3+,V!M5!DEBQY9B22223V=% '\X?_!J[^PU^SK^U7\&/CE\
M&_VEF\4>'M?U&^T^&VMM!\9:CX<U+5M&EM[A;NU<6TL37UFQ51)#(LD:D@D*
M6!/[V_ C]C#]EW]FG]G"']D;X,_!;1=)^'4>GW%E/X7> W,%[%<!A<"Y,Y=K
MEI0S!VE+%P<$D<5Z?10!\8_LX?\ !O\ _P#!+#]E+XV#X\?!G]GNZL]4@U&/
M4-.TR_\ %>HWFF6-W&V^*>.SGG:)I(V^:-I YB8!H]A52.\^-W_!([]@7]HS
M]J'2?VT/C!\(=:U3XG: ;7^P?%D'Q)\06<NFBVD:2!;>.VOXXH55W=]J(%+2
M.2"6;/TE10!Y]^T[^RU\"/VR?@5K?[-G[2/@*'Q-X-\0P1QZGI5S<RQLQCD6
M6*1)8G62.1)$1U=6# KUZY^9]4_X-U/^"-VK?!G1O@1-^Q;I,.B:'K)U2TNK
M/7-1@U*6Y90KF>_2X%S.C* /+>1D7 VJI (^V:* /G[]K/\ X);?L*?MN_"#
MPM\#?VC/@1::OX?\#R(_@]+/4KJQN=(VHL96&XMI4E561$#J6(?8K,"RJPP_
MV@_^".'_  3H_:H^%OA/X*?'KX"WNO>%?!#S2>'=%/CW7;6&&>5F:6ZE^SWL
M9NKF1G=GN)S),YD<LY+'/T[10!\O_M+_ /!&O_@G9^V+X/\ !7@']IKX+:WX
MPTCX=Z8VG^#[+4_B;XB"V$+;=Q)CU!3-(0B*992\FU$7=M50'_&+_@CG_P $
M]_C_ /';PM^TY\8?A)XCUSQ_X)M=.M_"?BJY^*OB5+K3$L7\RU,1CU%0&63,
MA?!9Y'=W+.[,?IVB@#\,O^"KO[#?A[]J;_@M#XP\4^._VKO&W[)-MI7PUT:R
MTCXK7<=U-I?C\E \L=I<I+:PV7V?*Q2PR7+M*\:NL:X9F]#_ ."/'[+/[:O[
M,G_!2.V\.?"C_@I1XT_:._9ZG\ WEQXV\1>(+.^71[+4RP2SM;*6YN;F"XNB
MX$C/:R?+$&64#='N_8JB@ KY:^,__!&W]@WXP?'67]J73/A]KGP_^)UP9#>>
M/_A1XPO_  UJ5V7_ -89VL)8TG9R 6:1&9\?,2.*^I:* /(/@9^PW\ _@+XS
MD^*6D6_B/Q/XSDLWM!XV^(?B^_\ $.JP6SD%[>WGOYI3:0L54M%;B-'*J65B
M :\X\7?\$5?^"87C_P#:ZN_VY/'?[)FA:U\1;ZYCN[O4-4NKF>RENT4*MTU@
M\IM&FPJ_.8B=RA_OY8_4U% 'RI\$?^")O_!-']G+P!\3/AE\%_V<H]$T;XNZ
M/=:3XWM4\0ZA,;BPN$*RVT#33N;6,AND.P_*G/R)MZ'X8_\ !++]D'X6?%GP
MC\9;'0?%.NZK\.K*XM/AK;^-/'NJ:W:>$89T6.9=/AO;B582R(B;SN94150J
MH KZ*HH ^;+?_@D9^P):_ME2?\%!8/A#K2_&*:]-U+XW_P"%D^(#.S&W^S;#
M%]O\@P^0!"(?+\H1@($V@"G_ +,W_!)/]@?]CSX_:]^U%^SO\']7T'QWXI^U
M?\)-K\_Q$UZ_;5C<R^=,US%>7TL4[-+^\W.A(?Y@0>:^D** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#\U?^#K#POH-A_P20\9_&;2]/6R\7>'
M=:T)-%\36),%_:1RZG##)$D\>)!&R32 IG:2V<9 (\6_X(S_ +.G["'Q+_X(
MD?!+XU?MG> 6U_Q)\0/%USX7_MV7Q'>P:IJ5_>^*[S3+1$FBN8Y"8XRA.QMR
MQ6[, =E>\?\ !US_ ,H1OB9_V'/#O_IYM*^8O^")'_!*CX+?M-?\$I/V2/VO
M]#TW5+?XF?#SXL'Q%;7W_"2W9L[BSM?&=REY"]I)*;9/]#C=E:.-)#)$GS'<
MX8 X'_@X<_9)U7_@G7_P1A^''@+PKXZUN75= _:3U&Q\-^+9=;E?53X>OTUV
M_@LY[I2'D"JEJ&!X+0!L"OU7T7]MO]G?]B7_ ()S?"/XV?M4_%%=%T^_\!^'
M+*QW6\UY?:OJ$VGPE+:VMX5>:YG<ACM12< LV "1\._\'J__ "BW^'__ &7W
M2_\ TR:W7S?_ ,%BD\>S?M0?\$L8O$IG'@%M,\("V+Y^S?;S>Z1]LW=MWD?9
M>O;/O0!^SGP!_P""BW[,W[0GQGUO]FG1=6UOPU\3?#VFQZEJ?P[\<>'KC2=7
M^PR*K)=Q13*%N(2&7+1,^PD!PI(%<A\"?^"R/[!O[2G[1/B/]DSX.^.O%.I?
M$;PC9:A=>)?"=Q\.-:M+K3X[)UCN!(+BU0!UD=(P@)9GD55!+"OS@_X*-S>/
M'_X._P#]F)?A LYU./P)I*ZU]C!S]@,^MF^\S'\/V(R9SVQ[5S__  6:\/\
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MBD=Y10!P/Q"_9C^"?Q3^-_P__:+\<^"H;[QA\+SJG_"$ZN[L&T_^T+=;:[P
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MHB9D5F,!?:K,!NQDXS7=?&D!O@YXM5AD'PS?Y!_Z]Y*^.?\ @V=_Y0>? ?\
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M75_^A0O?^^EH V**PYO%]];R1Q3^%KI&E;;&K2*"Q]!S4G_"2ZO_ -"A>_\
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M'SI=D:*H+2R2/ODDDD;K: /@;]NC]EW]JK_@HK^P?\*_V@C\';'P9\??A?\
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M_P /??\ JWG_ ,NW_P"Y*^L_XAGQO_T"?^5*7_R9\A_Q$_@;_H+_ /*=7_Y
M^NO$O_(7T?\ Z_3_ .@FMBOB'4_^"LW]HW=G=?\ "@=GV28R;?\ A*L[^,8_
MX]>*N?\ #WW_ *MY_P#+M_\ N2C_ (AGQO\ ] G_ )4I?_)A_P 1/X&_Z"__
M "G5_P#D#[2HKXM_X>^_]6\_^7;_ /<E=I^SW_P4?_X7Q\8-'^%'_"FO[*_M
M8SC[?_PD7G^5Y=O)-]S[.F[/E[?O#&<\XQ6&*\/>,,%AIXBMAK0@G*3YZ;LD
MKMV4VW9+IJ=&$\1N#<=BJ>&H8J\YR48KDJ*[D[)7<$E=OJ['T]1117Q9]L%%
M%% !1110!CV7_([WO_7E%_,UL5CV7_([WO\ UY1?S-;% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?G7\=? G_!6__@H]
M\<O&5A^RE^V'I'[-'P5\'>*+OP[8^(-,\*1ZQXB\8:G8O]FOKIU=XQ;VL=S'
M+;1A9E9_L[,RL"F/3_V6[+]O/]CGXQ^#_P!G;]MG]K#0OCQX=\?2WUIX(\=M
MX+BT'7=,U6ULYKTV=U!!+)#=026<%TRW(*R(\.UPXF4I3_:K_8^_X*=^#?'G
MB#XD_P#!+#]K_P $^&+/Q;?OJ6O?#;XL>&6O-)@U.1 LU]8W=O&]Q:^<5$DD
M!22-IC)*-ID<'$_8?_81_:\\"?M):1^UU_P5>_;>T[XG?%#[%>Z)\,O"'A;3
MQ8^'?#0GA,MY+:Q"*)KBYD@@9#,\2,L0=6,A92@!]V4444 %%%% $=X]S':2
MR64*R3+&QBC=]H9L< GL">]?CO\ L??M.?LY_M+?\$Q?BW\=_P!K+XO^)-._
M:@\$S:_%\0U?Q5?67B/PMXA^UW$>E6FD6L4RFWB+_9;>WM[=/+EE#1.LDC2[
MOV \1:Y9^&/#]_XEU".9[?3[.6YG2WCWR,D:%V"J/O-@' [FOQC@_P""?GQ3
M_P""I7[..C?\%\?V7_'<'PW_ &HM2O[[Q-\/[/1+6W&EMI=G-/:6FBW@\O\
MTNYD@@_>7DVXM).T++Y"1I$ >_?MO_MO_MJ_ G_@FA^S3\(_%^L2>%_VC_VC
M-?\ "?@'5M8M;6-;G0+R_6)=1OUCQL2Y0,$PHVQS7&Y1B,5H_MYZUI__  1S
M^)O[._[0WP2U_P 0P^ _%_Q2LOAO\7_#^M>*;W4XM6MM1@E:WUF4WDLA%[;2
M6SNUPI$DRR-'(S KM^=/VY?VBO%/[:7[,G_!-;_@JQXR\'KHNFZ=^T%X>G\?
MV\"M]GTQ[F]B@ENQN)*6WG6#E"Q.!-$I8ELGW7_@YI\)ZO\ &GX-_LV_LO\
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M ."LL&N0Q> O[9OH9LMJGE^3%MQ_QZ9S^E?=^&G_ "6V$_[?_P#3<SX'Q/\
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MS)(8#M*Y. !6G]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\
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M4154>AT4 %%%% !7A?[6'_);/@?_ -CW+_Z3-7NE>%_M8?\ );/@?_V/<O\
MZ3-0![I7Q?\ \%?/]5\/O][5?_;.OM"OB_\ X*^?ZKX??[VJ_P#MG7W?AI_R
M6V$_[?\ _3<SX'Q/_P"2&Q?_ '#_ /3L#XKHHHK^L3^10HHHH *]G_X)[?\
M)X'@_P#WK[_T@N*\8KV?_@GM_P G@>#_ />OO_2"XKPN*/\ DF<=_P!>:O\
MZ1(][A7_ )*C _\ 7ZE_Z7$_3VBBBOXP/[:"OS&_X*(?\G@>+?\ =T__ -(+
M>OTYK\QO^"B'_)X'BW_=T_\ ](+>OUCP=_Y*>K_UYE_Z73/R/QG_ .26H_\
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M?_IV!\5T445_6)_(H4444 %>S_\ !/;_ )/ \'_[U]_Z07%>,5[/_P $]O\
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MNL8IE9"1V..*TM#T+1/#&C6OAWPUHUIIVGV,"PV5A8VZPPV\2C"HB( J*!P
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M;_@DS^SEJ_[5WBKX.W7CWXC#2M'\,6-_:RIXO83M+*[!@S^7@KQP,#%>G?\
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MF\9?"K]GGP-X9UBX#"XU7P_X2L[*YEW9W;I88U9LY.<GG-=S0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ew-20230930_g11.jpg
<TEXT>
begin 644 ew-20230930_g11.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%FP 2/AW_@]7_P"46_P__P"R^Z7_ .F36Z^;_P#@L4GCV;]J#_@EC%XE,X\
MMIGA 6Q?/V;[>;W2/MF[MN\C[+U[9]Z /V<^ /\ P46_9F_:$^,^M_LTZ+JV
MM^&OB;X>TV/4M3^'?CCP]<:3J_V&159+N**90MQ"0RY:)GV$@.%) KD/@3_P
M61_8-_:4_:)\1_LF?!WQUXIU+XC>$;+4+KQ+X3N/AQK5I=:?'9.L=P)!<6J
M.LCI&$!+,\BJH)85^<'_  4;F\>/_P '?_[,2_"!9SJ<?@325UK[&#G[ 9];
M-]YF/X?L1DSGMCVKG_\ @LUX?^+?_!+O_@X,^"G_  4?_9L^'LNN'XTVPT'4
M/#EJVQ-8UCRTTR6V;' ,D-QI\J9QNFB9NH) !^HW[)/_  6!_82_;F\:>+?A
MU^S!\0/$7B37/ MA)=^*=+;P!J]G-8*C,AC9;FVC)F+HZ"(9<LI &:N>(?\
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MY'VJ2$0$(@9MJC<V?5Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /!?VU/V[M/_9)?1?!?@O\ 9_\ 'GQ;^('B6"XN
M=#\ ?#G2EN+O[) 46:]NI9&6*SM5>2./S)&R[R*J*Y#;>)_X)V?\%;_@[^W_
M .._&GP$NOA/XS^%GQ:^'>R3Q?\ ##XAZ<MOJ-M;N5"W415B)H27C!;"D>9&
M=NV2-G^H(/"WAVU\4W7C:WT:!-6OM/M[&[U )^]EMH'FDAB)_NH]Q.P'K(U?
M%'[+WP6L?CU_P6<^+_\ P4H\+62P^$O#7PXMOA'X?U2%,1^)=2M[[[7JUXAX
M\R.VECAL!)RK203J#^ZS0![#XR_;ZCO/CUXO_9O_ &:/@1KWQ4\2_#C3;6\^
M(AT75;*QM-%DN4:2VT\3W<J+/?RQ*9%@7"*NWS98BR@]C\#/VT_V=/V@OV7(
MOVQ?!/CR*U\"KI5W?:OJ&M)]DDT46F\7L-ZC\V\MNT4JRJWW3&2"1@GX=_X-
M>M;U7XD_L_\ [1GQY\83-/XC\9_M7>*+K6+B4Y?(M[!EB/H%:63 Z -@8%?G
MQ^T=\9?'/PM_X)T?\%2O@SX%OI[70;?]KD6UFL#$+:1:EK96]A3LJ,EG'$5Z
M;9#ZT ?L3H?_  5H\#MX$\%_M%?$/X">+O"/P6^(NLVFF^$?BEKL]HL1^V/L
ML+V^LUE,]A97;;!#/(#CSHC,D ?(^M:^ _\ @M!\.O"ND?\ !O-\2OAY]DB_
MLW0_A%I$=A%M&U#9R636^.PP\49'T%?3'_!.GQ]XG^*W_!/KX%?%#QM=2SZS
MXC^#GAG5-7GG)+RW5QI5M+*[$\DEW8\\\T >R445D^.O$.J>%/"-_P"(]$\*
MW>N7=I 9(-)L643739'R(6XS]?2@#6HKPO\ X:P^-G_1C_CO_P "K;_XJNM^
M"7[0,WQK\%'QEIWPZU"Q"7\]I-:RW<4K1R1-M8%D)&<]NU 'H]%8_P#PDNK_
M /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A
M>_\ ?2T ;%%8<WB^^MY(XI_"UTC2MMC5I%!8^@YJ3_A)=7_Z%"]_[Z6@#8HK
M'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X
M275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A
M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6HYO%]];R1Q
M3^%KI&E;;&K2*"Q]!S0!N45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
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MB_X#_#?0=&F-_KWC+4+1;6SL[>#R[:PLK>U/,K2O#RQVK%'+\K$@K]JT4 ?
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M)KW2O"_^">__ "1/5O\ L>]9_P#2DT >Z4444 %%%% &/XE_Y"^C_P#7Z?\
MT$UL5C^)?^0OH_\ U^G_ -!-;% !1110 4444 %%%% !1110 5C^)?\ D+Z/
M_P!?I_\ 036Q6/XE_P"0OH__ %^G_P!!- &Q1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y/\ [<7[7?\ P0V\*_\
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M** "BBB@ KPO_@GO_P D3U;_ +'O6?\ TI->Z5X7_P $]_\ DB>K?]CWK/\
MZ4F@#W2BBOEWX^_\%)?^%'?%S6?A7_PIC^U/[(DB3[?_ ,)%Y'F[X4DSL^SO
MMQOQ]X],^U>ODV19KQ!B98? 4^>:7,U>*TNE>\FENUYGCYUG^4\.X:.(S"IR
M0D^5.TI:V;M:*;V3\CZBHKXM_P"'OO\ U;S_ .7;_P#<E'_#WW_JWG_R[?\
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M^?-;_P !A_\ +#]0:*_,3_AX;^V%_P!%?_\ +?T__P"1Z/\ AX;^V%_T5_\
M\M_3_P#Y'H_X@YQ/_P _J/\ X%/_ .5A_P 1HX6_Y\UO_ 8?_+#].Z*_,3_A
MX;^V%_T5_P#\M_3_ /Y'KZD_X)R_M _%WX\Z=XMG^*_BW^U7TR:R6Q/V"W@\
MH2"<O_J8TW9V+USC''>O(SWPVSWA_*ZF/Q%2FX0M=1<F]9**M>"6[[['L9!X
MFY#Q%FM/+\-3JJ<[V<E%+W8N3O:;>R[;GTO1117YZ?HH4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!^=?QU\"?\%;_ /@H]\<O&5A^RE^V
M'I'[-'P5\'>*+OP[8^(-,\*1ZQXB\8:G8O\ 9KZZ=7>,6]K'<QRVT8696?[.
MS,K ICT_]ENR_;S_ &.?C'X/_9V_;9_:PT+X\>'?'TM]:>"/';>"XM!UW3-5
MM;.:]-G=002R0W4$EG!=,MR"LB/#M<.)E*4_VJ_V/O\ @IWX-\>>(/B3_P $
ML/VO_!/ABS\6W[ZEKWPV^+'AEKS28-3D0+-?6-W;QO<6OG%1)) 4DC:8R2C:
M9'!Q/V'_ -A']KSP)^TEI'[77_!5[]M[3OB=\4/L5[HGPR\(>%M/%CX=\-">
M$RWDMK$(HFN+F2"!D,SQ(RQ!U8R%E* 'W91110 4444 %%%% !1110 4444
M%>%_\$]_^2)ZM_V/>L_^E)KW2O"_^">__)$]6_['O6?_ $I- 'NE?EY^WS_R
M=SXR_P"OFU_](X*_4.OR\_;Y_P"3N?&7_7S:_P#I'!7ZWX.?\E)6_P"O+_\
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M ,:;K]I']DOX7?M#WUK'!/X\^'>B>(IX(AA8GO;"&Y9 .P!D(Q[4 >BT444
M%>%_\$]_^2)ZM_V/>L_^E)KW2O"_^">__)$]6_['O6?_ $I- 'NE?EY^WS_R
M=SXR_P"OFU_](X*_4.OR\_;Y_P"3N?&7_7S:_P#I'!7ZWX.?\E)6_P"O+_\
M2X'X_P"-/_)-4/\ K\O_ $B9X]1117](G\SA1110 4444 ?;?_!(?_D$^//^
MOG3O_0;FOLFOC;_@D/\ \@GQY_U\Z=_Z#<U]DU_)GB3_ ,EKB_\ MS_TW _K
MSPR_Y(?">D__ $Y,****^&/O#\O/V^?^3N?&7_7S:_\ I'!7CU>P_M\_\G<^
M,O\ KYM?_2."O'J_M'AG_DF\%_UYI_\ I$3^(^*/^2EQO_7ZI_Z7(****]L\
M,**** "OMO\ X)#_ /()\>?]?.G?^@W-?$E?;?\ P2'_ .03X\_Z^=._]!N:
M^"\3?^2*Q7_;G_IR!^@>%W_)<87TJ?\ IN9]DT445_*!_7 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7R7^U;^S5_P2E_:N_;P\%_#G]K7PIX
M)\8?%ZR^&^H3^&_ _B:U6X>ZT62\C8W9B=2K>5+;SK'DY EN2%(!*_6E?,O[
M7G[=G_!/W]A_]I+P?J'[7VO^$?!?B'Q)X.U)?#'C_7=.'VDVUM<VOGZ<ERL+
M/&C-<QR["ZJQ4G:2,@ ^6OBI;?\ !J#\$/B/K7PB^+7P_P#V;- \2^'=0DL=
M;T;4/!\*36=Q&</&X\CJ#Z<>E=+^Q7XK_P"#>_7OVS?!,'_!-NP^'"_% 6FJ
M&-_A?I/V7;IHLY/M'VS$:HT6XP[1_K/,V%?D$@*2_P#!0+_@VBO_ (E>+/C!
MXC^-_P !M;\2^-M5BU#Q!K.O:#!>W$TL=G;6:*LDULS+&(K6([ =N\N^-SL3
MUW[.7[7'_!%/XW?M?> /!_["Q^%VN?$<)JEPFH?#[P_%8SZ?IB6$PN#-+%;*
M)(G=H$$!<99ED&?*((!]VT444 <E\?=5TS0O@7XSUG6M0@M+2U\*:A+<W-S*
M$CB06TA+,QX  [FOCC_@V/U73-3_ ."'_P #XM.U&"=K2SUJ&Z6&4,89!KFH
M$HP'W6P0<'G!![U]P>,/ _@KXA:,?#OC[P?I>N:>9%D-CK&GQW,)=?NMLD4K
MD9.#CBJ?@;X2_"KX8-=-\-/AGX?\.F]""].A:-!:?:-F[9O\I%W[=S8SG&XX
MZF@#\^?^"+&AZ#_P3J\<_M5_L,?'3Q'I_AK_ (1OXP:C\1_"^H:Y>I:PZAX0
MU2WA$%]')(0KQPFS>.=P2(I258CC/S%X2_X)C_&+]MC_ ((_?MH_&70_"%]!
MXI_:7^,>I_$GX6Z)=6[17-YI%EJ7VS34\MP&5[J,72Q!@ 4GA?.&S7[._$/X
M*_!OXNRZ?/\ %CX2^&?$[Z1<>?I+^(M!M[TV4O'[R(S(WEMP.5P>!Z5TP  P
M!@#H!0!^87_!1S]I_1OVP?\ @@IHG@+X#W4.N_$;X_Z!X?\ "7A+P9:S*;Z3
M69+BU&I6LD7WHC9I%>&X9@%A\AMY4<U^@O[,?P9L_P!G']FWX>_L]:?>BYM_
M ?@?2?#L%RJX$J65G%;!\'ID19_&M'0O@I\&O"_C[4/BMX:^$GAC3O%&KILU
M7Q)8Z#;PW]ZN0<2W"())!D#AF/2NGH *R?'7@[2_B#X1O_!>MW%W#::C 89Y
M+&Y:&95)!RCKRIXZBM:B@#PO_AWO\$_^AM\=_P#A97/^-8G_  3Q\!:-!\#=
M2MTNKXK%XTU6)2;QB2$FV#)[G"C)[G)KZ/KPO_@GO_R1/5O^Q[UG_P!*30!Z
MY_P@^D?\_-[_ .!;5^9W[==E%I_[5WB^S@9RB7%M@R/N/_'I">2:_4FOR\_;
MY_Y.Y\9?]?-K_P"D<%?K?@Y_R4E;_KR__2X'X_XT_P#)-4/^OR_](F>/4445
M_2)_,X4444 %%%% 'V=_P2=T*SUG2O'+74LZ^7<:?M\F8KU6XZXZ]*^OO^$'
MTC_GYO?_  +:OD[_ ()#_P#()\>?]?.G?^@W-?9-?R9XD_\ ):XO_MS_ --P
M/Z\\,O\ DA\)Z3_].3,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**^&/O#
M\MOVZ[*+3_VKO%]G SE$N+;!D?<?^/2$\DUY)7L/[?/_ "=SXR_Z^;7_ -(X
M*\>K^T>&?^2;P7_7FG_Z1$_B/BC_ )*7&_\ 7ZI_Z7(****]L\,**** "OL[
M_@D[H5GK.E>.6NI9U\NXT_;Y,Q7JMQUQUZ5\8U]M_P#!(?\ Y!/CS_KYT[_T
M&YKX+Q-_Y(K%?]N?^G('Z!X7?\EQA?2I_P"FYGUC_P (/I'_ #\WO_@6U:&F
MZ=!I5J+2W>1E#$YE<L>?<U8HK^4#^N HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O!/V[?^"9G[&?_  4@\,:5X?\ VK?A%:ZY=>'GED\,Z[$W
MEWND22%"YB?!1T8QQEH94DA?8-\;8KWNOB__ (*_?\%J?@O_ ,$C]"\)Z7XP
M^%VO>-/&7Q ^UKX,\/:9<P6=K*UNT*R-=WLQVVT8-Q&-P20\D[0 6 !Y</\
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MJ'7Y>?M\_P#)W/C+_KYM?_2."OUOP<_Y*2M_UY?_ *7 _'_&G_DFJ'_7Y?\
MI$SQZBBBOZ1/YG"BBB@ HHHH ^V_^"0__()\>?\ 7SIW_H-S7V37QM_P2'_Y
M!/CS_KYT[_T&YK[)K^3/$G_DM<7_ -N?^FX']>>&7_)#X3TG_P"G)A1117PQ
M]X?EY^WS_P G<^,O^OFU_P#2."O'J]A_;Y_Y.Y\9?]?-K_Z1P5X]7]H\,_\
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MX\_Z^=._]!N:^R:^-O\ @D/_ ,@GQY_U\Z=_Z#<U]DU_)GB3_P EKB_^W/\
MTW _KSPR_P"2'PGI/_TY,****^&/O#\O/V^?^3N?&7_7S:_^D<%>/5[#^WS_
M ,G<^,O^OFU_](X*\>K^T>&?^2;P7_7FG_Z1$_B/BC_DI<;_ -?JG_I<@HHH
MKVSPPHHHH *^V_\ @D/_ ,@GQY_U\Z=_Z#<U\25]M_\ !(?_ )!/CS_KYT[_
M -!N:^"\3?\ DBL5_P!N?^G('Z!X7?\ )<87TJ?^FYGV31117\H']<!1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>IQVL'FMG9$I<C?(V#M1<LV#@&LC]F;]L;]EC]LSPG=>-_V5_CYX7\>:987
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M-]2ATV^NK=T1]I25]JRCS ICW9+!E&2IQTO_  R?^RS_ -&U?#__ ,(VQ_\
MC5:7Q2^ 7P)^.,%E:_&OX*^$O&$6FNS:='XI\.6NH+:LP 8QB>-PA( R5QG
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7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ew-20230930_g12.jpg
<TEXT>
begin 644 ew-20230930_g12.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)"^!/CS/^T%X8_94AM]0N+S[4_A__A(+YM$\W>'YT\S>0\>\9$#*T(P,1@
M>E_M#?\ !(W]@3]JK]HW0OVM_CO\']9UKXB>%VLV\->)(?B/X@LGTDVLQGMS
M:Q6M]'%!LF)D&Q%RY+'))-?25% 'S7\4?^"17[ 7QH_:HT?]MGXE_"'6]2^*
M7A^2T?0_%W_"RO$,,MA]F),*Q1Q7ZPHBEF)0)M8NY8'>V7^ /^"2'[ OPO\
MVNK_ /;P\#_"#6;/XLZK=3SZGXP?XC:_-)=F8!9$EAEOF@DB*A0(FC,:A% 4
M!5Q](T4 ?SI7G_!-;P;\>?VQ/VB/BW\0/^"EGCG]BG5M=^,VKW)^&OB=;I9=
M7B:7S?[7CO6N[&&ZAN)9IGB2(3")"%\V0$,?T#_X-]_A#^W/\$_$GQN\!?''
M]JCQA\9?@UI^K:3%\'?B#XYT^]M;C5Y3!(^HR6<5])).MHK/#%NWO!))$SPL
M09"?TJHH CO+.TU"TEL+^UCG@GC:.:&9 R2(PP58'@@@D$'K7R/IG_!$#]@[
MP!\2=6^*O[..E>._@UJFOR!]?@^#OQ*U7P]8ZB020)+.VG%NH&3A4C4+G( /
M-?7E% 'G7[/_ .RE\#/V9+'4XOA1X3N$U#7IDF\1^)-=UBZU;6-:D0$(]YJ%
M[++<W.T,P422%4#$(%!Q7SKX)_X-ZO\ @CI\/[KQG>:!^Q%X>9_'5E=6>L_;
M]0O;D6UO<9\V.R$L[?V?U.&MO+=0<*P4 #[/HH ^7/"/_!&?_@G9X$_9CTW]
MC_PE\#KNP\":5XIB\26MC:^+]4CO!JD7F&*Y%\MR+I&C>1I$"2J$?YE YSVO
MP)_X)\?LX?L__$GQ/\;?#5EXEUKQWXPT>+2-<\=^+O&-_JFL-IL0'EV<5U/*
MSV\*D!L1%"SJKL6958>W44 ?*OP7_P""*7_!-W]GB\\>:C\%_@GK^@7/Q.TB
MXTSQ[<6OQ5\3-)K-O.S/*)6?46(<L[GS5(D'F/AAO;/;_L1?\$VOV,_^"<OA
M_6O"?[&GPIO/!VE>(+Q;O5M,;QAJVHV\UPJ!!,([^ZF6.0JJJ60*6"J"2%&/
M<Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\U?^#K#POH-A_P
M20\9_&;2]/6R\7>'=:T)-%\36),%_:1RZG##)$D\>)!&R32 IG:2V<9 (\6_
MX(S_ +.G["'Q+_X(D?!+XU?MG> 6U_Q)\0/%USX7_MV7Q'>P:IJ5_>^*[S3+
M1$FBN8Y"8XRA.QMRQ6[, =E>\?\ !US_ ,H1OB9_V'/#O_IYM*^8O^")'_!*
MCX+?M-?\$I/V2/VO]#TW5+?XF?#SXL'Q%;7W_"2W9L[BSM?&=REY"]I)*;9/
M]#C=E:.-)#)$GS'<X8 X'_@X<_9)U7_@G7_P1A^''@+PKXZUN75= _:3U&Q\
M-^+9=;E?53X>OTUV_@LY[I2'D"JEJ&!X+0!L"OU7T7]MO]G?]B7_ ()S?"/X
MV?M4_%%=%T^_\!^'+*QW6\UY?:OJ$VGPE+:VMX5>:YG<ACM12< LV "1\._\
M'J__ "BW^'__ &7W2_\ TR:W7S?_ ,%BD\>S?M0?\$L8O$IG'@%M,\("V+Y^
MS?;S>Z1]LW=MWD?9>O;/O0!^SGP!_P""BW[,W[0GQGUO]FG1=6UOPU\3?#VF
MQZEJ?P[\<>'KC2=7^PR*K)=Q13*%N(2&7+1,^PD!PI(%<A\"?^"R/[!O[2G[
M1/B/]DSX.^.O%.I?$;PC9:A=>)?"=Q\.-:M+K3X[)UCN!(+BU0!UD=(P@)9G
MD55!+"OS@_X*-S>/'_X._P#]F)?A LYU./P)I*ZU]C!S]@,^MF^\S'\/V(R9
MSVQ[5S__  6:\/\ Q;_X)=_\'!GP4_X*/_LV?#V77#\:;8:#J'ARU;8FL:QY
M::9+;-C@&2&XT^5,XW31,W4$@ _4;]DG_@L#^PE^W-XT\6_#K]F#X@>(O$FN
M>!;"2[\4Z6W@#5[.:P5&9#&RW-M&3,71T$0RY92 ,U<\0_\ !5W]C?P[\"_
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MP\D_9:_Z'*?_ ,%5W_\ &:/]5N)_^@&M_P""I_\ R(?ZU\+?]!]'_P &P_\
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M]ZS_ .E)KW2@#\D/VD=/L-)_:"\;:7I5C#;6UOXIOX[>WMX@D<2"=P%51PH
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M7Q#^ GB[PC\%OB+K-IIOA'XI:[/:+$?MC[+"]OK-93/865VVP0SR X\Z(S)
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M?\$\_&OA2;X':G/%KD#))XVU:2-@3\R//O4_0JP/XU[O_P )CX8_Z#4'_?5
M'Y4?M0_\G(>//^QNU#_TH>N$KN/VFIX;G]HKQS<6\@=)/%E^R,.A!N'P:X>O
M[<RC_D4X?_!#_P!)1_#&<?\ (VQ'^.?_ *4PHHHKT#S@HHHH Z_]G[_DO7@C
M_L;]-_\ 2J.OUUK\A_@)+';_ !T\%SS.%1/%FG,['L!=1Y-?K-_PF/AC_H-0
M?]]5_/GC/_R,<)_@E^:/Z*\$O^1;B_\ ''_TEFE16;_PF/AC_H-0?]]4?\)C
MX8_Z#4'_ 'U7XL?MQ\]?\%5O^3;]._[&ZV_])[FOSRK] ?\ @J-K^C:I^SKI
M]OI^HQRN/%ELQ5#SC[/<\_K7Y_5_4/A-_P DBO\ '/\ 0_E;Q=_Y+"7^"'ZA
M1117Z6?F 4444 %?H#_P2<_Y(+KW_8WR_P#I+;5^?U?>O_!*S7M'TKX%Z[!J
M.H1PNWBR5@KGJ/LMOS^E?F_BM_R1\_\ '#\S],\)/^2RA_@G^1]7T5F_\)CX
M8_Z#4'_?57+&_L]2@%U8W"RQDD!UZ9K^6S^K":BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /SK^.O@3_@K?_P4>^.7C*P_92_;#TC]FCX*
M^#O%%WX=L?$&F>%(]8\1>,-3L7^S7UTZN\8M[6.YCEMHPLRL_P!G9F5@4QZ?
M^RW9?MY_L<_&/P?^SM^VS^UAH7QX\.^/I;ZT\$>.V\%Q:#KNF:K:V<UZ;.Z@
M@EDANH)+."Z9;D%9$>':X<3*4I_M5_L??\%._!OCSQ!\2?\ @EA^U_X)\,6?
MBV_?4M>^&WQ8\,M>:3!J<B!9KZQN[>-[BU\XJ))("DD;3&24;3(X.)^P_P#L
M(_M>>!/VDM(_:Z_X*O?MO:=\3OBA]BO=$^&7A#PMIXL?#OAH3PF6\EM8A%$U
MQ<R00,AF>)&6(.K&0LI0 ^[**** /G7]H+_@DE_P3<_:K^*=_P#&W]HG]C_P
MCXM\6:G%!'J&NZM;2-/.D,2Q1!BK@?+&BJ..@%>.?\%%OCC^TK^S;X<\$_L:
M_L/?L ?%/Q1X&M]$MK+Q+K_PT,%H=(T2"+R8=)TV>:4&*X=(UC:X W6\)S$?
M.99(/NVB@#XJ_8>_;&_:M^)GQ+\)_LYZ;_P2-\7_  '^&^@Z-,;_ %[QEJ%H
MMK9V=O!Y=M865O:GF5I7AY8[5BCE^5B05YC]DKX1^/O^"2_QW_:"\")\$/&O
MC#X6_%3X@3_$;X9WG@#P\^J26^J7L21ZAHES%$<V962& P3S;;9HC\\R,C"O
MORB@#\U?@]_P1,\2_$3_ ()8?'W]GC]I:ZL-(^*7[3WC+6/'OBV6WG%U!X>U
MJYNTO-/M?-3B>.VEAA,A3AF><(S*58I^TAX-_;#_ &]?^"97AS_@E]JG[/\
MXN\'_$GQ%9:#X<^+_B[6-**:%H%A87%L]_J=M?$^1J0N5M2+>"W:23_21YPA
MV.1^E=% &-\.? /AGX5?#W0?A?X*L?LNC>&]&M=*TBVW9\FUMXEAB3/?"(H_
M"MFBB@"*^L+'5+233]3LHKBWE7;+!/&'1QZ%3P16/_PJ[X9_]$[T+_P40_\
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M?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ*_%C]N/F3_@JC:6L'[..GO!;1H?\
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MAOXMR:=9Z6C6ENDT:QQORTETES.3G $RJ%&S)V/V6/\ @E!_P3S_ &*_VS/
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M+&@#])J*\Z_8_P#C3=?M(_LE_"[]H>^M8X)_'GP[T3Q%/!$,+$][80W+(!V
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M*\+_ .">_P#R1/5O^Q[UG_TI->Z4 ?DM^U#_ ,G(>//^QNU#_P!*'KA*[O\
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M_P#2DU[I0!^2?[3%NEI^T1XXM8RQ6/Q7?JI9LG G?J>]</7=_M0_\G(>//\
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M ,(/I'_/S>_^!;5H:;IT&E6HM+=Y&4,3F5RQY]S5BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O(/V@OVME^"GQ:\$? GPC\#/&'Q"\6>.;
M;4+VVTOPD;!%TO3K(VZW%_>37MS;QPPB2Z@C7YF=WD"HK'BO7Z^)/^"D/P4^
M*?P_^-NC_ML_"#]GWXF?%N%?"UUX=\8^"?AW\9M7\.ZI;(98)K2^LH[>]ABF
MC#1S1SVZ;6<S13 ,8WR >E?\%'O^"FOP<_X)K? W2?B9\4?#&KZ]XJ\6:C%I
M/@+X:>'@DVK^(M4DV@6L*KN&$+J'E&X+N4*'>2-'Q/V*/^"C'Q?^//Q&A^!W
M[7_["'C']G[QOJVC3:OX2T[Q!K=MJUAK]G"8Q.L%[;*BK=1"6-I+61%D5'W#
M<%?;\@?\$]O^"3OQY_:]_:JU;_@I+_P5$\$>.O!::2#8_ 3X17_QCUV^U/PA
M;$CS+^;4OMQNDG?D!/-7+22L8HP(57Z#\1_L\Z%\2?\ @H#\-/A]X ^''[0,
M/ACX<7.K^(_%?Q#\5?$WQ>FERW2V4NG6VFV,E[J),[R/>O,\D2B-XK8J'DCE
MD6@#[HHHHH *YCXM_&GX3? ;PF/'/QE^(6E>&]*>\BM(+O5KM8A<7,IQ%;Q*
M?FFF<C"1(&=SPJDUT]?GE_P7 UKX\?LP?&#]GO\ X*B>!OAA>_$#X?? '5O$
M$GQ3\&Z85:[M].U.RBM3K,",0K/:(LQ+'[HEY*1M+(H!]K?"']I'X&_'FZU7
M3/A/\2=/U;4-">)=<T<%X+_3?,!:(W%K,J30AP"49T <*2I.#6=\;/VP/V8O
MV<M9M?#GQN^-V@>'=1O+"2_BTZ^N\W"V4;;9+QXT!:*V1CAKAPL2GAF%?)O[
M%'C_ ,*?\%,O^"@]O_P55_9N\11Q?"+PS\)+CP!IMZTJQ:AXHU*>^BO;@7%J
M"9+:WL]H1%N DCRRO(B^44DEY3_@WO\ 'U_^UQK7[5O[>7C\"\UKQQ^T)J'A
MK3Y;@;S;>'M)M+<:?9+G[L<:7<@*C 9MS$98F@#]&M"UW0_%.B6?B;PSK-IJ
M.FZC:QW.GZA87"S07,+J&26.1"5=&4@A@2"""*\W\(?MN_LC>/OB</@WX+_:
M'\+:EXCDO;BRM=/M-41A=W=N";BV@E_U=Q/$%;S(8V:2/8V]5VG'XQS?MX_%
M#]BK_@DE^W[^S7\-/$MU:2_!/X^:GX'^%EY#,5DT71-8U9H(X(6!S&8(A>O&
MPY1G4+@*,?9/_!43]GC0O@1_P;JCPK\,$&@:O\%/ GA?Q!X(UC3@([C2M6TR
M:SE%Y$X'RS/^_#/U;SY"<EC0!^DU%>=?L?\ QINOVD?V2_A=^T/?6L<$_CSX
M=Z)XBG@B&%B>]L(;ED [ &0C'M7HM !1110!X7_P3W_Y(GJW_8]ZS_Z4FO=*
M\+_X)[_\D3U;_L>]9_\ 2DU[I0!^2W[4/_)R'CS_ +&[4/\ TH>N$K]2O%'[
M#'[+'C3Q)?\ B[Q+\+OM.HZG>275]<?VW?)YLKL69MJ3A5R23@ #T%4/^'>7
M['O_ $2#_P N#4/_ )(K^B<#XN<-X7!4J,Z56\8Q3M&%KI)?\_#^;\?X/<38
MK'5:T*U&TI2:O*=[-MZ_NS\Q**_3O_AWE^Q[_P!$@_\ +@U#_P"2*S;7]@+]
MDB3Q3=::_P )LPQVR.B?V]?\$DY.?/S77_Q&/AC_ )\UO_ 8?_+#D_X@OQ3_
M ,_J/_@4_P#Y6?FM17Z=_P##O+]CW_HD'_EP:A_\D4?\.\OV/?\ HD'_ )<&
MH?\ R11_Q&/AC_GS6_\  8?_ "P/^(+\4_\ /ZC_ .!3_P#E9^>?[/W_ "7K
MP1_V-^F_^E4=?KK7D7A_]A#]E+PMKUCXGT'X5^1?:;>175E/_;E\WERQN'1M
MK3D'# '!!![BO7:_+?$'BS+N*\70JX2$XJ$6GSI+=WTM*1^K>'?".9<)82O2
MQDX2<Y)KD;>RMK>,0HHHK\]/T4**** "LWQC_P BQ>_]<#6E6;XQ_P"18O?^
MN!H N:=_R#X/^N*_R%35#IW_ "#X/^N*_P A4U !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\C_ +5O_!.C
M]JK]H/XWZI\5/A?_ ,%8OBY\+-%OX+9+;P5X4T^QDL;)HX4C=T:92Y,C*9&R
M?O.<<5YG^VR?&OP^_:^_8H_9R_:.^(5[K?P8DDU"W\;>*?$.R.V\5>,;'3(_
M[%356&(PTMPDMU%"V(Y;I%X8Q(!^@E9OB[P=X1^('AR[\'>//"NFZWI%_'Y=
M]I6KV,=S;7"9SMDBD!5QD X(/2@#\Y/A5^QQX;_8J_X+ZZ=)^PA*-)\"_%/X
M9ZQK'[0'PYTAA_96@W4#Q#3-0$*_):R74\LBQ1@ [8;PH-C.%G_X(L:'H/\
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M6>G16*QL)(FA8DN3T(.: .&_X=U? _\ Z&[QW_X5\]'_  [J^!__ $-WCO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>._M0_\ !03]B;]BJ[TS3?VK/VGO!_@6\UE#)I>GZ]JZ1W-S&"5,JPC,AC#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
(B@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ew-20230930_g2.jpg
<TEXT>
begin 644 ew-20230930_g2.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
MF@*J P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9^!])\/:;+\%_"=PVG:)IT5K;B5A$&<1Q*J@MM!) Y/)YH _2VBBB@ HK/\
M%?BOPYX&\.7?BWQ;J\-AIMA"9;R\G.$B3IN..W-><?\ #<_[(_\ T7K0?^_S
M_P#Q- 'J]%<OX-^-'PL^(6AIXE\%>-[+4;!Y&1+JW<E2RG!'([&M;_A,?#'_
M $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J
M#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ
M*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@
M_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*B
MLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_
M $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J
M#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ
M*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@
M_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*B
MLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_
M $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J
M#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ
M*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@
M_P"^JN6-_9ZE +JQN%EC)(#KTS0!-1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?"W_!0C_@KU^QY\)?B[)^PIJ?[9WAGX<>
M(KJQ$OQ \8SZB//\+:>X ^SVH57SJLZDB(,-MLA-Q)DB"&X]/_X)^_ML?\$Z
MOC9IW_#,O_!/#QUIGB'PY\-O#%L;Q_"]G-_9FB0.YCMH)+B4+OGF\NXDX+LW
MD2O(P9E+^R:W^S5^SGXEU>Y\0>(_@#X)U"_O)FFO+V]\*V<LT\C'+.[M&69B
M>22<FMCP/\+?AC\,8KFW^&OPYT'P]'>,K7::'I$-H)RN0I<1*NXC)QGID^M
M'(?LF_MC_LT_MS_"EOC?^RE\5+7QAX675KG3&U:TL[BW5;N @2QE+B.-QC<I
M!V[65E9258$_%?[+'BKPS=?\',G[3^BVWB&RDN_^%)>%8Q;)=(9"\8A,B[0<
MY42(6';<,]:_0GP+\._A_P#"_0?^$5^&?@71O#NE_:9;C^S="TR*TM_.E<O)
M)Y<2JNYW)9FQEB23DFL+1OV;?V=?#NLV_B/P_P# /P58ZA:3B:UO[/PM:130
MR Y#HZQAE8'D$'- ':T444 17UA8ZI:2:?J=E%<6\J[98)XPZ./0J>"*Q_\
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M_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\
MY\8?^_0H_L[3_P#GQA_[]"IJ* ,CQ99VD/AN\EAM8T982594 (JY86%BUC"S
M641)B4DF,<\5!XQ_Y%B]_P"N!JYIW_(/@_ZXK_(4 ']G:?\ \^,/_?H4?V=I
M_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\
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M_P!H7X?_ !A_9W\/?M.^#+;6I?#7B;PQ:Z]ID(T.>6_-K<0K+&IM(5>4R[6
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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MQ+%X[L](MH[^U\166CBXDOC=A1+O6[A=7^?F,/&?EXH ^A_^"C?QSO\ PO\
MMC?LG?\ !+OX?:O=^#/"7QCUS6I_&-[X7NWTVX_L?1M/^TQZ3;SP%'MDNIBD
M<C0LD@C38K#S#7(_M%^+[W_@E?\ \%1?V<=$^#.NZK!\)?VC=4O_  9XS^']
M[K-Q=V.GZW&(#IVJV*3N_P!EED><13+&5CD1 S*9,..6^%/[%?Q4_P""I/\
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MGI,E[X>N9I;6[6WMXXA.%FC1XBQ4DQ9?;_?;/'H%% 'RAX7_ &'?VE?VC?\
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M//@GHO[/?PT\6>(M1\+^&K**Q\.6GB.^BN9-.M(UVI;I*L2.Z*.GF%R!@ @
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MK--=7$C<O/,[R.>68UVM% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOO\ U;S_ .7;_P#<E'_#WW_JWG_R[?\ [DKXMHK^K_\ B&?!'_0)_P"5*O\
M\F?R/_Q$_CG_ *"__*=+_P"0/M+_ (>^_P#5O/\ Y=O_ -R4?\/??^K>?_+M
M_P#N2OBVBC_B&?!'_0)_Y4J__)A_Q$_CG_H+_P#*=+_Y ^QH/^"LWDZW/K/_
M  H'/G0K'Y?_  E73'?/V6KG_#WW_JWG_P NW_[DKXMHH_XAGP1_T"?^5*O_
M ,F'_$3^.?\ H+_\ITO_ ) ^TO\ A[[_ -6\_P#EV_\ W)1_P]]_ZMY_\NW_
M .Y*^+:*/^(9\$?] G_E2K_\F'_$3^.?^@O_ ,ITO_D#[7L/^"N?VV^ALO\
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MG_TI->Z4 %%%% !1110 5C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A4
M;%%%% !1110 4444 %%%% !1110 4444 9OC'_D6+W_K@:N:=_R#X/\ KBO\
MA5/QC_R+%[_UP-7-._Y!\'_7%?Y"@":BBB@ HHHH **** "BBB@#\NOV]?\
MD[?QE_U]VW_I)#7D%>O_ +>O_)V_C+_K[MO_ $DAKR"O[2X:_P"2<P?_ %ZI
M_P#I"/XCXG_Y*7&_]?JG_I<@HHHKVCPPHHHH **** "OU&_8*_Y-(\&_]>ES
M_P"E<U?ES7ZC?L%?\FD>#?\ KTN?_2N:OR3QD_Y)RA_U]7_I$S]@\%O^2EK_
M /7E_P#I<#UZBBBOYN/Z8"JNN_\ (#O/^O23_P!!-6JJZ[_R [S_ *])/_03
M5T_XB]2*G\-^A^,M%%%?W2?P4%%%% !1110 4444 6]"_P"0Y9_]?<?_ *$*
M_9FOQFT+_D.6?_7W'_Z$*_9FOP;QJ_B8'TJ?^V'[_P""'\+'^M/_ -R!1117
MX8?O(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% 'Q?\ \'#X#?\ !%O]H $9_P"*0A_]+K:OH[]D;_DU'X8_]D\T7_TAAKY_
M_P""[_@[XD?%_P#X)@?%']GSX+_"OQ+XQ\8^.-$CL/#^C>'-&EN"[K>6SNTL
MH B@54#-F1U+;2%#$$#W+]C'5M2O?V4_ -AK?@W7="U32/!^FZ=JVB^(=(EL
M[JUNX+.))8RLH <!@0)$+1MCAC@T =9\8_"/C#Q_\)_$O@7X??$*3PEKFLZ'
M=6.E>*8+$7,FD3RQ,B7:1%T#O&6#J"P&Y1GCBORDL?%'_!4+_@WCF\ 6'[17
MQTT?X_\ [)!U/3O"M_KL?A:/2=;^'\4K+;VT[)$7\RW4E5R\DP<C9^Y=TW_;
M'P\_;I_:[\:_L%^)OVK-8_X)C>-M$^(6AZK=6^G? ^^\20+JFKVT-U'%]IBN
M&A51NA:254\LES"5C,@>-WXOXN:O\0O^"O/[/5M^S/JG[&WQ+^&/@WQ/JVE7
M/Q,U3XM:3;:9/:V%G?6]]+865LL\DUS<SO;K")BBP11O)+YC.B0N ?;=%%%
M&?XK\5^'/ WAR[\6^+=7AL--L(3+>7DYPD2=-QQVYKSC_AN?]D?_ *+UH/\
MW^?_ .)KU*^L+'5+233]3LHKBWE7;+!/&'1QZ%3P16/_ ,*N^&?_ $3O0O\
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M^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\
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M4 %%%% !1110 4444 %%%% !1110!X7_ ,$]_P#DB>K?]CWK/_I2:]TKPO\
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M ))RA_U]7_I$S]@\%O\ DI:__7E_^EP/7J***_FX_I@*JZ[_ ,@.\_Z])/\
MT$U:JKKO_(#O/^O23_T$U=/^(O4BI_#?H?C+1117]TG\%!1110 4444 %%%%
M %O0O^0Y9_\ 7W'_ .A"OV9K\9M"_P"0Y9_]?<?_ *$*_9FOP;QJ_B8'TJ?^
MV'[_ ."'\+'^M/\ ]R!1117X8?O(4444 %%%% !1110 4444 %%%% !1110
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MI(!^Q5%%% !1110!X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\D3U;_L>]9_\
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M7/\ Z5S5^7-?J-^P5_R:1X-_Z]+G_P!*YJ_)/&3_ ))RA_U]7_I$S]@\%O\
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M^HW[!7_)I'@W_KTN?_2N:OR3QD_Y)RA_U]7_ *1,_8/!;_DI:_\ UY?_ *7
M]&^Q>-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_QK8HK^;C^F#'^Q>-_P#H-V7_ (#'
M_&JNN67C;^Q;S=K5GC[+)G_1C_=/O7155UW_ ) =Y_UZ2?\ H)JZ?\1>I%3^
M&_0_&6BBBO[I/X*"BBB@ HHHH **** +6AY_MJSVGG[5'C_OH5^P7V+QO_T&
M[+_P&/\ C7X_:%_R'+/_ *^X_P#T(5^S-?@WC5_$P/I4_P#;#]_\$/X6/]:?
M_N0Q_L7C?_H-V7_@,?\ &M#38]1BM0FJ7$<LNXY>)-HQVXJQ17X8?O(4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7R[_P4E_X))_LI_P#!4ZZ^
M'$?[4>B7E[8_#W6[Z[CMK"^EMI+RVN[1HI;8RQ,KQJ9X[.8LIY^R[>CDCZBH
MH _)J'_@WO\ ^#=:Y_:)O?V4;+X,>,KGQWINFP:AJ>D6NM^*)8;*TG5VAFFN
MTS;0H^QPK/* 60H/F&*\R_80_9F_X-PKW]O?PU;_ + UKX[TCQWX"^("1^'?
M']R=8O/#&LZC;*[W&E0WES(UO)+) )MA)0L55XC*,*_V9_P4+_9P_P""FOB#
M3_BM\./V [?X<K9?'I+:+7?'7BOQ'=6.I^#,:=;Z9<^1#%;R"ZB:VMU>)ED2
M2&::=MC[E(L>"?V$/BE^RY\$/@)_P3Z_9;^$6BR?"[P-XKT#6/B)\0=4UN*W
MOKV73[V/4Y)K:S56+S7%_#&\CO(H2(R1HK@J5 /MZBBB@ HHHH **** "BBB
M@ HHHH \+_X)[_\ )$]6_P"Q[UG_ -*37NE>%_\ !/?_ )(GJW_8]ZS_ .E)
MKW2@ HHHH **** "L?P/_P @B7_K]F_]"K8K'\#_ /((E_Z_9O\ T*@#8HHH
MH **** "BBB@ HHHH **** "BBB@#-\8_P#(L7O_ %P-7-._Y!\'_7%?Y"J?
MC'_D6+W_ *X&KFG?\@^#_KBO\A0!-1110 4444 %%%% !1110!^77[>O_)V_
MC+_K[MO_ $DAKR"O7_V]?^3M_&7_ %]VW_I)#7D%?VEPU_R3F#_Z]4__ $A'
M\1\3_P#)2XW_ *_5/_2Y!1117M'AA1110 4444 %?J-^P5_R:1X-_P"O2Y_]
M*YJ_+FOU&_8*_P"32/!O_7I<_P#I7-7Y)XR?\DY0_P"OJ_\ 2)G[!X+?\E+7
M_P"O+_\ 2X'KU%%%?S<?TP%5==_Y =Y_UZ2?^@FK55==_P"0'>?]>DG_ *":
MNG_$7J14_AOT/QEHHHK^Z3^"@HHHH **** "BBB@"WH7_(<L_P#K[C_]"%?L
MS7XS:%_R'+/_ *^X_P#T(5^S-?@WC5_$P/I4_P#;#]_\$/X6/]:?_N0****_
M##]Y"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /)/!W[:O
MP4\>?MD>,?V%_#;:W+XX\">%;#7_ !&[:-(NGP6]XP$,8N3\K3$%6V=U+8)*
M2!/6F=$&78 9 R3W)P*_.7]O/]E[_@H!J7_!1!OCA\#O^"M7A']G+POXD\*:
M+X?\+1:YX$T&_N?$.KO<74;Z4JW7E27WEDQ30B9IF234YD@5-S@Q^!?V-?\
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MT+0K/7_B#??&*U@E\+^'(K@$VRR13%!),T;!P1(K8;"+(0^S=_X)Z:U^TO\
ML->+]+^$7[6G_!+?X)_![0O'FK0Z;8_$C]G&.WBT?^U9"5M;35+0J+F+SG_=
M17):2/S9(XCL,BF@#]$**** /$?CY^VSX<^%'QU\-_LG?#?X?ZEX^^*GBG1+
MC7+3PCI%Y!;)INCP2"*34[^YG8+:VQE984(#R2RMM1&P[+J?LI_MA?#[]JNV
M\5Z)H^B:EX<\8?#[Q$^@_$'P/KWE?;]"OPHD0,8G>.:":)EEAN(V9)8VR"&#
MHOQ%_P $Y-;U7XF?\'$O[<WC3Q5*SW'A/P[X0\-Z%%(<_9K!K7S&1,]%>2 2
MD="TA-/_ &<_$6H>%O\ @ZH_:#^'VA2-'I?BS]FW1-=U^&,X66_LI]-M+>1Q
MT++!<2*"><,?>@#]#_C'\8/AM^S_ /"KQ!\;?C#XLMM"\+^%M)FU+7=7O"?+
MMK:)2SM@ EC@8"J"S,0J@D@5\Y>*/^"J-A\(M!\$?%[]I7]F#QC\._A=\0M4
ML]/T7Q_K=_8RC2)KS'V)M8M(9FDTV*?( D)D6)G59_))('._\'#7[.OQL_:F
M_P""0WQ;^$/[/FB7NK>)9;33M1AT+3D+3ZG;V>HVUW/;QJO,CF*%V6-06=D5
M "6%?)?_  5J_P""L'[$'[97_!O]\0CX7^(-K>>*M<\+:);:KX$CL)WO_#NL
M+J-DS6]]$L9^Q>5/&P62;8DAC C9BR@@'[$45YM^QG;^.;3]C_X4VOQ.,_\
MPDL?PVT)/$/VK/F_;AI\ GWYYW>9OSGO7I- !16?XK\5^'/ WAR[\6^+=7AL
M--L(3+>7DYPD2=-QQVYKSC_AN?\ 9'_Z+UH/_?Y__B: ,+_@GO\ \D3U;_L>
M]9_]*37NE?.W_!//QKX4F^!VISQ:Y R2>-M6DC8$_,CS[U/T*L#^->[_ /"8
M^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!I45F_\)CX8
M_P"@U!_WU1_PF/AC_H-0?]]4 :58_@?_ )!$O_7[-_Z%4W_"8^&/^@U!_P!]
M5E^$O$N@V.F20W>J11L;J5@K'L6X- '345F_\)CX8_Z#4'_?5'_"8^&/^@U!
M_P!]4 :5%9O_  F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?
M5'_"8^&/^@U!_P!]4 :5%9O_  F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_
M\)CX8_Z#4'_?5'_"8^&/^@U!_P!]4 :5%9O_  F/AC_H-0?]]4?\)CX8_P"@
MU!_WU0 >,?\ D6+W_K@:N:=_R#X/^N*_R%8?BCQ1X?O/#]W:VNJQ/(\1"(IY
M)JW8^+O#4=E#&^LPAEB4$$]#B@#7HK-_X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^
M^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&H/\ OJC_
M (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#\S/V]?^3M
M_&7_ %]VW_I)#7D%>M?MU7=M??M7^,+NSF$D;W5OM=>A_P!%A%>2U_:7#7_)
M.8/_ *]4_P#TA'\1\3_\E+C?^OU3_P!+D%%%%>T>&%%%% !1110 5^HW[!7_
M ":1X-_Z]+G_ -*YJ_+FOTW_ &%?$V@V/[*'@^TO-4BCD2UN-R,>1_I4QK\D
M\9/^2<H?]?5_Z1,_8/!;_DI:_P#UY?\ Z7 ]MHK-_P"$Q\,?]!J#_OJC_A,?
M#'_0:@_[ZK^;C^F#2JKKO_(#O/\ KTD_]!-5_P#A,?#'_0:@_P"^JJ:YXP\,
MMHMXHUF')M9,<_[)JZ?\1>I%3^&_0_'BBBBO[I/X*"BBB@ HHHH **** +>A
M?\ARS_Z^X_\ T(5^S-?C+H9"ZU9L3P+J//\ WT*_8C_A,?#'_0:@_P"^J_!O
M&K^)@?2I_P"V'[_X(?PL?ZT__<AI45F_\)CX8_Z#4'_?57+&_L]2@%U8W"RQ
MDD!UZ9K\,/WDFHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#\Y?VK=%_P""KOPS_P""IGBCXM?\$[?V1?ACKNF:U\,-$@\7>(O%WB2?3XM=
M"3WJ6L,JAANN[1X[@K)%@?9[Q$E#$PF/D_C-K/\ P<R?&F;PUI>L_L8_L[66
MA:'XJT_7[[2[3X@7._5+BPN%N[.-Y6<^7$EU%;SD(H9C;JN\*SJWZC5D>%/B
M#X"\=O>1^!_&^D:RVG7'D:@NE:E%<&UEY_=R>6QV-P>#@\4 ?+/_  3^^)O_
M  50\=?M$>.M,_X*,_!7P5X(TVT\'Z1+X*LO &M2W]E<RO=7PNWEDDD8B8!+
M<;=JX0K][)Q]>T44 ?#?B?\ 9W\<_L7?\%;_ !1_P4*\&_#O7_$_PY^-OP^M
M-#^)EMX2TB74=1T+7M-,:V.H?8X T]Q:RVJ&!A!'(\<H#L-C$C2_8$_9*^)%
MS^W5\>O^"I/QQ\#WOAG5?BJFF^'_ (>^$-4,?V_2O#6GV\48FNE1F6&>\FB2
M<P%BT*J@?#ED3[2HH \'_9"_:\^+'QQ_9HN_CY^TO^QUXU^#.JV>O7EC)X&U
M"WGUK4GMXIEBBNXXK.W\Z19-V<+$<!68%X\2-XK\?/V7_BO_ ,%8?COX&3XZ
M?#W4O!7[-_PS\10^)(_"_B6$0ZQ\1];A!%JUS:9+6.EP;F;RKC;/.S$/#&H1
MZ^XJ* "BBB@"*^L+'5+233]3LHKBWE7;+!/&'1QZ%3P16/\ \*N^&?\ T3O0
MO_!1#_\ $UNT4 >"?\$]M-TY?@EJJKI\  \<ZP !$. +@@#IV  _"O=?[.T_
M_GQA_P"_0KQ'_@GO_P D3U;_ +'O6?\ TI->Z4 0_P!G:?\ \^,/_?H4?V=I
M_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\
M\^,/_?H5D>"[*SETJ1I;2)C]LE&6C!XW5NUC^!_^01+_ -?LW_H5 &E_9VG_
M //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A
M4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9V
MG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\
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MJP9'5E(>.16 99$974@%2#S0!^4/_!1;]NC]JC]K_P >V?\ P0N_X)U? =/
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M "BBB@#PO_@GO_R1/5O^Q[UG_P!*37NE>%_\$]_^2)ZM_P!CWK/_ *4FO=*
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M@NF7)8@1N-TB;)9/H:TOO#-A_P &RB7T+1'2X_V&<]MK)_PA^"#[GICKD^M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_\
M!/?_ )(GJW_8]ZS_ .E)KW2O"_\ @GO_ ,D3U;_L>]9_]*37NE !7RG^U_\
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M6BBBO[I/X*"BBB@ HHHH **** +>A?\ (<L_^ON/_P!"%?LS7XS:%_R'+/\
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M>U@MX8H((-SE(X\L\DCR2OZ;6/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_^">__ "1/5O\
ML>]9_P#2DU[I7A?_  3W_P"2)ZM_V/>L_P#I2:]TH \D_;B_Y-OUK_KYM/\
MTHCKX.K[Q_;B_P"3;]:_Z^;3_P!*(Z^#J "BBB@ HHHH **** "O7/V'?^3D
M-%_Z]KO_ -)Y*\CKUS]AW_DY#1?^O:[_ /2>2@#[PHHHH **** /E'_@I1_R
M%O"/_7M>_P#H4-?,-?3W_!2C_D+>$?\ KVO?_0H:^8: "BBB@ HHHH ****
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MY#EG_P!?<?\ Z$*_9FOQFT+_ )#EG_U]Q_\ H0K]F:_!O&K^)@?2I_[8?O\
MX(?PL?ZT_P#W(%%%%?AA^\A1110 4444 %%%% !1110 4444 %%%% !1110
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M** "O7/V'?\ DY#1?^O:[_\ 2>2O(Z]<_8=_Y.0T7_KVN_\ TGDH ^\****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/"_^">__ "1/5O\ L>]9_P#2DU[I7A?_  3W_P"2)ZM_V/>L_P#I2:]TH \D
M_;B_Y-OUK_KYM/\ THCKX.K[Q_;B_P"3;]:_Z^;3_P!*(Z^#J "BBB@ HHHH
M **** "O7/V'?^3D-%_Z]KO_ -)Y*\CKUS]AW_DY#1?^O:[_ /2>2@#[PHHH
MH **** /E'_@I1_R%O"/_7M>_P#H4-?,-?3W_!2C_D+>$?\ KVO?_0H:^8:
M"BBB@ HHHH **** "OJ__@FO_P @GQ=_U\V7_H,U?*%?5_\ P37_ .03XN_Z
M^;+_ -!FH ^G:*** "BBB@#\NOV]?^3M_&7_ %]VW_I)#7D%>O\ [>O_ "=O
MXR_Z^[;_ -)(:\@K^TN&O^2<P?\ UZI_^D(_B/B?_DI<;_U^J?\ I<@HHHKV
MCPPHHHH **** "OU&_8*_P"32/!O_7I<_P#I7-7Y<U^HW[!7_)I'@W_KTN?_
M $KFK\D\9/\ DG*'_7U?^D3/V#P6_P"2EK_]>7_Z7 ]>HHHK^;C^F JKKO\
MR [S_KTD_P#035JJNN_\@.\_Z])/_035T_XB]2*G\-^A^,M%%%?W2?P4%%%%
M !1110 4444 6]"_Y#EG_P!?<?\ Z$*_9FOQFT+_ )#EG_U]Q_\ H0K]F:_!
MO&K^)@?2I_[8?O\ X(?PL?ZT_P#W(%%%%?AA^\A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A
M?_!/?_DB>K?]CWK/_I2:]TKPO_@GO_R1/5O^Q[UG_P!*37NE 'DG[<7_ ";?
MK7_7S:?^E$=?!U?>/[<7_)M^M?\ 7S:?^E$=?!U !1110 4444 %%%% !7KG
M[#O_ "<AHO\ U[7?_I/)7D=>N?L._P#)R&B_]>UW_P"D\E 'WA1110 4444
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M^"E?AZ1+CX?:;X6TSX7^!_$,;;K?7)[=+2?5I;=Q\LD4%W:K!YBDHS[P"2C
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MQ_\ C5?8U% 'QS_PY"_9-_Z*-\4__"V/_P :H_X<A?LF_P#11OBG_P"%L?\
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M+8__ !JOL:B@#XY_X<A?LF_]%&^*?_A;'_XU1_PY"_9-_P"BC?%/_P +8_\
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M'L7B?Q/X:\%>'+_QAXR\0V.DZ1I=I)=:GJFIW:06UI!&I9Y99'(6-%4$EF(
M ))KR7]F?_@HK^PO^V5XEU3P7^RW^U5X*\<:QHT)FU'2M!UJ.6XCA#!#,(SA
MGB#%5\Q04RRC/S#/RG_P0>_:*_X>X?\ !)/P?J_[7UDOC#5/"'BF30O%)U9O
M,@UZYTTQ3VD]Y&?EN#Y4UI(ZR;E>>'S"">*X>#7?^"<G[4'_  <,_"GQ+^RI
M\<?A_I?C#X.> /$ \:P>&)8X7\9W%W;FVM-,A>)1%>&RA-W<S%6<H'A4 [9/
M) /U,KA?AC^TU^S]\9[_ ,9Z7\+/B_H.N7'P[U^?1/'$5C?JQT2_A&9;>XSC
MRV3# YX!1AG*L!W5?%G[-W_!*SP]X2L?VI/ _P 5+1X_#_QW_:$N/%UY!9W2
MXU?0Y8]/N9;&78VY8I[@:A;S(V&:*608 <,0#UOX)_\ !4/_ ()W?M(?%B7X
M&? G]LWX>>*O%L9D$6A:/XDAEFNO+!+_ &?G%SM +'RB^%!/09KT']H+]I3X
M ?LH_#J;XM_M)_&'P_X)\-P3I VK^(]22VB>9LE8DW',DC!6(1 6(4D#@U^>
M'_!>G]@?X#W7PV^ \W[)_P &/#7@SXV+\>/#FE?"G5O!6AP:==PC?)-<*WV9
M%)M8+>![EB1MB^SALJ"=WZ ?&WP)^S18:C#^TA^T7:>'$@\%Z5/'::[XPFB^
MPZ)#,Z>=,GGGRH9)-L2&7ARJA 0&(8 G_9Q_:H_9Q_:]\ ?\+2_9B^-7AWQS
MH"W36TVI>'=22X2"=0"890IW12 ,K;' ;#*<8()[^OS2_P""%EK^QG\3/VN_
MVNOVN_V'_BKX:D\%>//&NC66F_#_ ,-@VW]FK86<D<^JS6A5#"M]>27<L)"X
M,:ELAF:./]+: "BBB@ HHHH JZWK6D^&]'NO$&O:A%:6-C;O/>74[[4AB12S
M.Q/0  DGVKRGX/?\%!OV%_VA?&O_  K?X#_M??#CQGX@",[:+X7\86E_=*JG
M#,8H9&90#P21@&O8*_)#_@H#X(N_^"(G_!372/\ @L-\)?##_P#"D_B_=1>&
M/VE]$TVTW#2KJ>53!KL:(.-T@5WP/FE61<[KP;0#]*OCQ^UY^RS^RV+!OVD_
MVA_!O@)=5?9IC^+O$5OIZW;<_+&9W4.W!X&3Q7/?$K_@HK^P3\&M<TWPQ\7/
MVR?AIX8U+6-*BU/2M.\0>,[.SGN[*1G6.XCCED5GC8QR .!@E&P>#7ENECP/
M_P %+OVJ=(\?VG]G>(O@M\!M=%]X8U"/9<6?BCQR;=D^V0MRLMMIEO</&KKD
M->74G(:R&?HK0/@?\.O#GQF\1?'^QT1&\5>)])L-+U'5)8T,BV5F9FAMT8*&
M6,//-(5)(+.3Z8 /)#_P5T_X)9+!+=-_P43^"PB@?9-(?B3INV-LXVL?.X.>
MQKI?''_!1#]@[X9>$M"\??$7]L7X;:%H/BBS2[\-:WJ_C*SM[358'7<LEO,\
M@292.<H3Q7P__P &W-A8ZI<_MK:9J=E%<VUQ^UWXIBN+>>,.DJ,5#*RGA@02
M"#P0:Y?_ (.4/@A\//@%_P $S?@3\'?AOHZVOA_0/VG?#<>BV#(FVR@>/576
M",*JA8XUD,:+CA%4$D@D@'WUX0_X*<?\$X_'VN6OACP;^WG\'M1U*_*BPT^V
M^(^FF>Z)Z")/.W2=ON@]1ZU[D"",@Y!Z$5P'[2G[+GP _:_^$>J? S]H_P"%
MFD>*_#.K6SPSV&J6BN825P)87QN@F7JLL95T(!!!%?G;_P &X7QR^+W@+XF?
MM(?\$F/C!X^U#Q5;_LW^.C8_#[7]6F,EU)H4EQ=0QV[L?X8Q;Q.B\[1<L@PD
M:* #]4:*** "BBB@ HHHH Y/XS?';X+_ +.O@J3XD?'OXJZ!X-\/13+#-KGB
M758K*TC=L[5:65E12<'&3S6;\!_VJOV:?VI-*NM>_9M^//A+QY86,OE7E]X1
MUZ#4(89.NQI(&90V".,YYKK?&'A#PM\0?">I^ _''A^TU;1=:T^:QU;2[^ 2
MP7=M*A22*1&X9&5BI!X()K\E/V ?B5IG_! O]N;QK_P2L_:8\81Z3\!O'0U#
MQW^SWX^UVXV6]C&J&2_TFYG;C?&D?<@[XPV,WB  'Z5:Y^V]^QYX:^,L7[.O
MB']IWP-9>/IY D'@JZ\36R:K*QSC;:E_-;.UN0O8^E<MXC_X*H?\$TO!_B35
MO!WBK]OGX0:=JV@WLUGK>FWOQ"T^.>PN(7:.6*9&E!C='5E96 (*D'I6#^Q#
M\*[_ .*OQ#\0?\%*?C'X(.G>,?B1I-OIG@;3-2M EYX9\$P2236%DX8;HKFY
M>:2_N4X*R7$<!S]F4GC_ /@IM\#_ (=?L^?\$7?VD/ /PST1+.RF^&/BW5+V
M3RT$MY>WD=S<W-Q*450\CRRNQ;&>0.U 'I>B_P#!5C_@F9XCUK3/#>@?M_?!
MZ\U#6KN.UTBRMOB'ISRWLTCJD<<2B;,C,S*H"Y)+ =ZT/B-_P4K_ .">WP>\
M:3?#?XL_ML?"_P ,>(;<@3Z'X@\;65G>(2<#,,LBN,D'''/:O&O^"7WP*^&W
M[1O_  1$_9]^%WQ3T&.^TVX^%?A^Y@<Q1M+9W<$<<UO=0EU8)-%*B.C8."HX
M(R*\0_:'M;8_\'9GP$N#;IYA_9@U/+[1DXNM9QS[9/YT ?>7P:_;=_8T_:)U
MY_"?P$_:P^&_C/5XU+2Z1X8\;6-]=QJ!DEH(96D48YR5Z<UZA7Q-_P %S/\
M@GO\*?VNOV*_&GQ:L-#CT7XM?#'PU=^*/AK\1-&'V75]-OM/A:Z2%+J/$@BE
M\HQE22%+K(H#HI'1_P#!#/\ ;8\;?\% O^"8/PS_ &C/BC.LWBR>RN=)\4W2
MQA1=WMC<R6K7)"X :98TF8  !I6   % 'UM1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZO!I^HR6SY&TH[[?,5@Z%%8DM&^W<%)K>B_94_9>@E6>#]F[P"CHP9'3P?9
MJ1T(/E<&K_Q1_9[^ ?QQELIOC5\#_!_C!]-W?V<_BGPU:Z@;7=C=Y9GC;9G
MSMQG H ^(_V5_P!F_P"%VH_\%W_B=^V?^R-9Z;#\.Y/@?!X<^(>J^&50:3K'
MC275EG81-%^ZGN(;.VB-PT>=DDR!SYCR"OT+JKH>A:)X9TBW\/\ AO1[73["
MSB$5I8V-NL4,"#HJ(H"J!Z 8JU0 4444 %%%% !7S!_P6KE\)1?\$D?VC/\
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M\3?%71;'Q]XMTRZU#PUX3N+P+>ZC;6P+3RQ1]6"@,?4A'(R$;'GOQR_X*?\
M_!/']F?XJP_ _P"/O[97P^\)^+)1&7T+6?$<,4]L) "AGYQ;!@0P,I3*D'IS
M7,?&?]A^\^)'_!5WX(?MT6^GQFQ^'?PV\6:5J5V\R!DN[I[&.QC5"=[;HKC5
M26 *KY8!(+J#2^+W_!-G_@GAX<_9 ^('AC]H/X,^%=6TB_T+5=:^)'CO7M%M
MWU6^N6CDN+S5Y;QE\Q+@-OE1U8>3M18]JHJ@ ^G9_$_AJV\-/XSN?$-C'H\=
MB;V35GNT%LML$\PSF4G8(]GS;\[=O.<5XQ\ ?^"G'_!/?]J?XE7'P=_9V_;%
M\ >+_%%LLC?V'HOB**6XG2/.]X%S_I"J 26BW@#DG'-?-?\ P1O_ &.?&/Q)
M_P""%7P1_9P_;.&H75G?:<FIZQX;U DM>Z(=2FOM/TNYW?-]G: V8DA/!A!M
MV&PL*X?_ (+9?L)_!-OB%^RAK7[)/PB\/^#OC5_PT5H=GX2U3P9HT-A<KHT$
M<]UJ33+;JOF6EO# LS%@0F-HP)65P#]0:*** "BBB@ HHHH **** "BBB@#B
M?AQ^TC\!OB_XX\:?#7X8_%C1-<U[X=:C%8>.=*T^]5YM%N9$9TCG'\!*J_MF
M-QU1@/.OAA_P5+_X)R_&GXT-^SQ\*/VU?ASK_C3[0\$&@:9XG@DENIDSNC@8
M-LN'&#E8F8_*>.#7EWP4_P""7^G:#\7?VP-4\9M<:=X=_:'^(6D73'3KU5FU
M'18M*LS?0,T;;X5GN9]5MFY60(S.N-R,?!/^#A;_ ()\?LV3_L&>&-/_ &8_
M@#X6\)?&*T^)GAC1_@3>^"]#@TN\BU6?4(4-O');(K");5;F<C[J?9EDX\O(
M /T9^.7Q]^"?[,WPXO?B_P#M!_%30O!OAC3BHO-<\1:E':VZ,QPB!G(W.QX5
M%RS'@ FL7]F?]K_]E[]LKP;<?$#]ECX[>&O'>D6=U]FOKOP[J:3FTFQD1S(/
MGB8CD!P"1R,CFI?BQ\,/@1J(T7XQ_M'6V@WB> ;&XGMM6\4O$NGZ9)*L:S7Q
M28^3%+MC*+,1NC265%95ED#?!G_!'27]A_XV?\%.OVJ_VO\ ]AWXN^%#X;UI
M-$T%O!'A@?9OM5Q;1;KK77M-J!89;@O%#*BD2,MS(3F4%@#]-J*** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX+B\-ZWJEU8:1J<%S+.+R6WE$,[QI%&SO"DA"FX"^3EA\_(SY?\ \&^OP/\
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M,S^0'C<X\UTW?2?P=_84\3?LY?\ !0#3OB5\*/BQX]N_A#J?PAUW39O FO\
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MP_K$=C;W%U$7V3RND)F<@28V&3R_E5MFX;J]_HH ^8_%7_!*?X'_ !/\'_\
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MKV5SJ6E7.G6>KW&GS3V[QQ7]HL;2VS,I D02HZ%E)R ZLN0,J1D5\W_LR_\
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M/CA\2/VC/AA\8/B'#XN^+;Q3>/=1O]7L[I-2N(8Y8[:<0R6ABA>$2OY8C54
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M2Z\2^+O&>OS:KK6M31KLB:YNYB698T)5(U"QH&8JH+N6]FHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ew-20230930_g3.jpg
<TEXT>
begin 644 ew-20230930_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^S%\&_VC_P!J?POX6\5^(/AYIPM-+U:]8R*9GD$3W#JK+:K(0VUYV16VL02
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MC>IR' PP(XKM_P#@M'K'@/\ 9V^/_P"R:3K4'PO\!>,/VBIK[X@>,/#>D:=
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MYAN&?AK_ (+9^"O!_@+XY?L )X(\+Z?HZ:+^UCH&E:1%IEFD"65C,A66VB5
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M\//B9*9!H?Q7\&LL&HP7EG,]L8[V.-PETT$T#1YW+,GDA4F0#% 'T#_P3O\
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MW'QGT'X6:6FHV>HP@-)XAO##:VYNHUP"ZRSQR3HN!F.4# QCVK_@HK_P35^
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M_@7X??%.(>(?!=M'<^+/#7B#2[O1M3TFWD7>D]Q9ZA%!/'"R\B4IL/K7A_\
MP5G\9_LVZ+K_ .SWX5^*7PJO/'/Q)OOC=I]]\"?"\/B*72K5O$=K&Y6]OKE
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MO@]\$-+M-;^*GBZWE'A/1KMF-M81*0LNKZ@4^:*PMRZESPTKF."/,DJX\/\
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M7R-F.VU'5+F[LU1 "\DDL5Q;[(D!>1Y55%9F (!Y'X%_9_\ C'_P23_X+._
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M'6JP6TFO6";?+@O[>ZM[BUN@@10LCP^8H5 ' 1-NYH7["'P3\(?L^^+?V=_
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MBB@#Y8\&?\$F_A1X'\0^*I],_:@^/T_AGQEJMS?ZYX"O/BW>/I1:X<O+'$P
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M1I&F6JP6UG;1($CABC0!415 4*    *TJ* /"OV[/^"=O[.W_!0SPIX9\/\
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ME];!7DVEB%4-EC@=!0![K16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WT
MM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &
MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8=MXOOKR,RVOA:ZD4
M,5+)(I&1U'6I/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^
MEH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:
M/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_
M (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: -BBL2X\6ZA:PM<7/A6[2-!EG9U  _.G)XHU61 Z>$;PAAD$.O(
M_.@#9HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_
M[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI:
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M]_Z*_P#^6_J'_P CT?\ #PW]CW_HK_\ Y;^H?_(]5_JMQ/\ ] -;_P %3_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#O9)XO\ AA\0].6WU&VMW*A;J(JQ$T)+Q@MA2/,C.W;)&S@'UA117QU^UO\
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MT'X@^!]>\K[?H5^%$B!C$[QS031,LL-Q&S)+&V00P=% /6J*** "O"_VL/\
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MZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?
MV=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ
M%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
M/C#_ -^A1_9VG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJK
MG]G:?_SXP_\ ?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[
MZJY_9VG_ //C#_WZ%']G:?\ \^,/_?H4 8?BCQ1X?O/#]W:VNJQ/(\1"(IY)
MJW8^+O#4=E#&^LPAEB4$$]#BCQ=8V4?AJ\>.SB5A"<%8P"*MZ?I]@UA 390D
MF%<DQCT% $/_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.
MT_\ Y\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C
M^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_
M0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y
M\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3
M_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[
M.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]5^:O_  4'O;74/VMO
M%-W93K)$Z6&UUZ'%C /YU^FW]G:?_P ^,/\ WZ%?F9_P4/CCA_:\\51Q1JJA
M+#"J,#_CQ@K]8\'?^2GJ_P#7F7_I=,_(_&?_ )):C_U^C_Z14/%****_I0_F
M,**** "BBB@ HHHH **** "BBB@#V+]@2\M;#]K;PC=WDRQQH][N=N@S8W K
M],/^$Q\,?]!J#_OJOS2_X)^QQR_M>>$(Y4#*7OLJPR#_ *#<5^G/]G:?_P ^
M,/\ WZ%?S;XQ_P#)2T?^O,?_ $NH?TUX+_\ )+UO^OTO_2*93_X3'PQ_T&H/
M^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5^2GZ\4_^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7A?[6'_);/@?_ -CW+_Z3-7NE>%_M8?\
M);/@?_V/<O\ Z3-0![I1110 4444 %%%% !1110 4444 8_@?_D$2_\ 7[-_
MZ%6Q6/X'_P"01+_U^S?^A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 9OC'_D6+W_K@:N:=_R#X/\ KBO\A5/QC_R+%[_UP-7-._Y!
M\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** "OS(_X*)_\G?>*O^N=
MA_Z0V]?IO7YD?\%$_P#D[[Q5_P!<[#_TAMZ_6/!W_DIZO_7F7_I=,_(_&?\
MY):C_P!?H_\ I%0\2HHHK^E#^8PHHHH **** "BBB@ HHHH **** /9O^"?/
M_)W_ (/_ -^^_P#2"XK]/J_,'_@GS_R=_P"#_P#?OO\ T@N*_3ZOYM\8_P#D
MI:/_ %YC_P"EU#^FO!?_ ))>M_U^E_Z13"BBBOR4_7@HHHH **** /R3_::_
MY.-\>_\ 8XZE_P"E4E</7<?M-?\ )QOCW_L<=2_]*I*X>O[=RG_D5T/\$?\
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M?^E4E</7]NY3_P BNA_@C_Z2C^%\W_Y&V(_QS_\ 2F%%%%=YYX4444 %%%%
M!1110 4444 %?3?_  2D_P"3C=5_[$VY_P#2JTKYDKZ;_P""4G_)QNJ_]B;<
M_P#I5:5\IQS_ ,DCC/\  _T/K> _^2PP7^-?J?H31117\?']EA1110 4444
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M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
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M?^O,?_2ZA_37@O\ \DO6_P"OTO\ TBF;%%8__"2ZO_T*%[_WTM'_  DNK_\
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M_P"01+_U^S?^A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"EU#^FO!?_ ))>M_U^E_Z13"BBBOR4_7@HHHH **** /R3_::_Y.-\>_\
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M /L>Y?\ TF:O=*\+_:P_Y+9\#_\ L>Y?_29J /=**** "BBB@ HHHH ****
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M4E</7]NY3_R*Z'^"/_I*/X7S?_D;8C_'/_TIA1117>>>%%%% !1110 4444
M%%%% !7TW_P2D_Y.-U7_ +$VY_\ 2JTKYDKZ;_X)2?\ )QNJ_P#8FW/_ *56
ME?*<<_\ )(XS_ _T/K> _P#DL,%_C7ZGZ$T445_'Q_984444 %%%% !1110
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M]*K2OE..?^21QG^!_H?6\!_\EA@O\:_4_0FBBBOX^/[+"BBB@ HHHH ****
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M?!Z+Q/\ LY^)?"ZV?C0O ^JS0L+HM"5*IL/4 [CGL*^O:\+_ &L/^2V? _\
M['N7_P!)FH ]<_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6MBB@#'_ .$EU?\
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MN#QUJWXQ_P"18O?^N!JYIW_(/@_ZXK_(4 9O_"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
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M(V5 !^E]%%% !1110!2T'PUX<\*V3Z=X7T"RTVWDN9;B2"PM4A1YI7+R2%4
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M8\'?^2GJ_P#7F7_I=,_(_&?_ )):C_U^C_Z14/$J***_I0_F,**** "BBB@
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M/+% 'ZLT5#IU]!JFGP:G;),L=S"LL:W-L\,@5@" T<@#HV#RK ,#P0",5-0
M4444 %%%% !1110 4444 %%%% !7A?[6'_);/@?_ -CW+_Z3-7NE>%_M8?\
M);/@?_V/<O\ Z3-0![I1110 4444 %%%0:KJNF:'IESK>MZC!9V5G \]W=W4
MRQQ01(I9W=V("JH!)).  2: )Z*^?_AQ_P %2_V ?BI\1+OX8>$OVI/"+:E%
MJL.G:7+=:S##:ZY/+;17"+I\[L([W*3+Q$S$D-@$#<?5?B]\=/@_\ _#]OXH
M^,GQ$TOP]9WM\ECIQU"Y"R7UVX)2VMXAE[B9@&(BC5G(4D# - '5T5QGP?\
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MOB!XFURW^*?BG1]5N-.26]ALT_LJPN[ZV9);6T>>5GE =!*D3;SY4<H/2_\
M!,_]DJ;P)\-?V>OVA_@-\1_$UCX9U3X;"'Q_X/;QA=W>BZGYUBDEIJ$5I<2R
M10SQRH%W6X3>L^7W! 1].?M$?"_]F']JG0-1_8\_:/\ !VC>++'Q%H3ZA=^%
M-8MV;SK2.5(C<QL,&-XY9(]LB,LB,RLI!P:_*K_@EE_PU+_P2R_:-_9D_9DT
M[XPWOQ!^ /[5'A;4KSPYX6UQC)?^ -7L]/%]<+:ODEK)MZ?+PH#NQ4.A>< ^
MC?V#]9\,?\%<OBG^TS\2_P!I#4-;U#1/ 'QKU/X;> /!UEXEO=/MM#TW38(
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MQ-#X@@^'&E>&4C.KZA!!(MM)>WSS,\B0W#BX2...-=T<>X.4#CVZB@ HHHH
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MGB&W3X17GPC@^&_A,QSJ+GQ5=6^JO?7&J7-N#OM%@9C:PQSA9R&F<HB/'O\
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M^4:R_P#C-'_#:O[3/_12_P#RC67_ ,9KRRB@#U/_ (;5_:9_Z*7_ .4:R_\
MC-'_  VK^TS_ -%+_P#*-9?_ !FO+** /4_^&U?VF?\ HI?_ )1K+_XS6[\+
MOVO/VA_$?Q-\.^'M9^(7G6=_KMI;W</]DVB[XGF167*Q C()&00:\/KI_@G_
M ,EF\(_]C/8?^E$= 'Z2T444 %%%% !1110 5^9'_!1/_D[[Q5_USL/_ $AM
MZ_3>OS(_X*)_\G?>*O\ KG8?^D-O7ZQX._\ )3U?^O,O_2Z9^1^,_P#R2U'_
M *_1_P#2*AXE1117]*'\QA1110 4444 %%%% !1110 4444 >S?\$^?^3O\
MP?\ []]_Z07%?I]7Y@_\$^?^3O\ P?\ []]_Z07%?I]7\V^,?_)2T?\ KS'_
M -+J']->"_\ R2];_K]+_P!(IA1117Y*?KP4444 %%%% 'Y)_M-?\G&^/?\
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ME_Z13"BBBOR4_7@HHHH **** /R3_::_Y.-\>_\ 8XZE_P"E4E</7<?M-?\
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M_P#P47_Y+-I/_8L1?^E%Q7@% !1110 4444 %%%% !1110 4444 %=/\$_\
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MT?%#Q&/'GQ>^('A[X5^&/'>OZF=1UFS@N'2&[U>6>4'SKS9@>80,2W(D &P
M87[>>M:?_P $<_B;^SO^T-\$M?\ $,/@/Q?\4K+X;_%_P_K7BF]U.+5K;48)
M6M]9E-Y+(1>VTEL[M<*1),LC1R,P*[0#]&:*_/O4?B[J/_!0/_@M!X]_8;\1
M:[JD?PC_ &>_AY87_B?P[I6JSVD?B7Q/J?E2P?;9('1I[6WM7;;;$[#."[AM
MBA=?_@GW^T-XP^%O_!2_]H#_ ()0>,O%>IZYH7@K2],\;_"*^UO49;R]L]"O
MHX!=Z9)/,S22PVMW.B0,[.XCDV%L(@ !]VT444 %>%_M8?\ );/@?_V/<O\
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M^Q-N?_2JTKY3CG_DD<9_@?Z'UO ?_)88+_&OU/T)HHHK^/C^RPHHHH ****
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M*** "BBB@ HHHH ]@_8(2]D_:T\))ITZ1S%[W8\BY _T&XSQ],U^EGV+QO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ2N'KN/VFO\ DXWQ[_V..I?^E4E</7]NY3_R*Z'^"/\ Z2C^%\W_ .1MB/\
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M3_<'\J_+6OU*@_U"?[@_E0 ZBBB@ HHHH **** /C+_@HO\ \EFTG_L6(O\
MTHN*\ KW_P#X*+_\EFTG_L6(O_2BXKP"@ HHHH **** "BBB@ HHHH ****
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M57O_ ,11_P .PO\ @HI_T7WX6?\ @JO?_B* .,HKL_\ AV%_P44_Z+[\+/\
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MHG]NO_HM/PL_\ =0_P#B:_7?^(Q\,?\ /FM_X##_ .6'X]_Q!?BG_G]1_P#
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M_P" .H?_ !-'_#HG]NO_ *+3\+/_  !U#_XFC_B,?#'_ #YK?^ P_P#E@?\
M$%^*?^?U'_P*?_RL\*HKW7_AT3^W7_T6GX6?^ .H?_$T?\.B?VZ_^BT_"S_P
M!U#_ .)H_P"(Q\,?\^:W_@,/_E@?\07XI_Y_4?\ P*?_ ,K/"J^F_P#@E)_R
M<;JO_8FW/_I5:5S/_#HG]NO_ *+3\+/_  !U#_XFNG^%'_!.S_@IG\$/$<OB
MWX7_ +1GPLTO4)[-K26X_L6[GW0LR.5VS1LH^9%.<9XZ\FO#XD\4<@SC(L1@
MJ-*JIU(V3<86OYVFW^#/<X9\*N(<FS[#XZO5I.%.2;493O;RO!+\4?H117QS
M_P *7_X+6_\ 1Y'PL_\ "1_^YJ/^%+_\%K?^CR/A9_X2/_W-7X.?OY]C45\<
M_P#"E_\ @M;_ -'D?"S_ ,)'_P"YJ^A?V:/#O[1WA?X:#2_VI?B%H?B;Q1_:
M$K_VGX?T_P"S6_V8A?+39L7Y@0V3@=1Z4 >@T444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E'QY_8]^&
M7QW^('AKXT/K>O>$O'_@^WN;7PYX\\'W<4&HVUI< ?:+-Q/%-!<V\A5&,,\4
MB*Z*ZA7 :M3]G#]E[X1?LL>%=3\-?"O2;K[1K^MSZUXIU[5[Y[O4M>U.?'G7
MMY<2$M+*VU5'1$151%1%51Z'10 4444 %%%% !1110 4444 %%%% !1110 4
M444 >0?L4^!?%WP^^$^I:)XTT&?3KN;QAJEU'!< !FADG+(_!Z$<BO7Z** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /./VN_"GB/QS^
MS3XQ\(^$=(EO]2O]':*SLX "\K[E.T9[\5U_P^L;O2_ .AZ9J%NT4]OH]M%/
M$_5'6)0RGW!!%;%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M25_9BG\"+HOB+Q?\4=3\7&UQ-\5;CXL:TGB4WFW_ (_$NTN0(7W?,(HT6W7
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MP)X\U+1C/;313+IWAMVLIXPTET[-=RG'FPV]K'AD-U&U-_X. _V?OA?\?_\
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ML]_"C1O@;X]U[P[>VW[2O@8ZO?>']1EMI#8W&H_86$C1$$QK+=PRD'C,2G'
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M/6_&'B;4M1\5^-=?O?+BOO$^LW,T;:CJ;0@DK'YDL,:HN5AB^SQ9P%)^9O\
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MO]G3X,:7<6?AKPM8FVTV.[NFGG?=(TLDLLC<R2R2.\CN>69V/>NYHH ****
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:BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ew-20230930_g4.jpg
<TEXT>
begin 644 ew-20230930_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_.7_@Z)U;QC\,/
M^"5?BKX__";XG>,/!_C#PUK>BQZ5KGA#QA?Z5*D<^H102QN+6:-959)7X<-@
MX(P0*_1JOSA_X.OO^4)/Q(_[#_AW_P!.]K0!Z]XW_P""?7[-_C7]GK1] U+X
MY?&+P=X@\8:1;V&A>)])^/GBQ;N#59[4O')$C:DT<K@J\FR1&0A#D8KW35OC
M%X!_97^$'A"P_:-^*5I#JTMC9Z1"X\ZZO->U-+<>8EG;HK7-Y*VR239&CR;0
MS$8!(\5^'?\ P2R_9H&I_!GX_P#A ^+++Q)X O;36["75/B'K>J6THDTZ6VF
MB^S7MY+ NY+@D.J!E*@ A2RGQ76OB7JUW_P=-Z%\-?BXQ31[#]D^]D^$]M=?
MZIM2N-5B>^N( >//:WMKF)RO/EVX!XH ^T_@E^V3^S%^T1IOB34?A+\8M+OV
M\&SF'QCI]ZLEA?: X4OB^M+M(I[,%59@9D0$*Q&0#CS'Q%_P6<_X)7^%O#LO
MB_6/VZ/A^-)B\6?\(T-3M=6^T6\NIB..5H8Y(E9951)HF>9"T48==[KFOG']
MH+PAKO@;_@Y[^ 7C/X/0-;'Q[\#/$5K\7H;(;5O-+LDG-E/<J.&(O&LXE=N<
M1(N< "LS_@B;\"/@IX^^.G[>;^//A/X=UU;K]L#7K>>'6M'ANXFB@E6XB7RY
M591MF=I!@9W8/55P ?I9XL\5>'O WAC4/&?BS5([+3-*LY+J_NY02L,,:EF8
M@ DX / !)Z $U\9_L%?\%0?V=O\ @K)I/Q/^&L&J:UI5H?B!JF@^%=+M#JFC
MZG<Z-9VEF6NWNK<QO;223FY<()(Y%C9(W7(;/VY7YW?\&W?_ ";I\?QZ?M=^
M.<_]_+2@#QC_ ((*?\%(/V./V+_^".?PN;]LC]J+1O#&J>(?%/B:2V.O7<MQ
M=W0.NW2&YE6-7D6,R':9Y $W$@MFOU3\5_&3X3^!OAFWQF\7?$;1=/\ ":V4
M-V/$5QJ,8LY(9=HA=)<[9/,+H$"DERZA<E@#^0__  26^''@&X_X-1_BU?2^
M#M--QKOP]^)4VL7/V)/,O)(/[36!Y&QEFC")L)^X5!&#6=JOQJU#P1^Q9_P2
MCM_B1\7M4\&> -4N[&'Q#XMLULV&GZG'X?-OHSN;^">V"I+,[ S1LJ"+S!M:
M-74 _53X(_MT_LJ?M$?$K6/@O\+/BS%/XST"S2\U;P?K&E7FDZM!:N0%N/L=
M_##,T)+*/-5"F649^89[3XR?%_P!\ _AAK7QB^*.LO8:!X?LFNM2N8;26XD"
M @!4BB5I)79B%5$4LS,  2:^9O%__!.;X+:=^WI\(/VZ/C/^V%\4M<^)7AK[
M;X:\"VVH'0;:VU:.XL[R6:RGBT[2('N(UA^U3\N FPOD &OJWQESX0U7'_0-
MG_\ 1;4 ?GCX._X**_"/_@K+_P $?_BQ\0;'7]:T'Q%+X"\>:S9Z-HFH:CI5
MWIMA97>IP:9)+<VSHDDGV>.S>6-9'C9V8,I4$"'_ ()2_P#!3']A']EC_@F;
M^S%\&_VC_P!J?POX6\5^(/AYIPM-+U:]8R*9GD$3W#JK+:K(0VUYV16VL02
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MC>IR' PP(XKM_P#@M'K'@/\ 9V^/_P"R:3K4'PO\!>,/VBIK[X@>,/#>D:=
M?[=_LN6+3+V[:ZMIK>1Q,Y<RW$;[1;B3*F)70 ^R_@I^W9^RE^T)\3M6^"7P
MP^+44WC30[%+W4_!^LZ3>:3JL5HQ 6Y%I?PPS20DLH\U%9,LOS?,,TOCO_P4
M,_8X_9HU+4M,^-'QKMM*.AM"OB.YM]*O;VVT(S!3$-0GM89(M/+JZ,OVAH]R
ML&'RD&O)O'7_  3F^"UO^W+\'?VYOC7^V-\4];^(WA.>[\/> 8+XZ!;0:JMU
M:W3S64T6G:/!)<1B'[5-]\"-4=\@!J^9?^"*/@JY_;\_X)X>/? GQ#_;'^(&
ME>)-3\?^--)^.7@C2M/\,OY5]J&I7C2B4WNCSW6);6:-0TDK8*,B%5B"( ?J
M;X8\3^&_&OARP\8^#O$%EJVD:K9Q7>F:IIMTD]O=V\BAXYHI$)61&4AE9200
M00:XOXS_ +5/P'_9_P!<T7PE\3O'#0Z]XC6=] \,Z1I-WJFK:E'" TTD%C8Q
M37,L<8(+R+&43<-Q&17&_P#!-W]G7X(?LD_L?^&_V:OV<OBCXD\8^#O!5_JV
ME:7K?BN]BN;PR1:E<BXMS+#!!&Z0W'G0KM0 +$%!;;FO%_C5XN^%FN?\%BM*
M\&_LW_#JSU3]HW3O@1+%K_C+Q1JUTNA>%/",FJ*Z%K*%U-_>27;C;"AA/EL2
M]Q&-@(!]!^"_V[?V./'_ ,!;[]J#PY^TGX1'@#2KN:TUGQ3J6L1V-MIES$P6
M2WNC<F-K692R@Q2A7&Y?E^89\\\4?\%G/^"6W@KPYX0\7>*_VV/!=CIWCM/,
M\,74]S*!<P_:)+<7#CR\V\!EAE033!(V\MB&(!-?'W_!)[1-4M? O_!2/PIX
MTU.SU:Y7X]^,QJD]KIOV:VNIY-.83R);EY/*5SD["[D X+-U/G7P)^&WP_B_
MX,UM<GB\&:8DNJ?![6]4U.5;) ]W>P:C<&&XE;&9)$\F$*S9*B) ,!0  ?K]
M\4?C#\+/@G\/+WXL_%KX@:3X>\-:?$DEWK6J7JQ0*'8+& Q/S,[,JHJY9V95
M4$D _F!^US\<?@;\7O\ @OS^P]>?"#X@^*)-8DO?&I\9>%/$/]LZ>UG''X?7
M^S[D:5J2Q"V219+S;/%"BS%9/F<HV.?^)WQ@U%_VA_\ @DC\)?BYJ97X?:]X
M0CUR^%\^8-1\30>&;2/2FD+<-+%=7,9C[[[G/7&/:/\ @IQH^D6__!=C_@G9
MXBCT^%+ZZO/B3;7%V$ DDBCT2U:.-FZE5::4@=C(WJ: /T2UK6M'\-Z/=^(?
M$6K6UAI]A;/<7U]>SK%#;PHI9Y)'8A415!)8D  $FOG#Q#_P61_X)=^&/ACJ
M'QFU/]MKP/)X8TWQ-/X?FUC3[][N.?488()YHK<0([70CBN8'>2$/&HE7+"O
MI@@,"K#(/4&OS,_X-]OA9\-M3A_;:N[_ ,"Z5+-J/[9?CS0[Z:2Q0O-IH^RD
M6;'&3#F60^7]WYSQ0!]<?M/_ !G_ &$/B[^PCK?C#X^?M$>&=/\ @K\2/"<M
MC-XP_P"$M2PMKZRO('7;;W(=2963=M1<N2I7:<%:R?#'[6W_  3I_8<_8U^%
M-Y=_M+:!X<^&EWX+TFW^&%YXCUR1[S6M,^RPBT:".7_2;IC"T3'"%@&RP7M^
M=_\ P3Q8ZU_P9K^,8-6_TE+;X1?$<0+-\PCV7NK.F,]-K<CTJ7_@I=IEAJ7_
M  :H_L\+?6J2;/!_PF*%ARI-O8(2#U!VNPR.S'UH _2KPU_P4M_8,\9?M/O^
MQEX5_:E\*:A\34:=!X5M;TO))+ &,T"2A?)DGC"/OA5S(GEON4;6QV7QL_:D
M^!7[/$EI9?%7QNUK?W]M-<V.BZ7I5UJ>HW%O%M\ZX2SLHI;AH8]R;Y1'L3>N
MYAN&?AK_ (+9^"O!_@+XY?L )X(\+Z?HZ:+^UCH&E:1%IEFD"65C,A66VB5
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M\//B9*9!H?Q7\&LL&HP7EG,]L8[V.-PETT$T#1YW+,GDA4F0#% 'T#_P3O\
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MW'QGT'X6:6FHV>HP@-)XAO##:VYNHUP"ZRSQR3HN!F.4# QCVK_@HK_P35^
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M_@7X??%.(>(?!=M'<^+/#7B#2[O1M3TFWD7>D]Q9ZA%!/'"R\B4IL/K7A_\
MP5G\9_LVZ+K_ .SWX5^*7PJO/'/Q)OOC=I]]\"?"\/B*72K5O$=K&Y6]OKE
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MO@]\$-+M-;^*GBZWE'A/1KMF-M81*0LNKZ@4^:*PMRZESPTKF."/,DJX\/\
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M7R-F.VU'5+F[LU1 "\DDL5Q;[(D!>1Y55%9F (!Y'X%_9_\ C'_P23_X+._
M7]GG]G/]H_XB>-/@Y^T1HGB9/$O@#X@>)IM8.@W6D6*W)U"WFEYA5FEMQG&6
MQ*C,VZ,1_3O[4W_!+2__ &_?B-XA\4_M/_M0_%30/#MM*++X=^#/ACXV?1K3
M3+=(5#:C<^4A^UWTLYF=3)NCBA\J,)N$C-V'P(^#]_KOQSU;_@HK^U#81^'O
M$>JZ'#X:^'WAO6;B-#X-\/27"NL$S;MG]I7UPT4EQM)V;;>U0OY+22]U^TO\
M>?$7@);+X/?!#2[36_BIXNMY1X3T:[9C;6$2D++J^H%/FBL+<NI<\-*YC@CS
M)*N #Y3_ ." OQ(_:G?PA\>/V3?VEOBUJ7Q&B^ OQKO_  7X3^(FM.TE[JME
M%&CB&XD8LTDL09&)9F9?/"%B$6OL#]FG]K']G+]L7P1?_$G]F/XN:3XST+2]
M?N=%U#4]'=FCAO[?898#N4'($D; @;66164E6!.5^R'^SG\,/V.?A3IW[/?A
M+Q3_ &IK,TEYKWB35]3EC&I^)-3NKCS=0U>X5>6>6YFRQ VH'CC7"JHKMOAE
M\(/A+\%="N/"_P &_A?X=\):9>:E/J%WIWAG18+"">\F;=-</' BJTKD LY&
MYB.2: .BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *\(_;T_X)Z?!?\ X*._"[_A1_[1WBOQ<?!CW,%S=^&O
M#VKQV,%W<0N7CEED6$S/M)!">9Y>54[=PS7N]% '+?!GX71_!CX=Z=\-;3QU
MK_B"TTFWCMM/O/$MS#/=QV\<:HD32QQ1F4*%^_)ND))W.W&///VN?V _@!^V
M7J_A#QQ\1(M;T3QI\/=3:_\  ?Q!\':L=/UK0IG 640SA65XI% 5X94DB<?>
M0U[910!Y%\'?V-/A[\(/&>O_ !@?QGXG\4_$;Q)HL6D:E\2O%MY;W.K)81%G
MAM8%C@CM+6!)':7R8;=(WD.^19&YKF_V0?\ @G'\&?V)?B%X\^)'P>\?>.;F
M[^)OB"?7O'%KXBUZ.]M]3U65F9[W:808926;/E%%(P"I"J%^@:* "OF?X2?\
M$HOV9?@'\3OB!\6/@GXC\>^&=0^(>O7NNWMA8>,YWTW2=6O5VWFHV%C-OMK>
MZF0M&9S&\B1NR1-&IQ7TQ10!\L_![_@D?^SO\!?V-?$'[ WPM^(_Q#T[X8>)
M;>]MM0T0Z_;RS);WBRK>P17,ELTT23^:Q?#Y!Y0IN?==U'_@DK^QUXJ_82MO
M^"<?Q/\ #NK^,/A?ID4<?AZQ\1ZF)+W15B'[@VMW$D<J-$2^QV+,%D:,EHSY
M=?3-% 'RS^P=_P $@?V4O^"?7B!_&?PRUWQ[XMUZ+3&TS1];^)/C"75YM$T]
MF5GL[%&5(K2)BB;O+0,P106(&*^I71)$,<BAE8892,@BEHH ^2?A%_P1<_9!
M^ GP8\:?L_\ P@\0_$71?"GC6RU'3I](7QU<7,.CZ9?N7O=/TV.X$B6$,[$&
M1XE$SE$S*=HQH:C_ ,$COV=M6_86C_X)P7_Q%^(3_"2*W2U70/[>MQ.;-)EG
M2T-V+;SS"LJAP-^?X"2F$'U-10!\K_%C_@DA\!_C9I7PFT?XB_&'XH7<?P0O
M+2]^&LD'B6"WDTR[MM@@N&>*V5KF5$CC0-,7RJ\Y+N6]4_:K_8Q_9_\ VWOV
M>+W]F/\ :H\'CQAX:U"*$W#WKB&Z6YB'[N\BE@$?D7 .3NC"CYF7;L8H?5**
M /E7]@[_ ((]?LG?\$^O$?\ PFOPRUWQ[XMURVTU]-T/5_B3XQEU>30K!RI>
MUL(RJ16D;;$#%$#L$"EB,@\9\??^#?S]@'X\_M-:I^UA"_Q"\!^*/$LID\:1
M_#/QU<:):^)68YD-VD(W9DZR&%HB[9=LNS,?MVB@#%^''PY\"_"#P#HWPM^&
M/A:ST3P[X>TV&PT72-/BV0VEM$@2.-!Z!0/<]3DUX)^T?_P2H_9B_:7_ &I-
M!_;)U[7/'_A/X@:+H1T.ZUSX<^.[S09=8TKS&D^Q7;VC+(\6YFY1HWZ N0B;
M?I6B@#Y1^&?_  1J_8W^"6J_%35O@J?&/A0_%TS?\)%9Z1XHD^R6(GB\JY:Q
MMI5>&VEF3<K7 0SJKLL<D8.*LZ%_P20_9W\-?L+W'_!.'1OB-\0H?A+<VTMH
M^@_V];M.MG+*\TMHMT;;SQ"\LA8C?G^$,$)0_4M% 'S!\8/^"17[(?Q__8[\
M+?L2_&:U\1Z_X8\!K:#P#K=SK(BUOPV;6)8;9K6]AC1PT<:A09 Y88W[\#'-
MO_P1)_98U_XE?#+XR_%;XP?&WQSXM^%#7K>&O$OBGXNZBU\YN%@7]Y/;M"Z!
M!!@+"8E?SI?.$N[C[#HH KZG93WVEW&GVFJ7%C+-;O'%>VP1I;=BI D02JZ%
ME/(WJRY'((R*^>/V9_\ @F5\)?V0]"^(>@? ?XQ?$C2HOB?K]WKWBN:XUVVN
MII-8NFC-QJ,3S6K&&>18]A*X7#9"AUC=/H^B@#Y2^&__  1\_9I^$O[$.N?\
M$[O 7C[XA67PH\0+<17V@_\ "0022K;7)E:[MH[E[<S1Q3M*6=0^<KA2H>0.
MGQ1_X(]_LU_&3]CKPI^P9\0OB)\1;SX9^"VM/["T:/Q'##,D=HJK9PO<QVZS
M21P!?W89SU&XMLCV?5U% 'SG^TI_P32^%/[6NI_#?6_C?\8?B+J%[\*-?M]>
M\%W5GK5I:/;:O ^Z*_D\BU433+A5&\%,+]S+N6YO]NS_ ((R_L;_ /!0GQ=X
M7^+'QF/B[1?B%X1M$M-)^)?@/Q!_9&MF!=Q\N26*,QN-S.P_=@H7<(4#,#]8
M44 >9_LG_LD?!7]B[X31_!_X(:/?163WLE_JVJ:UJDM_J6L7T@427EY=3,TE
MQ.P1%+,>%1$4*B*HYG]NS_@G]\%_^"B/P[TWX2?M ^)/%D7AO3=8AU5-*\-:
MRMB)KV$DP322+&928RS%5#A,D$J2JD>Y44 ?.O[37_!-?X4_M=ZG\.=;^-_Q
M?^(E]>?"KQ!;:_X-N+#6;6S:VUBW?=%J$@@M5$TR\ !P8\ _)EG+.^-G_!-O
MX5?'_P#:-^'G[5OQ"^+?Q!;QK\*HYAX"U"PU>TMX=+>X@2&[D$"6OE2M<*@,
MOF*ZG)50J!47Z(HH ^>_BS_P3:^"7Q!_:9_X;*^'_C;QG\,?BA<Z.NDZ]XO^
M'6JP6TFO6";?+@O[>ZM[BUN@@10LCP^8H5 ' 1-NYH7["'P3\(?L^^+?V=_
M]_XAT:Q\?7%[=>.?$EMJWG:UKUU>KLO+FYO+A)'::5/DW@*8T"K%Y2H@7VBB
M@#Y:T[_@DA^SOI/["TO_  3@L/B-\0D^$LML]HV@_P!O6YG%F\S3O:"[-MYX
MA:5BQ&_./D#!"4-[XN?\$IOV9_CG^R9X(_8[^)NO>-;[0/AKJNF:C\/M>M_$
MIM=;T"YTZ(PV4D%Y B-NBB9D#N'?#9+%@K+]+T4 ?,'Q'_X)-_L[_$OQW\+?
MB-JGQ#^(]KJGP8NI[SX>7%OXM\U[&]N&5[N]F>YBEDOKBX==\LETTQ<LV>&8
M'<\3?\$X_A-XN_;1T#]OG6_B?X\?XB^&-%?1=%NX]7MDLX-,=G:6S-JML(GC
M<R.69@9,L"'!5"OT'10!\N)_P2>^#,7@3Q7\%(OCG\5A\-?'>M:CJ7C'X:/X
MGMY-+U)K^YDN;R 2O:F]M+>:260O#:W,*,)'!!WMN^F="T/1O#&B6?AKPYI5
MO8Z?IUK';6%C:1".*WAC4(D:*O"JJ@  <  "K5% 'R1^W3_P14_8J_;[^,&C
M?M%?$./QAX.^(NB6RVL'CSX9^)WT?4[BV7(6&:15=7 #,H?:) IVA]H '1>,
M/^"4G[*?BO\ 8IN/V +5/$VC_#G5)#+XFM]+UYCJ'B&9IEGDFOKZ=9+B:629
M%=W#JS;0A/E@)7TK10!\P?'K_@E%\!OVF/V:?"7[)'QC^*/Q&U+P1X+FLI=&
ML8?$$%M.7LDV6;37$-LLLIA7A=S<G#/O8!A8_:]_X)4_LV_ML2>!O%OQ<\2^
M-=/^('PX?=X/^+/@_P 0+I/B6QR<L!<V\2QLK'G:8B 2Q4*7?=]+T4 ?+?PL
M_P""0W[+/PL_:QL?VW(O%WQ/UWXD67A6'07\0>(?B9J,[WL"3M,7N0DB?:=[
M% T$NZV"PQ!(4V"N!^,O_!O?_P $]_C!^TMK/[4EBOQ"\#ZWXKN#/XXTKX<^
M/+G1M.\3.S%I3>10?/\ O"27$+Q;V9F/SLS'[BHH ^?_ -K'_@F)^QK^V5^S
MCH/[+GQ7^%J67AGP>;5_ TGA>X.G7GAB2VC$<$EA-%S 40!=N"A &Y3@8\];
M_@B7^RQKWQ.^&?QI^*OQ?^-OCGQ=\*3>GPUXF\4_%S46OG-RL"_O)[=H70(L
M. L)B5_.E\T2[N/L*B@  P,#MZFOECX??\$F?@_\";74[3]EK]H;XQ?"Q->U
M*XU+Q)!X5\:1W=MJ=]<.7GNS:ZK;WEO;32%OF:UC@Z+TVC'U/10!Y3^S1^Q;
M\ /V4_AYK?P[^&OABXO4\6:I<ZGXVUGQ/?/J>H^)[^X&V>ZU"XG+-<NZ_*0?
MD"_*JJO%?,OPO_X-R?\ @FS\'OC!/\2? VD^/;?P[<:TNKR?"9_'=RWA%[Q'
M#I))I_\ RW5652(I7>/Y0I0J-M?>%% 'Y0?MSW'P@^)G_!RM\!?!VH?M /X4
MU32?@9K*V>L^'/$UO:WVF:F;JY,41$H>)W>/S5-O/'(DB,P,;<5^A/P)_9 ^
M&_P-^(/B/XUR^(->\8?$'Q=:VUIXB\?>,;J";4;FSM]Q@LXUMX8;:TMD9W<0
MV\,2,[L[!F.ZO2I/#GAZ:Y-Y+H5FTQ;<96M4+%O7.,YJY0!\\_ G_@F'^RU^
MSC^TCXT_:<^%EOXJM-5\=>)+OQ%J_AV?Q==R:%#K-TC)=:E#IQ?R%NI4>16E
M9695D=4V*Q6O$H?^#<+_ ()I:9\<-6^+WA70_'6@Z/XAU'[=XD^%V@>.;FT\
M*:O*6W%;BQCP9(2V2;?S!#@E/+V?)7WG10!\^?M#_P#!-[X+_M*_'[X=?M)>
M,_'?C73/$?PDEFE^'">'M6M[6TT.29(XYV2 V[++YBQ(K";S%VKM "_+1XR_
MX)Q_"?QU^V7H'[>>M?%+Q\OQ$\+Z/)H^@7=MK%LEG::=(7,MI]E^S>4Z.9'+
M,ZM)D@[P50K]!T4 ?/W@_P#X)R_"+P5^VOK'[?\ IOQ)\=3?$7Q!HB:+K5Q=
MZQ;M976EHZ/'9&U%N(TC1HT(9 LF5)WDLQ;FO#'_  22^ ?PTU[QC)\"_C!\
M5_A[X9^(6K7.I^-/ 7A#QN8=(U&\N?\ CYGC\Z*2YL))>CO93V[8  *[5Q]3
M44 >5^,OV(_V4?'O[*,O[#WB7X':')\*I=#CTA?!D%N8;6&UC(:,1F,AXY$=
M5D656$@D <-N^:O$/V'O^"'O[%W[!7CZQ^(WPSUCXA>)KS0DF3P;:?$#QK-J
MEEX665&CD.G6Q5(H':-FC\TJT@1F4. [!OL.B@#YY^!?_!-KX0?L^_M5^-?V
MR_!GQ.\?W7C?XD+;KX^GU?7()K36UMXO*MA);BW6.+R4P(S"(RH&T':S*?H:
MBB@#Y8\&?\$F_A1X'\0^*I],_:@^/T_AGQEJMS?ZYX"O/BW>/I1:X<O+'$P
MNX(V+$%8[A2P.&)%?1NB?#?X>^&_A[;?"3P_X'TFS\+6>D+I5KX<MM/C2QBL
M5C\H6RP ;!$(_DV8V[>,8K:HH ^;O!'_  2S_9J\%CPCX:FUCQ?K?@?X>:TF
MK_#OX9>(-?\ M.@^'+V-F:"6&(QB:<0%V\B.ZFGCM_E,2QE$*\'_ ,%'?^">
M_AO]K;]J7X&_''PE-XZL?B1\,O%%C?:+X@TK59+71-(TI=2MKG49+H,NV>:6
MW@EM8X(FWN;I3*IA1G3[-HH 1U+H5#E21@,.H]^:^"-=_P"#<_\ 8;\2>+M<
M\>ZO\7OCR^L>)=6EU/7K^+XR:A$]]>28#S2;" 6(55SCA551@* /OBB@#Q?]
MCW]@;]G7]B+X(ZM\ ?A#HNI7^A>(-6NM2\12>+M4?5;K5KBXBCAE:YEGR9@8
M8HXL-D;$ KEO!'_!+/\ 9J\%CPCX:FUCQ?K?@?X>:TFK_#OX9>(-?^TZ#X<O
M8V9H)88C&)IQ 7;R([J:>.W^4Q+&40K](T4 ?+?[;G_!([]FO]O_ .*&B_%G
MX[_$#XH6^H>'-.>ST&U\*?$"YTNUL$D/[YXXH, 22<!Y,[F5$4G:J@9W[(W_
M  1<_8[_ &,_CI:?M%?#K6OB+KWB;3M*NK#2Y_'?CZ[UB*P2XV"62&.<D1R%
M%*;QSL=QWKZUHH ^6/!G_!)OX4>!_$/BJ?3/VH/C]/X9\9:K<W^N> KSXMWC
MZ46N'+RQQ, +N"-BQ!6.X4L#AB17TKX-\&^$OAWX2TSP%X"\-6.C:)HMA%9:
M1I&F6JP6UG;1($CABC0!415 4*    *TJ* /"OV[/^"=O[.W_!0SPIX9\/\
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M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
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M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
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M_P#?2UH:;>3WUJ)[BPDMF+$>5*1GZ\4 6**** "BBB@ HHHH **** "BBB@
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M*LWQC_R+%[_UP- %S3O^0?!_UQ7^0J:H=._Y!\'_ %Q7^0J:@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'LO\ D=[W_KRB_F:V*Q[+
M_D=[W_KRB_F: -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#-\8_\BQ>_P#7 U<T[_D'P?\ 7%?Y"J?C'_D6+W_K@:N:=_R#X/\
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MQBW22J8%V2$[DWR8/SFO5=4TO3-<TRYT76M.@O+.\@>"[M+J%9(IXG4JR.K
MAE()!!&""0: /SD_X(>^*_#&N_MQ?M]6FB^(;*[E_P"&BVF\NVND<^7Y,D>_
M /W=Z.N>F5(ZBNX^(/\ P3)_X*//^TC\2/CS^SI_P63O?AW9_$778KZ?0&^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_D6+W_K@:N:=_P @^#_KBO\ (4 34444 %%%% !1110 4444 %%%% !1110
M5\P?\%8?^3>]$_['.#_TDNZ^GZ^8/^"L/_)O>B?]CG!_Z27=?6\"?\E?@_\
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M %P-:59OC'_D6+W_ *X&@"YIW_(/@_ZXK_(5-4.G?\@^#_KBO\A4U !1110
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M)D__ *5VE?+]?4'_  2>_P"3A-;_ .Q,G_\ 2NTKY+CO_DD,9_@_5'U_ /\
MR6."_P ?Z,_02BBBOY /[)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
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M^BK@4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KPO\ X)[_ /)$]6_['O6?_2DU[I7A?_!/
M?_DB>K?]CWK/_I2: /=**** "BBB@ HHHH **** "LWQC_R+%[_UP-:59OC'
M_D6+W_K@: +FG?\ (/@_ZXK_ "%35#IW_(/@_P"N*_R%34 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %8]E_R.][_P!>47\S6Q6/9?\
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M*_D _LD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O"_^">__)$]6_['O6?_ $I->Z5X
M7_P3W_Y(GJW_ &/>L_\ I2: /=**** "BBB@ HHHH **** "LWQC_P BQ>_]
M<#6E6;XQ_P"18O?^N!H N:=_R#X/^N*_R%35#IW_ "#X/^N*_P A4U !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/9?\CO>_P#7E%_,
MUL5CV7_([WO_ %Y1?S- &Q1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!F^,?^18O?^N!JYIW_ "#X/^N*_P A5/QC_P BQ>_]<#5S
M3O\ D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@ HHHH *^8/^"L/_)O>
MB?\ 8YP?^DEW7T_7S!_P5A_Y-[T3_L<X/_22[KZW@3_DK\'_ (_T9\AQ]_R1
MV-_P?JC\^J***_K\_C8**** "BBB@ HHHH **** "BBB@ KZ@_X)/?\ )PFM
M_P#8F3_^E=I7R_7U!_P2>_Y.$UO_ +$R?_TKM*^2X[_Y)#&?X/U1]?P#_P E
MC@O\?Z,_02BBBOY /[)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPO_@GO_P D3U;_
M +'O6?\ TI->Z5X7_P $]_\ DB>K?]CWK/\ Z4F@#W2BBB@ HHHH **** "B
MBB@ K-\8_P#(L7O_ %P-:59OC'_D6+W_ *X&@"YIW_(/@_ZXK_(5-4.G?\@^
M#_KBO\A4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,T ;%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% &;XQ_P"18O?^N!JYIW_(/@_ZXK_(53\8
M_P#(L7O_ %P-7-._Y!\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH ****
M"OF#_@K#_P F]Z)_V.<'_I)=U]/U\P?\%8?^3>]$_P"QS@_])+NOK>!/^2OP
M?^/]&?(<??\ )'8W_!^J/SZHHHK^OS^-@HHHH **** "BBB@ HHHH **** "
MOJ#_ ()/?\G":W_V)D__ *5VE?+]?4'_  2>_P"3A-;_ .Q,G_\ 2NTKY+CO
M_DD,9_@_5'U_ /\ R6."_P ?Z,_02BBBOY /[)"BBB@ HHHH **** "BBB@
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MK'._AMOVQ+-;AH 3&YB\0G[2>.#^\>S8G_=)H _4WXC?MV_MR?LN?L/^$?\
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MVXJ?=22I]U- 'T?16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\
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M7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM $WC'_ )%B]_ZX&KFG?\@^#_KBO\A7/^)=>U.Y
MT&Z@F\,74*M$0979<+[FK-EXCU5+.)%\)7C 1* P9<'CK0!NT5C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\
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M/5O^Q[UG_P!*30![I1110 4444 %%%% !1110 5F^,?^18O?^N!K2K-\8_\
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M<:SX@\;^.)H)/&7CWQ;J/VS5M7$"%((G<*D<,$2DB.W@CBA3+$("Q)Y3P_\
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M_@H#^UUJ%J]E=_%K?%(N'7^P; 9'U$%21_\ !0G]K^*-8H_B[A54!1_8&G\
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M !1110 4444 %%%% !7U!_P2>_Y.$UO_ +$R?_TKM*^7Z^H/^"3W_)PFM_\
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MHNL?#:TO+?2+VQTJ3[+=7ZRWTK/)$;N*Z17*QC;!N(^;@ ^OJ*_.WP/\=O\
M@N]^V#J$'[0G[&WB']DK2O@?XIU,W'@P>-%\07?B--$,NV*XNH[0"W%S+"!.
M(-Z[/-6-RK*V/T14,% 9LD#DXZT +1110 5X7_P3W_Y(GJW_ &/>L_\ I2:]
MTKPO_@GO_P D3U;_ +'O6?\ TI- 'NE%%% !1110 4444 %%%% !6;XQ_P"1
M8O?^N!K2K-\8_P#(L7O_ %P- %S3O^0?!_UQ7^0J:H=._P"0?!_UQ7^0J:@
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M -"A>_\ ?2UF6NN:BOBFZNE\-W+.]M&K0!EW* 3R:ZNL>R_Y'>]_Z\HOYF@
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M&0/M5KSS]/UKYIKZ@_X)/?\ )PFM_P#8F3_^E=I7R7'?_)(8S_!^J/K^ ?\
MDL<%_C_1GW9_PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL45_(!_9)C_P#"
M2ZO_ -"A>_\ ?2UH:;>3WUJ)[BPDMF+$>5*1GZ\58HH **** "BBB@ HHHH
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M %Y1?S-;%8]E_P CO>_]>47\S0!L4444 %%%% !1110 4444 %%%% !1110
M4444 ?D=^T9_R<)X[_['/5/_ $KEKC*[/]HS_DX3QW_V.>J?^E<M<97]O97_
M ,BRA_@C_P"DH_A;-?\ D:5_\<O_ $IA1117<< 4444 %%%% !1110 4444
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M!HGACPKH]QJFO:K<@E+6UA0O(^%!9C@'"J"S'  )(%=)7F'[:?[+GA3]M?\
M90\?_LH^-=:N=,T[QWX:N-*EU.S0-+9.XS%.JD@.4D"/M) ;;@D9S0!\XW'_
M  5]\=Z%<^)_BEXJ_8-^(L7PK\/?#+0/&UQJUE<Z7/KMCI&HS:NO]HW.G"\W
M"W$6FB4Q1L]S$HD:2('Y%^IOCQ\?_ G[//P&U[]H7QLE_<:-H.CF^^QZ7:&:
M]OW;"P6EM#D&6YGE>.&*(8+R2HHY-?D5^R9^W%\4O^"7G[6NK_L"_P#!<>PL
M7TKQ!\+?"_@;P=\9M)B,N@ZGHEK=:^EB=5DSNMY)UNKN R.J,!9%I5V[[@_H
M=_P4P_8;^-/[=?P6\)?#[]G7]L.?X.W/A;Q79>);'6M/\+1ZN+RYLQOL597G
MC41QRE9A]_+QQ-CY!D Q_P!C'_@JGXG_ &Q?C.OPAN/^"9'[3_PM@&ESWT_B
MWXN?#0:+I,2Q[0(O.><EYG9U"QHK,1N; 5&(XS]JK_@L/-^SU\6?&5E\&/V"
M_C-\9]#\"*;;Q]XP\ Z'&=,TJ>$;KF"*25@;R: 9$RQ+MB8%6<,KA>=_X)Q?
MMM_M]_#7]L_5/^"5/_!5>TT+6_'0\)R>)OAC\7/"MF+>R\9Z7%*(YDEA1$2*
MZC))(5(\"-P5_P!7)-]>>-O&_P '_P!DWP3XN^)OB?[/H/A7PUI%QJ^J&VAR
M6>262>4H@YEGFGD;"C+RRR@#+/R 1?L6?MF? ?\ ;\_9R\/_ +4?[.'B274?
M#'B&)_*6\@\FZLIXV*36MQ%D^7-&X*L 2IX969&5CZI7Q_\ \$.?V-O&'[%G
M[!MCX7^)/AD:!XF\<>*M5\;:]X73&W09=2F$D6G#' :"W2WC<#@2+(!D $^U
M_M9_'W7?@MX,T[PW\+M$MM;^)'C?4?[%^'7AZZ=A%<7[(SO=7.WYDLK6)7N;
MAQR(XBBYDDC5@#@O%O\ P4\^!7A__@I1X1_X)A:-I]]K'C?Q%X<O]8UB_LG3
M[)H*P6WVF.WG)Y:>6+Y_+'*(\3MQ*N?I*ORMUG]G[0OV:_\ @O=^R)\/=.UN
MYUK4[CX4>.]3\5>*-111=^(-7N(WDN]0GV\!Y9"<(/EB18XD"QQHH_5*@ HH
MHH **** "BBB@ HHHH **** /R._:,_Y.$\=_P#8YZI_Z5RUQE=G^T9_R<)X
M[_['/5/_ $KEKC*_M[*_^190_P $?_24?PMFO_(TK_XY?^E,****[C@"BBB@
M HHHH **** "BBB@ HHHH _7+]G/_DWOP)_V)FE_^DD5=E7&_LY_\F]^!/\
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MS3O^0?!_UQ7^0J:H=._Y!\'_ %Q7^0J:@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %?4'_!)[_DX36_\ L3)__2NTKY?KZ@_X)/?\G":W_P!B9/\
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MOP?^/]&?(<??\D=C?\'ZH_/JBBBOZ_/XV"BBB@ HHHH **** "BBB@ HHHH
M*^H/^"3W_)PFM_\ 8F3_ /I7:5\OU]0?\$GO^3A-;_[$R?\ ]*[2ODN._P#D
MD,9_@_5'U_ /_)8X+_'^C/T$HHHK^0#^R0HHHH **** "BBB@ HHHH ****
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M_M[*_P#D64/\$?\ TE'\+9K_ ,C2O_CE_P"E,****[C@"BBB@ HHHH ****
M"BBB@ HHHH _7+]G/_DWOP)_V)FE_P#I)%795QO[.?\ R;WX$_[$S2__ $DB
MKLJ_B',_^1E7_P <O_2F?W3E7_(KH?X(_P#I*"BBBN$[PHHHH *^8/\ @K#_
M ,F]Z)_V.<'_ *27=?3]?,'_  5A_P"3>]$_['.#_P!)+NOK>!/^2OP?^/\
M1GR''W_)'8W_  ?JC\^J***_K\_C8**** "BBB@ HHHH **** "BBB@ KZ@_
MX)/?\G":W_V)D_\ Z5VE?+]?4'_!)[_DX36_^Q,G_P#2NTKY+CO_ ))#&?X/
MU1]?P#_R6."_Q_HS]!****_D _LD**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"_P#@
MGO\ \D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)H ]THHHH **** "BBB
M@#XW_;Y_:^^!OQ!^ W[77[%^LZ[I5IXT\'?!'6;K_A'M0OHS-JVG7GAV:=+N
M&%P"ZK+YL3A=^PQHS$>8HKP+_@F5\%_A[^QO_P %=OVD/AU^QQXO^Q_LOZ;\
M/++6?&.G_P!J^9H'A3QN]PK2VEM-(QCBV6"2S3JK?NA)$C[5CB5?O_\ :4_9
M)_9T_:Z^'VI_#?\ :#^$6@>);+4](N=.%SJ>D03W5E'/&T;26TTB,UO* Q99
M$P58!AR*ZC0?A7\,/"O@3_A5OA?X<:#IOAC[,]O_ ,(Y8:/!#8>2X(>/[.BB
M/8P)RNW!R<T ?G)XA_X+/?\ !)O]K'XT0:O\:_VW/ VE?#+X=>)!<^%O"NH7
MDAE\5ZU:R?NM7NT"$"RMY%W6D#<RRJ+IP!';5]>2^,OV1_\ @J#^Q+JWB"7P
MS:>-_A)XPANH(7\1:6T-KJ\%M<M&;N))=LB1B:%FBE(1LQK(F 4<]]_PR?\
MLL_]&U?#_P#\(VQ_^-5-\4?@I\&O%OPF/PZ\5?"3PQJ?A_3D5]/T+4-!MYK.
MV9055HX'0HA"NP! & Q'<T ?EUI7_!.+]FW]N']MCX1?#W]DKX>:A_PSC^SA
MKB:[XK\?:WXKU37+;Q'KUOM%IX=T:YU*YN&:RMF0M<_9V%MDF(XDC6OTPUS]
MLK]F?PW^U?HO[#NN?%:TM_BIXB\+R^(M&\(M:7!EN=-C>1&G$HC,*\PS81G#
MD1.P4A2:]"\.Z;IVCZ!8Z3I%A#:VMM:1Q6UM;1!(XD50%554 * !@ <"J=S\
M._A_>>.K;XH7?@71Y?$UGISV%GXBDTR)K^"T=@[VZ7!7S%B9@&*!MI(R1F@#
MYM_X+%>+?$<G['C?LU?#[5)+/Q5\??%6F_#+0;B$_/;QZK(4U&Y'<"'3(]0G
MR.GE"OI?P7X/\-_#SP=I/@#P=I4=CI&AZ9!I^E64(PEO;0QK'%&OLJ*H'TI-
M;\#>"O$VNZ/XH\1^#]+U#4_#US+<:!J-]I\<L^F321/#));R,I:%VBD>-F0@
ME'93D$BM2@ HHHH **** "BBB@ HHHH **** / ?^"B__)%M*_[&B'_TFN:^
M,:^SO^"B_P#R1;2O^QHA_P#2:YKXQH **** "BBB@ HHHH **** "BBB@ HH
MHH ]^_X)T?\ ):=5_P"Q7F_]*;:OLZOC'_@G1_R6G5?^Q7F_]*;:OLZ@ HHH
MH **** "BBB@#\COVC/^3A/'?_8YZI_Z5RUQE=G^T9_R<)X[_P"QSU3_ -*Y
M:XRO[>RO_D64/\$?_24?PMFO_(TK_P".7_I3"BBBNXX HHHH **** "BBB@
MHHHH **** /UR_9S_P"3>_ G_8F:7_Z215V5<;^SG_R;WX$_[$S2_P#TDBKL
MJ_B',_\ D95_\<O_ $IG]TY5_P BNA_@C_Z2@HHHKA.\**** "OF#_@K#_R;
MWHG_ &.<'_I)=U]/U\P?\%8?^3>]$_['.#_TDNZ^MX$_Y*_!_P"/]&?(<??\
MD=C?\'ZH_/JBBBOZ_/XV"BBB@ HHHH **** "BBB@ HHHH *^H/^"3W_ "<)
MK?\ V)D__I7:5\OU]0?\$GO^3A-;_P"Q,G_]*[2ODN._^20QG^#]4?7\ _\
M)8X+_'^C/T$HHHK^0#^R0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **^"/VB?\ @C!XP_;3M_$/QA^.O[<W
MQE\,_$[4Y[FX\%#P)XZFL-$\#H'8V-M;V4(59S&@B%Q,S>9/()&5X@4"3?\
M!&;]O'XK?$'_ ((PZ/\ MA_MP:_-?7_A#3]>77/$\4'F2ZW8Z5<W$2W:JH'G
M2NL!CRO,LD9/WGQ0!]XT5^*7[ ES^Q-_P62^*#_$R^_X+.?M/:#\8M;OGUWQ
M1\"_#'Q6G\.:3I@\PR'3-/M)+,-<6UO"%@=X)F=A&\K&,OQ^UBJJ*$4< 8%
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M!/\ DK\'_C_1GR''W_)'8W_!^J/SZHHHK^OS^-@HHHH **** "BBB@ HHHH
M**** "OJ#_@D]_R<)K?_ &)D_P#Z5VE?+]?4'_!)[_DX36_^Q,G_ /2NTKY+
MCO\ Y)#&?X/U1]?P#_R6."_Q_HS]!****_D _LD**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***1@64J&*DCJ.HH
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M W4EGUVQ:0>--5$K"U.&D$V'(YX!;<0.P(KZ/KPO_@GO_P D3U;_ +'O6?\
MTI- 'KGV+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+
M_P !C_C7YX?&=9U^,/BQ;EU:0>);\2,HP"WVA\D#ZU^D]?FW\;_^2T^+_P#L
M:-0_]*9* .7HHHH **** "BBB@ HHHH **** "BBB@ K]#_@Q:>,&^#WA-K;
M6+18SX:L#&K6Y)"_9TP#SZ5^>%?I)\$/^2+>$/\ L5]/_P#2:.@#0^Q>-_\
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MO'YXKYIKZ@_X)/?\G":W_P!B9/\ ^E=I7R7'?_)(8S_!^J/K^ ?^2QP7^/\
M1GW9]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL45_(!_9)C_ &+QO_T&
M[+_P&/\ C6AIL>HQ6H35+B.67<<O$FT8[<58HH **** "BBB@ HHHH ****
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M $DBKLJ_B',_^1E7_P <O_2F?W3E7_(KH?X(_P#I*"BBBN$[PHHHH *^8/\
M@K#_ ,F]Z)_V.<'_ *27=?3]?,'_  5A_P"3>]$_['.#_P!)+NOK>!/^2OP?
M^/\ 1GR''W_)'8W_  ?JC\^J***_K\_C8**** "BBB@ HHHH **** "BBB@
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M* "BBB@ HHHH **** "BBB@ K])/@A_R1;PA_P!BOI__ *31U^;=?I)\$/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKPO_ ()[_P#)$]6_['O6?_2DU[I7A?\ P3W_ .2)ZM_V/>L_^E)H ]THHHH
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M\'ZH_/JBBBOZ_/XV"BBB@ HHHH **** "BBB@ HHHH *^H/^"3W_ "<)K?\
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MD]I^RK_P5#^&OG:%\!?VG_AQI&B7%U+>2VM]X;DE<W4KEY7R\4A )(P-V!V
MH ^S**^.?^%+_P#!:W_H\CX6?^$C_P#<U'_"E_\ @M;_ -'D?"S_ ,)'_P"Y
MJ /L:OS;^-__ "6GQ?\ ]C1J'_I3)7KW_"E_^"UO_1Y'PL_\)'_[FKS;7/\
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MP44_Z+[\+/\ P57O_P 10!QE%=G_ ,.PO^"BG_1??A9_X*KW_P"(H_X=A?\
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M,KZ"\1_\$JO^"@?BWQ#?^*O$'QT^%EQ?ZG>RW=]/_9M^GF32.7=MJJ%&6).
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MY_4?_ I__*SPJBO=?^'1/[=?_1:?A9_X ZA_\31_PZ)_;K_Z+3\+/_ '4/\
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M?X?6-WI?@'0],U"W:*>WT>VBGB?JCK$H93[@@BMBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KR#P;X%\76'[:?C3X@7F@SQZ+J'@
M_3K6RU%@/+EFC=BZ#GJ :]?HH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /./VN_"GB/QS^S3XQ\(^$=(EO]2O]':*SLX "\K[E
M.T9[\5U_P^L;O2_ .AZ9J%NT4]OH]M%/$_5'6)0RGW!!%;%% !1110 4444
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M?$SPU!I^GSR^$I?!OCBYT+2_!=K##N^V&&%UCN[C<KS2SW.\;2(T$:("=/\
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M?&'Q#I=G/JL=[J<2W"K9WT1B&V"'*(50E,E3DY^R/^",'_*);]G#_LC7A_\
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M>XTWQ'=6-[KFI:7=1E);$:A>SW<,+H>4D6"6+>A *OO! (H /B;\+?C=?_\
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M?&4S;A>S2NJPPP2MY8;RHU_>JL;0[B ?JK1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7._%KX1_#'X\?#?6/A!\9O >E^)O"^OV9M
M=9T+6;19[:[B)!VLC#&00&!'*LH8$$ CHJ* /RV_;S_8#_X*I_L[Z9X?L_\
M@G3^TOXZ\=? +39K:#QA^SS<>)H+7Q"FD(P6:TT?Q#,GVX1F#*)$UTLL6U0C
M2@A$^R/V7-!_8W\<?LH?\,M?L^>![WX?>&'\*W&F7OP[:QN_#NO:';W,;1SF
M6"3R[N"<M*Y^U@DO(?-25R0Y^@:* /E[X._\$H?@M\,/".G_  U\;?';XQ?$
M_P (Z3>0W6F^#_BC\09-4TV.2&020K)$(XS=Q1NJLD%R98E*(0F44CZAHHH
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M444 %4?$VCWNOZ#<Z/IWB:_T::XCVQZGIBPF>WY!W()XY(\XX^9&Z^N"+U%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ew-20230930_g5.jpg
<TEXT>
begin 644 ew-20230930_g5.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_.7_@Z)U;QC\,/
M^"5?BKX__";XG>,/!_C#PUK>BQZ5KGA#QA?Z5*D<^H102QN+6:-959)7X<-@
MX(P0*_1JOSA_X.OO^4)/Q(_[#_AW_P!.]K0!Z]XW_P""?7[-_C7]GK1] U+X
MY?&+P=X@\8:1;V&A>)])^/GBQ;N#59[4O')$C:DT<K@J\FR1&0A#D8KW35OC
M%X!_97^$'A"P_:-^*5I#JTMC9Z1"X\ZZO->U-+<>8EG;HK7-Y*VR239&CR;0
MS$8!(\5^'?\ P2R_9H&I_!GX_P#A ^+++Q)X O;36["75/B'K>J6THDTZ6VF
MB^S7MY+ NY+@D.J!E*@ A2RGQ76OB7JUW_P=-Z%\-?BXQ31[#]D^]D^$]M=?
MZIM2N-5B>^N( >//:WMKF)RO/EVX!XH ^T_@E^V3^S%^T1IOB34?A+\8M+OV
M\&SF'QCI]ZLEA?: X4OB^M+M(I[,%59@9D0$*Q&0#CS'Q%_P6<_X)7^%O#LO
MB_6/VZ/A^-)B\6?\(T-3M=6^T6\NIB..5H8Y(E9951)HF>9"T48==[KFOG']
MH+PAKO@;_@Y[^ 7C/X/0-;'Q[\#/$5K\7H;(;5O-+LDG-E/<J.&(O&LXE=N<
M1(N< "LS_@B;\"/@IX^^.G[>;^//A/X=UU;K]L#7K>>'6M'ANXFB@E6XB7RY
M591MF=I!@9W8/55P ?I9XL\5>'O WAC4/&?BS5([+3-*LY+J_NY02L,,:EF8
M@ DX / !)Z $U\9_L%?\%0?V=O\ @K)I/Q/^&L&J:UI5H?B!JF@^%=+M#JFC
MZG<Z-9VEF6NWNK<QO;223FY<()(Y%C9(W7(;/VY7YW?\&W?_ ";I\?QZ?M=^
M.<_]_+2@#QC_ ((*?\%(/V./V+_^".?PN;]LC]J+1O#&J>(?%/B:2V.O7<MQ
M=W0.NW2&YE6-7D6,R':9Y $W$@MFOU3\5_&3X3^!OAFWQF\7?$;1=/\ ":V4
M-V/$5QJ,8LY(9=HA=)<[9/,+H$"DERZA<E@#^0__  26^''@&X_X-1_BU?2^
M#M--QKOP]^)4VL7/V)/,O)(/[36!Y&QEFC")L)^X5!&#6=JOQJU#P1^Q9_P2
MCM_B1\7M4\&> -4N[&'Q#XMLULV&GZG'X?-OHSN;^">V"I+,[ S1LJ"+S!M:
M-74 _53X(_MT_LJ?M$?$K6/@O\+/BS%/XST"S2\U;P?K&E7FDZM!:N0%N/L=
M_##,T)+*/-5"F649^89[3XR?%_P!\ _AAK7QB^*.LO8:!X?LFNM2N8;26XD"
M @!4BB5I)79B%5$4LS,  2:^9O%__!.;X+:=^WI\(/VZ/C/^V%\4M<^)7AK[
M;X:\"VVH'0;:VU:.XL[R6:RGBT[2('N(UA^U3\N FPOD &OJWQESX0U7'_0-
MG_\ 1;4 ?GCX._X**_"/_@K+_P $?_BQ\0;'7]:T'Q%+X"\>:S9Z-HFH:CI5
MWIMA97>IP:9)+<VSHDDGV>.S>6-9'C9V8,I4$"'_ ()2_P#!3']A']EC_@F;
M^S%\&_VC_P!J?POX6\5^(/AYIPM-+U:]8R*9GD$3W#JK+:K(0VUYV16VL02
M<<3_ ,$<2#_P:;Q8/3X1_$O_ -.>O5YKX_\ AQX!LO\ @S*"V/@W38?M?PFT
MG5[IHK)%::_&J6K?:7(&6E^51O/.% S@ 4 ?JK\9/VVOV2/V>_B+X;^$/QH_
M:(\*>'?%?BZ^AM/#GAJ_U9!?WKRL51E@4F18MP(,S 1KCEA6+\'?^"CG["_Q
M_P#A5XH^.7P@_:A\):WX0\%ZJVF^)_$4.H>7:V-R-FU&>0*&#F1!&R;EE+ (
M6)Q7P;_P54\->'_BA!_P34L_B#H]OJ\.K_&KPS'JD5\F];N.;38FECDS]]'*
MC>IR' PP(XKM_P#@M'K'@/\ 9V^/_P"R:3K4'PO\!>,/VBIK[X@>,/#>D:=
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MYAN&?AK_ (+9^"O!_@+XY?L )X(\+Z?HZ:+^UCH&E:1%IEFD"65C,A66VB5
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M\//B9*9!H?Q7\&LL&HP7EG,]L8[V.-PETT$T#1YW+,GDA4F0#% 'T#_P3O\
MV;?C!^RY:?%[X?\ Q4^,7B_QY87OQ=EU+P+XC\<ZS)?ZA)HDFAZ.D5N\TA+.
M()X[F#<>7,)D;YG8G4U7_@IE^PKH7C[2/AUK?[16DV=WX@UIM'T#5+NTNH](
MU+458HUG;ZHT0L9IPZLAB28N'!3&X8K\TO@A^V+_ ,%*?#?_  3H_;Z_8D_:
M9\>3>+OBA^S#X/ELM%^*&FLQN=3T^^T^[D29I0 SSPV\!G$K?O<2KO)>,LWO
MWA+]A;]F+_@II_P1^\!Z#\1?V\?B--\%;SP!HVI/;:6OA&QM]"73H(W:(7":
M&)+8VKPO%)E]RB.17)^;(!]B?$#_ (*#?L0?"OXGWWP7^(?[5/@?2O%6DZ)=
MZQK.AW/B"'S]+L;9 \UQ=@$BU15((,I3=_#FL[]F?_@I7^PC^V-X.\2^//V:
M/VF_#?BW3?!L+3>*'L99(Y=-A"L_FRPRHDJQD(^V3;M;8P4D@X^)?BW\,?A7
MXV_X.&OV7-+\0::WBK3;?]ER_NK&[\5V8>YOGM[F22VN;J.2--TZL?.P\:E)
M?G"HRC;?\7?!#1/@]_P=+_#KQC^S]X?@T<>/OV=M8OOBW9:/ (HKJ*&YDAM[
MV=$ &Y[A+*/<>I@7ODD ]V_X)L?\%@O@9_P4-\=_$OPOX5O[BP?0_BIJ'A[P
M+IM]HEW;W6H:99:9822W<V^/;"SW3WQ6.0I(L:QJR!\@^I?$7_@IA^PM\)?%
M4?A3XC_M$:5I&_7O[#;6[JSNO[&AU,,5:QEU01&QAN%965HGF5T8$, 1BOA?
M_@E5XF^('@O]@7_@HKXP^$YF'BK2/VGOB[>>&OLP)D&H1:7:/;[0.=WFJF/>
MMG]@?]C[X+?\%//^"&_PY^%7B+]M[XCW/PYU[X<:9IGC+PWHT'A6*/3=2LA"
M]Y#YSZ*]Q&\=Y"TGF2RM*P*R,[E][ 'WA\1_VXOV0/A%\8]$_9Z^)'[1_A'2
M?''B%9'TOPI<:S&;YHH[=[EYI(E):"$0QN_FR[(R%.&KC_A7_P %7O\ @G%\
M:[OQE9?#;]L7P5?/\/\ 3&U+Q>T^I&U2PL5*J;S?.J++;Y=!Y\9:/,D8W?.N
M?B#]LOX5?!8?MN?\$K/ 'A;5;CQUX/LK;Q)9:%KGBR*.YNM9TZ'P]IQM;BY)
MBC661UCBE)\M06^;:,XKNOVE/A]X%UW_ (.=?@)J>M^$--O)Y/V=]:N))+JS
M20M-;7TKV\AW Y>)F+(QY5L$8(! !]??L[?MI_L8?\%#O"GBK1?V:/C[:>+;
M?191I_BB'0-1O--O]-:4-LSCR;F#=L?9*FT$H^ULJ<?G7_P12_X*"_L6?\$_
M/V*?'UE^V#^U'IGA5M1_:;\966A_\)-JEQ>ZA?QP/:Q>80!+<2JH"!IF! )&
MYLD9]G^ 5G:Z/_P<[?'F'2[=+=-4_9I\/WFHK"H47-PE]#$LKX^\XC 0$\X&
M*YK_ (-W/@5\%?B)^R-\?E\>_";P[K7_  DW[1WC32_$+:IH\,[:C8K-'MM9
MBZDR0CS)"(S\H,CD#+$D _1/2?CE\&-<^#\7[0>D?%?P[/X$FT;^UH_&,>L0
M_P!F&P";S<_:=WEB(*"2Y; P<]*X3X7?\%!?V/\ XQ?&%/V?O!/QE@7QM/IA
MU*P\,:YI%[I5YJ-F,DW-I'?0PF\B 5F\R#>NT%LXYK\1_AAXL\0_LR_\$@?#
M>@W_ ([UG1O@CIO_  4O32K?Q';B*X6T\!VMXTRW*BZBF@E@34[4RD21R1O(
MA#(VXBOU/_:#_P""=/P/^*GQA^!_[8'[0_[='Q4UO4OA;XYL+SX:7D;^&[>W
MO;O4+JTC2T<Z?HL4EQ;W3)#&ZJX'EL[;D&YP =WXU_X+"_\ !,#X?:;XNUGQ
M+^V]X!%GX$O+"S\4W5AJ_P!LCL[J\,XM[8-;AQ-,WV6X)BBWN@A<NJ@$U]">
M%/%/ASQSX7TWQMX.UJVU+2-8L(;[2M1LY0\-U;2H)(I48<,K(RL".H(K\U_V
M$_@S\)/B%_P7F_X*'VWC[X:Z'K<']F_#JQ:TU?3(KF![:[T(R7,312*4997A
MB+ @Y*#WK],=.T[3]'T^#2-(L(;6TM85AM;6VB"1PQJ JHJJ %4   #@ 4 ?
MG[_P5+_X)K:;\2?V??BM^UI\3?VR_BUHOQ"\-Z!JFM^!-5\)>.[S2M+\-&V2
M26PLK73K=Q'*6*0QRR,&N+B5V*/'NCCCV?B_^W+^TU_P3\_X((6O[87[5FG1
MW'QGT'X6:6FHV>HP@-)XAO##:VYNHUP"ZRSQR3HN!F.4# QCVK_@HK_P35^
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M_@7X??%.(>(?!=M'<^+/#7B#2[O1M3TFWD7>D]Q9ZA%!/'"R\B4IL/K7A_\
MP5G\9_LVZ+K_ .SWX5^*7PJO/'/Q)OOC=I]]\"?"\/B*72K5O$=K&Y6]OKE
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MO@]\$-+M-;^*GBZWE'A/1KMF-M81*0LNKZ@4^:*PMRZESPTKF."/,DJX\/\
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M7R-F.VU'5+F[LU1 "\DDL5Q;[(D!>1Y55%9F (!Y'X%_9_\ C'_P23_X+._
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M'6JP6TFO6";?+@O[>ZM[BUN@@10LCP^8H5 ' 1-NYH7["'P3\(?L^^+?V=_
M]_XAT:Q\?7%[=>.?$EMJWG:UKUU>KLO+FYO+A)'::5/DW@*8T"K%Y2H@7VBB
M@#Y:T[_@DA^SOI/["TO_  3@L/B-\0D^$LML]HV@_P!O6YG%F\S3O:"[-MYX
MA:5BQ&_./D#!"4-[XN?\$IOV9_CG^R9X(_8[^)NO>-;[0/AKJNF:C\/M>M_$
MIM=;T"YTZ(PV4D%Y B-NBB9D#N'?#9+%@K+]+T4 ?,'Q'_X)-_L[_$OQW\+?
MB-JGQ#^(]KJGP8NI[SX>7%OXM\U[&]N&5[N]F>YBEDOKBX==\LETTQ<LV>&8
M'<\3?\$X_A-XN_;1T#]OG6_B?X\?XB^&-%?1=%NX]7MDLX-,=G:6S-JML(GC
M<R.69@9,L"'!5"OT'10!\N)_P2>^#,7@3Q7\%(OCG\5A\-?'>M:CJ7C'X:/X
MGMY-+U)K^YDN;R 2O:F]M+>:260O#:W,*,)'!!WMN^F="T/1O#&B6?AKPYI5
MO8Z?IUK';6%C:1".*WAC4(D:*O"JJ@  <  "K5% 'R1^W3_P14_8J_;[^,&C
M?M%?$./QAX.^(NB6RVL'CSX9^)WT?4[BV7(6&:15=7 #,H?:) IVA]H '1>,
M/^"4G[*?BO\ 8IN/V +5/$VC_#G5)#+XFM]+UYCJ'B&9IEGDFOKZ=9+B:629
M%=W#JS;0A/E@)7TK10!\P?'K_@E%\!OVF/V:?"7[)'QC^*/Q&U+P1X+FLI=&
ML8?$$%M.7LDV6;37$-LLLIA7A=S<G#/O8!A8_:]_X)4_LV_ML2>!O%OQ<\2^
M-=/^('PX?=X/^+/@_P 0+I/B6QR<L!<V\2QLK'G:8B 2Q4*7?=]+T4 ?+?PL
M_P""0W[+/PL_:QL?VW(O%WQ/UWXD67A6'07\0>(?B9J,[WL"3M,7N0DB?:=[
M% T$NZV"PQ!(4V"N!^,O_!O?_P $]_C!^TMK/[4EBOQ"\#ZWXKN#/XXTKX<^
M/+G1M.\3.S%I3>10?/\ O"27$+Q;V9F/SLS'[BHH ^?_ -K'_@F)^QK^V5^S
MCH/[+GQ7^%J67AGP>;5_ TGA>X.G7GAB2VC$<$EA-%S 40!=N"A &Y3@8\];
M_@B7^RQKWQ.^&?QI^*OQ?^-OCGQ=\*3>GPUXF\4_%S46OG-RL"_O)[=H70(L
M. L)B5_.E\T2[N/L*B@  P,#MZFOECX??\$F?@_\";74[3]EK]H;XQ?"Q->U
M*XU+Q)!X5\:1W=MJ=]<.7GNS:ZK;WEO;32%OF:UC@Z+TVC'U/10!Y3^S1^Q;
M\ /V4_AYK?P[^&OABXO4\6:I<ZGXVUGQ/?/J>H^)[^X&V>ZU"XG+-<NZ_*0?
MD"_*JJO%?,OPO_X-R?\ @FS\'OC!/\2? VD^/;?P[<:TNKR?"9_'=RWA%[Q'
M#I))I_\ RW5652(I7>/Y0I0J-M?>%% 'Y0?MSW'P@^)G_!RM\!?!VH?M /X4
MU32?@9K*V>L^'/$UO:WVF:F;JY,41$H>)W>/S5-O/'(DB,P,;<5^A/P)_9 ^
M&_P-^(/B/XUR^(->\8?$'Q=:VUIXB\?>,;J";4;FSM]Q@LXUMX8;:TMD9W<0
MV\,2,[L[!F.ZO2I/#GAZ:Y-Y+H5FTQ;<96M4+%O7.,YJY0!\\_ G_@F'^RU^
MSC^TCXT_:<^%EOXJM-5\=>)+OQ%J_AV?Q==R:%#K-TC)=:E#IQ?R%NI4>16E
M9695D=4V*Q6O$H?^#<+_ ()I:9\<-6^+WA70_'6@Z/XAU'[=XD^%V@>.;FT\
M*:O*6W%;BQCP9(2V2;?S!#@E/+V?)7WG10!\^?M#_P#!-[X+_M*_'[X=?M)>
M,_'?C73/$?PDEFE^'">'M6M[6TT.29(XYV2 V[++YBQ(K";S%VKM "_+1XR_
MX)Q_"?QU^V7H'[>>M?%+Q\OQ$\+Z/)H^@7=MK%LEG::=(7,MI]E^S>4Z.9'+
M,ZM)D@[P50K]!T4 ?/W@_P#X)R_"+P5^VOK'[?\ IOQ)\=3?$7Q!HB:+K5Q=
MZQ;M976EHZ/'9&U%N(TC1HT(9 LF5)WDLQ;FO#'_  22^ ?PTU[QC)\"_C!\
M5_A[X9^(6K7.I^-/ 7A#QN8=(U&\N?\ CYGC\Z*2YL))>CO93V[8  *[5Q]3
M44 >5^,OV(_V4?'O[*,O[#WB7X':')\*I=#CTA?!D%N8;6&UC(:,1F,AXY$=
M5D656$@D <-N^:O$/V'O^"'O[%W[!7CZQ^(WPSUCXA>)KS0DF3P;:?$#QK-J
MEEX665&CD.G6Q5(H':-FC\TJT@1F4. [!OL.B@#YY^!?_!-KX0?L^_M5^-?V
MR_!GQ.\?W7C?XD+;KX^GU?7()K36UMXO*MA);BW6.+R4P(S"(RH&T':S*?H:
MBB@#Y8\&?\$F_A1X'\0^*I],_:@^/T_AGQEJMS?ZYX"O/BW>/I1:X<O+'$P
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M1I&F6JP6UG;1($CABC0!415 4*    *TJ* /"OV[/^"=O[.W_!0SPIX9\/\
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M_M<BVLU@8A;2+4M;*WL*=E1DLXXBO3;(?6@#]B=#_P""M'@=O G@O]HKXA_
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M\2_#W^VOAT?AQH7C;7?#\0LH[2+5M'NXS?11*H7Y9;B.7YBHP9""_)(8-\U
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MQ/\ AX;^V%_T5_\ \M_3_P#Y'H_X>&_MA?\ 17__ "W]/_\ D>C_ (@YQ/\
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MJJG4=DY1@E\[3;_!GV'1117YN?I84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>%_P#!
M/?\ Y(GJW_8]ZS_Z4FO=*\+_ .">_P#R1/5O^Q[UG_TI- 'NE%%% !1110 4
M444 %%%% !6;XQ_Y%B]_ZX&M*LWQC_R+%[_UP- %S3O^0?!_UQ7^0J:H=._Y
M!\'_ %Q7^0J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ K'LO\ D=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \@_:=_;)\"_LU^*O WPH'A36/%OQ ^)NI75EX"\
M"^'3 MWJ9M8//N[AY+F6*&WMK>+#RRNXP&4*KNRH?-_V//\ @HWXI^.E]\.?
M ?QT_9C\3>!O$'Q*\&2>(/#&M036M_H&J)#%%)<0QW$,[36\R+*K>5<1(64D
MHS[6QPO_  6"_8,_:L^._BKX4_MQ_P#!/OQSIFF?''X"7VHW/AC0_$&!IOB:
MPOHHX[S39F) C:1(]BL652)74O&2LL? ?\$*_P#@IA^S;^V'\(O _P"RA\0/
M"5UX+^.GPA\,P";P=XFA,,US"+7R#J>FN>+BWDAER1]Y5D!PR;)6 /LO]J?]
MLGX*_LB:3H;?$J]U'4-?\6ZG_9G@CP1X:L#>ZWXEOL9,%G:J07VJ0SRN4AB4
M[I)$7FNK^$WBWXG>--!?7/B7\)/^$,EE939Z1<Z]#?7B(1DBX^S@P1N#@;8I
MIEZ_/Z_E1^Q1XH_;$_;C_P""LG[5_P"V]\(_"_@#5;KX4>()OA/\*KCXD:S>
MI9:#;6<LHO/L]M:P.Y>[>..5Y_,C:,3NH657*)Z3J_\ P77\;:__ ,$O/VHO
MC+XE^$:?#[X[?LZ27/A?Q=X56]%]:66M3S?8K"_MY&4>=;-.Q<*PS^X<992K
ML ?6'Q._;O\ !>M?%GQ%^RQ^SMX!UCXF>-/#5K&WC9M"F@@T?PD9.8H]2U"9
MPD<[@$K;0+/<8&YHE3YJZ/X[_M?>&/V;M+^'_@[Q)X2O=?\ B'\2+T:7X+^'
MWA:YCFN=4O8[;S[MDEN#"B6EM$K2S7,FQ4C .TNZ1M^;O[/7C#]N[_@D3_P1
MB\(?M'Z3^S?\/O&7A*72H/&OQCC_ .$OOI/%NK-JSI<76L/.]LL#3()XE:)_
M,*Q0#]ZVTXZ3]O3]HNP\ _MX?L1?\%F%MM5U+]G*Y\"ZCIOB+Q+;:?),OA9-
M;L0;:_NXXPQ@1O.B$C8.T6KH?F*!@#[D^"W[?&@^-_VG=3_8I^-GPMU3X;_%
M*T\.KXATC0]5U"WO+/Q%I!D,37>G7D#;9O*D!26)UCE0_-L9,N/?Z_(_]M7]
MJ/X.?M3?\%VOV!+O]CKQ_;^*;S3'\8W6N^(M AEDL;C1YK"($1W>T0W*!(+X
M-Y;N$9L-AF /Z:_M2^.->^&/[,GQ&^)7A4D:IX>\":OJ>FD#)%Q!92RQ\?[R
M"@#Q'Q!_P5)\.7</Q)\<?!']GKQ=\0_A_P#!W5;K3?B)XX\/75DD:7=I&)+^
M'3K>:59=2:T0YFV!%)#)"9G!2OHKX5_%+X??&[X:Z#\8/A1XJM=<\->)M*@U
M+0M7LG)BN[69 \<BY (RI'! (.00""*^&_\ @V4\(:.W_!#7X21ZG MZ?$B^
M([O6WN#O-Y)-KNH(YD)Y8E%5"3R=M<K_ ,&G'C/7_$O_  2&TGPSJ]_-<6?A
M/XA>(-'T.29BQ^QBX6X4 GJ!)<R@>G3M0!^EM%%% !1110 4444 %%%% !7S
M!_P5A_Y-[T3_ +'.#_TDNZ^GZ^8/^"L/_)O>B?\ 8YP?^DEW7UO G_)7X/\
MQ_HSY#C[_DCL;_@_5'Y]4445_7Y_&P4444 %%%% !1110 4444 %%%% !7U!
M_P $GO\ DX36_P#L3)__ $KM*^7Z^H/^"3W_ "<)K?\ V)D__I7:5\EQW_R2
M&,_P?JCZ_@'_ )+'!?X_T9^@E%%%?R ?V2%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7A?_  3W_P"2)ZM_V/>L_P#I2:]TKPO_ ()[_P#)$]6_['O6?_2DT >Z4444
M %%%% !1110 4444 %9OC'_D6+W_ *X&M*LWQC_R+%[_ -<#0!<T[_D'P?\
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M_P#2DT >Z4444 %%%% !1110 4444 %9OC'_ )%B]_ZX&M*LWQC_ ,BQ>_\
M7 T 7-._Y!\'_7%?Y"IJAT[_ )!\'_7%?Y"IJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "L>R_Y'>]_Z\HOYFMBL>R_Y'>]_P"O*+^9
MH V**** "BBB@ HHHH **** "BBB@ HHHH **** /(_$?[=O[*GA+Q#?^%?$
M'Q3^SW^F7LMI?0?V'?/Y<T;E'7<L!4X8$9!(..":I?\ #PW]CW_HK_\ Y;^H
M?_(]?GO^T9_R<)X[_P"QSU3_ -*Y:XROZ*P7A%PWB,'3JRJUKRBF[2AU2?\
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M\-?"_2]9<BQLG^3[5JU[MP?LEHDB.X!R2ZCA=[+V/[%?P/\ @7H>E1^.+/\
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M<RPPR9&&=!]X8SQ0!K5X7_P3W_Y(GJW_ &/>L_\ I2:/^$!_X*"?]%_\"?\
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ML45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\
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MQKA.\V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8KY@_P""L/\
MR;WHG_8YP?\ I)=U]#_8O&__ $&[+_P&/^-?-'_!4RW\10_ /16U?4;>:/\
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M !R_]*9_=.5?\BNA_@C_ .DH****X3O"BBB@ KY@_P""L/\ R;WHG_8YP?\
MI)=U]/U\P?\ !6'_ )-[T3_L<X/_ $DNZ^MX$_Y*_!_X_P!&?(<??\D=C?\
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M]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _([]HS_ ).$\=_]CGJG_I7+7&5V?[1G_)PGCO\ ['/5/_2N6N,K^WLK
M_P"190_P1_\ 24?PMFO_ "-*_P#CE_Z4PHHHKN. **** "BBB@ HHHH ****
M "BBB@#]<OV<_P#DWOP)_P!B9I?_ *215V5<;^SG_P F]^!/^Q,TO_TDBKLJ
M_B',_P#D95_\<O\ TIG]TY5_R*Z'^"/_ *2@HHHKA.\**** "OF#_@K#_P F
M]Z)_V.<'_I)=U]/U\P?\%8?^3>]$_P"QS@_])+NOK>!/^2OP?^/]&?(<??\
M)'8W_!^J/SZHHHK^OS^-@HHHH **** "BBB@ HHHH **** "OJ#_ ()/?\G"
M:W_V)D__ *5VE?+]?4'_  2>_P"3A-;_ .Q,G_\ 2NTKY+CO_DD,9_@_5'U_
M /\ R6."_P ?Z,_02BBBOY /[)"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#\YO^"@&N?'7]E7XL_&;XN?LW?\$\O%_Q-^-_Q2TG
M3]+^#GQ-\*>%;>^M?#]N-.BLS;WUVS[]/%O=_:[PEE$4XN85+XC<Q<'^S?\
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M% !1110 5CV7_([WO_7E%_,UL5CV7_([WO\ UY1?S- &Q1110 4444 %%%%
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MH^OX!_Y+'!?X_P!&?H)1117\@']DA1110 4444 %%%% !1110 4444 %%%%
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M !R_]*9_=.5?\BNA_@C_ .DH****X3O"BBB@ KY@_P""L/\ R;WHG_8YP?\
MI)=U]/U\P?\ !6'_ )-[T3_L<X/_ $DNZ^MX$_Y*_!_X_P!&?(<??\D=C?\
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MVX,HM/$.FR"&2TM6DP66XD>#R=_3[0J,<JQH ^SJ*_/OXC?MV_MR?LN?L/\
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M .Q,G_\ 2NTKY+CO_DD,9_@_5'U_ /\ R6."_P ?Z,_02BBBOY /[)"BBB@
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M4^ZFOH^O"_\ @GO_ ,D3U;_L>]9_]*30!ZY_PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2UL44 8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2UL44 8__"2ZO_T*%[_WTM'_  DNK_\
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M_"2ZO_T*%[_WTM;%% &/_P )+J__ $*%[_WTM9EKKFHKXINKI?#=RSO;1JT
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MTM8O[.?_ ";WX$_[$S2__22*NRK^(<S_ .1E7_QR_P#2F?W3E7_(KH?X(_\
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MAC]H3QKH5IX5O[R- 'CDFTU9)(-08R*-L]EY2+M5FB1LJ #]+Z*** "BBB@
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M*Y:XRNS_ &C/^3A/'?\ V.>J?^E<M<97]O97_P BRA_@C_Z2C^%LU_Y&E?\
MQR_]*84445W' %%%% !1110 4444 %%%% !1110!^N7[.?\ R;WX$_[$S2__
M $DBKLJXW]G/_DWOP)_V)FE_^DD5=E7\0YG_ ,C*O_CE_P"E,_NG*O\ D5T/
M\$?_ $E!1117"=X4444 %?,'_!6'_DWO1/\ L<X/_22[KZ?KY@_X*P_\F]Z)
M_P!CG!_Z27=?6\"?\E?@_P#'^C/D./O^2.QO^#]4?GU1117]?G\;!1110 44
M44 %%%% !1110 4444 %?4'_  2>_P"3A-;_ .Q,G_\ 2NTKY?KZ@_X)/?\
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M$_'GXL7,RW.I?$CXQ_M,7&K7#W(Q^\AMY?#S0Q$$ J[B29,#$M?97B[X]?\
M!3:W\5>!M(\4_L9>!?"7A/4?'NCV7BSQ/X?^,<FLW>GV,ETBX2S?2+4,LLGE
M0,XD)1)6.P_>7Q[XF_\ !Q%\._V4]1D\(_M\?\$_?V@OA1K=L=L]RGA2WUK0
MKELXS9ZI;7 CNES_ !!%[ @'($?PT_X.+OAE^U1J4?A']@O_ ()__M"_%G6[
MDA8)T\(VVD:+;L> ;O4[FX,=HF<?.RD?4X! /T6HKS7]FWPA\>-/T.]^(/[3
M7B+39O&?B,Q/=Z#X;N)7T?P];1[O)L+1I K7#+O=I;MU5YY&)VQQ)##%Z50
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M>J?^E<M<979_M&?\G">._P#L<]4_]*Y:XRO[>RO_ )%E#_!'_P!)1_"V:_\
M(TK_ ..7_I3"BBBNXX HHHH **** "BBB@ HHHH **** /UR_9S_ .3>_ G_
M &)FE_\ I)%795QO[.?_ ";WX$_[$S2__22*NRK^(<S_ .1E7_QR_P#2F?W3
ME7_(KH?X(_\ I*"BBBN$[PHHHH *^8/^"L/_ ";WHG_8YP?^DEW7T_7S!_P5
MA_Y-[T3_ +'.#_TDNZ^MX$_Y*_!_X_T9\AQ]_P D=C?\'ZH_/JBBBOZ_/XV"
MBBB@ HHHH **** "BBB@ HHHH *^H/\ @D]_R<)K?_8F3_\ I7:5\OU]0?\
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M9OA)\"?"A\=?&GXF:%X4T<7"6ZZEX@U2*TA>=SB.%&D8!Y'/"QKEF/ !-7_
M_C?P_P#$3PU;^+O"SWCV%UN-O)?:7<6;N <;A'<(C[3C(;;AA@@D$&OQX_8B
M_P""COP__:&\<_$?_@M9^U]\'_BGXL\->&_$-_HWP8T[PY\.[W4])^'7A:W
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M;O J#^R? WA2PT2RD";3,MM D1E8?WW*EV/4LQ)ZUW= !1110 4444 %%%%
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MW\/O 7Q2\+W'@CXF^"-'\1Z+=E#=Z1KVFQ7EK.4<.A>*561MKJK#(X*@CD4
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M7\@']DA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^WLK_P"190_P1_\ 24?PMFO_ "-*_P#CE_Z4PHHHKN. **** "BBB@ HHHH
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M\#44 ??/_#:O[,W_ $4O_P HU[_\9H_X;5_9F_Z*7_Y1KW_XS7P-10!]\_\
M#:O[,W_12_\ RC7O_P 9H_X;5_9F_P"BE_\ E&O?_C-? U% 'WS_ ,-J_LS?
M]%+_ /*->_\ QFO2=#UK3/$FBV?B+1;GSK._M8[FTFV,OF1.H96PP!&00<$
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M\+9K_P C2O\ XY?^E,****[C@"BBB@ HHHH **** "BBB@ HHHH _7+]G/\
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MT$HHHK^0#^R0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\+_P"">_\ R1/5O^Q[UG_T
MI->Z5X7_ ,$]_P#DB>K?]CWK/_I2: /=**** "OS;^-__):?%_\ V-&H?^E,
ME?I)7YM_&_\ Y+3XO_[&C4/_ $IDH Y>BBB@ HHHH **** "BBB@ HHHH **
M** "OTD^"'_)%O"'_8KZ?_Z31U^;=?I)\$/^2+>$/^Q7T_\ ])HZ .HHHHH
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MFE_^DD5=E7&_LY_\F]^!/^Q,TO\ ])(J[*OXAS/_ )&5?_'+_P!*9_=.5?\
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M)ZM_V/>L_P#I2: /=**** "OS;^-_P#R6GQ?_P!C1J'_ *4R5^DE?FW\;_\
MDM/B_P#[&C4/_2F2@#EZ*** "BBB@ HHHH **** "BBB@ HHHH *_23X(?\
M)%O"'_8KZ?\ ^DT=?FW7Z2?!#_DBWA#_ +%?3_\ TFCH ZBBBB@ HHHH ***
M* / ?^"B_P#R1;2O^QHA_P#2:YKXQK[._P""B_\ R1;2O^QHA_\ 2:YKXQH
M**** "BBB@ HHHH **** "BBB@ HHHH ]^_X)T?\EIU7_L5YO_2FVK[.KXQ_
MX)T?\EIU7_L5YO\ TIMJ^SJ "BBB@ HHHH **** /R._:,_Y.$\=_P#8YZI_
MZ5RUQE=G^T9_R<)X[_['/5/_ $KEKC*_M[*_^190_P $?_24?PMFO_(TK_XY
M?^E,****[C@"BBB@ HHHH **** "BBB@ HHHH _7+]G/_DWOP)_V)FE_^DD5
M=E7&_LY_\F]^!/\ L3-+_P#22*NRK^(<S_Y&5?\ QR_]*9_=.5?\BNA_@C_Z
M2@HHHKA.\**** "OF#_@K#_R;WHG_8YP?^DEW7T_7S!_P5A_Y-[T3_L<X/\
MTDNZ^MX$_P"2OP?^/]&?(<??\D=C?\'ZH_/JBBBOZ_/XV"BBB@ HHHH ****
M "BBB@ HHHH *^H/^"3W_)PFM_\ 8F3_ /I7:5\OU]0?\$GO^3A-;_[$R?\
M]*[2ODN._P#DD,9_@_5'U_ /_)8X+_'^C/T$HHHK^0#^R0HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* "BBB@ HHHH ]^_X)T?\EIU7_L5YO\ TIMJ^SJ^,?\ @G1_R6G5?^Q7F_\
M2FVK[.H **** "BBB@ HHHH _([]HS_DX3QW_P!CGJG_ *5RUQE=G^T9_P G
M">._^QSU3_TKEKC*_M[*_P#D64/\$?\ TE'\+9K_ ,C2O_CE_P"E,****[C@
M"BBB@ HHHH **** "BBB@ HHHH _7+]G/_DWOP)_V)FE_P#I)%795QO[.?\
MR;WX$_[$S2__ $DBKLJ_B',_^1E7_P <O_2F?W3E7_(KH?X(_P#I*"BBBN$[
MPHHHH *^8/\ @K#_ ,F]Z)_V.<'_ *27=?3]?,'_  5A_P"3>]$_['.#_P!)
M+NOK>!/^2OP?^/\ 1GR''W_)'8W_  ?JC\^J***_K\_C8**** "BBB@ HHHH
M **** "BBB@ KZ@_X)/?\G":W_V)D_\ Z5VE?+]?4'_!)[_DX36_^Q,G_P#2
MNTKY+CO_ ))#&?X/U1]?P#_R6."_Q_HS]!****_D _LD**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O"_P#@GO\ \D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)H
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MCO\ ['/5/_2N6N,K^WLK_P"190_P1_\ 24?PMFO_ "-*_P#CE_Z4PHHHKN.
M**** "BBB@ HHHH **** "BBB@#]<OV<_P#DWOP)_P!B9I?_ *215V5<;^SG
M_P F]^!/^Q,TO_TDBKLJ_B',_P#D95_\<O\ TIG]TY5_R*Z'^"/_ *2@HHHK
MA.\**** "OF#_@K#_P F]Z)_V.<'_I)=U]/U\P?\%8?^3>]$_P"QS@_])+NO
MK>!/^2OP?^/]&?(<??\ )'8W_!^J/SZHHHK^OS^-@HHHH **** "BBB@ HHH
MH **** "OJ#_ ()/?\G":W_V)D__ *5VE?+]?4'_  2>_P"3A-;_ .Q,G_\
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M?3[WR'29B%"D#=N&.<C'I78_\.B?VZ_^BT_"S_P!U#_XFC_B,?#'_/FM_P"
MP_\ E@?\07XI_P"?U'_P*?\ \K/"J*]U_P"'1/[=?_1:?A9_X ZA_P#$T?\
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MZ/(^%G_A(_\ W-1_PI?_ (+6_P#1Y'PL_P#"1_\ N:OP@_?C[&HKXY_X4O\
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M0 4444 %%%% !1110 4444 %><?M=^%/$?CG]FGQCX1\(Z1+?ZE?Z.T5G9P
M%Y7W*=HSWXKT>B@#'^'UC=Z7X!T/3-0MVBGM]'MHIXGZHZQ*&4^X((K8HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\@\&^!?%UA^
MVGXT^(%YH,\>BZAX/TZULM18#RY9HW8N@YZ@&O7Z* "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#SC]KOPIXC\<_LT^,?"/A'2);
M_4K_ $=HK.S@ +RON4[1GOQ77_#ZQN]+\ Z'IFH6[13V^CVT4\3]4=8E#*?<
M$$5L44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'D'@WP+XNL/VT_&GQ O-!GCT74/!^G6MEJ+ >7+-&[%T'/4 UZ_110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P
MU_P6G_X*$_%S]EFV^$?[(7[*-]967QD_:+\<P^%_"&NZA:K<0^&[0S017>JM
M"V5E>+[3$$1QM)9W(81%&^Y:_)7_ (.$?#FJ?!+_ (*(?L/?\%"_$L3K\/?
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M>-O^"A'QGT3]H/3/#UWXDL-<\._$">S\/:#>PPO<+IEG81!5BT^/;Y._/G,
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M.0(G[DI'*98]Z$*V_P"N_P!H3]F7PQ_P4)\)^'7U[X\>+K#X5ZAHD>I1Z)X
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MZJT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  Z_X53^R]\'-'\':&]RUS=0:;&S37MP>#/<SRLTUU*0 #)*[O@ 9P!7H]%
M!7SK^WA_P3'^ 7_!12X\,GX_>-OB':6WA&X>ZT73_!_C6?2H$NV!7[4RP@%Y
M@A9%<G**SA<;VW?15% 'QA^SW_P0C_8D_9R^.GAC]H/PYXC^*/B'7/!][)>:
M%;>-OB3>ZK907+P20B8V\Q*%T65BC=5;##D"L_XQ_P#! ?\ 8T^.OQJ\3_M
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8H **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ew-20230930_g6.jpg
<TEXT>
begin 644 ew-20230930_g6.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
MF@.J P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_.7_@Z)U;QC\,/
M^"5?BKX__";XG>,/!_C#PUK>BQZ5KGA#QA?Z5*D<^H102QN+6:-959)7X<-@
MX(P0*_1JOSA_X.OO^4)/Q(_[#_AW_P!.]K0!Z]XW_P""?7[-_C7]GK1] U+X
MY?&+P=X@\8:1;V&A>)])^/GBQ;N#59[4O')$C:DT<K@J\FR1&0A#D8KW35OC
M%X!_97^$'A"P_:-^*5I#JTMC9Z1"X\ZZO->U-+<>8EG;HK7-Y*VR239&CR;0
MS$8!(\5^'?\ P2R_9H&I_!GX_P#A ^+++Q)X O;36["75/B'K>J6THDTZ6VF
MB^S7MY+ NY+@D.J!E*@ A2RGQ76OB7JUW_P=-Z%\-?BXQ31[#]D^]D^$]M=?
MZIM2N-5B>^N( >//:WMKF)RO/EVX!XH ^T_@E^V3^S%^T1IOB34?A+\8M+OV
M\&SF'QCI]ZLEA?: X4OB^M+M(I[,%59@9D0$*Q&0#CS'Q%_P6<_X)7^%O#LO
MB_6/VZ/A^-)B\6?\(T-3M=6^T6\NIB..5H8Y(E9951)HF>9"T48==[KFOG']
MH+PAKO@;_@Y[^ 7C/X/0-;'Q[\#/$5K\7H;(;5O-+LDG-E/<J.&(O&LXE=N<
M1(N< "LS_@B;\"/@IX^^.G[>;^//A/X=UU;K]L#7K>>'6M'ANXFB@E6XB7RY
M591MF=I!@9W8/55P ?I9XL\5>'O WAC4/&?BS5([+3-*LY+J_NY02L,,:EF8
M@ DX / !)Z $U\9_L%?\%0?V=O\ @K)I/Q/^&L&J:UI5H?B!JF@^%=+M#JFC
MZG<Z-9VEF6NWNK<QO;223FY<()(Y%C9(W7(;/VY7YW?\&W?_ ";I\?QZ?M=^
M.<_]_+2@#QC_ ((*?\%(/V./V+_^".?PN;]LC]J+1O#&J>(?%/B:2V.O7<MQ
M=W0.NW2&YE6-7D6,R':9Y $W$@MFOU3\5_&3X3^!OAFWQF\7?$;1=/\ ":V4
M-V/$5QJ,8LY(9=HA=)<[9/,+H$"DERZA<E@#^0__  26^''@&X_X-1_BU?2^
M#M--QKOP]^)4VL7/V)/,O)(/[36!Y&QEFC")L)^X5!&#6=JOQJU#P1^Q9_P2
MCM_B1\7M4\&> -4N[&'Q#XMLULV&GZG'X?-OHSN;^">V"I+,[ S1LJ"+S!M:
M-74 _53X(_MT_LJ?M$?$K6/@O\+/BS%/XST"S2\U;P?K&E7FDZM!:N0%N/L=
M_##,T)+*/-5"F649^89[3XR?%_P!\ _AAK7QB^*.LO8:!X?LFNM2N8;26XD"
M @!4BB5I)79B%5$4LS,  2:^9O%__!.;X+:=^WI\(/VZ/C/^V%\4M<^)7AK[
M;X:\"VVH'0;:VU:.XL[R6:RGBT[2('N(UA^U3\N FPOD &OJWQESX0U7'_0-
MG_\ 1;4 ?GCX._X**_"/_@K+_P $?_BQ\0;'7]:T'Q%+X"\>:S9Z-HFH:CI5
MWIMA97>IP:9)+<VSHDDGV>.S>6-9'C9V8,I4$"'_ ()2_P#!3']A']EC_@F;
M^S%\&_VC_P!J?POX6\5^(/AYIPM-+U:]8R*9GD$3W#JK+:K(0VUYV16VL02
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MC>IR' PP(XKM_P#@M'K'@/\ 9V^/_P"R:3K4'PO\!>,/VBIK[X@>,/#>D:=
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MYAN&?AK_ (+9^"O!_@+XY?L )X(\+Z?HZ:+^UCH&E:1%IEFD"65C,A66VB5
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M\//B9*9!H?Q7\&LL&HP7EG,]L8[V.-PETT$T#1YW+,GDA4F0#% 'T#_P3O\
MV;?C!^RY:?%[X?\ Q4^,7B_QY87OQ=EU+P+XC\<ZS)?ZA)HDFAZ.D5N\TA+.
M()X[F#<>7,)D;YG8G4U7_@IE^PKH7C[2/AUK?[16DV=WX@UIM'T#5+NTNH](
MU+458HUG;ZHT0L9IPZLAB28N'!3&X8K\TO@A^V+_ ,%*?#?_  3H_;Z_8D_:
M9\>3>+OBA^S#X/ELM%^*&FLQN=3T^^T^[D29I0 SSPV\!G$K?O<2KO)>,LWO
MWA+]A;]F+_@II_P1^\!Z#\1?V\?B--\%;SP!HVI/;:6OA&QM]"73H(W:(7":
M&)+8VKPO%)E]RB.17)^;(!]B?$#_ (*#?L0?"OXGWWP7^(?[5/@?2O%6DZ)=
MZQK.AW/B"'S]+L;9 \UQ=@$BU15((,I3=_#FL[]F?_@I7^PC^V-X.\2^//V:
M/VF_#?BW3?!L+3>*'L99(Y=-A"L_FRPRHDJQD(^V3;M;8P4D@X^)?BW\,?A7
MXV_X.&OV7-+\0::WBK3;?]ER_NK&[\5V8>YOGM[F22VN;J.2--TZL?.P\:E)
M?G"HRC;?\7?!#1/@]_P=+_#KQC^S]X?@T<>/OV=M8OOBW9:/ (HKJ*&YDAM[
MV=$ &Y[A+*/<>I@7ODD ]V_X)L?\%@O@9_P4-\=_$OPOX5O[BP?0_BIJ'A[P
M+IM]HEW;W6H:99:9822W<V^/;"SW3WQ6.0I(L:QJR!\@^I?$7_@IA^PM\)?%
M4?A3XC_M$:5I&_7O[#;6[JSNO[&AU,,5:QEU01&QAN%965HGF5T8$, 1BOA?
M_@E5XF^('@O]@7_@HKXP^$YF'BK2/VGOB[>>&OLP)D&H1:7:/;[0.=WFJF/>
MMG]@?]C[X+?\%//^"&_PY^%7B+]M[XCW/PYU[X<:9IGC+PWHT'A6*/3=2LA"
M]Y#YSZ*]Q&\=Y"TGF2RM*P*R,[E][ 'WA\1_VXOV0/A%\8]$_9Z^)'[1_A'2
M?''B%9'TOPI<:S&;YHH[=[EYI(E):"$0QN_FR[(R%.&KC_A7_P %7O\ @G%\
M:[OQE9?#;]L7P5?/\/\ 3&U+Q>T^I&U2PL5*J;S?.J++;Y=!Y\9:/,D8W?.N
M?B#]LOX5?!8?MN?\$K/ 'A;5;CQUX/LK;Q)9:%KGBR*.YNM9TZ'P]IQM;BY)
MBC661UCBE)\M06^;:,XKNOVE/A]X%UW_ (.=?@)J>M^$--O)Y/V=]:N))+JS
M20M-;7TKV\AW Y>)F+(QY5L$8(! !]??L[?MI_L8?\%#O"GBK1?V:/C[:>+;
M?191I_BB'0-1O--O]-:4-LSCR;F#=L?9*FT$H^ULJ<?G7_P12_X*"_L6?\$_
M/V*?'UE^V#^U'IGA5M1_:;\966A_\)-JEQ>ZA?QP/:Q>80!+<2JH"!IF! )&
MYLD9]G^ 5G:Z/_P<[?'F'2[=+=-4_9I\/WFHK"H47-PE]#$LKX^\XC 0$\X&
M*YK_ (-W/@5\%?B)^R-\?E\>_";P[K7_  DW[1WC32_$+:IH\,[:C8K-'MM9
MBZDR0CS)"(S\H,CD#+$D _1/2?CE\&-<^#\7[0>D?%?P[/X$FT;^UH_&,>L0
M_P!F&P";S<_:=WEB(*"2Y; P<]*X3X7?\%!?V/\ XQ?&%/V?O!/QE@7QM/IA
MU*P\,:YI%[I5YJ-F,DW-I'?0PF\B 5F\R#>NT%LXYK\1_AAXL\0_LR_\$@?#
M>@W_ ([UG1O@CIO_  4O32K?Q';B*X6T\!VMXTRW*BZBF@E@34[4RD21R1O(
MA#(VXBOU/_:#_P""=/P/^*GQA^!_[8'[0_[='Q4UO4OA;XYL+SX:7D;^&[>W
MO;O4+JTC2T<Z?HL4EQ;W3)#&ZJX'EL[;D&YP =WXU_X+"_\ !,#X?:;XNUGQ
M+^V]X!%GX$O+"S\4W5AJ_P!LCL[J\,XM[8-;AQ-,WV6X)BBWN@A<NJ@$U]">
M%/%/ASQSX7TWQMX.UJVU+2-8L(;[2M1LY0\-U;2H)(I48<,K(RL".H(K\U_V
M$_@S\)/B%_P7F_X*'VWC[X:Z'K<']F_#JQ:TU?3(KF![:[T(R7,312*4997A
MB+ @Y*#WK],=.T[3]'T^#2-(L(;6TM85AM;6VB"1PQJ JHJJ %4   #@ 4 ?
MG[_P5+_X)K:;\2?V??BM^UI\3?VR_BUHOQ"\-Z!JFM^!-5\)>.[S2M+\-&V2
M26PLK73K=Q'*6*0QRR,&N+B5V*/'NCCCV?B_^W+^TU_P3\_X((6O[87[5FG1
MW'QGT'X6:6FHV>HP@-)XAO##:VYNHUP"ZRSQR3HN!F.4# QCVK_@HK_P35^
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M_@7X??%.(>(?!=M'<^+/#7B#2[O1M3TFWD7>D]Q9ZA%!/'"R\B4IL/K7A_\
MP5G\9_LVZ+K_ .SWX5^*7PJO/'/Q)OOC=I]]\"?"\/B*72K5O$=K&Y6]OKE
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MO@]\$-+M-;^*GBZWE'A/1KMF-M81*0LNKZ@4^:*PMRZESPTKF."/,DJX\/\
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M7R-F.VU'5+F[LU1 "\DDL5Q;[(D!>1Y55%9F (!Y'X%_9_\ C'_P23_X+._
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M'6JP6TFO6";?+@O[>ZM[BUN@@10LCP^8H5 ' 1-NYH7["'P3\(?L^^+?V=_
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MBB@#Y8\&?\$F_A1X'\0^*I],_:@^/T_AGQEJMS?ZYX"O/BW>/I1:X<O+'$P
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M1I&F6JP6UG;1($CABC0!415 4*    *TJ* /"OV[/^"=O[.W_!0SPIX9\/\
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M_M<BVLU@8A;2+4M;*WL*=E1DLXXBO3;(?6@#]B=#_P""M'@=O G@O]HKXA_
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M*%[_ -]+0!L45AKXOOGN6LU\+71E10S1B1<@'H<9J3_A)=7_ .A0O?\ OI:
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M0(A/J.FIJUDEO'K%I:Y!NS$4\N6./=-Y4F8T?YEK*@_9CM_VB/\ @L!\/_\
M@HA\+/A;KOA#1O WPVUG1/&?B?Q#X=N=%N?&=S=^5'8V0L[N.*Y9+11<2O<3
M1*I+6Z1F0(?+^WJ* /@/]DKX1^/O^"2_QW_:"\")\$/&OC#X6_%3X@3_ !&^
M&=YX \//JDEOJE[$D>H:)<Q1'-F5DA@,$\VVV:(_/,C(PKD?@]_P1,\2_$3_
M ()8?'W]GC]I:ZL-(^*7[3WC+6/'OBV6WG%U!X>UJYNTO-/M?-3B>.VEAA,A
M3AF><(S*58_I510!^:G[2'@W]L/]O7_@F5X<_P""7VJ?L_\ B[P?\2?$5EH/
MASXO^+M8THIH6@6%A<6SW^IVU\3Y&I"Y6U(MX+=I)/\ 21YPAV.1^B7PY\ ^
M&?A5\/=!^%_@JQ^RZ-X;T:UTK2+;=GR;6WB6&),]\(BC\*V:* "BBB@ KPO_
M ()[_P#)$]6_['O6?_2DU[I7A?\ P3W_ .2)ZM_V/>L_^E)H ]THHHH ****
M "BBB@ HHHH *S?&/_(L7O\ UP-:59OC'_D6+W_K@: +FG?\@^#_ *XK_(5-
M4.G?\@^#_KBO\A4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#R1/5O^Q[UG_TI->Z5X7_P3W_Y(GJW_8]ZS_Z4F@#W2BBB@ HHHH ****
M"BBB@ K-\8_\BQ>_]<#6E6;XQ_Y%B]_ZX&@"YIW_ "#X/^N*_P A4U0Z=_R#
MX/\ KBO\A4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S- &Q1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!F^,?^18O?^N!JYIW_(/@_P"N*_R%
M4_&/_(L7O_7 U<T[_D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HJO-J^DVVIV^B7&J6\=[=122VMH\ZB69(RHD9$)RP4NFX@8&
M]<]15B@ HHHH Q[+_D=[W_KRB_F:V*Q[+_D=[W_KRB_F:V* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *\+_X)[_\D3U;_L>]9_\ 2DU[
MI7A?_!/?_DB>K?\ 8]ZS_P"E)H ]THHHH **** "BBB@ HHHH *S?&/_ "+%
M[_UP-:59OC'_ )%B]_ZX&@"YIW_(/@_ZXK_(5-4.G?\ (/@_ZXK_ "%34 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_R.][_ ->4
M7\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% &;XQ_Y%B]_ZX&KFG?\ (/@_ZXK_ "%4_&/_ "+%[_UP
M-7-._P"0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH *KZK
M/?6NEW-SI=D+FYCMW:WMVD""60*2J;CTR<#/;-6*KZOJMAH6E76MZK<"&UL[
M=Y[F4J3LC12S-@ DX )XYH _&#_@E1X^^$/_  5+\:^!;W]ISXI>,=1^/MOI
MGQ$3XPZ0OCG5='U/PE>QZKIBV,5A!;W$1TRVC@95C\@(ID242%Y5DK[[^*O[
M3[_\$EO^"8%W\;OVQ_'FJ>--4^'>D26;:C>WJ/J'BF[-T\&GHT@&/.G#0%VV
MG8"[L"$:OFG_ (*7?\$Q/!G[6/[7GPN_:F_X)_?%!?A#\;/$'@/7_$VA?%/P
MJK11>();3^R391ZA&ORS0RQ7DB/(4+E'0.)43RC\S_\ !0?]JCXE_P#!2O\
MX(7_ ++'[57[17A&#3M-7]IK1+;XT)IZ%;"2SM;O4M+FO<@X6WDD"9&2JR3!
M03M!H _0C]A+X>7'QSBM/BI^W]\=-*\9?&O6;6/6;WX/6OB<#1_A[ X62+3H
MM&27:\\*LBRW=RDLS2[@L@3:#H_MC_\ !+?X@?MT_'NX^)/CW_@H#\<_A=X8
MTC2+;3/"7A3X%^/#H:S8S+<7VH.\,HFG>60Q*BJ D5M&VXF1E7YI_P"#AO\
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M^>@5[>T2T.>IOE'>@#>_X(U?"KXN_"3_ ()J?"G2?CY\0O%7B;QGK/AU=?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_A_]DKQ'8:#-XAT\'3_&ZS-K4SLZ[5OWN+B21[^5$9G1II) S ;MRE@0#O\
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M^0J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'LO\
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M3C"Z<6TUJMFM4?,?_#PW]L+_ **__P"6_I__ ,CT?\/#?VPO^BO_ /EOZ?\
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MAO[87_17_P#RW]/_ /D>O%J*/]5N&/\ H!H_^"H?_(A_K7Q3_P!!];_P;/\
M^2/:?^'AO[87_17_ /RW]/\ _D>C_AX;^V%_T5__ ,M_3_\ Y'KQ:BC_ %6X
M8_Z :/\ X*A_\B'^M?%/_0?6_P#!L_\ Y(]I_P"'AO[87_17_P#RW]/_ /D>
MO>/^">W[4_QX^./QCU3PK\4O'?\ :EA;>&9KN&#^R[6#;,MQ;H&W0Q(Q^5V&
M"<<].!7P]7U!_P $GO\ DX36_P#L3)__ $KM*^7XTX>R#"\+8NK1PE*,XQT:
MIP36JV:5T?4\$\1\0XOBO"4:^,JSA*=FI5)M/1[INS/T$HHHK^6#^L HHHH
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M_@H#^UUJ%J]E=_%K?%(N'7^P; 9'U$%21_\ !0G]K^*-8H_B[A54!1_8&G\
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M !1110 4444 %%%% !7U!_P2>_Y.$UO_ +$R?_TKM*^7Z^H/^"3W_)PFM_\
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M2L+4X:038<CG@%MQ [ B@#Z/HK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\
M&@#8HK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\ &@#8HK'^Q>-_^@W9?^ Q
M_P :/L7C?_H-V7_@,?\ &@#8HK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\
M&@#8K-\8_P#(L7O_ %P-0_8O&_\ T&[+_P !C_C5'Q+:>+4T&Z>^U:U>(1'S
M$2W()'L: .@T[_D'P?\ 7%?Y"IJPK*S\:&SB,6LV87REV@VQR!CZU+]B\;_]
M!NR_\!C_ (T ;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\
M8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B
M\;_]!NR_\!C_ (T ;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q1
M6/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\
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M5F^,?^18O?\ K@: +FG?\@^#_KBO\A4U0Z=_R#X/^N*_R%34 %%%% !1110
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M0 4444 %%%% !1110 4444 %>%_\$]_^2)ZM_P!CWK/_ *4FO=*\+_X)[_\
M)$]6_P"Q[UG_ -*30![I1110 4444 %%%% !1110 5F^,?\ D6+W_K@:TJS?
M&/\ R+%[_P!<#0!<T[_D'P?]<5_D*FJ'3O\ D'P?]<5_D*FH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q[+_D=[W_KRB_F:V*Q[+_D
M=[W_ *\HOYF@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH _([]HS_DX
M3QW_ -CGJG_I7+7&5V?[1G_)PGCO_L<]4_\ 2N6N,K^WLK_Y%E#_  1_])1_
M"V:_\C2O_CE_Z4PHHHKN. **** "BBB@ HHHH **** "BBB@#]<OV<_^3>_
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M7<3+<78DNIB1EB7=B<D]R:Y3Q+^S)_P0T_:E^)^L_LP7OPD_9Q\2>/=$C?\
MM?POH=GI$?B'2]A <_Z)MN[9D)7<5*E"5S@D4 ?7U%><_L[?"/QI\"-'O/A7
M??$'4_%'A33A$?!NH^)-1>[U>TMR&#V%S</E[M82J>5<R,TSI)LE+M%YTOHU
M !1110 4444 %%%% !1110 5X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\D3U;
M_L>]9_\ 2DT >Z4444 %%%% !1110 4444 %9OC'_D6+W_K@:TJS?&/_ "+%
M[_UP- %S3O\ D'P?]<5_D*FJ'3O^0?!_UQ7^0J:@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ K'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\
MHOYF@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH _([]HS_DX3QW_P!C
MGJG_ *5RUQE=G^T9_P G">._^QSU3_TKEKC*_M[*_P#D64/\$?\ TE'\+9K_
M ,C2O_CE_P"E,****[C@"BBB@ HHHH **** "BBB@ HHHH _7+]G/_DWOP)_
MV)FE_P#I)%795QO[.?\ R;WX$_[$S2__ $DBKLJ_B',_^1E7_P <O_2F?W3E
M7_(KH?X(_P#I*"BBBN$[PHHHH *^8/\ @K#_ ,F]Z)_V.<'_ *27=?3]?,'_
M  5A_P"3>]$_['.#_P!)+NOK>!/^2OP?^/\ 1GR''W_)'8W_  ?JC\^J***_
MK\_C8**** "BBB@ HHHH **** "BBB@ KZ@_X)/?\G":W_V)D_\ Z5VE?+]?
M4'_!)[_DX36_^Q,G_P#2NTKY+CO_ ))#&?X/U1]?P#_R6."_Q_HS]!****_D
M _LD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /SF
M_P""@&N?'7]E7XL_&;XN?LW?\$\O%_Q-^-_Q2TG3]+^#GQ-\*>%;>^M?#]N-
M.BLS;WUVS[]/%O=_:[PEE$4XN85+XC<Q<'^S?_P3M^$__!/+X>?L]_LW>%_V
M7/$7BWX_W_Q'T/Q#\2/CQI7P\OKJ/1I6N5NM6>?7C;[/L\ML+C3%A67E+DR2
MHI9V/J?[4?C#_@L!^TO^WQX\_97_ &(_VA? OP/\(?#7PAH&J/XB\1^#$UK4
MO$\FJ"Z/FP1SJT26\3V<T!( (DC/+[L1YW@W]D7_ (+H^#_BWX"\8?M,?\%1
M_"/Q%^'^E^/=)G\5^#M)^&>GZ%/J%O\ :45-MS%&K'9,T4ABW+Y@C*C<2$8
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M ,F]^!/^Q,TO_P!)(J[*N-_9S_Y-[\"?]B9I?_I)%795_$.9_P#(RK_XY?\
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M7O\ WTM;%% &/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\
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M?^E<M<97]O97_P BRA_@C_Z2C^%LU_Y&E?\ QR_]*84445W' %%%% !1110
M4444 %%%% !1110!^KG[/?B'5(?@'X'AC\*W<BIX/TQ5D5EPP%K'R/K78?\
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M6HGN+"2V8L1Y4I&?KQ5BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB\!%AM%:358@1CR;F&XMQGYD'6O)O^"1?_!3?]OG]MSXF77ACQ/^R#XG\7_
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MSPR!6 (#1R .C8/*L P/! (Q4U !1110 4444 %%%% !1110 5X7_P $]_\
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M!;632C;[A<Q7:LQ$+PE&W_,5P-ZLR,K'Q/6?^"N/P_O?@19?M5ZU\"/%VD?
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M\L-1M([FQN[=]T<\,BAT=3W5E((/H:MT %%%% !1110 4444 %%%% !1110
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M/6-9\6>);3PYX&\'^'XHY-2\1ZQ<L1#9VRRND:G 9WDD=(XT1F=@!SB?!O\
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MJ_\ CE_Z4S^Z<J_Y%=#_  1_])04445PG>%%%% !7S!_P5A_Y-[T3_L<X/\
MTDNZ^GZ^8/\ @K#_ ,F]Z)_V.<'_ *27=?6\"?\ )7X/_'^C/D./O^2.QO\
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MP_V?<1;8@RJ6S)&H/+J,9SS79U\8_P#!.C_DM.J_]BO-_P"E-M7V=0 4444
M%%%% !1110!^1W[1G_)PGCO_ +'/5/\ TKEKC*[/]HS_ ).$\=_]CGJG_I7+
M7&5_;V5_\BRA_@C_ .DH_A;-?^1I7_QR_P#2F%%%%=QP!1110 4444 %%%%
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MZH^OX!_Y+'!?X_T9^@E%%%?R ?V2%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?*G_  4D_P""K'[-W[ JZ'\+/&7Q
MK\(:!\0O&VY/#L/BF](L](MAD2:M?K&?,^S1[6"1+A[F4")"@\V:'E/^"??[
M?'_!+N\\2:/^R5^Q[^TW;?%+QSXMU#4->\5:MI5O)<7FI7IB:>^UK4Y_+2*(
M.RQQ*HP$WV\$4:QHJI]5^,/@/\#OB%K!\1>/_@UX4US4#$L9OM8\.VUS,47[
MJ[Y$+8&3@9P,T_P7\#_@M\-M5?7OAW\(/"^@7TD!@DO=%\/VUK*T1*L4+Q(I
M*DJI(SC*@]A0!\ _\$6-#T'_ ()U>.?VJ_V&/CIXCT_PU_PC?Q@U'XC^%]0U
MR]2UAU#PAJEO"(+Z.20A7CA-F\<[@D12DJQ'&?F+PE_P3'^,7[;'_!'[]M'X
MRZ'X0OH/%/[2_P 8]3^)/PMT2ZMVBN;S2++4OMFFIY;@,KW48NEB#  I/"^<
M-FOV=^(?P5^#?Q=ET^?XL?"7PSXG?2+CS])?Q%H-O>FREX_>1&9&\MN!RN#P
M/2NF  & , = * /S"_X*.?M/Z-^V#_P04T3P%\![J'7?B-\?] \/^$O"7@RU
MF4WTFLR7%J-2M9(OO1&S2*\-PS +#Y#;RHYK]!?V8_@S9_LX_LV_#W]GK3[T
M7-OX#\#Z3X=@N57 E2RLXK8/@],B+/XUHZ%\%/@UX7\?:A\5O#7PD\,:=XHU
M=-FJ^)+'0;>&_O5R#B6X1!)(,@<,QZ5T] !63XZ\':7\0?"-_P""];N+N&TU
M& PSR6-RT,RJ2#E'7E3QU%:U% 'A?_#O?X)_]#;X[_\ "RN?\:Q/^">/@+1H
M/@;J5NEU?%8O&FJQ*3>,20DVP9/<X49/<Y-?1]>%_P#!/?\ Y(GJW_8]ZS_Z
M4F@#US_A!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:OS
MP^,\"6WQA\66T98K'XEOU4L<G N'')[U^D]?FW\;_P#DM/B__L:-0_\ 2F2@
M#EZ*** "BBB@ HHHH **** "BBB@ HHHH *_0_X,>#M+N?@]X3N9+B[#2>&K
M!F"W3 9-NAX':OSPK])/@A_R1;PA_P!BOI__ *31T :'_"#Z1_S\WO\ X%M1
M_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &
M/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!\Y?\ !0+P[8Z1\'M+N;6:
MX9F\2Q*1+.6&/L]P>A^E?(%?9W_!1?\ Y(MI7_8T0_\ I-<U\8T %%%% !11
M10 4444 %%%% !1110 4444 >Z_\$_=*MM7^,.J6UU)*JKX:E8&*0J<_:+<=
M1]:^O_\ A!](_P"?F]_\"VKY)_X)T?\ ):=5_P"Q7F_]*;:OLZ@#'_X0?2/^
M?F]_\"VH_P"$'TC_ )^;W_P+:MBB@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_
M ,"VK8HH Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VK8HH _(O\ :$@2V^/O
MCBVC+%8_&&IJI8Y.!=2#D]ZX^NS_ &C/^3A/'?\ V.>J?^E<M<97]O97_P B
MRA_@C_Z2C^%LU_Y&E?\ QR_]*84445W' %%%% !1110 4444 %%%% !1110!
M^KG[/?@[2[GX!^![F2XNPTG@_3&8+=,!DVL9X':NP_X0?2/^?F]_\"VK%_9S
M_P"3>_ G_8F:7_Z215V5?Q#F?_(RK_XY?^E,_NG*O^170_P1_P#248__  @^
MD?\ /S>_^!;4?\(/I'_/S>_^!;5L45PG>8__  @^D?\ /S>_^!;4?\(/I'_/
MS>_^!;5L44 8_P#P@^D?\_-[_P"!;5\T?\%3/#MCI'P#T6YM9KAF;QA I$LY
M88^RW1Z'Z5]7U\P?\%8?^3>]$_['.#_TDNZ^MX$_Y*_!_P"/]&?(<??\D=C?
M\'ZH_/JBBBOZ_/XV"BBB@ HHHH **** "BBB@ HHHH *^EO^"6>E6VK_ !\U
MJVNI)55?!\[ Q2%3G[5:CJ/K7S37U!_P2>_Y.$UO_L3)_P#TKM*^2X[_ .20
MQG^#]4?7\ _\EC@O\?Z,^[/^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VK8HK^0
M#^R3'_X0?2/^?F]_\"VK0TW3H-*M1:6[R,H8G,KECS[FK%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7A?_!/?_DB>K?\ 8]ZS_P"E)KW2O"_^">__ "1/5O\ L>]9_P#2
MDT >Z4444 %?FW\;_P#DM/B__L:-0_\ 2F2OTDK\V_C?_P EI\7_ /8T:A_Z
M4R4 <O1110 4444 %%%% !1110 4444 %%%% !7Z2?!#_DBWA#_L5]/_ /2:
M.OS;K])/@A_R1;PA_P!BOI__ *31T =11110 4444 %%%% '@/\ P47_ .2+
M:5_V-$/_ *37-?&-?9W_  47_P"2+:5_V-$/_I-<U\8T %%%% !1110 4444
M %%%% !1110 4444 >_?\$Z/^2TZK_V*\W_I3;5]G5\8_P#!.C_DM.J_]BO-
M_P"E-M7V=0 4444 %%%% !1110!^1W[1G_)PGCO_ +'/5/\ TKEKC*[/]HS_
M ).$\=_]CGJG_I7+7&5_;V5_\BRA_@C_ .DH_A;-?^1I7_QR_P#2F%%%%=QP
M!1110 4444 %%%% !1110 4444 ?KE^SG_R;WX$_[$S2_P#TDBKLJXW]G/\
MY-[\"?\ 8F:7_P"DD5=E7\0YG_R,J_\ CE_Z4S^Z<J_Y%=#_  1_])04445P
MG>%%%% !7S!_P5A_Y-[T3_L<X/\ TDNZ^GZ^8/\ @K#_ ,F]Z)_V.<'_ *27
M=?6\"?\ )7X/_'^C/D./O^2.QO\ @_5'Y]4445_7Y_&P4444 %%%% !1110
M4444 %%%% !7U!_P2>_Y.$UO_L3)_P#TKM*^7Z^H/^"3W_)PFM_]B9/_ .E=
MI7R7'?\ R2&,_P 'ZH^OX!_Y+'!?X_T9^@E%%%?R ?V2%%%% !1110 4444
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MAC/\'ZH^OX!_Y+'!?X_T9^@E%%%?R ?V2%%%% !1110 4444 %%%% !1110
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M,^0X^_Y([&_X/U1^?5%%%?U^?QL%%%% !1110 4444 %%%% !1110 5]0?\
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M10![]_P3H_Y+3JO_ &*\W_I3;5]G5\8_\$Z/^2TZK_V*\W_I3;5]G4 %%%%
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MO^#]4?GU1117]?G\;!1110 4444 %%%% !1110 4444 %?4'_!)[_DX36_\
ML3)__2NTKY?KZ@_X)/?\G":W_P!B9/\ ^E=I7R7'?_)(8S_!^J/K^ ?^2QP7
M^/\ 1GZ"4445_(!_9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>%_\$]_^2)ZM_P!C
MWK/_ *4FO=*\+_X)[_\ )$]6_P"Q[UG_ -*30![I1110 5^;?QO_ .2T^+_^
MQHU#_P!*9*_22OS;^-__ "6GQ?\ ]C1J'_I3)0!R]%%% !1110 4444 %%%%
M !1110 4444 %?I)\$/^2+>$/^Q7T_\ ])HZ_-NOTD^"'_)%O"'_ &*^G_\
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MZ+[\+/\ P57O_P 11_P["_X**?\ 1??A9_X*KW_XB@#C**[/_AV%_P %%/\
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M?\*7_P""UO\ T>1\+/\ PD?_ +FH ^5/VC/^3A/'?_8YZI_Z5RUQE?07B/\
MX)5?\% _%OB&_P#%7B#XZ?"RXO\ 4[V6[OI_[-OT\R:1R[MM50HRQ)P  ,\
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M[K_PZ)_;K_Z+3\+/_ '4/_B:/^'1/[=?_1:?A9_X ZA_\31_Q&/AC_GS6_\
M 8?_ "P/^(+\4_\ /ZC_ .!3_P#E9X517NO_  Z)_;K_ .BT_"S_ , =0_\
MB:/^'1/[=?\ T6GX6?\ @#J'_P 31_Q&/AC_ )\UO_ 8?_+ _P"(+\4_\_J/
M_@4__E9]^_LY_P#)O?@3_L3-+_\ 22*NRKXL\.?L[?\ !9;PEX>L/"OA_P#:
M\^%EO8:9916EC!_PBK/Y<,:!$7<UN6.% &223CDFKO\ PI?_ (+6_P#1Y'PL
M_P#"1_\ N:OYTQE:.(Q=2K':4FU\W<_I+!498;!TZ4MXQ2=O))'V-17QS_PI
M?_@M;_T>1\+/_"1_^YJ/^%+_ /!:W_H\CX6?^$C_ /<U<QTGV-17QS_PI?\
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MB?VZ_P#HM/PL_P# '4/_ (FC_B,?#'_/FM_X##_Y8'_$%^*?^?U'_P "G_\
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M^%G_ ( ZA_\ $T?\1CX8_P"?-;_P&'_RP/\ B"_%/_/ZC_X%/_Y6>%5]0?\
M!)[_ ).$UO\ [$R?_P!*[2N4_P"'1/[=?_1:?A9_X ZA_P#$UU'PG_X)X?\
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M/U1UB4,I]P016Q110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5Y!X-\"^+K#]M/QI\0+S09X]%U#P?IUK9:BP'ERS1NQ=!SU ->OT4
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M>.-?B\!6W[+FL)/X?AU.1-/NM2@UN%#NAW>69634(6W$9_T9.?E%>2?MB_\
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M]J=U\0;K1II+NZUU6&HSV!NIOL$EWO\ F,[6GD,Q?]X<@R?O"]>F?ML_L._
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M>'[ W=\]_>)+J6I3W,TLEQJ=WC#/+<W/GR-)@*7+A<!=H].H **** "BBB@
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M\+[;3++2?"%M;Z-;Z-I3IY>DQPV\1AM2BG]UM@:$A#@['0]&!/YC_P#!2/\
M89NOV+?V^OV>O^"BO[%'Q(\;V'C;X@?'CP_X"^)/AG5O&FH:K;>)]&OC*9MP
MO9I75888)6\L-Y4:_O56-H=Q /U5HHHH **** "BBB@ HHHH **** "BBB@
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MQ3$<2EBS,226=V=F=W8EW=V9BS,2>@HH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ew-20230930_g7.jpg
<TEXT>
begin 644 ew-20230930_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_A'XD:D/#?BC4?'5UJMUJ?B"]BTL6]CHD7EW'V6ZD$-GY:RW!:18XRP8LY.
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M:^-/&EY;^(/%?C+QWXLNOB]/>JLDNH:Q<ZE.9/M0/5WLGLP0W\!0=,4 7O\
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MVEIXD"8R=-O)X4MM1'(Q]FDDW9XS7M]S<V]G;R7=W.D442%Y99&"JB@9))/
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M.^$OCGXQ66C?&CQMX0GG@O[#1!$\IMDN+?\ ?6RSE#YDD)$WEPR+&<O@T_\
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M7[('[.-KX;NOC;^T=X1\/GQC<6T/A*VNM8C>XUIKAU2%K2&,M)<(S.GSHK*
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M4 %%%% !4.HVL][I\]E;:C-9R30LD=W;JAD@8@@.HD5D+ \C<K+D<@CBIJ*
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M;X%_:N\8_ML>%OC)\1;;XB^/-%CTGQ+K!U>SDAN+.)$6");5[0P1>5Y:%&1
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MO^":/P'_ &;/B=\3?BKX5\5>+M;O/C+=M=?$W3_%>I6]]8Z[.5D3?) ;<+$
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M:[*?U#O;"QU&'[/J%E%/'G.R:,,,^N#3;'3--TQ&CTW3H+=6.66"%4!/O@4
M>-?MC_\ !/W]G#]N+X+Z#\"_B]HFIZ;I7A/Q!8:YX/O?!VJ/I5[H&H62LEM/
M9RPX\ED1W10!@!N "JD<7^UA_P $?OV(/VT/V>?#?[.GQQ\%ZU>VG@ZZDO/"
MWBN+Q)<GQ!IUY*_F7%T-0F:26:69\R2F8R"1\.P+*K+]044 ?.O[)G_!,KX#
M_L7?#OQ#X1^#?C?Q[/X@\56\-OKGQ)\4^*#JWB.>&'<(8A=74;I%'&'DV1I&
MJ*9&8+O.ZLKX$_\ !*'X!?LV?LC^(/V'O@[\2OB'I?PZ\1QWD5YI;:_!//!'
M>!Q>)#<R6S31"82-NPV5/*%"6+?3]% 'R]#_ ,$FOV?8/V%V_P""<<7Q'^(0
M^$[6AL3HG]O6_P!H^PF0RFS^U_9O/\DR'=C?NQ\F[9\E7?B+_P $K/V9/BQ^
MSK\/_P!G'Q]J_C2\M?A-=V=U\,/%=OXHDL]=\,SVD2Q6TMM>6RQEFCC4*#*L
MF< MN(!'TI10!XW\(_V)?AS\-OBC;?'?QIXZ\6_$CQ[IVC2:1H_C'XA:C!<W
M6E6,A4RP6D5M!!;6QE*)YLL<*S3!%$DCA5 \=_;*_P""&?[#_P"VE^T);_M7
M>))?'/@3XC"U2UU/Q?\ "WQ=)HMYJT"*$2.Y9%8.0BA-ZA9"BJI8A$"_8U%
M'S-\;/\ @DQ^R1\</V-]._8#U2R\1:'\*;)TDN_#7AW6S"VJRK<+=+-=W,B2
M7$\GVE3.SF0&25V>3><$>]?"_P !_P#"L? .E^ %\8:SKT>DVJVT&I^(;B.:
M\EC4802R1QH)"%PN\C<V,L68ECOT4 >-_MD?L3^!?VT_#OAW1O%OQ7^)'@N\
M\*ZZNK:)KWPS\:SZ->PW 0H0S1[DE0@]'1L<X(RV;_P3_9!^&WP9\6M\3[OQ
M)XH\:^-7TG^RO^$V\>ZXVHZC%8[U=K:#Y4AM8W=$>18(X_-9$:3>40KZK10!
MY1\>/V/?AG\=?B%X;^-1US7O"7Q \(6US:>'O'G@^\B@U&WL[C;Y]G()XIH+
MJW<JC&&>*1%=%=0KC=1\*OV2/@9^SO\ !SQ5\.O!&DZNMOXKFU#4_&NO/?W%
MWK6NWUU&5N;V:Y7,\MRRX"[/N!42)5540>KT4 ?(W_!'C]@VQ_X)^?!'QC\+
M/!,OBVT\"ZQX]EU7P!X>\;ZH+K4M.T\V5I#))/M55@>YNH;FZ$ "F-)T#JDI
ME1?0/V\/^"=OP2_X*)^$]!\"_'OQAXZLM'\/:J-3M-/\'>+9M*2>\4J8IYO*
M&9'B*DQDGY&9F'."/>:* /A_X3?\&_G["GPD^+'A?XPVOBKXM>(;_P (:_;:
MUH^G^+_BA?:E8"]MW$D$KV\K%',<BJZYZ,H/:OHGX\?L>_#/XZ_$+PW\:CKF
MO>$OB!X0MKFT\/>//!]Y%!J-O9W&WS[.03Q3075NY5&,,\4B*Z*ZA7&ZO5Z*
M /(?AU^Q/\'/A'\%/%7P6^&=_P"(]%/CBZO;[Q;XQL]>E_X2#5-1NUVW&H27
M[9D^TL  LBX$2JBQ"-40+\J:3_P;1_\ !/G0=,31-#^)/QULK*,,([2T^,NI
M1Q+N)9L(I &223QR2:_0FB@#YF\>?\$I_P!GGQ5^S9\-OV7_  5\0OB;\/M'
M^%%S%<>$-8^'GCVYTS4XY55@\D\R[EN6D9W=VD1B7=B,;FSZ)\$_V0?AM\&?
M%K?$^[\2>*/&OC5])_LK_A-O'NN-J.HQ6.]7:V@^5(;6-W1'D6"./S61&DWE
M$*^JT4 %?&6A_P#!!W]@70%^)?A^RL_'A\'?%2?4+KQ!\-#X_OE\-6][>QM'
M->V^G(XB6X&[=&\@D\EDC:,(8HRGV;10!\=^(O\ @A_^QWXF_9C\#?LB7_BW
MXE#P7\/];L]9T.W'C>1[I]1M(_*M+F6YD1I3Y$6(XH49((T1 D2[5QW7[0O_
M  37^%?[4'Q+^&OQ?^+OQ@^(=UXA^$>H_P!H^!;ZPU>SM!97Y$8>Z>.*T6.=
MW\I PD5DQE0@5F!^BJ* /ES]I+_@D?\ LS?M&_M'Z/\ MAP^,/B#\//BKI>F
M+IMWX]^%WBPZ-?ZQ9* !;WNR-HYTP ,[ VT*N[:B!=7]E7_@EE^RS^QU\?/'
M/[2OPAN?',GBOXAS6\GB:YUWX@:C>PW1A@\I#+"\NRZ?YI)/.N1-,'FD99!N
M(KZ.HH \K_;+_9"^&W[<WP(U+]G'XP^)/%.G^&-9E0ZU#X3UY].FOX5#9MI9
M4!9H&)!>/@/L .5R#\HR_P#!M?\ \$][Z$:?X@\>?&[5M/8J+G2=6^,6I3VE
MU&""8I8F;#QL!@J>H.*_0*B@#S7]HK]D_P"#_P"TWX<T'1O'NG7EC?\ A#6X
M-9\%>(_#]W]CU'P]J$*E4N+2900AV,R-&RM%(C,DB.I*U4^!?['_ ,,/@/XF
M\5?$O2]7USQ!XZ\;K GBOX@^*+V.XU:_C@0I;P@I&D%O!$&;9!!%'"&9FV%F
M9CZK10!\":C_ ,&XW["NJ^(M7\6WOQ<^/1U+7]5FU/6KR/XS:BCWMY*<R3R;
M2-SM@98\\ =A7IL/_!&W]D:Q_8DU3]@/1M;^(&G^!/$.OS:OXJN+/QM.NJZ]
M-* )$O+P@R31,JQ*4. RP1J<J"#]744 ?G[+_P &U_\ P3WOH1I_B#QY\;M6
MT]BHN=)U;XQ:E/:748()BEB9L/&P&"IZ@XKZ8_:6_8+^!7[5?Q1^$'Q<^)4_
MB&VU/X(^+?\ A(O!<&@:V]G;-=;8U"7,2#$T0\I/E^4XW)G9)(K>U44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T ;%%8_P#PDNK_ /0H7O\
MWTM'_"2ZO_T*%[_WTM &Q16/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2T
M;%%8_P#PDNK_ /0H7O\ WTM1KXOOGN6LU\+71E10S1B1<@'H<9H W**Q_P#A
M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\
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M9'4=:D_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
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MX9:7J T[P_)\:(=:_MC59(4"7-V$L-R);M<"58MP5GC19!E9%) /O2BOA_\
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M-WQ;TKP=XS\'^,[/Q#H]]KVC27UA>B&.:&:QN8XI8G6&>&XEC9T8LH;*C."
M#\J/V;OC_P#M7_\ !OM\=_'/P;_:&OM1^+W[*9^+FF^&+OXOW9SKWA#4I_#V
MB26;7J;V\VS2RFL;7(XQ:$Q^6=EO)^Q?QHT'XP>)_AOJ6A? GXD:-X1\3W,#
M)IWB#7?##ZQ!9L01O^RK<VWF,#@C,FW(Y5AQ7P[XP_X)]?M<?MVZI\4?@E^V
M-I_@GP9\+?$WQMT3Q3XPLO"FH7FJ77C"#3] \/QQ6=K+<6]LMG9O<Z>IEE*R
M3;XI85"A1/)]#_&O0O\ @J-9_M*0>*?V;_'?P6U#X63Z+%#>^$_'>FZE;:I:
MWH9M\\-Y:>8L@8%?E=  !M !^<@'S'_P0U^*O[5'PG^.WQY_X)?_ +:6D>'M
M3\<?#36H/%T?Q(\,V/D+XQM];DEN7OKH87=<E]N6P#@F+'[@,WUK_P %$/VS
M?"O[ 7[(OBO]I_Q79?:5T6.WMM.MWMYY(GO;J>.VMS,+=))5@6257E:-'<1H
MY1'?:C3?LQ?LH3_!KX@^//VAOB;XNM?$OQ-^)]S8MXLURPTPV=E;6=E"T-CI
MME TDCQV\*O*VYY'DEEFED8@,L<?DG_!+KQ#_P %#8?B5\;/A1^W5\>?"?Q/
MMO"_B*Q/A3Q=X0T!+"WM);G[7)<Z*P2*,2/:PKI\A)#LAO3&TKE. #\N?^"D
M'_!3O_@ESXC_ &._A-\*O@A^U=J'COQM:_M,^&?'OQ3\37WPXU[3YM8GC>9M
M0U)OM-C&NU08HX;9&9HX(H88U*Q#'V%^W+_P69_X)U^//$7P_P#A5XZ_:)U#
M1/@]\4O"9\3>*O$<?@/7I)/$.APWLUHNB1PP633P"[N;:=;AI4C_ -%MY8UR
M;I'3ZK_X*E?L(>+?^"@'PH^'OP[\'^/-.\/S>#/C+X?\:75SJ5M)*MS!I[S,
M]NH3D._F#!/ QS7T%9?\CO>_]>47\S0!^-W[*O\ P5M_X)V^,_\ @XA\6_%/
MP'\;9I/"_P 0_@WX<\">!KF/P+K, O-;;4X$CL_)>R62W7E1YLJQPC^^ *_6
MW]J3X^^%?V5_V;O'?[27C=@=+\#>$[_6[N(OM,XMX'D$*_[;LH11U+.!WKR'
MP%^PAXM\(?\ !6+QY_P43N?'FG3:+XO^$FG>$+;PXEM(+JWGMKI)VG9S\A0A
M< #G)KJ/V^/V8/&O[8'PS\*_!'1];TNT\+3?$K0M5^)5OJ,D@?4M!T^Z%])8
MP!$8,\]Q;VL;!BB^2TWS9PK &=_P2T^ 'BK]G']A;P)X/^):EO&VMV<WBCXA
MW$B8DF\0ZM/)J.H%R>6*W%S)&"?X8U';%3?\%1/'/[*GP^_8(^)6M_MK>%I-
M?^'%QH/V'7/#UK$7NM6DN)4AMK2V 92+F2X>%8F#*4DVON786'L_CVQ\7ZGX
M&UK3?A[KMMI>OW&DW,6AZG>VGGPVEXT3"&:2+(\Q$D*L4R-P!&>:^6_'/_!/
MCX]?MB?\$N8?V-/^"@W[15CKGQ2N8TN[_P")_@[0X[:*VU:VU W>GW<5J$AC
M<1!((W39$)0LF!&7R #\[?@_X)_:E_X(J?M$_ K2_P#@IGI%Y\4/V=9M3ATS
MX1^(KS7GU(_!?7;W*1V]W^[CCO&BC8VZ7;1XCB65[40 R6[_ +F5\H_'?]D;
M]IO]NGX1:%^S9^V1_P *YL/"%OX@TC5?&VH^"[^]NKKQ1_9UW%>1V\-O<V\2
MZ3'+/!$9&$UVXC\R)2"XE7ZNH **** "O"_ /_*03Q__ -B)I7_HQJ]TKPOP
M#_RD$\?_ /8B:5_Z,:@#W2BBB@ K\[OVS]!^+.M_\%P_V8_VB?"W[/?Q!UCP
M#\+/#?BW3_&_BS2_"%S-;64^HV+P6XC4+YERH<+N:%'4!Q@G! _1&B@#Y%_X
M+%_L0_$3]L3X$>#/'?[/]I:S_%/X*?$O2/B'\.K*]N%MX]4O-/EWOISROQ$)
MX\A6;"B6.+<57<1Y]^UO\'_'?_!6WXU_L_>"#\$/&OA#X7?"SXAVWQ%^)5]X
M_P##[Z5+<ZE90.EAHEM!+\]VS23S>?/%FV6,?)-(S*M??=% 'PWXG_9W\<_L
M7?\ !6_Q1_P4*\&_#O7_ !/\.?C;\/K30_B9;>$M(EU'4="U[33&MCJ'V. -
M/<6LMJA@801R/'* [#8Q(T_V OV2?B/=_MV?'G_@J/\ '/P3>>%]5^*RZ9X>
M^'OA'52GV_2?#.GV\48FNU1F$4UY-$EP8-Q:%50/ARR)]HT4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5X7^UA_R6SX'_P#8]R_^DS5[
MI7A?[6'_ "6SX'_]CW+_ .DS4 >Z4444 %%%% !1110 4444 %8]E_R.][_U
MY1?S-;%8]E_R.][_ ->47\S0!L4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!C^)?\ D+Z/_P!?I_\ 036Q6/XE_P"0OH__ %^G_P!!-;%
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M#_[+/C[]C_PE9^%X?C1X2\6Z5\7?#GAFS2TL=1L-+LDGAO;F&(*@<27$6)"
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M] _:X_9[\4:Y9^&]"^(/GWM_<I;VD/\ 9-VOF2.P55RT0 R2.20* /2****
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M[+_@N%[CQ'X^_:H\.0:?;1#+K;Q6U]]HN..B1"2-F;HJDDX H ZO4?B[J/\
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M/'?$_P#T3J#_ ,&?_P!IH ^N**^1_P#AX[XG_P"B=0?^#/\ ^TT?\/'?$_\
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M:/L7C?\ Z#=E_P" Q_QH V*\+\ _\I!/'_\ V(FE?^C&KUS[%XW_ .@W9?\
M@,?\:\<^&$=_%^WUX^34[B.6;_A!=*W/&FT']X^.* />Z*** "BBB@ HHHH
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MB6ZBN?%/BOQ#JDM_JNLS1IY<1N+F8EBD:96.%=L42DB-$!(/?44 ?"_[*_\
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M+_D=[W_KRB_F:V*Q[+_D=[W_ *\HOYF@#8HHHH **** "BBB@ HHHH ****
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M'/&'P^\1/H/Q!\#Z]Y7V_0K\*)$#&)WCF@FB998;B-F26-L@A@Z* >M4444
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MG_!1#_DN-A_V+,'_ */N*^TZ^+/^"B'_ "7&P_[%F#_T?<4 >#4444 %%%%
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
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M#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\
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MON* /":*** "BBB@ HHHH **** "BBB@ KJ_@3/%;?&OPE<3R!4C\1V3.QZ
M"=,FN4KK?@*JO\;_  @CJ"#XEL@01P?WZ4 ?H;_PF/AC_H-0?]]4?\)CX8_Z
M#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]5\WK
M\>?@]\,/V\?'&M>/_B!I^E6MUX-TN"WGNG(6216+%1@'D*0?QKZ<_L[3_P#G
MQA_[]"O ?"OA7POK?[?WCVVUKPW87D:>!]*=([JS2158NP) 8'!QQF@#O?"G
M[7?[-/CGQ':>$?"/QCT>_P!2OY?*L[."5B\KXSM&5Z\5Z/6/8_#[P#I=Y'J&
MF>"-'M[B)MT4\&F1(Z'U#!<@UL4 >>?M=_#CQG\8OV3_ (G_  C^'&H"T\1>
M*OAYK6CZ#=M+Y8AO;FPFA@<M_#B1U.>V,U^:?_!-C_@H[^RS\-/^",=]^QU^
MU1JTO@_XH_"+X;:[X:^('PHUK2+C^V!%;0W/[]+18VDFMWMBKO,JF./+[V 7
M<?UJOKR'3K&;4+A)6C@B:1U@@>5R%&2%1 6<\<*H))X )KXP_;F\"_'_ /X*
MC>$#^Q?\)O#'B?X>?"'7[F)?B[\3O$VD2Z5J&I:6CJ\FC:/872K=>;<%0DMW
M<11P)$6"?:"Y50#\J/A7J?Q.U3_@F'_P2D^ ?Q'FN?[$\6_M1I>WUM<DC[18
MVOB*4643Y^\C07;E >-OE^@K[W_X.B/$6H?#G]F?]G[XS^%9&@\1>$OVKO"E
M]H5U"<2"46^H,8P1R0VQ<KWVBO7_ /@J%_P39OOC#^R+\,- _8V\):;I_C']
MFWQIX?\ %_P>\.M<"WMKDZ055=)\USB)98%"J[''F1Q;V"[F',_M;_!_QW_P
M5M^-?[/W@@_!#QKX0^%WPL^(=M\1?B5?>/\ P^^E2W.I64#I8:);02_/=LTD
M\WGSQ9MEC'R32,RK0!]]T444 %%%% '+?&KX3_#;XX?#+4_A?\8-%MM2\,:D
M(6UK3KX*;>Z@BF28Q3!P5:)O+"NIX9"P/6OA/Q/_ ,%4_P#@VFT/QS-\"-?^
M*GP+DNF=K">*#X=BYTHC[C(U[%8M9>7@X),NS&>< U]"_P#!7OX(_';]I#_@
MF=\9O@?^S1=RQ^-O$?@N:VT:""X$3WH#H\]FKD@!KB!9;<9(7,W) R:XS]CG
MP?\ \$\OV4?^":S^-?@;\!M/B\)>"_ ,EYXXT&Q\(I-X@EN;2R\Z\M=1MG03
MR:CPP>&?#[F X7% '3_\$DO@I\:_@3^R3_PB_P :O$7P\U-M1\7:KJ_A&;X8
MR--I<7A^YF\S3XDN&16NMD)"K,V]C$(5+N5+'Z<KY5_X(^^)/^$Z_9:U3XD^
M%?@1KOPP^'WB?QYJ>J_"CP%XDL$L[O2= F6$C-LC,MK'->"^N8X5)1(KF,)\
MFVOJJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX[_;
M_P#V7?\ @JI\>/VB/#.H?L/_ /!1@_!3P(O@VYC\2P/\/]+UT-JT5TA@94NE
M64&:&XE!(D*)]A7Y09<G[$KRK6_V=_'VK?MD:+^U!:_M-^,;+PUI7@>?0;KX
M2V\J?V'J%U)<-*NIRJ?F^T*K",'KA$PRC>K@'QK_ ,.T_P#@OA_TL-?^:WZ)
M_P#':Z_]F+]AO_@J?\'/VL? GQ/_ &P/^"H\7QR\&Z>=3A_X1B3X=:?X<-C>
MRV$RPWB_9G)NB%$L>P_,HF+ ;=Y&5\8O^"0W[;/QL_:.^(_Q4L?^"R?QU^'O
MA;6_% NO!?@_PCK;/;Z=9/:6[2H?,D&P"[:Z5(U4*L2Q<DD@7OV:O^"9?QU_
M9,_; ^'GQ9^+'_!5GXI?&*S)U:PM/!/Q,U(R1&:73Y6^UVJJ[ RQK&RG<O"3
M/AU/RN ?>]%%% !1110!R7@7X,>$_ OC37_B7'<WVJ>)/$ODQ:IKNK3K).;2
M!I6MK*,(JI#;P^=+LC15!:621]\DDDC=;110 4444 %%%% !1110 5X7^UA_
MR6SX'_\ 8]R_^DS5[I7A?[6'_);/@?\ ]CW+_P"DS4 >Z4444 %%%% !1110
M 4444 %8]E_R.][_ ->47\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 8_B7_D+Z/_U^G_T$UL5C^)?^0OH_
M_7Z?_036Q0 4444 %%%% !1110 4444 %%%% !4=W_QZ2_\ 7-OY5)4=W_QZ
M2_\ 7-OY4 ?EO1110 4444 %%%% !1110 4444 %%%% 'U5_P34_X]/&7_72
MP_E<5]15\N_\$U/^/3QE_P!=+#^5Q7U%0 4444 %%%% !7Q9_P %$/\ DN-A
M_P!BS!_Z/N*^TZ^+/^"B'_)<;#_L68/_ $?<4 >#4444 %%%% !1110 4444
M %%%% !77? +_DN/@_\ [&:Q_P#1Z5R-==\ O^2X^#_^QFL?_1Z4 ?H]1110
M 5X7X!_Y2">/_P#L1-*_]&-7NE>%^ ?^4@GC_P#[$32O_1C4 >Z4444 %%%%
M !1110 4444 %%%% 'C/_!0W]L#1?V!?V*OB+^U]KGAN368_!&@-=VVDQR^7
M]MNI)$@MH6?!V(T\L2LX!*J6.#C!^#OASH/_  <#^,O@AX3_ &R_CO\ \%*/
M"_PWN/''B7PS!IWP<\/?!32]2LM(M-9U:RLXQ<W5PRW+21QW8=H5E+ IL\\$
ML1]\_M[6W[,]_P#L?>/='_;)M8I/A=J.B_8?&TDSE$MK*>5(6N6<$-&(BZR^
M8IW)Y>]<LH%?&'QV_:1_8$^,_P#P3_N?V)M/_P""]WPF\/ZU:7>B?\(G\5[#
MQ7I:ZQIMOI>H65W;O,L6H1I/>$6>QKF/R%S('$(*D. ?;7[)GQF\:_%KP5KF
MA?%BWT9/&W@3Q3<>&?&;^&VD.G7%[#%!<)<6PD+/&DUM=6TQA=F:%I7B+R&/
MS&]3KY:_X(Y^&_V3_#?[$.FQ?L>_%W5OB%X>G\5:XVN?$#Q#J@O=1\3ZU'J$
MT%]J5Q,"?,,TD.^-N\#0GG.3]2T %%%% !1110 4444 %%%% !1110 4444
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M5W_!U$NI7O[(?P+T'PR&;7=0_:M\)PZ D7^L-V;;4MA3'.<\9']X>M>_^/\
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M5^)O[3'B7QWX+N?$7AV6*"_T>]=/)<RKN2&7"9,4A5OF& <' !]X?\)+J_\
MT*%[_P!]+7YY?\'$>M:A=_#W]E$3^'+F'R_VW? ;H9"OS$)J/RCW-?0FM?\
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M=WDD#;@7'7/K_2OI;_A)=7_Z%"]_[Z6OG7_@FI_QZ>,O^NEA_*XKZBH Q_\
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M?X#;]G+]IO5_@=K?COQ?X/N6^!GC32(M0BT*VUNVM?-.AZK&JB:1?(5[B*>
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M_M)>*]7US4/A'\<-0TGPEXV>X']HM)I,\36M^)75A)*CO)&6=75U!5PV6S]
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MI7_HQJ /=**** "BBB@ HHHH **** "BBB@#\6/VO_AEX?\ A-_P0L_;SO\
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MG!P3@UU?BSPAX5\96,%GXPT.'4;6SO([R.UN8S)&9HB6C=H^DA5L.H8'#JK
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MH *_2?X+_P#)'?"?_8LV'_I.E?FQ7Z3_  7_ .2.^$_^Q9L/_2=* .EHHHH
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MU+X@_LY^//#?C?XE6-U:R/J<OAM+E/M%S-'CS&N%M8K*:;(W@>>[8*FO;O\
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M$VB7^F:3XQ^,NNZ]X0T_4[5[>8:;,T2K,89 'A$TD<LP1E4XD#$#?7T%110
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MX-^%/C)HUC):VGBKP[9:M;VLS9>!;B!)1&Q[E=V">^* .HKU?]B3_DY7P_\
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MDBD1UDBFCD0AHY$D575U(*LH(J;R_P!K+_HPCXI_^"8?XT>7^UE_T81\4_\
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MK+_HPCXI_P#@F'^-'E_M9?\ 1A'Q3_\ !,/\: .@HKG_ "_VLO\ HPCXI_\
M@F'^-'E_M9?]&$?%/_P3#_&@#H**XOPGXN_:-\<:;)J_A7]B;XC:C;174EO)
M/8:>LJ++&VUT)'1@>".QK4\O]K+_ *,(^*?_ ()A_C0!T%%<_P"7^UE_T81\
M4_\ P3#_ !H\O]K+_HPCXI_^"8?XT =!17/^7^UE_P!&$?%/_P $P_QH\O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^9OC+^Q-XZT?]M[3O^"B7[*>I>'[
M?QQ<>"I/"'CWPOXIGGMM-\4Z4)EGMI#<V\<KVEW;RH-LWDS!XF,150%8:G[%
M?[#\_P"SO\2/BE^T]\6?%5CXD^+7QIUVUU#QMK6FV;065E:6D MM/TJS21F?
M[/;0C;YCG?,Y9V"Y5$^A:* "BBB@ HHHH **** "BBB@ HHHH **** "O"_
M/_*03Q__ -B)I7_HQJ]TJ"/2],BU"35HM.@6[EC"2W2PJ)'4=%+8R0/2@">B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_P!K#_DMGP/_
M .Q[E_\ 29J]TJ"[TO3+^>"YOM.@FDM9-]M)-"K-$V,;E)'RG'<5/0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X7_P3W_Y(GJW_ &/>
ML_\ I2:]TJ#3]+TS2(#;:5IT%K&TC.T=O"J*6)R6P .2>IJ>@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !6!\5];U/PU\+O$OB/1+GR+
MW3] O+FTFV*WERI [(V&!!P0#@@CUK?KEOCG_P D2\8_]BKJ'_I-)0!\7_\
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M[\?(M#-UXC/AY?$%SX>U)M!AU=<[]/FUA+9M/@N4P=\,EPKIM.Y1@UB_!_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP/H]CJ^ME#K6JV>F117-_L&$\^55#2[1P-Q.!TH _!/]OK]JS]G[]IC_ ()
M_"/]HOQ3^UU:^-?B3J?CKP?K/B;PCX<U=X-&^'MM]K'G6']D6C>1I\5NP-NE
MS>JT\Q1MLS*X0?7_ /P5:_:(_9*\ _MR?LB?MM>&/VF_#7A/Q7!!XD;0/$WB
MXS+X3\0>%VM?*NH);N)&9))7GB-I/$'0B5Y2)%\H/^B5A^SA^SSI7A#4/A]I
M?P&\&6V@ZM>B\U71+?PO:)9WMP'#B:6$1[)) ZJVY@3E0<Y%?'_[=O@?]N#0
M/VV--^,UA^PEX<_:6^!\'@ :1IO@&'7=-L]1\+ZHUQYEUJ0M=4Q;WK2QI!"I
M5A(B(541@R^< 0?\$\=<_8U^//\ P4*^)O[</AS]N'X3>/\ XK^-_"-CX?L/
M OPY\6PWD?AWP_9E)&4%V6>^>294DDN##$BX1 @Y+?&'_!)O]H7_ ()-?LM?
M!3Q/_P $_?\ @KA\)OA1X2^,_P (?%6M6&O:K\4/ %G-)XJL9KV>ZAO8[J:W
M?[3N2?8J%BSQK$Z!E<8^X_@#^QQI?QD^.?P__:#U+_@EIX&_9J'PZUN;5[74
M+=-$;Q/J\KV5S:+9YT96BM[(BY,LGF7#M(8D3R5!,B_6WC;]GKX!?$OQCIGQ
M$^(WP.\'^(/$&BE3H^NZWX9M;N\L"K;E\F:6-GBPQ)&TC!.: .?_ &,HOA@G
M[-OARY^"G[/^G_##PA=_:[KPSX.TS0(]*BM["6[FD@N?L4<40M7N8V6Z:%D5
MT:X99!O#5\*?%#Q5??L9_P#!S!I'QT^/^H#3?AU\=_@,O@CP5XMU&016%CKE
MK>Q77]FR3/A(GD$#,BDCS'NT"Y(8#].ZQ?B!\-_AW\6/"\_@CXI^ M%\2Z+=
M%3<Z1X@TN&]M9B#D;HIE9&P>F10!\"^/OAO_ ,-%?\'(7PU^,_PBOHK[2O@A
M\#-2@^).MZ=()+>&ZU&2[AL-)ED3(%P5GDN_))RL:AR!N7.=^P[XW\':E_P<
M?_MJ:#I_BBPGO'\!^!D2VBNT9V:WT^-9P #DF-I(U<?PE@#@U^A/P]^&/PV^
M$GA6'P+\*?A[H?AC1+<L;?1_#VDPV5K$6ZE8H55%SWP.:P]*_9D_9MT+5+;6
M]$_9[\#V=[9W"3V=Y:^$[..6"5&#)(CK&"K*P!!!R" 10!V[ND:&21@JJ,LQ
M. !7Y5_\$)O&7A"Z_P""4O[2^MV_B?3WLK;XQ?$:XN;I;M#'%"T*2+(S9PJE
M"&!/!4YZ5^I>MZ'HOB;2+GP_XCT>UU"PO(6BN[&^MUEAGC88*.C JRD=01@U
MR5K^S-^S?8V-UIEC^S]X(AMKY$6]MXO"EFJ7"JP=0ZB/#@, PSG! /6@#\.-
M-;4-(_X-O/V*?VI[/X81?$?P5\$/C#'XE^*O@]+*.^2?18]1UBUNVD@<%&,8
MN I#C:@FWMA58U]]?L[?M(_\$*?VD_BG\.Q^PM\!/@QX]^(EWJ$.IZ*GAGX9
M65MJ/A*U1DDN=4NIC9A],,*@!=Q1Y9S#$G+[E^Y?"'PH^%OP]T^[TCP#\-?#
M^AVE_P#\?]KH^C06T=SP5_>+&H#\$CG/!-4?A=\ _@5\#Q?CX*_!;PEX/_M6
M42ZG_P (OX<M=/\ MD@SAY?(C7S&&3RV3R?6@#\\?^"<OQN^$GP?_P""U_[=
M7PE^)WQ TW1?%/C+Q_X*?PEX<OK@+?ZTC:3-E[6#_67"(LB/(Z*5BC/F2%4!
M8?>'[9WB_P"%/P__ &0OBEXX^._A0:]X'TGX>ZQ=^,=$*EAJ&E)92M=P8')W
MPB1<#UKM/^%?> O^$V_X67_PA&D?\)']A^Q?\)!_9L7VW[-G=Y/G[?,\O/.S
M.,\XJ]K&CZ1XATFYT'7]+MKZQO8'@O+*\@66*>)@59'1@0RD$@@@@@T ?D1\
M.?@]\9?^"2_[1W[.<W_!/']LB^^,'[,?Q[^)-IX<LOA!XDU)-7ET"SNH9;B3
M5M'NU);[':PI++)M"A %$OFF7>FS??M\?"3]J_XA_M?_  N_:>^.B_#R?X:^
M+-:\)>!_@=X>U632]4\7&WLWBCUJX6TVW^M27+1E4M8B8$@C4212[EDK],OA
M_P#LU_LY_"?Q5>^.OA9\ ?!7AK6]1C*:AK'A_P *V=E=72DY*R2PQJ[@D X8
MGD5J1?"3X50?$&?XM0_#+P\GBNYM!:W/B9=%@&H2P 8$37.SS&0 8VEL8[4
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%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ew-20230930_g8.jpg
<TEXT>
begin 644 ew-20230930_g8.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_A'XD:D/#?BC4?'5UJMUJ?B"]BTL6]CHD7EW'V6ZD$-GY:RW!:18XRP8LY.
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M:^-/&EY;^(/%?C+QWXLNOB]/>JLDNH:Q<ZE.9/M0/5WLGLP0W\!0=,4 7O\
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MVEIXD"8R=-O)X4MM1'(Q]FDDW9XS7M]S<V]G;R7=W.D442%Y99&"JB@9))/
M '>OA#]J3]@?]F;]N?\ 9;\%?&/XV_\ !1;XK:O\-O".H:=X^\%>(_#Z^%;,
M6TL$+?99[>6RT%93E9MJPIRSE%"EPH'WD0&!5AD'J#0!\[:I_P %;/\ @FMI
M7A3Q5XY?]LWP/=:1X+U2'3?$.HZ7JGVR**\ECDE2VB, ?[5+Y<,KE(/,95B<
ML %.(_%W_!73_@FMX&^ _A[]IGQ'^V)X0C\%>*Q,?#VKVUS)</?"%@DY2WA1
MIQY+$++F,>46 ?:2,_-'_!'+P;X2B_X*??M_^)X_#5C_ &E#\8].@AO_ +*A
MFBBFLY)9D5\957D"LP!PQ52<E1C*_P"#=7X3_#*W_9__ &J+&'P!HZQ3?M4>
M.= E4:?'\^E1+;>78GCFW7SIB(ON RN0/F.0#]$/#/QO^#OC'X/VO[07AGXH
M:#=^!KS1/[8M_%R:I$-.-AY?F&Y,Y8(L80$EF("@'.,&O/\ P'_P4/\ V-?B
M/\2=%^$7AOXVVL7B#Q/;/<>$K+6=*O=-3Q'"@#-)ILUY#%%J*A2&S;-*-OS=
M.:_$/0/BKXH\#_\ !J/^R]'J=Q._@?5?VBK?3/BDS$M'_P (TOB76+F6*;_I
MBT\%LI!X.0N,-7Z&?\'1'@^PU;_@DKJ_Q;\)N\/C/X?>.?"^N?#35-+XO+75
M7U:UM$:U9/FWF*YE("]=H/84 ?7/CK_@H#^Q)\,_C#+^S_X]_:E\$Z7XRM=)
MN]4U'P_<Z]$)].LK:$SS7%W@D6B+$"^Z8ID#C-4_V<_^"C7[$/[6WA3Q;XU_
M9T_:.T#Q3IW@/)\8261ECDTI0CN))8I4601LL<A5PI5_+?:25./C']I+P58>
M-?\ @X;_ &09/B[X/TN]U9?@1XANM2M[BT26*._@5I5=0003%.S.A_A;#+@@
M&NC^ MC9Z+_P<[_':+2;9+==7_9GT"]U-85VBYN$OH84E?'WG$:A 3S@8H [
MW]@G_@JE^SM_P5-O?BQ\*;35=8TRUM?B7J7AKP?IT":GI&I7VDV>FV$DMV]Q
M!Y<EJ[W+7I5?,BE6(1JRAL@_,'_!"3_@H=^QW^P]_P $I?#S_MA_M/:7X9N]
M9^)OBH64GB"\FNKV\5=4>,W$BHLDI3<55IW 3<P!;)KV?_@W2_Y)]^UF/3]N
M3Q]G_OC3J\(_X(]?#?P#>_\ !N/\>+ZZ\'::]QX@L?B2FMW#62&2]6);U8A(
MV,N$'W0?NY)&"30!^JOCC]HKX)?#KX9:=\8_%/Q'T]?#>LFT70=2L6:\_M=[
MH VL=E';AY+R28,#''"KLX.5!%9WP1_:Q^ ?[1/B;Q)X(^$WC>6]UWP<MF?%
MF@:CHM[IU_H_VL3&W6YMKR&*6%I!!*P5E!VJ#C#*3^;WP,_9P^-_[5G_  1(
M_8MNOV9OVC],\!_&?P!9Z?XF^%TWB6 SZ?J]S9V%Y;26%P@5B(S:32#<%<JJ
ML N"2/</^"6W[<_Q+^.'[7'Q._9Q_;B_9$@^%'[2_ASP5H\OBFXT2^-UH_BK
M0+:YNQ:7MF^Y]J)-J$XVEY#^^QYA*-'$ ?=NLZSI'AW2+KQ!X@U6VL;"QMGN
M+Z^O)UBAMX44L\CNQ"HBJ"2Q(  )->-^ O\ @HU^Q9\2?B[I/P)\+_'6R'BK
MQ#9/>>%],U73;S3QX@MT&YIM.ENH8XM13;EMUL\@*@L"1S7SW_P<>_$?6OA?
M_P $R[_Q$FHW]EX;D^(WA2W^(%[ID"22PZ"VKVYNL+(CHP<K'&4='1Q(4965
MBIT_VHO^"?/[/_[4WACX6_M*?M ?\%"/BIKNA_#OQ=I7B_X<Z_I4OA>".2^D
MEA6S\F6PT-);A+AW@18HV)E9HPN6VT >R^(?^"H7_!/+PMK_ (Q\,:U^V'X#
M2]^']@EWXSC@UV.9=)5YO(2*5X]RB=I2$%N"9BQ "9(KL_V7?VN/V;?VU/A>
MOQG_ &6?B]I/C3PT;Z6RDU+2G<>1<QA2\$L<BK)#( Z-L=5.UU;&&!/P]^SM
MX%\&:I_P<Y_M$^)-3\*Z?<7^F? [PM<:==SVB/):S.L<+2QDCY',0\O>,-L)
M7."0?!/!OQ$^(G[.W@'_ (*Z^,?@ 9M-U?0/&%SJ6C-I@*-I]S/IDS7%]&%^
M[(@+3[O[T8)Z4 ?37_!:W]LO]C_QK_P3D^.G@2R^/>J0ZKH_A;6+32M;\,W>
MKV>F#Q%;VLIBTR35;,)92W'F@1FQEG8M)A&B+X%>V?\ !//XJ_#KX,_\$B/V
M=?B#\5?&=AH6CVOP&\%1RW^HSA%:631[*.*)!UDED=E1(U!=W954%B ?F?5=
M'^$'B#_@TUGM/ .GZ==Z$/V0FNBD2*Z?VG%I'G7,C=O/6_25W/43*QZBO(O%
M'Q6E\$^%/^"1/A+QI\8M5\!^!=>^&*+=>*=-CL'6TU__ (0_3;;22XU"VN+8
M,S7ES$C/$Q4SLRE"NX 'Z=_ 7]M_]EK]ICQOK_PO^#OQ8@OO%?A6..3Q%X2U
M/3;O2]6T^)\;)9+&^BAN%B.Y<2;-F6 SDBN9_:=_:Y_8NTS3/%OP*^,GQKO=
M/6PT^-/&UUX8EU:/_A&8I@&C?4-2TQ<:.&7#!KB: -&<DE&.?+/'7_!/_P"%
MGPQ_;F\'?\%"?%O[4GQ/\6_&73_!VK>%O!6A:J=$M[+Q! MA?W9L[F#3-)MW
ME5,RS*[2*%D2$%B2B-YK_P &SOB?PM\?/^"/MGXQ\97L'B'Q5XR\:^+;GXO7
M%Z%DEU'6+G4[@R&Z!ZN]D]GD-_ 4'3% &C_P:UZGJ6M?\$2OA5K&LZA/=W=U
MJWB:6ZNKJ5I))I&\0:@6=F8DLQ)))/))J3_@X"_:ZU_]E?X??!+3?$_C;Q-X
M.^$OCGXQ66C?&CQMX0GG@O[#1!$\IMDN+?\ ?6RSE#YDD)$WEPR+&<O@T_\
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M7[('[.-KX;NOC;^T=X1\/GQC<6T/A*VNM8C>XUIKAU2%K2&,M)<(S.GSHK*
MP)('-8/PU_X*6_L%_&+]H^]_9&^%W[4OA37/B+8QSM+X:T^]+O)Y&?/2&7;Y
M4[Q[7WI&[,GEON V-C\T/^"@FCZ5XK_X-[/V#K3Q'817L<WB;X/1S+<+NWJ^
ME"-@2?5&93[,:^@/^"MOA;PUX/\ ^"CW_!/"Z\)>'[+2VT[XM:OI5@-/MDA%
MO8OI\*M;($ "Q;5 V#C QB@#[?\ C3^U#\"/@3JNF^$/B9XVEBUO7K>>71_#
M>B:5>:IJU[!$!YT\-E812W+Q1[EWRK'L3<NYAD5^?_\ P0B\5_#;QG_P46_;
MPUSX-?$:_P#%/A.7Q?X-;0=6U'Q!=ZG*8FL-0DDB,]Y(\^4F>5#'(VZ-E9"%
M*D#H?^"77Q3F^*7_  6M_;O7XL78/C+PSJ7A;0_"EG>G][9^&(8;LHMLK<K#
M)*\=Q)MX:2>-CRRU-_P2.T?1]!_X*\?\%%-/T33X;6)_'_@RYDB@0*#+-IE[
M++(0/XGD=W)[LQ/>@#[;_:<\&_&/XC_""^^'/P,^(4GA#6M>N+>RG\7VR(]S
MHM@\J_:[FV60,INO($B0E@5262.1@RH5/Y=?MY_L7?%+_@CO\1_@K^V=^PQ^
MUS\8]>O?$GQGT/P9X_\ A_\ $7QY<:[:^,(-2E==Q6;_ )>249<X)!E#Q^68
MSO\ U_U#4+#2;"?5=5O8;:UMH6EN;FXE"1Q1J"6=F/"J "23P *^8_#W@JS_
M &ZOCSX4_:X\=6QA^$_PON)]1^$.FWZ;%\0ZL\+PMXHF1\;;>*!Y8K$, 6$T
MUU]U[<@ \M_;S_:%\7_&C_@JA\#/^"3'A/Q=JVA^&=?\,:CX_P#C#=:!J4MG
M>ZEH]L)XK'2UN8&62"&>[@;[1L97>(*@8*[!J_A/XO:E^PE_P6B\+_L!:%K6
MHS?"GX\?#&[USP7H&IZG-=CPWXDTPSO=Q6;SNS16D]G$)&@!*+,I9 F]PW"_
M%'15\$_\'1OP9^-ES=17'ASXL_LS:IH?A/5HI \%U?V4\]]-'$X)5_\ 16AD
M!!Y$N?<S_M@^$]6^+_\ P<U?LI:)X8A>9/AA\'_$WBSQ2\(S]EL[M+O3H&8C
MH'N3&G/7<: .H_:/_P""+7CW]KCPQX@^.7Q@_;T^,GAGXRZA%<7_ (6N_!_C
M^:PT#P5+DO:6-K9PA5>"$"-)9B1-.RR2[XRX"V?^"7'QO_;;_P""A_\ P1)^
M&_CGQ!\29O#7Q(\913Z1JWQ&BMHQ=PZ;;ZI/:S:K!&RE#>R6<#"-RI07$BS%
M2@V'WG]K3Q-XK_:)N=6_84^ 7B6?3]5UK3E@^)_C2P(/_"&Z)<H0Z1M@C^U+
MJ$LEM'UA5S=.-J1)/ZM\*_"_P8^!?PQLO@[\+ET?1/#7P]T>WTR+2K:[01Z-
M:0VZ&-)<MF/$.U\N<E3O).<D _*G]O/]B[XI?\$=_B/\%?VSOV&/VN?C'KU[
MXD^,^A^#/'_P_P#B+X\N-=M?&$&I2NNXK-_R\DHRYP2#*'C\LQG?^H7QH_:Q
M_9R_9W\;^!/AM\;/BYI/AS7?B;K_ /8O@/3-0=A)K-_\@\B+:I .9(ERQ"[I
M8USN=0?(/#W@JS_;J^//A3]KCQU;&'X3_"^XGU'X0Z;?IL7Q#JSPO"WBB9'Q
MMMXH'EBL0P!83377W7MR/>?$?PR^"GQDN_"_Q \6_#_PMXJG\/7:ZOX+UO4=
M*MKY]-G=!MN[*9U8PNR$8EB()&.<4 =31110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !4.HVL][I\]E;:C-9R30LD=W;JAD@8@@.HD5D+ \C<K+D<@CBIJ*
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M;X%_:N\8_ML>%OC)\1;;XB^/-%CTGQ+K!U>SDAN+.)$6");5[0P1>5Y:%&1
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MO^":/P'_ &;/B=\3?BKX5\5>+M;O/C+=M=?$W3_%>I6]]8Z[.5D3?) ;<+$
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M:[*?U#O;"QU&'[/J%E%/'G.R:,,,^N#3;'3--TQ&CTW3H+=6.66"%4!/O@4
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M>))?'/@3XC"U2UU/Q?\ "WQ=)HMYJT"*$2.Y9%8.0BA-ZA9"BJI8A$"_8U%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-2N_#/B'3E_MNUGN@@@TUK6)WS?/))'#Y"L2)&VDC#$<]X+_ &^Q:_&WP7\
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M *\HOYFMBL>R_P"1WO?^O*+^9H V**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH Q_$O_(7T?_K]/_H)K8K'\2_\A?1_^OT_^@FMB@ HHHH
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M **** "BBB@ HHHH **** ,?Q+_R%]'_ .OT_P#H)K8K'\2_\A?1_P#K]/\
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M0/C_ / ?QU:>)/!_B>P%YH>N6:NL=Q#N*DE9%5XV5E961U5D965@""!\&_\
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M-!8V_F'&7\N%57<<#)QGB@#?HHHH **** "BBB@ KXL_X*(?\EQL/^Q9@_\
M1]Q7VG7Q9_P40_Y+C8?]BS!_Z/N* /!J*** "BBB@ HHHH **** "BBB@ KK
MO@%_R7'P?_V,UC_Z/2N1KKO@%_R7'P?_ -C-8_\ H]* /T>HHHH *\+\ _\
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MP,Q FEPJ$G./T>TK1=&T+1[?P]HFDVUGI]I;K;VEC:P+'##$JA5C1% 55"@
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M:Y"A(2XV!S\IR.2.HXKZ]KPO]K#_ )+9\#_^Q[E_])FH ]<_X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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M110 4444 ?57_!-3_CT\9?\ 72P_E<5]15\N_P#!-3_CT\9?]=+#^5Q7U%0
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M:^,7['?C_P !? 2>T3QS-H9N_!R:@0+>;5+61+JUAE)( CDFA2-B2 %<D\4
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M'=S#)L;RKB(.ZI* 5;$@10#Z@HHHH *\+_:P_P"2V? __L>Y?_29J]TKPO\
M:P_Y+9\#_P#L>Y?_ $F:@#W2BBB@ HHHH **** "BBB@ K'LO^1WO?\ KRB_
MF:V*Q[+_ )'>]_Z\HOYF@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#'\2_\A?1_^OT_^@FMBL?Q+_R%]'_Z_3_Z":V* "BBB@ HHHH
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M]K'P5H_[>/PO^"FC_#*6+4FO;_X.WFI3S/?BSD-M%=_;)&*6_$C JN#*L0+
ME5;AO^%$_P#!T7_T?%^R_P#^$1?_ /R-79_LN?!__@N5X<_:L\$^(_V\/VC/
MA3XQ^&UJFIB[TSX::+<64\-^]E(MM/<^; GF0 >:F V!)+&2K<,@!]UT444
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MEK8HH Q_^$EU?_H4+W_OI:S+77-17Q3=72^&[EG>VC5H R[E )Y-=76/9?\
M([WO_7E%_,T '_"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\
M0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7
MO_?2UL44 8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+6Q10!C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2UL44 8__  DNK_\
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M* "BBB@ HHHH **** "BBB@ HHHH *^._P!O_P#9=_X*J?'C]HCPSJ'[#_\
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M1110 4444 %%%% !1110 5X7^UA_R6SX'_\ 8]R_^DS5[I7A?[6'_);/@?\
M]CW+_P"DS4 >Z4444 %%%% !1110 4444 %8]E_R.][_ ->47\S6Q6/9?\CO
M>_\ 7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M8_B7_D+Z/_U^G_T$UL5C^)?^0OH__7Z?_036Q0 4444 %%%% !1110 4444
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MWP"_Y+CX/_[&:Q_]'I7(UUWP"_Y+CX/_ .QFL?\ T>E 'Z/4444 %>%^ ?\
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M)M5T[X8ZQX9\.R7&C>.]-GN9[BPE:^'^C:8R^?Y,T=[)#Y8BW*9 PR ?-O\
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MPC=>//@1JVC*?'/@;3Y+?3=>L-5M9+JU9HI"?*G$2*Y"X&)=I4&,LX!]H_\
M"8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"
MG_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0
MH I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\
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MG^8KZ9_X3'PQ_P!!J#_OJOFS_@FU;6]Q:^,?/@1\26&-Z@XXN*^G_P"SM/\
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M8^$>BW:S^(-;GUKQ5K^L:C+>ZGKVIS8\V]O+J8EYI6PHY(5%541550H]'HH
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MM:ZVESBU;1Q=7-S+J?VLKY31RVTRP!=^YG<Q%<JP !^@E%%% 'U5_P $U/\
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M/.%50.?2@#2KKO@%_P EQ\'_ /8S6/\ Z/2N1KKO@%_R7'P?_P!C-8_^CTH
M_1ZBBB@ KPOP#_RD$\?_ /8B:5_Z,:O=*^5/$7P#\&?&S]O7QQIWBS5=;MDM
MO!^EW$9T?6)+5BYRF"4/*X4<>N30!]5T5Y!X%_8I^$_P^\76'C31/$GC":[T
MZ<2P1W_BF>:%FP1AT8X8<]#7K] !7XQ_\''>IZK^V3_P2Z^+G[42:E<1_"[X
M?ZOH^F_"BVAF98_$FIMKMG:7_B%\'$ENJ//96>?E='N[@;TGMV7]5?VN_@CX
MQ_:3_9E\;? /P#\8KWX?ZKXNT";2[?QCIU@+J?3%E 621(S)'N8QETR'4C?D
M$$"OQ\_X+P_L-?\ !1S]G;_@C_XZO/C%_P %:V^(OPZ\/+X>LC\,[;]G[P]X
M?MYH5U6Q@MHTN;'][;I"WE.JH,$1!#\I- 'U+_P<+_$W7-5\-_LQ?L)Z?>20
MZ1^T'^T)X>\/^-UC<K]LT&*ZMVNK1L<[)'F@+#^)8V4Y#$5+_P '"'CRY_9(
MM/V6_P!N'X=[=/USX??M#Z7H,K6RA/M'A[5+2YCU&P.,?NY4M81MZ H&&"H-
M<5_P51_9%_:L^&'[+'[/7[6OQF^/]_\ '+Q3^S+\?-*\<^,O$MOX'M-'GG\+
M_:HFO EC890FW2*%F91DQ)*[?=KKO^"UOA[0O^"BWC/]E?\ 89^!?B2P\2/X
MB^,>F?$3Q3>:'>)=1:=X0TVVG\Z_E>,E8XIC=I' S$":7"H2<X /TGHHHH *
M*** /Q8_:_\ AEX?^$W_  0L_;SO_'GAK3Y?&=S^T3XHO/$=W?VB//\ :;SQ
M!9KI\X+C<F[3;NT>+&,1W VXW'.Y\8_A!_P0@_82^,5MHO\ P5'^#-CH-E-X
M%T;_ (5'::YX2U74/#$-@MG&-1BLK:RBEMX+]M0%Q/<AD61Q/;R#+22,WWM_
MP4)^!W_!/K2_A?XB_:^_;:^'R7?A_P #:?!K?B,KJ=[%;:H-/?S;-+RQMYXX
M-5>.4@01722A7D 4#<:^3/"/_!6/_@I-^U1\.-$_:1\._P#!&#P[+\%M?\2:
M3:>#Y?B/\4+:TU;6!?WT-C9WD5NUI((%>2YB(9E*;'++(ZG?0!]*?\$9/&GP
M1^(O[(^H>-OV3O#>JZ/\%;[Q[JJ_![3-7:0/;Z1"8[>X$4<K-)! =3BU-XH7
M.8XV1=J "-?K2O(/V'+_ .%%S\!QI_PF^&NJ^"H[7Q1K;^)/!>O7'FWVB:Y<
MZC<7VI03-YLJMNNKJ69&C=HGBFC>(F)HZ]?H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Y?XG?&[X+_  2L[/4?C-\7O"_A&WU&X,&G
MS^)]?MK!+J4#)CC:=U#MCG:,G%=17P%_P43^*&J?L]_\%!OAG\=_C3X]^#WA
M7P=9>!M;T_X<^*_BK;WBZ?I>M2S6$EXCW".L5O>S6\7[AR5+0PW2*<E@P!]K
M_$OXT?"/X-?#"_\ C7\5_B5HGA[PCI=DMW?^)=7U*."RA@;&US*Q"X8LH7!^
M8LH7)(!XS]E/]NW]CW]N+0]1\0_LE_M#^&?'5OH\RQ:LFB7VZ>R9L[#+"X62
M-6VMM9E"MM;:3@X_)&YUO]K7_@Y-_:J'@[1M2\#WW[,'P#\1I=ZCJ4>G:I:Z
M!\2-?4*4MRKN)YH8E+]"H$;$G'VF,K]9ZU\(OB?\"O\ @HA\"=+^%_A#]G?P
MIXYU?3];L]5T_P  >&[S3Y;GPC#8M)-]KBC<!X([U-/$!8?),^%.TR @'Z*4
M444 %%%% !1110 4444 %%%% !1110 5X7^UA_R6SX'_ /8]R_\ I,U>Z5X7
M^UA_R6SX'_\ 8]R_^DS4 >Z4444 %%%<!XS_ &HO@5\/O$MUX/\ %_CG[)J-
MF5%S;_V9=2;-R*Z_,D14_*P/![T =_17EG_#:O[,W_12_P#RC7O_ ,9H_P"&
MU?V9O^BE_P#E&O?_ (S0!ZG17EG_  VK^S-_T4O_ ,HU[_\ &:;+^VU^S#!&
MTTWQ."HBDLS:/>X '?\ U-.,92DHQ5VQ2E&,7*3LD>JUCV7_ ".][_UY1?S-
M?&GQV_X*G>*+K6)]#^ 6AVMKI\3%%UO5;<R3W&/XXXB0L:^F\,2,9"GBO-?#
M/_!1S]J#0?$#:_J7B/3=7\P!9;:_TB)$90>!F 1L/KG\Z_2,)X4\68K"*LU"
M#:ORRDU+[DFD_)M-=;'YGB_%KA'"8MT%*<TG;FC%./WN2;7FDT^ES]+:*^?/
M@U_P4<^!7Q"\-+<^.+Z7PUK$7%UILEK/<HW^W&\49RI]& (/&",$]A_PVK^S
M-_T4O_RC7O\ \9KX3,<MQV4XR6%Q<'"I'=/^K-/HUHS[_+<RP.;X..+P<U.G
M+9K\GU375/5'J=%>6?\ #:O[,W_12_\ RC7O_P 9H_X;5_9F_P"BE_\ E&O?
M_C-<)W'J=%>6?\-J_LS?]%+_ /*->_\ QFM;P1^T[\#OB-XEM_!_@SQO]LU&
MZ#F"W_LVYCW;$+M\TD:J,*I/)[4 =[1110 4444 %%%% 'G_ .T9\=?^% >#
MK/Q9_P (M_:WVO4UM/L_V[R-N8Y'W;MCY^YC&._7BO&?^'EO_5%?_+C_ /N:
MNF_X*,?\D=TC_L9H_P#TGGKXSH ^IO\ AY;_ -45_P#+C_\ N:C_ (>6_P#5
M%?\ RX__ +FKY9HH ^IO^'EO_5%?_+C_ /N:@_\ !2X*"S?!; '4GQ)_]S5\
MLUP_CCQ+/?7KZ3:RE;>%MK[3_K&'7/L#7TW"O#&,XJS/ZK1?+%*\I/517IU;
MZ+KZ)L^7XLXIP7">6?6JRYI-VC%:.3]>B6[?3S;2/L#6O^"HOANXO[2:7X9Q
MJ;2<OM37RX;C&,BVXK6L/^"H.G:FA>P^$4<H'4+XEY'U'V;(KX)J2UN[FQN%
MNK29HY$.5937Z_B_!G+'A&L-B9JK;>7*XM^B2:7S=NS/QS!^->:+%IXK#0=*
M^T>922]6VF_*ROW1]]?\/+?^J*_^7'_]S4?\/+?^J*_^7'_]S5\D^&M:77=+
M2\( D!VRJ.S#_.:T*_!<=@L3EN,J87$1M.#::\U^G9]4?T!@,=ALSP5/%8>5
MX32DGY/]>ZZ,^IO^'EO_ %17_P N/_[FH_X>6_\ 5%?_ "X__N:OEFBN0ZSZ
MF_X>6_\ 5%?_ "X__N:OI/P7XB_X2_P=I/BS[']G_M33(+O[/YF_RO,C5]N[
M W8W8S@9QT%?F-7Z3_!?_DCOA/\ [%FP_P#2=* .EHHHH **** "H[O_ (])
M?^N;?RJ2H[O_ (])?^N;?RH _+>BBB@ HHHH **K:KJMGHUFU[>OA1P%'5CZ
M"N/U#XB:U<2'["L=NG\(VAF_$GC]*^LX=X*SWB>+J82"5-.W/)VC?LM&WYV3
MMU/D>).-\@X6DJ>,FW4:NH15Y6[O5)+M=J_0[FBN&T_XB:U;R#[<L=PG\0*A
M6_ CC]*[#2M5L]9LUO;)\J>"IZJ?0T<1<%9]PQ%5,7!.F].>+O&_9Z)I]KI7
MZ!PWQOD'%,G3P<VJB5W"2M*W=:M-=[-VZEFBBBODSZX**** /JK_ ()J?\>G
MC+_KI8?RN*^HJ^7?^":G_'IXR_ZZ6'\KBOJ*@ HHHH **** "OBS_@HA_P E
MQL/^Q9@_]'W%?:=?%G_!1#_DN-A_V+,'_H^XH \&HHHH ***9<W$5I;O=3MA
M(T+.?0 9JH0G4FH15V]$N[)G.%.#G-V2U;[(+BYM[2(SW4Z1H.K.V *S_P#A
M,O#/F>7_ &JF?78V/SQBN(UW7;S7;PW%PY" _NHL\(/\?>J-?O64>#F%E@XS
MS*O)5&KVARI1\FVI<UNMK+MW/Y_SCQHQ<<;*&64(NDG;FGS-R\TDX\M^E[OO
MV/5;>YM[N(3VLZ2(>C(V0:?7FNA:[>:%>"XMW)0G][$3PX_Q]Z]'MKB*[MTN
MH&RDB!E/J",U^<\:<%XGA+$P]_GI3ORRM9W6\9+O^#7S2_2>">-\+QAA9^Y[
M.M3MS1O=6>THOMY;I_)M]%%%?$GW(5UWP"_Y+CX/_P"QFL?_ $>E<C77? +_
M )+CX/\ ^QFL?_1Z4 ?H]1110 5X7X!_Y2">/_\ L1-*_P#1C5[I7A?@'_E(
M)X__ .Q$TK_T8U 'NE%%% !6=XJ\(>$_'6AS>&/&_AC3M9TRX*FXT[5;*.X@
ME*L&7='("K88 C(X(![5HT4 (T:,AB9 5(P5(X(]*YKX<_!?X._!Y;]?A)\)
M_#/A8:K<>?J8\.:#;V/VR7G]Y+Y*+YC<GYFR>37344 %%%% !1110!X_^W[^
MR!X8_;X_8W^('[(/B_Q%/I%GXXT(V::M;1"1K*X21)[>?82/,5)XHF*9&Y5*
MY&<CR+]H/X:?MZ:S_P $S+3X7?!7X5^"X?C=X)U'PD?#UC>ZN'\.:E/I&K:;
M<F[C<&*5+5HK:1A#((Y5*F,;@%=_KVB@#P3_ ()U?LY_'O\ 9X^!FHR?M7_%
M+3O&'Q3\<^*[OQ3\0-6T2V,.G1W\\<,"6MFC*K"W@MK:V@0L S>46(&[ ][H
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P_B-\,?A
MK\8?"5SX ^+?P]T/Q3H-[M^V:)XCTF&^M)]IRN^&961L$ C(."*W** ,;P!\
M.OA]\*/"=IX!^%O@71O#6A:>A6PT70-,BL[2V4DDB.&%51 22< #DFL'PG^S
M+^S=X!^*^K_'CP+^S[X(T7QSK\$D.N^,])\*6=MJVI1R2))(EQ=QQB:96D1'
M(=B"R*3R :[>B@ HHHH **** *^JC5&TNY70WMUO3;O]C:[1FB$NT["X4@E=
MV,@$'&<&ORI_X*R_\$X?B]\!O@II_P"V/^R=^V+\;-5_:AC\=:';>')I_'-Q
M):>+[^\OXH9=/&E;OLEO:)"\\_D1(L4<%JXDW1AVK]7J_/O_ (+V_P#!.'X:
M_M"?LL^,OVS=%^*OC;P7\5/@QX4U#Q;X$\4:5X\U"&UL)["U:=HEM&F-O;^:
MD.PRPI'+N8,7;#*P!T__  6O_;)^,'[-GP&^&/P)^"/BC^POB=^T%\5-$^'F
MB^(=.0,^B)>RJEY?VX<'YT4B.,GE6G1^J5P?[>>M:?\ \$<_B;^SO^T-\$M?
M\0P^ _%_Q2LOAO\ %_P_K7BF]U.+5K;48)6M]9E-Y+(1>VTEL[M<*1),LC1R
M,P*[?&/^"G-W\9/&/P*_X)E_MU?M ::\%]X9^+O@2^^*[O;^4-.NM3AL)9[F
M5  (56>!U(. KR*O<5ZC_P '-/A/5_C3\&_V;?V7_!<+W'B/Q]^U1X<@T^VB
M&76WBMK[[1<<=$B$D;,W15))P!0!U>H_%W4?^"@?_!:#Q[^PWXBUW5(_A'^S
MW\/+"_\ $_AW2M5GM(_$OB?4_*E@^VR0.C3VMO:NVVV)V&<%W#;%"Z__  3[
M_:&\8?"W_@I?^T!_P2@\9>*]3US0O!6EZ9XW^$5]K>HRWE[9Z%?1P"[TR2>9
MFDEAM;N=$@9V=Q')L+81 //?^"?WA+4/@M_P<4?MI^"/%D+13_$3P9X3\8^%
M9)1@WNFQ1&VGD3/58[J4PDCC='1^RYX3U?XA_P#!T-^TM\:=$B>30_ 'P'T#
MP?JMV@_=C4;\Z?J$<6[H6$5M+D=N^* /TOHHHH *\+_:P_Y+9\#_ /L>Y?\
MTF:ND^*WA3]K/5_%SWGP?^*_A?2-%,"!++5M">XF$@'SL7!'!/05XE\7?#'[
M46D_'+X/-\7?B?X:U>.3QH1IRZ5HC6YAD$)+E\D[@5R /6@#Z]HK'^Q>-_\
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MW16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\
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M;LK]4?MG@OD^-CBZ^9SBU2<>2-_M-R3;7?EY;7[NW<?1117X&?T$%==\ O\
MDN/@_P#[&:Q_]'I7(UU7P,6=OC3X36UD5)3XCLQ&S#(#><F"10!^D5%8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q7A?@'_E()X_\ ^Q$TK_T8U>N?
M8O&__0;LO_ 8_P"->.?#"._B_;Z\?)J=Q'+-_P (+I6YXTV@_O'QQ0![W111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?_ZYWG_I)-7E%>K_ +$G_)ROA_\ ZYWG_I)-0!]ZT444 %%%% !1110!\_\
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MO:1""U@2-!T5%  _*GT45Q3G.I-RF[M[M[L[H0A3@H05DMDMD%%%%24%==\
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M44 %>%_M8?\ );/@?_V/<O\ Z3-7NE>%_M8?\EL^!_\ V/<O_I,U 'NE%%%
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MX>TM"KS3;8HXRT$$:1-)+*7ED\N&'S TR[@#TZW^('B7QO\ &^3P5X&N(X]
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MBN9'/0;%)Y"U]6^,/$:^#_"VH>*&T/4=3^P6CSC3M(M#/=7149$<48QN=CP
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M4\1? /P9\;/V]?'&G>+-5UNV2V\'Z7<1G1]8DM6+G*8)0\KA1QZY-?5=>%^
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MB?\ BG_X%C_Y'H ^QJ^ OVR_^3E?$_\ UTM?_22&NW_X>4_M9?\ 2)_XI_\
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M/_P3#_&CR_VLO^C"/BG_ ."8?XT =!17/^7^UE_T81\4_P#P3#_&CR_VLO\
MHPCXI_\ @F'^- '045S_ )?[67_1A'Q3_P#!,/\ &CR_VLO^C"/BG_X)A_C0
M!T%%<7X3\7?M&^.--DU?PK^Q-\1M1MHKJ2WDGL-/65%EC;:Z$CHP/!'8UJ>7
M^UE_T81\4_\ P3#_ !H Z"BN?\O]K+_HPCXI_P#@F'^-'E_M9?\ 1A'Q3_\
M!,/\: .@HKG_ "_VLO\ HPCXI_\ @F'^-'E_M9?]&$?%/_P3#_&@#[*_X)J?
M\>GC+_KI8?RN*^HJ_.C]FK]I?]K+]GB+68O^':7Q3UC^UVMSGR1;^5Y7F?\
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MN[G;G&,X./2@#]5:*^.?^'E/[67_ $B?^*?_ (%C_P"1Z/\ AY3^UE_TB?\
MBG_X%C_Y'H ^QJ\+\ _\I!/'_P#V(FE?^C&KRW_AY3^UE_TB?^*?_@6/_D>O
M1/V1H_B7\5OB/XB_:J^(_P )=6^'\^N:;!HR>#]?!-W$+9MPN"VU04?=@# .
M5/L: /H*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#YF^,O[$WCK1_P!M[3O^"B7[*>I>'[?QQ<>"I/"'CWPOXIGGMM-\4Z4)
MEGMI#<V\<KVEW;RH-LWDS!XF,150%8:G[%?[#\_[._Q(^*7[3WQ9\56/B3XM
M?&G7;74/&VM:;9M!965I:0"VT_2K-)&9_L]M"-OF.=\SEG8+E43Z%HH ****
M "BBB@ HHHH **** "BBB@ HHHH *\+\ _\ *03Q_P#]B)I7_HQJ]TJ"/2],
MBU"35HM.@6[EC"2W2PJ)'4=%+8R0/2@">BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /"_VL/\ DMGP/_['N7_TF:O=*@N]+TR_G@N;[3H)
MI+63?;230JS1-C&Y21\IQW%3T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 >%_P#!/?\ Y(GJW_8]ZS_Z4FO=*@T_2],TB VVE:=!:QM(
MSM';PJBEB<EL #DGJ:GH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KPOP#_RD$\?_ /8B:5_Z,:O=*@CTO3(M0DU:+3H%NY8PDMTL*B1U'12V
M,D#TH GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .3^
M._QO^&7[-7P:\3?'WXR^)HM'\+>$=&GU37-1E4MY4$2EFVJ.7<\*J+EF9E4
MD@5\M_LF_%W_ (*#?\%&?@YI_P"UGX?^(F@_ GP'XNB-[\-_"O\ PA::YKMU
MI3$_9[_4KB>=8(S.@$JVT$7R1NN9W+?+YY_P=4Z?XUU#_@B7\4!X02=X8=5T
M"77$@SDV2ZM:[B0.JB3RF/8!23P*^M/^"?.I>&]8_8*^"6J>#FB.DW'PC\-R
M:;Y'W! =+M]@'L%P* /$_P!G/_@HG\4?!W[>-Y_P2V_;TTOP]:_$B\\/'Q#\
M,/'?A.TFM-(\=Z2OF>8!:S2RO97T0AF,D'FRHPAD9&50@>_^V7'_ ,%CO&L_
MB7Q+^PYXJ^%7@72/"\<H\/:+XZT&?4]1\93Q)N=I)8YEBTVW=P8X@%DD8#S'
M:,.$3Y,_X+8:=JFM?\%X/^">.G_#-&?Q/%XIU.XU86V?-&D1W-E),6QSL^SQ
MZAGM@/[U]\_\%$?@E^V)^T)^S5X@^%/[&'[1_A_X9^(]8TNYM9=:UKPM+?R2
MI(FWRH9TN$^PE@74S^3<.H8,BJR@T 9O_!*#]M;Q)_P41_X)]_#?]L+QCX C
M\,:OXNTVY.J:3;E_(6XMKR>TDE@WDMY,C0&5 Q8A)%!9L;CR7_!7_P#:J_:E
M_9-^%7PE\1_LGZ5H]WK'C#]H/PMX0UV/6M/:XC_LS49)HG"A64H[3"WCWYRH
MD;'.".?_ .""G[4?Q$_:/_86E\$?&+X1:+X(\8_!+QQJ7PN\4Z'X;LEMM.2[
MTA(%S;PKE8E$<T:,JG;YD;E=JD*/K?X@_#'P'\5-/T[2OB!X;AU.WTG7K#6M
M.CF=E\B_LKA+BVG4J0=R2QHP'0XP002" ?,O[5^N_P#!6+XS_$[7OA[_ ,$^
M]8^&'P[\.>#Q#;7_ (T^)VDW=_<>(=4DMX[@P64$(V16<231I)<OO9IC(B(/
M)8MRG_!*W_@I[\;/VD_AA\:? _[:_P '[;P[\7/V<=>GTKXC6'@R&2XL]518
M99H;JRC9F<M*L$H$89@V$92!*$3ZW^-_QH\#_L_?#34?BC\0+BX^Q6(2.WLK
M"W,]YJ-U(XCM[*UA7YI[F:5DBBB7EW=0.M>,?\$V_P!DCQ7^SUX5\=_&KXT:
M?:P?%'XW^.;GQGX_M;.<31:2TH"6>CQRCB5+.V6.(R#(>4S.#M90 #Y6_;(_
M:._X.$?V4_@]J_\ P4$O_#GP'O/ WABW_MGQ1\";.VO9=4TW1%.Z;=JF0D]W
M#$=TKQ@1 H[(DJJ%?]!OV;/CGX8_:>_9X\"_M'^"K.YMM(\>^$=.\0:;:W@
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M[8__  5$N/\ @KQ<?\$M#^T!\&A#!\&QXY_X3<?!+4=S/]K6W^R?9/\ A(<
M?-N\SS>V-O>OTEK\P=-_Y6W]0_[,_7_T[14 >U_%/XQ?\%0/V??V2OVB_B5\
M5_&/POO?$WPF\/W_ (G\!>(M*^'>H6^D>)-+MM):\,$]K)J3O#<">">)O+N'
M"!HVP<X//?L%?&7_ (*U?ML_L+>!OVQ-&_:+^ VEZKXWT$ZG9^$=1^">KM:0
MGS'C6"2\C\0B3G9GS%AXS]QL<^]_\%4?^48/[1__ &07QA_Z9;NO,_\ @WZ_
MY0S?L^?]B*O_ *4S4 9W_!/O_@J[XL^/?[4'C?\ X)V?MH?!.U^&'Q^\ 6HO
MIM)TO56O-'\4:8=A&H:9-(JN4VR1L87!<*X.25E6+Z8_:M\;_$'X9?LN?$GX
MD?"2QMKGQ7X>\ ZQJ7AFVO8C)#+J$%E-+;)(H(+(940$ @D$C(K\Q/VS[=O$
MO_!W'^R[!\+/GUG1/@[?3>-YK/D6]@8=="+<8X&1* -W/[Z'U6OUTOK*SU.R
MFTW4+9)K>XB:.>&1<JZ,,,I'<$$B@#X;^"/[6'_!2?\ :0_X)X? 'Q%\'/!_
M@=/C+\7? J^(/$'C#Q58W,?AWP[IRI"QO&M[<F2:YF6ZM1#;*RJS--(2(X64
M\G^R;^WA_P %&?@1_P %+M(_X)A?\%.M,\">*)_B'X4O=>^%7Q0^'6GS6<-[
M]D226YL[JWD)",L<4ARH4J0@S*)0R??/@'P-X'^#7PVT7X:>!=*ATCPUX4T.
MVTS1[+SF,=E8VL*Q11[Y&+%4C11N8DX7))ZU\O\ P*^%,/[8'[?!_P""F.MV
M)7P9X+\&S^$/@4LR8;5H[F7S-3\1@'E8)]L=K:GI+!').,I<1&@#+_::US_@
MLQ\=/&WB67]@'6OA'\.O!_A2]FT[2+SXFZ3>7NI>,+Z#*W#A(AY=C8B</ CE
M7ED,3RC$;1YVO^"-_P#P41^(?_!1']G#Q%KWQW^%5OX+^)_PT\?:CX(^)?A^
MP=FM(]7LA&9'M]S.5C(D *%V*NCC<PVLWO7[1WQ[T+]G7X9S^-[_ $6[UO5;
MJ=;#PIX4TL@WWB+590WV?3[8'C?(5)+G"11I)-(5CB=U\X_X)K?L:ZC^QA^S
M[?:%XZU.RU'X@>/_ !EJOCKXJ:MIRD6]WXBU2;S[H0[N?)B'EP1D@%D@5B 6
M(H ^@Z*** "BBB@ HHHH *\^_:?T_P#::O\ X-:P_P"R'XJ\)Z7X\M[62;0U
M\;:'-?:;>3*C%+:807$#Q!VVKYP9MF=VQ\;3Z#10!\*?\$*?^"COQX_X*%?"
M'QX_[6=WX9T7XK?#OQK<>'_&OPZT+PW/ITOA]XV81M+Y]W.\HD*2KN^0!X9%
M .S<>]\$_&#]M_XQ_P#!0OQQ\-?A?\2/AZ/@;\.[6RMO$6KW'@>ZEU6;Q%,&
MFFT2WN%U!8&^SVK6DLMP8CL>Z6+RRP=D^,O^"T'@7XH?\$U_^"AGPJ_X*<_L
M/>)-)T+Q+\=M>A^%/Q%T#5K5Y-.U6\O(673]6EB0C>\!B1W (+&UA XDFW?J
M!^S5^S_X/_9@^"NB?!?P7=75Y#ID4DNH:QJ+[[S6-0GD:>\U"Y?^.XN+B26>
M1N[RM@ 8  /CS]HWX\?\%=?@+^Q+\5OVXO%/Q2^#>BQ^#],US7?#OPYN_@_J
MD]T=,MIIC91W=ZVMP[9Y+=8F?;; (S$8/2I?@)\;_P#@KS\;/V*OA/\ MN>$
M?BG\&]=3QCHV@>(/$GPZMOA!JEO=KIEV\#WD5G>KK<V^>*!Y2FZWP[(.%Z'U
M3_@MU_RB)_:,_P"R2ZQ_Z3M5S_@C!_RB6_9P_P"R,^'_ /TABH \&^/?[:W_
M  45T#_@M)X4_P""8GPJ^*WPKTWPWXP^%,GC>V\3Z_\ "^^U"\L5CN+V%K-H
MXM8MTE)-ID2Y3 DY4[>=G]MO]MC_ (*8_P#!+CPE%^TG\>/ 7PX^./P8TR[A
MC\<ZE\./#E]X;\1^';>618_MGV6ZO[Z"\A1F4';)$>5W;%W2+YU\<?\ E;6^
M#7_9I=[_ .G+6*^QO^"I.J>"-'_X)J_'Z_\ B/) NBCX.>)$OA<D;7#Z;.BH
M,]79V55 Y+%0.<4 >H?!3XR_#?\ :'^$?AOXZ?!_Q-#K/A?Q;HUOJFA:G "!
M/;3('0E3RC '#(P#*P*D @BOG'XA?M6?M2:#_P %J/ '[&OA_3-&;X2:Y\!]
M4\6:]<S6#&]74+;4#;%DFW *B^;9+MP0?M#D\[<>:_\ !KUH?CG0?^"(WP=M
M_',=Q&UP=;N=)BN00Z6,NL7CPGGG:P)=?]AUQQBON*[^&'@.^^)^G_&>Z\-P
MOXGTO0;S1;#5]["2*PNI[:>># .UE:6SMFR02#'P0&8$ _/_ /:6^,?_  7^
MN?AAK?[;?[-6D?!;1?!>CZ=-KF@?!7Q1HU]<>(-5T6)#*&O;D,B0WTL(\S[+
M$4$>Y8C(TBMGZ&_9D_;I\??MP?\ !.'P5^V5^R_\(K67Q1\0-'0:5X=\0:D8
M[#2]0%R]I<R74Z*'>TMY89W)C7S)DC5457D&-[]OSXE^-H?A/=?LT_ *.&\^
M*WQ3TR[T;P?;2Y,6DP2((KO7+O'*6EE',)&)_P!9*T%NN9)T![7]D?\ 9E^'
MO[&G[,W@C]EKX51R?V#X'\/6^EV4TX EN2BYDN),<>9+(7E?'&Z1L8% 'QAX
M7_:Q_P""J?[(G_!3#X0?LB_MM>(OAO\ %#P+\?;?6H_#?B/P!X5N-(O?#VH:
M=:_:IDD@DGF$EL$9!N9F8AB^Y3&4?]%*_+3]M3QO_P %!_V!_P#@JC\$_P!L
M#XU>,O OQ4^$/Q'\66?PILM-TWP4^F7W@*35IU(FM=]Q<.S3/ C33F0^<MLL
M)CC_ ')'ZET %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@_%#X8^ ?C5\.
M-=^$7Q4\+6NM^&O$VDSZ9KND7R;HKRUF0QR1MC!P58C(((Z@@@&OSU\9V/\
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M$22^1%//Y-NL48220R/)*50)[[X'\#>'_AWH">&/"_V\643$PQW^KW-ZT8P
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METSQ9<OXOAT>*XU2*!)YM+TXO#,;RZB22,2;Q#"KR",3-(DB1@'T917Y5?\
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LH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ew-20230930_g9.jpg
<TEXT>
begin 644 ew-20230930_g9.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_A'XD:D/#?BC4?'5UJMUJ?B"]BTL6]CHD7EW'V6ZD$-GY:RW!:18XRP8LY.
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M:^-/&EY;^(/%?C+QWXLNOB]/>JLDNH:Q<ZE.9/M0/5WLGLP0W\!0=,4 7O\
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MVEIXD"8R=-O)X4MM1'(Q]FDDW9XS7M]S<V]G;R7=W.D442%Y99&"JB@9))/
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M.^$OCGXQ66C?&CQMX0GG@O[#1!$\IMDN+?\ ?6RSE#YDD)$WEPR+&<O@T_\
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M7[('[.-KX;NOC;^T=X1\/GQC<6T/A*VNM8C>XUIKAU2%K2&,M)<(S.GSHK*
MP)('-8/PU_X*6_L%_&+]H^]_9&^%W[4OA37/B+8QSM+X:T^]+O)Y&?/2&7;Y
M4[Q[7WI&[,GEON V-C\T/^"@FCZ5XK_X-[/V#K3Q'817L<WB;X/1S+<+NWJ^
ME"-@2?5&93[,:^@/^"MOA;PUX/\ ^"CW_!/"Z\)>'[+2VT[XM:OI5@-/MDA%
MO8OI\*M;($ "Q;5 V#C QB@#[?\ C3^U#\"/@3JNF^$/B9XVEBUO7K>>71_#
M>B:5>:IJU[!$!YT\-E812W+Q1[EWRK'L3<NYAD5^?_\ P0B\5_#;QG_P46_;
MPUSX-?$:_P#%/A.7Q?X-;0=6U'Q!=ZG*8FL-0DDB,]Y(\^4F>5#'(VZ-E9"%
M*D#H?^"77Q3F^*7_  6M_;O7XL78/C+PSJ7A;0_"EG>G][9^&(8;LHMLK<K#
M)*\=Q)MX:2>-CRRU-_P2.T?1]!_X*\?\%%-/T33X;6)_'_@RYDB@0*#+-IE[
M++(0/XGD=W)[LQ/>@#[;_:<\&_&/XC_""^^'/P,^(4GA#6M>N+>RG\7VR(]S
MHM@\J_:[FV60,INO($B0E@5262.1@RH5/Y=?MY_L7?%+_@CO\1_@K^V=^PQ^
MUS\8]>O?$GQGT/P9X_\ A_\ $7QY<:[:^,(-2E==Q6;_ )>249<X)!E#Q^68
MSO\ U_U#4+#2;"?5=5O8;:UMH6EN;FXE"1Q1J"6=F/"J "23P *^8_#W@JS_
M &ZOCSX4_:X\=6QA^$_PON)]1^$.FWZ;%\0ZL\+PMXHF1\;;>*!Y8K$, 6$T
MUU]U[<@ \M_;S_:%\7_&C_@JA\#/^"3'A/Q=JVA^&=?\,:CX_P#C#=:!J4MG
M>ZEH]L)XK'2UN8&62"&>[@;[1L97>(*@8*[!J_A/XO:E^PE_P6B\+_L!:%K6
MHS?"GX\?#&[USP7H&IZG-=CPWXDTPSO=Q6;SNS16D]G$)&@!*+,I9 F]PW"_
M%'15\$_\'1OP9^-ES=17'ASXL_LS:IH?A/5HI \%U?V4\]]-'$X)5_\ 16AD
M!!Y$N?<S_M@^$]6^+_\ P<U?LI:)X8A>9/AA\'_$WBSQ2\(S]EL[M+O3H&8C
MH'N3&G/7<: .H_:/_P""+7CW]KCPQX@^.7Q@_;T^,GAGXRZA%<7_ (6N_!_C
M^:PT#P5+DO:6-K9PA5>"$"-)9B1-.RR2[XRX"V?^"7'QO_;;_P""A_\ P1)^
M&_CGQ!\29O#7Q(\913Z1JWQ&BMHQ=PZ;;ZI/:S:K!&RE#>R6<#"-RI07$BS%
M2@V'WG]K3Q-XK_:)N=6_84^ 7B6?3]5UK3E@^)_C2P(/_"&Z)<H0Z1M@C^U+
MJ$LEM'UA5S=.-J1)/ZM\*_"_P8^!?PQLO@[\+ET?1/#7P]T>WTR+2K:[01Z-
M:0VZ&-)<MF/$.U\N<E3O).<D _*G]O/]B[XI?\$=_B/\%?VSOV&/VN?C'KU[
MXD^,^A^#/'_P_P#B+X\N-=M?&$&I2NNXK-_R\DHRYP2#*'C\LQG?^H7QH_:Q
M_9R_9W\;^!/AM\;/BYI/AS7?B;K_ /8O@/3-0=A)K-_\@\B+:I .9(ERQ"[I
M8USN=0?(/#W@JS_;J^//A3]KCQU;&'X3_"^XGU'X0Z;?IL7Q#JSPO"WBB9'Q
MMMXH'EBL0P!83377W7MR/>?$?PR^"GQDN_"_Q \6_#_PMXJG\/7:ZOX+UO4=
M*MKY]-G=!MN[*9U8PNR$8EB()&.<4 =31110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !4.HVL][I\]E;:C-9R30LD=W;JAD@8@@.HD5D+ \C<K+D<@CBIJ*
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M;X%_:N\8_ML>%OC)\1;;XB^/-%CTGQ+K!U>SDAN+.)$6");5[0P1>5Y:%&1
MV5.2V]]VA^PW_P $[/@M_P $^-,\2^'O@'XQ\:3:3XLU^XUW6M)\2ZZM_%)J
MD^SSKU6>(2)(XC4,%<(>I4G!'O=% 'Q/^TA_P0)_8*_:._::OOVMC-\0? /C
M'7?^1NN?A?XXGT2+Q%G&[[6L0)RX WM$T9<_,Q+$L?8_CS_P37_8M_:/_9"M
M?V%OB;\$-/E^&NF6EO#H6B6,CP/I#P*5AN+:93YD<Z[F_>;BS[W#[Q(X;W6B
M@#Y=_8._X)&?LK_\$^=;F\7_  RUWQWXMU_^S&TO3-?^)/B^76+G2-.9E9K*
MR#!(K6%F1"PC0,_EH&9@H ]]^,OP?^'/[0/PF\1_ [XN^&8M9\+^+-&N-*U[
M2YG95N;6>,QR)N0AD.&.&4AE.""" :Z6B@#X;F_X-\_V#M4_9[T?]G#Q9XF^
M+.O:1X7UBSO_  7J6N?$^^N+WPN+9RT5OIC$^781#)4^3&KLH3+DQQE/4-?_
M ."6OP#UK]ICP+^UG:^/O'^G^+OAGHDFC^!Y;3Q$DD&G64L;I<1-'/#)]K:;
MS)&EFN3+*[.6+Y"E?I2B@#Y_\-_\$YOA'X7_ &W-3_X*"V/Q)\=2_$;6=!70
MM4N+C6+=K*?2%E25+#[*+<1K$K1H0RA9<@MYA9F)X70_^"*W[(G@?]H/Q5\>
M_A#XM^)O@.#QY?&]\>> ? WQ!NM+\.^(+EB2\MQ:0X92Q9LB*2-2'<8VLP/U
MU10!X7_P3_\ ^">'[/'_  35^"$7P"_9LD\4G0TF:>7_ (2;Q7=:@7F9F9Y$
MBD86]L69B6%O%$KGE@3S4?[9W_!//X-_MV:OX'U3XT^,O&5LGPZ\3VOB3PC9
M^&]:CLHK/6;=F,%^2(F>25-V%#L4 Z("S%O>** /G;XW?\$VOA9^T%^T%\.?
MVHOB-\7_ (A2>-/A-',/ .I6.K6=O'IDEQ#'#=S>0EH(I7N!&#*)$93DJJJ@
M5!/'_P $X_A%%^W%-_P4-A^)7CM?B3/X?/A][H:Q;_8O[%\\3C3!:FW\OR X
M#9QYNX;C(7^:OH*B@#YV^ 7_  38^%?[-/QB^)7Q[^%?Q?\ B'!XI^+EREWX
M]U"_U:SNDU"[C258+A89;0Q0/$)7V")53&%*LH"U%^S'_P $M_V8_P!ECX:_
M$+X+^%)?$?B/P;\4]4U#4_'/A?QMJ<>IVFI7M\BQW=PV^(.&E1%5E#;#C.W/
M-?1U% 'Q!^RQ_P &^_\ P3^_9#^*UC\2OAJ_Q#U'3M$UG^U_"_@+Q/X\N;[P
M[H=^'WQW5O8MA7FC;YDDG:5D8!P=ZJP^W9XWEA>*.=HF92%D0#<A(ZC((R/<
M$>U.HH ^=OV>/^";/PJ_9=^*7Q*^,_PD^+OQ"@\1?%R^_M#QW?:CJ]I=K?7P
M601W212VIC@DC\U]JQJL>-JLC*JJ(?V9/^"9/PB_8_\  GCSX=_ 3XO_ !'T
MK3_B-KMWKGB-[C7K>[G_ +5NC$+F^AEGMF:&:5(@C%3M )955PKK]'T4 ?-'
MP+_X),_L?? K]C36O^"?5KX?U?Q1\'];CF27P9XQU(7D5L)IFGE\F542:,M,
MPF!WDQR*KQE&R2[X8?\ !+GX+> K+P7X:\9_%KXE?$3PS\-M1M[_ .'OA#XA
M>)8KW3]"N;=2MK*HCMXI;QK=3B$WDEQY)"LFUE5E^E:* /G_ .)/_!.;X1_%
M']LKPS^W?KGQ(\=6WQ \&Z7-IGA>XT_6+=+/3[&8.)K86S6[1RK)YC[FE#OR
M,,-B;3PC_P $YOA'X-_;8UC_ (* :=\2?'4WQ%\0:&FB:S<76L6[65SI2.CQ
MV/V46XC2-6B0AD"R9!)<EG+?0%% 'S5\+O\ @E3^S-\$/C9X_P#CW\'-?\=>
M&]:^(FOWFOZG8V'C"=]+T_6;Q&2[U2TT^8/;1WDJ/(AF>-V19&6/RU.*H_!#
M_@DO^S]^SK^RAXH_8I^$GQ-^(NF_#WQ<+U=6TN3Q!!<3JMZC)>+%<RVS31"9
M7.[:^0?F0HQ8GZCHH ^6M!_X))?L_>$O@7\-/@#X-^*?Q-T?2_@[KSZM\,]3
MTWQ6D6H:%,T$T!C6?R/W\.RXG4Q3B5664HP*80>G?!']D#X?_!KXH^(?CYJ7
MBKQ!XT^(GBG3+72]9\=>+Y;5KY].MF=X+&*.SM[>VMH$>220I#"F]W+R%V (
M]7HH YSXO?"'X9_'WX8:[\%_C)X+L?$7A;Q+ILEAKFBZC'NAN[=QAE.""#T(
M92&5@&4@@$?)W['/_!!3]A/]B;XF:?\ $GX:WWQ$UV/P_?27O@[PMXT\<SZC
MHOAJZ<,/M%G9$+&)@'<+++YCJ6+!@V&'VI10!\]^"?\ @G#\)_A_^V+XI_;L
M\.?%+QZOQ#\::3%I7B.]GU>UDM+JQB"""V%JUMY4:Q^7'M9%5\J26.]]S/V=
MO^":/P'_ &;/B=\3?BKX5\5>+M;O/C+=M=?$W3_%>I6]]8Z[.5D3?) ;<+$
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M:[*?U#O;"QU&'[/J%E%/'G.R:,,,^N#3;'3--TQ&CTW3H+=6.66"%4!/O@4
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M>))?'/@3XC"U2UU/Q?\ "WQ=)HMYJT"*$2.Y9%8.0BA-ZA9"BJI8A$"_8U%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6A_X-]/A?X(O+2)]-UCX9:S)J4; ;9!>7-]+/N]<F9\YH ^IOC;^VO\ LW?
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M_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
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MMI;R..A98+B103SAC[T ?II1110 4444 %%%% !1110 4444 %%%% !1110
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MNE>%_M8?\EL^!_\ V/<O_I,U 'NE%%% !1110 4444 %%%% !6/9?\CO>_\
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M?_036Q6/XE_Y"^C_ /7Z?_036Q0 4444 %%%% !1110 4444 %%%% !1110
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MI.L^!]9NG"6]QK>CHEO>Z4'; -SY;R783O$Q(SM($'_!/_X?R?M!_P#!<_\
M:>_X*,>&)5NO FG>$M+^&?@G7H3NM];F@6SEU62W<<2107=H(/,4E6;> 248
M  H?M<?#+X=>#/\ @Y(_8Z\7>$/ ND:5J?B'P7\0)->O].TV*";49$TN4K).
MZ*#*X,LGS-D_,>>:_2ZOS=_;H\5^&+#_ (.-/V(]+OO$-E#<IX)\>J\$MTBN
MIFTMUA!!.079'"_WBI SBOM7]K+]L?\ 9I_88^%(^-_[5OQ4M?!_A9M6MM,7
M5KNSN+A3=3DB*,);QR.<[6).W:JJS,0JD@ ^/_\ @N!K7QX_9@^,'[/?_!43
MP-\,+WX@?#[X ZMX@D^*?@W3"K7=OIVIV45J=9@1B%9[1%F)8_=$O)2-I9%T
M_P!BCQ_X4_X*9?\ !0>W_P""JO[-WB*.+X1>&?A)<> --O6E6+4/%&I3WT5[
M<"XM03);6]GM"(MP$D>65Y$7RBDDNE_P4I\8ZNW_  4)_9)^&/QDO$M/@+XA
M\0ZY<>))KMPNF:IXIM[)9=!LK]S\FSSO,F@B<[9KB%.&:-0/.OA5^QQX;_8J
M_P""^NG2?L(2C2? OQ3^&>L:Q^T!\.=(8?V5H-U \0TS4!"OR6LEU/+(L48
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MQ5K-QXB\4? 3P7J6H7DADN[Z_P#"UI--.YZL[O&68^Y-;?CCX<_#WXG>'_\
MA$_B3X$T;Q#I0N(IQIFN:7%=V_FQ.'BD\N567<C ,K8RI (P16S10!F^+O!W
MA'X@>'+OP=X\\*Z;K>D7\?EWVE:O8QW-M<)G.V2*0%7&0#@@]*H_#CX2_"OX
M.Z(_AGX1?#/P_P"%=-DF,TFG^'-&@L8&D/5S'"BJ6.!SC/%=!10 4444 %%%
M% !7A?@'_E()X_\ ^Q$TK_T8U>Z5X7X!_P"4@GC_ /[$32O_ $8U 'NE%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6SX'_P#8]R_^DS4 >N?\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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MN;.RET2*X>)XXY29&EF4G+J3T1>.G%?6=?%G_!1#_DN-A_V+,'_H^XH X?\
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M/+?K\)/A/X9\+#5;CS]3'AS0;>Q^V2\_O)?)1?,;D_,V3R: .FHHHH ****
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M_P#8B:5_Z,:O=*\+\ _\I!/'_P#V(FE?^C&H ]THHHH **** "BBB@ HHHH
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M0-SM&I)P.!R>U?CO\4?^"NW_  4=_P""D_@/5O\ @F-\-_\ @D9\1/AMX_\
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M=HWQ8^'?A%=7T_5CJ,OGM;Z@T<BR6EY;L3:HL@*R6]M R/U1:_[(G[;'Q?\
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MWP"_Y+CX/_[&:Q_]'I7(UUWP"_Y+CX/_ .QFL?\ T>E 'Z/4444 %>%^ ?\
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MW<CHCM+=%5N1N1"(YX@$0 */JZ@ HHHH **** "BBB@ HHHH **** "BBB@
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M>)_V<_$OA=;/QH7@?59H6%T6A*E4V'J =QSV%?7M>%_M8?\ );/@?_V/<O\
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MX275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\
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M/2@#]!O^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\
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M "BBB@ HHHH **** "H[O_CTE_ZYM_*I*CN_^/27_KFW\J /RWHHHH ****
M"BBB@ HHHH **** "BBB@#ZJ_P"":G_'IXR_ZZ6'\KBOJ*OEW_@FI_QZ>,O^
MNEA_*XKZBH **** "BBB@ KXL_X*(?\ )<;#_L68/_1]Q7VG7Q9_P40_Y+C8
M?]BS!_Z/N* /!J*** "BBB@ HHHH **** "BBB@ KKO@%_R7'P?_ -C-8_\
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M+NK?$+P]/XJUQM<^('B'5!>ZCXGUJ/4)H+[4KB8$^89I(=\;=X&A/.<GZEH
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MW$;,DL;9!#!T4 ]:HHHH *\+_:P_Y+9\#_\ L>Y?_29J]TKPO]K#_DMGP/\
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MC*\LO#OB)+FTOK*TCC52^G7[Q.KI<1,2!,L9CD5E#%&4E_N"@ HHHH ****
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MGXV_#ZTT/XF6WA+2)=1U'0M>TTQK8ZA]C@#3W%K+:H8&$$<CQR@.PV,2-/\
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MWX7^(K:+P]\?KZ'6M=U3PC-$B7<4VG6EE/+:W$!P#<VUL#]HC.X-*9%);YJ
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M%X2_:N\*7VA74)Q()1;Z@QC!')#;%RO?:*Z_]M?_ ((S?#_0_P!B#P!\._\
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M'8X8XH]!N-*A>R6.,@QH("NP*I52HQ@%1CI0!^;O@#_@M)_P27^._P 6]/\
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M"+1K6=[:8QR*DFFQ(Q1QRK8)PPY!YH )_P#@HW^P7;S/;S?M>?#]7C8JZ_\
M"36_!!P1]ZO7O#^OZ+XJT&R\4>&]4AOM.U*TCNK"]MI T=Q#(H=)$8<%64@@
M]P:^9/VT_P!G7X :+\$='^ 7PT^!W@_2-4^(OB*P\(Z1-IWAJUCEL[69C)?3
MH5CW QV$-VX8'(8*<YKZ?TO3-/T73+?1M)LX[>UM($AMK>)<+%&JA54#L
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M,/,E_>?0'A/Q3X?\<^%M-\:^$]4COM*UC3X;W3;V'.RXMY4$D<BY[,K CZT
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MPP):V:,JL+>"VMK:!"P#-Y18@;L#WNBB@ HHHH **** "BBB@ HHHH ****
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MEUN(_NO$-Q:S+*OA>U<??3SDC-_*IPB)]D!,DL_V8 ^?OVZ_^"C_ .T=H/\
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MJ_M,_P#12_\ RC67_P 9H_X;5_:9_P"BE_\ E&LO_C->644 >I_\-J_M,_\
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MJ]/K\"\1>$\-PQFD'A?X-5-Q3UY6K<RONUJFKZZVZ7?]!^&_%V)XIRJ:Q?\
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M;#_TG2OS8K]$?@_9^,6^$GA9K;6+18SX<L3&K6Y)"_9TP#S0!W=%8_V+QO\
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M^#_^QFL?_1Z5R-==\ O^2X^#_P#L9K'_ -'I0!^CU%%% !7A?@'_ )2">/\
M_L1-*_\ 1C5[I7A?@'_E()X__P"Q$TK_ -&-0![I1110!B_$?P3#\2? .L?#
M^X\2ZSHT>LZ=+9RZIX>U VE]:K(I5G@G4%H9 "=KK\RGD$$ U\(:5_P;1_\
M!/G0=,31=#^)7QULK./=Y=I:?&;4HXEW$LV%4@#)))XY))[U^A-% 'CNB?L%
M?LM:5^QC;_L W_PTBU;X7P^'1HTVA:O</,]S#N\PRR39#FX,V9_.4JXE_>*5
M8 BI\+_V#_A;X!^*^A_''QIX[\9_$7Q9X2T>;2O!.M?$+6H[V3PY9S*J3K:+
M%%$@FE1$22ZD62ZD10KS,I(/MM% !1110 4444 %%%% !1110 4444 %%%%
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M&H>%O 8\7?%CQ[J.D_V@^CP32I%8Z79V[.B&[FWB=I)=T<< X1W<;-7]AO\
M;:\9?%7]H/XQ?L)_M#II:_%+X*:G9-=:IHMHUM9^)M"OX%N+#5(H'=S#)L;R
MKB(.ZI* 5;$@1?F/_@F79ZA8_P#!PS^WXGB\,-5ELO!<NG&4?,UB=/\ D*^J
MA/LXX] .U.^ *ZG??\'8'QTO-'#'3;#]EW2[;6F3[@O'O-*D@#8_B\H2$9[
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M*.,M!!&D322REY9/+AA\P-,N[V?3=*_:CT?3K?2-*_X)^_$^WM;6!(;:"+1
M%CC4!54#/    'M6#HWPO_:<TSXEZO\ %:\_88^+=]JNIV<-C:FYT=-FFV48
MW&W@ QM#REI9&.6=B@)VQ1JH!XGXA^-'CGX)^)?'/[/G[/T.D^5\(_A>?%_B
M#4O%%I+<W'B+4[AKBX,;O'+'Y9E\J:26?#'S)QA0J%7^B/@E\4=,^-WP;\*?
M&31K&2UM/%7AVRU:WM9FR\"W$"2B-CW*[L$]\5Y5\9_V./C[\8/%FM>-+?\
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M9.IP7?V;^RPGF^6X?;NYVYQC.#CTH _56BOCG_AY3^UE_P!(G_BG_P"!8_\
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MK%Q\$_%4>E+ #O-RVD70C"X_BWE<>]?/G_!#V^\,Z?\ \$!OA+J*O%_9UO\
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M $8U>Z5!'I>F1:A)JT6G0+=RQA);I85$CJ.BEL9('I0!/1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'A?[6'_);/@?_P!CW+_Z3-7NE07>
MEZ9?SP7-]IT$TEK)OMI)H59HFQC<I(^4X[BIZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /"_P#@GO\ \D3U;_L>]9_]*37NE0:?I>F:
M1 ;;2M.@M8VD9VCMX512Q.2V !R3U-3T %%%% !1110 4444 %%%% !1110
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M\._%S]G'7I]*^(UAX,ADN+/546&6:&ZLHV9G+2K!*!&&8-A&4@2A$^M_C?\
M&CP/^S]\--1^*/Q N+C[%8A([>RL+<SWFHW4CB.WLK6%?FGN9I62**)>7=U
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M0ZSX7\6Z-;ZIH6IP @3VTR!T)4\HP!PR, RL"I ((KYQ^(7[5G[4F@_\%J/
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MQ@_:^B^/_P "OVN?@YX;\,^&H)+?X>^%_$G@>[U,Z4TB%)M0<EPC7TB%H_-
M_=0N\4>T2S-+Z#^S#\"O^"L'@E/'7C?]JK]L+P!X[\37'AI=/^&>C:-X4FTO
M0=+NF9WFN[^*,^==,S+;!<,"B)*J%/.8U]844 ?FE\+/V"_^#@#X0G7K[PQ_
MP41^!4^J>*-9EU3Q'KNI_"NYGO=1N7^53)(S_<BC"111 ".**-$1548K[M_9
M9^'?Q@^%?P$\.^"_V@?BZ_CSQQ#;R3^*_%9MA!'?7TTKS2^3"H A@1I/+BC
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MO$/AFU\,VK:#ISVNF>'M"@G>Y73[197>65I+B1IIKB1@966,+'$D:I7N%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKD?C"WTR;4I=-9EU(:3 \4GVX6SQS1,TCVX>6"1(C+@$@'U517ROX>_X*P?
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M **** "BBB@ HHHH **** "BBB@#XP_X*+?\EMTO_L58/_2FYKP*ON3]HO\
M9#_X7]XVM?&/_"PO[)^S:4EE]F_LGS]VV65]^[S4Q_K,8QVZ\\<#_P .TO\
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M!-QXC\*:MJURO_".:CXO9KJ."[O)B?)?[,$MO*,A*P23I*2HDW#YY_X* _&
M?\$\?^"BWCC_ (*'_P#!*7XOQ^+OAM\3?#XMOVHQ\-M-_M^Q\$W4TJ1QZX)H
M6^QB])E>ZBAEEW"43F0"&ZX_;CQ;^S1^SCX^^']M\)O'7[/_ ((UKPK9S&:T
M\,ZMX4L[G3X)"S,72WDC,:L69CD+G+$]S6UX0^&/PU^'W@U/ASX"^'NAZ)X>
MCB>*/0M(TF&VLE1AAD$$:A I!.1C!S0!\Y_L ?MR_P#!-OXE>#? O[,?_!/W
MXNZ9XQT_3?"@DMM-\.LT\VAZ=!&H^T:IYFV2VEDE9$(F GEFF9MK 2NGQU_P
M1V^/_P "?"'_  6!_P""BUQXN^-'A328]5^(_AP:6^J>(K:W%Y]F&L1W'E>8
MX\SRW95?;G:6 .,BOTY\ ?LW?L[?"CP]J_A'X6_ 3P7X:TGQ 7.O:9H'A:TL
M[?4BRE6-Q'#&JS95F!W@Y#$=ZJ?\,G_LL_\ 1M7P_P#_  C;'_XU0!^:?_!:
MKXN#_@L;#X9_X)&?\$ZM7@\=-J_C2QU'XS?$OP__ *9X>\&Z5:L7\J>]CS ]
MTTA600(Y?_1]A&Z08_5/X>^!] ^&/@'0_AMX5@:+2_#VCVVF:;&[9*6\$2Q1
M@GN0J"KNAZ#H?AG3(M$\-Z+::?90#$-I8VRQ11CT5%  _ 5;H **** "BBB@
M HHHH *\F_;ITS4M6_9.\:6NDJQE33XIG"CGRH[B*23\-B-GVKUFH=1TZQU?
M3Y])U2TCGMKJ%H;B"5<K)&P*LI'<$$@CWKNRS&?V=F5'%6O[.<96[\K3M^!P
MYG@_[1RVOA+V]I"4;]N:+5_Q/QAHKZ"_:C_8(^)GP>\0W6N?#S0+W7_"TLC2
M6LUC$9KBR0G/ES(HW?+_ ,] "I !.TG%>&:9X4\4:WJ8T71O#=_=WA;:+2UL
MWDE)]-J@G/X5_9669UE>;X)8K"U5*#5]U=>4ET:ZIG\59ID>:Y/C7A,72<9I
MVV=GYQ?5/HT+X4TS4M:\4Z;HVC*S7EWJ$,-HJ#DRNX5<>^2*_92OC;]A']A'
MQ-X1\36OQK^->E?8KBR_>:%H4V#*DI'$\PZ(5!^5/O!N3M*@'[)K^?/%;B'
M9SF='#X22G&BI7DM4Y2M=)];**UVNWV/Z*\)>',PR7*ZV)Q<7"59QM%Z-1BG
M9M=&W)Z/6R7<****_*C]9"ORM_X.O/%?@_1/V;_V<M.\3Z]86Q/[5GAN^E@O
M)T7-G!9ZB)YBK'F-/-C#-T'F+GJ*_5*N3\7? 7X&?$#6F\1^//@OX3UO47C5
M'O\ 5_#EK<S,JC"J7D0L0!T&>* )O OPE^#G@.ZF\0?#/X9^&=%FU&,&>^T+
M1;>V:Y0X8;GB0%P>#R3ZU^3WQ/\ BU^QE^Q1_P %UOCQHW_!5KX1^$'\%?'C
M1_#6N_"+XD^/O!\&HZ?;2:?ID=A>6#3RPR"WRZ_[*KY*%\>=&3^N_A;PGX5\
M#:%!X6\%>&=/T?3+7=]FT[2[)+>"'<Q=ML<8"KEF9C@<EB>IK*^*'P:^#_QO
MT!/"GQI^%/AKQ?I<<XFCTWQ1H5OJ%NLH! <1SHRA@"><9YH _/3]IOQS^P+X
MI_X)(?MA?$C]@SX)> ?#'@&_^%FJ6$WQ"\&^%K71K/QAJJV=VCQQF*"+[:D#
MS11)<9='FN)XD^:)]W02?#'QA^U=_P &ON@?"7X 7(U?Q!KG[)&B6.DVNF3!
MWO+N#1;826*[3_K7>&2W*GH[%3CFONW5_@[\(O$'A&P^'^O?"SPY?:#I>S^S
M-$O-#MY;2TV(43RH60I'M5F4;0, D#@U;\%?#SP!\-=+DT3X<^!M'T"RFN#/
M+9Z)ID5I$\I55,A2)5!8JJC)&<*!V% 'YY?\$[/^"[/["7CK]@KX<>%-6\>P
MGXNZ-X6T_P +WGP2AM'/B"_\06L*6HL[6T*Y=99HP4E_U<:OF5H_+DV>3_M;
M_%+]FO\ 8L_X+G:K\1?^"I_P7\+7GPL^.OPDT.S\(^./%7A:/6=*\/:YIAD2
M>Q\R:!C"C^:[,X4?ZVW9P%+,GZGZ/^S_ / ?P]\2[SXTZ!\$_"-CXQU!&6_\
M66?ANUBU.Y5NHDNEC$K@]P6.:O\ Q)^%7PO^,OA>3P/\7_AOH'BO19I%DET?
MQ)H\%]:NZYPQBG5D)&3@D<9H ^')OB)_P3>\:_LA_M/_ !*_X)_?!3X;:7X4
MLO@[K-KXG^+'@;PG9Z58ZS??V==L;!+B&WC^V_9X]CR2;VC1KF-%+/Y@C^;?
M%OB+P^W_  9E0W7]MV9B/P5LK02?:%VFX&J11^5G/W]XV[>NX8ZU^M[?!CX/
M-X"M?A4WPH\-'PO8A19>&SH5O]@MPI)4);[/+3!)(PHQDUFG]F;]F\Z2- /[
M/O@C["+@W LO^$4L_)$Q7:9-GE[=VT ;L9P,4 ?F5_P4O\>^"O!_P1_X)G?'
M#Q3XKT_3_!VC_&;P3<ZMXHN[M$L+*!M*5A-+.3LCCVH[%V(4!&)( )KTO]JG
M_@IY\)?$G_!2?X:_LK:[^TCH?PK^$/B;X.7WC _&9=1@TZ7Q:W]H/;)HMAJ]
MP EE:NEL]TUS PDG58?(EC#QR2??,WP0^"]QX&/PPN/A#X7D\-&83'P\^@6Q
ML3(&WA_(*>7NW -G;G//6IO%_P (/A+\0;G2+WQ[\+O#NMS>'[CS] EU?1(+
MEM-EP!YEN9$)A;"CYDP>!Z4 ?EG_ ,$6/'W[+=Y^V!^W;\"(O%DUSIOB?X@1
M76G:)JMS?W&IZCH7]F3+/>L+G==R0E6 -S)G>T\7SLTT>_P[]E']HW]C?XC_
M /!):Y_X)B3_ /!4#X,^$?AEX@U#4+'2==\<ZT;3QCHGAB?5Y;@6%U82*EJ]
MZT99?M(G$<2RK^YDV M^Q7[2WPC^(M]\#_B==_L=Q^%O"?Q>\6>&)[?1/&%_
MI:+NU%8#':S74D<;/)Y? 1G$@3 ^1@"I^'/@AX(^,\G@;0/@O\?/^#;3PKJG
MBC2-)@T_4O%NI>)_"&HZ/J,J1A'OI;VY,EXPF93*^Z&:?+G<)&R2 <=_P6)E
M^!'[-=G^P_\ MFZ7\/-*^*?[+WP;O]1\.>+8K.U@\0:>NBZEI=KIUAJ)&)(K
MA(!;LRR<@R>6H(:1<_0_[)WQJ_X(R?'C]I#PC=_\$\?@;\'?&'C&RL[F_P!0
M\:^ OA]96MQX,TQ[6=/.EO%M%>VEGD=+5;7>DSK/,VTI%+7O/[&7[(7A/]F+
M]F8? &]\)>&8K#4M5U?4]4\+:!I^W0M/.I7DUU+IUG!(H LXO.,2@H@<*7,<
M>\HOH7PM^"GP:^!NBS>&_@I\)/#'@_3KBX,]Q8>%M!M]/@EE/!D9($16;_:(
MS0!Y!_P5G^!_Q0_:2_X)J?&WX&_!:.67Q3XC^'NH6VBV<+;7O91'O^R*>F9E
M5H1G S+R0,U\P_LQ_MO?LW_$K_@W:;4O%7BS3;2Y\)_ &?P'XU\)WLRQW]KK
MEII3:8^F/:M^\$\\R*L4)7?()XPH.X5^DE<4_P"S7^SG)\4!\;Y/@#X);QH'
MW#Q>?"MF=4#8QG[5Y?FYQQG=0!^3O[7OP.\:_L9_\&>$OP"^/=S_ &;XIM/
MVCK>:;J,H2>WN[SQ';WJV!5CDRPI-Y909QY+=ES7ZR?LYZYH_B;]GWP-XA\/
M:I;WMC>^#]-FM+RUE$D<T;6L95U8<$$'J*T_'/PE^%?Q/-JWQ+^&?A_Q$;(/
M]B.NZ-!=_9]^W?L\U&V;MJYQC.T9Z"K'@KX>> /AKI<FB?#GP-H^@64UP9YK
M/1-,BM(GE*JID*1*H+%549(SA0.PH _/C_@N3XD\/:-^V=^P+:ZOKEI:RO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
IBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543210544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Oct. 25, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-15525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EDWARDS LIFESCIENCES CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4316614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Edwards Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Zip Code</a></td>
<td class="text">92614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">250-2500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $1.00 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">606,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001099800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295541292336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,410.1<span></span>
</td>
<td class="nump">$ 769.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments (Note&#160;5)</a></td>
<td class="nump">453.8<span></span>
</td>
<td class="nump">446.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $7.9 and $7.9, respectively</a></td>
<td class="nump">739.8<span></span>
</td>
<td class="nump">643.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">62.3<span></span>
</td>
<td class="nump">56.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories (Note&#160;2)</a></td>
<td class="nump">1,032.4<span></span>
</td>
<td class="nump">875.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">133.3<span></span>
</td>
<td class="nump">110.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">235.8<span></span>
</td>
<td class="nump">195.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,067.5<span></span>
</td>
<td class="nump">3,095.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments (Note&#160;5)</a></td>
<td class="nump">704.6<span></span>
</td>
<td class="nump">1,239.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">1,681.3<span></span>
</td>
<td class="nump">1,632.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">90.9<span></span>
</td>
<td class="nump">92.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,297.4<span></span>
</td>
<td class="nump">1,164.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net (Note 7)</a></td>
<td class="nump">429.8<span></span>
</td>
<td class="nump">285.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">651.9<span></span>
</td>
<td class="nump">484.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets (Note 6)</a></td>
<td class="nump">447.4<span></span>
</td>
<td class="nump">299.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,370.8<span></span>
</td>
<td class="nump">8,292.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">190.6<span></span>
</td>
<td class="nump">201.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedAndOtherLiabilitiesCurrent', window );">Accrued and other liabilities (Note 2)</a></td>
<td class="nump">1,024.0<span></span>
</td>
<td class="nump">795.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">24.3<span></span>
</td>
<td class="nump">25.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,238.9<span></span>
</td>
<td class="nump">1,022.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">596.8<span></span>
</td>
<td class="nump">596.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration liabilities (Note 8)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Taxes payable</a></td>
<td class="nump">81.2<span></span>
</td>
<td class="nump">143.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">70.0<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Uncertain tax positions</a></td>
<td class="nump">312.1<span></span>
</td>
<td class="nump">267.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Litigation settlement accrual</a></td>
<td class="nump">104.4<span></span>
</td>
<td class="nump">143.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">240.3<span></span>
</td>
<td class="nump">217.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,643.7<span></span>
</td>
<td class="nump">2,485.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note&#160;12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $1.00 par value, 1,050.0 shares authorized, 649.9 and 646.3 shares issued, and 606.5 and 608.3 shares outstanding, respectively</a></td>
<td class="nump">649.9<span></span>
</td>
<td class="nump">646.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,211.3<span></span>
</td>
<td class="nump">1,969.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">8,622.5<span></span>
</td>
<td class="nump">7,590.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss (Note 13)</a></td>
<td class="num">(250.1)<span></span>
</td>
<td class="num">(254.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 43.4 and 38.0 shares, respectively</a></td>
<td class="num">(4,576.1)<span></span>
</td>
<td class="num">(4,144.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Edwards Lifesciences Corporation stockholders' equity</a></td>
<td class="nump">6,657.5<span></span>
</td>
<td class="nump">5,806.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest (Note 7)</a></td>
<td class="nump">69.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">6,727.1<span></span>
</td>
<td class="nump">5,806.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 9,370.8<span></span>
</td>
<td class="nump">$ 8,292.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543184592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000.0<span></span>
</td>
<td class="nump">50,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,050,000,000<span></span>
</td>
<td class="nump">1,050,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">649,900,000<span></span>
</td>
<td class="nump">646,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">606,500,000<span></span>
</td>
<td class="nump">608,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">43,400,000<span></span>
</td>
<td class="nump">38,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295533418608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,480.9<span></span>
</td>
<td class="nump">$ 1,319.0<span></span>
</td>
<td class="nump">$ 4,470.7<span></span>
</td>
<td class="nump">$ 4,034.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">350.4<span></span>
</td>
<td class="nump">253.8<span></span>
</td>
<td class="nump">1,022.9<span></span>
</td>
<td class="nump">822.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,130.5<span></span>
</td>
<td class="nump">1,065.2<span></span>
</td>
<td class="nump">3,447.8<span></span>
</td>
<td class="nump">3,211.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expenses</a></td>
<td class="nump">439.6<span></span>
</td>
<td class="nump">377.3<span></span>
</td>
<td class="nump">1,344.6<span></span>
</td>
<td class="nump">1,156.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">270.3<span></span>
</td>
<td class="nump">233.6<span></span>
</td>
<td class="nump">801.8<span></span>
</td>
<td class="nump">713.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property agreement and litigation expense (income), net (Note 3)</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="nump">193.6<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration liabilities (Note 8)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(26.2)<span></span>
</td>
<td class="num">(36.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Special charge (Note&#160;4)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">66.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">66.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income, net</a></td>
<td class="nump">418.4<span></span>
</td>
<td class="nump">402.4<span></span>
</td>
<td class="nump">1,134.0<span></span>
</td>
<td class="nump">1,300.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income, net</a></td>
<td class="num">(15.1)<span></span>
</td>
<td class="num">(6.9)<span></span>
</td>
<td class="num">(32.8)<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="num">(9.6)<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">439.3<span></span>
</td>
<td class="nump">407.3<span></span>
</td>
<td class="nump">1,176.4<span></span>
</td>
<td class="nump">1,308.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">55.6<span></span>
</td>
<td class="nump">63.8<span></span>
</td>
<td class="nump">146.7<span></span>
</td>
<td class="nump">184.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">383.7<span></span>
</td>
<td class="nump">343.5<span></span>
</td>
<td class="nump">1,029.7<span></span>
</td>
<td class="nump">1,123.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interest (Note 7)</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Edwards Lifesciences Corporation</a></td>
<td class="nump">$ 384.9<span></span>
</td>
<td class="nump">$ 343.5<span></span>
</td>
<td class="nump">$ 1,032.5<span></span>
</td>
<td class="nump">$ 1,123.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 1.70<span></span>
</td>
<td class="nump">$ 1.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 1.69<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">607.0<span></span>
</td>
<td class="nump">619.8<span></span>
</td>
<td class="nump">607.2<span></span>
</td>
<td class="nump">621.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">609.5<span></span>
</td>
<td class="nump">624.5<span></span>
</td>
<td class="nump">610.2<span></span>
</td>
<td class="nump">626.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483613/220-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543230848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 383.7<span></span>
</td>
<td class="nump">$ 343.5<span></span>
</td>
<td class="nump">$ 1,029.7<span></span>
</td>
<td class="nump">$ 1,123.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), net of tax (Note&#160;13):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(23.4)<span></span>
</td>
<td class="num">(41.7)<span></span>
</td>
<td class="num">(31.1)<span></span>
</td>
<td class="num">(94.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gain on hedges</a></td>
<td class="nump">18.2<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">65.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Unrealized pension (costs) credits</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on available-for-sale investments</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="num">(10.4)<span></span>
</td>
<td class="nump">29.5<span></span>
</td>
<td class="num">(68.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="num">(31.6)<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="num">(98.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">389.1<span></span>
</td>
<td class="nump">311.9<span></span>
</td>
<td class="nump">1,034.5<span></span>
</td>
<td class="nump">1,025.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive loss attributable to noncontrolling interest</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Edwards Lifesciences Corporation</a></td>
<td class="nump">$ 390.3<span></span>
</td>
<td class="nump">$ 311.9<span></span>
</td>
<td class="nump">$ 1,037.3<span></span>
</td>
<td class="nump">$ 1,025.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295534675552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,029.7<span></span>
</td>
<td class="nump">$ 1,123.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">108.2<span></span>
</td>
<td class="nump">104.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash operating lease cost</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation (Note&#160;10)</a></td>
<td class="nump">108.9<span></span>
</td>
<td class="nump">98.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge (Note 4)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">55.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration liabilities (Note 8)</a></td>
<td class="num">(26.2)<span></span>
</td>
<td class="num">(36.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Loss on investments, net</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">49.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(180.7)<span></span>
</td>
<td class="num">(148.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts and other receivables, net</a></td>
<td class="num">(123.0)<span></span>
</td>
<td class="num">(83.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(189.7)<span></span>
</td>
<td class="num">(151.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">112.6<span></span>
</td>
<td class="num">(55.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="nump">106.3<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(63.7)<span></span>
</td>
<td class="nump">20.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_IncreaseDecreaseInLegalSettlementAccrual', window );">Intellectual property agreement accrual</a></td>
<td class="num">(26.0)<span></span>
</td>
<td class="num">(36.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidRoyalties', window );">Long-term prepaid royalties (Note 3)</a></td>
<td class="num">(111.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(14.8)<span></span>
</td>
<td class="num">(39.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">759.2<span></span>
</td>
<td class="nump">935.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(164.7)<span></span>
</td>
<td class="num">(175.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchases of held-to-maturity investments (Note 5)</a></td>
<td class="num">(23.5)<span></span>
</td>
<td class="num">(285.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds from held-to-maturity investments (Note 5)</a></td>
<td class="nump">91.5<span></span>
</td>
<td class="nump">324.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of available-for-sale investments (Note 5)</a></td>
<td class="num">(8.4)<span></span>
</td>
<td class="num">(302.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from available-for-sale investments (Note 5)</a></td>
<td class="nump">486.9<span></span>
</td>
<td class="nump">761.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions', window );">Business combination, net of cash (Note 7)</a></td>
<td class="num">(141.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for acquisition options (Note 6)</a></td>
<td class="num">(15.0)<span></span>
</td>
<td class="num">(107.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireReceivables', window );">Issuances of notes receivable</a></td>
<td class="num">(47.5)<span></span>
</td>
<td class="num">(51.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Collections of notes receivable</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(18.4)<span></span>
</td>
<td class="num">(22.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">159.7<span></span>
</td>
<td class="nump">157.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(431.2)<span></span>
</td>
<td class="num">(861.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from stock plans</a></td>
<td class="nump">136.7<span></span>
</td>
<td class="nump">118.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(3.3)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(297.8)<span></span>
</td>
<td class="num">(746.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">20.2<span></span>
</td>
<td class="nump">37.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">641.3<span></span>
</td>
<td class="nump">384.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">772.6<span></span>
</td>
<td class="nump">867.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period (Note 2)</a></td>
<td class="nump">$ 1,413.9<span></span>
</td>
<td class="nump">$ 1,251.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_IncreaseDecreaseInLegalSettlementAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Legal Settlement Accrual</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_IncreaseDecreaseInLegalSettlementAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for royalties that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of all receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295539653520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Edwards Lifesciences Corporation Stockholders' Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 5,835.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 642.0<span></span>
</td>
<td class="num">$ (2,416.9)<span></span>
</td>
<td class="nump">$ 1,700.4<span></span>
</td>
<td class="nump">$ 6,068.1<span></span>
</td>
<td class="num">$ (157.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">373.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(28.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued under stock/equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under stock/equity plans</a></td>
<td class="nump">37.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">32.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(405.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (405.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">5,844.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 642.9<span></span>
</td>
<td class="num">$ (2,822.5)<span></span>
</td>
<td class="nump">1,769.4<span></span>
</td>
<td class="nump">6,441.7<span></span>
</td>
<td class="num">(186.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">5,835.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 642.0<span></span>
</td>
<td class="num">$ (2,416.9)<span></span>
</td>
<td class="nump">1,700.4<span></span>
</td>
<td class="nump">6,068.1<span></span>
</td>
<td class="num">(157.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,123.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">6,217.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645.7<span></span>
</td>
<td class="num">$ (3,278.0)<span></span>
</td>
<td class="nump">1,914.5<span></span>
</td>
<td class="nump">7,191.6<span></span>
</td>
<td class="num">(256.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">5,844.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 642.9<span></span>
</td>
<td class="num">$ (2,822.5)<span></span>
</td>
<td class="nump">1,769.4<span></span>
</td>
<td class="nump">6,441.7<span></span>
</td>
<td class="num">(186.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">406.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(37.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued under stock/equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under stock/equity plans</a></td>
<td class="nump">49.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">36.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(355.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (355.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">5,943.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645.0<span></span>
</td>
<td class="num">$ (3,177.6)<span></span>
</td>
<td class="nump">1,852.5<span></span>
</td>
<td class="nump">6,848.1<span></span>
</td>
<td class="num">(224.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">343.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(31.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued under stock/equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under stock/equity plans</a></td>
<td class="nump">32.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">30.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(100.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 6,217.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645.7<span></span>
</td>
<td class="num">$ (3,278.0)<span></span>
</td>
<td class="nump">1,914.5<span></span>
</td>
<td class="nump">7,191.6<span></span>
</td>
<td class="num">(256.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">608.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 5,806.7<span></span>
</td>
<td class="nump">$ 5,806.7<span></span>
</td>
<td class="nump">$ 646.3<span></span>
</td>
<td class="num">$ (4,144.0)<span></span>
</td>
<td class="nump">1,969.3<span></span>
</td>
<td class="nump">7,590.0<span></span>
</td>
<td class="num">(254.9)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 340.5<span></span>
</td>
<td class="nump">340.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued under stock/equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under stock/equity plans</a></td>
<td class="nump">41.9<span></span>
</td>
<td class="nump">41.9<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">38.9<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(249.5)<span></span>
</td>
<td class="num">(249.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (249.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Changes to noncontrolling interest</a></td>
<td class="nump">84.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 6,062.0<span></span>
</td>
<td class="nump">5,978.0<span></span>
</td>
<td class="nump">$ 647.1<span></span>
</td>
<td class="num">$ (4,393.5)<span></span>
</td>
<td class="nump">2,049.3<span></span>
</td>
<td class="nump">7,930.5<span></span>
</td>
<td class="num">(255.4)<span></span>
</td>
<td class="nump">84.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">608.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 5,806.7<span></span>
</td>
<td class="nump">5,806.7<span></span>
</td>
<td class="nump">$ 646.3<span></span>
</td>
<td class="num">$ (4,144.0)<span></span>
</td>
<td class="nump">1,969.3<span></span>
</td>
<td class="nump">7,590.0<span></span>
</td>
<td class="num">(254.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,029.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="nump">606.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">649.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">$ 6,727.1<span></span>
</td>
<td class="nump">6,657.5<span></span>
</td>
<td class="nump">$ 649.9<span></span>
</td>
<td class="num">$ (4,576.1)<span></span>
</td>
<td class="nump">2,211.3<span></span>
</td>
<td class="nump">8,622.5<span></span>
</td>
<td class="num">(250.1)<span></span>
</td>
<td class="nump">69.6<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="nump">43.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">$ 6,062.0<span></span>
</td>
<td class="nump">5,978.0<span></span>
</td>
<td class="nump">$ 647.1<span></span>
</td>
<td class="num">$ (4,393.5)<span></span>
</td>
<td class="nump">2,049.3<span></span>
</td>
<td class="nump">7,930.5<span></span>
</td>
<td class="num">(255.4)<span></span>
</td>
<td class="nump">84.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">305.5<span></span>
</td>
<td class="nump">307.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued under stock/equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under stock/equity plans</a></td>
<td class="nump">60.8<span></span>
</td>
<td class="nump">60.8<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">37.4<span></span>
</td>
<td class="nump">37.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Changes to noncontrolling interest</a></td>
<td class="num">(11.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">649.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">6,446.5<span></span>
</td>
<td class="nump">6,375.7<span></span>
</td>
<td class="nump">$ 649.1<span></span>
</td>
<td class="num">$ (4,401.0)<span></span>
</td>
<td class="nump">2,145.5<span></span>
</td>
<td class="nump">8,237.6<span></span>
</td>
<td class="num">(255.5)<span></span>
</td>
<td class="nump">70.8<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">383.7<span></span>
</td>
<td class="nump">384.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock issued under stock/equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Common stock issued under stock/equity plans</a></td>
<td class="nump">34.0<span></span>
</td>
<td class="nump">34.0<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">32.6<span></span>
</td>
<td class="nump">32.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">$ (175.1)<span></span>
</td>
<td class="num">(175.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (175.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="nump">606.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">649.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">$ 6,727.1<span></span>
</td>
<td class="nump">$ 6,657.5<span></span>
</td>
<td class="nump">$ 649.9<span></span>
</td>
<td class="num">$ (4,576.1)<span></span>
</td>
<td class="nump">$ 2,211.3<span></span>
</td>
<td class="nump">$ 8,622.5<span></span>
</td>
<td class="num">$ (250.1)<span></span>
</td>
<td class="nump">$ 69.6<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="nump">43.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295547258416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text">BASIS OF PRESENTATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 250<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//250/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542352448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</a></td>
<td class="text">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2023 and December&#160;31, 2022, $142.5 million and $128.6 million, respectively, of the Company's finished products inventories were held on consignment. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295547269200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET</a></td>
<td class="text">INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0&#160;million and will pay annual royalty payments that are tied to net sales of certain Edwards products.  Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0&#160;million upfront payment based on their respective fair values.  The Company recorded a $37.0&#160;million pre-tax charge in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Litigation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in March 2023 related primarily to prior commercial sales incurred through March 31, 2023.  The Company recorded a prepaid royalty asset of $124.0&#160;million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement.  Separately, the Company recorded a $139.0&#160;million pre-tax charge in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Litigation Expense</span>" in April 2023 related to products currently in development.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295541279056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SPECIAL CHARGE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock', window );">SPECIAL CHARGE</a></td>
<td class="text">SPECIAL CHARGE<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Company decided to exit its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HARPOON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> surgical mitral repair system program. As a result, the Company recorded a charge to its United States segment of $68.4&#160;million, of which $66.8&#160;million was included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Special Charge</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and $1.6&#160;million was included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed statements of operations. The charge primarily related to the full impairment of intangible assets associated with the technology and other related exit costs. The Company believes that no additional contingent consideration is due and, in September 2022, recorded an $11.7&#160;million contingent consideration gain associated with the exit.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//220-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544571344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS</a></td>
<td class="text">INVESTMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of September&#160;30, 2023, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1&#160;year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1&#160;year through 5&#160;years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 5&#160;years through 10&#160;years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  &#160;&#160;&#160;&#160;Consists of mortgage- and asset-backed securities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September&#160;30, 2023 and December&#160;31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.411%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value.  Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of September&#160;30, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Unconsolidated Entities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities.  These investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets, and are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023, the Company made $1.7 million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program.  The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities.  The NMTC is equal to 39% of the qualified investment and is taken over seven years.  These limited liability companies are variable interest entities ("VIEs").  The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company does not consolidate these entities.  Instead, the NMTC investments are accounted for as equity method investments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.  As of September&#160;30, 2023, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $3.1 million due to impairments and observable price changes.   </span></div>During the three and nine months ended September 30, 2023, the gross realized gains or losses from sales of available-for-sale investments were not material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br> -Publisher SEC<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//946-320/tableOfContent<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//940-320/tableOfContent<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295547366816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN VARIABLE INTEREST ENTITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_VariableInterestEntitiesAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">INVESTMENTS IN VARIABLE INTEREST ENTITIES</a></td>
<td class="text">INVESTMENTS IN VARIABLE INTEREST ENTITIES <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE.  The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest.  Edwards concluded that it is the primary beneficiary and consolidated the VIE.  See Note 7 for additional information. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unconsolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company agreed to pay a medical device company up to $45.0&#160;million as consideration for an option to acquire the medical device company, of which $15.0&#160;million had been paid as of September&#160;30, 2023. Also, in March 2023, Edwards advanced $5.0&#160;million to the medical device company under a convertible promissory note. The option and the note are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet as of September&#160;30, 2023.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into a $45.0&#160;million secured promissory note agreement with a privately-held medical device company (the "Investee"), of which $25.0&#160;million had been advanced as of September&#160;30, 2023.  Also in 2021, the Company invested $39.3&#160;million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in the Investee's preferred equity securities and paid $13.1&#160;million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for an option to acquire the Investee.  Pursuant to the agreement, the Company may be required to invest up to an additional $6.5&#160;million in the Investee's preferred equity securities and up to an additional $14.4&#160;million for the option to acquire the Investee.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into an option agreement with a medical device company.  Under the option agreement, Edwards paid $47.1&#160;million for an option to acquire the medical device company.  The $47.1&#160;million option is included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company.  Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5&#160;million, of which $32.5&#160;million had been advanced as of September&#160;30, 2023.  In addition, in 2019 the Company paid $35.0&#160;million for an option to acquire the medical device company. The $35.0&#160;million option and the $32.5&#160;million note receivable are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an option agreement with a medical technology company.  Under the option agreement, Edwards paid $60.0&#160;million for an option to acquire the medical technology company, of which $10.0&#160;million was paid in 2021. The $60.0&#160;million option is included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet. In addition, in August 2023, the Company entered into a $15&#160;million promissory note with the medical technology company.  </span></div>In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs.  For more information, see Note 5.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_VariableInterestEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in Variable Interest Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_VariableInterestEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295636175808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2023, the Company acquired 61% of the then outstanding shares of a medical technology company in an all cash transaction.  The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated condensed financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination.  Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date.  The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill.  The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  Includes the fair value of the noncontrolling interest of $94.4&#160;million, offset by the purchase consideration allocated to the option of $22.0&#160;million, which was ascribed to the noncontrolling interest.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Includes $22.5&#160;million paid in a previous year under option agreements and $5.3&#160;million for the settlement of a pre-existing note.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition.  Goodwill was assigned to the Company&#8217;s Rest of World segment and is not deductible for tax purposes.     </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295636175808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable.  As of September&#160;30, 2023, the fair value of the notes payable, based on Level 2 inputs, was $565.7 million.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents included money market funds for the periods presented above.  The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets.  The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs.  The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source.  The Company&#8217;s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.  </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in trading securities related to its deferred compensation plans.  The investments are in a variety of stock, bond and money market mutual funds.  The fair values of these investments are based on quoted market prices.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures.  All derivatives contracts are recognized on the balance sheet at their fair value.  The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates.  Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange.  The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements.  Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals.  These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs.  As of September&#160;30, 2023, the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was zero.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295547285232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default.  It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy.  The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities.  The Company also uses International Swap Dealers Association master-netting agreements.  The master-netting </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges).  The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets.  For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item.  The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges.  The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings.  Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated.  The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative.  The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument.  Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-870"><span style="-sec-ix-hidden:f-871">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-876"><span style="-sec-ix-hidden:f-877">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.891%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from <br/>Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.998%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from<br/>&#160;Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cross currency swap contracts have an expiration date of June 15, 2028.  At maturity of the cross currency swap contracts, the Company will deliver the notional amount of &#8364;257.2 million and will receive $300.0 million from the counterparties.  The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,022.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(822.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during the next twelve months it will reclassify to earnings a $5.5 million gain currently recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542438736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION  <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2023 and 2022 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2023, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $254.5 million, which will be amortized on a straight-line basis over each award's requisite service period.  The weighted-average remaining requisite service period is 33 months.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2023, the Company granted 2.0 million stock options at a weighted-average</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise price per share of $88.45, and 1.0 million restricted stock units at a weighted-average grant-date fair value per share of $87.36. During the nine months ended September 30, 2023, the Company also granted 0.1 million market-based restricted stock units at a weighted-average grant-date fair value per share of $110.10.  The market-based restricted stock units granted during the nine months ended September 30, 2023 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a three-year performance period and may range from 0% to 175% of the target number of shares granted.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Disclosures</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements.  The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the nine months ended September 30, 2023 and 2022 included a risk-free interest rate of 3.6% and 2.9%, respectively, and an expected volatility rate of 32.6% and 33.9%, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542417456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">ACCELERATED SHARE REPURCHASE</a></td>
<td class="text">ACCELERATED SHARE REPURCHASE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023 and 2022, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreement, less a discount.  The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreements were each accounted for as two separate transactions: (1)&#160;the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2)&#160;the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and subsequently, upon settlement, was transferred to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544244176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act ("FCPA").  The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company&#8217;s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> product infringes certain of its patents.  The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued.  The Company intends to vigorously defend itself in this litigation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of </span></div>operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295547294864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE LOSS</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credits</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.387%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on hedges</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//220/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295547294864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 6.5 million and 4.0 million common shares for the three months ended September 30, 2023 and 2022, respectively, and 6.1&#160;million and 3.1&#160;million shares for the nine months ended September 30, 2023 and 2022, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542467440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective income tax rates were 12.7% and 15.7% for the three months ended September 30, 2023 and 2022, respectively, and 12.5% and 14.1% for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022, respectively.  The decrease in the effective rate between the nine months ended September 30, 2023 and 2022 is primarily due </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the impact of temporary relief provided by the Internal Revenue Service ("IRS") relating to U.S. foreign tax credit regulations.  On July 21, 2023, the IRS issued Notice 2023-55 which delayed the application of certain U.S. foreign tax credit regulations that had previously limited the Company's ability to claim credits on certain foreign taxes for tax years 2022 and 2023.  In addition, there was an increase in the benefit from the federal research and development credit and the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation.   The effective rates for the nine months ended September 30, 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective rates include a tax benefit from employee share-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compensation of $1.9 million and $3.4 million for the three months ended September 30, 2023 and 2022, respectively, and $14.2 million and $36.7 million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2022, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the IRS and other taxing authorities are in different stages of examining various years of the Company's tax filings.  During these audits the Company may receive proposed audit adjustments that could be material.  Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition.  The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time.  While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements.  Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2023 and December&#160;31, 2022, the gross liability recorded for income taxes associated with uncertain tax positions was $542.9 million and $475.3 million, respectively. The Company estimates that these liabilities would be reduced by $226.4 million and $182.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $316.5 million and $293.2 million, respectively, if not required, would favorably affect the Company's effective tax rate.   </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.  The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively &#8220;Surgical/TAVR&#8221;) intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits.  In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward.  An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021.  The execution of some or all of these APA renewals depends on many variables outside of the Company's control. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company&#8217;s United States federal income tax returns through 2014 have been closed.  The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters.  The IRS began its examination of the 2018 through 2020 tax years during the first quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015.  While not material, the Company continues to address matters in India for years from 2010 and on. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company received a Notice of Proposed Adjustment (&#8220;NOPA&#8221;) from the IRS for the 2015-2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries.  The NOPA proposed an increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $220 million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS.  The Company disagreed with the NOPA and submitted a formal protest on the matter during the fourth quarter of 2021.  During the second quarter of 2022, the Company received the IRS's rebuttal to the Company's protest and was notified that the case had been transferred to the IRS Independent Office of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Appeals ("Appeals").  The opening conference was held with Appeals during March 2023 and discussions with Appeals continued into the third quarter of 2023.  While Appeals still maintains jurisdiction over the matter as of September&#160;30, 2023, the Company and Appeals have concluded that a satisfactory resolution of this matter at the administrative level is not possible.  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company plans to vigorously contest the proposed adjustments through the judicial process.  Final resolution of this matter is not likely within the next 12 months.  The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOPA received or as a result of the Appeals proceedings to date.  Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements.  As noted below, similar material tax disputes may arise for the 2018-2023 tax years. While no payment of any amount related to the NOPA has yet been required, the Company made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any potential deficiency that may be ultimately sustained.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018-2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of September&#160;30, 2023.  The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions.  The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company&#8217;s consolidated financial statements.  Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542352880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,453.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,453.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,470.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,435.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,285.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charge (Note&#160;4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and litigation (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enterprise-wide Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,470.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,470.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544341088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 384.9<span></span>
</td>
<td class="nump">$ 343.5<span></span>
</td>
<td class="nump">$ 1,032.5<span></span>
</td>
<td class="nump">$ 1,123.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295535291856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ew_JeanLucLemercierMember', window );">Jean-Luc Lemercier [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On August 31, 2023, Jean-Luc Lemercier, Corporate Vice President of EMEA, Canada, Latin America, and JAPAC, entered into a 10b5-1 trading plan (the &#8220;Plan&#8221;) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the potential sale of 43,200 shares of the Company&#8217;s stock commencing March 11, 2024.  The Plan terminates on the earlier of May 10, 2024 or the date all shares are sold.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Jean-Luc Lemercier<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Corporate Vice President of EMEA, Canada, Latin America, and JAPAC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">August 31, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">43,200<span></span>
</td>
<td class="nump">43,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ew_JeanLucLemercierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ew_JeanLucLemercierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295548481952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544303536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued and Other Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Cash Flow Information</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542492400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Schedule of Investments in Debt Securities</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of September&#160;30, 2023, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1&#160;year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1&#160;year through 5&#160;years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 5&#160;years through 10&#160;years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  &#160;&#160;&#160;&#160;Consists of mortgage- and asset-backed securities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September&#160;30, 2023 and December&#160;31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.411%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock', window );">Schedule of Investments in Unconsolidated Affiliates</a></td>
<td class="text">These investments are recorded in "<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets, and are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543281712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Fair Values of Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)  Includes the fair value of the noncontrolling interest of $94.4&#160;million, offset by the purchase consideration allocated to the option of $22.0&#160;million, which was ascribed to the noncontrolling interest.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Includes $22.5&#160;million paid in a previous year under option agreements and $5.3&#160;million for the settlement of a pre-existing note.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295541103856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes in Fair Value of Contingent Consideration and Other Liability</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543251840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock', window );">Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-870"><span style="-sec-ix-hidden:f-871">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-876"><span style="-sec-ix-hidden:f-877">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsTableTextBlock', window );">Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesTableTextBlock', window );">Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.891%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from <br/>Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.998%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in&#160;Income on Derivative (Amount Excluded from<br/>&#160;Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Location&#160;of&#160;Gain&#160;or<br/>(Loss)&#160;Reclassified&#160;from<br/>Accumulated&#160;OCI<br/>into&#160;Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,022.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income) expense, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(822.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544262784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2023 and 2022 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions for Options Granted</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542340784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesTextBlock', window );">Schedule of Accelerated Share Repurchases</a></td>
<td class="text">The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481138/505-30-25-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542424992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credits</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.387%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on hedges</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295547192032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295541096464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,453.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,453.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,470.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,435.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,285.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charge (Note&#160;4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and litigation (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Enterprise-Wide Information</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,470.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,470.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,034.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295533499440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 204.9<span></span>
</td>
<td class="nump">$ 156.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">223.7<span></span>
</td>
<td class="nump">177.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished products</a></td>
<td class="nump">603.8<span></span>
</td>
<td class="nump">541.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">1,032.4<span></span>
</td>
<td class="nump">875.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment', window );">Finished products inventories held on consignment</a></td>
<td class="nump">$ 142.5<span></span>
</td>
<td class="nump">$ 128.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542527664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued and other liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and withholdings</a></td>
<td class="nump">$ 340.0<span></span>
</td>
<td class="nump">$ 268.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Taxes payable</a></td>
<td class="nump">172.1<span></span>
</td>
<td class="nump">50.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent', window );">Property, payroll, and other taxes</a></td>
<td class="nump">57.1<span></span>
</td>
<td class="nump">45.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_ResearchAndDevelopmentAccruals', window );">Research and development accruals</a></td>
<td class="nump">70.1<span></span>
</td>
<td class="nump">66.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedRebates', window );">Accrued rebates</a></td>
<td class="nump">139.5<span></span>
</td>
<td class="nump">116.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Fair value of derivatives</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued marketing expenses</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedLitigationAndInsuranceReserves', window );">Legal and insurance</a></td>
<td class="nump">30.3<span></span>
</td>
<td class="nump">28.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Litigation settlement</a></td>
<td class="nump">65.9<span></span>
</td>
<td class="nump">53.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedRelocationCostsCurrent', window );">Accrued relocation costs</a></td>
<td class="nump">22.3<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional services</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Accrued realignment reserves</a></td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">15.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">80.9<span></span>
</td>
<td class="nump">80.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AccruedAndOtherLiabilitiesCurrent', window );">Total accrued and other liabilities</a></td>
<td class="nump">$ 1,024.0<span></span>
</td>
<td class="nump">$ 795.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedLitigationAndInsuranceReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Litigation And Insurance Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedLitigationAndInsuranceReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AccruedRelocationCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Relocation Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AccruedRelocationCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_ResearchAndDevelopmentAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_ResearchAndDevelopmentAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542490032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Cash paid during the year for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">$ 219.1<span></span>
</td>
<td class="nump">$ 315.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">22.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new lease liabilities</a></td>
<td class="nump">21.2<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures accruals</a></td>
<td class="nump">$ 33.0<span></span>
</td>
<td class="nump">$ 25.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544199552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,410.1<span></span>
</td>
<td class="nump">$ 769.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash included in other current assets</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash included in other assets</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 1,413.9<span></span>
</td>
<td class="nump">$ 772.6<span></span>
</td>
<td class="nump">$ 1,251.7<span></span>
</td>
<td class="nump">$ 867.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295541370320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 12, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_IntellectualPropertyAgreementTerm', window );">Intellectual property agreement term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="num">$ (2.4)<span></span>
</td>
<td class="nump">$ 193.6<span></span>
</td>
<td class="nump">$ 10.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=ew_MedtronicIncMember', window );">Medtronic Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 139.0<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidRoyalties', window );">Prepaid royalty asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_IntellectualPropertyAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intellectual Property Agreement Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_IntellectualPropertyAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ew_MedtronicIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ew_MedtronicIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542495696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SPECIAL CHARGE (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Special charge</a></td>
<td class="nump">$ 68.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_RestructuringContingentConsiderationGainLoss', window );">Restructuring contingent consideration gain</a></td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ew_SpecialChargeMember', window );">Special Charge</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Special charge</a></td>
<td class="nump">66.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Special charge</a></td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_RestructuringContingentConsiderationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Contingent Consideration, Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_RestructuringContingentConsiderationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ew_SpecialChargeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ew_SpecialChargeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543324368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Investments in Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAbstract', window );"><strong>Held-to-maturity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,059.2<span></span>
</td>
<td class="nump">$ 1,549.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(38.7)<span></span>
</td>
<td class="num">(68.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,020.6<span></span>
</td>
<td class="nump">1,481.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember', window );">Bank time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAbstract', window );"><strong>Held-to-maturity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Amortized Cost</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="nump">96.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="nump">96.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">83.9<span></span>
</td>
<td class="nump">137.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">79.6<span></span>
</td>
<td class="nump">131.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">227.5<span></span>
</td>
<td class="nump">380.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(7.8)<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">219.7<span></span>
</td>
<td class="nump">366.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">745.0<span></span>
</td>
<td class="nump">1,028.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(26.4)<span></span>
</td>
<td class="num">(47.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">718.7<span></span>
</td>
<td class="nump">980.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Available-for-sale</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543244096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost', window );">Due in 1&#160;year or less</a></td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost', window );">Due after 1&#160;year through 5&#160;years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost', window );">Due after 5&#160;years through 10&#160;years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount', window );">Instruments not due at a single maturity date</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Due in 1&#160;year or less</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Due after 1&#160;year through 5&#160;years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue', window );">Due after 5&#160;years through 10&#160;years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Instruments not due at a single maturity date</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair Value</a></td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Due in 1&#160;year or less</a></td>
<td class="nump">435.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">Due after 1&#160;year through 5&#160;years</a></td>
<td class="nump">365.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis', window );">Due after 5&#160;years through 10&#160;years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Instruments not due at a single maturity date</a></td>
<td class="nump">258.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,059.2<span></span>
</td>
<td class="nump">$ 1,549.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Due in 1&#160;year or less</a></td>
<td class="nump">425.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Due after 1&#160;year through 5&#160;years</a></td>
<td class="nump">347.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue', window );">Due after 5&#160;years through 10&#160;years</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Instruments not due at a single maturity date</a></td>
<td class="nump">247.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 1,020.6<span></span>
</td>
<td class="nump">$ 1,481.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295533550096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">$ 21.4<span></span>
</td>
<td class="nump">$ 353.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">953.4<span></span>
</td>
<td class="nump">1,111.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(38.3)<span></span>
</td>
<td class="num">(60.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">974.8<span></span>
</td>
<td class="nump">1,465.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">(38.7)<span></span>
</td>
<td class="num">(68.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">61.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">76.7<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">79.3<span></span>
</td>
<td class="nump">131.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">103.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">200.1<span></span>
</td>
<td class="nump">254.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">218.9<span></span>
</td>
<td class="nump">357.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">(7.8)<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">189.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">674.0<span></span>
</td>
<td class="nump">784.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(26.4)<span></span>
</td>
<td class="num">(42.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">674.0<span></span>
</td>
<td class="nump">973.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">(26.4)<span></span>
</td>
<td class="num">(47.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair value, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Gross unrealized losses, less than 12 months</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair value, 12 months or greater</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Gross unrealized losses, 12 months or greater</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair value, total</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross unrealized losses, total</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544494016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract', window );"><strong>Equity method investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying value of equity method investments</a></td>
<td class="nump">$ 22.9<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Equity securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of non-marketable equity securities</a></td>
<td class="nump">86.9<span></span>
</td>
<td class="nump">86.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total investments in unconsolidated entities</a></td>
<td class="nump">$ 109.8<span></span>
</td>
<td class="nump">$ 108.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295535054096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying value of equity method investments</a></td>
<td class="nump">$ 22.9<span></span>
</td>
<td class="nump">$ 21.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Increase in non-marketable equity securities due to observable price changes</a></td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount', window );">Decrease in non-marketable equity securities due to observable price changes</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember', window );">Limited Liability Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquityMethodInvestmentsInvestmentPeriod', window );">Investments taken period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember', window );">Limited Liability Company | New Markets Tax Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying value of equity method investments</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Investment percentage (in percent)</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquityMethodInvestmentsInvestmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Investment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquityMethodInvestmentsInvestmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_LimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_NewMarketsTaxCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_NewMarketsTaxCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295534990800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for option to acquire company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="nump">$ 107.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of non-marketable equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86.9<span></span>
</td>
<td class="nump">86.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyMember', window );">Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote', window );">Maximum secured promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding', window );">Investee drew additional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of non-marketable equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIOptionToAcquireInvestment', window );">Investment option to acquire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment', window );">Maximum additional option to acquire investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyMember', window );">Investee | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIMaximumAdditionalRequired', window );">Maximum additional required investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember', window );">Investee | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_LoansReceivablesMaximumLendingCapacity', window );">Loans receivables, maximum lending amount</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for option to acquire company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">Financing receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.5<span></span>
</td>
<td class="nump">32.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_OptionToAcquireInvestmentAmount', window );">Option to acquire investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.0<span></span>
</td>
<td class="nump">$ 35.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember', window );">Investee | Variable Interest Entity, Not Primary Beneficiary | Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableGross', window );">Financing receivable</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ew_MedicalTechnologyCompanyMember', window );">Medical Technology Company | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for option to acquire company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_OptionToAcquireInvestmentAmount', window );">Option to acquire investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_EquitySecuritiesFVNIMaximumPromissoryNote', window );">Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIMaximumAdditionalRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Maximum Additional Required</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIMaximumAdditionalRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIMaximumPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Maximum Promissory Note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIMaximumPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Maximum Secured Promissory Note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIOptionToAcquireInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Option To Acquire Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIOptionToAcquireInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_EquitySecuritiesFVNIPromissoryNoteOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI Promissory Note Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_EquitySecuritiesFVNIPromissoryNoteOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_LoansReceivablesMaximumLendingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loans Receivables, Maximum Lending Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_LoansReceivablesMaximumLendingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_OptionToAcquireInvestmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option To Acquire Investment, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_OptionToAcquireInvestmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 80<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479294/326-20-55-80<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 79<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479294/326-20-55-79<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br> -Publisher SEC<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (2)<br> -Publisher SEC<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1404<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-14<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-7A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ew_MedicalDeviceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ew_MedicalDeviceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ew_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ew_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ew_MedicalTechnologyCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ew_MedicalTechnologyCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543291664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ew_MedicalTechnologyCompanyMember', window );">Medical Technology Company | Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">61.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ew_MedicalTechnologyCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ew_MedicalTechnologyCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544224592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,297.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,164.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for option to acquire company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="nump">$ 107.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ew_MedicalTechnologyCompanyMember', window );">Medical Technology Company | Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Assets</a></td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">133.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">In-process research and development</a></td>
<td class="nump">136.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities assumed</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(28.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Fair value of net assets acquired</a></td>
<td class="nump">248.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet', window );">Less: Noncontrolling interest</a></td>
<td class="num">(72.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Total purchase price</a></td>
<td class="nump">175.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: cash acquired</a></td>
<td class="num">(6.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Total purchase price, net of cash acquired</a></td>
<td class="nump">169.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interest, gross</a></td>
<td class="nump">94.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment', window );">Noncontrolling interest, option adjustment</a></td>
<td class="nump">22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payment for option to acquire company</a></td>
<td class="nump">22.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of pre-existing notes</a></td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ew_MedicalTechnologyCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ew_MedicalTechnologyCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544340672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember', window );">Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liability</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=ew_MeasurementInputProbabilityOfMilestoneAchievementMember', window );">Probability of Milestone Achievement | Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability measurement input</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Financial instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Notes payable fair value disclosure</a></td>
<td class="nump">$ 565,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=ew_MeasurementInputProbabilityOfMilestoneAchievementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=ew_MeasurementInputProbabilityOfMilestoneAchievementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295534200224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">$ 1,020.6<span></span>
</td>
<td class="nump">$ 1,481.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">718.7<span></span>
</td>
<td class="nump">980.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">219.7<span></span>
</td>
<td class="nump">366.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">79.6<span></span>
</td>
<td class="nump">131.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">820.9<span></span>
</td>
<td class="nump">280.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Investments held for deferred compensation plans</a></td>
<td class="nump">123.0<span></span>
</td>
<td class="nump">112.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">89.3<span></span>
</td>
<td class="nump">65.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">2,053.8<span></span>
</td>
<td class="nump">1,939.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">67.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">718.7<span></span>
</td>
<td class="nump">980.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">219.7<span></span>
</td>
<td class="nump">366.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">79.6<span></span>
</td>
<td class="nump">131.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">554.5<span></span>
</td>
<td class="nump">280.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Investments held for deferred compensation plans</a></td>
<td class="nump">123.0<span></span>
</td>
<td class="nump">112.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">677.5<span></span>
</td>
<td class="nump">429.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">37.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">266.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Investments held for deferred compensation plans</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">89.3<span></span>
</td>
<td class="nump">65.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">1,376.3<span></span>
</td>
<td class="nump">1,509.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">718.7<span></span>
</td>
<td class="nump">980.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">219.7<span></span>
</td>
<td class="nump">366.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">79.6<span></span>
</td>
<td class="nump">94.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Investments held for deferred compensation plans</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">40.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | United States government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale investments:</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544281184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details) - Fair Value on a Recurring Basis - Level 3 - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 40.2<span></span>
</td>
<td class="nump">$ 76.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="num">(29.9)<span></span>
</td>
<td class="num">(36.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember', window );">Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">62.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="num">(26.2)<span></span>
</td>
<td class="num">(36.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">25.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherLiabilitiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Changes in fair value</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="nump">$ 14.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ew_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295548529536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) - Derivatives designated as hedging instruments - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Foreign currency forward exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,686.1<span></span>
</td>
<td class="nump">$ 1,678.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Cross currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295544414864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge', window );">Changes due to currency rate movements and expenses expected to occur, maximum term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow gain to be reclassified in the next twelve months</a></td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Cross currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative liability, fair value</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedges | Derivatives designated as hedging instruments | Cross currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative Financial Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative liability, fair value</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="nump">&#8364; 257.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 30<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295540020480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other current assets, Other assets (Note 6)<span></span>
</td>
<td class="text">Other current assets, Other assets (Note 6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other liabilities, Accrued and other liabilities (Note 2)<span></span>
</td>
<td class="text">Other liabilities, Accrued and other liabilities (Note 2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair value of derivative assets</a></td>
<td class="nump">$ 53.9<span></span>
</td>
<td class="nump">$ 24.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liabilities</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair value of derivative assets</a></td>
<td class="nump">35.4<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair value of derivative assets</a></td>
<td class="nump">53.9<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Foreign currency contracts | Accrued and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liabilities</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Foreign currency contracts | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Cross currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair value of derivative assets</a></td>
<td class="nump">$ 35.4<span></span>
</td>
<td class="nump">$ 40.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=ew_AccruedAndOtherLiabilitiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=ew_AccruedAndOtherLiabilitiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295531558208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingDerivativeAssetsAbstract', window );"><strong>Derivative assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amounts</a></td>
<td class="nump">$ 53.9<span></span>
</td>
<td class="nump">$ 24.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossLiability', window );">Gross Amounts Offset in the Consolidated Balance Sheet</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Net Amounts Presented in the Consolidated Balance Sheet</a></td>
<td class="nump">53.9<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueNetAbstract', window );"><strong>Gross Amounts Not Offset in the Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Cash Collateral Received</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">47.2<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingDerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amounts</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossAsset', window );">Gross Amounts Offset in the Consolidated Balance Sheet</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Net Amounts Presented in the Consolidated Balance Sheet</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract', window );"><strong>Gross Amounts Not Offset in the Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Cash Collateral Received</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Cross currency swap contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingDerivativeAssetsAbstract', window );"><strong>Derivative assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amounts</a></td>
<td class="nump">35.4<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossLiability', window );">Gross Amounts Offset in the Consolidated Balance Sheet</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Net Amounts Presented in the Consolidated Balance Sheet</a></td>
<td class="nump">35.4<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueNetAbstract', window );"><strong>Gross Amounts Not Offset in the Consolidated Balance Sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Cash Collateral Received</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">$ 35.4<span></span>
</td>
<td class="nump">$ 40.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueGrossLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueGrossLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(ii)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralObligationToReturnCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralObligationToReturnCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralRightToReclaimCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralRightToReclaimCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueGrossAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-20<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueGrossAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(ii)<br> -SubTopic 20<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingDerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingDerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingDerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingDerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295542532432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of Gain or (Loss) Recognized in Income on Derivative</a></td>
<td class="nump">$ 14.6<span></span>
</td>
<td class="nump">$ 24.0<span></span>
</td>
<td class="nump">$ 19.1<span></span>
</td>
<td class="nump">$ 66.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</a></td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
<td class="nump">60.4<span></span>
</td>
<td class="nump">138.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">27.1<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
<td class="nump">50.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedges | Cross currency swap contracts | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
<td class="nump">40.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedges | Cross currency swap contracts | Derivatives designated as hedging instruments | Interest income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Amount of Gain or (Loss) Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair value hedges | Foreign currency contracts | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of Gain or (Loss) Recognized in Income on Derivative</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 16.1<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295535026512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">$ (350.4)<span></span>
</td>
<td class="num">$ (253.8)<span></span>
</td>
<td class="num">$ (1,022.9)<span></span>
</td>
<td class="num">$ (822.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">5.8<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on fair value hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on cash flow hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of gain (loss) reclassified from accumulated OCI into income</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">27.1<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
<td class="nump">50.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on fair value hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on fair value hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on cash flow hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amount of gain (loss) reclassified from accumulated OCI into income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts | Other (income) expense, net | Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract', window );"><strong>Gain (loss) on fair value hedging relationships:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295535025968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 32.6<span></span>
</td>
<td class="nump">$ 30.3<span></span>
</td>
<td class="nump">$ 108.9<span></span>
</td>
<td class="nump">$ 98.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(17.3)<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Total stock-based compensation expense, net of tax</a></td>
<td class="nump">26.8<span></span>
</td>
<td class="nump">25.4<span></span>
</td>
<td class="nump">91.6<span></span>
</td>
<td class="nump">83.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general, and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">19.1<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">63.9<span></span>
</td>
<td class="nump">57.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Allocation of stock-based compensation expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">$ 26.3<span></span>
</td>
<td class="nump">$ 22.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295535271888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total remaining unrecognized compensation cost</a></td>
<td class="nump">$ 254.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">33 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price of options granted (in dollars per share)</a></td>
<td class="nump">$ 88.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod', window );">Performance period (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 87.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ew_MarketBasedRestrictedStockUnitsMember', window );">Market Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 110.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Average risk-free interest rate (as a percent)</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">32.60%<span></span>
</td>
<td class="nump">33.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ew_MarketBasedRestrictedStockUnitsMember', window );">Market Based Restricted Stock Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget', window );">Shares expected to be granted as percentage of target (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ew_MarketBasedRestrictedStockUnitsMember', window );">Market Based Restricted Stock Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget', window );">Shares expected to be granted as percentage of target (as a percent)</a></td>
<td class="nump">175.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ew_MarketBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ew_MarketBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295533407136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ew_EmployeeAndNonemployeeStockOptionsMember', window );">&#160;Option Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">32.70%<span></span>
</td>
<td class="nump">31.50%<span></span>
</td>
<td class="nump">32.80%<span></span>
</td>
<td class="nump">31.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value, per option/share (in dollars per share)</a></td>
<td class="nump">$ 31.16<span></span>
</td>
<td class="nump">$ 32.00<span></span>
</td>
<td class="nump">$ 31.02<span></span>
</td>
<td class="nump">$ 34.77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">&#160;ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">34.80%<span></span>
</td>
<td class="nump">31.10%<span></span>
</td>
<td class="nump">31.50%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">7 months 6 days<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">7 months 6 days<span></span>
</td>
<td class="text">7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value, per option/share (in dollars per share)</a></td>
<td class="nump">$ 18.53<span></span>
</td>
<td class="nump">$ 21.53<span></span>
</td>
<td class="nump">$ 19.03<span></span>
</td>
<td class="nump">$ 28.18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ew_EmployeeAndNonemployeeStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ew_EmployeeAndNonemployeeStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295541297872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCELERATED SHARE REPURCHASE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledJanuary2022Member', window );">Initial Delivery of Shares Settled January 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Amount Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares Received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare', window );">Initial delivery, price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount', window );">Value of Shares as % of Contract Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledFebruary2023Member', window );">Initial Delivery of Shares Settled February2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Amount Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares Received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare', window );">Initial delivery, price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount', window );">Value of Shares as % of Contract Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member', window );">January 2022 Stock Repurchase Program Shares Sold in February 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares Received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Final settlement per share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member', window );">February 2023 Stock Repurchase Program Shares Sold in March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares Received (in shares)</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Final settlement per share price (in dollars per share)</a></td>
<td class="nump">$ 79.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481138/505-30-25-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481138/505-30-25-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledJanuary2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledJanuary2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledFebruary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=ew_InitialDeliveryOfSharesSettledFebruary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295547244400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>lawsuit</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber', window );">Number of lawsuits that if settled could have a material adverse impact on net income or cash flows</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295533220832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,806.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">$ 27.3<span></span>
</td>
<td class="nump">$ 24.5<span></span>
</td>
<td class="nump">20.5<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="num">$ (30.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="num">(14.6)<span></span>
</td>
<td class="num">(23.2)<span></span>
</td>
<td class="num">(27.5)<span></span>
</td>
<td class="num">(28.7)<span></span>
</td>
<td class="num">(13.2)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax benefit (expense)</a></td>
<td class="num">(7.3)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="num">(11.1)<span></span>
</td>
<td class="num">(25.0)<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">6,657.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(255.5)<span></span>
</td>
<td class="num">(255.4)<span></span>
</td>
<td class="num">(254.9)<span></span>
</td>
<td class="num">(224.4)<span></span>
</td>
<td class="num">(186.6)<span></span>
</td>
<td class="num">(157.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(250.1)<span></span>
</td>
<td class="num">(255.5)<span></span>
</td>
<td class="num">(255.4)<span></span>
</td>
<td class="num">(256.0)<span></span>
</td>
<td class="num">(224.4)<span></span>
</td>
<td class="num">(186.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(226.5)<span></span>
</td>
<td class="num">(215.0)<span></span>
</td>
<td class="num">(218.8)<span></span>
</td>
<td class="num">(225.7)<span></span>
</td>
<td class="num">(182.5)<span></span>
</td>
<td class="num">(172.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(20.7)<span></span>
</td>
<td class="num">(11.3)<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="num">(35.7)<span></span>
</td>
<td class="num">(36.5)<span></span>
</td>
<td class="num">(7.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax benefit (expense)</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(249.9)<span></span>
</td>
<td class="num">(226.5)<span></span>
</td>
<td class="num">(215.0)<span></span>
</td>
<td class="num">(267.4)<span></span>
</td>
<td class="num">(225.7)<span></span>
</td>
<td class="num">(182.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Unrealized Gain on Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">23.8<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">43.1<span></span>
</td>
<td class="nump">29.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">38.6<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">59.2<span></span>
</td>
<td class="nump">57.9<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="num">(14.1)<span></span>
</td>
<td class="num">(25.2)<span></span>
</td>
<td class="num">(29.8)<span></span>
</td>
<td class="num">(31.6)<span></span>
</td>
<td class="num">(16.3)<span></span>
</td>
<td class="num">(7.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax benefit (expense)</a></td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">30.1<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">95.0<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
<td class="nump">43.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Loss on Available-for-sale Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(46.7)<span></span>
</td>
<td class="num">(52.6)<span></span>
</td>
<td class="num">(65.6)<span></span>
</td>
<td class="num">(65.0)<span></span>
</td>
<td class="num">(39.2)<span></span>
</td>
<td class="num">(6.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="num">(20.9)<span></span>
</td>
<td class="num">(47.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax benefit (expense)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(36.1)<span></span>
</td>
<td class="num">(46.7)<span></span>
</td>
<td class="num">(52.6)<span></span>
</td>
<td class="num">(75.4)<span></span>
</td>
<td class="num">(65.0)<span></span>
</td>
<td class="num">(39.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Unrealized Pension Credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Deferred income tax benefit (expense)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="num">$ (8.2)<span></span>
</td>
<td class="num">$ (8.1)<span></span>
</td>
<td class="num">$ (8.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295531619520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Affected Line on Consolidated Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="num">$ (2.0)<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="num">$ (1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(55.6)<span></span>
</td>
<td class="num">(63.8)<span></span>
</td>
<td class="num">(146.7)<span></span>
</td>
<td class="num">(184.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net of tax</a></td>
<td class="nump">384.9<span></span>
</td>
<td class="nump">343.5<span></span>
</td>
<td class="nump">1,032.5<span></span>
</td>
<td class="nump">1,123.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(350.4)<span></span>
</td>
<td class="num">(253.8)<span></span>
</td>
<td class="num">(1,022.9)<span></span>
</td>
<td class="num">(822.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income, net</a></td>
<td class="nump">15.1<span></span>
</td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">32.8<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amount Reclassified from Accumulated Other Comprehensive Loss | Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Affected Line on Consolidated Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net of tax</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amount Reclassified from Accumulated Other Comprehensive Loss | Gain on hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Affected Line on Consolidated Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(14.8)<span></span>
</td>
<td class="num">(13.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net of tax</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">24.1<span></span>
</td>
<td class="nump">54.3<span></span>
</td>
<td class="nump">41.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">27.1<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
<td class="nump">50.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total before tax</a></td>
<td class="nump">14.1<span></span>
</td>
<td class="nump">31.6<span></span>
</td>
<td class="nump">69.1<span></span>
</td>
<td class="nump">55.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amount Reclassified from Accumulated Other Comprehensive Loss | Loss on available-for-sale investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Affected Line on Consolidated Condensed Statements of Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net of tax</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(11.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income, net</a></td>
<td class="num">$ (1.2)<span></span>
</td>
<td class="num">$ (4.7)<span></span>
</td>
<td class="num">$ (9.0)<span></span>
</td>
<td class="num">$ (14.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295539583360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to Edwards Lifesciences Corporation</a></td>
<td class="nump">$ 384.9<span></span>
</td>
<td class="nump">$ 343.5<span></span>
</td>
<td class="nump">$ 1,032.5<span></span>
</td>
<td class="nump">$ 1,123.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding (in shares)</a></td>
<td class="nump">607.0<span></span>
</td>
<td class="nump">619.8<span></span>
</td>
<td class="nump">607.2<span></span>
</td>
<td class="nump">621.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 1.70<span></span>
</td>
<td class="nump">$ 1.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to Edwards Lifesciences Corporation</a></td>
<td class="nump">$ 384.9<span></span>
</td>
<td class="nump">$ 343.5<span></span>
</td>
<td class="nump">$ 1,032.5<span></span>
</td>
<td class="nump">$ 1,123.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding (in shares)</a></td>
<td class="nump">607.0<span></span>
</td>
<td class="nump">619.8<span></span>
</td>
<td class="nump">607.2<span></span>
</td>
<td class="nump">621.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock plans (in shares)</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Dilutive weighted-average shares outstanding (in shares)</a></td>
<td class="nump">609.5<span></span>
</td>
<td class="nump">624.5<span></span>
</td>
<td class="nump">610.2<span></span>
</td>
<td class="nump">626.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 1.69<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543299600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295541370032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="nump">12.70%<span></span>
</td>
<td class="nump">15.70%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Tax benefit from employee share-based compensation</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 14.2<span></span>
</td>
<td class="nump">$ 36.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Liability for income taxes associated with uncertain tax positions</a></td>
<td class="nump">542.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 475.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in unrecognized tax benefits is reasonably possible</a></td>
<td class="nump">226.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Net amounts that would favorably affect effective tax rate</a></td>
<td class="nump">$ 316.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 316.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 293.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ew_NumberOfAdvancePricingAgreementsRenewed', window );">Number of APAs renewed | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss', window );">Additional federal tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ew_NumberOfAdvancePricingAgreementsRenewed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Advance Pricing Agreements Renewed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ew_NumberOfAdvancePricingAgreementsRenewed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ew_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated amount of loss resulting from an adverse tax position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295533464048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,480.9<span></span>
</td>
<td class="nump">$ 1,319.0<span></span>
</td>
<td class="nump">$ 4,470.7<span></span>
</td>
<td class="nump">$ 4,034.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,476.1<span></span>
</td>
<td class="nump">1,370.5<span></span>
</td>
<td class="nump">4,453.7<span></span>
</td>
<td class="nump">4,104.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Segment operating income</a></td>
<td class="nump">884.4<span></span>
</td>
<td class="nump">842.0<span></span>
</td>
<td class="nump">2,677.0<span></span>
</td>
<td class="nump">2,543.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ew_UnitedStatesSegmentMember', window );">United States | Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">869.9<span></span>
</td>
<td class="nump">786.8<span></span>
</td>
<td class="nump">2,614.3<span></span>
</td>
<td class="nump">2,337.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Segment operating income</a></td>
<td class="nump">571.7<span></span>
</td>
<td class="nump">535.0<span></span>
</td>
<td class="nump">1,727.5<span></span>
</td>
<td class="nump">1,596.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ew_EuropeSegmentMember', window );">Europe | Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">317.8<span></span>
</td>
<td class="nump">291.9<span></span>
</td>
<td class="nump">989.2<span></span>
</td>
<td class="nump">901.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Segment operating income</a></td>
<td class="nump">168.5<span></span>
</td>
<td class="nump">156.0<span></span>
</td>
<td class="nump">527.9<span></span>
</td>
<td class="nump">487.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ew_JapanSegmentMember', window );">Japan | Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">107.2<span></span>
</td>
<td class="nump">130.9<span></span>
</td>
<td class="nump">321.2<span></span>
</td>
<td class="nump">416.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Segment operating income</a></td>
<td class="nump">63.9<span></span>
</td>
<td class="nump">87.3<span></span>
</td>
<td class="nump">190.7<span></span>
</td>
<td class="nump">282.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ew_RestOfWorldSegmentMember', window );">Rest of World | Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment Net Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">181.2<span></span>
</td>
<td class="nump">160.9<span></span>
</td>
<td class="nump">529.0<span></span>
</td>
<td class="nump">449.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Segment Operating Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Segment operating income</a></td>
<td class="nump">$ 80.3<span></span>
</td>
<td class="nump">$ 63.7<span></span>
</td>
<td class="nump">$ 230.9<span></span>
</td>
<td class="nump">$ 178.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ew_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ew_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ew_EuropeSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ew_EuropeSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ew_JapanSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ew_JapanSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ew_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ew_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295534977648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Sales Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,480.9<span></span>
</td>
<td class="nump">$ 1,319.0<span></span>
</td>
<td class="nump">$ 4,470.7<span></span>
</td>
<td class="nump">$ 4,034.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Pre-tax Income Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Consolidated operating income</a></td>
<td class="nump">418.4<span></span>
</td>
<td class="nump">402.4<span></span>
</td>
<td class="nump">1,134.0<span></span>
</td>
<td class="nump">1,300.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Unallocated amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Special charge (Note&#160;4)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(66.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(66.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property agreement and litigation (expense) income, net</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="num">(193.6)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">36.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">439.3<span></span>
</td>
<td class="nump">407.3<span></span>
</td>
<td class="nump">1,176.4<span></span>
</td>
<td class="nump">1,308.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Sales Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,476.1<span></span>
</td>
<td class="nump">1,370.5<span></span>
</td>
<td class="nump">4,453.7<span></span>
</td>
<td class="nump">4,104.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Pre-tax Income Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Consolidated operating income</a></td>
<td class="nump">884.4<span></span>
</td>
<td class="nump">842.0<span></span>
</td>
<td class="nump">2,677.0<span></span>
</td>
<td class="nump">2,543.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Reconciling items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Sales Reconciliation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="num">(51.5)<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
<td class="num">(70.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Unallocated amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Special charge (Note&#160;4)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(66.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(66.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Intellectual property agreement and litigation (expense) income, net</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="num">(193.6)<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">59.6<span></span>
</td>
<td class="nump">83.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating income</a></td>
<td class="nump">20.9<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">42.4<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Unallocated amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Corporate items</a></td>
<td class="num">$ (473.9)<span></span>
</td>
<td class="num">$ (415.6)<span></span>
</td>
<td class="num">$ (1,435.2)<span></span>
</td>
<td class="num">$ (1,285.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483613/220-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140295543354112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 1,480.9<span></span>
</td>
<td class="nump">$ 1,319.0<span></span>
</td>
<td class="nump">$ 4,470.7<span></span>
</td>
<td class="nump">$ 4,034.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ew_TranscatheterAorticValveReplacementMember', window );">Transcatheter Aortic Valve Replacement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">960.9<span></span>
</td>
<td class="nump">862.3<span></span>
</td>
<td class="nump">2,900.4<span></span>
</td>
<td class="nump">2,650.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ew_TranscatheterMitralAndTricuspidTherapiesMember', window );">Transcatheter Mitral and Tricuspid Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">52.4<span></span>
</td>
<td class="nump">29.7<span></span>
</td>
<td class="nump">141.6<span></span>
</td>
<td class="nump">84.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ew_SurgicalHeartValveTherapyMember', window );">Surgical Structural Heart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">246.6<span></span>
</td>
<td class="nump">219.7<span></span>
</td>
<td class="nump">751.1<span></span>
</td>
<td class="nump">669.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ew_CriticalCareMember', window );">Critical Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">221.0<span></span>
</td>
<td class="nump">207.3<span></span>
</td>
<td class="nump">677.6<span></span>
</td>
<td class="nump">630.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">869.9<span></span>
</td>
<td class="nump">786.8<span></span>
</td>
<td class="nump">2,614.3<span></span>
</td>
<td class="nump">2,337.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">322.3<span></span>
</td>
<td class="nump">270.1<span></span>
</td>
<td class="nump">989.6<span></span>
</td>
<td class="nump">884.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">108.4<span></span>
</td>
<td class="nump">104.1<span></span>
</td>
<td class="nump">340.4<span></span>
</td>
<td class="nump">362.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ew_RestOfWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Enterprise-Wide Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 180.3<span></span>
</td>
<td class="nump">$ 158.0<span></span>
</td>
<td class="nump">$ 526.4<span></span>
</td>
<td class="nump">$ 450.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ew_TranscatheterAorticValveReplacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ew_TranscatheterAorticValveReplacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ew_TranscatheterMitralAndTricuspidTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ew_TranscatheterMitralAndTricuspidTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ew_SurgicalHeartValveTherapyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ew_SurgicalHeartValveTherapyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ew_CriticalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ew_CriticalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ew_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ew_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>ew-20230930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:ew="http://www.edwards.com/20230930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ew-20230930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2023-10-25</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2023-04-12</startDate>
            <endDate>2023-04-12</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-12</startDate>
            <endDate>2023-04-12</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ew:MedtronicIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ew:SpecialChargeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:NewMarketsTaxCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ew:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalDeviceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ew:MedicalTechnologyCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">ew:MeasurementInputProbabilityOfMilestoneAchievementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ew:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ew:AccruedAndOtherLiabilitiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ew:AccruedAndOtherLiabilitiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:MarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:MarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:MarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:MarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ew:EmployeeAndNonemployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledJanuary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledJanuary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:January2022StockRepurchaseProgramSharesSoldInFebruary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:InitialDeliveryOfSharesSettledFebruary2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:JapanSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ew:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ew:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterAorticValveReplacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:TranscatheterMitralAndTricuspidTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:SurgicalHeartValveTherapyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ew:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:JeanLucLemercierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:JeanLucLemercierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001099800</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ew:JeanLucLemercierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="lawsuit">
        <measure>ew:lawsuit</measure>
    </unit>
    <unit id="agreement">
        <measure>ew:agreement</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0001099800</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-29">false</dei:AmendmentFlag>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration contextRef="c-4" id="f-870">http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration contextRef="c-3" id="f-871">http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-4" id="f-876">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20230930#AccruedAndOtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-3" id="f-877">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20230930#AccruedAndOtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <ecd:TrdArrDuration contextRef="c-423" id="f-1460">P60D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">1-15525</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">EDWARDS LIFESCIENCES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">36-4316614</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">One Edwards Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">92614</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">250-2500</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $1.00 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">EW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">606500000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-30" unitRef="usd">1410100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-31" unitRef="usd">769000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-3" decimals="-5" id="f-32" unitRef="usd">453800000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-4" decimals="-5" id="f-33" unitRef="usd">446300000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-3" decimals="-5" id="f-34" unitRef="usd">7900000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-4" decimals="-5" id="f-35" unitRef="usd">7900000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-5" id="f-36" unitRef="usd">739800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-37" unitRef="usd">643000000.0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivables contextRef="c-3" decimals="-5" id="f-38" unitRef="usd">62300000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="c-4" decimals="-5" id="f-39" unitRef="usd">56100000</us-gaap:OtherReceivables>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-40" unitRef="usd">1032400000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-41" unitRef="usd">875500000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-3" decimals="-5" id="f-42" unitRef="usd">133300000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-4" decimals="-5" id="f-43" unitRef="usd">110000000.0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-44" unitRef="usd">235800000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-45" unitRef="usd">195900000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-5" id="f-46" unitRef="usd">4067500000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-5" id="f-47" unitRef="usd">3095800000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments contextRef="c-3" decimals="-5" id="f-48" unitRef="usd">704600000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-4" decimals="-5" id="f-49" unitRef="usd">1239000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-5" id="f-50" unitRef="usd">1681300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-5" id="f-51" unitRef="usd">1632800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-5" id="f-52" unitRef="usd">90900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-53" unitRef="usd">92300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-3" decimals="-5" id="f-54" unitRef="usd">1297400000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-5" id="f-55" unitRef="usd">1164300000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-3" decimals="-5" id="f-56" unitRef="usd">429800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-5" id="f-57" unitRef="usd">285200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-3" decimals="-5" id="f-58" unitRef="usd">651900000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-5" id="f-59" unitRef="usd">484000000.0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-60" unitRef="usd">447400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-61" unitRef="usd">299100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-5" id="f-62" unitRef="usd">9370800000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-5" id="f-63" unitRef="usd">8292500000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-5" id="f-64" unitRef="usd">190600000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-5" id="f-65" unitRef="usd">201900000</us-gaap:AccountsPayableCurrent>
    <ew:AccruedAndOtherLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-66" unitRef="usd">1024000000</ew:AccruedAndOtherLiabilitiesCurrent>
    <ew:AccruedAndOtherLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-67" unitRef="usd">795000000.0</ew:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-5" id="f-68" unitRef="usd">24300000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-69" unitRef="usd">25500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-70" unitRef="usd">1238900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-71" unitRef="usd">1022400000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-5" id="f-72" unitRef="usd">596800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-5" id="f-73" unitRef="usd">596300000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-74" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-75" unitRef="usd">26200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent contextRef="c-3" decimals="-5" id="f-76" unitRef="usd">81200000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent contextRef="c-4" decimals="-5" id="f-77" unitRef="usd">143400000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-78" unitRef="usd">70000000.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-79" unitRef="usd">69500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="c-3" decimals="-5" id="f-80" unitRef="usd">312100000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="c-4" decimals="-5" id="f-81" unitRef="usd">267500000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LitigationReserveNoncurrent contextRef="c-3" decimals="-5" id="f-82" unitRef="usd">104400000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent contextRef="c-4" decimals="-5" id="f-83" unitRef="usd">143000000.0</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-5" id="f-84" unitRef="usd">240300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-5" id="f-85" unitRef="usd">217500000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-5" id="f-86" unitRef="usd">2643700000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-5" id="f-87" unitRef="usd">2485800000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-88" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-89" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-90"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-91"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-92" unitRef="shares">50000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-93" unitRef="shares">50000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-94" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-95" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-5" id="f-96" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-5" id="f-97" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-98"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-99"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-100" unitRef="shares">1050000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-101" unitRef="shares">1050000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="-5" id="f-102" unitRef="shares">649900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-5" id="f-103" unitRef="shares">646300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="-5" id="f-104" unitRef="shares">606500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-5" id="f-105" unitRef="shares">608300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-5" id="f-106" unitRef="usd">649900000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-5" id="f-107" unitRef="usd">646300000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-5" id="f-108" unitRef="usd">2211300000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-5" id="f-109" unitRef="usd">1969300000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-110" unitRef="usd">8622500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-111" unitRef="usd">7590000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-5" id="f-112" unitRef="usd">-250100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-5" id="f-113" unitRef="usd">-254900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="-5" id="f-114" unitRef="shares">43400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="-5" id="f-115" unitRef="shares">38000000.0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-3" decimals="-5" id="f-116" unitRef="usd">4576100000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-5" id="f-117" unitRef="usd">4144000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-118" unitRef="usd">6657500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-119" unitRef="usd">5806700000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-3" decimals="-5" id="f-120" unitRef="usd">69600000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-5" id="f-121" unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-5" id="f-122" unitRef="usd">6727100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-123" unitRef="usd">5806700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-5" id="f-124" unitRef="usd">9370800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-5" id="f-125" unitRef="usd">8292500000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-126" unitRef="usd">1480900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-127" unitRef="usd">1319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-128" unitRef="usd">4470700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-129" unitRef="usd">4034100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-130" unitRef="usd">350400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-5" id="f-131" unitRef="usd">253800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-132" unitRef="usd">1022900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-5" id="f-133" unitRef="usd">822500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-5" decimals="-5" id="f-134" unitRef="usd">1130500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-6" decimals="-5" id="f-135" unitRef="usd">1065200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-136" unitRef="usd">3447800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-7" decimals="-5" id="f-137" unitRef="usd">3211600000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-5" id="f-138" unitRef="usd">439600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-6" decimals="-5" id="f-139" unitRef="usd">377300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-140" unitRef="usd">1344600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-7" decimals="-5" id="f-141" unitRef="usd">1156600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-5" id="f-142" unitRef="usd">270300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-5" id="f-143" unitRef="usd">233600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-144" unitRef="usd">801800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-5" id="f-145" unitRef="usd">713000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-5" decimals="-5" id="f-146" unitRef="usd">2200000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-6" decimals="-5" id="f-147" unitRef="usd">-2400000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-1" decimals="-5" id="f-148" unitRef="usd">193600000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-7" decimals="-5" id="f-149" unitRef="usd">10800000</us-gaap:LitigationSettlementExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-5" decimals="-5" id="f-150" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-6" decimals="-5" id="f-151" unitRef="usd">-12500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-5" id="f-152" unitRef="usd">-26200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-7" decimals="-5" id="f-153" unitRef="usd">-36300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-5" decimals="-5" id="f-154" unitRef="usd">0</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-6" decimals="-5" id="f-155" unitRef="usd">66800000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-1" decimals="-5" id="f-156" unitRef="usd">0</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-7" decimals="-5" id="f-157" unitRef="usd">66800000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-158" unitRef="usd">418400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-159" unitRef="usd">402400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-160" unitRef="usd">1134000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-5" id="f-161" unitRef="usd">1300700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-5" decimals="-5" id="f-162" unitRef="usd">15100000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-6" decimals="-5" id="f-163" unitRef="usd">6900000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-1" decimals="-5" id="f-164" unitRef="usd">32800000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-7" decimals="-5" id="f-165" unitRef="usd">8400000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-166" unitRef="usd">5800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-167" unitRef="usd">-2000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-168" unitRef="usd">9600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-169" unitRef="usd">-1000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-170" unitRef="usd">439300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-171" unitRef="usd">407300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-172" unitRef="usd">1176400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-173" unitRef="usd">1308100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-174" unitRef="usd">55600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-175" unitRef="usd">63800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-176" unitRef="usd">146700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-177" unitRef="usd">184600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-5" id="f-178" unitRef="usd">383700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-5" id="f-179" unitRef="usd">343500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-5" id="f-180" unitRef="usd">1029700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-5" id="f-181" unitRef="usd">1123500000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-182" unitRef="usd">-1200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-183" unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-184" unitRef="usd">-2800000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-185" unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-186" unitRef="usd">384900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-187" unitRef="usd">343500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-188" unitRef="usd">1032500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-189" unitRef="usd">1123500000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-190"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-191"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-192"
      unitRef="usdPerShare">1.70</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-193"
      unitRef="usdPerShare">1.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-194"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-195"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-196"
      unitRef="usdPerShare">1.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-197"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-198" unitRef="shares">607000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-199" unitRef="shares">619800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-200" unitRef="shares">607200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-201" unitRef="shares">621000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-202" unitRef="shares">609500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-203" unitRef="shares">624500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-204" unitRef="shares">610200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-205" unitRef="shares">626900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-5" id="f-206" unitRef="usd">383700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-5" id="f-207" unitRef="usd">343500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-5" id="f-208" unitRef="usd">1029700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-5" id="f-209" unitRef="usd">1123500000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-5" id="f-210" unitRef="usd">-23400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-6" decimals="-5" id="f-211" unitRef="usd">-41700000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-5" id="f-212" unitRef="usd">-31100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-7" decimals="-5" id="f-213" unitRef="usd">-94900000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-5" decimals="-5" id="f-214" unitRef="usd">18200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-6" decimals="-5" id="f-215" unitRef="usd">20600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-1" decimals="-5" id="f-216" unitRef="usd">6300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="c-7" decimals="-5" id="f-217" unitRef="usd">65300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-5" decimals="-5" id="f-218" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-6" decimals="-5" id="f-219" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-5" id="f-220" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-7" decimals="-5" id="f-221" unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-5" id="f-222" unitRef="usd">10600000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-5" id="f-223" unitRef="usd">-10400000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-5" id="f-224" unitRef="usd">29500000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-7" decimals="-5" id="f-225" unitRef="usd">-68500000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-5" id="f-226" unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-5" id="f-227" unitRef="usd">-31600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-5" id="f-228" unitRef="usd">4800000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-5" id="f-229" unitRef="usd">-98300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-230" unitRef="usd">389100000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-231" unitRef="usd">311900000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-232" unitRef="usd">1034500000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-233" unitRef="usd">1025200000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-234" unitRef="usd">-1200000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-235" unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-236" unitRef="usd">-2800000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-237" unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-5" id="f-238" unitRef="usd">390300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-5" id="f-239" unitRef="usd">311900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-240" unitRef="usd">1037300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-5" id="f-241" unitRef="usd">1025200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-5" id="f-242" unitRef="usd">1029700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-5" id="f-243" unitRef="usd">1123500000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-244" unitRef="usd">108200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-5" id="f-245" unitRef="usd">104200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-5" id="f-246" unitRef="usd">20700000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-7" decimals="-5" id="f-247" unitRef="usd">20600000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-248" unitRef="usd">108900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-5" id="f-249" unitRef="usd">98900000</us-gaap:ShareBasedCompensation>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-5" id="f-250" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-7" decimals="-5" id="f-251" unitRef="usd">55100000</us-gaap:AssetImpairmentCharges>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-5" id="f-252" unitRef="usd">-26200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-7" decimals="-5" id="f-253" unitRef="usd">-36300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainLossOnInvestments contextRef="c-1" decimals="-5" id="f-254" unitRef="usd">-4400000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c-7" decimals="-5" id="f-255" unitRef="usd">-49100000</us-gaap:GainLossOnInvestments>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-1" decimals="-5" id="f-256" unitRef="usd">180700000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c-7" decimals="-5" id="f-257" unitRef="usd">148700000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-5" id="f-258" unitRef="usd">-4400000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-7" decimals="-5" id="f-259" unitRef="usd">-5500000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-1" decimals="-5" id="f-260" unitRef="usd">123000000.0</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-7" decimals="-5" id="f-261" unitRef="usd">83000000.0</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-5" id="f-262" unitRef="usd">189700000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-7" decimals="-5" id="f-263" unitRef="usd">151100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-5" id="f-264" unitRef="usd">112600000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-7" decimals="-5" id="f-265" unitRef="usd">-55700000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-1" decimals="-5" id="f-266" unitRef="usd">106300000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-7" decimals="-5" id="f-267" unitRef="usd">8800000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-5" id="f-268" unitRef="usd">63700000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-5" id="f-269" unitRef="usd">-20300000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <ew:IncreaseDecreaseInLegalSettlementAccrual contextRef="c-1" decimals="-5" id="f-270" unitRef="usd">-26000000.0</ew:IncreaseDecreaseInLegalSettlementAccrual>
    <ew:IncreaseDecreaseInLegalSettlementAccrual contextRef="c-7" decimals="-5" id="f-271" unitRef="usd">-36100000</ew:IncreaseDecreaseInLegalSettlementAccrual>
    <us-gaap:IncreaseDecreaseInPrepaidRoyalties contextRef="c-1" decimals="-5" id="f-272" unitRef="usd">111900000</us-gaap:IncreaseDecreaseInPrepaidRoyalties>
    <us-gaap:IncreaseDecreaseInPrepaidRoyalties contextRef="c-7" decimals="-5" id="f-273" unitRef="usd">0</us-gaap:IncreaseDecreaseInPrepaidRoyalties>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-1" decimals="-5" id="f-274" unitRef="usd">14800000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="c-7" decimals="-5" id="f-275" unitRef="usd">39700000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-276" unitRef="usd">759200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-5" id="f-277" unitRef="usd">935400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-278" unitRef="usd">164700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-279" unitRef="usd">175700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities contextRef="c-1" decimals="-5" id="f-280" unitRef="usd">23500000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities contextRef="c-7" decimals="-5" id="f-281" unitRef="usd">285500000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities contextRef="c-1" decimals="-5" id="f-282" unitRef="usd">91500000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities contextRef="c-7" decimals="-5" id="f-283" unitRef="usd">324500000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-5" id="f-284" unitRef="usd">8400000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-7" decimals="-5" id="f-285" unitRef="usd">302800000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-1" decimals="-5" id="f-286" unitRef="usd">486900000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-7" decimals="-5" id="f-287" unitRef="usd">761100000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions contextRef="c-1" decimals="-5" id="f-288" unitRef="usd">141200000</ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions>
    <ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions contextRef="c-7" decimals="-5" id="f-289" unitRef="usd">0</ew:PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-1" decimals="-5" id="f-290" unitRef="usd">15000000.0</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-7" decimals="-5" id="f-291" unitRef="usd">107600000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:PaymentsToAcquireReceivables contextRef="c-1" decimals="-5" id="f-292" unitRef="usd">47500000</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:PaymentsToAcquireReceivables contextRef="c-7" decimals="-5" id="f-293" unitRef="usd">51500000</us-gaap:PaymentsToAcquireReceivables>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable contextRef="c-1" decimals="-5" id="f-294" unitRef="usd">0</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable contextRef="c-7" decimals="-5" id="f-295" unitRef="usd">18000000.0</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-5" id="f-296" unitRef="usd">18400000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-7" decimals="-5" id="f-297" unitRef="usd">22900000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-298" unitRef="usd">159700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-5" id="f-299" unitRef="usd">157600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-300" unitRef="usd">431200000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-7" decimals="-5" id="f-301" unitRef="usd">861100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockPlans contextRef="c-1" decimals="-5" id="f-302" unitRef="usd">136700000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans contextRef="c-7" decimals="-5" id="f-303" unitRef="usd">118900000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-1" decimals="-5" id="f-304" unitRef="usd">-3300000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-7" decimals="-5" id="f-305" unitRef="usd">-3900000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-306" unitRef="usd">-297800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-5" id="f-307" unitRef="usd">-746100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-5" id="f-308" unitRef="usd">20200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-309" unitRef="usd">37400000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-310" unitRef="usd">641300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-5" id="f-311" unitRef="usd">384300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-312" unitRef="usd">772600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-8" decimals="-5" id="f-313" unitRef="usd">867400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-314" unitRef="usd">1413900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-5" id="f-315" unitRef="usd">1251700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-10" decimals="-5" id="f-316" unitRef="shares">646300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-10" decimals="-5" id="f-317" unitRef="usd">646300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-11" decimals="-5" id="f-318" unitRef="shares">38000000.0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-11" decimals="-5" id="f-319" unitRef="usd">-4144000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-5" id="f-320" unitRef="usd">1969300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-5" id="f-321" unitRef="usd">7590000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-5" id="f-322" unitRef="usd">-254900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-5" id="f-323" unitRef="usd">5806700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-16" decimals="-5" id="f-324" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-325" unitRef="usd">5806700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-17" decimals="-5" id="f-326" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-18" decimals="-5" id="f-327" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-19" decimals="-5" id="f-328" unitRef="usd">340500000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-20" decimals="-5" id="f-329" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-18" decimals="-5" id="f-330" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-19" decimals="-5" id="f-331" unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-21" decimals="-5" id="f-332" unitRef="shares">800000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-21" decimals="-5" id="f-333" unitRef="usd">800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-22" decimals="-5" id="f-334" unitRef="usd">41100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-18" decimals="-5" id="f-335" unitRef="usd">41900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-19" decimals="-5" id="f-336" unitRef="usd">41900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-22" decimals="-5" id="f-337" unitRef="usd">38900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-18" decimals="-5" id="f-338" unitRef="usd">38900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-19" decimals="-5" id="f-339" unitRef="usd">38900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-23" decimals="-5" id="f-340" unitRef="shares">3100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-23" decimals="-5" id="f-341" unitRef="usd">249500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-18" decimals="-5" id="f-342" unitRef="usd">249500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-19" decimals="-5" id="f-343" unitRef="usd">249500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-24" decimals="-5" id="f-344" unitRef="usd">84000000.0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-19" decimals="-5" id="f-345" unitRef="usd">84000000.0</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-25" decimals="-5" id="f-346" unitRef="shares">647100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-5" id="f-347" unitRef="usd">647100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-26" decimals="-5" id="f-348" unitRef="shares">41100000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-5" id="f-349" unitRef="usd">-4393500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-5" id="f-350" unitRef="usd">2049300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-5" id="f-351" unitRef="usd">7930500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-5" id="f-352" unitRef="usd">-255400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-5" id="f-353" unitRef="usd">5978000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-5" id="f-354" unitRef="usd">84000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-5" id="f-355" unitRef="usd">6062000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-33" decimals="-5" id="f-356" unitRef="usd">307100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-34" decimals="-5" id="f-357" unitRef="usd">307100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-35" decimals="-5" id="f-358" unitRef="usd">-1600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-36" decimals="-5" id="f-359" unitRef="usd">305500000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-37" decimals="-5" id="f-360" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-34" decimals="-5" id="f-361" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-36" decimals="-5" id="f-362" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-38" decimals="-5" id="f-363" unitRef="shares">2000000.0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-38" decimals="-5" id="f-364" unitRef="usd">2000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-39" decimals="-5" id="f-365" unitRef="usd">58800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-34" decimals="-5" id="f-366" unitRef="usd">60800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-36" decimals="-5" id="f-367" unitRef="usd">60800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-39" decimals="-5" id="f-368" unitRef="usd">37400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-34" decimals="-5" id="f-369" unitRef="usd">37400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-36" decimals="-5" id="f-370" unitRef="usd">37400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-40" decimals="-5" id="f-371" unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-40" decimals="-5" id="f-372" unitRef="usd">7500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-34" decimals="-5" id="f-373" unitRef="usd">7500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-36" decimals="-5" id="f-374" unitRef="usd">7500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-35" decimals="-5" id="f-375" unitRef="usd">-11600000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease contextRef="c-36" decimals="-5" id="f-376" unitRef="usd">-11600000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-41" decimals="-5" id="f-377" unitRef="shares">649100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-5" id="f-378" unitRef="usd">649100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-42" decimals="-5" id="f-379" unitRef="shares">41200000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-5" id="f-380" unitRef="usd">-4401000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-5" id="f-381" unitRef="usd">2145500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="-5" id="f-382" unitRef="usd">8237600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-5" id="f-383" unitRef="usd">-255500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-5" id="f-384" unitRef="usd">6375700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-5" id="f-385" unitRef="usd">70800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-5" id="f-386" unitRef="usd">6446500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-49" decimals="-5" id="f-387" unitRef="usd">384900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-50" decimals="-5" id="f-388" unitRef="usd">384900000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-51" decimals="-5" id="f-389" unitRef="usd">-1200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-5" id="f-390" unitRef="usd">383700000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-52" decimals="-5" id="f-391" unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-50" decimals="-5" id="f-392" unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-393" unitRef="usd">5400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-53" decimals="-5" id="f-394" unitRef="shares">800000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-53" decimals="-5" id="f-395" unitRef="usd">800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-54" decimals="-5" id="f-396" unitRef="usd">33200000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-50" decimals="-5" id="f-397" unitRef="usd">34000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-5" decimals="-5" id="f-398" unitRef="usd">34000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-54" decimals="-5" id="f-399" unitRef="usd">32600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-50" decimals="-5" id="f-400" unitRef="usd">32600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-5" id="f-401" unitRef="usd">32600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-55" decimals="-5" id="f-402" unitRef="shares">2200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-55" decimals="-5" id="f-403" unitRef="usd">175100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-50" decimals="-5" id="f-404" unitRef="usd">175100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-5" decimals="-5" id="f-405" unitRef="usd">175100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-56" decimals="-5" id="f-406" unitRef="shares">649900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-5" id="f-407" unitRef="usd">649900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-57" decimals="-5" id="f-408" unitRef="shares">43400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-57" decimals="-5" id="f-409" unitRef="usd">-4576100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-5" id="f-410" unitRef="usd">2211300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-59" decimals="-5" id="f-411" unitRef="usd">8622500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-60" decimals="-5" id="f-412" unitRef="usd">-250100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-61" decimals="-5" id="f-413" unitRef="usd">6657500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-62" decimals="-5" id="f-414" unitRef="usd">69600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-5" id="f-415" unitRef="usd">6727100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-63" decimals="-5" id="f-416" unitRef="shares">642000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-63" decimals="-5" id="f-417" unitRef="usd">642000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-64" decimals="-5" id="f-418" unitRef="shares">17900000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-64" decimals="-5" id="f-419" unitRef="usd">-2416900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-65" decimals="-5" id="f-420" unitRef="usd">1700400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-66" decimals="-5" id="f-421" unitRef="usd">6068100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-67" decimals="-5" id="f-422" unitRef="usd">-157700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-8" decimals="-5" id="f-423" unitRef="usd">5835900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-68" decimals="-5" id="f-424" unitRef="usd">373600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-69" decimals="-5" id="f-425" unitRef="usd">373600000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-70" decimals="-5" id="f-426" unitRef="usd">-28900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-69" decimals="-5" id="f-427" unitRef="usd">-28900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-71" decimals="-5" id="f-428" unitRef="shares">900000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-71" decimals="-5" id="f-429" unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-72" decimals="-5" id="f-430" unitRef="usd">36600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-69" decimals="-5" id="f-431" unitRef="usd">37500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-72" decimals="-5" id="f-432" unitRef="usd">32400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-69" decimals="-5" id="f-433" unitRef="usd">32400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-73" decimals="-5" id="f-434" unitRef="shares">3600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-73" decimals="-5" id="f-435" unitRef="usd">405600000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-69" decimals="-5" id="f-436" unitRef="usd">405600000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-74" decimals="-5" id="f-437" unitRef="shares">642900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-74" decimals="-5" id="f-438" unitRef="usd">642900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-75" decimals="-5" id="f-439" unitRef="shares">21500000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-75" decimals="-5" id="f-440" unitRef="usd">-2822500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-76" decimals="-5" id="f-441" unitRef="usd">1769400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-77" decimals="-5" id="f-442" unitRef="usd">6441700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-78" decimals="-5" id="f-443" unitRef="usd">-186600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-79" decimals="-5" id="f-444" unitRef="usd">5844900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-80" decimals="-5" id="f-445" unitRef="usd">406400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-81" decimals="-5" id="f-446" unitRef="usd">406400000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-82" decimals="-5" id="f-447" unitRef="usd">-37800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-81" decimals="-5" id="f-448" unitRef="usd">-37800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-83" decimals="-5" id="f-449" unitRef="shares">2100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-83" decimals="-5" id="f-450" unitRef="usd">2100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-84" decimals="-5" id="f-451" unitRef="usd">46900000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-81" decimals="-5" id="f-452" unitRef="usd">49000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-84" decimals="-5" id="f-453" unitRef="usd">36200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-81" decimals="-5" id="f-454" unitRef="usd">36200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-85" decimals="-5" id="f-455" unitRef="shares">3700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-85" decimals="-5" id="f-456" unitRef="usd">355100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-81" decimals="-5" id="f-457" unitRef="usd">355100000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-86" decimals="-5" id="f-458" unitRef="shares">645000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-86" decimals="-5" id="f-459" unitRef="usd">645000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-87" decimals="-5" id="f-460" unitRef="shares">25200000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-87" decimals="-5" id="f-461" unitRef="usd">-3177600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-88" decimals="-5" id="f-462" unitRef="usd">1852500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-89" decimals="-5" id="f-463" unitRef="usd">6848100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-90" decimals="-5" id="f-464" unitRef="usd">-224400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-91" decimals="-5" id="f-465" unitRef="usd">5943600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-92" decimals="-5" id="f-466" unitRef="usd">343500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-5" id="f-467" unitRef="usd">343500000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-93" decimals="-5" id="f-468" unitRef="usd">-31600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-469" unitRef="usd">-31600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-94" decimals="-5" id="f-470" unitRef="shares">700000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-94" decimals="-5" id="f-471" unitRef="usd">700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-95" decimals="-5" id="f-472" unitRef="usd">31700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-6" decimals="-5" id="f-473" unitRef="usd">32400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-95" decimals="-5" id="f-474" unitRef="usd">30300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-5" id="f-475" unitRef="usd">30300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-96" decimals="-5" id="f-476" unitRef="shares">1100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-96" decimals="-5" id="f-477" unitRef="usd">100400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-6" decimals="-5" id="f-478" unitRef="usd">100400000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-97" decimals="-5" id="f-479" unitRef="shares">645700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-97" decimals="-5" id="f-480" unitRef="usd">645700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-98" decimals="-5" id="f-481" unitRef="shares">26300000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-98" decimals="-5" id="f-482" unitRef="usd">-3278000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-99" decimals="-5" id="f-483" unitRef="usd">1914500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-100" decimals="-5" id="f-484" unitRef="usd">7191600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-101" decimals="-5" id="f-485" unitRef="usd">-256000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-9" decimals="-5" id="f-486" unitRef="usd">6217800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c-1" id="f-487">BASIS OF PRESENTATION&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the unaudited interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-488">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-489">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method.  All intercompany accounts and transactions have been eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-490">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements.  Actual results could differ from those&#160;estimates.</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-491">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met.   The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years.  The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-492">OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Composition of Certain Financial Statement Captions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in the consolidated condensed balance sheets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2023 and December&#160;31, 2022, $142.5 million and $128.6 million, respectively, of the Company's finished products inventories were held on consignment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and withholdings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, payroll, and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued relocation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued realignment reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the year for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing transactions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.&lt;/span&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-493">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in the consolidated condensed balance sheets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-3" decimals="-5" id="f-494" unitRef="usd">204900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-4" decimals="-5" id="f-495" unitRef="usd">156400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-3" decimals="-5" id="f-496" unitRef="usd">223700000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-4" decimals="-5" id="f-497" unitRef="usd">177400000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-3" decimals="-5" id="f-498" unitRef="usd">603800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-4" decimals="-5" id="f-499" unitRef="usd">541700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-500" unitRef="usd">1032400000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-5" id="f-501" unitRef="usd">875500000</us-gaap:InventoryNet>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment contextRef="c-3" decimals="-5" id="f-502" unitRef="usd">142500000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment contextRef="c-4" decimals="-5" id="f-503" unitRef="usd">128600000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-504">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.586%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and withholdings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, payroll, and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal and insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued relocation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued realignment reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-505" unitRef="usd">340000000.0</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-506" unitRef="usd">268700000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-3" decimals="-5" id="f-507" unitRef="usd">172100000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-4" decimals="-5" id="f-508" unitRef="usd">50600000</us-gaap:AccruedIncomeTaxesCurrent>
    <ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent contextRef="c-3" decimals="-5" id="f-509" unitRef="usd">57100000</ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent>
    <ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent contextRef="c-4" decimals="-5" id="f-510" unitRef="usd">45600000</ew:AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent>
    <ew:ResearchAndDevelopmentAccruals contextRef="c-3" decimals="-5" id="f-511" unitRef="usd">70100000</ew:ResearchAndDevelopmentAccruals>
    <ew:ResearchAndDevelopmentAccruals contextRef="c-4" decimals="-5" id="f-512" unitRef="usd">66900000</ew:ResearchAndDevelopmentAccruals>
    <ew:AccruedRebates contextRef="c-3" decimals="-5" id="f-513" unitRef="usd">139500000</ew:AccruedRebates>
    <ew:AccruedRebates contextRef="c-4" decimals="-5" id="f-514" unitRef="usd">116100000</ew:AccruedRebates>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-515" unitRef="usd">6700000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-516" unitRef="usd">20700000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-3" decimals="-5" id="f-517" unitRef="usd">16000000.0</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-4" decimals="-5" id="f-518" unitRef="usd">17000000.0</us-gaap:AccruedMarketingCostsCurrent>
    <ew:AccruedLitigationAndInsuranceReserves contextRef="c-3" decimals="-5" id="f-519" unitRef="usd">30300000</ew:AccruedLitigationAndInsuranceReserves>
    <ew:AccruedLitigationAndInsuranceReserves contextRef="c-4" decimals="-5" id="f-520" unitRef="usd">28100000</ew:AccruedLitigationAndInsuranceReserves>
    <us-gaap:LitigationReserveCurrent contextRef="c-3" decimals="-5" id="f-521" unitRef="usd">65900000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent contextRef="c-4" decimals="-5" id="f-522" unitRef="usd">53300000</us-gaap:LitigationReserveCurrent>
    <ew:AccruedRelocationCostsCurrent contextRef="c-3" decimals="-5" id="f-523" unitRef="usd">22300000</ew:AccruedRelocationCostsCurrent>
    <ew:AccruedRelocationCostsCurrent contextRef="c-4" decimals="-5" id="f-524" unitRef="usd">25200000</ew:AccruedRelocationCostsCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-5" id="f-525" unitRef="usd">9300000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-5" id="f-526" unitRef="usd">6600000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:RestructuringReserveCurrent contextRef="c-3" decimals="-5" id="f-527" unitRef="usd">13800000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent contextRef="c-4" decimals="-5" id="f-528" unitRef="usd">15600000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-529" unitRef="usd">80900000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-530" unitRef="usd">80600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <ew:AccruedAndOtherLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-531" unitRef="usd">1024000000</ew:AccruedAndOtherLiabilitiesCurrent>
    <ew:AccruedAndOtherLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-532" unitRef="usd">795000000.0</ew:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="c-1" id="f-533">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.706%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the year for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing transactions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-5" id="f-534" unitRef="usd">219100000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-7" decimals="-5" id="f-535" unitRef="usd">315900000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-536" unitRef="usd">21500000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-7" decimals="-5" id="f-537" unitRef="usd">22200000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-538" unitRef="usd">21200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-7" decimals="-5" id="f-539" unitRef="usd">24700000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-5" id="f-540" unitRef="usd">33000000.0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-5" id="f-541" unitRef="usd">25300000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-542">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-543">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-544" unitRef="usd">1410100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-545" unitRef="usd">769000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-3" decimals="-5" id="f-546" unitRef="usd">400000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-4" decimals="-5" id="f-547" unitRef="usd">500000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-3" decimals="-5" id="f-548" unitRef="usd">3400000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-5" id="f-549" unitRef="usd">3100000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-550" unitRef="usd">1413900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-551" unitRef="usd">772600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="c-1" id="f-552">INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0&#160;million and will pay annual royalty payments that are tied to net sales of certain Edwards products.  Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0&#160;million upfront payment based on their respective fair values.  The Company recorded a $37.0&#160;million pre-tax charge in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intellectual Property Agreement and Litigation Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" in March 2023 related primarily to prior commercial sales incurred through March 31, 2023.  The Company recorded a prepaid royalty asset of $124.0&#160;million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agreement.  Separately, the Company recorded a $139.0&#160;million pre-tax charge in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intellectual Property Agreement and Litigation Expense&lt;/span&gt;" in April 2023 related to products currently in development.</us-gaap:LegalMattersAndContingenciesTextBlock>
    <ew:IntellectualPropertyAgreementTerm contextRef="c-102" id="f-553">P15Y</ew:IntellectualPropertyAgreementTerm>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-103" decimals="-5" id="f-554" unitRef="usd">300000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-103" decimals="-5" id="f-555" unitRef="usd">300000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LitigationSettlementExpense contextRef="c-104" decimals="-5" id="f-556" unitRef="usd">37000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:PrepaidRoyalties contextRef="c-105" decimals="-5" id="f-557" unitRef="usd">124000000</us-gaap:PrepaidRoyalties>
    <us-gaap:LitigationSettlementExpense contextRef="c-106" decimals="-5" id="f-558" unitRef="usd">139000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock contextRef="c-1" id="f-559">SPECIAL CHARGE&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, the Company decided to exit its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HARPOON&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; surgical mitral repair system program. As a result, the Company recorded a charge to its United States segment of $68.4&#160;million, of which $66.8&#160;million was included in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Special Charge&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" and $1.6&#160;million was included in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of Sales&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" on the consolidated condensed statements of operations. The charge primarily related to the full impairment of intangible assets associated with the technology and other related exit costs. The Company believes that no additional contingent consideration is due and, in September 2022, recorded an $11.7&#160;million contingent consideration gain associated with the exit.&lt;/span&gt;</us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c-107" decimals="-5" id="f-560" unitRef="usd">68400000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c-108" decimals="-5" id="f-561" unitRef="usd">66800000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c-109" decimals="-5" id="f-562" unitRef="usd">1600000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <ew:RestructuringContingentConsiderationGainLoss contextRef="c-107" decimals="-5" id="f-563" unitRef="usd">11700000</ew:RestructuringContingentConsiderationGainLoss>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="c-1" id="f-564">INVESTMENTS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in debt securities at the end of each period were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.164%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost and fair value of investments in debt securities, by contractual maturity, as of September&#160;30, 2023, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-for-Sale&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1&#160;year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after 1&#160;year through 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after 5&#160;years through 10&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments not due at a single maturity date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)  &#160;&#160;&#160;&#160;Consists of mortgage- and asset-backed securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual maturities may differ from the contractual maturities due to call or prepayment rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September&#160;30, 2023 and December&#160;31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.703%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.703%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value.  Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of September&#160;30, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Unconsolidated Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a number of equity investments in unconsolidated entities.  These investments are recorded in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" on the consolidated condensed balance sheets, and are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of non-marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investments in unconsolidated entities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2023, the Company made $1.7 million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program.  The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities.  The NMTC is equal to 39% of the qualified investment and is taken over seven years.  These limited liability companies are variable interest entities ("VIEs").  The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company does not consolidate these entities.  Instead, the NMTC investments are accounted for as equity method investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer.  As of September&#160;30, 2023, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $3.1 million due to impairments and observable price changes.   &lt;/span&gt;&lt;/div&gt;During the three and nine months ended September 30, 2023, the gross realized gains or losses from sales of available-for-sale investments were not material.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock contextRef="c-1" id="f-565">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in debt securities at the end of each period were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.164%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Held-to-maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bank time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:HeldToMaturitySecurities contextRef="c-110" decimals="-5" id="f-566" unitRef="usd">28000000.0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain contextRef="c-110" decimals="-5" id="f-567" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss contextRef="c-110" decimals="-5" id="f-568" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue contextRef="c-110" decimals="-5" id="f-569" unitRef="usd">28000000.0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecurities contextRef="c-111" decimals="-5" id="f-570" unitRef="usd">96000000.0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain contextRef="c-111" decimals="-5" id="f-571" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss contextRef="c-111" decimals="-5" id="f-572" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue contextRef="c-111" decimals="-5" id="f-573" unitRef="usd">96000000.0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-112" decimals="-5" id="f-574" unitRef="usd">83900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-112" decimals="-5" id="f-575" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-112" decimals="-5" id="f-576" unitRef="usd">4300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-112" decimals="-5" id="f-577" unitRef="usd">79600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-113" decimals="-5" id="f-578" unitRef="usd">137700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-113" decimals="-5" id="f-579" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-113" decimals="-5" id="f-580" unitRef="usd">6100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-5" id="f-581" unitRef="usd">131600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-114" decimals="-5" id="f-582" unitRef="usd">227500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-114" decimals="-5" id="f-583" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-114" decimals="-5" id="f-584" unitRef="usd">7800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-114" decimals="-5" id="f-585" unitRef="usd">219700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-115" decimals="-5" id="f-586" unitRef="usd">380600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-115" decimals="-5" id="f-587" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-115" decimals="-5" id="f-588" unitRef="usd">14000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-5" id="f-589" unitRef="usd">366600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-116" decimals="-5" id="f-590" unitRef="usd">745000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-116" decimals="-5" id="f-591" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-116" decimals="-5" id="f-592" unitRef="usd">26400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-116" decimals="-5" id="f-593" unitRef="usd">718700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-117" decimals="-5" id="f-594" unitRef="usd">1028100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-117" decimals="-5" id="f-595" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-117" decimals="-5" id="f-596" unitRef="usd">47800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-5" id="f-597" unitRef="usd">980300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-118" decimals="-5" id="f-598" unitRef="usd">2800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-118" decimals="-5" id="f-599" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-118" decimals="-5" id="f-600" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-118" decimals="-5" id="f-601" unitRef="usd">2600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-119" decimals="-5" id="f-602" unitRef="usd">2700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-119" decimals="-5" id="f-603" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-119" decimals="-5" id="f-604" unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-119" decimals="-5" id="f-605" unitRef="usd">2500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-606" unitRef="usd">1059200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-5" id="f-607" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-5" id="f-608" unitRef="usd">38700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-5" id="f-609" unitRef="usd">1020600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-5" id="f-610" unitRef="usd">1549100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-5" id="f-611" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-5" id="f-612" unitRef="usd">68100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-5" id="f-613" unitRef="usd">1481000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-614">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost and fair value of investments in debt securities, by contractual maturity, as of September&#160;30, 2023, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-to-Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Available-for-Sale&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1&#160;year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after 1&#160;year through 5&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after 5&#160;years through 10&#160;years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments not due at a single maturity date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)  &#160;&#160;&#160;&#160;Consists of mortgage- and asset-backed securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost contextRef="c-3" decimals="-5" id="f-615" unitRef="usd">28000000.0</us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue contextRef="c-3" decimals="-5" id="f-616" unitRef="usd">28000000.0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-617" unitRef="usd">435800000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue contextRef="c-3" decimals="-5" id="f-618" unitRef="usd">425800000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost contextRef="c-3" decimals="-5" id="f-619" unitRef="usd">0</us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue contextRef="c-3" decimals="-5" id="f-620" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-621" unitRef="usd">365300000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue contextRef="c-3" decimals="-5" id="f-622" unitRef="usd">347100000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost contextRef="c-3" decimals="-5" id="f-623" unitRef="usd">0</us-gaap:HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue contextRef="c-3" decimals="-5" id="f-624" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-625" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue contextRef="c-3" decimals="-5" id="f-626" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount contextRef="c-3" decimals="-5" id="f-627" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue contextRef="c-3" decimals="-5" id="f-628" unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost contextRef="c-3" decimals="-5" id="f-629" unitRef="usd">258100000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue contextRef="c-3" decimals="-5" id="f-630" unitRef="usd">247700000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c-3" decimals="-5" id="f-631" unitRef="usd">28000000.0</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue contextRef="c-3" decimals="-5" id="f-632" unitRef="usd">28000000.0</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-5" id="f-633" unitRef="usd">1059200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-5" id="f-634" unitRef="usd">1020600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock contextRef="c-1" id="f-635">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of September&#160;30, 2023 and December&#160;31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.703%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.703%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.270%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;974.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or Greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-112" decimals="-5" id="f-636" unitRef="usd">2600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-112" decimals="-5" id="f-637" unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-112" decimals="-5" id="f-638" unitRef="usd">76700000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-112" decimals="-5" id="f-639" unitRef="usd">4200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-112" decimals="-5" id="f-640" unitRef="usd">79300000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-112" decimals="-5" id="f-641" unitRef="usd">4300000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-114" decimals="-5" id="f-642" unitRef="usd">18800000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-114" decimals="-5" id="f-643" unitRef="usd">300000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-114" decimals="-5" id="f-644" unitRef="usd">200100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-114" decimals="-5" id="f-645" unitRef="usd">7500000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-114" decimals="-5" id="f-646" unitRef="usd">218900000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-114" decimals="-5" id="f-647" unitRef="usd">7800000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-116" decimals="-5" id="f-648" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-116" decimals="-5" id="f-649" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-116" decimals="-5" id="f-650" unitRef="usd">674000000.0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-116" decimals="-5" id="f-651" unitRef="usd">26400000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-116" decimals="-5" id="f-652" unitRef="usd">674000000.0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-116" decimals="-5" id="f-653" unitRef="usd">26400000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-118" decimals="-5" id="f-654" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-118" decimals="-5" id="f-655" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-118" decimals="-5" id="f-656" unitRef="usd">2600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-118" decimals="-5" id="f-657" unitRef="usd">200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-118" decimals="-5" id="f-658" unitRef="usd">2600000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-118" decimals="-5" id="f-659" unitRef="usd">200000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-3" decimals="-5" id="f-660" unitRef="usd">21400000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-3" decimals="-5" id="f-661" unitRef="usd">400000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-3" decimals="-5" id="f-662" unitRef="usd">953400000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-3" decimals="-5" id="f-663" unitRef="usd">38300000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-3" decimals="-5" id="f-664" unitRef="usd">974800000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-3" decimals="-5" id="f-665" unitRef="usd">38700000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-113" decimals="-5" id="f-666" unitRef="usd">61600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-113" decimals="-5" id="f-667" unitRef="usd">1500000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-113" decimals="-5" id="f-668" unitRef="usd">69500000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-113" decimals="-5" id="f-669" unitRef="usd">4600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-113" decimals="-5" id="f-670" unitRef="usd">131100000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-113" decimals="-5" id="f-671" unitRef="usd">6100000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-115" decimals="-5" id="f-672" unitRef="usd">103300000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-115" decimals="-5" id="f-673" unitRef="usd">1300000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-115" decimals="-5" id="f-674" unitRef="usd">254600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-115" decimals="-5" id="f-675" unitRef="usd">12700000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-115" decimals="-5" id="f-676" unitRef="usd">357900000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-115" decimals="-5" id="f-677" unitRef="usd">14000000.0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-117" decimals="-5" id="f-678" unitRef="usd">189000000.0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-117" decimals="-5" id="f-679" unitRef="usd">5300000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-117" decimals="-5" id="f-680" unitRef="usd">784800000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-117" decimals="-5" id="f-681" unitRef="usd">42500000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-117" decimals="-5" id="f-682" unitRef="usd">973800000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-117" decimals="-5" id="f-683" unitRef="usd">47800000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-119" decimals="-5" id="f-684" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-119" decimals="-5" id="f-685" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-119" decimals="-5" id="f-686" unitRef="usd">2500000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-119" decimals="-5" id="f-687" unitRef="usd">200000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-119" decimals="-5" id="f-688" unitRef="usd">2500000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-119" decimals="-5" id="f-689" unitRef="usd">200000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-4" decimals="-5" id="f-690" unitRef="usd">353900000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-4" decimals="-5" id="f-691" unitRef="usd">8100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-4" decimals="-5" id="f-692" unitRef="usd">1111400000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-4" decimals="-5" id="f-693" unitRef="usd">60000000.0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-4" decimals="-5" id="f-694" unitRef="usd">1465300000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-4" decimals="-5" id="f-695" unitRef="usd">68100000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock contextRef="c-1" id="f-696">These investments are recorded in "&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" on the consolidated condensed balance sheets, and are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of non-marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total investments in unconsolidated entities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock>
    <us-gaap:EquityMethodInvestments contextRef="c-3" decimals="-5" id="f-697" unitRef="usd">22900000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-4" decimals="-5" id="f-698" unitRef="usd">21400000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-3" decimals="-5" id="f-699" unitRef="usd">86900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-4" decimals="-5" id="f-700" unitRef="usd">86900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-3" decimals="-5" id="f-701" unitRef="usd">109800000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-4" decimals="-5" id="f-702" unitRef="usd">108300000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:EquityMethodInvestments contextRef="c-120" decimals="-5" id="f-703" unitRef="usd">1700000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-120" decimals="2" id="f-704" unitRef="number">0.39</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <ew:EquityMethodInvestmentsInvestmentPeriod contextRef="c-121" id="f-705">P7Y</ew:EquityMethodInvestmentsInvestmentPeriod>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount contextRef="c-122" decimals="-5" id="f-706" unitRef="usd">8800000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount contextRef="c-122" decimals="-5" id="f-707" unitRef="usd">3100000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount>
    <us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="c-1" id="f-708">INVESTMENTS IN VARIABLE INTEREST ENTITIES &lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE.  The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated VIEs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest.  Edwards concluded that it is the primary beneficiary and consolidated the VIE.  See Note 7 for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unconsolidated VIEs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2023, the Company agreed to pay a medical device company up to $45.0&#160;million as consideration for an option to acquire the medical device company, of which $15.0&#160;million had been paid as of September&#160;30, 2023. Also, in March 2023, Edwards advanced $5.0&#160;million to the medical device company under a convertible promissory note. The option and the note are included in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" on the consolidated condensed balance sheet as of September&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company entered into a $45.0&#160;million secured promissory note agreement with a privately-held medical device company (the "Investee"), of which $25.0&#160;million had been advanced as of September&#160;30, 2023.  Also in 2021, the Company invested $39.3&#160;million, included in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Investments,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" in the Investee's preferred equity securities and paid $13.1&#160;million, included in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" for an option to acquire the Investee.  Pursuant to the agreement, the Company may be required to invest up to an additional $6.5&#160;million in the Investee's preferred equity securities and up to an additional $14.4&#160;million for the option to acquire the Investee.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Company entered into an option agreement with a medical device company.  Under the option agreement, Edwards paid $47.1&#160;million for an option to acquire the medical device company.  The $47.1&#160;million option is included in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" on the consolidated condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company.  Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5&#160;million, of which $32.5&#160;million had been advanced as of September&#160;30, 2023.  In addition, in 2019 the Company paid $35.0&#160;million for an option to acquire the medical device company. The $35.0&#160;million option and the $32.5&#160;million note receivable are included in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" on the consolidated condensed balance sheets.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company entered into an option agreement with a medical technology company.  Under the option agreement, Edwards paid $60.0&#160;million for an option to acquire the medical technology company, of which $10.0&#160;million was paid in 2021. The $60.0&#160;million option is included in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" on the consolidated condensed balance sheet. In addition, in August 2023, the Company entered into a $15&#160;million promissory note with the medical technology company.  &lt;/span&gt;&lt;/div&gt;In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs.  For more information, see Note 5.</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <ew:LoansReceivablesMaximumLendingCapacity contextRef="c-123" decimals="-5" id="f-709" unitRef="usd">45000000</ew:LoansReceivablesMaximumLendingCapacity>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-124" decimals="-5" id="f-710" unitRef="usd">15000000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:NotesReceivableGross contextRef="c-125" decimals="-5" id="f-711" unitRef="usd">5000000</us-gaap:NotesReceivableGross>
    <ew:EquitySecuritiesFVNIMaximumSecuredPromissoryNote contextRef="c-126" decimals="-5" id="f-712" unitRef="usd">45000000</ew:EquitySecuritiesFVNIMaximumSecuredPromissoryNote>
    <ew:EquitySecuritiesFVNIPromissoryNoteOutstanding contextRef="c-127" decimals="-5" id="f-713" unitRef="usd">25000000</ew:EquitySecuritiesFVNIPromissoryNoteOutstanding>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-128" decimals="-5" id="f-714" unitRef="usd">39300000</us-gaap:EquitySecuritiesFvNi>
    <ew:EquitySecuritiesFVNIOptionToAcquireInvestment contextRef="c-128" decimals="-5" id="f-715" unitRef="usd">13100000</ew:EquitySecuritiesFVNIOptionToAcquireInvestment>
    <ew:EquitySecuritiesFVNIMaximumAdditionalRequired contextRef="c-129" decimals="-5" id="f-716" unitRef="usd">6500000</ew:EquitySecuritiesFVNIMaximumAdditionalRequired>
    <ew:EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment contextRef="c-128" decimals="-5" id="f-717" unitRef="usd">14400000</ew:EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-130" decimals="-5" id="f-718" unitRef="usd">47100000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <ew:OptionToAcquireInvestmentAmount contextRef="c-131" decimals="-5" id="f-719" unitRef="usd">47100000</ew:OptionToAcquireInvestmentAmount>
    <ew:LoansReceivablesMaximumLendingCapacity contextRef="c-132" decimals="-5" id="f-720" unitRef="usd">47500000</ew:LoansReceivablesMaximumLendingCapacity>
    <us-gaap:NotesReceivableGross contextRef="c-133" decimals="-5" id="f-721" unitRef="usd">32500000</us-gaap:NotesReceivableGross>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-134" decimals="-5" id="f-722" unitRef="usd">35000000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <ew:OptionToAcquireInvestmentAmount contextRef="c-133" decimals="-5" id="f-723" unitRef="usd">35000000</ew:OptionToAcquireInvestmentAmount>
    <us-gaap:NotesReceivableGross contextRef="c-133" decimals="-5" id="f-724" unitRef="usd">32500000</us-gaap:NotesReceivableGross>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-135" decimals="-5" id="f-725" unitRef="usd">60000000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-136" decimals="-5" id="f-726" unitRef="usd">10000000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <ew:OptionToAcquireInvestmentAmount contextRef="c-137" decimals="-5" id="f-727" unitRef="usd">60000000</ew:OptionToAcquireInvestmentAmount>
    <ew:EquitySecuritiesFVNIMaximumPromissoryNote contextRef="c-138" decimals="-6" id="f-728" unitRef="usd">15000000</ew:EquitySecuritiesFVNIMaximumPromissoryNote>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-729">BUSINESS COMBINATION&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 28, 2023, the Company acquired 61% of the then outstanding shares of a medical technology company in an all cash transaction.  The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated condensed financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination.  Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date.  The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill.  The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.818%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Noncontrolling interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price, net of cash acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)  Includes the fair value of the noncontrolling interest of $94.4&#160;million, offset by the purchase consideration allocated to the option of $22.0&#160;million, which was ascribed to the noncontrolling interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) &#160;&#160;&#160;&#160;Includes $22.5&#160;million paid in a previous year under option agreements and $5.3&#160;million for the settlement of a pre-existing note.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition.  Goodwill was assigned to the Company&#x2019;s Rest of World segment and is not deductible for tax purposes.     &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-139" decimals="2" id="f-730" unitRef="number">0.61</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c-1" id="f-731">The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.818%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Noncontrolling interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price, net of cash acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)  Includes the fair value of the noncontrolling interest of $94.4&#160;million, offset by the purchase consideration allocated to the option of $22.0&#160;million, which was ascribed to the noncontrolling interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) &#160;&#160;&#160;&#160;Includes $22.5&#160;million paid in a previous year under option agreements and $5.3&#160;million for the settlement of a pre-existing note.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="c-139" decimals="-5" id="f-732" unitRef="usd">8100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:Goodwill contextRef="c-139" decimals="-5" id="f-733" unitRef="usd">133200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-139" decimals="-5" id="f-734" unitRef="usd">136600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities contextRef="c-139" decimals="-5" id="f-735" unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="c-139" decimals="-5" id="f-736" unitRef="usd">28000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-139" decimals="-5" id="f-737" unitRef="usd">248200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <ew:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet contextRef="c-139" decimals="-5" id="f-738" unitRef="usd">72400000</ew:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest contextRef="c-139" decimals="-5" id="f-739" unitRef="usd">175800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-140" decimals="-5" id="f-740" unitRef="usd">6800000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-140" decimals="-5" id="f-741" unitRef="usd">169000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue contextRef="c-139" decimals="-5" id="f-742" unitRef="usd">94400000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <ew:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment contextRef="c-139" decimals="-5" id="f-743" unitRef="usd">22000000</ew:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c-140" decimals="-5" id="f-744" unitRef="usd">22500000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-140" decimals="-5" id="f-745" unitRef="usd">5300000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-746">FAIR VALUE MEASUREMENTS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Unobservable inputs that are not corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable.  As of September&#160;30, 2023, the fair value of the notes payable, based on Level 2 inputs, was $565.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.433%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held for deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,376.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,053.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held for deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Equivalents and Available-for-sale Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents included money market funds for the periods presented above.  The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets.  The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs.  The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source.  The Company&#x2019;s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in trading securities related to its deferred compensation plans.  The investments are in a variety of stock, bond and money market mutual funds.  The fair values of these investments are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:20.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures.  All derivatives contracts are recognized on the balance sheet at their fair value.  The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates.  Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange.  The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Consideration Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's acquisitions involve contingent consideration arrangements.  Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals.  These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs.  As of September&#160;30, 2023, the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-141" decimals="-5" id="f-747" unitRef="usd">565700000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-748">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.433%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.216%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.220%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;820.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held for deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,376.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,053.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;980.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments held for deferred compensation plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,939.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-142" decimals="-5" id="f-749" unitRef="usd">554500000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-143" decimals="-5" id="f-750" unitRef="usd">266400000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-144" decimals="-5" id="f-751" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-145" decimals="-5" id="f-752" unitRef="usd">820900000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-146" decimals="-5" id="f-753" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-147" decimals="-5" id="f-754" unitRef="usd">718700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-148" decimals="-5" id="f-755" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-149" decimals="-5" id="f-756" unitRef="usd">718700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-150" decimals="-5" id="f-757" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-151" decimals="-5" id="f-758" unitRef="usd">219700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-152" decimals="-5" id="f-759" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-153" decimals="-5" id="f-760" unitRef="usd">219700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-154" decimals="-5" id="f-761" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-155" decimals="-5" id="f-762" unitRef="usd">79600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-156" decimals="-5" id="f-763" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-157" decimals="-5" id="f-764" unitRef="usd">79600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-158" decimals="-5" id="f-765" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-159" decimals="-5" id="f-766" unitRef="usd">2600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-160" decimals="-5" id="f-767" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-161" decimals="-5" id="f-768" unitRef="usd">2600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-142" decimals="-5" id="f-769" unitRef="usd">123000000.0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-143" decimals="-5" id="f-770" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-144" decimals="-5" id="f-771" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-145" decimals="-5" id="f-772" unitRef="usd">123000000.0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DerivativeAssets contextRef="c-142" decimals="-5" id="f-773" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-143" decimals="-5" id="f-774" unitRef="usd">89300000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-144" decimals="-5" id="f-775" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-145" decimals="-5" id="f-776" unitRef="usd">89300000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-142" decimals="-5" id="f-777" unitRef="usd">677500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-143" decimals="-5" id="f-778" unitRef="usd">1376300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-144" decimals="-5" id="f-779" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-145" decimals="-5" id="f-780" unitRef="usd">2053800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-142" decimals="-5" id="f-781" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-143" decimals="-5" id="f-782" unitRef="usd">6700000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-144" decimals="-5" id="f-783" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-145" decimals="-5" id="f-784" unitRef="usd">6700000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-142" decimals="-5" id="f-785" unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-143" decimals="-5" id="f-786" unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-144" decimals="-5" id="f-787" unitRef="usd">10300000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-145" decimals="-5" id="f-788" unitRef="usd">10300000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-142" decimals="-5" id="f-789" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-143" decimals="-5" id="f-790" unitRef="usd">6700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-144" decimals="-5" id="f-791" unitRef="usd">10300000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-145" decimals="-5" id="f-792" unitRef="usd">17000000.0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-162" decimals="-5" id="f-793" unitRef="usd">280400000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-163" decimals="-5" id="f-794" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-164" decimals="-5" id="f-795" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-165" decimals="-5" id="f-796" unitRef="usd">280400000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-166" decimals="-5" id="f-797" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-167" decimals="-5" id="f-798" unitRef="usd">980300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-168" decimals="-5" id="f-799" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-169" decimals="-5" id="f-800" unitRef="usd">980300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-170" decimals="-5" id="f-801" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-171" decimals="-5" id="f-802" unitRef="usd">366600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-172" decimals="-5" id="f-803" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-173" decimals="-5" id="f-804" unitRef="usd">366600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-174" decimals="-5" id="f-805" unitRef="usd">37100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-175" decimals="-5" id="f-806" unitRef="usd">94500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-176" decimals="-5" id="f-807" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-177" decimals="-5" id="f-808" unitRef="usd">131600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-178" decimals="-5" id="f-809" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-179" decimals="-5" id="f-810" unitRef="usd">2500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-180" decimals="-5" id="f-811" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-181" decimals="-5" id="f-812" unitRef="usd">2500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-162" decimals="-5" id="f-813" unitRef="usd">112100000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-163" decimals="-5" id="f-814" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-164" decimals="-5" id="f-815" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="c-165" decimals="-5" id="f-816" unitRef="usd">112100000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DerivativeAssets contextRef="c-162" decimals="-5" id="f-817" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-163" decimals="-5" id="f-818" unitRef="usd">65500000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-164" decimals="-5" id="f-819" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-165" decimals="-5" id="f-820" unitRef="usd">65500000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-162" decimals="-5" id="f-821" unitRef="usd">429600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-163" decimals="-5" id="f-822" unitRef="usd">1509400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-164" decimals="-5" id="f-823" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-165" decimals="-5" id="f-824" unitRef="usd">1939000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-162" decimals="-5" id="f-825" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-163" decimals="-5" id="f-826" unitRef="usd">27200000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-164" decimals="-5" id="f-827" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-165" decimals="-5" id="f-828" unitRef="usd">27200000</us-gaap:DerivativeLiabilities>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="c-162" decimals="-5" id="f-829" unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="c-163" decimals="-5" id="f-830" unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="c-164" decimals="-5" id="f-831" unitRef="usd">26200000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="c-165" decimals="-5" id="f-832" unitRef="usd">26200000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-162" decimals="-5" id="f-833" unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-163" decimals="-5" id="f-834" unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-164" decimals="-5" id="f-835" unitRef="usd">14000000.0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="c-165" decimals="-5" id="f-836" unitRef="usd">14000000.0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-162" decimals="-5" id="f-837" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-163" decimals="-5" id="f-838" unitRef="usd">27200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-164" decimals="-5" id="f-839" unitRef="usd">40200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-165" decimals="-5" id="f-840" unitRef="usd">67400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="c-182" decimals="2" id="f-841" unitRef="number">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-183" decimals="INF" id="f-842" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-843">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-184" decimals="-5" id="f-844" unitRef="usd">26200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-185" decimals="-5" id="f-845" unitRef="usd">14000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-186" decimals="-5" id="f-846" unitRef="usd">40200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-187" decimals="-5" id="f-847" unitRef="usd">-26200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-188" decimals="-5" id="f-848" unitRef="usd">-3700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-189" decimals="-5" id="f-849" unitRef="usd">-29900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-190" decimals="-5" id="f-850" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-191" decimals="-5" id="f-851" unitRef="usd">10300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-192" decimals="-5" id="f-852" unitRef="usd">10300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-193" decimals="-5" id="f-853" unitRef="usd">62000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-194" decimals="-5" id="f-854" unitRef="usd">14000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-195" decimals="-5" id="f-855" unitRef="usd">76000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-196" decimals="-5" id="f-856" unitRef="usd">-36300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-197" decimals="-5" id="f-857" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-198" decimals="-5" id="f-858" unitRef="usd">-36300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-199" decimals="-5" id="f-859" unitRef="usd">25700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-200" decimals="-5" id="f-860" unitRef="usd">14000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-201" decimals="-5" id="f-861" unitRef="usd">39700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-862">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.319%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.043%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,686.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative financial instruments involve credit risk in the event the counterparty should default.  It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy.  The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities.  The Company also uses International Swap Dealers Association master-netting agreements.  The master-netting &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (b) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges).  The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets.  For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item.  The Company reports in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges.  The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings.  Changes in the fair value of net investment hedges are reported in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated.  The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative.  The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument.  Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.897%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-870"&gt;&lt;span style="-sec-ix-hidden:f-871"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-876"&gt;&lt;span style="-sec-ix-hidden:f-877"&gt;Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.296%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts &lt;br/&gt;Not Offset in&lt;br/&gt;the Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt;Offset in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amounts&lt;br/&gt;Presented in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash&lt;br/&gt;Collateral&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;Accumulated OCI&lt;br/&gt;into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Reclassified&#160;from&lt;br/&gt;Accumulated&#160;OCI&lt;br/&gt;into&#160;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative &lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;Accumulated OCI&lt;br/&gt;into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Reclassified&#160;from&lt;br/&gt;Accumulated&#160;OCI&lt;br/&gt;into&#160;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.487%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.785%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative &lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in&#160;Income on Derivative (Amount Excluded from &lt;br/&gt;Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.944%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.998%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in&#160;Income on Derivative (Amount Excluded from&lt;br/&gt;&#160;Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Reclassified&#160;from&lt;br/&gt;Accumulated&#160;OCI&lt;br/&gt;into&#160;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The cross currency swap contracts have an expiration date of June 15, 2028.  At maturity of the cross currency swap contracts, the Company will deliver the notional amount of &#x20ac;257.2 million and will receive $300.0 million from the counterparties.  The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.654%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,022.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The effects of fair value and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized in earnings based on an amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) reclassified from accumulated OCI into income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.785%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.513%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.684%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(822.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The effects of fair value and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized in earnings based on an amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) reclassified from accumulated OCI into income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects that during the next twelve months it will reclassify to earnings a $5.5 million gain currently recorded in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;."&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock contextRef="c-1" id="f-863">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.319%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.043%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,686.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-202" decimals="-5" id="f-864" unitRef="usd">1686100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-203" decimals="-5" id="f-865" unitRef="usd">1678400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-204" decimals="-5" id="f-866" unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-205" decimals="-5" id="f-867" unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge contextRef="c-1" id="f-868">P1Y</us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge>
    <us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock contextRef="c-1" id="f-869">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.897%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-870"&gt;&lt;span style="-sec-ix-hidden:f-871"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-876"&gt;&lt;span style="-sec-ix-hidden:f-877"&gt;Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock>
    <us-gaap:DerivativeAssets contextRef="c-206" decimals="-5" id="f-872" unitRef="usd">53900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-207" decimals="-5" id="f-873" unitRef="usd">24900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-204" decimals="-5" id="f-874" unitRef="usd">35400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-205" decimals="-5" id="f-875" unitRef="usd">40600000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-208" decimals="-5" id="f-878" unitRef="usd">6700000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-209" decimals="-5" id="f-879" unitRef="usd">20700000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-210" decimals="-5" id="f-880" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-211" decimals="-5" id="f-881" unitRef="usd">6500000</us-gaap:DerivativeLiabilities>
    <us-gaap:OffsettingAssetsTableTextBlock contextRef="c-1" id="f-882">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.296%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts &lt;br/&gt;Not Offset in&lt;br/&gt;the Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt;Offset in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amounts&lt;br/&gt;Presented in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash&lt;br/&gt;Collateral&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OffsettingAssetsTableTextBlock>
    <us-gaap:OffsettingLiabilitiesTableTextBlock contextRef="c-1" id="f-883">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.296%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.822%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.234%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.032%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts &lt;br/&gt;Not Offset in&lt;br/&gt;the Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amounts&lt;br/&gt;Offset in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amounts&lt;br/&gt;Presented in the&lt;br/&gt;Consolidated&lt;br/&gt;Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash&lt;br/&gt;Collateral&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OffsettingLiabilitiesTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-212" decimals="-5" id="f-884" unitRef="usd">53900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability contextRef="c-212" decimals="-5" id="f-885" unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets contextRef="c-212" decimals="-5" id="f-886" unitRef="usd">53900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction contextRef="c-212" decimals="-5" id="f-887" unitRef="usd">6700000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash contextRef="c-212" decimals="-5" id="f-888" unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral contextRef="c-212" decimals="-5" id="f-889" unitRef="usd">47200000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-213" decimals="-5" id="f-890" unitRef="usd">35400000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability contextRef="c-213" decimals="-5" id="f-891" unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets contextRef="c-213" decimals="-5" id="f-892" unitRef="usd">35400000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction contextRef="c-213" decimals="-5" id="f-893" unitRef="usd">0</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash contextRef="c-213" decimals="-5" id="f-894" unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral contextRef="c-213" decimals="-5" id="f-895" unitRef="usd">35400000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-212" decimals="-5" id="f-896" unitRef="usd">6700000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset contextRef="c-212" decimals="-5" id="f-897" unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilities contextRef="c-212" decimals="-5" id="f-898" unitRef="usd">6700000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction contextRef="c-212" decimals="-5" id="f-899" unitRef="usd">6700000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash contextRef="c-212" decimals="-5" id="f-900" unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral contextRef="c-212" decimals="-5" id="f-901" unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-214" decimals="-5" id="f-902" unitRef="usd">24900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability contextRef="c-214" decimals="-5" id="f-903" unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets contextRef="c-214" decimals="-5" id="f-904" unitRef="usd">24900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction contextRef="c-214" decimals="-5" id="f-905" unitRef="usd">12000000.0</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash contextRef="c-214" decimals="-5" id="f-906" unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral contextRef="c-214" decimals="-5" id="f-907" unitRef="usd">12900000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-215" decimals="-5" id="f-908" unitRef="usd">40600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability contextRef="c-215" decimals="-5" id="f-909" unitRef="usd">0</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets contextRef="c-215" decimals="-5" id="f-910" unitRef="usd">40600000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction contextRef="c-215" decimals="-5" id="f-911" unitRef="usd">0</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash contextRef="c-215" decimals="-5" id="f-912" unitRef="usd">0</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral contextRef="c-215" decimals="-5" id="f-913" unitRef="usd">40600000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-214" decimals="-5" id="f-914" unitRef="usd">27200000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset contextRef="c-214" decimals="-5" id="f-915" unitRef="usd">0</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilities contextRef="c-214" decimals="-5" id="f-916" unitRef="usd">27200000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction contextRef="c-214" decimals="-5" id="f-917" unitRef="usd">12000000.0</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash contextRef="c-214" decimals="-5" id="f-918" unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral contextRef="c-214" decimals="-5" id="f-919" unitRef="usd">15200000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="c-1" id="f-920">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.726%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;Accumulated OCI&lt;br/&gt;into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Reclassified&#160;from&lt;br/&gt;Accumulated&#160;OCI&lt;br/&gt;into&#160;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.889%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative &lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Reclassified from&lt;br/&gt;Accumulated OCI&lt;br/&gt;into Income&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Reclassified&#160;from&lt;br/&gt;Accumulated&#160;OCI&lt;br/&gt;into&#160;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.487%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.782%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.785%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative &lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in&#160;Income on Derivative (Amount Excluded from &lt;br/&gt;Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Recognized in&#160;Income on Derivative (Amount Excluded from Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.944%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.325%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.998%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in OCI&lt;br/&gt;on Derivative&lt;br/&gt;(Effective Portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in&#160;Income on Derivative (Amount Excluded from&lt;br/&gt;&#160;Effectiveness Testing)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Location&#160;of&#160;Gain&#160;or&lt;br/&gt;(Loss)&#160;Reclassified&#160;from&lt;br/&gt;Accumulated&#160;OCI&lt;br/&gt;into&#160;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of Gain or (Loss)&lt;br/&gt;Recognized in Income on&lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-216" decimals="-5" id="f-921" unitRef="usd">33500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-217" decimals="-5" id="f-922" unitRef="usd">55500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-218" decimals="-5" id="f-923" unitRef="usd">9300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-219" decimals="-5" id="f-924" unitRef="usd">27100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-220" decimals="-5" id="f-925" unitRef="usd">60400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-221" decimals="-5" id="f-926" unitRef="usd">138100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-222" decimals="-5" id="f-927" unitRef="usd">53000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-223" decimals="-5" id="f-928" unitRef="usd">50700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-224" decimals="-5" id="f-929" unitRef="usd">3800000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-225" decimals="-5" id="f-930" unitRef="usd">16900000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred contextRef="c-226" decimals="-5" id="f-931" unitRef="usd">1700000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred contextRef="c-227" decimals="-5" id="f-932" unitRef="usd">1800000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-228" decimals="-5" id="f-933" unitRef="usd">-5200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax contextRef="c-229" decimals="-5" id="f-934" unitRef="usd">40200000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred contextRef="c-230" decimals="-5" id="f-935" unitRef="usd">5200000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred contextRef="c-231" decimals="-5" id="f-936" unitRef="usd">5400000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeNotionalAmount contextRef="c-232" decimals="-5" id="f-937" unitRef="eur">257200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-232" decimals="-5" id="f-938" unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-233" decimals="-5" id="f-939" unitRef="usd">4800000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-234" decimals="-5" id="f-940" unitRef="usd">4500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-235" decimals="-5" id="f-941" unitRef="usd">16100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-236" decimals="-5" id="f-942" unitRef="usd">4500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-237" decimals="-5" id="f-943" unitRef="usd">14600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-238" decimals="-5" id="f-944" unitRef="usd">24000000.0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-239" decimals="-5" id="f-945" unitRef="usd">19100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-240" decimals="-5" id="f-946" unitRef="usd">66100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-947">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.654%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,022.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The effects of fair value and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized in earnings based on an amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) reclassified from accumulated OCI into income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.785%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.513%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.684%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(822.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;The effects of fair value and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount excluded from effectiveness testing recognized in earnings based on an amortization approach&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (loss) on cash flow hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) reclassified from accumulated OCI into income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-948" unitRef="usd">350400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-949" unitRef="usd">5800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-950" unitRef="usd">1022900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-951" unitRef="usd">9600000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-241" decimals="-5" id="f-952" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-242" decimals="-5" id="f-953" unitRef="usd">-3600000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-243" decimals="-5" id="f-954" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-244" decimals="-5" id="f-955" unitRef="usd">-12500000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-245" decimals="-5" id="f-956" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-246" decimals="-5" id="f-957" unitRef="usd">3600000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-247" decimals="-5" id="f-958" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-248" decimals="-5" id="f-959" unitRef="usd">12500000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-241" decimals="-5" id="f-960" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-242" decimals="-5" id="f-961" unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-243" decimals="-5" id="f-962" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-244" decimals="-5" id="f-963" unitRef="usd">3600000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-241" decimals="-5" id="f-964" unitRef="usd">9300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-242" decimals="-5" id="f-965" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-243" decimals="-5" id="f-966" unitRef="usd">53000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-244" decimals="-5" id="f-967" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-5" id="f-968" unitRef="usd">253800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-969" unitRef="usd">-2000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-5" id="f-970" unitRef="usd">822500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-971" unitRef="usd">-1000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-249" decimals="-5" id="f-972" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-250" decimals="-5" id="f-973" unitRef="usd">-4100000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-251" decimals="-5" id="f-974" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 contextRef="c-252" decimals="-5" id="f-975" unitRef="usd">-4100000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-253" decimals="-5" id="f-976" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-254" decimals="-5" id="f-977" unitRef="usd">4100000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-255" decimals="-5" id="f-978" unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 contextRef="c-256" decimals="-5" id="f-979" unitRef="usd">4100000</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-249" decimals="-5" id="f-980" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-250" decimals="-5" id="f-981" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-251" decimals="-5" id="f-982" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax contextRef="c-252" decimals="-5" id="f-983" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-249" decimals="-5" id="f-984" unitRef="usd">27100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-250" decimals="-5" id="f-985" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-251" decimals="-5" id="f-986" unitRef="usd">50700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-252" decimals="-5" id="f-987" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="c-1" decimals="-5" id="f-988" unitRef="usd">5500000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-989">STOCK-BASED COMPENSATION  &lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2023 and 2022 was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.333%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2023, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $254.5 million, which will be amortized on a straight-line basis over each award's requisite service period.  The weighted-average remaining requisite service period is 33 months.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2023, the Company granted 2.0 million stock options at a weighted-average&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;exercise price per share of $88.45, and 1.0 million restricted stock units at a weighted-average grant-date fair value per share of $87.36. During the nine months ended September 30, 2023, the Company also granted 0.1 million market-based restricted stock units at a weighted-average grant-date fair value per share of $110.10.  The market-based restricted stock units granted during the nine months ended September 30, 2023 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a three-year performance period and may range from 0% to 175% of the target number of shares granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements.  The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the nine months ended September 30, 2023 and 2022 included a risk-free interest rate of 3.6% and 2.9%, respectively, and an expected volatility rate of 32.6% and 33.9%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, per option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-990">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and nine months ended September 30, 2023 and 2022 was as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.333%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-257" decimals="-5" id="f-991" unitRef="usd">5500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-258" decimals="-5" id="f-992" unitRef="usd">5300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-259" decimals="-5" id="f-993" unitRef="usd">18700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-260" decimals="-5" id="f-994" unitRef="usd">18400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-261" decimals="-5" id="f-995" unitRef="usd">19100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-262" decimals="-5" id="f-996" unitRef="usd">18100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-263" decimals="-5" id="f-997" unitRef="usd">63900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-264" decimals="-5" id="f-998" unitRef="usd">57900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-265" decimals="-5" id="f-999" unitRef="usd">8000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-266" decimals="-5" id="f-1000" unitRef="usd">6900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-267" decimals="-5" id="f-1001" unitRef="usd">26300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-268" decimals="-5" id="f-1002" unitRef="usd">22600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-1003" unitRef="usd">32600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-5" id="f-1004" unitRef="usd">30300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-1005" unitRef="usd">108900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-5" id="f-1006" unitRef="usd">98900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-5" decimals="-5" id="f-1007" unitRef="usd">5800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-6" decimals="-5" id="f-1008" unitRef="usd">4900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-5" id="f-1009" unitRef="usd">17300000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-7" decimals="-5" id="f-1010" unitRef="usd">15200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-5" decimals="-5" id="f-1011" unitRef="usd">26800000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-6" decimals="-5" id="f-1012" unitRef="usd">25400000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-1" decimals="-5" id="f-1013" unitRef="usd">91600000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax contextRef="c-7" decimals="-5" id="f-1014" unitRef="usd">83700000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-3" decimals="-5" id="f-1015" unitRef="usd">254500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-1016">P33M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-5" id="f-1017" unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1018"
      unitRef="usdPerShare">88.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-269"
      decimals="-5"
      id="f-1019"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-269"
      decimals="2"
      id="f-1020"
      unitRef="usdPerShare">87.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-270"
      decimals="-5"
      id="f-1021"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-270"
      decimals="2"
      id="f-1022"
      unitRef="usdPerShare">110.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod contextRef="c-1" id="f-1023">P3Y</ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod>
    <ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget
      contextRef="c-271"
      decimals="INF"
      id="f-1024"
      unitRef="number">0</ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget>
    <ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget
      contextRef="c-272"
      decimals="INF"
      id="f-1025"
      unitRef="number">1.75</ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-270"
      decimals="3"
      id="f-1026"
      unitRef="number">0.036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-273"
      decimals="3"
      id="f-1027"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-270"
      decimals="3"
      id="f-1028"
      unitRef="number">0.326</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-273"
      decimals="3"
      id="f-1029"
      unitRef="number">0.339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1030">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, per option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-274"
      decimals="3"
      id="f-1031"
      unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-275"
      decimals="3"
      id="f-1032"
      unitRef="number">0.032</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-276"
      decimals="3"
      id="f-1033"
      unitRef="number">0.034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-277"
      decimals="3"
      id="f-1034"
      unitRef="number">0.030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-274"
      decimals="INF"
      id="f-1035"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-275"
      decimals="INF"
      id="f-1036"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-276"
      decimals="INF"
      id="f-1037"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-277"
      decimals="INF"
      id="f-1038"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-274"
      decimals="3"
      id="f-1039"
      unitRef="number">0.327</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-275"
      decimals="3"
      id="f-1040"
      unitRef="number">0.315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-276"
      decimals="3"
      id="f-1041"
      unitRef="number">0.328</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-277"
      decimals="3"
      id="f-1042"
      unitRef="number">0.315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-274" id="f-1043">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-275" id="f-1044">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-276" id="f-1045">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-277" id="f-1046">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-274"
      decimals="2"
      id="f-1047"
      unitRef="usdPerShare">31.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-275"
      decimals="2"
      id="f-1048"
      unitRef="usdPerShare">32.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-276"
      decimals="2"
      id="f-1049"
      unitRef="usdPerShare">31.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-277"
      decimals="2"
      id="f-1050"
      unitRef="usdPerShare">34.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1051">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value, per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-278"
      decimals="3"
      id="f-1052"
      unitRef="number">0.053</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-279"
      decimals="3"
      id="f-1053"
      unitRef="number">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-280"
      decimals="3"
      id="f-1054"
      unitRef="number">0.046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-281"
      decimals="3"
      id="f-1055"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-278"
      decimals="INF"
      id="f-1056"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-279"
      decimals="INF"
      id="f-1057"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-280"
      decimals="INF"
      id="f-1058"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-281"
      decimals="INF"
      id="f-1059"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-278"
      decimals="3"
      id="f-1060"
      unitRef="number">0.348</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-279"
      decimals="3"
      id="f-1061"
      unitRef="number">0.311</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-280"
      decimals="3"
      id="f-1062"
      unitRef="number">0.315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-281"
      decimals="3"
      id="f-1063"
      unitRef="number">0.320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-278" id="f-1064">P0Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-279" id="f-1065">P0Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-280" id="f-1066">P0Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-281" id="f-1067">P0Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-278"
      decimals="2"
      id="f-1068"
      unitRef="usdPerShare">18.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-279"
      decimals="2"
      id="f-1069"
      unitRef="usdPerShare">21.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-280"
      decimals="2"
      id="f-1070"
      unitRef="usdPerShare">19.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-281"
      decimals="2"
      id="f-1071"
      unitRef="usdPerShare">28.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-1072">ACCELERATED SHARE REPURCHASE&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2023 and 2022, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreement, less a discount.  The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Initial Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Settlement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agreement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Price per&lt;br/&gt;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value of&lt;br/&gt;Shares as %&lt;br/&gt;of Contract&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlement&lt;br/&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Shares&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Price&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ASR agreements were each accounted for as two separate transactions: (1)&#160;the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2)&#160;the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Additional Paid-in Capital&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" and subsequently, upon settlement, was transferred to "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:AcceleratedShareRepurchasesTextBlock contextRef="c-1" id="f-1073">The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Initial Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Settlement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Agreement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Price per&lt;br/&gt;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value of&lt;br/&gt;Shares as %&lt;br/&gt;of Contract&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlement&lt;br/&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Shares&lt;br/&gt;Received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Price&lt;br/&gt;per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AcceleratedShareRepurchasesTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-282" decimals="-5" id="f-1074" unitRef="usd">250000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-283"
      decimals="-5"
      id="f-1075"
      unitRef="shares">1900000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare
      contextRef="c-283"
      decimals="2"
      id="f-1076"
      unitRef="usdPerShare">104.87</us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare>
    <ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount
      contextRef="c-283"
      decimals="2"
      id="f-1077"
      unitRef="number">0.80</ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-284"
      decimals="-5"
      id="f-1078"
      unitRef="shares">2300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="c-284"
      decimals="2"
      id="f-1079"
      unitRef="usdPerShare">110.31</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-285" decimals="-5" id="f-1080" unitRef="usd">200000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-286"
      decimals="-5"
      id="f-1081"
      unitRef="shares">2000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare
      contextRef="c-286"
      decimals="2"
      id="f-1082"
      unitRef="usdPerShare">80.44</us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare>
    <ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount
      contextRef="c-286"
      decimals="2"
      id="f-1083"
      unitRef="number">0.80</ew:AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-287"
      decimals="-5"
      id="f-1084"
      unitRef="shares">2500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="c-287"
      decimals="2"
      id="f-1085"
      unitRef="usdPerShare">79.28</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1086">COMMITMENTS AND CONTINGENCIES&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act ("FCPA").  The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company&#x2019;s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards&#x2019; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;SAPIEN 3 Ultra&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; product infringes certain of its patents.  The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued.  The Company intends to vigorously defend itself in this litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent considerations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of &lt;/span&gt;&lt;/div&gt;operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber
      contextRef="c-1"
      decimals="INF"
      id="f-1087"
      unitRef="lawsuit">1</ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c-1" id="f-1088">ACCUMULATED OTHER COMPREHENSIVE LOSS&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the activity for each component of "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain on Hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Loss on Available-for-sale Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit (expense)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax (expense) benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Loss on Available-for-sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Pension&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax (expense) benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax (expense) benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about amounts reclassified from "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.771%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected Line on Consolidated Condensed&lt;br/&gt;Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Comprehensive Loss Components&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on available-for-sale investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-1089">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the activity for each component of "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain on Hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Loss on Available-for-sale Investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit (expense)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax (expense) benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Loss on Available-for-sale Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Pension&lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax (expense) benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax (expense) benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity contextRef="c-288" decimals="-5" id="f-1090" unitRef="usd">-218800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-289" decimals="-5" id="f-1091" unitRef="usd">23800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-290" decimals="-5" id="f-1092" unitRef="usd">-65600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-291" decimals="-5" id="f-1093" unitRef="usd">5700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-14" decimals="-5" id="f-1094" unitRef="usd">-254900000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-292" decimals="-5" id="f-1095" unitRef="usd">4900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-293" decimals="-5" id="f-1096" unitRef="usd">6700000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-294" decimals="-5" id="f-1097" unitRef="usd">9000000.0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-295" decimals="-5" id="f-1098" unitRef="usd">-100000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-19" decimals="-5" id="f-1099" unitRef="usd">20500000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-292" decimals="-5" id="f-1100" unitRef="usd">1700000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-293" decimals="-5" id="f-1101" unitRef="usd">29800000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-294" decimals="-5" id="f-1102" unitRef="usd">-4000000.0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-295" decimals="-5" id="f-1103" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-19" decimals="-5" id="f-1104" unitRef="usd">27500000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-292" decimals="-5" id="f-1105" unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-293" decimals="-5" id="f-1106" unitRef="usd">-5900000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-294" decimals="-5" id="f-1107" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-295" decimals="-5" id="f-1108" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-19" decimals="-5" id="f-1109" unitRef="usd">-6500000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity contextRef="c-296" decimals="-5" id="f-1110" unitRef="usd">-215000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-297" decimals="-5" id="f-1111" unitRef="usd">6600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-298" decimals="-5" id="f-1112" unitRef="usd">-52600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-299" decimals="-5" id="f-1113" unitRef="usd">5600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-5" id="f-1114" unitRef="usd">-255400000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-300" decimals="-5" id="f-1115" unitRef="usd">-11300000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-301" decimals="-5" id="f-1116" unitRef="usd">33500000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-302" decimals="-5" id="f-1117" unitRef="usd">2100000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-303" decimals="-5" id="f-1118" unitRef="usd">200000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-36" decimals="-5" id="f-1119" unitRef="usd">24500000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-300" decimals="-5" id="f-1120" unitRef="usd">1800000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-301" decimals="-5" id="f-1121" unitRef="usd">25200000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-302" decimals="-5" id="f-1122" unitRef="usd">-3800000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-303" decimals="-5" id="f-1123" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-36" decimals="-5" id="f-1124" unitRef="usd">23200000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-300" decimals="-5" id="f-1125" unitRef="usd">-1600000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-301" decimals="-5" id="f-1126" unitRef="usd">3000000.0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-302" decimals="-5" id="f-1127" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-303" decimals="-5" id="f-1128" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-36" decimals="-5" id="f-1129" unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity contextRef="c-304" decimals="-5" id="f-1130" unitRef="usd">-226500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-305" decimals="-5" id="f-1131" unitRef="usd">11900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-306" decimals="-5" id="f-1132" unitRef="usd">-46700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-307" decimals="-5" id="f-1133" unitRef="usd">5800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-5" id="f-1134" unitRef="usd">-255500000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-308" decimals="-5" id="f-1135" unitRef="usd">-20700000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-309" decimals="-5" id="f-1136" unitRef="usd">38600000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-310" decimals="-5" id="f-1137" unitRef="usd">9400000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-311" decimals="-5" id="f-1138" unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-5" decimals="-5" id="f-1139" unitRef="usd">27300000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-308" decimals="-5" id="f-1140" unitRef="usd">1700000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-309" decimals="-5" id="f-1141" unitRef="usd">14100000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-310" decimals="-5" id="f-1142" unitRef="usd">-1200000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-311" decimals="-5" id="f-1143" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-5" decimals="-5" id="f-1144" unitRef="usd">14600000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-308" decimals="-5" id="f-1145" unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-309" decimals="-5" id="f-1146" unitRef="usd">6300000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-310" decimals="-5" id="f-1147" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-311" decimals="-5" id="f-1148" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-5" decimals="-5" id="f-1149" unitRef="usd">7300000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity contextRef="c-312" decimals="-5" id="f-1150" unitRef="usd">-249900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-313" decimals="-5" id="f-1151" unitRef="usd">30100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-314" decimals="-5" id="f-1152" unitRef="usd">-36100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-315" decimals="-5" id="f-1153" unitRef="usd">5800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-60" decimals="-5" id="f-1154" unitRef="usd">-250100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-316" decimals="-5" id="f-1155" unitRef="usd">-172500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-317" decimals="-5" id="f-1156" unitRef="usd">29700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-318" decimals="-5" id="f-1157" unitRef="usd">-6900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-319" decimals="-5" id="f-1158" unitRef="usd">-8000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-67" decimals="-5" id="f-1159" unitRef="usd">-157700000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-320" decimals="-5" id="f-1160" unitRef="usd">-7400000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-321" decimals="-5" id="f-1161" unitRef="usd">24700000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-322" decimals="-5" id="f-1162" unitRef="usd">-47600000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-323" decimals="-5" id="f-1163" unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-69" decimals="-5" id="f-1164" unitRef="usd">-30300000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-320" decimals="-5" id="f-1165" unitRef="usd">1600000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-321" decimals="-5" id="f-1166" unitRef="usd">7300000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-322" decimals="-5" id="f-1167" unitRef="usd">-4800000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-323" decimals="-5" id="f-1168" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-69" decimals="-5" id="f-1169" unitRef="usd">4100000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-320" decimals="-5" id="f-1170" unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-321" decimals="-5" id="f-1171" unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-322" decimals="-5" id="f-1172" unitRef="usd">-10500000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-323" decimals="-5" id="f-1173" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-69" decimals="-5" id="f-1174" unitRef="usd">-5500000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity contextRef="c-324" decimals="-5" id="f-1175" unitRef="usd">-182500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-325" decimals="-5" id="f-1176" unitRef="usd">43100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-326" decimals="-5" id="f-1177" unitRef="usd">-39200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-327" decimals="-5" id="f-1178" unitRef="usd">-8000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-78" decimals="-5" id="f-1179" unitRef="usd">-186600000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-328" decimals="-5" id="f-1180" unitRef="usd">-36500000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-329" decimals="-5" id="f-1181" unitRef="usd">57900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-330" decimals="-5" id="f-1182" unitRef="usd">-20900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-331" decimals="-5" id="f-1183" unitRef="usd">-100000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-81" decimals="-5" id="f-1184" unitRef="usd">400000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-328" decimals="-5" id="f-1185" unitRef="usd">2000000.0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-329" decimals="-5" id="f-1186" unitRef="usd">16300000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-330" decimals="-5" id="f-1187" unitRef="usd">-5100000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-331" decimals="-5" id="f-1188" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-81" decimals="-5" id="f-1189" unitRef="usd">13200000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-328" decimals="-5" id="f-1190" unitRef="usd">4700000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-329" decimals="-5" id="f-1191" unitRef="usd">10300000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-330" decimals="-5" id="f-1192" unitRef="usd">10000000.0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-331" decimals="-5" id="f-1193" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-81" decimals="-5" id="f-1194" unitRef="usd">25000000.0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity contextRef="c-332" decimals="-5" id="f-1195" unitRef="usd">-225700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-333" decimals="-5" id="f-1196" unitRef="usd">74400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-334" decimals="-5" id="f-1197" unitRef="usd">-65000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-335" decimals="-5" id="f-1198" unitRef="usd">-8100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-90" decimals="-5" id="f-1199" unitRef="usd">-224400000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-336" decimals="-5" id="f-1200" unitRef="usd">-35700000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-337" decimals="-5" id="f-1201" unitRef="usd">59200000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-338" decimals="-5" id="f-1202" unitRef="usd">-15100000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-339" decimals="-5" id="f-1203" unitRef="usd">-200000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="c-6" decimals="-5" id="f-1204" unitRef="usd">8200000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-336" decimals="-5" id="f-1205" unitRef="usd">1800000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-337" decimals="-5" id="f-1206" unitRef="usd">31600000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-338" decimals="-5" id="f-1207" unitRef="usd">-4700000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-339" decimals="-5" id="f-1208" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="c-6" decimals="-5" id="f-1209" unitRef="usd">28700000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-336" decimals="-5" id="f-1210" unitRef="usd">4200000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-337" decimals="-5" id="f-1211" unitRef="usd">7000000.0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-338" decimals="-5" id="f-1212" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-339" decimals="-5" id="f-1213" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="c-6" decimals="-5" id="f-1214" unitRef="usd">11100000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity contextRef="c-340" decimals="-5" id="f-1215" unitRef="usd">-267400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-341" decimals="-5" id="f-1216" unitRef="usd">95000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-342" decimals="-5" id="f-1217" unitRef="usd">-75400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-343" decimals="-5" id="f-1218" unitRef="usd">-8200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-101" decimals="-5" id="f-1219" unitRef="usd">-256000000.0</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock contextRef="c-1" id="f-1220">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about amounts reclassified from "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.771%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected Line on Consolidated Condensed&lt;br/&gt;Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Comprehensive Loss Components&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on hedges&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on available-for-sale investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-344" decimals="-5" id="f-1221" unitRef="usd">1700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-345" decimals="-5" id="f-1222" unitRef="usd">1800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-346" decimals="-5" id="f-1223" unitRef="usd">5200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-347" decimals="-5" id="f-1224" unitRef="usd">5400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-344" decimals="-5" id="f-1225" unitRef="usd">500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-345" decimals="-5" id="f-1226" unitRef="usd">400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-346" decimals="-5" id="f-1227" unitRef="usd">1300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-347" decimals="-5" id="f-1228" unitRef="usd">1300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-344" decimals="-5" id="f-1229" unitRef="usd">1200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-345" decimals="-5" id="f-1230" unitRef="usd">1400000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-346" decimals="-5" id="f-1231" unitRef="usd">3900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-347" decimals="-5" id="f-1232" unitRef="usd">4100000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-348" decimals="-5" id="f-1233" unitRef="usd">-9300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-349" decimals="-5" id="f-1234" unitRef="usd">-27100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-350" decimals="-5" id="f-1235" unitRef="usd">-53000000.0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-351" decimals="-5" id="f-1236" unitRef="usd">-50700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-348" decimals="-5" id="f-1237" unitRef="usd">4800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-349" decimals="-5" id="f-1238" unitRef="usd">4500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-350" decimals="-5" id="f-1239" unitRef="usd">16100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-351" decimals="-5" id="f-1240" unitRef="usd">4500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-348" decimals="-5" id="f-1241" unitRef="usd">14100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-349" decimals="-5" id="f-1242" unitRef="usd">31600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-350" decimals="-5" id="f-1243" unitRef="usd">69100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-351" decimals="-5" id="f-1244" unitRef="usd">55200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-348" decimals="-5" id="f-1245" unitRef="usd">2900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-349" decimals="-5" id="f-1246" unitRef="usd">7500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-350" decimals="-5" id="f-1247" unitRef="usd">14800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-351" decimals="-5" id="f-1248" unitRef="usd">13900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-348" decimals="-5" id="f-1249" unitRef="usd">11200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-349" decimals="-5" id="f-1250" unitRef="usd">24100000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-350" decimals="-5" id="f-1251" unitRef="usd">54300000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-351" decimals="-5" id="f-1252" unitRef="usd">41300000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-352" decimals="-5" id="f-1253" unitRef="usd">-1200000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-353" decimals="-5" id="f-1254" unitRef="usd">-4700000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-354" decimals="-5" id="f-1255" unitRef="usd">-9000000.0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="c-355" decimals="-5" id="f-1256" unitRef="usd">-14600000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-352" decimals="-5" id="f-1257" unitRef="usd">-400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-353" decimals="-5" id="f-1258" unitRef="usd">-1100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-354" decimals="-5" id="f-1259" unitRef="usd">-2300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-355" decimals="-5" id="f-1260" unitRef="usd">-3500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-352" decimals="-5" id="f-1261" unitRef="usd">-800000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-353" decimals="-5" id="f-1262" unitRef="usd">-3600000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-354" decimals="-5" id="f-1263" unitRef="usd">-6700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-355" decimals="-5" id="f-1264" unitRef="usd">-11100000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1265">EARNINGS PER SHARE&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Edwards Lifesciences Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,123.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Edwards Lifesciences Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,123.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 6.5 million and 4.0 million common shares for the three months ended September 30, 2023 and 2022, respectively, and 6.1&#160;million and 3.1&#160;million shares for the nine months ended September 30, 2023 and 2022, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1266">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Edwards Lifesciences Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,123.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Edwards Lifesciences Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,123.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-5" decimals="-5" id="f-1267" unitRef="usd">384900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-6" decimals="-5" id="f-1268" unitRef="usd">343500000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-5" id="f-1269" unitRef="usd">1032500000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-7" decimals="-5" id="f-1270" unitRef="usd">1123500000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-1271" unitRef="shares">607000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-1272" unitRef="shares">619800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-1273" unitRef="shares">607200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-1274" unitRef="shares">621000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-1275"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-1276"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1277"
      unitRef="usdPerShare">1.70</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-1278"
      unitRef="usdPerShare">1.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-5" decimals="-5" id="f-1279" unitRef="usd">384900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-6" decimals="-5" id="f-1280" unitRef="usd">343500000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-5" id="f-1281" unitRef="usd">1032500000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-7" decimals="-5" id="f-1282" unitRef="usd">1123500000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-1283" unitRef="shares">607000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-1284" unitRef="shares">619800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-1285" unitRef="shares">607200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-1286" unitRef="shares">621000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-5" decimals="-5" id="f-1287" unitRef="shares">2500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-6" decimals="-5" id="f-1288" unitRef="shares">4700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-5" id="f-1289" unitRef="shares">3000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-7" decimals="-5" id="f-1290" unitRef="shares">5900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-1291" unitRef="shares">609500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-1292" unitRef="shares">624500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-1293" unitRef="shares">610200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-1294" unitRef="shares">626900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-1295"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-1296"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1297"
      unitRef="usdPerShare">1.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-1298"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-356"
      decimals="-5"
      id="f-1299"
      unitRef="shares">6500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-357"
      decimals="-5"
      id="f-1300"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-358"
      decimals="-5"
      id="f-1301"
      unitRef="shares">6100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-359"
      decimals="-5"
      id="f-1302"
      unitRef="shares">3100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1303">INCOME TAXES&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's effective income tax rates were 12.7% and 15.7% for the three months ended September 30, 2023 and 2022, respectively, and 12.5% and 14.1% for the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2023 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022, respectively.  The decrease in the effective rate between the nine months ended September 30, 2023 and 2022 is primarily due &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to the impact of temporary relief provided by the Internal Revenue Service ("IRS") relating to U.S. foreign tax credit regulations.  On July 21, 2023, the IRS issued Notice 2023-55 which delayed the application of certain U.S. foreign tax credit regulations that had previously limited the Company's ability to claim credits on certain foreign taxes for tax years 2022 and 2023.  In addition, there was an increase in the benefit from the federal research and development credit and the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation.   The effective rates for the nine months ended September 30, 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective rates include a tax benefit from employee share-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;based&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; compensation of $1.9 million and $3.4 million for the three months ended September 30, 2023 and 2022, respectively, and $14.2 million and $36.7 million for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended September 30, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the IRS and other taxing authorities are in different stages of examining various years of the Company's tax filings.  During these audits the Company may receive proposed audit adjustments that could be material.  Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition.  The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time.  While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements.  Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2023 and December&#160;31, 2022, the gross liability recorded for income taxes associated with uncertain tax positions was $542.9 million and $475.3 million, respectively. The Company estimates that these liabilities would be reduced by $226.4 million and $182.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $316.5 million and $293.2 million, respectively, if not required, would favorably affect the Company's effective tax rate.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.  The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively &#x201c;Surgical/TAVR&#x201d;) intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits.  In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward.  An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021.  The execution of some or all of these APA renewals depends on many variables outside of the Company's control. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The audits of the Company&#x2019;s United States federal income tax returns through 2014 have been closed.  The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters.  The IRS began its examination of the 2018 through 2020 tax years during the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015.  While not material, the Company continues to address matters in India for years from 2010 and on. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the Company received a Notice of Proposed Adjustment (&#x201c;NOPA&#x201d;) from the IRS for the 2015-2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries.  The NOPA proposed an increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $220 million and reflects a departure from a transfer pricing method the Company had previously agreed upon with the IRS.  The Company disagreed with the NOPA and submitted a formal protest on the matter during the fourth quarter of 2021.  During the second quarter of 2022, the Company received the IRS's rebuttal to the Company's protest and was notified that the case had been transferred to the IRS Independent Office of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Appeals ("Appeals").  The opening conference was held with Appeals during March 2023 and discussions with Appeals continued into the third quarter of 2023.  While Appeals still maintains jurisdiction over the matter as of September&#160;30, 2023, the Company and Appeals have concluded that a satisfactory resolution of this matter at the administrative level is not possible.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company plans to vigorously contest the proposed adjustments through the judicial process.  Final resolution of this matter is not likely within the next 12 months.  The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOPA received or as a result of the Appeals proceedings to date.  Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements.  As noted below, similar material tax disputes may arise for the 2018-2023 tax years. While no payment of any amount related to the NOPA has yet been required, the Company made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any potential deficiency that may be ultimately sustained.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Surgical/TAVR intercompany royalty transactions covering tax years 2018-2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of September&#160;30, 2023.  The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions.  The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company&#x2019;s consolidated financial statements.  Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="3" id="f-1304" unitRef="number">0.127</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-6" decimals="3" id="f-1305" unitRef="number">0.157</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1306" unitRef="number">0.125</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-7" decimals="3" id="f-1307" unitRef="number">0.141</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-5" decimals="-5" id="f-1308" unitRef="usd">-1900000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-6" decimals="-5" id="f-1309" unitRef="usd">-3400000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-5" id="f-1310" unitRef="usd">-14200000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-7" decimals="-5" id="f-1311" unitRef="usd">-36700000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-3" decimals="-5" id="f-1312" unitRef="usd">542900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-5" id="f-1313" unitRef="usd">475300000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible contextRef="c-3" decimals="-5" id="f-1314" unitRef="usd">226400000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible contextRef="c-4" decimals="-5" id="f-1315" unitRef="usd">182100000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-3" decimals="-5" id="f-1316" unitRef="usd">316500000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-4" decimals="-5" id="f-1317" unitRef="usd">293200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <ew:NumberOfAdvancePricingAgreementsRenewed
      contextRef="c-360"
      decimals="INF"
      id="f-1318"
      unitRef="agreement">3</ew:NumberOfAdvancePricingAgreementsRenewed>
    <us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss contextRef="c-361" decimals="-6" id="f-1319" unitRef="usd">220000000</us-gaap:IncomeTaxExaminationEstimateOfPossibleLoss>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1320">SEGMENT INFORMATION&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents information about Edwards Lifesciences' reportable segments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,337.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,453.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,727.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,453.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,470.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,034.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-tax Income Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,435.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,285.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Special charge (Note&#160;4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intellectual property agreement and litigation (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated pre-tax income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Enterprise-wide Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Geographic Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,337.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,470.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,034.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Major Product Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transcatheter Aortic Valve Replacement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;960.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transcatheter Mitral and Tricuspid Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical Structural Heart&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,470.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,034.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1321">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents information about Edwards Lifesciences' reportable segments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,337.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,453.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Operating Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,727.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,453.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,470.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,034.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pre-tax Income Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,677.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,435.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,285.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Special charge (Note&#160;4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intellectual property agreement and litigation (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated pre-tax income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-362" decimals="-5" id="f-1322" unitRef="usd">869900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-363" decimals="-5" id="f-1323" unitRef="usd">786800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-364" decimals="-5" id="f-1324" unitRef="usd">2614300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-365" decimals="-5" id="f-1325" unitRef="usd">2337100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-366" decimals="-5" id="f-1326" unitRef="usd">317800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-367" decimals="-5" id="f-1327" unitRef="usd">291900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-368" decimals="-5" id="f-1328" unitRef="usd">989200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-369" decimals="-5" id="f-1329" unitRef="usd">901800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-370" decimals="-5" id="f-1330" unitRef="usd">107200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-371" decimals="-5" id="f-1331" unitRef="usd">130900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-372" decimals="-5" id="f-1332" unitRef="usd">321200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-373" decimals="-5" id="f-1333" unitRef="usd">416900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-374" decimals="-5" id="f-1334" unitRef="usd">181200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-375" decimals="-5" id="f-1335" unitRef="usd">160900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-376" decimals="-5" id="f-1336" unitRef="usd">529000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-377" decimals="-5" id="f-1337" unitRef="usd">449100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-378" decimals="-5" id="f-1338" unitRef="usd">1476100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-379" decimals="-5" id="f-1339" unitRef="usd">1370500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-380" decimals="-5" id="f-1340" unitRef="usd">4453700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-381" decimals="-5" id="f-1341" unitRef="usd">4104900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-362" decimals="-5" id="f-1342" unitRef="usd">571700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-363" decimals="-5" id="f-1343" unitRef="usd">535000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-364" decimals="-5" id="f-1344" unitRef="usd">1727500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-365" decimals="-5" id="f-1345" unitRef="usd">1596000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-366" decimals="-5" id="f-1346" unitRef="usd">168500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-367" decimals="-5" id="f-1347" unitRef="usd">156000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-368" decimals="-5" id="f-1348" unitRef="usd">527900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-369" decimals="-5" id="f-1349" unitRef="usd">487100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-370" decimals="-5" id="f-1350" unitRef="usd">63900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-371" decimals="-5" id="f-1351" unitRef="usd">87300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-372" decimals="-5" id="f-1352" unitRef="usd">190700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-373" decimals="-5" id="f-1353" unitRef="usd">282700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-374" decimals="-5" id="f-1354" unitRef="usd">80300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-375" decimals="-5" id="f-1355" unitRef="usd">63700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-376" decimals="-5" id="f-1356" unitRef="usd">230900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-377" decimals="-5" id="f-1357" unitRef="usd">178000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-378" decimals="-5" id="f-1358" unitRef="usd">884400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-379" decimals="-5" id="f-1359" unitRef="usd">842000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-380" decimals="-5" id="f-1360" unitRef="usd">2677000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-381" decimals="-5" id="f-1361" unitRef="usd">2543800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-378" decimals="-5" id="f-1362" unitRef="usd">1476100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-379" decimals="-5" id="f-1363" unitRef="usd">1370500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-380" decimals="-5" id="f-1364" unitRef="usd">4453700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-381" decimals="-5" id="f-1365" unitRef="usd">4104900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-382" decimals="-5" id="f-1366" unitRef="usd">4800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-383" decimals="-5" id="f-1367" unitRef="usd">-51500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-384" decimals="-5" id="f-1368" unitRef="usd">17000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-385" decimals="-5" id="f-1369" unitRef="usd">-70800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1370" unitRef="usd">1480900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-1371" unitRef="usd">1319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1372" unitRef="usd">4470700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-1373" unitRef="usd">4034100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-378" decimals="-5" id="f-1374" unitRef="usd">884400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-379" decimals="-5" id="f-1375" unitRef="usd">842000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-380" decimals="-5" id="f-1376" unitRef="usd">2677000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-381" decimals="-5" id="f-1377" unitRef="usd">2543800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:CostsAndExpenses contextRef="c-386" decimals="-5" id="f-1378" unitRef="usd">473900000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-387" decimals="-5" id="f-1379" unitRef="usd">415600000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-388" decimals="-5" id="f-1380" unitRef="usd">1435200000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-389" decimals="-5" id="f-1381" unitRef="usd">1285400000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-382" decimals="-5" id="f-1382" unitRef="usd">0</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-383" decimals="-5" id="f-1383" unitRef="usd">66800000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-384" decimals="-5" id="f-1384" unitRef="usd">0</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense contextRef="c-385" decimals="-5" id="f-1385" unitRef="usd">66800000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-382" decimals="-5" id="f-1386" unitRef="usd">2200000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-383" decimals="-5" id="f-1387" unitRef="usd">-2400000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-384" decimals="-5" id="f-1388" unitRef="usd">193600000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense contextRef="c-385" decimals="-5" id="f-1389" unitRef="usd">10800000</us-gaap:LitigationSettlementExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-5" decimals="-5" id="f-1390" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-6" decimals="-5" id="f-1391" unitRef="usd">-12500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-1" decimals="-5" id="f-1392" unitRef="usd">-26200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="c-7" decimals="-5" id="f-1393" unitRef="usd">-36300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-382" decimals="-5" id="f-1394" unitRef="usd">10100000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-383" decimals="-5" id="f-1395" unitRef="usd">27900000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-384" decimals="-5" id="f-1396" unitRef="usd">59600000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-385" decimals="-5" id="f-1397" unitRef="usd">83600000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-1398" unitRef="usd">418400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-1399" unitRef="usd">402400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-1400" unitRef="usd">1134000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-5" id="f-1401" unitRef="usd">1300700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-382" decimals="-5" id="f-1402" unitRef="usd">20900000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-383" decimals="-5" id="f-1403" unitRef="usd">4900000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-384" decimals="-5" id="f-1404" unitRef="usd">42400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-385" decimals="-5" id="f-1405" unitRef="usd">7400000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-1406" unitRef="usd">439300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-1407" unitRef="usd">407300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-1408" unitRef="usd">1176400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-1409" unitRef="usd">1308100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="c-1" id="f-1410">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Geographic Region&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;786.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,614.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,337.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;884.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,470.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,034.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales by Major Product Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transcatheter Aortic Valve Replacement&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;960.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transcatheter Mitral and Tricuspid Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical Structural Heart&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;630.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,470.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,034.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-390" decimals="-5" id="f-1411" unitRef="usd">869900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-391" decimals="-5" id="f-1412" unitRef="usd">786800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-392" decimals="-5" id="f-1413" unitRef="usd">2614300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-393" decimals="-5" id="f-1414" unitRef="usd">2337100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-394" decimals="-5" id="f-1415" unitRef="usd">322300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-395" decimals="-5" id="f-1416" unitRef="usd">270100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-396" decimals="-5" id="f-1417" unitRef="usd">989600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-397" decimals="-5" id="f-1418" unitRef="usd">884000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-398" decimals="-5" id="f-1419" unitRef="usd">108400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-399" decimals="-5" id="f-1420" unitRef="usd">104100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-400" decimals="-5" id="f-1421" unitRef="usd">340400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-401" decimals="-5" id="f-1422" unitRef="usd">362500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-402" decimals="-5" id="f-1423" unitRef="usd">180300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-403" decimals="-5" id="f-1424" unitRef="usd">158000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-404" decimals="-5" id="f-1425" unitRef="usd">526400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-405" decimals="-5" id="f-1426" unitRef="usd">450500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1427" unitRef="usd">1480900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-1428" unitRef="usd">1319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1429" unitRef="usd">4470700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-1430" unitRef="usd">4034100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-406" decimals="-5" id="f-1431" unitRef="usd">960900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-407" decimals="-5" id="f-1432" unitRef="usd">862300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-408" decimals="-5" id="f-1433" unitRef="usd">2900400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-409" decimals="-5" id="f-1434" unitRef="usd">2650500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-410" decimals="-5" id="f-1435" unitRef="usd">52400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-411" decimals="-5" id="f-1436" unitRef="usd">29700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-412" decimals="-5" id="f-1437" unitRef="usd">141600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-413" decimals="-5" id="f-1438" unitRef="usd">84600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-414" decimals="-5" id="f-1439" unitRef="usd">246600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-415" decimals="-5" id="f-1440" unitRef="usd">219700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-416" decimals="-5" id="f-1441" unitRef="usd">751100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-417" decimals="-5" id="f-1442" unitRef="usd">669000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-418" decimals="-5" id="f-1443" unitRef="usd">221000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-419" decimals="-5" id="f-1444" unitRef="usd">207300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-420" decimals="-5" id="f-1445" unitRef="usd">677600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-421" decimals="-5" id="f-1446" unitRef="usd">630000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-1447" unitRef="usd">1480900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-5" id="f-1448" unitRef="usd">1319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1449" unitRef="usd">4470700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-1450" unitRef="usd">4034100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-5" id="f-1451">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-1452">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-1453">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-422" id="f-1454">On August 31, 2023, Jean-Luc Lemercier, Corporate Vice President of EMEA, Canada, Latin America, and JAPAC, entered into a 10b5-1 trading plan (the &#x201c;Plan&#x201d;) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the potential sale of 43,200 shares of the Company&#x2019;s stock commencing March 11, 2024.  The Plan terminates on the earlier of May 10, 2024 or the date all shares are sold.</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-423" id="f-1455">August 31, 2023</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-423" id="f-1456">Jean-Luc Lemercier</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-423" id="f-1457">Corporate Vice President of EMEA, Canada, Latin America, and JAPAC</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-423" id="f-1458">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-424"
      decimals="INF"
      id="f-1459"
      unitRef="shares">43200</ecd:TrdArrSecuritiesAggAvailAmt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>95
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( "6&6U<'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  EAEM7Y/ LT>\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M:L,P#(=?9?B>*''V#Y/ZLM+3!H,5-G8SMMJ:Q8FQ-9*^_1RO31G; ^QHZ>=/
MGT"M]D(/ 9_#X#&0Q7@UN:Z/0OL5.Q!Y 1#U 9V*94KTJ;D;@E.4GF$/7ND/
MM4?@574+#DD910IF8.$7(I.MT4('5#2$$][H!>\_0Y=A1@-VZ+"G"'59 Y/S
M1'^<NA8N@!E&&%S\+J!9B+GZ)S9W@)V24[1+:AS'<FQR+NU0P]O3XTM>M[!]
M)-5K3+^B%73TN&+GR:_-PWJ[89)7O"GJJN!W6UZ)ZWMQ4[_/KC_\+L)N,'9G
M_['Q65"V\.LNY!=02P,$%     @ )89;5YE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MN?XB7W\3K4.AF2^5>57_1J^M;3!"Z;;2LF@' X(B*YN__'L;B-X S 8&D'8
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MTH&"QSP*A2SC%$=\'NFX@3@KHS-"HU.UVQQ2JQ6<"K(7'<K:"<?'8,QKASK
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M+=/BXT;PI5#& +Y?21B/ZL+\P.&5G-F_4$L#!!0    ( "6&6U<&U6LINA,
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MH!$$OZAJ99X%U;/"=\CM^G(M_6IE5(E:$=GY(.DE1/KH$)0]\"<XU_R9SY4
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MH'EZCOT_',K_P;-YX*P2-CO.!*<UOP!."JQ=TRK[S'>XT'QV0 [P21-H"L#
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M?7J3 $Z; Z%Z18:#N>MP ,'K9C)'>Y.Y34AW0BETSUWSK92R.7X7CBOPWD[
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M<X$?.>3X LYG%I73+EA!][/IZ#]02P,$%     @ )89;5V8'/7\)"P  XAX
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MR:H[4]Q1',BLRC6\8(YP0$=$:TAKU_2Z51G8<L<T/E<E\%? !6556?-=HX"
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M$ZT:1X/:XU.K4RR5I"%#:$DHF=IFVQ[/L6GRS#4<<N"V)E,Y7]LLY%WH43&
MPD ZW";(_,\Z1*.FXSHNTXX</83GF"YNTG3Q@=-%JLZ%@2W3Y,K])^ 2J+6^
M:%7!O1LXH1AQ3S8*HJ<4">(D$N2WFMI1ZM&\R6Z!*D,QH=P)JLO:UT &A[Y
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M+E!"*TL+\'YFD#OC@ YH/VM?_1]02P,$%     @ )89;5\W6N/-Z"P  DRH
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M9_(01W28F,]=&I# %)Y<D5/&,5P8SN/P:N(Z 96;8U*K@XJ[R-SYVO/C#LM
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M;?L'Y3K\.'@F#[]?/J-U*02OD#.PQM'IL(,"Z']IA(73M?^-,-7.Z=(_+J1
MQV4"[,^T=IL%*VC_*UW]!U!+ P04    "  EAEM78P0:W><$   $"P  &0
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;)5776\;-Q#\*\0%2%-
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M7DWI?D/ .DT:!+EER&-^ LL>H"ND?N R-0&_ND%@^=MI:?EHUWV2EK[C6-Z
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MCQIS^38?JE[H"^^T5K@^Z]>Y2#+1\ #TS^I:=1^\P.H?D(-_ %!+ P04
M"  EAEM7]AD%&>P#  #M"0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6S-5E&/XC80_BNC]%2UTEX2$F"! A*[M^V=U%LAN/8>JCZ89"#6.G;.=F#Y
M]QT[D.5N@?;>^A([]LPWWXQGQA[OE'XR!:*%YU)(,PD*:ZM1%)FLP)*94%4H
M:6>M=,DL_>I-9"J-+/=*I8B2..Y')>,RF([]VEQ/QZJV@DN<:S!U63*]OT.A
M=I.@$QP7%GQ36+<03<<5V^ 2[1_57--?U*+DO$1IN)*@<3T)9IW17=?)>X$_
M.>[,R1R<)RNEGMS/AWP2Q(X0"LRL0V T;/$>A7! 1./+ 3-H33K%T_D1_5?O
M._FR8@;OE?C,<UM,@D$ .:Y9+>Q"[=[CP9^>P\N4,/X+NT8VC0/(:F-5>5 F
M!B67S<B>#W$X41A<4D@."HGGW1CR+-\QRZ9CK7:@G32AN8EWU6L3.2[=H2RM
MIEU.>G;Z,%L\?GC\;0GSAP4LW\\6#^/($J[;C;(#QEV#D5S &,)')6UAX$'F
MF'^M'Q&?EE1R)'677 5<8A5"&M] $B?I%;RT=3+U>.DE)YF67&X,S%'#LF :
MX:_9REA-.?'W.7\;N.YY.%<G(U.Q#"<!%8)!O<5@^N,/G7[\RQ6RW99L]QKZ
M?SR1JQCG&;X&ACMF> 9X#$]%X3$^/-Q ILJJMIC#:@\YW_*<1$!2F^"2MM M
MVP)AY_,>\[=LBYK*V.F55&X>QP#U 6.9],IYK=W@M,@25WD([[CP-OZ- M5=
M#H3ZG18K41NO@^LUM0%0:W*%+%(C@$I9E)8S\3V,(6,BJP5SI&ISW+/4#DVM
M]T#EFCU!B;9HG;MFBB(IZIS8E950>Z3)EYK;_2$ JG)]R]R 5'*+QIEL]&Z
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MG0#MKQ75^>''&6A?>--_ %!+ P04    "  EAEM7;3_*+ML-   Z)0  &0
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MQ+%LA U&F";%#8>C3)":6&*,._:;*L*TVHB"^[&/!KTA,JT9=J994]R\[W4
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M;GAN2!<;H6D!WB\4*+1]H .ZK[:G_P902P,$%     @ )89;5YITL06  @
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M! \K:X#O9Q+/H4W##E!_MAG\!U!+ P04    "  EAEM7:;9*6<T%   9#@
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M1_L#F'^QJG:'GKFR.$*YQQ7.K$*3 +XOE+(O+^2@/06/_@502P,$%     @
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M-G0A88IXU7;(,'!&C;)NWPE.R6#D1,0+!LY@O1 YWBG,>;!R#2:9\RF-G\'
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MJOQRGQM&+MR%>B(-7<_=:T+_0ZCL /H^D])L##M!^8<U^!]02P,$%     @
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M0WXDA]3\G]09XE@*"O8K++IQBD)0&QI]HO/G*'3M?7-K5H >P,F4SW@F(L2
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MN^-;[N^][M!E*EMU8JJONG2+PT$V8*6:R57EKLSZH^KU\0 +4[7^GZW[L\&
M%:O6F65/# 1+77=?>=W;X3D$HB<0'G<GR*/\0SIY=&#-FEDZ#6XT\*IZ:H#3
M-3EE["QV->C<T?CTP_GIQ82=7;S_='5^/#G[=,%V)G):J7;W8.0@@<Z-BI[;
MNXZ;>(1;SLY-[18M.ZU+56[3CX!L T_<PGLGGF0X5LV0A<$>$X$(G^ 7;M0-
M/;_P47YS1)1C5ZHQUNEZSOX^GK;.(CC^>4C=CEOT,#=*F/VVD84Z'" C6F6_
MJ\'1JQ<\"=X^@37:8(V>XGXT1@*6JTHQ,V-G=9=_/I"G2*Y> W(4ZY5JF:Q+
MK!>F+G2EN\.@O=7Y BD^EG"L/W=IU9N)O ;GPBS50[H_B>YAW2<+Q3I,4TIW
MYG<(F;Z'_[1<2UNV["\]4VVA55VH]C72?*-5>ZO5CJX1^54%VG9WGTT65JFM
M.&,7P+:]0N%"?^+.Z+X=/M?:X?#828?92Y8E^3#'-\V288:OV$MX- S]* S3
M(6>G*XMZR$*>XH#(.8[G63X4+ \X5OZ4C:P9#U*L\## ;B@XQA%/,+Y2K2.'
M?#6V*AG/: >Q@IU8Y,. 15$.$1/C9'6K/:L!MO5@7S*^%Z4)3M H3(-AC%&T
M%\7A,/4C'D3@=:OFIT99Z4.\<_$];>.4>\(XC"&<F*8B]4SY7IPG6.NUY4F&
M91[34HPC.8LR,D:G;1)B ?.0\3P 0Y$)_&_KF@783@BG\%;A:09>VYJ:#5[=
MX84_LF@8T3<2'B'\D:;]*(Y"&/S1@+-;:= 2E/LF=8;A5&LJ74HRS8\=RI!'
M@?U,!J%O'%*IW_Y=\?HC3G_*Z?$OQP8:&=I4C<9B+3+NAD6PX4[,A_$N? ++
M[H TVV4G#UO%B\D"GR,0PW/O"XA)@UY,$$8 <=D;I ^\1^#_DL,_U[*J3.&!
MR:59P=?[@&M1-K#&$.%+5(PH15#NXLOC88(O8"/(A1^)+!Y&NVS<J$(C_(J%
MM',X[<* '.NO7F2"B[=L)TG($C]-SVJ'"P1N%"N0-I0=UMTP.8>+O4X4-Y5V
M>MZINJ.N<7MJU6ZOXIXWYHX@* *:[O \[ !V9E_(&E@0/S.I+?LNJY6O_C ?
MV8D$4.#ITAL._&'2J29Y<,XM4B[@?)&@MH0)LNZ>RR&*,Y_%<3Y,6 8 V_Z^
MYY>(9\ :!828[W&X."#W!^3T"U._N4<@*$0HWB(B2?$[>2)?$#=A[JML%*3^
M"R$(YJB+LB #WB?::;QII_&SV^DIW&@;JUOU!K<K=;>]/M0)GV3\>"><&83J
MFNRB?LA;D[R[[5"W_EH)N_L[*@76K/>9NBZZB+"^9*_H%(+#@?>)6:+XWKQN
MMTL1)B4%7,EFNI:UC_"6"KYOI</?48RF-^R#,G,KFX4ND-MS4N+7.ZD06!8I
M!25UTL37@&#322GRJ'9Q%D8!QF%"X?US)Z7VPN/,]R<*G"@.^D;VG'*UI=NY
M_-=85#!3K@K'/EBS:MC$RKI%S5DHN)$=T\VQ8%]D]9UJ6U/!]3[Y7[(\Z:1E
MB>B5S8/ !S(,X#%MLSK7N'I6OFI,K,9UO]$E]308EU(ZIO3!U2!E/.)DF@A_
MXY6=ZP)4B$% 7!&#CTI:QT248%]P(DA1U#E+$M+YQ*)"$,6)M$A.W$@".)52
MC:IK@L8<]!> YUCKH50<W7F +!7J*3VS*#11G[NWR&9U\Y([[AXP/XYWS\!S
ME&.-AEVI&4@A&LEGNZ=5-W&F\<^9J7%X'/GA J]19>D ]F<&E;R?D(#-^_;H
M?U!+ P04    "  EAEM7VLY6_]@"  "Z!P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6RME6]OFS 0QK^*Q:JIE38@_,VZ!"E-4C52FU8A6U^[<$FL
M&LQL)^F^_6R@B#0DVJ2] =O<<_R>PYP'>\9?Q09 HK>,YF)H;*0LKBU+)!O(
ML#!9 ;EZLF(\PU)-^=H2!0><EJ*,6HYM!U:&26Y$@W+MB4<#MI64Y/#$D=AF
M&>:_;X"R_=#H&>\+"[+>2+U@18,"KR$&^:-XXFIF-5E2DD$N",L1A]70&/6N
MQZ&.+P-^$MB+UAAI)R^,O>K)+!T:M@8""HG4&;"Z[6 ,E.I$"N-7G=-H7JF%
M[?%[]MO2N_+R@@6,&7TFJ=P,C;Z!4ECA+94+MK^#VH^O\R6,BO**]G6L;:!D
M*R3+:K$BR$A>W?%;78>6H.>=$#BUP/E;@5L+W-)H15;:FF")HP%G>\1UM,JF
M!V5M2K5R0W+]%6/)U5.B=#)Z7-Y-%VC\.(\?[V>3T7(Z0;>S^6@^GHWN4;Q4
M"P_3^1)-ILO1[#Y&7U&L]E&ZI8#8"LWR'>22<0("74Y 8D+%E8KY$4_0Y<45
MND D1P^$4O7!Q,"2BE>_U4IJMIN*S3G!%D-A(M?^@AS;<3ODX_/R"21*WBOE
MSJ'<4E5J2N4TI7+*?.Z)?"VW75XJL=<MUC_CM2AP D-#_6T"^ Z,Z/.G7F!_
M[W+VGY(=^'0;G^ZY[-$"[]4.D\ )IIU.*WE0RG67V$6.[9G?!M:N;>$XJN<'
MIM=$';!Y#9MWENU9]02]J0K.$A"==%6"?IO.<<WP ]UQ5"\,3]'Y#9U_ENZ6
MY$3]BJG&2[>)[.3SC]X<V*[9_\!W'.5[O9:+ [Z@X0O.\BV9Q%25[^P^#HXK
M8[M.JS05X'%8/_1-OQLP; ##?RM@&Q9M@*9(M?Y$=1.RSM59(KL,A,<;SW-:
M9!5_1Y33-X,/_%:KL^I3[0'S-<D%HK!2.ML,U7?BU4E1320KRF;[PJ1JW>5P
MHPY7X#I /5\Q)M\GNG\WQW7T!U!+ P04    "  EAEM7L*J'MSD$   M#@
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M@U)8X0U5"[Z[ANI IX8OX53:?[0K;?M]!R4;J7A>@;6"G+"RQ4^5(QJ ,#P
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M78_:.!B%_XJ5K:I6ZI+82?B8 E(+K3H74XU*.WMMB &K2<S:#G3VUZ^=9))
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MT)@-;F"6P]I$(G_8@Z>874046&84: XI%_C-J,8!'7_40Z<@V7/]ZG.^-ZH
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MS=(^3JA=@ETOE**]XP:F?>[2OU!+ P04    "  EAEM7V_50)HT%  #'(
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MOYPFEK$ 6;:0F5D0\7J!GAA1'Q[H%F)8$Y_(XS;>VK+/Y6U2;&%2S#,D5NO
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M+8Y5\/!H>L_\&#H(!Z+'A^H@G)2.47E3TP0ZQG$=9 C #7J'?B_89-2R:N?
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M8IID'SA31']BRBPEB4#@+#TL0K^K'0CT3/":4**^H8\/H#"A\I-&+\-H:[2
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M:BWR@]I=[+N.D6EV-[Y)0S=MUES1OQ J&T#S"RG-OF.OV^+OJOL'4$L#!!0
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M-XZTH?@J^4SPP)7B47*Y)!CFK3O _07GZJ6AOSSD7YH&_P)02P,$%     @
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MMR014[_@D&$M RQWC),X"Q8CB,,D_4<O62(* 7:W)L#. NQJ0*\FP,D"G&J
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M$B">KPCAIQO907[4/?D74$L#!!0    ( "6&6U=;E&S7&04  ,DC   9
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MCN!L (7)! O>AE"NY&X(Y8GW603U2VHQ!E#6Q(1][.Y]["I]'- 5+4OFQBZ
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M=_#E"6?;XB7S ^.<Q<7AA@8KFN8 N+]FC+^<Y /4_PDQ_Q]02P,$%     @
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MI^7ENVQP4JC;Y9)P<5=5CQL$$T0E0+Q?$<(/#9F@_@ED_"]02P,$%     @
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M9=49NNI"BD-Y2.Q>2"F2\N.>AUN>%0;J^P<AY/-%T4!SDG'Y/U!+ P04
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MHUGU<4?PFA0"P+_?4-Z/-!=B@/8UI.6_4$L#!!0    ( "6&6U>R,BK_K04
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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M>^<V?QP_/LO.-OU;/AO_OGG^ E!+ 0(4 Q0    ( "6&6U<'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ )89;5^3P+-'O    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ )89;5YE<G",0!@  G"<  !,
M     ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  EAEM7
MD_+B%\H%  "Q'@  &               @($."   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ )89;5P*]7\WX!P  /"(  !@
M     ("!#@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M "6&6U>GB&C$4P,  !0+   8              " @3P6  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    "  EAEM7,#PJON,&  #_'0  &
M            @('%&0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ )89;5SI@Q(*G!   V!$  !@              ("!WB   'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( "6&6U=2E-@*" @  )XC
M   8              " @;LE  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    "  EAEM7!M5K*;H3  !S]@  &               @('Y+0
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ )89;5XY&$8I
M!@  WPX  !@              ("!Z4$  'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( "6&6U? 2GAQHP4  (\,   8              "
M@5](  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    "  EAEM7
MOQ=E-84$  ":"@  &0              @($X3@  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( "6&6U<T7JFV40,  #4'   9
M      " @?12  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ )89;5UN=.I[V"0  W1H  !D              ("!?%8  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  EAEM7'=ME6%T&  #%$P
M&0              @(&I8   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( "6&6U?,,.8[G 4  $(-   9              " @3UG  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ )89;5V8'/7\)
M"P  XAX  !D              ("!$&T  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    "  EAEM7S=:X\WH+  "3*@  &0
M@(%0>   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( "6&
M6U>_=3%VM@8  &,2   9              " @0&$  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ )89;5V,$&MWG!   ! L  !D
M         ("![HH  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    "  EAEM7.FL/35(&  "+#0  &0              @($,D   >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( "6&6U==FGPJ)08   T1
M   9              " @966  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ )89;5_89!1GL P  [0D  !D              ("!\9P
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    "  EAEM7;3_*
M+ML-   Z)0  &0              @($4H0  >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( "6&6U<V-AK;Q0@  ,$5   9
M  " @2:O  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
M)89;5YITL06  @  P <  !D              ("!(K@  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    "  EAEM7;9578G $  #"$0  &0
M            @('9N@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( "6&6U=IMDI9S04  !D.   9              " @8"_  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ )89;5]N1G\^<!0
M$0\  !D              ("!A,4  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    "  EAEM77)>Z(Y\&   _$P  &0              @(%7
MRP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( "6&6U?\
M[59^I@,   D(   9              " @2W2  !X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ )89;5YYE]I^[!   ;0T  !D
M     ("!"M8  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "6&6U=L-%N)-@,  +T'   9              "
M@>[Q  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ )89;
M5R-]P\0G!@  ZPX  !D              ("!6_4  'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    "  EAEM7VLY6_]@"  "Z!P  &0
M        @(&Y^P  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0
M   ( "6&6U>PJH>W.00  "T.   9              " @<C^  !X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ )89;5[0]!!R( P  -PH
M !D              ("!. ,! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q0
M2P$"% ,4    "  EAEM7X!7:AD\#  !."P  &0              @('W!@$
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( "6&6U=6D4L?
M1P0  *L9   9              " @7T* 0!X;"]W;W)K<VAE971S+W-H965T
M-#$N>&UL4$L! A0#%     @ )89;5PO3R2G! @  ZP@  !D
M ("!^PX! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    "  E
MAEM7]E^9]'4%  #G'@  &0              @('S$0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( "6&6U=90LQX/00    8   9
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M970T."YX;6Q02P$"% ,4    "  EAEM7\@K6;$T"  #Z!   &0
M    @(%H,@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    (
M "6&6U?;]5 FC04  ,<@   9              " @>PT 0!X;"]W;W)K<VAE
M971S+W-H965T-3 N>&UL4$L! A0#%     @ )89;5R<,/DRX @  HP@  !D
M             ("!L#H! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"
M% ,4    "  EAEM7ESWX;6L*  "97@  &0              @(&?/0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( "6&6U<LT(01X ,
M / /   9              " @4%( 0!X;"]W;W)K<VAE971S+W-H965T-3,N
M>&UL4$L! A0#%     @ )89;5TJ*;"K\ @  :0D  !D              ("!
M6$P! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    "  EAEM7
M25<"WMT#   S$   &0              @(&+3P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4U+GAM;%!+ 0(4 Q0    ( "6&6U<>22DUU00  '4:   9
M      " @9]3 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%
M  @ )89;5WW'EQ>K!    !@  !D              ("!JU@! 'AL+W=O<FMS
M:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    "  EAEM7(QWU:YD%  #F(0
M&0              @(&-70$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+
M 0(4 Q0    ( "6&6U?12XH&W 4  ,PB   9              " @5UC 0!X
M;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ )89;5V RL?51
M!   Z!8  !D              ("!<&D! 'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6Q02P$"% ,4    "  EAEM7,6#V#Q$%  #U&0  &0
M@('X;0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( "6&
M6U?_^*A<Q 0  /86   9              " @4!S 0!X;"]W;W)K<VAE971S
M+W-H965T-C(N>&UL4$L! A0#%     @ )89;5UN4;-<9!0  R2,  !D
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M=#8W+GAM;%!+ 0(4 Q0    ( "6&6U>$S@7EU@(  ),)   9
M  " @6^4 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @
M)89;5UX72:*Y!   ;Q@  !D              ("!?)<! 'AL+W=O<FMS:&5E
M=',O<VAE970V.2YX;6Q02P$"% ,4    "  EAEM7Z#*3#[$%  #5*   &0
M            @(%LG $ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4
M Q0    ( "6&6U<D"HBA/08  )(D   9              " @52B 0!X;"]W
M;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ )89;5[(R*O^M!0
M7"@  !D              ("!R*@! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX
M;6Q02P$"% ,4    "  EAEM7,5\P8TD#   F%   #0              @ &L
MK@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( "6&6U>7BKL<P    !,"   +
M              "  2"R 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( "6&6U=N
M)UQ_>04  , O   /              "  0FS 0!X;"]W;W)K8F]O:RYX;6Q0
M2P$"% ,4    "  EAEM7K&U05SP"  "O*@  &@              @ &ON $
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  EAEM70&L7
MN@ "  #&*0  $P              @ $CNP$ 6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     4 !0 .<5  !4O0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>424</ContextCount>
  <ElementCount>367</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>79</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - COVER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/COVER</Role>
      <ShortName>COVER</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED CONDENSED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET</Role>
      <ShortName>INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - SPECIAL CHARGE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SPECIALCHARGE</Role>
      <ShortName>SPECIAL CHARGE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTS</Role>
      <ShortName>INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES</Role>
      <ShortName>INVESTMENTS IN VARIABLE INTEREST ENTITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - BUSINESS COMBINATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/BUSINESSCOMBINATION</Role>
      <ShortName>BUSINESS COMBINATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - ACCELERATED SHARE REPURCHASE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/BASISOFPRESENTATIONPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSTables</Role>
      <ShortName>INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/INVESTMENTS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - BUSINESS COMBINATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/BUSINESSCOMBINATIONTables</Role>
      <ShortName>BUSINESS COMBINATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/BUSINESSCOMBINATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.edwards.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails</Role>
      <ShortName>INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - SPECIAL CHARGE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SPECIALCHARGEDetails</Role>
      <ShortName>SPECIAL CHARGE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/SPECIALCHARGE</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Investments in Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - INVESTMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSNarrativeDetails</Role>
      <ShortName>INVESTMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails</Role>
      <ShortName>INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - BUSINESS COMBINATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails</Role>
      <ShortName>BUSINESS COMBINATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - BUSINESS COMBINATION - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>BUSINESS COMBINATION - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - ACCELERATED SHARE REPURCHASE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails</Role>
      <ShortName>ACCELERATED SHARE REPURCHASE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails</Role>
      <ShortName>EARNINGS PER SHARE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.edwards.com/role/INCOMETAXES</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ew-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails</Role>
      <ShortName>SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="ew-20230930.htm">ew-20230930.htm</File>
    <File>ew-20230930.xsd</File>
    <File>ew-20230930_cal.xml</File>
    <File>ew-20230930_def.xml</File>
    <File>ew-20230930_lab.xml</File>
    <File>ew-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ew-20230930_g1.jpg</File>
    <File>ew-20230930_g10.jpg</File>
    <File>ew-20230930_g11.jpg</File>
    <File>ew-20230930_g12.jpg</File>
    <File>ew-20230930_g2.jpg</File>
    <File>ew-20230930_g3.jpg</File>
    <File>ew-20230930_g4.jpg</File>
    <File>ew-20230930_g5.jpg</File>
    <File>ew-20230930_g6.jpg</File>
    <File>ew-20230930_g7.jpg</File>
    <File>ew-20230930_g8.jpg</File>
    <File>ew-20230930_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1380">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>101
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ew-20230930.htm": {
   "nsprefix": "ew",
   "nsuri": "http://www.edwards.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "ew-20230930.htm"
     ]
    },
    "schema": {
     "local": [
      "ew-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ew-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ew-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ew-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ew-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 341,
   "keyCustom": 26,
   "axisStandard": 30,
   "axisCustom": 0,
   "memberStandard": 52,
   "memberCustom": 25,
   "hidden": {
    "total": 10,
    "http://xbrl.sec.gov/ecd/2023": 1,
    "http://xbrl.sec.gov/dei/2023": 5,
    "http://fasb.org/us-gaap/2023": 4
   },
   "contextCount": 424,
   "entityCount": 1,
   "segmentCount": 79,
   "elementCount": 693,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1380,
    "http://xbrl.sec.gov/ecd/2023": 10,
    "http://xbrl.sec.gov/dei/2023": 29
   },
   "report": {
    "R1": {
     "role": "http://www.edwards.com/role/COVER",
     "longName": "0000001 - Document - COVER",
     "shortName": "COVER",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
     "longName": "0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS",
     "shortName": "CONSOLIDATED CONDENSED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical",
     "longName": "0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
     "longName": "0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "longName": "0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
     "longName": "0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "longName": "0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-63",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-69",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.edwards.com/role/BASISOFPRESENTATION",
     "longName": "0000008 - Disclosure - BASIS OF PRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS",
     "longName": "0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET",
     "longName": "0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET",
     "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.edwards.com/role/SPECIALCHARGE",
     "longName": "0000011 - Disclosure - SPECIAL CHARGE",
     "shortName": "SPECIAL CHARGE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.edwards.com/role/INVESTMENTS",
     "longName": "0000012 - Disclosure - INVESTMENTS",
     "shortName": "INVESTMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES",
     "longName": "0000013 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES",
     "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.edwards.com/role/BUSINESSCOMBINATION",
     "longName": "0000014 - Disclosure - BUSINESS COMBINATION",
     "shortName": "BUSINESS COMBINATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS",
     "longName": "0000015 - Disclosure - FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES",
     "longName": "0000016 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATION",
     "longName": "0000017 - Disclosure - STOCK-BASED COMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE",
     "longName": "0000018 - Disclosure - ACCELERATED SHARE REPURCHASE",
     "shortName": "ACCELERATED SHARE REPURCHASE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES",
     "longName": "0000019 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS",
     "longName": "0000020 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.edwards.com/role/EARNINGSPERSHARE",
     "longName": "0000021 - Disclosure - EARNINGS PER SHARE",
     "shortName": "EARNINGS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.edwards.com/role/INCOMETAXES",
     "longName": "0000022 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATION",
     "longName": "0000023 - Disclosure - SEGMENT INFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R25": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies",
     "longName": "9954471 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables",
     "longName": "9954472 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.edwards.com/role/INVESTMENTSTables",
     "longName": "9954473 - Disclosure - INVESTMENTS (Tables)",
     "shortName": "INVESTMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONTables",
     "longName": "9954474 - Disclosure - BUSINESS COMBINATION (Tables)",
     "shortName": "BUSINESS COMBINATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables",
     "longName": "9954475 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables",
     "longName": "9954476 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables",
     "longName": "9954477 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables",
     "longName": "9954478 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables)",
     "shortName": "ACCELERATED SHARE REPURCHASE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables",
     "longName": "9954479 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.edwards.com/role/EARNINGSPERSHARETables",
     "longName": "9954480 - Disclosure - EARNINGS PER SHARE (Tables)",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATIONTables",
     "longName": "9954481 - Disclosure - SEGMENT INFORMATION (Tables)",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails",
     "longName": "9954482 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Inventories (Details)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails",
     "longName": "9954483 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Accrued and Other Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails",
     "longName": "9954484 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Supplemental Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxesPaid",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxesPaid",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "longName": "9954485 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RestrictedCashCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails",
     "longName": "9954486 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET (Details)",
     "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-102",
      "name": "ew:IntellectualPropertyAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-102",
      "name": "ew:IntellectualPropertyAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.edwards.com/role/SPECIALCHARGEDetails",
     "longName": "9954487 - Disclosure - SPECIAL CHARGE (Details)",
     "shortName": "SPECIAL CHARGE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails",
     "longName": "9954488 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)",
     "shortName": "INVESTMENTS - Schedule of Investments in Debt Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:HeldToMaturitySecuritiesFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails",
     "longName": "9954489 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)",
     "shortName": "INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
     "longName": "9954490 - Disclosure - INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)",
     "shortName": "INVESTMENTS - Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails",
     "longName": "9954491 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)",
     "shortName": "INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
     "longName": "9954492 - Disclosure - INVESTMENTS - Narrative (Details)",
     "shortName": "INVESTMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-122",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails",
     "longName": "9954493 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)",
     "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherPaymentsToAcquireBusinesses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-126",
      "name": "ew:EquitySecuritiesFVNIMaximumSecuredPromissoryNote",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
     "longName": "9954494 - Disclosure - BUSINESS COMBINATION - Narrative (Details)",
     "shortName": "BUSINESS COMBINATION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-139",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-139",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
     "longName": "9954495 - Disclosure - BUSINESS COMBINATION - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)",
     "shortName": "BUSINESS COMBINATION - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-139",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "longName": "9954496 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-183",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-183",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
     "longName": "9954497 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-145",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
     "longName": "9954498 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration and Other Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-186",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-186",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
     "longName": "9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-202",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-202",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
     "longName": "9954500 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails",
     "longName": "9954501 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-206",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
     "longName": "9954502 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-212",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
     "longName": "9954503 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-237",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-237",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
     "longName": "9954504 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-241",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9954505 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "longName": "9954506 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)",
     "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
     "longName": "9954507 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)",
     "shortName": "STOCK-BASED COMPENSATION - Schedule of Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-274",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-274",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails",
     "longName": "9954508 - Disclosure - ACCELERATED SHARE REPURCHASE (Details)",
     "shortName": "ACCELERATED SHARE REPURCHASE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-282",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-282",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "longName": "9954509 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber",
      "unitRef": "lawsuit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber",
      "unitRef": "lawsuit",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
     "longName": "9954510 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
     "longName": "9954511 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-344",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails",
     "longName": "9954512 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)",
     "shortName": "EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails",
     "longName": "9954513 - Disclosure - EARNINGS PER SHARE - Narrative (Details)",
     "shortName": "EARNINGS PER SHARE - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-356",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-356",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.edwards.com/role/INCOMETAXESDetails",
     "longName": "9954514 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
     "longName": "9954515 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-378",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails",
     "longName": "9954516 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-378",
      "name": "us-gaap:OperatingIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails",
     "longName": "9954517 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)",
     "shortName": "SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-406",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ew-20230930.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r114",
      "r119"
     ]
    },
    "ew_JapanSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "JapanSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Japan",
        "label": "Japan Segment [Member]",
        "documentation": "Represents the Japan reportable segment of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r119",
      "r586"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r356",
      "r673",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r866",
      "r897",
      "r911",
      "r1007",
      "r1071",
      "r1072",
      "r1079",
      "r1103"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r767",
      "r781",
      "r782",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r790",
      "r791",
      "r792",
      "r793",
      "r803",
      "r804",
      "r805",
      "r806",
      "r809",
      "r810",
      "r811",
      "r812",
      "r831",
      "r832",
      "r837",
      "r840",
      "r913",
      "r915"
     ]
    },
    "us-gaap_OffsettingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsTable",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting Assets [Table]",
        "label": "Offsetting Assets [Table]",
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148"
     ]
    },
    "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares expected to be granted as percentage of target (as a percent)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquitySecuritiesFVNIPromissoryNoteOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EquitySecuritiesFVNIPromissoryNoteOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investee drew additional amount",
        "label": "Equity Securities, FV-NI Promissory Note Outstanding",
        "documentation": "Equity Securities, FV-NI Promissory Note Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss)",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum additional option to acquire investment",
        "label": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment",
        "documentation": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r114",
      "r119",
      "r121",
      "r126",
      "r127",
      "r586"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-operating income",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred tax liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "ew_OptionToAcquireInvestmentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "OptionToAcquireInvestmentAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to acquire investment amount",
        "label": "Option To Acquire Investment, Amount",
        "documentation": "Option To Acquire Investment, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r356",
      "r673",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r866",
      "r897",
      "r911",
      "r1007",
      "r1071",
      "r1072",
      "r1079",
      "r1103"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued liabilities",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total investments in unconsolidated entities",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ew_ShareInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "ShareInformationAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share information (Note 14)",
        "label": "Share Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_OffsettingAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets",
        "label": "Offsetting Assets [Table Text Block]",
        "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r256"
     ]
    },
    "ew_RestructuringContingentConsiderationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "RestructuringContingentConsiderationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/SPECIALCHARGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring contingent consideration gain",
        "label": "Restructuring, Contingent Consideration, Gain (Loss)",
        "documentation": "Restructuring, Contingent Consideration, Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, payroll, and other taxes",
        "label": "Accrual for Property Payroll and Other Taxes Other than Income Taxes Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "ew_ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Note",
        "label": "Convertible Promissory Note [Member]",
        "documentation": "Convertible Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingDerivativeAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingDerivativeAssetsAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative assets",
        "label": "Offsetting Derivative Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENTS",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r206",
      "r207",
      "r226",
      "r364",
      "r367",
      "r610",
      "r611"
     ]
    },
    "ew_MedicalDeviceCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "MedicalDeviceCompanyMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical Device Company",
        "verboseLabel": "Investee",
        "label": "Medical Device Company [Member]",
        "documentation": "Medical Device Company"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r937",
      "r948",
      "r958",
      "r983"
     ]
    },
    "ew_EquitySecuritiesFVNIOptionToAcquireInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EquitySecuritiesFVNIOptionToAcquireInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment option to acquire",
        "label": "Equity Securities, FV-NI, Option To Acquire Investment",
        "documentation": "Equity Securities, FV-NI, Option To Acquire Investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Derivatives designated as hedging instruments",
        "terseLabel": "Derivatives designated as hedging instruments",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ew_TranscatheterMitralAndTricuspidTherapiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "TranscatheterMitralAndTricuspidTherapiesMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transcatheter Mitral and Tricuspid Therapies",
        "label": "Transcatheter Mitral And Tricuspid Therapies [Member]",
        "documentation": "Transcatheter Mitral And Tricuspid Therapies [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r480",
      "r494",
      "r596",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r713",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1053",
      "r1054",
      "r1055",
      "r1056"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of treasury stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ew_RestOfWorldSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "RestOfWorldSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of World",
        "label": "Rest of World Segment [Member]",
        "documentation": "Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World)."
       }
      }
     },
     "auth_ref": []
    },
    "ew_LoansReceivablesMaximumLendingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "LoansReceivablesMaximumLendingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans receivables, maximum lending amount",
        "label": "Loans Receivables, Maximum Lending Capacity",
        "documentation": "Loans Receivables, Maximum Lending Capacity"
       }
      }
     },
     "auth_ref": []
    },
    "ew_NumberOfAdvancePricingAgreementsRenewed": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "NumberOfAdvancePricingAgreementsRenewed",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of APAs renewed",
        "label": "Number Of Advance Pricing Agreements Renewed",
        "documentation": "Number Of Advance Pricing Agreements Renewed"
       }
      }
     },
     "auth_ref": []
    },
    "ew_IntellectualPropertyAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "IntellectualPropertyAgreementTerm",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property agreement term",
        "label": "Intellectual Property Agreement Term",
        "documentation": "Intellectual Property Agreement Term"
       }
      }
     },
     "auth_ref": []
    },
    "ew_MarketBasedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "MarketBasedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Based Restricted Stock Units",
        "label": "Market Based Restricted Stock Units [Member]",
        "documentation": "Market Based Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collections of notes receivable",
        "label": "Proceeds from Collection of Notes Receivable",
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ew_IncreaseDecreaseInLegalSettlementAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "IncreaseDecreaseInLegalSettlementAccrual",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property agreement accrual",
        "label": "Increase (Decrease) In Legal Settlement Accrual",
        "documentation": "Increase (Decrease) In Legal Settlement Accrual"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115",
      "r126"
     ]
    },
    "ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet",
        "label": "Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "February2023StockRepurchaseProgramSharesSoldInMarch2023Member",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "February 2023 Stock Repurchase Program Shares Sold in March 2023",
        "label": "February 2023 Stock Repurchase Program Shares Sold In March 2023 [Member]",
        "documentation": "February 2023 Stock Repurchase Program Shares Sold In March 2023"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EmployeeAndNonemployeeStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EmployeeAndNonemployeeStockOptionsMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Option Awards",
        "label": "Employee and Nonemployee Stock Options [Member]",
        "documentation": "An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsLineItems",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting Assets [Line Items]",
        "label": "Offsetting Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ew_MedtronicIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "MedtronicIncMember",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medtronic Inc",
        "label": "Medtronic Inc [Member]",
        "documentation": "Medtronic Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow gain to be reclassified in the next twelve months",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ew_AccruedAndOtherLiabilitiesCurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "AccruedAndOtherLiabilitiesCurrentMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and other liabilities",
        "label": "Accrued And Other Liabilities, Current [Member]",
        "documentation": "Accrued And Other Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EquitySecuritiesFVNIMaximumSecuredPromissoryNote",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum secured promissory note",
        "label": "Equity Securities, FV-NI, Maximum Secured Promissory Note",
        "documentation": "Equity Securities, FV-NI, Maximum Secured Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r936",
      "r947",
      "r957",
      "r982"
     ]
    },
    "ew_AccruedRebates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "AccruedRebates",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued rebates",
        "label": "Accrued Rebates",
        "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate debt securities",
        "verboseLabel": "Corporate debt securities",
        "netLabel": "Corporate debt securities",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r901",
      "r1104"
     ]
    },
    "ew_MedicalTechnologyCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "MedicalTechnologyCompanyMember",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical Technology Company",
        "label": "Medical Technology Company [Member]",
        "documentation": "Medical Technology Company"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquityMethodInvestmentsInvestmentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EquityMethodInvestmentsInvestmentPeriod",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments taken period",
        "label": "Equity Method Investments, Investment Period",
        "documentation": "Equity Method Investments, Investment Period"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r934",
      "r945",
      "r955",
      "r980"
     ]
    },
    "ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interest, option adjustment",
        "label": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment",
        "documentation": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from available-for-sale investments (Note 5)",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r281",
      "r1042"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of common shares outstanding:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Held-to-maturity",
        "label": "Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r196"
     ]
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Primary Beneficiary",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r574",
      "r575",
      "r579",
      "r580"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency forward exchange contracts",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r782",
      "r787",
      "r792",
      "r805",
      "r811",
      "r835",
      "r836",
      "r837",
      "r915"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income attributable to Edwards Lifesciences Corporation",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r307",
      "r312",
      "r313",
      "r314",
      "r315",
      "r317",
      "r320"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of held-to-maturity investments (Note 5)",
        "label": "Payments to Acquire Held-to-Maturity Securities",
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r366"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-Sale",
        "label": "Available-for-Sale Securities, Debt Maturities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Held-to-Maturity",
        "label": "Debt Securities, Held-to-Maturity, Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable fair value disclosure",
        "label": "Notes Payable, Fair Value Disclosure",
        "documentation": "Fair value portion of notes payable."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for legal settlements",
        "label": "Payments for Legal Settlements",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r286",
      "r331",
      "r345",
      "r351",
      "r354",
      "r405",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r458",
      "r460",
      "r462",
      "r463",
      "r615",
      "r884",
      "r1074"
     ]
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Axis]",
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCK-BASED COMPENSATION",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r514",
      "r542",
      "r543",
      "r545",
      "r905"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r467",
      "r484",
      "r637",
      "r878",
      "r879"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from held-to-maturity investments (Note 5)",
        "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities",
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r1042"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r931",
      "r1001"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Operating Income",
        "verboseLabel": "Pre-tax Income Reconciliation",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r931",
      "r1001"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r931",
      "r1001"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Edwards Lifesciences Corporation stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r141",
      "r142",
      "r173",
      "r778",
      "r795",
      "r817",
      "r818",
      "r910",
      "r926",
      "r1034",
      "r1058",
      "r1085",
      "r1107"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r131",
      "r132"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Taxes Paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r54"
     ]
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r105",
      "r106",
      "r108",
      "r112",
      "r115",
      "r119",
      "r122",
      "r123",
      "r127",
      "r596"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r500",
      "r508",
      "r537",
      "r538",
      "r539",
      "r645",
      "r672",
      "r737",
      "r766",
      "r767",
      "r823",
      "r825",
      "r827",
      "r828",
      "r844",
      "r864",
      "r865",
      "r885",
      "r896",
      "r904",
      "r912",
      "r915",
      "r1064",
      "r1078",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r482"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of interest acquired",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r508",
      "r672",
      "r737",
      "r766",
      "r767",
      "r823",
      "r825",
      "r827",
      "r828",
      "r844",
      "r864",
      "r865",
      "r885",
      "r896",
      "r904",
      "r912",
      "r1078",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r500",
      "r508",
      "r537",
      "r538",
      "r539",
      "r645",
      "r672",
      "r737",
      "r766",
      "r767",
      "r823",
      "r825",
      "r827",
      "r828",
      "r844",
      "r864",
      "r865",
      "r885",
      "r896",
      "r904",
      "r912",
      "r915",
      "r1064",
      "r1078",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Liabilities assumed",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r252",
      "r286",
      "r405",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r458",
      "r460",
      "r462",
      "r463",
      "r574",
      "r579",
      "r615",
      "r910",
      "r1074",
      "r1075",
      "r1089"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r508",
      "r672",
      "r737",
      "r766",
      "r767",
      "r823",
      "r825",
      "r827",
      "r828",
      "r844",
      "r864",
      "r865",
      "r885",
      "r896",
      "r904",
      "r912",
      "r1078",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r88",
      "r569",
      "r902",
      "r903"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r290",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r628",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r1033"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r569",
      "r902",
      "r903"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r642",
      "r643",
      "r644",
      "r892",
      "r893",
      "r899",
      "r900",
      "r901"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and other liabilities",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]",
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Domain]",
        "label": "Litigation Case [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r88",
      "r569"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash operating lease cost",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_EquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Securities",
        "label": "Equity Securities [Member]",
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r921",
      "r922",
      "r923",
      "r1110"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": {
       "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of equity method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r401",
      "r1018",
      "r1057"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments not due at a single maturity date",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r695"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price of options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_LitigationSettlementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LitigationSettlementExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property agreement and litigation expense (income), net (Note 3)",
        "verboseLabel": "Intellectual property litigation expense",
        "negatedLabel": "Intellectual property agreement and litigation (expense) income, net",
        "label": "Litigation Settlement, Expense",
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r701",
      "r910"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r135",
      "r136",
      "r195",
      "r197",
      "r290",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r628",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r1033"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment percentage (in percent)",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before provision for income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r153",
      "r202",
      "r331",
      "r345",
      "r351",
      "r354",
      "r693",
      "r708",
      "r884"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r383",
      "r385",
      "r687"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r784"
     ]
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LitigationReserveNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation settlement accrual",
        "label": "Estimated Litigation Liability, Noncurrent",
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r1068"
     ]
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesFairValueLineItems",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives designated as hedging instruments",
        "label": "Derivatives, Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate (as a percent)",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_ForeignExchangeContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeContractMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency contracts",
        "label": "Foreign Exchange Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r879",
      "r899",
      "r908"
     ]
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r274",
      "r688",
      "r712"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r935",
      "r946",
      "r956",
      "r981"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income attributable to Edwards Lifesciences Corporation",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r268",
      "r270",
      "r277",
      "r691",
      "r716"
     ]
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on investments, net",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r1003"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      },
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of contingent consideration liabilities (Note 8)",
        "verboseLabel": "Change in fair value of contingent consideration liabilities (Note 8)",
        "negatedLabel": "Change in fair value of contingent consideration liabilities",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r1029"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-process research and development",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss (Note 13)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r151",
      "r247",
      "r703",
      "r742",
      "r743"
     ]
    },
    "us-gaap_InterestIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income, net",
        "label": "Interest Income [Member]",
        "documentation": "Primary financial statement caption in which reported facts about interest income have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Type [Axis]",
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r758",
      "r759",
      "r762",
      "r765",
      "r822",
      "r824",
      "r826",
      "r829",
      "r830",
      "r842",
      "r843",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r915"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r938",
      "r949",
      "r959",
      "r984"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r950",
      "r960",
      "r985"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r950",
      "r960",
      "r977",
      "r985"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interest (Note 7)",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r198",
      "r286",
      "r405",
      "r451",
      "r454",
      "r455",
      "r456",
      "r462",
      "r463",
      "r615",
      "r705",
      "r778"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r950",
      "r960",
      "r985"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r950",
      "r960",
      "r985"
     ]
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interest, gross",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/SPECIALCHARGEDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of Sales",
        "terseLabel": "Cost of sales",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueHedgingMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value hedges",
        "label": "Fair Value Hedging [Member]",
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r950",
      "r960",
      "r985"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r939",
      "r950",
      "r960",
      "r985"
     ]
    },
    "ew_TranscatheterAorticValveReplacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "TranscatheterAorticValveReplacementMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transcatheter Aortic Valve Replacement",
        "label": "Transcatheter Aortic Valve Replacement [Member]",
        "documentation": "Transcatheter Aortic Valve Replacement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts and other receivables, net",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accelerated Share Repurchases",
        "label": "Accelerated Share Repurchases [Table Text Block]",
        "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe [Member]"
       }
      }
     },
     "auth_ref": [
      "r1109",
      "r1111",
      "r1112",
      "r1113"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amounts",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r116",
      "r149",
      "r253",
      "r879"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets, net (Note 7)",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Cash Flow Information",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amounts",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r116",
      "r149",
      "r253",
      "r879"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r180",
      "r704",
      "r741",
      "r743",
      "r749",
      "r777",
      "r910"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unallocated amounts:",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments in Unconsolidated Affiliates",
        "label": "Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]",
        "documentation": "A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial Instruments",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset",
        "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r27",
      "r222"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r336"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r935",
      "r946",
      "r956",
      "r981"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r424",
      "r686",
      "r890",
      "r910",
      "r1062",
      "r1063"
     ]
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial Instruments",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset",
        "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r27",
      "r222"
     ]
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in Income on Derivative",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic:",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r1086",
      "r1087"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDilutedAbstract",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted:",
        "label": "Earnings Per Share, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnusualOrInfrequentItemsDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/SPECIALCHARGE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPECIAL CHARGE",
        "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]",
        "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive securities",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments in Debt Securities",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "documentation": "Tabular disclosure of unrealized gains and losses on investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative notional amount",
        "verboseLabel": "Derivative liability, fair value",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1081",
      "r1082"
     ]
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount Paid",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stock-based compensation expense, net of tax",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r415",
      "r698"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1027"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r118"
     ]
    },
    "us-gaap_OtherLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other liabilities."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r126"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r932",
      "r943",
      "r953",
      "r978"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_RestructuringReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringReserveCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued realignment reserves",
        "label": "Restructuring Reserve, Current",
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r1021",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for income taxes associated with uncertain tax positions",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r558"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted-Average Assumptions for Options Granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general, and administrative expenses",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized pension (costs) credits",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r151"
     ]
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest income, net",
        "verboseLabel": "Interest income, net",
        "label": "Interest Income (Expense), Net",
        "documentation": "The net amount of operating interest income (expense)."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income attributable to Edwards Lifesciences Corporation",
        "terseLabel": "Net Income (Loss)",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r169",
      "r203",
      "r232",
      "r266",
      "r269",
      "r273",
      "r286",
      "r294",
      "r296",
      "r297",
      "r298",
      "r299",
      "r302",
      "r303",
      "r316",
      "r331",
      "r345",
      "r351",
      "r354",
      "r405",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r458",
      "r460",
      "r462",
      "r463",
      "r600",
      "r615",
      "r711",
      "r797",
      "r814",
      "r815",
      "r884",
      "r924",
      "r1074"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "negatedTerseLabel": "Cost of sales",
        "negatedLabel": "Cost of sales",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r673"
     ]
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss) before reclassifications",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss), net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r28",
      "r267",
      "r270",
      "r274",
      "r621",
      "r622",
      "r627",
      "r688",
      "r712",
      "r1024",
      "r1025"
     ]
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE MEASUREMENTS",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Net of tax",
        "terseLabel": "Net income attributable to Edwards Lifesciences Corporation",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r296",
      "r297",
      "r298",
      "r299",
      "r305",
      "r306",
      "r317",
      "r320",
      "r331",
      "r345",
      "r351",
      "r354",
      "r884"
     ]
    },
    "us-gaap_OffsettingDerivativeLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingDerivativeLiabilitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liabilities",
        "label": "Offsetting Derivative Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred income tax benefit (expense)",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r16",
      "r186"
     ]
    },
    "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets",
        "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]",
        "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r343",
      "r348",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r360"
     ]
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": {
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r541",
      "r549"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liability",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r92",
      "r571"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allocation of stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r64",
      "r68"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net amounts that would favorably affect effective tax rate",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total before tax",
        "verboseLabel": "Segment operating income",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r345",
      "r351",
      "r354",
      "r718",
      "r884"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails": {
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax benefit",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r64",
      "r68"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ESPP",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r574",
      "r575",
      "r579",
      "r580",
      "r653",
      "r654",
      "r655"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation (Note\u00a010)",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from stock plans",
        "label": "Proceeds from Stock Plans",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r574",
      "r575",
      "r579",
      "r580",
      "r653",
      "r654",
      "r655"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1\u00a0year or less",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "verboseLabel": "Fair value of derivative liabilities",
        "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r257",
      "r614",
      "r755",
      "r756",
      "r757",
      "r759",
      "r762",
      "r763",
      "r764",
      "r766",
      "r767",
      "r790",
      "r792",
      "r793",
      "r832",
      "r833",
      "r834",
      "r837",
      "r838",
      "r840",
      "r841",
      "r879",
      "r1106"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general, and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENTS IN VARIABLE INTEREST ENTITIES",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss."
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 1\u00a0year through 5\u00a0years",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 1\u00a0year through 5\u00a0years",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails",
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r404"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r986"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r443",
      "r444",
      "r853",
      "r1067"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities",
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r940",
      "r951",
      "r961",
      "r986"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 5\u00a0years through 10\u00a0years",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments not due at a single maturity date",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r1043",
      "r1044"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated Other Comprehensive Loss",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1\u00a0year or less",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DerivativeLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Derivative Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r941",
      "r952",
      "r962",
      "r987"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 5\u00a0years through 10\u00a0years",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Fair Value",
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments not due at a single maturity date",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r696",
      "r1043"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r586"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1\u00a0year or less",
        "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 1\u00a0year through 5\u00a0years",
        "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 5\u00a0years through 10\u00a0years",
        "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of stock plans (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r320",
      "r513"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 43.4 and 38.0 shares, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r79",
      "r80"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total purchase price",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest",
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359",
      "r757",
      "r761",
      "r763",
      "r824",
      "r826",
      "r830",
      "r845",
      "r852",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r867",
      "r898",
      "r915",
      "r1079",
      "r1103"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-sale",
        "label": "Debt Securities, Available-for-Sale [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "totalLabel": "Fair Value",
        "verboseLabel": "Available-for-sale investments:",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r415",
      "r687",
      "r1041"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BASIS OF PRESENTATION",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r185"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net sales",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r333",
      "r344",
      "r349",
      "r350",
      "r356",
      "r358",
      "r360",
      "r498",
      "r499",
      "r673"
     ]
    },
    "us-gaap_CurrencySwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrencySwapMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cross currency swap contracts",
        "terseLabel": "Cross currency swap contracts",
        "label": "Currency Swap [Member]",
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r776"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in\u00a0Income on Derivative (Amount Excluded from Effectiveness Testing)",
        "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred",
        "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "totalLabel": "Fair Value",
        "label": "Debt Securities, Held-to-Maturity, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r390",
      "r687",
      "r698"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359",
      "r757",
      "r761",
      "r763",
      "r824",
      "r826",
      "r830",
      "r845",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r867",
      "r898",
      "r915",
      "r1079",
      "r1103"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net of allowances of $7.9 and $7.9, respectively",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r117",
      "r119",
      "r121",
      "r764",
      "r767",
      "r781",
      "r782",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r790",
      "r791",
      "r792",
      "r793",
      "r803",
      "r804",
      "r805",
      "r806",
      "r809",
      "r810",
      "r811",
      "r812",
      "r831",
      "r832",
      "r837",
      "r840",
      "r879",
      "r913",
      "r915"
     ]
    },
    "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes due to currency rate movements and expenses expected to occur, maximum term",
        "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge",
        "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r234",
      "r286",
      "r405",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r458",
      "r460",
      "r462",
      "r463",
      "r575",
      "r579",
      "r580",
      "r615",
      "r910",
      "r1074",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_OtherNonrecurringIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonrecurringIncomeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special charge (Note\u00a04)",
        "negatedTerseLabel": "Special charge (Note\u00a04)",
        "label": "Other Nonrecurring (Income) Expense",
        "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeCollateralRightToReclaimCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeCollateralRightToReclaimCash",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash Collateral Received",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset",
        "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r125",
      "r255",
      "r877"
     ]
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Compensation Plan",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "us-gaap_DerivativeCollateralObligationToReturnCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeCollateralObligationToReturnCash",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash Collateral Received",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset",
        "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r125",
      "r255",
      "r877"
     ]
    },
    "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Rolling Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of treasury stock",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r79",
      "r180"
     ]
    },
    "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1\u00a0year or less",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach."
       }
      }
     },
     "auth_ref": [
      "r1049",
      "r1098"
     ]
    },
    "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 5\u00a0years through 10\u00a0years",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach."
       }
      }
     },
     "auth_ref": [
      "r1051",
      "r1100"
     ]
    },
    "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due after 1\u00a0year through 5\u00a0years",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach."
       }
      }
     },
     "auth_ref": [
      "r1050",
      "r1099"
     ]
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/SPECIALCHARGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special charge",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Instruments not due at a single maturity date",
        "label": "Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r393",
      "r696"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital expenditures accruals",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Amount",
        "label": "Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction",
        "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r124"
     ]
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetBackedSecuritiesMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset-backed securities",
        "label": "Asset-Backed Securities [Member]",
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r1044",
      "r1048",
      "r1052"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r328",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r360",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r439",
      "r442",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r890",
      "r1007",
      "r1103"
     ]
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: cash acquired",
        "label": "Cash Acquired from Acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r235",
      "r868"
     ]
    },
    "us-gaap_DerivativeLiabilityFairValueGrossAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityFairValueGrossAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Amounts Offset in the Consolidated Balance Sheet",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset",
        "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r29",
      "r116",
      "r838",
      "r839",
      "r877"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r286",
      "r405",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r458",
      "r460",
      "r462",
      "r463",
      "r575",
      "r579",
      "r580",
      "r615",
      "r774",
      "r883",
      "r926",
      "r1074",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r239",
      "r286",
      "r331",
      "r346",
      "r352",
      "r405",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r458",
      "r460",
      "r462",
      "r463",
      "r574",
      "r579",
      "r615",
      "r699",
      "r789",
      "r910",
      "r926",
      "r1074",
      "r1075",
      "r1089"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Amount",
        "label": "Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction",
        "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r124"
     ]
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USTreasuryAndGovernmentMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government and agency securities",
        "verboseLabel": "U.S. government and agency securities",
        "netLabel": "United States government and agency securities",
        "label": "US Treasury and Government [Member]",
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r899",
      "r1104"
     ]
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity securities",
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment charge (Note 4)",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r71"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Attributable to Parent, Net of Tax",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of pre-existing notes",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "verboseLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r266",
      "r269",
      "r282",
      "r286",
      "r294",
      "r302",
      "r303",
      "r331",
      "r345",
      "r351",
      "r354",
      "r405",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r458",
      "r460",
      "r462",
      "r463",
      "r573",
      "r576",
      "r577",
      "r600",
      "r615",
      "r693",
      "r709",
      "r752",
      "r797",
      "r814",
      "r815",
      "r884",
      "r906",
      "r907",
      "r925",
      "r1026",
      "r1074"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNINGS PER SHARE",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r321",
      "r322",
      "r323"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540"
     ]
    },
    "us-gaap_LitigationReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LitigationReserveCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation settlement",
        "label": "Estimated Litigation Liability, Current",
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r1068"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r776"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r776",
      "r795",
      "r1107",
      "r1108"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r913",
      "r914",
      "r915",
      "r917",
      "r918",
      "r919",
      "r920",
      "r1035",
      "r1036",
      "r1084",
      "r1105",
      "r1107"
     ]
    },
    "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative asset."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid during the year for:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on available-for-sale investments",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r263",
      "r398"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r199",
      "r706",
      "r910",
      "r1034",
      "r1058",
      "r1085"
     ]
    },
    "us-gaap_DerivativeAssetFairValueNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetFairValueNetAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative liability."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r910"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "us-gaap_DerivativeAssetFairValueGrossLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetFairValueGrossLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Amounts Offset in the Consolidated Balance Sheet",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset",
        "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r29",
      "r116",
      "r838",
      "r839"
     ]
    },
    "us-gaap_NotesReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesReceivableGross",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing receivable",
        "label": "Financing Receivable, before Allowance for Credit Loss",
        "documentation": "Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r227",
      "r228",
      "r246",
      "r411",
      "r414",
      "r886",
      "r887",
      "r1015",
      "r1059"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for doubtful accounts",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r363",
      "r408"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss attributable to noncontrolling interest (Note 7)",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r187",
      "r266",
      "r269",
      "r302",
      "r303",
      "r710",
      "r1026"
     ]
    },
    "us-gaap_LimitedLiabilityCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedLiabilityCompanyMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited Liability Company",
        "label": "Limited Liability Company [Member]",
        "documentation": "Legal form of business company offering limited liability to its owners (denoted by L.L.C. or LLC in the U.S.)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r603"
     ]
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetInvestmentHedgingMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net investment hedges",
        "label": "Net Investment Hedging [Member]",
        "documentation": "Hedges of a net investment in a foreign operation."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives not designated as hedging instruments",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_HeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r381",
      "r411",
      "r1059"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash flow hedges",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Values of Assets Acquired and Liabilities Assumed",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r360",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r439",
      "r442",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r890",
      "r1007",
      "r1103"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued and Other Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r932",
      "r943",
      "r953",
      "r978"
     ]
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Cash",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r193",
      "r1102"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventories",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r144",
      "r145",
      "r146"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Dilutive weighted-average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r320"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r354"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r320"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r467",
      "r484",
      "r637",
      "r876",
      "r879"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r635",
      "r636",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r794",
      "r796",
      "r821",
      "r1088"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MaterialReconcilingItemsMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciling items",
        "label": "Segment Reconciling Items [Member]",
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax benefit from employee share-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r168",
      "r169"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r152"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income, net",
        "terseLabel": "Consolidated operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r345",
      "r351",
      "r354",
      "r884"
     ]
    },
    "us-gaap_OffsettingLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities",
        "label": "Offsetting Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r256"
     ]
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Enterprise-Wide Information",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LegalMattersAndContingenciesTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE (INCOME), NET",
        "label": "Legal Matters and Contingencies [Text Block]",
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r574",
      "r575",
      "r579",
      "r580",
      "r638",
      "r863",
      "r1073",
      "r1076",
      "r1077"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r574",
      "r575",
      "r579",
      "r580",
      "r638",
      "r863",
      "r1073",
      "r1076",
      "r1077"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Net Sales",
        "verboseLabel": "Net Sales Reconciliation",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments held for deferred compensation plans",
        "label": "Deferred Compensation Plan Assets",
        "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements."
       }
      }
     },
     "auth_ref": [
      "r1019"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ew_ContingentConsiderationLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "ContingentConsiderationLiabilityMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration",
        "label": "Contingent Consideration Liability [Member]",
        "documentation": "Contingent Consideration Liability"
       }
      }
     },
     "auth_ref": []
    },
    "ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of Shares as % of Contract Value",
        "label": "Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount",
        "documentation": "Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r547",
      "r548",
      "r753",
      "r1035",
      "r1036",
      "r1037",
      "r1084",
      "r1107"
     ]
    },
    "ew_AccruedLitigationAndInsuranceReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "AccruedLitigationAndInsuranceReserves",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal and insurance",
        "label": "Accrued Litigation And Insurance Reserves",
        "documentation": "Accrued Litigation And Insurance Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "ew_AccruedAndOtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "AccruedAndOtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued and other liabilities (Note 2)",
        "totalLabel": "Total accrued and other liabilities",
        "label": "Accrued And Other Liabilities, Current",
        "documentation": "Accrued And Other Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Liabilities, Fair Value Disclosure",
        "documentation": "Fair value portion of other liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ew_RestOfWorldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "RestOfWorldMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of World",
        "label": "Rest of World [Member]",
        "documentation": "Represents the geographic areas of the world other than the United States, Europe and Japan."
       }
      }
     },
     "auth_ref": []
    },
    "ew_UnitedStatesSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "UnitedStatesSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "United States Segment [Member]",
        "documentation": "Represents the United States reportable segment of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, per option/share (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross unrealized losses, less than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r419"
     ]
    },
    "ew_InitialDeliveryOfSharesSettledJanuary2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "InitialDeliveryOfSharesSettledJanuary2022Member",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Delivery of Shares Settled January 2022",
        "label": "Initial Delivery Of Shares Settled January 2022 [Member]",
        "documentation": "Initial Delivery Of Shares Settled January 2022"
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquitySecuritiesFVNIMaximumPromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EquitySecuritiesFVNIMaximumPromissoryNote",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory note",
        "label": "Equity Securities, FV-NI, Maximum Promissory Note",
        "documentation": "Equity Securities, FV-NI, Maximum Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "ew_ResearchAndDevelopmentAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "ResearchAndDevelopmentAccruals",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development accruals",
        "label": "Research And Development Accruals",
        "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials."
       }
      }
     },
     "auth_ref": []
    },
    "ew_EquitySecuritiesFVNIMaximumAdditionalRequired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EquitySecuritiesFVNIMaximumAdditionalRequired",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum additional required investment",
        "label": "Equity Securities, FV-NI, Maximum Additional Required",
        "documentation": "Equity Securities, FV-NI, Maximum Additional Required"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r420",
      "r421",
      "r480",
      "r494",
      "r596",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r713",
      "r888",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1053",
      "r1054",
      "r1055",
      "r1056"
     ]
    },
    "ew_SurgicalHeartValveTherapyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "SurgicalHeartValveTherapyMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Surgical Structural Heart",
        "label": "Surgical Heart Valve Therapy [Member]",
        "documentation": "This element represents the surgical heart valve therapy product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r178",
      "r179",
      "r180",
      "r242",
      "r243",
      "r244",
      "r326",
      "r482",
      "r483",
      "r484",
      "r486",
      "r489",
      "r494",
      "r496",
      "r745",
      "r746",
      "r747",
      "r748",
      "r896",
      "r1004",
      "r1032"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r326",
      "r482",
      "r483",
      "r484",
      "r486",
      "r489",
      "r494",
      "r496",
      "r745",
      "r746",
      "r747",
      "r748",
      "r896",
      "r1004",
      "r1032"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Standards Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ew_MeasurementInputProbabilityOfMilestoneAchievementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "MeasurementInputProbabilityOfMilestoneAchievementMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability of Milestone Achievement",
        "label": "Measurement Input, Probability Of Milestone Achievement [Member]",
        "documentation": "Measurement Input, Probability Of Milestone Achievement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ew_InitialDeliveryOfSharesSettledFebruary2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "InitialDeliveryOfSharesSettledFebruary2023Member",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Delivery of Shares Settled February2023",
        "label": "Initial Delivery Of Shares Settled February 2023 [Member]",
        "documentation": "Initial Delivery Of Shares Settled February 2023"
       }
      }
     },
     "auth_ref": []
    },
    "ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Noncontrolling interest",
        "label": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net",
        "documentation": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross unrealized losses, 12 months or greater",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r419"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected volatility (as a percent)",
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ew_NewMarketsTaxCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "NewMarketsTaxCreditMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Markets Tax Credit",
        "label": "New Markets Tax Credit [Member]",
        "documentation": "New Markets Tax Credit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Average risk-free interest rate (as a percent)",
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCELERATED SHARE REPURCHASE",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r285",
      "r481",
      "r483",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r497",
      "r597",
      "r819",
      "r820",
      "r851"
     ]
    },
    "ew_SpecialChargeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "SpecialChargeMember",
     "presentation": [
      "http://www.edwards.com/role/SPECIALCHARGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special Charge",
        "label": "Special Charge [Member]",
        "documentation": "Special Charge"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r512",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540"
     ]
    },
    "ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "January2022StockRepurchaseProgramSharesSoldInFebruary2022Member",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2022 Stock Repurchase Program Shares Sold in February 2022",
        "label": "January 2022 Stock Repurchase Program Shares Sold In February 2022 [Member]",
        "documentation": "January 2022 Stock Repurchase Program Shares Sold In February 2022"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r512",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r942",
      "r950",
      "r960",
      "r977",
      "r985",
      "r989",
      "r997"
     ]
    },
    "ew_AccruedRelocationCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "AccruedRelocationCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued relocation costs",
        "label": "Accrued Relocation Costs, Current",
        "documentation": "Accrued Relocation Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r40",
      "r229",
      "r271",
      "r272",
      "r273",
      "r291",
      "r292",
      "r293",
      "r295",
      "r301",
      "r303",
      "r325",
      "r406",
      "r407",
      "r497",
      "r546",
      "r547",
      "r548",
      "r562",
      "r563",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r598",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r634",
      "r738",
      "r739",
      "r740",
      "r753",
      "r816"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r291",
      "r292",
      "r293",
      "r295",
      "r301",
      "r303",
      "r406",
      "r407",
      "r546",
      "r547",
      "r548",
      "r562",
      "r563",
      "r589",
      "r591",
      "r592",
      "r594",
      "r598",
      "r738",
      "r740",
      "r753",
      "r1107"
     ]
    },
    "ew_EuropeSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "EuropeSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe Segment [Member]",
        "documentation": "Represents the Europe reportable segment of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r229",
      "r271",
      "r272",
      "r273",
      "r291",
      "r292",
      "r293",
      "r295",
      "r301",
      "r303",
      "r325",
      "r406",
      "r407",
      "r497",
      "r546",
      "r547",
      "r548",
      "r562",
      "r563",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r598",
      "r621",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r634",
      "r738",
      "r739",
      "r740",
      "r753",
      "r816"
     ]
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Loss on Available-for-sale Investments",
        "verboseLabel": "Loss on available-for-sale investments",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r264",
      "r272",
      "r273",
      "r1024"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total remaining unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance period (years)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period"
       }
      }
     },
     "auth_ref": []
    },
    "ew_VariableInterestEntitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "VariableInterestEntitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entities [Abstract]",
        "documentation": "Investments in Variable Interest Entities"
       }
      }
     },
     "auth_ref": []
    },
    "ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber",
     "presentation": [
      "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of lawsuits that if settled could have a material adverse impact on net income or cash flows",
        "label": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number",
        "documentation": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedMarketingCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued marketing expenses",
        "label": "Accrued Marketing Costs, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Business combination, net of cash (Note 7)",
        "label": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options",
        "documentation": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note\u00a012)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r133",
      "r700",
      "r775"
     ]
    },
    "ew_JeanLucLemercierMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "JeanLucLemercierMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jean-Luc Lemercier [Member]",
        "documentation": "Jean-Luc Lemercier"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.edwards.com/role/SPECIALCHARGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation Adjustments",
        "verboseLabel": "Foreign currency translation adjustments",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r17",
      "r44",
      "r272",
      "r273",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r1024"
     ]
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Pension Credits",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r17",
      "r44",
      "r1024",
      "r1025",
      "r1026"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r17",
      "r44",
      "r590",
      "r593",
      "r634",
      "r738",
      "r739",
      "r1024",
      "r1025",
      "r1026",
      "r1035",
      "r1036",
      "r1037"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "documentation": "Date upon which the accelerated share repurchase agreement was executed."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Fair value of net assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_MunicipalBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MunicipalBondsMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Municipal securities",
        "verboseLabel": "Municipal securities",
        "netLabel": "Municipal securities",
        "label": "Municipal Bonds [Member]",
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "negatedLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r225",
      "r302",
      "r303",
      "r339",
      "r555",
      "r565",
      "r719"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional services",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Corporate items",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "documentation": "Information by date of execution of accelerated share repurchases."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "verboseLabel": "Fair value of derivative assets",
        "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r257",
      "r614",
      "r755",
      "r756",
      "r757",
      "r759",
      "r760",
      "r762",
      "r763",
      "r764",
      "r766",
      "r767",
      "r782",
      "r783",
      "r831",
      "r834",
      "r837",
      "r838",
      "r840",
      "r841",
      "r879",
      "r915",
      "r1106"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_BankTimeDepositsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BankTimeDepositsMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank time deposits",
        "label": "Bank Time Deposits [Member]",
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts included in the measurement of lease liabilities:",
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r263",
      "r582",
      "r583",
      "r588"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r84",
      "r511"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount Reclassified from Accumulated Other Comprehensive Loss",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r617",
      "r618",
      "r619",
      "r813"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r631",
      "r632"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain on hedges",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r263"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Gain on Hedges",
        "verboseLabel": "Gain on hedges",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r272",
      "r273",
      "r578",
      "r880",
      "r1024"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finished products",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r873"
     ]
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affected Line on Consolidated Condensed Statements of Operations",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Work in process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r874"
     ]
    },
    "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished products inventories held on consignment",
        "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross",
        "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller."
       }
      }
     },
     "auth_ref": [
      "r1022"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r263",
      "r265"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of gain (loss) reclassified from accumulated OCI into income",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r265"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r875"
     ]
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r501",
      "r506",
      "r603",
      "r643",
      "r892",
      "r893",
      "r899",
      "r900",
      "r901"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other comprehensive income (loss), net of tax (Note\u00a013):",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r501",
      "r506",
      "r603",
      "r642",
      "r899",
      "r900",
      "r901"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r16",
      "r186",
      "r267",
      "r270"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r587",
      "r596"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amount excluded from effectiveness testing recognized in earnings based on an amortization approach",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax",
        "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r263",
      "r265",
      "r584"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1006",
      "r1028"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of available-for-sale investments (Note 5)",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r280",
      "r366"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r603",
      "r644",
      "r892",
      "r893",
      "r899",
      "r900",
      "r901"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails",
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403",
      "r404"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories (Note\u00a02)",
        "totalLabel": "Total inventories",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r869",
      "r910"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred income taxes",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r633",
      "r909"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "us-gaap_InventoryNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNetAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Inventory, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets (Note 6)",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax positions",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of derivatives",
        "label": "Derivative Liability, Current",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r942",
      "r950",
      "r960",
      "r977",
      "r985",
      "r989",
      "r997"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails": {
       "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofAccruedandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee compensation and withholdings",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other (income) expense, net",
        "verboseLabel": "Other (income) expense, net",
        "terseLabel": "Other (income) expense, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments (Note\u00a05)",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r1023"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash investing and financing transactions:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments [Domain]",
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r756",
      "r758",
      "r759",
      "r762",
      "r765",
      "r822",
      "r824",
      "r826",
      "r829",
      "r830",
      "r842",
      "r843",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r915"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, $1.00 par value, 1,050.0 shares authorized, 649.9 and 646.3 shares issued, and 606.5 and 608.3 shares outstanding, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r702",
      "r910"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Common stock, beginning balance (in shares)",
        "periodEndLabel": "Common stock, ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r138",
      "r776",
      "r795",
      "r1107",
      "r1108"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncurrentLiabilitiesMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Noncurrent Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetsAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Derivative Asset [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in non-marketable equity securities due to observable price changes",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount",
        "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liabilities",
        "label": "Obligations, Fair Value Disclosure",
        "documentation": "Fair value of obligations measured on a recurring basis."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r191"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Fair value, total",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r417",
      "r888"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Gross unrealized losses, total",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r418"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r888",
      "r1060"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Fair Value of Contingent Consideration and Other Liability",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r130"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r130"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": {
       "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails",
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of non-marketable equity securities",
        "label": "Equity Securities, FV-NI, Current",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r612",
      "r870"
     ]
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gain (loss) on cash flow hedging relationships:",
        "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate items",
        "label": "Corporate, Non-Segment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r345",
      "r346",
      "r347",
      "r348",
      "r354",
      "r1040"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r968"
     ]
    },
    "us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfFairValueHedgesOnResultsOfOperationsAbstract",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on fair value hedging relationships:",
        "label": "Effect of Fair Value Hedges on Results of Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r881"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.edwards.com/role/SPECIALCHARGEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term investments (Note\u00a05)",
        "label": "Long-Term Investments",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r190"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r603",
      "r608"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes to noncontrolling interest",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r450",
      "r1069",
      "r1070"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Table]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379"
     ]
    },
    "us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentFinancialStatementReportedAmountsAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investments",
        "label": "Equity Method Investment, Financial Statement, Reported Amounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r603",
      "r642",
      "r643",
      "r644",
      "r892",
      "r893",
      "r899",
      "r900",
      "r901"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r450",
      "r1069",
      "r1070"
     ]
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of financial instruments measured on a recurring basis",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r603",
      "r608"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r603",
      "r605",
      "r606",
      "r609"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidRoyalties",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Long-term prepaid royalties (Note 3)",
        "label": "Increase (Decrease) in Prepaid Royalties",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for royalties that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant, and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r697",
      "r707",
      "r910"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r944",
      "r954",
      "r979"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r422",
      "r423",
      "r871"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liability measurement input",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "documentation": "Value of input used to measure contingent consideration liability from business combination."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued under stock/equity plans",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r137",
      "r138",
      "r180"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in non-marketable equity securities due to observable price changes",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "us-gaap_PrepaidRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidRoyalties",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSEINCOMENETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid royalty asset",
        "label": "Prepaid Royalties",
        "documentation": "Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r872",
      "r889",
      "r1061"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, less than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r419",
      "r888"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofGrossUnrealizedLossesandFairValuesforInvestmentsinUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, 12 months or greater",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r419",
      "r888"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings per share (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r308",
      "r318",
      "r319",
      "r320",
      "r324",
      "r599",
      "r600",
      "r692",
      "r717",
      "r882"
     ]
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives designated as hedging instruments",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost, recognition period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r333",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r354",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r459",
      "r461",
      "r462",
      "r1074",
      "r1075"
     ]
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r551",
      "r557",
      "r560",
      "r561",
      "r564",
      "r566",
      "r567",
      "r568",
      "r750"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued under stock/equity plans (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r137",
      "r138",
      "r180"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails",
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r333",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r354",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r459",
      "r461",
      "r462",
      "r1074",
      "r1075"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExaminationEstimateOfPossibleLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.edwards.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional federal tax",
        "label": "Income Tax Examination, Estimate of Possible Loss",
        "documentation": "Estimated amount of loss resulting from an adverse tax position."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "ew_CriticalCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.edwards.com/20230930",
     "localname": "CriticalCareMember",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Critical Care",
        "label": "Critical Care [Member]",
        "documentation": "This element represents the critical care product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedged items",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r129",
      "r472",
      "r892",
      "r893"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of treasury stock (in shares)",
        "verboseLabel": "Shares Received (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r138",
      "r180"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration liabilities (Note 8)",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r92"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capital expenditures",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes payable",
        "label": "Taxes Payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r196",
      "r1101"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r910"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_PaymentsToAcquireReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Issuances of notes receivable",
        "label": "Payments to Acquire Receivables",
        "documentation": "The cash outflow for the purchase of all receivables."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (income) expense, net",
        "verboseLabel": "Other (income) expense, net",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain",
        "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r391"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r550",
      "r1097"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.edwards.com/role/COVER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r241"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Enterprise-Wide Information",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r156"
     ]
    },
    "country_JP": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "JP",
     "presentation": [
      "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Japan",
        "label": "JAPAN"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r392"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r892",
      "r893"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r635",
      "r636",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r794",
      "r796",
      "r821"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
      "http://www.edwards.com/role/SPECIALCHARGEDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r800"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails",
      "http://www.edwards.com/role/INVESTMENTSNarrativeDetails",
      "http://www.edwards.com/role/SPECIALCHARGEDetails",
      "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r438",
      "r800"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash included in other current assets",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1017",
      "r1031"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Estimate of Fair Value Measurement",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r614",
      "r892",
      "r893"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_OtherPaymentsToAcquireBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherPaymentsToAcquireBusinesses",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment for acquisition options (Note 6)",
        "verboseLabel": "Payment for option to acquire company",
        "label": "Other Payments to Acquire Businesses",
        "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationandOtherLiabilityDetails",
      "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value on a Recurring Basis",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r601",
      "r609"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash included in other assets",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r1019",
      "r1031"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r186",
      "r268",
      "r270",
      "r275",
      "r689",
      "r714"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r325",
      "r673",
      "r744",
      "r754",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r776",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r796",
      "r798",
      "r799",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r816",
      "r916"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive loss attributable to noncontrolling interest",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r95",
      "r104",
      "r268",
      "r270",
      "r276",
      "r690",
      "r715"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r325",
      "r673",
      "r744",
      "r754",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r776",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r785",
      "r786",
      "r787",
      "r788",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r796",
      "r798",
      "r799",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r816",
      "r916"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATIONScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total purchase price, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r167"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Final settlement per share price (in dollars per share)",
        "label": "Accelerated Share Repurchases, Final Price Paid Per Share",
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare",
     "presentation": [
      "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial delivery, price per share (in dollars per share)",
        "label": "Accelerated Share Repurchases, Initial Price Paid Per Share",
        "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS",
      "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period (Note 2)",
        "totalLabel": "Total cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r167",
      "r284"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS",
      "http://www.edwards.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic earnings per share (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r305",
      "r308",
      "r318",
      "r319",
      "r320",
      "r324",
      "r599",
      "r600",
      "r692",
      "r717",
      "r882"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r497",
      "r1035",
      "r1036",
      "r1037",
      "r1107"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails",
      "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS",
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r102",
      "r229",
      "r230",
      "r272",
      "r291",
      "r292",
      "r293",
      "r295",
      "r301",
      "r406",
      "r407",
      "r497",
      "r546",
      "r547",
      "r548",
      "r562",
      "r563",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r598",
      "r621",
      "r623",
      "r627",
      "r634",
      "r739",
      "r740",
      "r751",
      "r778",
      "r795",
      "r817",
      "r818",
      "r850",
      "r925",
      "r1034",
      "r1058",
      "r1085",
      "r1107"
     ]
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ParentMember",
     "presentation": [
      "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Edwards Lifesciences Corporation Stockholders' Equity",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.edwards.com/role/BUSINESSCOMBINATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BUSINESS COMBINATION",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r570"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "b",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a),(b),(c)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i),(j),(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "30",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-13"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-8"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20,22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a),(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//220/tableOfContent"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//220-20/tableOfContent"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "250",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//250/tableOfContent"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481138/505-30-25-5"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//815/tableOfContent"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "25",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//940-320/tableOfContent"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "b.",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//942-320/tableOfContent"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//946-320/tableOfContent"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-7"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "SubTopic": "20",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(b)",
   "Publisher": "SEC"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "(a)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "(a)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(dd)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-5"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CCC",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-6"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "79",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-79"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "80",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-80"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1404",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//210/tableOfContent"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>102
<FILENAME>0001099800-23-000039-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001099800-23-000039-xbrl.zip
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M6?@[&2.:4@IKE-K"P)&46E!QVB9%8*3??A_>I:>2RA:5B&]65:33J016W9
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M0V&4 T@A$DQ8"A:0IH%R((V:=2H@#MF1(_\J +"KD1^X,] J\!8GW#E!G&9
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M9L_F#IYBRS5>L6#:;EC72E*NK&/W3R=I91>F#S]%-# )"4XSSWN;Y/8[V#\
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M;,_@#I%?^;1Y;95/3TNUW)/. L1?1^&[&PP8V8E/-%OD'(B7Z2L2EC(T,8]
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M]S!^TG_%QMR_Z0ZS8H_@.K6!UBLBFXP.V0[C()T'"VQZ2,=C@:Y,+%#0.9%
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MHMO^Q2C_W),GW,??F;I0_E*@MGC '.PES):10YX&93+WVC*^,FS!9AFFRWX
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M10U9!A]1Z+_E#\*7+M=L8O&TB3=5^<VX)!<RY"V&W4G_E?ZT\:7X3WL(7I=
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M\6KVB7;PY%;7LE5UM#'UL:^=_"O;_[)=I%.%8(Q<I1.?%<T(_4R+>Z>_QT)
M_*;_^A6'X(:#E1"SRMV?;P?W9K]H1MYK["VM-NBGEG7$.A9C\*^4X5OTZDRT
M28 ^G=K+RTBAVUZ%D>T0\1]1=&+5Z# W!;'<LY9692)HL,1O3KDCQQRNJ)2
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MBO?FQE/AHJ&'#@!R/5"2J 5&-FPP;+H)NOES[#Q\U 9*FT? W-41E<'X^1!
MUB^0$W;^5O6<L6-WN+GV\N&Y\. OEAP'WX!%&*FP(LI'#5$6H:YWEQT7<S@&
M9UD!4BMG!<AD<UR+-<>;)\KZY$1VV(L]?4$3=.2 @QQJXR"LW9'N.&_X=3CB
M[B9Q_3.S0+A/P;C0YW/'_L5K/KEAV6K _PN)"Q^Y$]OQ1*\V2_= Y"9QL2YZ
MZ0F!P]O6!YR'C?:VM1&X2#PS" URL5(<W,Q0-%]=7O"P3<XH8$+3F$A5>C_R
M%^.%Y@X&=FN#=J<=<V,JJ.94;IW%1\S>G_QZ5:4L?)WPJU#I!I8<XV[F'P(,
MJ$^^8[EA!S'^$35)ME4WZEIJJ:M=*HLM$>%GR$4RXH)5/%C+.?,I)]05:_76
MXQ32&AXI9<U6917CY8ZP--#LGX4V.LSUN-'.<J.YR;!1\6R[[^C7(CMZY;%^
MO]YM='<I/-;JUEO-XDN$J6I=4SL'J&?6ILF6;+):\M<YBKI)D8K:2PM"8S(9
MGYF!M22Y:7?%+7F1,;:T/Y3 ],B0HKIEY<+TEF?M?@1&47,L*S'!MM04T,Z>
M GF@734*\+37R/JKE8$?O^K]2U8FYO3%I/7)G9H9G_18Z 4$HB?1D^@I+ST+
MNOW!TY>[(APIA_2/IP#FA_-:_^!,H[^]3RF>BMY*J.S5@H2&N)%K8):!_[E=
M 20VKKD9NNS7!NUV*S%SLZP5GX@C*LT1*5UG]^&(=J,VT#J=Q 1_X@B)4$,<
M$7!$2D_M'!P1/OL:F[^8<?D?YMAQG**B8<;3@(A7B%?*PRLI'9/WTA[8ED%K
MU/L2<41!P;&R>$K7+[HYQ9.^2Y!DEZ[.$Q.7B4-7IW;*:8PCC5&Z^M)E>?*$
M=3<BES0Z(5ET^EH<-[8SYVG.H%N&GN(N&VBG%+&H9@7L? JYLUTA+R7Z9]MY
M!'F^:D[^"4B]^E<>V[598=N5L!7"5K<H;&UBJ%4;=-5>3-H?(:A*".H=7SJU
M23J=![92JIWL(YTZ\DFG$Q1R+H'ER!,[+G'Q6 &A"+NQO 42<W%/.Z78QR$D
M<[<PR2Q9-47"5A1;*5=(]I',O=I 4_O[2V9"D-0(2CFV/X1TZI-T.@]LI1R
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M,.-($&!AQ;F[UUPZ/K*YQV9#YHA8:K-QH6@-K7GANWNK&<.S2\(KN#M UZ6
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MTK'50X);ACXR=H/7\ 9V:7BVJ_@6[V_$3V779'9LFPA]&#Q<"JR9S8!!SL(
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MR@9+1S#XYVD[<W*UBX])'#J*\.6MM).L29\C:@-%;:!RT..Y-)ZACCW4!HI
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MW&"=$QLP8L]Z@<=><"_\P L1]\WE$R>UY$WF&;1G-9Q>(^ODE*L:CE9"-1Q
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M9[R6B>PXA)/"YHP;C@W@\G"[Y6]<O67FBV\4Y86P%A&,*X1S8&;R\46L-IX
M#$N!I1ZSB$T#*IK*=8*!B\V9\_#H$__S7WU-[7V U9VA'B,6VDONEA%Q6HO+
M:\"T^8GW:@53A?VT?*1GQ39>_0NX8VR'9EQ^"/?A N=OF]'!AZ_@<N_SS(V$
M4%C9">(#*S\#J/"#0B;EQP _'4 @A5.2^<LK,S8<'-0X!!D&!1U8)KAK')U/
M//T;M@ &G)"VDR#%.<)K9FX C^-Q#8-">17Q"SC$-P"3@M]QU87\WRRNM%1
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MWY0-*G2Y[!7#2'B2FEEE.5N.DY:@41K,F> MRQES)+Q1&DQE\5:J<E/V<3E
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M-TZ)52_<ITM&Y9VPDE<BSX>5;F/8VZND!6%%:JSD$W_S8:7'#07K#BP"2UW
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MQBYJ<NDN>W2[&_V:"8'V-K($?9W$Q@ALE5)<11R@I65+<I X";@)'GTQ("L
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M(5"5 JIZ1>AM.&] OWG@^LWW)?6HI&IVA2 AG]U"NE)AM)ZTGK2>QUS/PH?
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MF0J\ 3[V5^@(I1M?RM^!([-=/_3@X5?X@O&#X8UCYO$O>9;_P^?O<^%N3YF
MYNMZ/CQJ!'#SFV),)FP<*&[H*:/0AV7PH]L%*>$K!'TUE0?&E/_YK[ZFM3[<
MNP&6.'J"*>,MGZ/9_Q'-_F$^>WZ_^D&9>6S,^+W?#"]0[BX49 V*JO"5^?_;
M^]+FMI$DT;^"T'IVY B*)GC3WNX(MBS/:-:V-)*Z>]^G"0@HDFB# !N')/:O
M?WE4 05>(JF#((6)F#9%XJC*.[/R $C^.X'O1>A-L7-2 )? )N&Q<$GMY-_5
MS2FH0)2WDLY^%X85"D+ET MN@1H\0#=@"@ S 00(?'$ Q"<<(!^'DAM=WP_N
M6,XAX<&2TU*7$9:Z(%$(*Q*$2%NE1-KXGG'@NT  @(BJ\3D$0\''7H86O(JI
M.P[@$=Y$O1IH$8AJ L_T84DIT=WC_"20UKA4Q*D-^W)!-/M,.T QL P;Z(W_
M=OT['+P$.U*_T->.N!->,$$ZP??&6,>-P1U>*6XL'@6P"W<\ :J%_<-*EVX5
MKKX?!?""/Q,7[AZ)<>!,?<"8K>W9<!+Z!]AE*,(IW@2+<L&F\2. !;VX:AB_
M$PM17\<@U2B\:=#W#%8")FDNQY#<G8F+H0B&H349$=Q#,<3[/QJ_PC+@:F(.
M "Q/F*\8-'ZTHE19-I^J:EP 4TZXP61$+[3ASB'LY"]Z*<(L_UIL0@DO6J\M
MF7%\=-/_[>KH?<78I(0>;_MV<X.W+:VU@FO4;W@=/BF7F?M\_+P+IF7KRA%V
MP*3Q,8'UAGC5T<^9D?)/N-[#>Y@'OEGA#Q$;OTX<P.&";;AC(,O0_NE(W)_4
M:_5&K=>H_6=H5O^8#(\,RXM_.H)7FT<S]G^CT9@\;!.":S3KDP<T;Q>_MYY_
M;_T9WVOR>U\>@QLI_%4X/;WX[?SSB=F3>+3# "[S Q0MOZ*B10L@UIM+%-8&
M6JV)1J['@L]E@4>^)$@:*6=2,,#:'(&['UEW))W#X$Z@TPMR.N3K@63JI#KH
M$AF'YI_$ XA4T"TV*ST6[I$RB>9? L(5Z;)"6@BDD6>AD0#?DMQD1>)&83*9
M6S388(,!B?L1B$"0U)&2U#E)3(]@80RR_V;A(BP'*#L2^&*IC%BJH04U2$(R
MK6:O@2NBB9![F[.OQB0/0 VXOCSDH&M R?P S6>SDL&U:AI(/L>6QR-P<Y1,
M)IY+'_'Z] U28T=*A[B@-.(I8","@U*0FA\CU<+_#<NV\1;4MTKKX^_X)L\=
MB)/(NL/5Q<(>^4"*0]0!]T0KB'B7#0#&<)# <T*D-"0O6AV:<O)IJ960+H]7
M#8^!AY.M2<:%\+R36R'M9+Q1C"=>,!5";@<H/4$[EG6Y!I]Y8@-[8Q+X]%$1
MFD8@"L^\#$6M!" Z#T$:0@!/:14Y %AT,)090U6C#W(!P(A7!N$0[/R_:%7$
M!:B[89=XZG2'!$*& RX>+2/0X^$4B07/N/!+D+I@O5,8Q\#714#V\& F<%XK
MFOSTH,RTP:6HU0Z(&0-?X=)RG)#( @ -T$&7@Z\$8(%%A90 L#U((]O$ YAS
M'T' (0,IS10Y."(""QE\:D YB+&*;HFSF)_J/$H&5ZKCV;X&JSS.^%G17S0C
M[  6(=A=QEV $3H/V7%&=NGO<?V!1_1CA5--)E?0H>/?@4;06@S9F 3-A=N.
MI)\8X3$@?AB O0IO9ZI)4FTUQ=TFL9$J,C =[V,VRT%LWM+ZJB0,([#2PW2U
M"?.:$M<,1?E7E-,>>)$N]&P+O)88_=D)0@QE*(A;]"G9$^Q7C*,K\%:-+^RB
M5HX4^_=]/P%@Y_U"#IV <_B_TE,0QA1,3T, N3G&9_ VQ[<BY*L:9H4T$EVI
M"('\*#Y+AK^>W\-\DQ':[O((;<&#K<4W0Q>Y%GMN<GX&]0R6&'&O/;(\3_A#
MD5H?J>AP$J&K:VD_Z7:X#&M5Z#X?_*R(QC0HR3!P0Q"5/MHDH#'C$9E2:%6"
M<@;5_*Y9;1D@\SS2UZ&88)C")X/$PO  B'@*,0S@RD:[VC;&?*T!"F/U"\ (
M=CC* C88$"6 D*(8M#HIWM )3]W\ ]7"'"N&S0[)2(+=#MPXA6P:0=$!R(+\
M6DQBDN1&HU:1CH"3QJT0? Q+UE^@4/ZAOP#,7<L #8Q"$80.0IPO!PZ3;\[P
M(JDLK]: @F +H%.3, 1%.@4U#H0*5$J*UQAX&/=@\U,Z#^K1N"=<G^.BZ'8,
M4$X8D8UP/>"1H$FXP:Z->]A+MG%T?%!TGL36 W).R)M[9S:ZU4Y*GIJI:W&8
M"S@,U^LA@& =J-6'H:!PD%3&%-EM*$ <O? YRH9!^5, ,R93T:[P%$CXB,-,
M,F:!YUT> %&.6NH7/LW*>.VUS\N?HH78_BG 01I1C/C,OW/!W42$5XP+<C8Q
M&]$5TDTZ377*_BK*6D>>1JGH?^J'8A3$2<!_@P_@_*)1,"7'3\0N.8_DGN3<
M$7 ^[@1[T5'"?C_<.@9YE6#D!BRH$8H7.EC2HO,@6M29PYW00M+2 [ZSO 3]
M=N.6/5%6W^!'_!"CP',H#B'/.6!Y8S>60DF^ N_Q 4YY!YL# S*^H+^=8Q04
MJT\=]P6/'H H55&5Q:(/Q*^*4) #@V<-VJY1H)_[J^T'\N[Y> />:W:JO;\I
MM9Y9(2O./0Y4W1/-2HP[1+82+4/AI\>* =AWL0P*65XE]449J7\"JL#K/ D&
M)QB% M)E3U89#? (;TK^M3H:RHZLLN,H&6"RIGCF*=4MJ_(8SX^4'!&Z'$E/
MN88!4 M@$UX+".6 #7YO.1R+F6$+).&41]/3$CIH=<28 RTQQ6@$QN. 2&(@
M60QJ+2""-3, NO,9 #LZ*%F<'H"/Z=L /K:F03W[CA4Z>RR..:TE4^D8CT#,
M6]DN([5+E*T<TF$3EVPKL[2MG@+ZZM'S2<SUF*QG[C[-9F6.4^&9:)ELT*8I
M7M$A>9$6O9C\CATLAF!E(MVLZ+U:]NM649BU6K7&L;!-RR@:]6JCLUX)P4;5
M&=5:]V6J*):_<]NUMJN]YG9/??VUMJH]<W_@6FLW]F:M^T,#^[76?:*!=GN]
M]2PNIC+K:U13%:O@=?%PXT=FHO:.P&.[Y\_U=3;(!U&OL\7N6CN\&85"&-_8
M@3_#0"M92KE@ZZJ9L"OV7ZQRN2TO/0 4?\<0S1O \+[*HO6PN/9XYF>&^+Y3
M_R6?=&'8VQ\N;W];-$(_8+"7?*K[PFLU1"@VKC'H_UP;7F=V_"$!KOXR$GTO
MMO^X2-X<  =%'"57E5SURESU%@8BY"H=-NU!_&9;>FV\_V)W[.JV>]7>=FVH
M"].^[I&.YR4IOPU2[G3;U6Y)RB4I[S\I=QM5\[ I.7W&&F,HGD;5Q<.N6:NV
MBX?=74#B;^MX=J60+(7D0@>WTC:;U4;Q.*DDYI*8-R?F1J-SZ$J_).8W0LR=
M3K5^V*3\INU7LX@AH]W;KT^=J:9OO,-E[446;]P79ZM)NOEN^0?#&(UZ?6-[
M=%-0['@6R%M&;[U3V]A"*]&[-^AMU3<V6@X8NWN(0+.WK?3=>].C9/\G [37
M[6T<ECU@_C\T]':[S6JM1.^AHM>LM4KNW6_MO7E4X5"T]S-EF^U+X("Z\VX5
M-UBP[WVA[EJWVMPN:+:G4<^]1%)SVR.8$DFOA:2MCWQ+%+T>BG;#1;O7Y"5]
MK!4G;]9*95AX)+7KU5:)I&(CZ;A>KYKO2_P4%C_MUT?/[K7@&SL(SXWF>LIY
M^!X2N-FM[>C0I0RMK8^D5G?;V'>)I%?++M@Z=Z3$T:LQ4G/;%(&]U^DE@:R7
M0]+>V+,MN?BUPU.MVL:>;8FD5T92I[6CX\ 21^NKPW9Y9'O #4(NDCC"F=9R
MH-_*?B&;Q'$.+?>D;9H;NU=EN<O>H+?5V#PQN$3OWJ"WTSWTKB$''F,'IWQ+
M!.Z]%5*R_].II])M;>ZS'[ $.#P$MWN=TCX[8 2W>B7_[K4&WQI_>Z_ W]A)
M^4T06UXV_G++2@TY":L!^W:"!.=JJ96_V08BSP^@8G.166EV:]L&'Y\/2CL.
M+Y?\4O++NOS2,'M/K'\L^:7DES?#+^VMJQ$/AEL._?!R5_E6N_<Z2G%:BM/7
MS;BI-#NU:N>-"]227TI^69=?:HW-BRA+?BGYY8WR2Z/]Q.XO^\\MAVZNUS8^
MY3\4<YT."3[$%E E_.NX=S__#_Q'K8DVXOJ.\../]7JU143!=^. X_1):]_W
MBINMTV!F=1Q@!"L2#@W7M[T$?L1?W/'$LJGF;A"$\"S?L),P%+X]-<2#39/?
MC!#N,@9>8L>)%;N!'U4-XV;;>XW SXXM##<R_""&+VP1158((('5.4 \L7N7
MKEZ]AV^$U0=C83@);""@W^T WAI- A^)TQ"#@=AJ52X.WO/I;\LS !G) %Z;
MA/A0RW>,8"+@/OS+#J(XJO"726B,A#.DBVQ8M1N[ @"TE%@DPIIU/F.:!)&+
M;_P8"H\V_>G>=>*1I%[]1BE7:]DMUBV(T"1>?LO<6,$=T66]EP>'_M]1.K=W
M8@W%R6THK!\GU@ 6^]'R[JUI=/0AMZ>QZY_,P'#9]L=6"'A1"@F''<IO4 -U
M5W+W/LN&N2F.J6RX)IZ[G1J78>  \1O_ "D_*=+:%]//L1-XGA6BY#+@\1YR
M[/NER]:0S$LF>9^Q$1DA-CYQ$HF/ZL,GQXTFGC7]Z/JT +KI4YZ$D-AFE!O!
MB'_.Z+!:8UJ4Q]'RS?+G*OTTHW+YMP8 N=Y:^G.M:B[];=5C.]5:M[/54U?_
MUFHL?^>V:VU7.[WFGJRU5>V9^P/76KNQ-VOM-;=[:KG6PZ&!=GN]]<C$GQG[
MRFRRZ-]T_/(.0Q6+IR\O]M323?6.C#"XGW575VRP>/.E;T:A$,8WN&X4&6=@
M;CAD4EV+22S&MR(T&K7*JD.7%?O?8!1W<2\] !1_AV_> H:7R*)ZT671>EA\
M1!2]&,3WG?HO18B+,DXI^+ WA'[ 8"_Y5/>%UPK(%QO7]5J]\5P;7H-]#@IP
M]9>1Z'NQ_<=%\N8 ."CB*+FJY*I7YJJWT!#D)H2;;2L>"4"=T0]P9<9OEG<G
MC"LQ\2Q;C &K+S?U]L"R- YLZF^OO7E%SI[589:D_#9(N=O>/#F\).62E M(
MRKWNQIEQ>T;):R6^'6KO [.(K0]VGS)7"LE22&[2>[O2JVT]DF9?Y&1)S&^%
MF-M;-#@NB;DDYB(2<[-WZ$&%MVR_%K)SU^[-UV=J"U5HD98/)G]SX]#RJ#CA
M)G3M))H /F]&(K0F[I;=IO>WUJE5+X=(%!U']=ZV]>PECEX-1_421T7'4:>]
MH]%DN]?R)8&LU][;W+:VN^3B5SLP:Y8X*CJ.6IMWP2YQ],HX:G?>;%.RMY!
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MO-/'%\ ;9/\\80%_(;@4X*?(H1R_0A#+LVYD/GH9+S6DVZR\-6'-/\?R 0A
M6;B>D>MAIK3<IFV'B<P'3->3!18MJ@9&,>3^$)1P#%#T@YCW\F?BPD^@1V)/
M=C^F]8*C0]:.@O+"13'2$9043*%?U4F^1!B@4>$ )5I*?=(6LV(5B=!ZPNH&
M0H:/+*",&4-)B&0R)H*1Y(?1U5">V,DS=3#:, \!(8?1VBBB^RN&.X ['!DH
MPGO%@PAMEZ@*J .Y#Y\ QK! ZD1U@(-4V$;%72I7BOD*[5UQ+]+#=H_#ODSX
MR <1 Q0(SK:34)(R4^0$[$0?%7HN!P)1J06"R1RN&%&"A!+!3B>1S$+7PC&L
M3IBER>[.:FH4/V8P(-]60R8EI?MB"/Z!Y(8T#C![E8LRD6)BRDOP0=*1@R&U
M"'[&&@;UFR>&;N3)M"[-9:@8L$T;+77/NM_O\.YC^8] 8'82<S"\[]P1="Y#
MUT8T:AE[1_U++-RA%!&SFXO%S+=@NP:F_ NH#3\/L1> SZB==9MJ/8Q'!<F0
M4O-J!O4-T,1]!71)3!(!&*;"&;\#K$:1ZY,R18:/$I]$E;/T.J C:XR"9GGW
M19[SL=;XV6- DJ<B6,:1>N8'K&@A2,'=:(<@CX?!U/)0\N"C+5O2&-9L((L"
M^_(!$^K*,TT@4P29!<K,>805D;FMRCVR8!K#]N^2F$/))*A_JGF_]%Y#/>MF
MX'$45  +P#4>'\'[L65V]%$E,0'J.Q4BE,O^(R3 S8A3A.I8-UL:ULW>)S;\
MTC=T*_Q^]?QK^-Z:H)K(GHN?TM\U8MOLS11T)T4%5@1C %0 <)9%<PXP4"KA
M2PLB39,U6<;O4_^_IB+[.)4+Z+&?A]$&:X1':3S1I&!NBBC.T#(EP?/74M1%
ME' <RK6CV8$+H/U@IW-'@%'@4$ACC!2)'(;".5>3CSH&C\#"P%L0/=\OT88
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M_[;HX&O_EY(.<G3PU;H5WELB@<NKLY($<B2 !3DXW'=;8;"_ 06S=I#GD[L
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MYK$C8LQLQW*FRS*SWTRJRECM W%GCAF[M#;Z^"BE41AK ?J?'5A>>YS:A'.
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M^V4^^]0C$Y:S-D-^IE(2Y;$Z?S7[]&F\K*M_E>[5;+JD78)VBPI()*5I@<[
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M\62^_;;84EO,@W?5-,@T)T:S V+*\013$DF.G ]6^4 ,RSG67AG70_:\*=3
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M;F+F5$01:I]M/,DBR6W8TM0H^UXDB=.@R(Q3X$;/+QQ$)\_E")QY&V5*!#W
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M$0UDF54PR6!\7CN'KZH V_H9"PQ+DN<./%K<A=D@9).D= JR%B4SW:&&6,[
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M'%A$!TY;!R(2U$$F!*A(@5AM?5#-KM9\<BU..AETDQ8G7:RQNQ8G3'"OJ>)
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MK3-Y=-?DOAS)+ML'F%Z1^=6WRQWACVG1S6GZ>?AEOD,0(R?"&5P-?2@GV3*
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MEJZ:;MG%?GIK+KX=>UX%MJ^^+=^WN4XHNG4T=-GPEDNC7"1 O$!=*:[ 4B^
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M+ R:I.1!HW/N(BZX43BP.+S $4*,YDD14KMGR$HP6T^[UU^\,B%78!SJB55
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M"(>0(E?@<\# C&8?@R.2B-JG;$M@/!,.;*O@!O/""L]I/@\:XX+.)?8FI16
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M">8Z*Q>M<[2TFM)$4F%+I1A^(L:IB'&P-;*VH3P3ZNNUIBYTUT(]^&.T[U&
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MYIFMG]O,A=%9%V\BJ#(:H#!ER[0UGT22.6>',7MELSJNX=H'-J(ZFGEJ,OH
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M\GY_%U 5PYVU0+H/=_;7T5.%5Q)PY4AG/;@(.6OIRP52+-WQLB).VT!R0"\
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MKQ_O05L?ZJH5:AC+@^>V^\FN7JASX]F@J946M%$^=5W9DQA'4TCH%#Q>>6'
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M&R5%V8VW<^V>[DA[::NM\WJC5X@!,8,\>0<VWY\265H\H$G$C!*#UB"M GE
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MR,UEH<,R]LIM7OUIS&5H0Z" W%+*?N;A@<M\LHS%> X\X2-S+.T*<)LYMWF
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MO#S/VO" 4C/=/SZO03@GW/H;#X@>X-PF?\CC >]48!!\K>=/CR1=@6%Q#T4
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M?L:M"UUEQ91-K6%HONW!CS!=HIWG63EWMG0:I/W73K(X)_&R<FQ0;VKJI\P
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MH;75<S#N$UK/>=0@B^]&@RY;/7A '%<7)+6&6;1I:$-I^="9]V.[0>O$ ,V
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M</#<CZ@%/TIPJDM7&X2L,'*UCQ6U ?'#R:!L6;GL_>A&3.5A;U^:!>E9D?N
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M%IZ!5:T.WN303=6:KV0%277NA]V2U/9(M,\5U8:"AEX;.*S<[!3=A!W$TM%
M!]E15E@4:4$OI3ZE1][D;8ZP"GB^/T'THV#9]??T..RX,%/T2 M"$$-ZL#F(
MGLF#^0M-]D )8S^2<(JV>F]7UB4_GIB;P[XU=82J)1"=VBA\J3CCIMU8?E0^
M4L#,@^$,RIK(E*P91\RQ2'>I)JUX$<"%6D%1J&E&Q-J/P:B,:>N1&;MSAQV\
M'G9:+(U6F!N.H6A7!MV@*MVZ>SIY0*#!-=&_@HC%4@.UY]O'X9*G.P+),"'
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M01?,C\E73I )MO(&Y"I[D8UZP\""RNR[;J_F6FPH,GJ\?U64QVR[QZ4&R08
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M.),_5_3NQ9#(V&&:H>MVG_)!I);+P4_&5\H.8S[8]QT/>QSX@\<GI%ZR=Y%
MFA-.RL@ZZ/;L&_ISK4MUY<=5[O$Q;^NC<M"6[[S;.BYZ<2[/_$<(D39%L6]:
ME(9%&VHS=(""E@/Q6T[I^^U"VDE=D7\F/Z7\'HF9YZ:%T._0<FI W8I9A\_9
MCE>GU=<V9^'HE_6$UJ,NJRM9%SXP7!DBGH8PML0!4VQ%&X8CIEN-#49Z) =P
MQ&_#R-]A51DL)0P%R^9.9IOE"HO_;JQ>=8CY8*LR8E"F&##H;8*@;*+G!\I'
M;B$&=U8'7!\.:@U\[+GEQ2T,^)KM9BTPIK@P+5<H(O-7VQ7YG=V/6+ZT2:!
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M%7R*7KN&M::.RV=,D-@B0Q(WZ#^Q-TXQ4.SD'??,HVL=S=@:::9D&YNWA8%
M04$-D+B\2$8TX\ 9*H\*\",QA"69!IT+E<,= KX99Z6&U)(\E1RVI]X::5%.
MJ='886Z\SDJ'70&1!:%L S)').$&H\GGQ7;=(6&$AKT/H]+&VQ^?"#?\Z797
M)1EOI@RIJ(;@($ 3M?$SFT^5<95IR+]E!+6;E6WHJ19[4_-\8I<O^U"404U%
M>36L13%+-<<Y]I@&/2-NQ(/\QJ'>F/#ONS=3H"IX,B5LZK'4L\D10XB$%>UM
M+L"[5KP>3;(F"K^=">O1DM+ B?F&[!63NS:W+6K'*9W3Q_BV071K-:X<HV+9
M?&TO %&4WRW&)916-_,:G>"%X!YF:F2--YUKKU%J7W "$*<SUP2[Z]Q_4CB:
M;](0_Y**LZ[G"J=OIE1@J38N4/HD$# ^JMM,X,<9:M("2 OO@G)1=H '=_>%
M=H\7QSUL?<V=+W<$7+OTX/A\C:J,>6-T0/9F$0U,U113JH;-.T6=$0;4I9,0
M)&(,6F9Z3*DGEY;1X,)_HNYP3D;1F$N;KUC#RTK"=,9E\_S$QZ;R:+<%ATP.
MR69,@X[>O/4B6^@6ZTW5XI8"Z+9AP/E43?^8P)JR/7*9DE?6RNKR,;I%9LWV
M$TCOV8*@GB<@W<B2N/EHQ@'F:0!3BI0F)3T53C(\1@UISN$).=Q[^_9:>Z 1
M^6W@-<V8T >1EVN^77;DK'O=<A2:?^UW?0<''S-$H.=UP4A58Z*LA.4P@Y.P
M;3>U!V<V(*V'^WJ'0N5Z>R_V"1;K?)'CBU.I<,D^91R:]G64< S=#I.]L3AD
M1K\.8!@GIF7UAFX6)=>)/T4F#<#?A'4[M85Y2GYJ;N/<FW^ND'1=X_(X.3E\
M@:TVR+SRACJB20D5W#IE6MFW^CKU"'\L*<=KGU!WB6:E9BHO]\$=4ER<2XOT
M;*!G \+#X8S:/0#SAP\NG0 T"P!MTQZ/@<KD"$75+ERIX;'G7H$[LPTRCG4I
M$9#'[@\UGSMY*C[T0U%(%[&B9IY XZ</;.X,(Y7I#:QTO+B3.24Y)DO/[%0G
MRN)YY6UTRNTKH:&96I-'55+[QTX5!8P^3_5(M#VN%UZ*8TJ(4Z03 XS%1MF?
M")"Z;&P<1DHONUVZ2?03OVG^X(<(N='@1?FG)8^# J985^<#MGR?=%H$S0)\
MD$!>G,,P#  -^B7 EBLV%PEMJAXZBU4!ECQ%=P@;/B)]5%Y,^5"_=SY<G9-"
MY&+WPZCG%P>UV7Q!U RZ/JN&:4(=IV BC(VFU\>1]BV*'-2JUI1;N8CIX/P9
MY/<[4P^,WI@EANCJBN[P&__LCNG:PZQDX0S]0(O-LWGD@O0*RP5:4F(2>C]5
MNP5QCR#)M/>@9IRMZF9*K+NLAD_V>=J=K"(&7IMH5U%?.N,1<,B/RU1YF /Z
MXL;_NYD-1NU4*TM?^B+5<VZXE'D*E"$*=K=*6!X(@F>QH=N MJ80Z2[@CC)'
MXBMA[A%!KN\F:[>$2AGG[HV^1\( )=S\-$4;4%^<4\UE=^<8T3*B<4S[P-"@
M2Q26=%.M?"WJ]M8"?O)<SFY_M>O!VPN%OABH/!^V/PAULA^'S0=1S2@#3'$B
MF]\T#Z7&BD>KMY$ZMK*)4C7]BKH])10_MDS?JS$U0O\-DK'#0L[8I WO(=L<
MBIW'GK*7X6$U#&UF$.L=^P#3!7A/$QMO,X;T&6\##%S?=;'E+0N00C1]C/2%
MH:-2*\U%YY#W1(A[Z=XJ@?O?A-Z2.>$C0;B#:3@*NQH [,4PQ9O8O!E!C!"4
M+5!&U;:BG<0*)=Q$1%<C>%9.Y55DK4]N4Q2N,:YU,A%]]+TN<N1<@E#5^A%J
MTV8*K #J4"=>#+6?.HI/)A,%O?=YU^[*\'F3U-\O(=JVO4.-KR#57"W57&6@
M'DJ]263F02D(5C3JR :D*-X)0F]77&+S%>?Z;D $ZFZ]8%X"X.,!W,AXVXKH
M-J>3\=1DZ^X52ZVO,UL'0_SV]_MW6\G/"S]25-UBM/B8,UD4\&9X8AK.L'4Q
M#2[X V#$9E"G3RLF;[V;AU*GMF:4?@.R&&2I/$S(<],P/V^=!A7OTJ,IY7+Y
M N'W&PWG7(C:1"P/B#53 6=VRV<H2R1]K8TA@_G4C:E68Z5J\V*FMZ8?5<!M
M'B#AUF95@]/M@>M!:EL\C)1+%#;D'2?><=W53^DJ96NA=G?AEK.)_"X66,T5
MA3TS,\OFXA"BH>[FNOH[YIM"%J2K*E&M^; I+D9/X33_L-RL^YORNJH'AC;-
M,S(J)^5URN\?DQ<)0FQ6-?URNRA"CP@HV;<NTWKO;UNH9.T1U#D4,ZI*ZYO[
MPL%CW5#O?WC/_A^"H09,,6T3VD 4@?00C C&(FF[CL2L9"/NCD$MWO@WB#42
M+L9_3FR8T&DK.V484:CHQ?DCZ]\!)A4#J#^K8H0 NG2_ ;0*IL$8VC 4G80Z
M5-2.$;Z'<B._B__!/)H2WMK/$[&P->)Z'K,NVC[L^7'_,3QMDS0.=#FVK/>&
MIJ!@%%CW*J%#-FUX'>K*!B1N0=O_JB$B'P@QR8 G'^V]A#)*:]%L7CC;)'%G
M,&HB7<YG:DO-'('605\$AFDAE-5FBV1Y@/,\H$P:O;UH!@0>2"0=:>YCN@1Y
M0YP'Q)X<HXB8H"H&"U.:6\GS$QZBSZTW(&+H 1@76A/38 2.2*63="/F6PTE
M 2U #9BG^89=&C<Z/+:+2'[BU$X)97F>Y?R>-#V_X+$O+=UQ0?6*=;$L;I;8
M)!R%Y@;V4Z>. ^;4MJ;@=5@T2K^PX=F/+)>7E"/.#N?,Y-T,'^]),E?),5=)
M.PI]C*">$QZ68_-O4B*!*"_"8X0]2I1$[T7Q]Z*LBIH*%.S)\QD-+&OUJY/X
MMQ$\=^<[2A_>;[YR*&!GB(0R9TF89,$8IL'VAB"&G)&L#TN \3+]2#A1G^IK
MP.RI+K3HC)/KBZ>#HT>'M>:?'6X?.JW\)&^)LSG7[/U2>" %\R>M8<R"-HN9
MBN#'?'OK!H8]8N'&G/]55=#Z/S'-*00W[34G.+UY U)N2M9F[>@N!KT::=+(
MID$V@"FJ,7X;.7.**\0)G;XU4[[9/Q68H5^!W'UQD62@(+E]>6NX\>3?4A,[
MWZD 0,4U>APGB&G0W(!XON>GG D1G3U X*DSSK@V&J$:B6Z0SI"[^\$C^?+]
M6]RG# >Z]/ZU0X#_Y+*/Q#0<)Y"P6&X8J8 (&28EM_*N*&A-P?MV]AONI,SS
M79)Z2FYW$GBD[?<X@E/K='F.C$.24#_B9GXX3!OFUP'L,6!*,-B\C\!@R9)A
MAN*@^E>1$Z\O])S"#(V?=6[K7$Y3WKMKU:[SDHEJY><4C9,U\0*/URP;$HV?
ML^)@%XG;T&W$"I[XJY@K'?'7D,D4M>:E,$I8R#@LID09;ZQ,$YR#JS@5=AV=
M2?8I/U7ZD';PF,R.0Y[><M.6-J=[]-L/C)_L7_ZFO7>![.5?HI7GJ)1U8+O[
MS8LFN[DBMC5L?0N[1ZP8:,"&TRS=J(CZAV-2/5<$$WE,'EKX:8FUO\V2D[CD
MQUEQO5W>ISTM];H7YR1 N$( =G?,:S",9[#EJ_,#M+MDP8=W*9;&EFJM>&7
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M9(]J(422I(]IOXR9QX:J!3S7F\9U3)SVJ<4I3B0''E%];A&=54]X5O9&_H0
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MHF4!!FDA,\7XS'Z7'9/R>^6S[BTUJ0VZ>M[QNHMIR,?2CXWZM1)T:ZF1(S#
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M(228REPET^W3QGLL&9,\@&06FDW>.$,WR,L.I-A4#>P-/OYC;T!-]: ]R3_
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M2EW<8B@7<YY_NFMG1,'?TGD:K(YC9_7<X0',PUT\H/"3V[R;/.L"^,$?0O(
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M6S-R<U]+^64?"KC_Y:*Y5B_0]V6<$T5IRX(5QB77S*&=3,38!%<,P?+G]O*
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M1SY_IAH=D&O=H007+@$N/>L9W86[28-3Q9:DOG?>S=T9JM>*VT]_G9&L.'E
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MUUU< DIZ?K[/:Q5>971117#>_!D/G]B-2\$>;NJ\@\HZZ&I[VEL'\098B&%
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M#4(F:/AE]%52=5%JA% A,>*&A!LZQ*$RJ2Y,[)V&_['O1\*O,=:8WU_!"S/
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M:%GT>3<,*O!HNL^*&G3E^T4?(\G8+717"#PZ^),'Z&?3&F4FU;^JN32N;6M
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M*>](!M')NN51[CW1L64ST@'@K?KZAD2OH+M?DLR=[-[JC@)9X );N9(+:#9
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M&HQ0$E!4:SYNP$*_T#6@/KY;S%WL9-+.KJ?C<>(DMT8;HAYI*/Z?8$Y"W[C
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MV(G*[[(4-=N58=#W(7L_2Q":D%V(9"#@PX+%3H!86 3]$.=HSTANG8_I+#"
MXA'D]TNN[;ZC.W\^Z'+BN:#&L8P)_Y:7:2$BV[X]*.1]R]>=S)9J;*54)ROV
MLJ6%F&&<1WCIT.'%(] N6CI?EUS8A@4^=]O'@1^!;YWC,??C5&\N+^F/^EDA
M,;$3[P>-/6:?X"0T;\;O!-'M9,"!&$ /%85"WS(+%!D2]R^U,E?DW)(*JJQ-
M.FYU3GH?= #C,JRE"(JAU\FUO6S9<US ']$8X9+4.@HOV0^=&-6E#SI3\SJW
MR-:E=H</*W'LYT,*J[->AA886'V4+" %(K?O8:\?M33G9#3%TGK'NF&1E@JV
M-D,HG>T0&M&P5IIH@3U?.=OC%QJR:!\>'9'=;;#?T\=JDY;RZL%V'G< '=5O
M(P,XV1 N$ELN8X(=T5 4'=M"A+:C6]#RN)RV-4I7K*^K130=*S"=9YK_*8>F
MXZ'4494R;'IOWEE[>[J:C3J_@5\(=89G!7T-22=*7 $&RHP![]$6VCGF[6[,
MO##UYKH VL *8_I$4:Y_Z/8&YY1/'JCE<+-=ZOOX7PB2.GLG^)AG.??K[F$W
MX$.@KX6X**>F%]FPGMG:@JG8>:7@;,;4/C>=<SY)+R]6:='N.*<26C'UF7,Z
MP5-DZ')I"RII',ETI,$7:ZOZ,HT6:_*C*40$I3[0#&-..'S/9=A+]6Z]G'6G
ML?DHLU(,H>@Q[%@BRR,(6Q<Z_WT*U#>NW$SHRT].JET-$5P,ILUO'_@2P+0G
M-6X.B-JJO5.A89?"6823!>T?B<#(_,HE; <_U00\F7Z=7AYE1GCH?;'&*ESL
MR;G</1MO1YS?FL2?(*S21&E%UR_,I4\MW&BC4A(0GQ+% KU4LYGT#R..M4.2
MB5^_OMQ.'Q<A#GUQW'AZ<5MZ_B&FR;)G*3HMG#")D<&<K834\N99+&.V$4-O
MJ(3,#UL&$H0@UVCQCG/]$0X^I_U5$^2$=MU1D:]4VN#T8#]5LVL, YYT')O:
M#R&-LN!,IBA[IU4A$AH"%B(TXD:<JLOGN(RIPT.U[\N_RV?M1NOVLL#>H:95
MD?<^^] E@\X/"$BZ*H:0 ]!C^K2H>51LT&9I:)$V>8.N1;WN?39F0CC$%9CC
MN9D6XUS4]]<KAD0D[)"NYMN-&0IS[RQF[7C05YU6)&H+N,"? \NA+.5E$D?+
M^/<MGE4]%M):OG^'6X0[UVGF8>67AW]S@7]'0;$3=VW9*1>1"9+A[$Q:VA1\
M<#23T8O<[FTCXUP8W;*^)I:%(;Z_ MIRTM="X=NVV.=UJ[+_\-'_Z?ZB#!+A
MNH0OR#= ]MX4>E5.GS@;7Z'=P\ADI\J3E]_V"?3\*[0]B5A8%6KA A[.JZ+Y
M__S9JU46\QZ#.#<$1DU1$F$#>*A KG]I7K969$F"CVYZ_>R-I:_*OV=^:*G7
M-.6>G#BSPR(U5)LV:J/:R3!7O2,76AB8G(+7H65NAD)8+<W&X/>DJI+ W,J@
MI]-NC_(]W#W?SIRBYVKQN$K&;RWC%=YMQ)-:C!.BYEU?>F),0>%T6AN8IDXW
M]$)U:R<"SMY%'70^M2U^6?#E0KIBZ%PTJ!BKQ$R'>LIP.F]UJ.]WE-8P+)_N
M+;B353(\8&6D9YBHF_:\W$?H!XYN<1M@7V6XPQ*1"*1YXWZVKQ"V0\[Z[0O7
MB*'W>V(>LW492[DFQ]^%9V]]E4%34;ZQR683H+G9.8JEB@3%&Q)XA#PF3Y<@
M=>XUIQ&J&$*=KR/*MM^C]Z:\7LH?ZBE)N51M(YW88"<3U[TU]<I-T1>%J&?-
M_&R71HA")4*N+R#38_T1GD>G2\#7LW(+H=&QI<'8'7^"HF6]1GJ"?V?M7N0_
MN#W+Y[)_\=ROHCA+6TX9PMO0=<[S0@SR2>@I2(9%.QCA--]4HD"U.V*3_-BT
M7!.'S5I*KXT^>-Q5.)*>LW)_*F5U@MD"6=-1HU.PZ$^6(F&"I, .C4'ZL@ 2
MZG>S-#1!/UHO*U%0J5?1.CIC^O%E!KK^BX>!T?V#SP^IG;?B6#VS5 -[D]CG
M"[]"SATPNFHHHA$Z8CH>\L@_9^++P2LE62^U9V(2A M12 @CV$2=P!,08W((
M'YIW0SM]\HY#>ZB]LH%D^<@8.0G.O4=>[GKU.0'F&7Q?'/5^OW/YO6MU #AE
M5TZ$5#J3UQFM65,XZQ3<AMYB85L*!<&2Y#3%S':BV(SB]QFWMB<XZY,-UZQB
M-V=OK-R\O6?J08N*EMUIU33X*ML4<@(;J#^3R31)R!H<V0<^S_EI1!XK4.HO
MK&I8W&  >VB7O:2>F[(XB=X(B[*5H,8=)$Q'YK5F!8;YM+PR(1M6Z0M><+C5
M1/BC:F":^V6#LU#\]#YTFM?ZW[7ZL,]RZC'43$I]9J<GJE6^#U?*S(.ZGK+M
M(/<B3_=:9]-\F]Q'S!YCBP:>V[^+Y>TWGN&QH^%I-5AK8HLM)H"CQ$0R+$'4
MOX 70D5N:&0H3<'Q-"X@@K-OR:W1:LYQS:8/!IZNMEDI,@F0I;WTY?'^HQ3M
MU$,HB />;N(KE/WHCQ6PE,!AN\:3.T(E\&I@YP-ZNJ=)8+-:55\PC?S&X^J-
M$$G^;/'XMEW3^Q0H->B6>YBQ+F8P%,/:&[!2](/REB T@#<7^/"<_^EY/]D7
M>.6[DGZ,Y_0433Z-+J\- _!6Z"!B_"M?.[Z8Y*<)*GRK>N7O>TIM<W&E-FY&
MYQV1-OG7GMFO8 8%EG/&3'E-(WT0H@ _ Y1+%WK[]?#7'94I'5,.I]6W,VYL
MVSYJ$'-?\_WO2T%?N<#?*%I3YG_P>F<?.IM8V_':C="OO+LNK<J%[4QXYEI]
M48-0^N;B\G]S?[.&:J05SNANR?TC)><H%_"AX^@&B8\^5['E:/#J-'IQ,88+
MQ =C;V%K5MAYE?S$4<ICI-T_&;DVB^TM,.0"[[I$8!&"/YP"VL,V+\D,I&+8
M^6+86]=LV6S$$%1W)Z1?LLSB AA3,B0W5/47VOK\G8'_?1UWA/K__>%3:"G(
M_DA57\ASVLO7>IL/Q*WHVM)U'I=3-B$K5R&/>$@ )ZM!K]MZ]X_7]?QP4]>0
M=\BXK?^W&4[G_IN] <'_3#3@W\CE'_ Z0O'4D]J&: 5KZ;L>53^_#/TS?T:_
ME5-(#CH/:3&"6M"\>%70L!.]L<EUZE[P?N:$/9CUPF9@:58UI$%^)<?KRT27
MN(K]$U7LW0>3^YZ4XRJQE3<PU!*,@*46&P--%,,3&&&,'^4&28Z&%?/$175:
MBD!1C'O.X.^G%Y)<MM<V5V=,,C<]3C,*M]W[.MC/T&:GN \^[HHS6R8&%@T"
MPV&1"M#4#KK+L&U3;'Y#KY0+W!5@R0L%T*@Y@;#*D-JX0+EV8]+&U\FW0L1>
M[4^.5K5MYZ1@J,5H>=B"?3"9&C5/9 GCNI@$1G-%L4,99'^4(=@07.82Q+QX
MIWU68+ZZJ&)PO\NXO:ODN9.Q;1>=)_X(L:4G8!%SQD_F&\ZSNE!(2Y\M*]VB
M; :Z!6P=9?-#-D1&IF?S('O;A4.+^C\&F[^$9$=]XU]TUE,K/YLF?(IPE8&>
M6WSXUZNE.+81%$M%):-KQ2TW06'A95!F!W$C^Q3#M&/Z47=$_?'IX?'@M+S7
M-PR;,J\L6F1IIM/KM94/?<_RY_N=LEYU?UCJL0,@!U"IU:<+HT#8%N"E-%#P
M1^?0CN6@NNL>'A_"9)L.$P(>7]J9M=4OO/6I\>>1GWEL>3XWB,':B3_#02@+
M]4F!(.0=P^"CK;S=XMXNA3\!AMPY]7Q^:?[H!YT3Y6_3]M>,JWRT1[]6_U82
MK)O"PVQH18_;4D.[[E4X'X$<&1J.0W42(G3/<%L!*ODS_JV;:EB004E?,G#+
M;]]F+>VC$G[X"YP7&%_]L6[7.O!GYT+ZN%!RI%*WB#[]<^7SQ8OU3O5C^LI&
M D7U!W<')8M)%2@DXN^Q9'!(E)+ $_J0YEXR6]:9&<*0"<.K@+VM]IE 0$.%
M=L<37/'Q@C6=B?BP0)'L\<E>_P/N<=D6U4W7FYWLU+]CJ$CPH['PB.+(O#LK
M&L<6ZPGJ0M=N?TBKL'2/;YK Q=C5-BC&9O_\W:7H^4XT33#XXT&7?("CV%?W
M%=5AIDZZT618/AYH%E(<M.43Z8F+AVZ?1^N,@OKZF2R%0]OBMR8(5YJ"R?.-
M+%4<BWX1,J62Q]&MXWG7O[UY65WW>=[X@'=45(C(R_H$['*4=+MLTSL?W^R]
MZ6^< [JF-E,:,CM0HV6PB#J+ /<0)2SL(P/T6S"9^:1X6,[+>I>KD:>TRU"^
M,#4Q_J.O<.)L9]LMOV,O17<Q'9% 8^+ZFOF)+:^+6\GB&_T5R2V.O#ALN[+P
ML!%5]>5 7;!!T!Z;;T>%N@UAMN%RJ.7^2RY]0M/&LC^Q55R@\U[EN"W3'O)D
M65/<NOAA"RBJ")>"4]GD4L!L5<K=9PZ<4U4>^E4+K!]ZHA%!1^*JRI4&3N:5
M7OA6_LKA_V";%2#8$_X1D8\W.;'$"=W*1@SU]5-E]F#CO%E&:;3ZT'(7\^N?
MZ.I&.=_QG$2/[*, 7]\I%!25-X>@W(&K7&"'!$*3LW76-/CH/R5H%T\^^73;
MO7/7T?[$Y]G811 .[8+VMH^61[KU51P<N)7?5!IC,DENQ.S2K/Q,_L=93$:8
MO)QL-8;#<#Y266O$+[_[19H884L=/8IGCV#9!RT1?"49D\%-Q#]M.?!6L@P7
MZ)W!0,BW5=?5"AL"@JEM360?RIH:>O5B()J=9<LV[UY_GU&$-+QY@@\1:B]#
M;/>A9:XNNG,!GF0NH(N"$M@G$*Q]@N05\OV[WT_2'(<+J,^VH)FFT^2U4UL(
MKT>R<$3F1LZM)KU*%XAD!3E_PP8T9'FZ.G)>X2<]JEY&!%?L$1+G:>%7IK^Y
M3-9C"*4:_-;IZ"N[=HW^4(YD9A\5JZ>%+L-%M>[)$_'6&>@\*A6>'9354%W?
MD+;^4JS7L7___\-;RG\_;_6."]2%LJ6+F<\XA;#I#$G64AZIQ"[-._"Z_:'4
M>OM0 =P)QZKLSO?%B:I1!^_:YZAJ9543%N^'>?FQ+I 4V9:<2O+9S+%N9@:4
M&%/!WI3ML)_2.:G%V/!NONG4E-(6 \S<R2&7LSL'OJ@U..T?S7 O\=K4'D=(
M.!V:VK2%AKZNO+D1C,JTT'D\>\6&3?!DWBX;[0H/OGCWTYC*3=FPFQN$]VKR
M+>;0G.?":&0DY<1F2^U8PH>-2+SL$Y!?>1"Z5JCMP;9DYNFKD7SM1CW[]I/5
MR_-.=*MT; +FD\#"T4]R_[M$%+\;L@<KJ;^OPPJ0#=C;!LM^/G>G9SN)UJ,H
MMDG1>NCCQ:*G/O&?##NL&2AJ90LYM7IZD>T"V=-(TLU983^G]>EZ@I-+8_9=
M"RJ&JM'!;[]?Q"G?XH$Z:/K0=DRG_H0/+,QA^;//][&WQ0JE$ .(:5=([:3$
MU^I#C3;AT26N@=@+GT]T7U3PFMD5424(R!3(?U(R7C)ERX0S2?WD"VAHZ^,;
M5/VXE6.S9,EFS"]E-)AWK4DAR.#>M/'='7H''P6I8:^H^F9Y*26=D4-O:[B]
M>63Z%R#.$V?&X]&9")Z@CB2R8Y_@3X,CK8[B 9.:0Y]]_T<[5QO/=/OVYRHM
MHA4)H8E$(7D6RZZN)"RI+*0DXI*PI<+4;*BVB"2A5)NGBK06$V&L,4F*/*XH
M>W!%>=IOJ?G5'OSG_GSN%]?_?G'_/__[?G&_N%\<+W_'YWO^CO,\C^_W.,[S
MK!*BC):-&D@'7[D4"%9Y&[\RM%<BOB>UE>DSY'>)?_+(+,80]?S6.!F4GV+>
M]O3H([Y/04#\$2C[:^Y:XKI995ZSPR?P9VR$L$M8F2[M8TA;=,6+, K*H( 4
M>7#G:]=O#Z^5,LD*(Q'@IR#QC)24,O*L0BFX]T/3E4NVL67IX^@UZS>*'_ND
MIE;CGD1V6@7E39[QVY0#)@6^6(#\,F F+4 NXW^(T/_Y 70!\N[3&$MF.5&F
M,!H$D J2:-%KZ(X+@VM4^"Q@EIZV /GNC%-R5?6?4UT(<ZDAWGZ0&$-=*[-H
M% =>?5EX'Q?0*AG,X_2K9=4T+?LH/XSC)](9,3W,[4"4?R\RVD8+'U\8G#;C
MV ,[_+4WZ''LQHR2<%3>NXM%$ %+\"ETB9)+8Y1<6F>N=P&R<A*$+T!V)5U;
M@ !T2O-D)@0(_3OV[\2_H::?+TU%Z/X=.OR?4(]6%,-4%R#D!#QL 5+2U$$$
M WN4&UH5GRC7''539MN6\_./+):PB7]#PU61'B1P6.HM^H0>BJ581)(%CFUJ
MZ?O^@/(!(SO@4+U6HVS<OVWE^4"N8P?A7:B&J,5.IBO6;97;^V>^'CO27S1L
M6?FNQM,;NG&EES 507[! _Q$%]?QTL^E_#G7WN*B'?(U8,['5!P[V41Q/)'V
M/N([[9^&^F/FF%;O?6#BLD,/S,_NE60=WDEDH@'=O*[2]+VP]K\ _I=^WX])
MXG*%-HCE=USDLMUU6 .S<5J"<:U3W)FS3A,O/243AJ?= OT6>\__<\.)%DL_
MJDOE&:SPJF9[7WD5,EH$!=?.'=ZUJ?#AU'#CGK-G]<SV5BU_0]KVHC(/\P[7
MC:/O >/%-@+>2YLET2QM@C9NRDOL3':\$Q9?/M6XLLSHT_V_/');MH>;&4:L
MOHXS5JX&KD)/5X+F,J/'0C-"=13JX(D.=Q/Q#X&[\: L3""-^;FNTR3(^CLH
M^PN[9<CB -KC>4!B08#JYS-$5V6JNE-TC:74;F-*1GI4,<*J-6<G3X22* 9@
MR=@G?\F%FJ;\A_52G9MQ<5B$ZES+X*Q@^<I](D;3W4*S5*3W,]9(DL03F&@_
M >PY*B^16<<)SPT(^J/ZS0:UY>L5QS6<#G8JGAA4+MF,2HK,G]\ZZ$:Z +N*
MU%7HX)>!*97X() KUMT-4$GG<!Z-E&:AIH\;"A6YT8*W\9*%V97]]@7AD*77
M+>>X$H3\-M-Z+ =TVL%4&7,CSJS@76$M2:"OG?K5/*6/P3K2/ VR?1/T(V)K
M"]7<VDQ><:Z'[2,<"&')M$I'6GG (2*X*73ZK70O@;LNUMVQ$9"04R39!IR
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MVY24MZOLT=+6V;MO_Z'#1L8FIF9'3IVVLK:QM;-WOG#QDHNKF_L-;Q]?/_^
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M4W*4V(" >_1D7O"QAT%\RO]\TM.$>>=9@(*E-0LHFK=C 5U)3E-.$HBFKK"
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M<"I02;,(?^ \#HW3]WW"BH6^DK)8:9QGQQZ(MTBF]=ECRSZM[/I4Y+']L)'
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MA'3I6@[0:WL'MRR9\Q8%WQZXB#Y=:_[\[HC2\-Y$GG'OA7%#!VDTY89F.#:
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M/'"2,A'/CJ[ N  3G?:B@?-:8Z-^U31;98%Y1=;8R[VYU"TV6U\J[5&YPU/
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M?]/K1<:9XKO)*B!O#]/TG4P]:-:M5S';91CB3CU^Q'B'\N83UP@'_R\<N_]
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MX.F;+KG&QJO[/[Q;;5)-DFHPDWP+$]*<;B^G_&!+*3)E.0\QD/X7)E.0*]$
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M^AW]KK'5*L$\U#LZ4N%&EOLFWT I[P<YGP:OQV,@P</_>F/K*WL'IXYTGJ2
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MABPQ]\YH;>?ZA*7Q)9GDA6G:5L: XF_R\B<L=_#%POD48.RW8!EDS'>@@7'
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MF6Q0R^_/U;R@)AS"OOGAOJN<?_8"6W=DI2SJFN7-?*V;EXY:?WRU],K*X:
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M->+KUCZA(W*[_,XF6\EO=E(\P$9(";=:UJW##CIA^TGBYI<9D;TJ8@FT(99
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MW7K^CCV(?[%>YW.(+\J^@G5P5$>G'F.N^,"08/G!U(5*8"F8,HZPB\V-7,X
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MKG37T=03+]>5:VXM1W;$*EG4+C4"L8BD0#E]J>D+)2QMCE3ZY*U17XY84_E
ME;?C8=P@3BQ2SCBZ;?OYT$OW3XF[_WX4F2XV82DL,01Y+M GUDME,MT1IZD4
M_? )FR.%-47!J7'873<?_=0I/H;ITKG_+MURU[/J "(?FO027 O=M*.77&)C
M;4&H:90RW2W'+-NRO76B<:30R+RMUJ-XV>&\QJ<K>87)+\[?=QY IG)!0C\
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MTR-\XA,R]"-**3S\U<+ZP:1)1#JM#Q8557Z9_[LA?=C*6#CHX:Y=08N\DI!
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M _I;">6M8P^ZYQ#2D@250;I.0R(Q_"//$$&7_=3<9VYMGED^!?_@'[= .FC
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M-IA,=V".,4(+[=\"?T80*2>7<)C*F=_O]C7.SBZ;')AWCC*:/=+QL#NG5_N
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MDFJL+,)QL+B%D.Z2G?\R/M\OVR;JP]T_<LC<E%/S?X*VORCPT>YML=0FF(I
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MF38ZWO=RKLE7;2G1 X:8]=[^=K7QT>S<.:?'SBL6*S'27T:TM?59Q]FE78;
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M)G"*?]B.FNLX 7V ^_=K/8HSH_'=Z1+2=_>@F/= -RCX,#!H=YFS"\YYI-7
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MR%JV)>\IUSH-\[I$5B'C\*Z7H=;1GT_L5^I00^2>VATUC>)*Z38?SH<33"B
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MF?!*49PBW35+<ECTH<5YA8F%S@^T!-'&"/UUOM)U"0>B=?)NB"B)7@:DKZ)
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MJBO;XV+D)I\(?UL<@%W354^<5ZG4AK\_;'!P0AVHW+$X?Q_X+$P2X"/&Y/.
MX3E;,IE@] V0-#K*)+HR2=6X;0<Z9WVV^&LY5NSSW;:]&#IW,/6RW^8W4SY]
MR(3M$\.OKG>% U7K8/R$C48Q;;"?HJI)^:2Z9DG0K58"7*?+:,6;T;IU)<CI
M+RM?EI_4KV@A:J0]T#@35W,C7FI-8(#1@0-:4^7L*5@1@""*7\[T".<CSE-
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M%N_\Z5P;1[-Z8J$[WMG9+/6XW^XKDAG6%?.V[Y"+/WC;S(M_S%2OP72/LL-
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MXSA=,O7!!05)VB9Z<"M>8=K0EA'^A79XN[E'WO!H68[LBZK8$>M@2SG.B."
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M'%CPPB% X0<8U/&:?<R2Q^3[*+LDS0_\/$5Y+^?(XAPKZ)\:7B_6D98_YUD
MOI@W%68YT>J3<^YNW)I6E&W2TK37]*H6#R4KK+:,6C4[P QF64 =0\#X#8Q(
M$$GP@\EDM!:A^;:BVTEQM;I0#;E3B^=.S^U%VO>@80_4E YS$TY5>SYBX:RF
MR7(5\0(.])%P K(>CL2Y+T&7540$?A5QQ8[[W<!O+?H*@0;K%Z6"M'@-R8^B
M):\BOE[X5+\5:B73'+43^,^21( +J,B,F+XW45V0VO#XPM(<&7HJ\?:J]HG%
MB3K$-0F)X55$\S/8L@F+:)PD0'D*6W1,+B0?"=]<?!61PZ3!R?9Z)Q++'!%P
MQ\ES%2'4!!,;!_3<6*,JK( ,*>+!JU(L\:-0_'Q3%TO"?15!%^=H6SNFU8@?
MXE-;19@OC7M"?$0 C$.-OX/#FNV*-@FF]3@LQ18[;FES(PI^UIR)9?G24KOB
M X43R4*^XY6#?HM+-NQM7_9@E%5;+CKHI^R>3ZIX]Q-:'PCMBIM=1?PPLOW/
M2 W=_5H=?I[HTT"C.>I+/6MMW\'Q^56$B.6/Q"(FU/]K;N[X<L_/1JNSQO'!
M _A(["?.X6EEB%- *YP'ON_G8)A(T+M8:@"HZ<]6L(2YH@PP,_ @')UHKN05
M8WPD ;2"LS ]Q(U$<RR<]?.A(7ZW581E\AJS>9'0YUQ(G,22K(+P2C UHBAV
MYUZDA_V?4Q4NY.\3B.N$%O]WMA ?@>[C&MV"V@AX$R(S(C]*YHRID9[Y*8YN
M/'_J>=)6[G2/7SPS)G_"T359705HLW"ZG,^6(L,/L1U.E*FJ/^/G7KES?TJS
MCL\GH)XYS<$, L;3RN@Z;N GVDC(89DW[VT%TVY?/1?$):"UR)\5,M@5#5 R
MT30[\D80UXZN +_1ZA3KR^*H>ND':]]+=._@YDV@,!X(G?FWZ<3O)U:O_.R)
M7'M0E$R YN OY..8M:6'Y.4?>6O,^:1E@+<!PV3B8NJF794RNX1XN+E$]B*S
M%YW:43]:,6K<9DVW@"\+II+ ^/_6*[U_@U[])/=[#_QP\X'/*!& <F]MI6D^
M7F%'#7T>UC(O[<CTE0I:PLF3JXBS8^:DLSXRK)*VISN>YH8:7A\:I0F+4C!N
MN[.TI:0/[GHT\?7AA_<Y*\\+7+6?T.HW7VI#Q2TXG]Z1DG!.)BXXT]O%PN;A
MV?EK6@2=SROJ'X#Q'E05FBU)@!^)\S% UP6:<P _THHF"N8/MQVL=C[?R6#"
MVAF4ICX 9<<JXE/T!)F^'LR' %C*#?FKB-==?#EU0Y"\&!,..CW>:_(.-8Q>
M18A9L@Q5&#.PO/K6V((($H:VX7\[%)Q7;43' 9/?D2P^@%5(>_HC07J=:T>7
MAGFO';W-#4G[H,3T2/%DP?SRGL+.%MJP,UKZY#Y._MKU728P7HMI;T9^^UP%
M<0I#SLC?$:F=4Y??3*(=1(ZFMY@B2X;F<#I8;2MB(?5YXKEG_0;K P4X&MHN
MA1SO @-MYX9@9<R'18>81K(.(^F;0 \("WN#!IB4#DYH,PG6PJYI% C_6789
M/^94#5O@[]@&8[WH ] '8-%US2:%LF&K@'V;"#X*-=GIS]J 9#U#4?GIMBP(
MCO(W;5<1J5D2YB'$GW'L3Y)C]C-,6C ^SQ+3AO@,:,0V29P)36J.@U;:[/A,
MRU=K%5'J?VYAJ:VGJD-QUR\%SSXJO)AQ)_Q$IXDO06;L);GCF7VMIY54VW3[
MT;NL/QRTS4VI>%A-> ;>:-X$B;UZ>GKGY82\[4D^R96%$^L'=P;7HH^,$/ZD
M3W5J)@3^&STV=P?J]^L67U!KW=K5 <J#^IUT^55$/-::/CI^[FWVDS&;H!L!
M['O8K(N].X-]G]YTTK!N@)W;XQ\E[K.BOIXZ*3C^[-CCUZD^;3N/]$06IZ"_
MT2"_=HQ)R[M"7]?N(HO>.QFU^2'Z9!;3>'O<$OI'X=*^$$:)4+PM['0X^E%@
MQO1OM?HRK$=25,(R&WZ^=;"4U/_!85#4G;1VUC+,B5#8]:1QL_;A8(=+Z =H
M\)^%LJ;'Q -@ZEJ[$W:YJ2RFJDE!= "GR=J3X2_EHYD_;%),N.Z@(I+^)C/4
MZ!(J6D7OW4\5_N^9W[_31_SHM/X[8GY,\$]T_4A)-1")I!WI M4(C<(B'50R
M''_*/9LZM>VR.HNV/H=::PB!&B\_7>V455U./A*09;C@TTRU%;\L,*'8<NIQ
M[]-\!_W#;9*D^X_(E*XK4=CM5+E,T^:)@H&'XT>L*Z2/,!9J15GV*R+_H)ZC
MPPFD/S:D@B_HX=QF4GEP)"0CJ,W( R.SP<Q6Y(@HB4&(7EQ%E+FQ[T8N])UO
M7;XI>/MF_W4[[@<]_]R4(L<GI +@08Y"RT.;,3X39C/7ER)J 0HS)!,MA/G6
MN!2P[_&HZPD.1KR!6*NNE/Z"A,6.+O&8XKAIB88+_>Q?4.?F(]"E[9%!*$&L
M>J]??0]QYLJ,N]I01<AD37_%W!'LM:&J=%'1WM>CQRT/'#A^X)CY<87HOW_J
MSC7NV:,4M!36%+1]XI6EV^W95_R9'O4D2$X*L<'K["^E*.YLN;CO*_\@]-K-
M+F:I45%R4*?I3AH^(C#6_[LZ6SZGK"QTW4+])R.+$/I)H'E&MDZ[P5#AWF.W
M\J.C7Q@]MF+?+9WO[")<VB=1\H\=<2@QB:P@1QI;3A"&\]M,16A)R9I0'I!;
M[GCU$L+=Z7V^5Q=.O>?+ P$@>M#@.CHTT$3'KLHKOZIG+B=+93JI1/6<*25,
M_<P_-MG&^7*M%\,ZL*:5(&DJZH.3Z_:L*>]FG=XZ6&2\6:(BHN&U_(NI+/6A
M+__$*NJ?O4 ?B!\.=^MYP1=,C5&L$OL6Z9SLC+IV J$<G72:1HK0^[!_P&\+
M[4-V!D_Q=\?(TM):M'>,XNX1&Z-;38J)2YJX@["G;C*5&S#E!1H/H$[/@ZKH
MV#-!8 @%B%//QDPZ!3 31?R^%KFJW[.E92?ZQ7J$"O#II-GO19[?!SNX5/;=
M?)KBEWI%.M J;]O:-B2&/?X<+"E2B3W\F0RR;,I?K)/Z\(TGU[SJ!)?(15GU
M-H"23*@BS0G2;:B>[01P&S"WCSJCZ3.!G&46OO+.!<<66BSJM_?D:6@$\=_=
MLIWKM7&X?E--&M48._H.NIG[,$Y^TZYG+S=_%$'?0=&L45P7 'D2I1Y5V37'
MIO3OPFP8\4%'CYPO0NJ//,J_D,8;_/'Y\ED1>3V;'1-2]K>L+B!0E ("[0@J
M 5TVU#0O# VM3;_-A=,+'-GYF52%V'/9IOD3-?=F6>>"@S')76=63BGVCO7N
M%EC:L"G7RJ.JXLYN5>GHZ5F%X!2"]^AG7X7S;^8^) 5D#2Q_@H7 A/U((-8(
M'&9J8CH84[3V5KPL1ITZU(CB0V.J&B"57E;P8W,?;\W(DOL4&XN[HZ/W4D2S
MSO**1UE8G#_]PFV6\&ZI#256KXA[A>3';<9>[.O,3_A.CC94R*;..(:_WC%]
MQ=EL:^_%AN'8C'U5<A[B'-\ /"3%NE0+WQC"2%&+[T\DXK0YW' =&4VVXV#0
M'C';ZOX'@^-FU?)C+JFW[2*K1 B+9R<_27PD5&JS1$C4X!9"J*DFNZC6%R:?
M!^S*P75?]XPN9EF?+L8$4[D8.(5N_].17Z4.E3V+V=Z:WU[UBDS8$[JK1D='
MC;V3F+&*\-G6OXKPE;WOS^ !CQ>]=_WBE*Q):$=NFEI(A5[V/C+WUC7RYN9V
MJ+L9MD-:O[),MZOB8X7+7N-1Q@[Z*F(N$;[KVI(\"BM-OUI'UV<VN.N ^!PW
M%3PVZ$&[?/T3G[S<MZ5DYPUF<D[!R8T\+NOFHN<Z=VF=,2?>745XHX=EJ026
M2#NCFYUAJ@NU A4&K8 (Y@IULJU.9WRIA11%V%CK$U#L=N$9>?YJO]*W%TG.
MN7'!WD('GR6$/3[KQ';H_BX<OK:I6?YPCI=AY<T'H%N#S!F7D\T2[^U&O"33
M!DNJ6[6W^/8:>8B-EU3N*EJRTJ/4<]/TJN9,Z-^L8<+#L?[EOF(-,#XKCU]%
M@$=E].L)Y[P</FM6U:O6NUR]J^ 6M%"4<UMP?8&-<N;9%UX4Q$I4G-5':SL;
ML2A'1(':2Z7!M)_ON)99:Y !F^9^G!:N0Y_, R,5[6&+E=<=$RIS4A-WL=KC
M@L%V%6XQ6 .O\V'J=<>S+Q82I4;.\"3II[S]N",F][HQDF:-'HX#UFG%4[6E
M6/;]K!.^ 0:M;OAXF5[,G3%8X/B6&IM;6VZ0=\3IN@4U[)-L+*W7646$1V#W
M/,6*PK>/P363:78DT989VA+\B.).^^EOBR>69!0_?' M=]I%&#>3^2#:CM@D
M[JF10W*U[S472I!V/KOQ,L\#X:ZU0LZY>:89U@&\1Y^$> E,.TQUARO8SC2=
MV>7J!1G4EH@0X\J];?CE]W_F.7AS%WYSY[/B3\_Q2'V&*<S9]6O[$0-89]A9
M]5(8@$%B)Z$N(A-=J^:,R1L7;31YOZ/DWW=Y3JC7U+0DA4CU<4BF,9(;/)_O
M:)4QDZ\KS&[<^T885":$Z:&2R#0T<M23 =$N2!MS^NH1F^=T'/&9OD>/5MAP
MU2R<P);R)&7DW0V(?_Q26>]Z-$MJ'N+MH<U/>,Y63&B/YC<C)8U]*<1X-!=+
M[0:5S D2;.ACV1)%#RLEVX)O:LIX^/N=MSIX[9:R@[2T]+VH3Z>$N]\9SV\U
M[:MZ,V+<>6^T1F["I(!*0K*TP?%K\&.Q:-JM)XW:95CNZRK9Z7H1A&;:].5M
MA* G^XJ:H@.-:LO4MV7S^RFAOKSJ>JT^)?SG_('$EWZ.Y?O,,[#:R$(J6&N0
MDTH>&6V#A8A/6%&9XWZ$N3[?DB8S&8W;;.LY/K>!L<E]/+##B">LT!4;@KV_
M_.TNIWJ9SBZ"'\S[&UAS]B,4)9M L_*/@'/&^JW80_U8D0E;!=#Q/4ALO;[^
MJ=GCNIPN98>3+BDUFL5:#V+ES_,=0'MKRWPZ*@_,G1TAS.5>*8(:D7P5-?$G
M^1:VEH$3$_*F#J1AF6,OB[9%^VZF3#L]VV'!N6UP\/P]1FU:@78MR&D# N-H
M03?6;M![PSWO// (CRY&]X;:[8[>%'5,@F.-.#1S49"7Y]+^77*GXA L"JUJ
MUH:NPX#A1M@;EB1M?M::WD<]7T$1E@,M6YQ6$0HLZ0E_.?>92L.@^^56:3*W
M349K6DU:9\=.G*W\[..]'S=[A'MJ '<<:#1#G<XDOL-#?%N8AD#C/N ,$&MJ
M4$+W;R'A99"A.%40[41_E%TP"J9;U+ID7=ODWJD1NL_?W^CB>X^$]:F2.D)N
MWQU_-.4GQ5\J%91[_%BHI[&)%7,US;NKJE-X]7=LGDO1=S(+;U83, P3=,L)
M16W&2B#Q*,HM,NU$D<'X_)P>?8+J&8_C@KHE_;UI1]WI52U%:(<R6EK=9S7#
M8S-7+M/K/P>(7SXHS>CT"Q8M>[;2QV@#G5%^Q%&S1E19\$U3%<RW9D//IF%%
M.JKM)-"09=Q?[F%2WG.H.CCJ0V%^@F[ZD<Y@M?9,P;I"S%D#^PH#2(B33:B7
M8@$P*ZU87K:QKCS5F8TXH3JZ?^2\A^_MJ9%B M?M1F/;A">[O4:1U_><=3<X
M7XFB1!MN-V")\8\[M1Y&'ZT;P-K3D<W/P*IV4Z4!OXR0#YY.M>;>Q9ZI+RY+
M>,1R'XC;=.NT'1_BB_%A.'F@T( 6\@BG(UA MZ3.MRS1%A7D^G3]N3%&S6CI
M6LO<8>>\Y_?R:^Y?U-[L$W_/W3?OTS53*SLV-8!&9(EP,Z[UH7S1/%"?)*'<
MH-T_<:5V3)"=6VLV[L^+=L-UFVJ49Q[LG>M%*FYZ8YA2<$?+RMOL-LL\6F*%
MC;Z+I%W,9X4"/EU,(]BQK2*^2"YR3))I)VVC &G@+!)4(<T.Y<))7CF,#Q^S
M3GO22<WU&^C<"8LP6^KR)F-T8WTKY,D7,9[XS@SSJJK@6XGCS;X716V'R3)K
M2&A$LHRV,BT\C&94@7.T_+;!P4_E2#$WEB]=H>J"ECANUMWYPM"0_M*EKVV?
M5.7"+DT?QL+Y [<C\"J;M1Y&%^4T I0\7;%RCFHKB@EIK%<@T8/C@SH.ZQSL
MG?T$Y_7JS,@H?F<EAP4;I1*^F*?\DLH(CFVAIC#2#I,$&FUPNZ#W@!"DC.5@
M$W4S^;634 B6ATIDO5)].E^K_Y,=*9CL>JO^]8E9-FYW@O:*!1KU;W\I<A4F
M_ 7 ;ZK/<F9G0>)>9$YL"!%SE3'*2*7M')BO13WN\-U2\KP?U]1D$1/FX>(W
M?B>\[<S1I/58.$QM&,6XG0 _,.VA823M:**V17493;@-';< 6_+S%S=S#//N
M%WUBI9Q<?VK7PQ-NQ>/)GS5>_9+K-',<@4UE.L/^2J<"-<JDXEX\QO4"Y?DM
M7<(@TL;Y(HN30HQRWW5#9IUIEVS74[3N0??/7]X;EU@D';(W7[<Q[]%MA;4.
MRG9TTMP]VLH\XRD["E)B'>O':6C/LB<PB\1(4QUZZC>]P7SYSE^J=GHO!9\H
MNV;D6[7S_2M&FOV"Q@72!5PO"DF$Q%V\(0[0X\$^JFTL3E.TF8+G>[7'ZE,@
MW];ZVB"NT2D&LV>2(+V<HMK<J;O3U'\VF&F $6:8@)<)/)HL;X6J"6&Q"Z[X
M.)8/<6PY (TAN+S(T.\/TH\0=43M<O8X=J)PYXTL#8K:9N3:[F4K@))"$*T7
M@%Y"J+73;S'J$)\]O<<4A=U#JYA/*,:>1B4IQUOW;RV-_%JLX=';S:-9)"]J
M-5YEFZHC0\JH:8;"H":4%+0%ZD:56#;9)I$D%X_UU=I/(*-6M,JH_+NS=SX,
M#M:W/ZS5;]R6]\NMZ%0NSM[:(5B.<T26N-/).C9>ES_J]KA%8F$+23:(&:QH
M<F[NHPLP+ED1L!3_\@ECZAA5]6:E=)JW:=<B(7J>91"2OZP@45>2T=OF6:J6
M_S)1OO962>)XTZ6$A#R^2\>>< F<"=7^/:X]>K+GHK%US@<0."XFZS,:'!7@
M'Z0L>O'4OE'EB\71W%$.FX*X9%@)M&.XM:Y'9D#CY7)R-*E\J!T?FZ4)BC'W
MNM3E-QX.:2.+5MPXV-7DNG3WX=31HLZ.-N:]%OM7JIZC>B_>'WS;_'WE;TE+
MZ"K"<SYR%8&$M3@%)2-&=0S3>D1#AQ.Q;N,A[T;/KEPMR&]4IMF*36P_(J/?
M/I;D(I4X_( ;]X[,SSTWP/3"J##\:"HM\PH8ST.@F[*["MA!!,7:,](2/"LS
MU-*/T$8K[M"C4J:&BS_M_G:ZJ@(O$#6M7SS:0J8=$>9F'68_T/./(XGCM%BV
M@/"^\4X="UIP>*T>/;/ENDEJG%ML1LB+P::%#<]?I'X><7>Z_3%2>$Q%;A7!
MVCAI;@$__6GL=O!)P71P-3'.5 F\BI0$)UNN%_79AA1.+\44Z;U9J-+:7QBP
M^4NRF:C =@ZTJQWW1^%_W@.*DT&M_&94 JE4F"5&9OCTE ,C /48;D<92!XG
M<V+"VZZKM!2Y]WYKD3E0.9(T7VFLT_ZY4W%TM.:E!6V\LI)7I1N@#-LN(Z A
M B,84EM%=&M^@650@/K8#:U;10R/8&!(:O7=%;%B,(%FB6;N'\0A3^YCJD.#
MJPCY>G%P9.1]93C5!TBL5QJ<,V_"?XCO$'1=^3SV5?[=^SS.6T?DK8OY(1X7
M.%W2!#N8 2PC,)G&S:CMO:A1OYO%24_(D@235DZH2]0_;+*F1BTKV4GJ7]/T
MLQ] '.Z>MRO8;,Z,;\E2IBV%8TT ZKSD3%K&^=2\X8[@)Q><EO@%))]9Y'U,
MLSPC(7),4L,*L>XPSAYHK!R3'#(UP/4#E98L\0F;GN)"^#[IU-HT.+/7TCKE
ME?3$T^<:H)R^SUG@B93DS/.SU^)W>:KV<RQ6L:2TQSW;R/'(,G)3HBS%'Q\T
M+S0VBNNMWV!8MQ3]7=KWH;Z!#/Z=LU7/QD,^FN]WW<*\.1C04+2*&&F'>.\_
M@<ADL>^=9HS;[#S3;1B@8<6UV9."7(_=1;_]I5N$@1F[X;"<X[!D8#'^*4[W
M\IDXU8V1FKIW5P9KVQG)(!N@Y738TH2;Y=<)BV)MZ%YI2"Z,H_5K2_4']IK?
M)QYO(]M6C>&-P:XWR18*WMFQ#:8&L+))8:H8I33/.!A =;U#33BU)3I1'>_1
MQ*A;*Q-IDU3N^/,A\1TU;@4N6I)OIR]^O3/ZN$HSQ>5P\^8MDGIH0WB 2J!Q
M-TX#*P:N(U3ZSW8R/; 7^TD79/TW?2G!G)]&R;Z7M96X8' ]8H?I/<GDFMEG
MKCP?,XY7):ZS%!"<E-YX<'*>]&X>MC;D; CMD^E&-[#7Q+]-85M_!5("'$+7
M+5#KZ:9E5W1]'T_[\B@7XLX^:WO\POD,T]BEP0&W=I#25]B%ZD.;<'V$4C(,
MNB[,:,>9ZM'\6V -')/H-W:A:(M/F1KU;Z[H\RO45+B1T__&]X&HAI$,)C?)
MSLIW<KTSYU<V/].3*=H%B>[T9^<RG"$RX]"R^]4>TOEKHS6[NW:WNA*5V*&U
M-^B>5.*L#BV8ZM\>[QG?EK4%],B>-E5S.26RAY31)+WM? +'IS(C2;6;Y2G/
MJ767_STS/),X3:P2Z$&?&*\OH85/&(0NDL0P:'29?O7;R,(1#<90@*C0H,6F
MEYMW**6>$^#9+-)COQ>91JXBS'+#!G24?7^Q2W@89IDAX W(8V8HDIEZY0H[
MV%E^QH?7$V..6EGPZSW"4Z5OSS7I;+!7],E+TWPJDL>E>".9J>6%*B$EH<X)
M@^>(P]\:EDC"M3L@B>=]VCCYBD1R=-"<T-AG_:0K&J+7@B\=<75"^7"EWUI^
MHIXBQ^8T1V#K:,$0KQG-;3PZ(G 5$56O#\[1XZE 1&#F2[]R,C?+'@S?]N11
MN_(NWBTNBB)M?M3$ 9?-+W:UY&V,>*V&M.LQ1QP?7&P;+'?KE-=3+U *]E%6
M7&C;>WNOR\'EY!(N]>++O-Q<0H)882F6K#>3:U_0M1!_NMM$O\.TU#<R^I54
MVWWKPZUOWI[-\&S&]AJ5Z>S\=#?%>AMI[^,'PG>,S>&DP8>=;+R/*>I-HMF^
MK" @ITA"LQ5/*MS 0*),ER!4$:39DJXQM'1*6BOZ_C9V8<!=ZL22-WYW#XGR
MG@"J0/>)4]6#91/:"=4LF:OY_M<#_458KOW:%[5EI!W-DS#*9TK;#H:^Q&Q.
M1H?\<7&4W'PK,0(0P!EC#09--V+/TQ32J?[\,XSS0R[=%9GF62-?%?>-O&R6
MYMK =;DP^R;7.I0^RA_U3ACBRV<:364AR];FFZ!>R) ^U*"I[^-E?)II_!Z3
MP8_>^.A6@J3/862+CLIHQ'F!G -#-AINQY0.\AQ@6^>$FN+8Z;K(=^1V9&DT
M:]?0[#(EA!P]M@G@>^^=3A(::9MOKF9$^U^1M=R3QFM<\UQ%4YU0$6;S$MN?
M^DH(QK#A:ZM^860!8Z5\EAZ]JMT_ 2W&4GHX9A;T"$11\2W2>H?U]VRY9<WW
M:F.23K"XW]-7ZU^E;56-V&9OM1(5A]A>7/5(OR)GS&OJR4D7V1J7+5)IN[@R
MUKUV>I,8L^7DE5M6NS=?NC @SK',_%.2K8M#@\KIL\V>3$EO]+/V,*P;'=F4
M)=-3>V#D.SZ&I3DQ6J ),*V+MS[WN:?=/W\__@W+2OJ2&&)3-[%?W(X[@27%
MCC&5Q:K0S]^F(UM1&[%7Z$JM.&1)1E<SI +>HSKV?PU\?-ZN[,8]":4P:64[
MD4FKB%Z5E[V[6!6S_3\7K\(YIBO4H2# +JWG]T&6S;?,2V/@3((8,WNVE"X?
M'46D5MPX,D"OYMWFE77 +$%$=AOE3:&SW#%T*??L/8K_NUQ*92K3A*5*Q\<2
M65O'F0<J:%_O44_N5Z_LV^S0_CKIM.C!5VE32J;=3Z6\-A$=<D)U6$=SR)CX
MYB7#;9G41#/SC/%UCY[D:6R@"NW;:@Q^Q"NO,SWKQ]LFQ$,3?G<%X@VGR4*\
M,P68K%4$(YC>E=0[U);QOKHK;I&X$0PSV2]H8Y]LY5.YJ^FL]9'+A_PR*XLI
M#1QHRYZ]2$/<&))VB' 32;,O,.$T8S_$^D_<TX4U]]:,ZX;H\;D;NLR0PP>5
M VT:>LP^USXMW>VPL./D7+G6D2NU_K#E9</X8M<7.U"'<0O,I</>-8J:JGR[
MJ5X'S'M<?^_JRWVVY:.CQNI7.1%7;3]K65CI+7X2YTBG$+@P.N/$B,!Y!-:(
MEI69[>5JDN'J;:B//R=?4?0+SXYD<_%3&E[<',<0Z@YKVZ/1(QX0CS]3&3>(
M1E;@1YRH[7"(2/"A)IX?4W<YUUVOZNZ\S]=;X=#59^9"DJK'RG;L:YL,WG/^
MO(G*[-I&_0@V'/P]ZHS:"V@>K611,6<P^D%K[O28^F#MM2LW"IQ'+"=]W=2?
ME [F!\Z.WK[_.G% '/\$]BY=-]0AP;RU&90OKIC>0-M80+YP[OC]M)&A"?T\
MN5,U4E<JG 5@K?VN8?UQ"';,9;:S4S02XR H,4X:[J.TI0=XCA/YG3-]]8UJ
M'F4%?U"R42Y]^?Z51HK1RZ_7SE\UF7GQDR#Q37MDB.%,\YQ+I;DYLPDX%4Q'
M2W5P)-;28VMZS*RQ'B!1,'V5F-AMK7-@05'N5,RPP89S9QJH=?IQB 7R,"?C
M$,U@UI[F=G -^6':6X8@41H[QQ4,/D37RI88];ZEYO')<D?LUK,=@<D$K^/\
MY0).V9A\\WJZ5/37P,,&K3)1\7I-ZP\?/>@LV"(7=O :_96"%1?VY7NQ!#F1
M;#@6C#.%@,8=.$Z@T23(7XP,O87VT$=<P3ZW=!>Z>RH5N='R\;XG%W:I"5YM
M<SX4J_;6.K'OZL#[38CMMFL]16_3E" ^/<\'7D Y/I%U95OB^(W+\CY[NUDF
MQ$<$?^\G!Y)B,3*JV*%41TL^=PO^NLK(5UT]@7;<;W!KZ8X=U 5(!ZIBI9E6
M6'NPAF[0'' PQ7H<+<URZ$<?JCF[.7_$=RY+HH8CU$CEFY22LLR*4J,I#\VS
M&<TS-88 @\=-#/9WEX?HEO<&^BJ\-O)QV[WQM&*<:H-SM]"ZQPC'/'&$4QNI
MO)VUD<RP8A?6HWR0Y<16?.PJ8M-0JTQGK6-I1S;6KO99V$BO\=VY4W%R&G9/
MSI\*3WS[]?*;-[C7L#=&LU, 2C*Z%#WK*9PT.GYC*>F[$3DF@^NZ%JD0)+8'
M9T2R'%55ULFZI9W6?+PM^(S'.=_7"3RJ#_?1PB%>%9K9.#YL#A('21-=;?ZQ
MIKSEU=9S:[U0J!K56>EW/XI:BI?$3/@\E@A+]K_4V[R0T'9)??JZ*@*ARI>+
M"/P?UYC_=?UU_77]1US"J\/_"U!+ P04    "  FAEM7&;7LP/.K  !G]0
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MB.E+C9_>>E (.8-5UF]+Z#!8U<KT8]<#WH4//G@<MQ1K!1$;HVVBJ3HD7!^
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MA_FSL&)"DBE4!/'CUYDIIDE$OE.X?LWMC5B9#U=>'!G1$&QI>31?/M1VC+(
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M;$<T2TAOT'^.%NQF'UKN41@M&#-Q@A0/4/\(/3S8NNLS@R;FX^OGLO!^>G!
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MRYYY-Z?MWOXN]^O6Z.2 Y1G/&9N;+1>?KTABY=%$#+H1.N@ZO]&+K0ON-\K
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M!3I_(ZNX0]%*@U35C%':0 EQ U6[EKI-*LPPY8":OMGL[;Q7]*Q@3XY_:+_
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M7N;YR.?SW&9C"L#Y^'4TY<Z1[9'?#->@TK,9U9H6]GYX/S3%W@Y6N4P05_?
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M=D]@K*7IUIN$]8&5>Q]L/%4UF .<_<]23?ROW/MS(BS\GP1S+@T1O)-%]<
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MCV]W:9LJ9K?97@Z/]R6_]2?=2M"0W=S E&9)H>X$!8N"YKWD2ODM3.L:2D1
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MV<5M^:]%RR*')1OKMU2]B+T;+$)^0GY+Y847OI\^07R__2JF0'G,BX[I43L
M8>CW#WX(W!C82M@50-=I75;F]*(TYIV0MX_ZFD-K^LOT.Z,;GQ=A]Q[;>%CF
M^<Y/@SF QL)+_9R^?]GVBT#,3OGAG_8%?L^?MOT8?P&^VS=5C_ ?^,O/R.57
M+?N2UMSJ"7"T4>N+YS_E"1X(1_X1?%"@N+7,;35?C8* H:?@L'UAO;4K>Q_X
MNCIP FDP0#'P@<^YFRG%SRES4H<7OD<^?0L4.DV9U"$CV\#A@ZBG_;;U5QQ*
MI%NKIP4QFZ@DL93<P7D327_+>N0M.(DGHG@J3]L4G9S]6<_)]%4MR#[4'35H
M<3:0/FZSAB._@B'8^0/HT%X<8OQ%4-J<#R)HQCY-?$=YKOF048_I82,"4T_@
M2QWE.+K<J)R=EU;=87<?M^Z\XZ]USLIZNEO/%C41A;[%>M0V)4YM-$PCJT##
M@YC>=M0UR"$2$$@SKM):'IA4V5N13R!)EAME>]+;1FL2KRVZZYZS5O^#?IQ.
M9.42!8\0P&<=0(A%W1'J]$+J%H+M*:B7JIE)15V%KLD &=K@"DNP&ZC2AAA8
M9R&?O-BYNT(BT+S64;\MNW ",\(%1*?'_:FF5S^H:7J-CU=9Q5G&2-R\LUOG
MZ:Y^J3),[P3K*?KD>DB;]:++<"F"^O%GKN@@,9">.:/B3E8=?4(\D#;LHMMN
M7]LUEENI'Z5QKS:BQLLXHDCO^B11A/.80GLY'UZ/ =PP!9@Q.49?%4YD!BLW
MW%6AS;2^6AY86C@>'?]FB=0BVGB<N:;R.7*AHG,H>X1G7OC_'">$^M"J?11W
MX:,L4TY$A0+!CU%79A\8?I QU0L9-@,: ;F.VWN&GP$7)\I3/GI_K4_CW*,X
M8<*H B"-5"'-"2GWR@#/0,26@6GB*J:]^P4=;.^X#I^?@.S^.XH8MT23CQ$G
MS)/["ZB]LZP33/*X 5.!EE/2-5T&+H*$Z/:.FYDI)!_%D(EC+YX5WAX^O/NA
MH(X[J*BW&7^JH<>Y[T5\3 ,KDQ$[+C)(Z>$"M2F2G'A$TSUE,13NYRG#:(CT
MRQ'6E;/;%N?V\6K1MZ5^<;J!42=N3>F%.CU8(=($]MU%!&ZB:U6US,L+2WN"
M,F,3BB@46RVK%THP2F]@XFFUR)H22BMLGOJAW\A3.;%8<U*@,\/^K&NO'.'T
MEE@Q8FUWDZ$$YS;%*[97K:9"GD&!)<+IV!JA9J'=G6-^7L8+*'L'- Z;!IW2
M"9#*N>0-;CA59!J1>J^W8<648N3&R=M7:I0[.@ K\YCR/4\#CU;K(0JM^FH!
MN0Z].UVNF.2=$G?88OPJ]$5+=UOADP<B0EP@[!F$OND^[" %%BSB O0L<41@
MD'[_-.YRZ2TRK>R3*_/QT['0)!5;KSKSTKAC[$QRVN@O=HN/DGXGI=55)\'S
M!RFM,Q8[5_YN.NQ?OO<8P93L$;!=N$,\T&E$TBUB<YFF](=NLQ\+L3)/T0TL
MU>E&C(1!'K'@JB3^F$*M'WI,_*?:K"6_=[A-89X1\$>'V]A)_.7O/6T[FAP)
M/1X9)NB=?\MJS=HI$Z"R>-(SZP>WY@;\?K:O2.7!LE]GS3V=(H$_2!/^A]PH
M\HK2*V9\=W B1BE.*II4+WO'K>]IO)_RDA?S8US@)W_,8J%/6M>(H<4B<;$#
M9[J1?0E_]Y@HW'5H^&5)YGP)VP */Q9.PUP>B*TN/J\:B#UH>=/F7*5MPZOY
M[I/_M!A1[&U<X/5+2!RI;=;B B;K<ALI$3[8.1FTUU64Z<>@[V?<I-I#9"D7
M&%;YPQ?+%2__\S-&3L;2,I-?LAXR1(S"1G>_*+087+HT[LA&\YZS+P9A)L[Z
MWZ8.T X1< WRR8 )78\+VT^5.M/F.AI$97C'K<JGICF>7Y)_42CXZ]IB?_ /
M9-UZDH<3]QN1=G,OCJ?:7ONFKECD5'OAR$T26=+I3Y0'#W(!2#U\7(X=0'R-
MY2M?R]Z%5&/S$X;J'/;L9OK$R@8:MFW[K.TV>=QAP]W&XI/J83MB\Y_U/O?Z
ME%!_/.BR$4#<1UA(-I:#5974@J&0AEJM!;RQGA%5UXM-/ID\L1?B/&QFN8?W
MA[G()D+KC]88K;$^LE15.("XG%-(H5$<E:'/C*8J7"$(BVO5D 0J5GF"HKY9
MYE*!W3544?49SRBW@P-IX:?2QZ)ES3;7">6OW6=ST)5SZI(T+,&:101,V'J;
M..F@!S6ZB\*'K'GY$&ED4H-U&]KU'8A1E49AK;9F5FOVZ=^]?5:CGNBRVO,U
MA7839!P%^X98'Z [?@.QXL@K0V4F6)EPSV0@ME>\OE0R(Q0_H;!3?IM2NY7)
MFHZ5K]+.L!R/:':>OB:G"F!-O_Y5HS\\<ZM_0N)EV%YME"4W@*QM(Z1Y:PWO
M!,Y+U!J\>AX.*7"!1VF0G2[JG-)!9A-Z_4F4<'M7_HIN$TN(/X'Q7#V6#Q>(
MO\10YEQ+QB%Q1@X)X(HOX.3FOT-]9+B1\LEZ#RR*7GT8Y=O5 7]CVP14'_E.
M+MS7BAWS03F_B>;H\/S/Y9U=#&4X <*BX'ENN2&J5#OD%JHY2/]RK<@ORCOM
M U#2%:8-8YX:4H+!3WE5(&H@OJZ7L,"]XF?M_S,9:^L&D&$30:&EIZA"6C3J
M%9!A"LH.]\LPNZ/UG5C;J==T,>NES=H4VK\-)1LE'O\T:?]ZE<IJT4=\]1\S
MOF"<K.\AK41AZ./3KXF.^IR[Y:89ME!+38YZHBPVXDN";_1%@45S7=*GUS0O
MYT2T?EQ7<&-_9)]+]..PPR)OR.\'D:4E3!S+E9D$:YE?IS .D1?#%Z \G\T?
M1G!BAIN0=FG9PIH/UXF3<A<(^N]J=P%9+^)<*FL+6=91%09@E5D.;$GS4JC#
MYB5=)JP?,#!N*#5(BM(W'^ "U\][ZET,NIZT_X6I7IO&'O7G%PYK7Q/8FQ!3
M,YO44*&$(LM:W'(N<,I@G_E2A(IAF%-[A0;V%9_Q;SF?(E'<5:"6^%;;]:F=
M_=)O2=A:T4N+>%Z)PCI<X$I4A0RQ4_864903@FH9B0L4:-7=/_LI-,27$5UT
M,[4OCR;W\M 76H/;G8:WC<8=M!4BK1YJS>!IZE)"8/OT#FH$MJ [HJ"GW)6N
M+?[QJZ'<BX1I4,3.N.SULP+W184UFK/N9S]:#MV\UK?*9-FFBY;_*5.%)93K
M&&G#U01>R)J.B29)ZULLN380*_AU5O;QRZ<?0HYT=4EH*0SL.KV57_!!_BI
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MOOFJC0)]1F_8B)J;%[1?QK/M*3^%1.3^E9H,=( #.ZK_=OC-KW 1YU<IVM%
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M]2^\^]$(U%M!O9H/[KQ;1;X_^ 8%Z3Z1.)R_T28JEWU;:(Q=Y=[/X+K Q'O
M79@,5^F3Z1N"[]\= M6>A(%&F.B6PY:_7VO;[0QGHG3WW>S#<S]1 ZK97YJC
M@-^;M W-W9_ZS<""+$SX GQRJHRZL[A PX='%4I.4;GPO\FHO[WXR_J-?^%M
M5!I0L>97*HKP2[5AZ2I>[#W=DVH2E'?K[%&>[,E_SWCXQ,>IN4"V)"C%/%?5
M8Z!BS!1N;BD-=9#E'^8BK=+[HA);8'32>+J >.$K,OWGYN4+5&$%-VY^<@$1
MW0H%_.XJV ?6AZ^!)WB&Z/(Y+"@'M*3^S?^_3<O_FVM* -PXW?,"$U#1%_2#
MYI/K88K7>!SAEJ!89-X?^HS>9?HUZM^F*.]2F1FG@\H)A)Y,^]J$E6@6\G:Y
MHS;3G7.HGH@G9P?_V;'XJ/Y_F*Z_#=/?^KW[ P*?3&SQC'EGJ)-QM-5(,42-
MTWSXO[$GD&HF@I.M+9 '")/5XT0WV[!%Z?\44-Q@QD%I.&F@CPPKT$\FX=^J
ML46D)>BQ1+R-J#D*#?ND,$^^X#^=)__I//FO=9Y @R!C4=PU+R#X)D&H>=>U
MQ.ON'Q@P0GTSL(+-^J00)HYOL_3$,__>DF3R6\PEU&?;>ICV^E!(L#T[>S\,
M$Z\3X);BN@$+*5@QNX 0KDN)MDCX&X=:2GT?C\%3,W]4JG]7ZR")/PA'L/5[
MI?J[81SQSSOX28O[0_,8PI0+Q:+T]B,GSP'?S8H21,(Z-.TDDFL'QX$=MRIX
M :&S[R_SEN 0*F-'_\CHPC/"VW!@CRQR$A^_3-@.:>XGC^"^&TX5K7X-?^PD
M%CJS:%=A5SKPLNPOJSKRX/"/F?G+6N+_Y_;-_M<.VM3_@F,#4 8)5H1]G?=A
MZ9(^[X#- 6#T'ZL J:*69!NXSB?RY+W_GC2F.EA) VTJW#AAPCP@NF&'S0F?
M=^#:B.RK8]!3[EUP>YQM@9CX3[?)_X_=)I1P.!*?B :WPL&W8Q$YJ4I <,C6
M%MGG6)KG&EM6NU=^[?;P'0_8%14CA1*%'L5VX4L4KPZE%(X_!&5%\A'@CM&9
M)"K7EIQXSDKF<<;T%QKM9]X2_N,'F_@9$5S'L]"YE"''#?RK'5)WB.^PRT2;
MB8U8KD.IDDC&FHE*H.B_H^P$D78=!"Q[./(H;^<8%VPZXA0B++WG/6@2*W;"
M]UE.6[P.MOS\\F]6'@<PXS,-J0E$#? C-[*1I&&I_NM90 T,HAUYFW1K**2,
M\Q9?GF+\U)8<"S\(3$34+/5A>S;4Y>X L_*&US;')5FM&%^:EPC<'M;:%RG-
MZ=F\_<S(A6M2H9'N/:C'[HVIB@0I82Q1CH#D)1EHDYF,*]I:'5\/#WW.-,L.
MJ5<D,WF/\Y >BW/.WI&2<) .X,]=0!RNZ/KZ8)7._N>4ZJTTN2PU?^NY6.-F
M1/ /TAG6:S#RPQ!I"[-?$KC/80'1['YC@/B*RCV(CJ6<N\)5Y9/ TT4!F:H'
M1AR#HUC/UH:%ZV>F?^;9[])-6M:G%9V'+-<CIP L1_C>P<#X9RL5@ 6CYU W
MT B#[B48P3K'")M@,@N#][/[XE-!W[=P%^:@#0!H@!-JVS72(5U D%T_> 3^
M;@A\2P?(H=0;G^@IS*>H.)T'PM>^&6+TS25^V#?ED2.K)JY[(QHQFR<ODS"U
M@&#U8;DNF'DCJNSB,I(%1)/+ D(>;GHO)0"=42 L,"^5,$1KHK>]TH<=$7<<
M:+!%CU,@N&H-;K .5;"#=LB*9#; IIAC^8MDR "8@&#KE=%%6K#9))07$ 4"
M+OQ%"7<J9!N&50..D0=AGRX@: ;^HW[5O'96!3_;-*LF5\-@W=2K"6FUH^.J
MEG-Y,B;N&!8#7-<+*9LW6:&>]'*(EI"1/?G1:$WRR;=D<XFS<F*-OMMV/OSX
M3_P\BCL%:\1BH2KC"@G<^'P!,:HGGE10AP;/J4+*KJ+$&=B,*Q;G8BD#M,<P
M2,+2G*@",!_.+2"NYLEO_0Y\I;[_&-FA8P'ASP W,6)GO=#RX]1*V(4O3TT9
M^%95Q(D4]N(,=9T?/@L^LQ\!^V!R%RK !:L)?^('+E] 7(&9A00<]H4O%[T0
MD[J "'.6ZNMV;T5S8?+(K*3.GD?!/DM;0$P'H;\/)#&^Z0H>_8\AD@H>6$!P
M/1GSEJFP$>P7$'.FB MVD#)69%^5#F/A'O2\$^RFWG)HKS"-RBP#5,X>KM_!
M$^>7@![W/1K.&OK C_',9U#OD'-_BL3ZN.-)[.S1'P21L]1*VW/ ]P;_40CM
MTCRYHA^.B#\:L_!'3D2<ONGN_Z,(K>&H\M<(*>'DY%I&PS8K<\)V+Z'JWJKN
M]351ZR9?GLVZZEQDR*%ICOF^C=;X;ZY:ZO<1)O8)^&.' 5:<L%T8L[A!'F-I
MY0."+0Q)_"S0HW@$$Q1R-T<@.7JT4^60?OR:8]MMM[?@X1!7ID(JU:)4'3CP
M%='"-[M0OO\G1!/AP7==MY1+/!2D6"*2D1IE+&> )4TH+2N5(]B)B*?##(PP
MAYA[XNWVB)"'^7L/P[BTDBD#5T@^7EB[@!BO6'3%"RV8%\63QQ^I)M:;QS5T
MW=WH1E8KXJB==0#HM&_5&LP9)9_3Z1M;*C7V.96\BO("ODQQ'^H/ ZQ.=#56
MJ$*"JR9^'^"9 +0"()0Z;X"&GU,*U@.CP24B'93<_]I8[<T"8CDV ?CK/F=_
M[AYP6W"UE8;ZZS9F*)X$6/R_=VZCRQ0\MV$C(25'?B^(YK9[@%FED#<8LO->
MLE_H^MA7C>!OF,<T/#_C9:4%^\U9-$19S16F4(-Y.:P+ME'^*YJ"#6+S:_3S
MCLE+&E\>2 63%L^F^^LF;A=_7V5>T+^GRKTB+24!S"<Z Q>#)=H"UM]*=I#%
M>OXD'/!=BP&/"$>*UOWCROQ;[$?]?@5&<ZZF\ Z5^71$D?LU[@H!+? F;*I^
MW+6IH.+)99'"(<!0K6.-X8?J3;_DR5UW:-5]Q_@^2 $+7WT[A<0'AW;L<R+G
M/!.NO52XR4S^S@8<'%9CUZU:"BC;?Y@Q<+5DL")9F,?9I2U:82E*]*',MTB@
MG@!^_&,ZVOTQ6:*M6KX;2 A#?9]][T6;B"TP%<6D6&E?;J0J4X,P5[+O7JF<
M&*9)03KEUE4G[78-YE]1@\IH2]BYMV7FM@4;Y]_PKR&$G!C:\(JCCWU_+G,T
M53;^<_W>\&L^FTW471]HK->_6SO21FT@Z79Z3_XHNPI_X'%L/=#DRTK]]@5^
M7C'XA4UH,=A91LWHOVZ B'=;,4WECI,&R:)$#/R48MUH,!O]G<M_?Q,D> F"
M<0$-8Q(3_OO>_XK+GZ^2';1W\43"_[EUXXOOJC.>;00IE? [>BAFD\ 2)EC-
M?8^;/:H^Z)S+FA4P5K_U6[W[FGFHVD<=[?0^&-;_+TX,F>_[:,Z0_NB+"2LE
M&,@MT<Q[5/%Z&W0"1474294UJ1/DK*O(!J:\'LSM_C7%_51G;6J6\I@<K_>&
MMZHBF'_-?[N*CL3>=#>+M*>AFZLF(YVH#;DS<GCWINV&0%RK>XE#X^VR[I-F
M_$COI40]H=0_DRWD1B0C]<G]'U'?=[-&4YTLQL .N/U<)IDI. #M[H"<1E,Y
M2[$"#&T>Z"\5O=[]+;#<!WH1V_9B8J>>>$? /]FEM)%2>C?P C\S+'\R^Y1J
MAGO5C,3[.]WZNJY-$V[L\&,V^AM67=ILO>H=K#4_,"2 ADV 'TF2'%._Q9 \
M*@Q^046&5_98:4.;>[_RPO+ <U]79B\]GMBNM'^588MTV;U<?>!F4]K-W52'
M?W 4W8J/J$K&%4L[-JF_N,5*@9N29B"Z"Q16'#KW"\+;?:@X@$[4[QS/DP/B
M>LPO8*//[C1VK@XHKN[D%.2NGTAYHG?2BGE)W^?/]DZLXN(N$HX>%P2"7:,2
M'RY;7C#,9PHM>MI=CED^\TONJY6_$!W<._ZG129RF[ ,VC"*UA2]L=K"38TY
M&X_[JB_4*B@OC_[I,^7]CKV1O*, ;5+CN=$+"^VL^UX5KH/C_$Z,TE>[PS>W
MDGZQ7O'DSYW7MUC.2UTFR(Y.(@<Q+:3E1B8KV9WA2*E//56>B6+OVTU"FSO"
MNL6]J7_NU,?_<G&G8;F> *B'::;W^PVR4%-7!'H,#P_""6$!%(:\ JTNFU I
M.8V,Y<AUV$8\K#!(3Q\5_&RMT/+68RA601GW+/BSNTA>@?OA ==1)+-:@ 0:
M=D..2F0:0QQR.2K;:E&7.A20&!$>U'GD%7!%+OBLHR;BF,OMIPD(P58DJ$N>
M:D9?5+7EJ2:*]":(AF8U.:.EK<W)@9;[<&8+B-;1HW=?+J?,W+)5-ZAEKDH\
MUN]MO(!8DB2$V6P +@&K9&4)9QC\4A!2U2,8"\.F_["?HQ.J92YCC2GO4/*&
MX[[WCS0L=5[G,K:R:L50M0+[PTCK[#(M7>?QAO18:ZE5"5 ^S$@<0!U7D ,G
M-T]8!>!F)/-OO##K\H2LNDP#OE6],]UQ\+$C=6UK^ZJKGQYZQ*G5)EVR<8:;
M"8E%)7H:\A'F4E3Q )\J3$&?0B5[5G,L&<MG'0V6?D5K#=']V?IU=4TID:I=
M8BH9_+07_C6;F]5MM)X_RF_8]1KM?NQ+_4W!?H9QP!<S_]"IL"0^F6X$&C$@
MI4(6HX7>']R"K<;$6FW"#S9@52A+P0."9HH4SRJ3_7RWOI?#*8.DF9\\35I&
MAEY?N_EEE7W1UJW&QLM>,4Z(6BE;P#L\);X]Z,439_OEAECZET';.[XB53TK
MM%WB7+,;5QK>\)-\_?/;935LM3QD#@1PJ>PK'R'5+R^H*\[.: ;S\#*#_",]
MB@"2]N!E=E3/7<EJ&:V.Z<^O'V7'&-0DP2"X'JU'UA4^ 9C)< -!T87$>#A.
M"!L'ZMFU1"GQ+W=9[HP8=5P61J,N7U_.Y5^.E#/ZI?;DG1CK0P96.RG[H6^O
MQ=+[L[(PGY()O0(/LV)!P- D\-BNL31TM'=W??PIT3:P%7.3S-^;OE7?(7_0
M?IM%^I2<0G1;9676O2CRVH>OQ#XPGL3!&'P*_LE62$' I"=6SL17C_S$(S5%
M*?9;1K)+);=QOCH>-= .SYA_L55MM*X^17KW2]53Z-# M#!% T*K8)_H)0,6
M.,P4=%7<5">OF*\O?$#1!Q-I)%4KTT\D)&4M9 )>87LEGQETBUU 1%;EH^Z\
M/M.LZ5IG?\8MYL0*FS74B8RX^P04Z,B="%&R?E>Q3*IQ!-&E^&I:K6PTMFM7
M155E<L^&\[*A:8-JI&7)3])QM=9D"2[Z8BDU<"8U&P,I:["C"@-RI<#P(BRL
M9&YU5LX*]'=G;@EYSK/]W%[QXO,@.3U$^5: @:>'[N#:=CN$5+?) ;LU^RX=
MOKWUL83'?FOMBN\/ZE@L[3DYD3L"C8S6VQ?$R[9O2EKALJM--Q<A_IP8 #1L
M%ZW'IXIDR]FH>*#R8PM:%4RA,]?'$G"G69@8E&R% 7%F7]6[ZP/;QD@>[[+?
MVK^G7'<QV;WCO&:#O*ZV5VT\<IS1A)0%&L.8.W$-V)!@'"=YS8=6CO3VQ#?Q
MA2,[6Z9$*[[!XE'RUE 05I;J,Q//>&+>5(><2KU*DJ(83V1H&W"ACTI>1;S=
MQTE:[.OV96ZH0FD'385=&E3N02?W%C37YKEL(YKK;-2OX<73I,H9$+#^!9 _
M:/H0GS+C_+:L8O#IR^R4VYEG7IX=?#DF37JV0?/>X;E\F4%1G3 ?[8>5@U&(
ML)[5VTNQQ-?26-[Y!78/[ KPXDWFZB:4-==9;JR,"?YP1MBIM!4GJI/3CHX9
MK!.F/82>+""D#H#1$R3NOCIZ/YUF<2I[<4$O83=W)A928 E,&>'W&<MVZS]/
M6S4&930[C,LE+-6();X!MPM,#^-]^09<S-0='M*MNSAN%QA1A \[5-]!L#Y_
M;^CGD$VLBP,[2K;[Y!JTZ+RRN+Y4ZI(MK"-A,',%,0(;$9VJ 4=$_\PAL'F4
MK@7)<MV;M-#[02,R..@6*6BZ/6!2VYSDOI7PEA9L><U+DW IP!\A]677?!?_
M'3<SJ1X0:$">W/6T.T%S3CSY2B[=^W%'I9;9N831GL\A5GAFQOH#*[5.G#QY
MS'K)3]O),0 S"_N4FD!EYF"Y'JA$[./J%]2KWCH]5C\%DR0>4=8<'E?GEZX%
MN575827/LP<>/54\^/H:P_'&EY?QVE]T[.I%=SJD7I#*45.G!;M$;P'NST;]
M.<SU3:0!]U:B&O<U8^F4*39^OOH*Y+"6?/5K3E9IR-W*MY0A&\=ECY7H'Y\J
MZ,CB?>04QL@;A+=$\E HC*/>0$-(_6J! D%;6$"(9#-@/JE&5)L0K:GEDIM0
MRQU*,"S]046[@579F*PUUS$;5W<! ])1',U0]#Z1$>3-1;X@Q\TQ%$6ZD^OH
M/S_MNWC\XH?<B?.:=LM*Z_5DAXXXZNB>IJGYIPV[6>O*\.C]5":Q,!_RXJWG
M?!2XV/D7$?;PA.FI<14AVM/SZS!28%2HL6]^JY[/]:-.8>:D,R^;3SQ+]TFJ
MM5':+*4D. .W.5LM907>'OBZ41S'2'"4\#.W6YU(LJ0H9C90MCWKJ*!*#-#D
M9ZK4CH>G3+//U+^EA]6'K#%1*/CI+(PV5P=:.1&C*'#M3&,4CC]*Z9ZFK!H.
MZ'*(""\K6;8W4CS<O$^WCO%EY4#72S\C >W:"2'KPBQ]T)^O!<)<5P(!;@"X
M2#Z<7S%9%<MVJSKH<!F),Q7ESZI8PP9W#Y>=2S]TL,;!=TD4[08I&V".P"HD
M "DE:L<J ?ZX%+1B.&IE'Z0%"D=Q/^%EFVLK[CE\-5#:'Z"3E.GC&)-5IJ-Y
M+4?.YFIT'O+Y_1\-67Z&^6XIUYT=,>7&N\R:@U;X,S\V(Q,]6QO)LF!5KT@5
MAK&=ZT=C*[626TB;&O;>Q856'U\C@SV19MA7?5[.V>@V9M+V)/YC@[8"F,4L
MQ;+H34CY@8EYE>?W,,63%FZSUJSZRFRSE,,G7.?2T[+L9TW$/C,X@[S41FQ%
M\12.A;M"?5K=I#](5Q)U5+GT02@>3%*L(TX:DN1Z1DZ-K XL/9%R\E+CN^SW
M%[>=WZ,R9?[KP[.0+9QH31V5. 1D!*X.%.R!CF*6XHU=,P_P8O.L-D\^GJ08
MW/8PK7<9#EH^5-IZ_>V^KOK3CHJ2*9L35"_R>B%U 3>,YBWSCAH@U H/\3J4
MR%)M"0EC5=-(G.>V9<#C^AW+)H<K2VLL[3X>V9;AYVS9D[")IWYQOG<7*NT<
MZJ>*+(#)EJ7W7< D 2LQC2^I?D]& R ](AI?%_ .J#B JOBV@!@@$@E/W7%9
MY;<Y=--9%,=%H,(0O2)Q,>2!NH/<3(XX;_><(P813#0"P\,?0H=[C4P!&<9
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M1[-]]<:#&8;-B8I.45YPW+/OP8Q#'SA1,I,PO[X5G300D4#<");3ML83MCR
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MH,F$A5K&=:"2XKX;L.WU^M/VH.H;RK K>Y7V5JGJNHGQ:$.O8/3=CPGOZV=
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M$ZUU,&?:,B:> I:-G)U534IK_@B%!HPW.L#%]X45.@<IREZ4\[X+$BS]W3\
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M%8OSP/FM#93^')7&J+SQ]*LUX@+#]=%QB?B6]+6U8XSX^Z[%YYJ-^!B+K!B
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MQ?443ZA%NVA?M)GRV>0<$-J, )/.!PMTFZ)[>["-DEM]X$Q-_6*O0NK0VE"
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MU\,E,V_;#SWY42GVZN08F:?K,(MX1C+[$2$$O8COY8+:W >CO"AG,IAZ".:
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MR?YD['64LXR7+[,H"7-UB#/NW!9_]Z2'B"7I/)-)<G,$(7'T8([87AJ8&OJ
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MV7I7I,A$R<+!E":VZ;_B%<P1LV;:LESIQ#YBYF+U "23T5[=FU.S9:]YR0_
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MUL8XL1VB:B]^NS;PN4Y][Z:7A<>,LK<]<8[6[NI'WW2SC-1K/A&7B XC+FS
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MJG=.=*GKCIFH$@WN/WVUS7!3??W<^>U%^"<X,7",=8.3#N[)PET&ES,S]%>
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M]&ZV]/5[H]71SX:)5\LCU\06SXP]5SX[="0LMV0[11N5X:[I@HM92#]@8^(
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M9%93JJ/Y0#1('3W9VMFFTXK^"0NJ$ZFS<6@$WHWK%C8,B4BS2?OY]^<[)3W
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M*BQ8UR<I-T-1EO_1V^>(A3@"7\D-X7D!F=-;N<J@&R.85<06X7RE+B'*=._
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MQE]E;G:?/9/TSDW,9%4IM!/6J\ 2P@N33%&JP7#W@ M,2G,ODZA %\T.^NH
MED;ZI0:^CM>PK7AJ+9-]NWE-GR=B51W]X55S!8[\<HZ$WF(!C(,ZE1;Z*I1M
M,3V0,#L]4\[W;5;5(!VO^W5.W0_VA9\SI.^'B^3O.7MQM';J1]UWOZ"#,*"F
M\*M@4-NGD)% I^FT6)I%8(2^G,=9RO7@T<RU\]Q(,Z>D/6[E._=M276*VGN;
M'C1!D]TI-Q\I*T!B>,AP&W.0Y=U&^K)32N_[)X]_<SA^2F']G*W^!YN-X8AK
MZ7MOK;EP 4,B#-!+0N$0$XB-HE6R%MC.S9::O3PMIJA-.5L^BU&T3^= W_3@
MD[E'/U/GGIX-ERX)$JNO%(S_IJ0M^(;B31KRJB<5Y]<'(CF1X.EQI,R4I2SP
M\4Z(Y\9>GAU1KO=S1FOVBQ8#:JJIV-@Z1<Y-@8/7XME+B#@Z8!M\E2Y/P9D%
M#R<T(94)NL.\P\7=Q.+Y3IG).D.W-26]H;9TKWB=,!FC&(/7!],U$HK/4-.P
M)[KW('=_I@ 'Z4/;N,RZ.';GN'$VDQ1?MQUX\Q K%D"4J_&**&K,M;N%'W;;
M2F*=LT\_\?6(P*:S1S9(B4>J6,L*8)U[AT_T!)4]ZM/3%>^HINJQWF]_D7$$
M]6#3U4:3U5$&<-99@P0"*2SYR@':+T0YR$*C.;\ 0RSH0#8GV;E.3?D:V)O?
M0'6J_[K]3?@9NRT#D^*R G-S,&:VH,_R=W&VE?!OUJQGDF-'-P#O8F+=/"O9
M6M$U$:'^3,$G1F\RQ2]J+&9_-?%?2[V6&9"OF"2R@%Z#/MT931<Q=\[E6;-]
MJ1@5WD&V3<SVB7+@4YRE5MC=<K,D31-G[^8A.?6HK=Z8VS/R^A9==_Q%4O-I
M_\6;&W\_?S]_/__?/))+0_\'4$L#!!0    ( ":&6U>YU_^B_JH  '+P   2
M    97<M,C R,S Y,S!?9S8N:G!G[+L'4%-OM"^ZZ4U NH 0I0A*4VE*BXJ
MB(B-+B @-4)$!8*$1$ Z$D$!@;]$041$.ABEA8Z*@!2I2AJ"4B01#5O3WO;<
M^\X]=^;-G//.W#=O[MSS,6L/3/+M_:WU_=9O_=;>&]X,CPQL/VGO: _P\?,!
MEZ ?@/<=D#IZ&1D0! 0!T.#CS0.V #_?W_'WR/]W" K\/0H)"@H("@L)"_^+
MB8B)0B8B+"PJ(2HF_G= OVV3$-_V]X^_)_EO4_F%! 2$Q$6$1<3_7P]>%R C
MRE\L\%R 3P/@E^$3D.'C]0$P:(U"_[(\/N"_#SY^ 4$A81%H&1+0%UJV0\L7
M$( 6+02M&/HT ?H<$)01DMU]X*BPW%E_$8TH^8.)N8]%-8\U="N<&Z-K&0=<
M2Q(35U3:H:RBO4='=^\^$U,S\T.'+6R/V]D[G' \>?Z"JYN[AZ=7X.6@X)#0
ML/#K-Z)C8E%Q-Y-OIZ2FI6=DYMV[GU]0^*"HN*S\2<73RF=5SQN;FEM>$EZ]
M;NWI[>L?&'SS]MWXQ.3'J>F9V3D*E;;X96GYZ[<5QH_-G[^86^#O/W_]X@,$
M^/[O\?_HEPSD%__?/1#YZQ<??^S?+\@("NT^("Q[]*R(?Y2<QL%$4?ECN8\;
MNL4TC<_1%0*NC8DK:IE0M!E_7?L7S_YCCB7]ISS[5\?^AU]SP#8!/FCS!&0
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M()$\''$-U:[\5*NULGL=>6'RB[>6=&R\</E5_U?Y#45:+GNVOYC=IW%DOSS
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M_G&ZJM*GX43M]\7<*8VL3D:6L.87@$5B)G#*N8+<C\1M5[@'N2-8^9_8':B
M/PZ9DGYVK;*[\J74=7::G*OJ"OVD5VM_Y 5^#LY\S\G'7K:&.T_"P["X4F4Z
MDCD\/A_ZLGCD257TLW<CSV07/@5[O@F^N.8V_\\_4HAW6#(>5H]?VV")HSW
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M,5O.]/U@8-"\<=O+/C$>2;ES\*Q6@9?/G4_2FB<>%5!GG*^.L(GWOSMJ%:_
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M;GB_^A5_N2GY5$Q,P?NYFOH,VG7-@F#A4_6[NR_H_52#ZA85VZW3N:V?[*+
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M&>"9)Z]QWX%CR[;/SR%0X\\E4K^*G%B-&I($$,#H*Q2#;S<> JS@EF'X>-,
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MG6@^<#I62GG1H#_?<;J.I?C()($LG3RQVV'J5>*4+1U-=HS,-J;%HD=VLGW
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MKSCWBU4DRQ=2BY.+/H\)Y2+*N8@;OH1U[-,]A&,S#=>F:YY3-#>Y^L^XY 4
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M3F/HW^W:A-ABTJGY4G \0)=I" _H,XBFDH*KS[*. '56;'F&& 5*I[U7 D3
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MI.?4=H+*_FPA/-4X&&O-V-?(S! (R&PV6%$3K/B2F*G2ENNN*V19VA;]IK[
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M\2KTC=U]0>"*WL;2=T?F7HM'>K87:TM(OK!,X"(J-:>+::B1^B#;1@S=B)B
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M\>(SHFTVC&:W#IQD^3/QU[&;'MD 3]"?9V4S'\#D[BYM(^M3XJ=Y"->1*9S
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M?E0@<2V4<W5PTM- M2PK/Y2Y>MHRW::V.-0U0']0\4E#X^91/NS^N_ZL?;K
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M)D>#FVMD.'==K>>QDUL0-9YL4,E8;)<U>9PN%I8I;S6A?,6:)3<K 7DYDEO
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MH*,O_T5')R7_TM&#(!T=?Y+CD(%N&$10X/N0>!P_-@S)A>T^B_:@.Z+A5.2
M)ZR;T!+?(?[L1OFYEGHJ!Y\W]E[(CVN3>D41N4XZ(S43:FXB0JXY24O!(,9\
M G ]1"@(.LV8D]3<33D%JDM:1S!Y 9<Z*_G,-]]A1BO<*%:AC:NR\^'\%T.*
MV)&39M(P2K!7^:M@!.5<;;S[0$,%/"(BO!)5Z%%9^<K=1B6[P[SBO['4GS:O
M0$FM3=A ,'-94+3()!J^@A1%&2UK9V!.N@42I8U#EWF^Q;!ZSPD;OYS7TMR'
M1(4T/#+US<HVS.=/E1HF38*P?V4."BC,]IP0M+/JBZ9C^_987>W,EQZT4*!
M*YDN!V('SZ2Q51G:/=:^H7%L9]AZM7%*[I-X6X[(X2\7%%T*I"R_GM ]4'9Y
MC.NCJ3$S!B.*&NS!\6(#1P&5B$&H6%#;^=I^;>[@,Y]PI-'DEKW$Q(Z I^=K
MW#K7/ULH3[TQLN+.PYZ&9'?DI0^#;;T5&**;H^4!]O(Y(OH*-27HYXT6P8.9
M+Q?<1N]C7UU(\EQI:FBVT=)RLY?T%@NY8NX3K8M(AS:/;FI3)UD"C5VQ+%Z0
M9'#T 3MD/ERL"*IG@$B&OX.*(3H77V0M7GSSJNF>TGM;\>2KF8U];O"BXY(.
M.]!T!K8*U< ZI#[5=1# TU*H5KT>P\3Y4C@V/KV4L,9/R#$H-R8\$DYW'-@R
MG@W,?GQ.>%YO'_+X31*$C2;XX&]W>K/;AXUUG]WB6JXEI':/ T:][G%Y<BHS
M.U&>>E_&:\:6JVM%MH?ONR4R?N4Z?+)D>U\CV+\/H;AG LJ(:$3WV@IL(;%;
M&LE0S1,FHJXN>ED_)T_82)_ZH61T,IA/YXV;ZL_QF!P>2"&5F 2CP''S"S1G
M!&%EY5 RW0S8 #])&'.2P3\=KBWWW4OUH2V=KQOI?0O)N3W?N'5FYI32G6]'
M\V&=^Q#KXU7.E@@59@;>%S>?3QYD2,\&+6\GP03N"C8$0P^$V]VY/*-:ES8J
M5X8,O:5T)O9B;T016X)F&OQ]UFO^H_%/!2M N0NC."-B\10X$[X,B]X.%VP&
M4LGY?9F'@@P&U'EJ-$/T/(HOB'5-*><H'S\9V')4S-$WYZ*XI>L7Q45].(%(
MBQC'B*Y!9<)AR?;GE[>%KC*+>G_)J,>&O_[L;TZ[[V$NU?KV\1_';+%;#;GI
MCX]!"AE1TS]8BDO8;G48Z:$A0OQ%6^AEUC14D ..NO3KFFJ'A*KJDZ@TCZU]
M2(#X#F(KEBKCL ])BL7P,22IM8.+V.75]&K,I[TI["']*#D!+8M;9+<=5/IT
M/?:&VZ)9O8U?@'1,13TN3S_DPGL2%($^SL3C?;336'S4@#[H =:XEXPT(KHF
M'9]1-O.CZ$)^;XYO&J(7_68X(.<PN\[3T'(.TBP/N1;0P#-$=KL1?(W8=+FC
MS$9C!<D$8_/[=X)+;[P9UMNX-[-[D!#D<#0=]][MT2 MILLAQ/N3Y2T6#[;;
MI(N--0IF@@-1&#,306S$]\'$&6X CK+N(8 \3U5<X_&N6+NG&T1EUFTU;NG,
MGWN#J^^KU[W=<&:Y_@(#1!@..P!)XL&3YK>3;MF2/IY,:%G&)]T*YIA703H>
MTS^\XG9)9UD,TDKOK#.#HAF^8%>IQ7:?P@<P(WJ]C@#M].N JG4K-;RX>#5F
MT.G7<N',5H3[YR$]A966&+\_I7G.Y\(Y8X5XH.J@GD(V>HJ:,YOW(=Z9*9KD
M:N?I .;SD.IPM:]4S;%)@=>6*B+ZE;8T7[]C[9^XH5+#PEY&I0!7MS"V^XE+
METM<XQ?#?0A[D5.77X-9&-*GU>E(7Z)4I.2'U. G68IFW+R0:6;G;P%!<D#/
M-J"<F-AU-)#6]C6AB2K9<ZS*=?V-!H6H5*@A=_UB!N_[ZH>MKD+OLLP/1INR
MF(584@61 L]<$"5CJBD(FB^SBJ&P A4+K!M27DTO0Q@6*5DO>+GRO:Z>NG&K
M0$&K5/YAC.XD&OW7$'_!^9SU;W!@B'K*U=,U"$OXIZRDJ-1K_<Y:,\<;R7P'
MUUY=PD).!L<D1]KCSP>5+YG*@?X;0?-2:A/W(7_+'CNP_:!$I&'25&68NC=K
MT=8^KNDL4[3-QXU>M%/^^4['0J#>9K=>6#6+G^MT $-DV)5JM25*MV<1Y#AG
ML&#T9 #=00)TR[!&P*6'8(!;GB_$"FK<=%N3/#W56/F* &U8./R(Q[A,.$;X
M8MP;+K!1B\!(I?@WR![MZ$+8%HPJ0VNBJ.23M(47]%BR5-DN^63RC#CJ5F"%
MVX]BN(#LA4\OA,SD9_)[!!?*:18 DSK83VQ =&=FLN2HJAEH'J&'_25')GY<
M?!@TW&&Y4"1S^$6<8IS_R5;>9=<'B#PBY4KF7 0M@!D-(WW&$;1!UQ:RU(#*
M_CUX8I=*X&S$Z(I,NT=RH^>%;\YC986?%JNK0Y];Q]U^4>3@$?SY8EG#(\0,
MV$$1'%V'&/H-DSN9$+36F%XJP# ,>"%PH=<FQ>CEFP=<#T,F.7_)*0T=3^L[
M8+-N!PG 3! Y&'#Z612O=GRARX"@$$K=>DH[GR52;-5CZ#_IW%;'_:>QJ1U1
M^'Y(-;?+ETE*]CVG]DD)GH#W(<[KDF<WSX.*]_DTBP<S@I VQI*UH]ORNW-G
M,?*HX$$Y];:9Z@[#FN%_*/.:C;L:H[*_!OF&ON9I^;BY#2%4D6M'=IZ<24\C
M1/5^J!L5M=SBV!:-[N6H?,:?6")E+?^36_]/T,KV7#ZH(&/"_U8$Y@#:DYEF
MJHAZ'XAOO%1)%C!<T7Z -B<O+'KQ[=1/VDVL^]L.^3U^/,31D;$@=?V<@E_@
M>ZZ7GHRK4S#24R+%#03?.LFDG44[4V',*$RPD3XJ@KIS85JU,;6O2W6*\<K;
ML):]%!Z,O#$B,5><<//3<K.\9R:@BM\27($F0"F.. (?B\=B!2Z^_L]J,BD4
M=I%:VV/$1#KD_:3-FN-3H$U!.7!=O?K^X/ S2@**1DE?YCRXHR._,41G>]P3
MNQ' *2QMEJ*=JA!88ZJ LNWQ.DEIS$F3630X5;@4*6IR1<O_1,ZIQ2/0^O*X
M'6P2@G*7:^LTM>%<_-<Q!B=%MY<E,*TUAMF@6]+I1O;6L7<UZ@A#6:;;%BD0
MIG:M'+,.PX%V8;[L4'W!$*.X#!1CE[<3FFQW\P=+E"EA3S7U6T,4TS8G-VL,
MZAJ#OOKJ7%7[7&=Q5&OFT1GZ@3/6[2LWW_T^?EM=AFS8AV1G*%(,7E'5R2[)
M6W=#^2P;@XMM'3NCZGH/[_DVB)Q]7:$Q<K9"*=H,IED%"X"E$BG6F0"(6)L;
M%!S-B_FB2Q'H7;;:$C*V> D^P/=!Q3Y6I1M$&?1K>3@VY2 *C7D4_4/"^BY5
MC=0?']S8Q4KJ"P)JA@R)^V3!S?-DDP@G>!RB8;1WR_177XGL1)/-UE&J=O(.
M[+BKW<:[[Y.$!4(#9[.J]Q/=MZ%)DI]-^="J'=26P=1M0&UWR^AEYJ$;?,N3
M3]$G* /XHV>7!,=4<I4*[Q</AOR3RTCENZA+?UP:,R<RK&OS2_4_&19(.+X.
MMP6EIBYK;RW3+X$M4F\Q#"EF2]+F)Z!62'HEFM.K;_-,SNS-Z.S9?1Q)FS1I
M:OH];B7:;IS*'V_K+20H"Z;Q8S"-U4R5,)]P]8896-(S/#^,5 8]DCA8F[#'
MP=+LH&+*5A*EO6IHKP-:&Z3=U5I:FNZ**!F\-Y"?RU#V[&Y'SCOU_(/OTP;.
ML-.> ///S_[\CCD 2"V#W'<]/Q 6SBR-8A97*)FW2;AN^;Z'1CSKCY*BGT==
M'V3QPLBVF?-6%[ PTFYB$P ?, E3I-<*+[I?K*]-T+P:!?2-#R"_.L5=ILMK
M*K5 _2'3%,M,:BIMEQG-$MF0,P$2:] &>.H^Y,%O$R09SE!HZ,RH./^I\.&H
M=]#M0W2!61&U2)?=2I&.0(?/UC@=UB"^/J"_=BZ5Q7>^DB'"?-REA]J']"'8
MPK5CU6L89I39#&.7\&H/%-(S;V>YWB/HAUO)Z6\9D@^'-:X.U#?D=%TBCM]7
MSQ0 <!8EHV>GY4O>Z]%$;,J\MGYZJ0;Z)?O&/\BP7CS"[2@EQ4VJA3Z6,V4F
MAPL"J@B&Q"Y)M9\XUTLV3$M(I9];[Y*?Q.@ DGURFIW3)+R'IMZBUDO?CCRW
MY+0LV_=;=7E*9R6<TZ(Q%2X)Z,M@@'(Q?5C.IDRA(*@PYHR'NVH<<KF.FE$=
M5(I8"BHYTI:/S#]8B@WER&L6*?Y^[ZJM#&3=&I*R>X81!SRH0DF204E73B-0
MP=S:[I&&QV/XO:XR+*89#F2$A%UXY7J7_BRK;^N5G4_8Y-&@O)?6I=8O<U?O
M<5LWIW[-CH;9L Q8GQ'U7)LKP<OMM>GXQH@XM"G:YU:H8%QU35/2THI[<.+E
M^&J%M,9\[I&U7\_KH]_E<.G'4F99O!YT3L9U9NDVUA<93VS2CM<?36H^^6D"
M"(9W:OV,E/HU(77OCU/'?<0_EIM#7[M(!@8P/1 2"TUSR7C L(%VJ)%Z),ZE
M[B,9&3L^TL+7_D_7(\5K-CN6?J8CP=\% 75D?(<^:1\"EAA#M&>CQPM:/[%P
M"6BJ7'-FAS=;G^],7:-4>LB;'>AO,IL[]6Y C1TDB.FP)L%WF0_.U!0M"R:7
M&.1I(KU:2CRAO?^HY$:^OC'[YAQ7L;&!L[#M;:I5:\2'NDV[X=:$\Q@L6"#<
M'2Z4A0$LQ0&YT'L5T*=*[T/Z347S^UD"H5S.4VCSB%<?K@<+G+4YJKMD_>NK
M2J3]H&)8>FY6_'&S[UA2/D)L]>_7G9S5S/99<O^<J0[E4]ERJ&!/7D3Y;C/F
M<(),?6I(]8=>I=HC?46H(-7T3(TF0X:(D=7X;RB@/L@0<X*/ZP&AU[%00&?5
M^JG9TV&#@OL:]4*PY"\1M^\WB"Y%FRXPRXUEJ)ED6 _?=B*,W53!9ED@V.MM
M2SVNG_8^\\[S.>-*6GN17Y9.4:V\=58>IZ.;8G;L<7%8/J(%M^E)M65Q;U.A
MI-JM8CH_9A9V>&>#*((.&&-(K>Q#0*(CC(Z\54, >@0NN'CV^^]#\G,<\D\I
M25D,?GW\:1\RR[2P?S,1HCH=[C$76AWZ+"@L+$R91]:A0KGX,>4U1.GANP-=
M/I3=F*I]2%AMIJD8L\8X/,0;@%.ZR%%6RX>*,$62?6<:>B@M*2I6 PNHIY'7
MZ_C9O/5F$>%;[R$_B0NCM'@J=B 3.)[X;A10&HQC>%8&8J1F&2<K@'W(BL#,
M@U>V ?=?!=)Z4%5WFUH?Y%DKE/PX2+<<<$'%/+U6TUT)P,FT,CI(M0,[M.EL
M@>XSI88]N$PH?]C.*.=WZ9)R_3D*,5FOUVBQW_]7NY[SP_D^I4 VM89COCR=
MO3?Q8G>O4.",(S*4@!6_CU,N<K)  UWW1B$T;B?PA2#G-//1+Z*=["4>EWW(
M^4!?#KESK;NZK#E3T>DN;3!M/B+J\Y*7D[Q\ 6\*MF])@VK;HTOS,&ILGWSJ
MK_CT_D/I.[.WGAXJI66"9:Z)VJ6]I0PFF9Y&7V-VFNJ@ E:TGHF#TBZ^A@%=
M^5.E)\AIFT/+,VB^&>\2(Z1HXZ]D9Z21LYWVEB^ Q7.+BJ<M_+TX UQ4!",#
M?.N#BOA39OLRI<Z;9E>B+5,()R,.%2%?PX,-*CE"R@0V\VZ>2/_P2%)$H_^"
M0.(2-A@NBJJE);=.X[WAT5[*./AT>/7I:P!NQ?: ($.A3?F#T)K,M<PMVPI;
MY<8H;Q?#2P8O;&"5:'4*OCOS 98_!"1X6I[0<Y39WD4YXL74"\WMYG+I00)M
MAR>N-OOT&2&T;E_>5OJFQ/ZSG/:+F=IU#-M]A*7($&<VX+TS"=]6Y#KOD^%I
M>]!88RQE'T+6SM327T <-G]U8>-M%?'GSPLZWSABU5",!BGB7CRUE%;'?((/
MP,H HLLM Z.IA?!$?6)RVSZ$IAW]^Z/YG$T5D1'[/O5&UB'?Y-M]6FL^5W^$
M<[TW-B%5PA8J5T;C8<&91SP.8T09VF]Q#H#%2^++?NJA*DJ')CDYF]J\I";G
M6F4!<;73GUV\?]OD6Q^6OXL7[=M.P?<)2C!@8):64W8(ZRR^F9TCQPE_?L\O
M'EQH/U;LVK,9=]TU2<GGB3V7TWDQ>[;_'<-^W:!A:>W7O,<-7;<A/8WLQ877
M4O+7N0\]/^^K(:AXN_[+;6[RR^?1IGX #Z@#JP$9NB%KJDN;6<>285P&P*3B
MF>T[MO)P,+\-EW2MM676V8!3L7!QB_%VVHS099V>;7/Y^"'UM>!V6UNZ6XCV
M5FD)STK@:H(O?X["X>/O*.9<'-(Y*9 _NCU0BB5Q/G9Y-I9QGN*T/-@'3?:"
M E;D]HW4XONDYESR,C1115*@C;PD[VV8USR1L^37U#EB_S;",=ZU.AS?#+8>
M(QJ*V=PA2L(G0,7"$6*!2Y) U.OY&R4BE&\Q3:Z_*SU-]S[*&7G$_7R^Q'^R
M]9S9DCN_-]MJ5\+SZ&.HB MM8[^-[.1V$9W3?LT/?!XZ3)WSBNIFWQ[Z>E1E
MA7BC@E:KQ&S!7L-'8UMVHQL%#S#NV&&F&:KD=K@(X-0G)S9;-JEO(G.YA?]H
M:TMKT@]+MKF(;H4$J2OY!+6G@H^[Y/\2(&Q ;1)6W%22X=,!Q%(E!J\"NK1R
MX-:M(/(S4/;LFF,6[BA>[5<GPF\/=P6%%?KG%K3(BJC?<09K[C9#"50YH1]U
M6;P"%0Q;Z@(#!&[%IVN[ZI4+U8_^.5VP&GJ*D(K5?!:0/72=OS6TQ^Q#E>D#
M,&S*S.<P4C3NC>$6']WN!JSIN2V5ZYV7)I4OC)K*.$'].)#,E<RC&-EN;1XR
M]*"C;USRM+_RD,_.=J]@@A<$T*9LGP?L*+4]>8701&.CE_W>S]<DA+=29I;T
M>9-:AXP/V2@]S+%1*EQ\'FVL2AOX>\T4J#!:N%)-H6@+H"&"O*C81^37MZTD
M'@1*WRUIMHV'RT";++,7S[9(C-0H%BBF(X*<>Y;=;L_W%[%XHBABF!DO26;#
M;YPL:N42-3^F0ZM$BO)Z/M@^50!VSI-(U?8(>)!CG4$;MFESM#;U_^IHF@7:
M>)>2SQ!U648^P-[8/LQ:D), I;;$ ECA>JZ_<2(;7"X-.3*II[(EN/.FM_B%
M([W<Q7S-YIUR%HCW$C<-P:3>!#3!,S!I;+N\'8TY27U!@*?JT],CW"?0MC75
M#,<;#S=_U5XI43AJ3=;G%^^1*[/IEML]#T'#Z=;8[@/8:[4$(UIA%[,ZC2B$
M9E\Y$L&RW,#%LT[ASJ7VN0UL-U69/7G+?O_<>#Y,5Z2OC@;+A%'LL',MM$QF
M5C76&YF,Y]#[@Y%>R\NC?'=73LMD7Q,\D)M )OB9^MZI666NDD<[>[=%3B'#
M04L]F;%X4C:N'L\0_>91!.(V?Q/Q"-""8(V$:E^<92D!79[7OUE/%N06?GA_
MPKK:V_^<AJ+9Z->G_M>>"D8!PQ3L\N@6.Z6H#\O>I07X:P;TL#3&:_2J[]L6
MS#NOSJ!&;JM\4<A:SI"R]CLE'\-6DY<" <*0@.$H[= T+* 32KM)#4CNTM@@
M6,7OI!J!9&/=_5L??2.5R)<:H"G>];COSSUA_ES3BS<VG^E\&92"V\_N0TAY
M>,A.+<'G';ZIN#:S UL.M"^7)*MDDB)#C<_EF)>[V<J4]=G)4H9HS44CV66%
M7X;5&_*TL\HPCT![L10B0[1H&1K_-_?A+%X^'ZKJH"/#<N:N^%B3;6KZ]<6J
M\@F)R[D:IA\T^X)%&@,MU-QN\T7&%R0OWX4!1ULVDTE8@F _0HXE!+20D=$D
MZE=J)_5;-%J >G##EK*=I.6:\_.SNT6"8W_1T6.*CD<&#!K8=Z;%V):Q?_\O
M#Z@F;H+4GV,:4)!\ISU?#Q<K%E )^KH/B2OJCW!_$%E04'(NQ5*"UE^0[(T4
MN_ MC^.7 VN>2('#8K$M_K6D**<5>%J'7PCN4 <\F SGG@>0[AD?U$W\%Q]W
M8ZR32VR<[HD9B;$_/S#BL03"1'&7(;;;H$L",X9HE.S%$5+)AF"(DQQ1D\MZ
M=P0AZ\YGFHH[_O'-%QH4^+QTUIV[[/Z#PSK)PH^^O'[]]++H(+C1%>"\Y%:_
M(4/, (1/(T2R+H &HGXDU"%IVIL(XTMZW3="&7CY4P)/(ML35A2PA5TQH)/O
M 9S@U#G A:['N [D4K>7$7^7O8DJ)W_]X GLVN.GJWX\M&]/5W;5DI *Y;<W
M/NLR=_3*1>\+]=%-DIM_UVUA@@K/+S,!+]3%!S@BA(',;KS8CIV%$W4TGA'Z
M:O 5X89+R_NZQ<\&0&Q"KO"51P:]:5NC^K_#Q=BH7)MUH(RC@P )P_O"4F9@
M(EW2^#X3JTOC^K@M+!_ U\<R;NVB_$C$0-$1SC3-^,A29(%2<9GO-=DCZU6F
MBR6&>9(IIPDJ?@J^9H8*BA7O%14_"V]=^FL8LP1&*H+QXOV(*0B1+EV&$M!.
MY1441E_M8HU1%VFEE03/ZAV*&T>$C5CSRU-*F1^C*J6K4(2JM->O%9@%,%(!
MC!OOLP\Y@/JU3'P'3P5)ZN]J&-F@/:(&E?Y#?^-^ZSZD*2SM[.J>5$"S?T*0
MHWS:Y2U(WA47WHW?46)LOZS>X0&ET<THBCI-;P9/PCEW04%-1,%Z9/CF=Y><
MG(K_XMP35!B)+K@B$CA\L>=:Q$/9E%HIRR$MP!OT:2N@25+7Y@2"![ 27<KH
M<Y31WE#+I7W(\G8<J-?SU!=A9UM;')OK*S*6CB&E%R\I&.9<C5125YFYXK?G
M#+94D./ _U4\_= %]5Y8"Z:5JCCH3!0REBG[^!+EM0*?T9P8A=<]/E4XYZ'?
M;G5\:-5T]9'1SQ.]UT.-%<'U5P$K$G'!QQ4$]>@@D*J'&_8AA *#G@<;2KKW
MM[M=7;/^3IUC/O)(FM /S$HPJ_<5N9IWFVCF8 ;51VN!DRZS1H@<I@:@_%TA
M=G_$#GK)S'0=#=XM9)7[>*_P$&TG=XKZ?-NG-?7^Q"Y811XW3O)'+6;[^F4.
M.Z644BQ8/-IT&.83OCXQ!78=%X<3Q1Q=PPNBKVJ[.$]\H7)(BKY>*E4F]]_1
M;+ 3*KCZ@_"':_5LFBNNXOM3P;Q&**"4O\E<UGZ %3"% (9D7-\BU!8PJC6M
MIHPZ3:*=LV](BWWD&#L\@U7<I6R^+;[HE'PESS&-UYNK'"W,S#*%,J2!4C(T
MLS _I<-\!9Y4<FQ2\VYGP*"7=MYT+>Y2<P!*XWK&IZ4E H$C4BGKQ8F7N[=_
M2E[CWOE'C?T)T$E)7,8-$A.DM[NQ:25\=53)^ [;ET/>-8%M:?>?M;?<2G"*
MX3;A]E/(C?:3C[8:(M:-,H2<:*+,Y"Z5H'V("$::B#XWZT-A_L[O.D1I23>^
M8UKZ'+BQUBO8Z#8O5)<<'<&GT>7SZGIWK'<BX9$]UR@&)&8Q-QFJ )9^'2BG
M;5*^]6O+U?;!I(-.!GDI=N)<FG(FU@?D8_B\;\PL70Z&YLO-G'?YD..Z'37"
M+,:3"F%L^Q#_T62B*.8XX-+OI36S;:JSV#3;MPCK_R>W<R>C_;2;*#I+YF8=
MY*%UT=&Y>(\@Q]=/HP3!!FCX%-N-1]19Q9E*HX@DU5A398;?..LPL$J@&>'B
MV[!]]#(*JT!YHKZ#UEQ5_HVSY?C(Q&"G0\K)\XKC'??!'(MBQK'4,+UM2(;H
M)%FRMQCA =QY-LC%4*0&FZIW=4[I)3]+_9 0;-N>[&5[/3G7=46=V]E7>-/?
MXO<.6%^&FU#P,YXQ'V-)N']RB2FFAS>Z3E.123_N$C??HYVHZOT3&Y(STF$[
MV#>$?+XC59SC4CE*CJMZ2Q[70[_=U0:.EF\FDA"92\>!+4IB/UZT@RMT96&U
MDTKLW8>PH\W;)ABG:S_7*7]]VYC(7Y9J<,[1\H61UF+5.V;$>0@J8!-T&\=/
M9@F65$AD?_;WBB+_>6/'NVJKNC8@*39,^=$D\1\-XJ=F:H/$?VT0CI&5(&;4
M;BK235F$75/A3F#-K[9S,'K'I@G!XX6*Z)<L//^IH**-P^/]MX:<T^?J*HQ,
MHW!&8<XK<D.@P^=A#%'H,BX=';",$\>,X^18Q]!7ZRE>=1+5RP@^]-G9JB\3
M(>'<=[YX=G;FEK4L^*<JE2X6T$3?WOFHS1#39O%8T4&7=5_\72NX#^D]#P2[
M-,XRE&]/ DX#2\+3"Y=F]/+\G?U2POEY\ZZ$UM2P0SZ(M]:^J'@JF-XECWD/
MJ]]FB-YA\512AVTHR*0=CC/$WL[;"!$4D0Q-*=F'.,_\2,B_)7M@E?:U_JO+
MEPQE0FIKL[Q6?P<[BSN7?A@MR2S'DM+Q/ SA&LSXTJD98ZXJ5#!+/3/>'9FR
MY6'SMM501[__Q4\-+ON6!"MG'7>K<%GMSN[,X'K<E-$"WQ%+:,.ZA -<[DY]
M8"__'FDRY.Y'PXN6F7:33UN<3_O%B)O!NS@AJ-DM4)-P,)E/8&':,7N"[_"I
M!)7REVM>HE3.A%82G<AU([/,Z[MT?$Z]!SQ X]1/-^%%,;9HF6C>5[*(K;^X
MBV$FP4(%Y[_U8AO*!Z&<&R[-)8?:<G[U+*FG]N6K]DF'?ZE=O>HI<-8_QZVL
MX)?22Q_Y;,HFW_%ZICD8H VZ"K9;IXN=U4\\Q+!8AL9B#*F;+'GJE0Z#O6]]
M.#'@Z?J28LGA".[KDBX.;>=EO;_,2UM6O+2\UOYI_0,@^C>= 4ZZ >8]2YZ9
M" K>"T!B&>,,538BVRLHM+;;F&*%DO52,M3QT!OGB4MO%\@U?G;6M67RMSW7
M\!@86!5\P!S,^QZ(![?ZJ5"R$'!I)J'O.VX!U Z!=)ZL#R&L61H2-J1S9([8
M#E79PBE[ F!7XZAB%IAJ@& +)D4 %'J#I=?1!-A%!(13>OOOL=1R1CTI([1L
M#>>)!2\/#;_"4U-J.E4%[S3?1EM-@/B3SE!D)F-D&09 :2B5.%!RAHKLRY1;
M(^@56F:N0)/<TR0-W:^DQ5]\XWX^E$-B9L Q>7585EVO6\Q&,=[>.(+V =RM
M% LLN>;\+1XDW065@Y %1,DGFFP]X2 /X4-[JJ1&5IJE""NV^CH?.JMFMRYQ
M-N6U:YP9W@?L-;KHOY<=7L0,065A/E%&-/9IC8[SSQC'ZN_F;/=Z'9D9T7S]
MH87O;H/GY_<Y5^&JA,N?/OD>M/$LL?O&<7^V9Q\"%G%/'>50/HF3FM!0:_6"
M4-THC4L*4RS\Z3KES5%O)<W#?57KIZ&!3O_C/"/0S>FL>6@=[ $V%'8(B+"D
M(ONQR7)\'92:MK;FY%JT+K5J3W_3D(U7Z*/<EUQNDR,RLJ2T9A#=F%D8&;04
M-1@-;Z>JIA@'K[A,8.OQRP;4'V\)&:7B&3OWFF._6H?Z1)R+E.!>^>4F_&+)
M@7>O6HSM*U0.YD-,P![!**"0*PZS^ML\:#-*?-/'\L2.2!+]_=.IT,T?!G]H
MMWG(A7R5$<?3O$N."7N*3ZFG3Z&/,W-,#_Z]?8O+^ IEHUOZ4DTS2[W(?HH1
M7&O"[%]JJB%Z6CJOTH)S1WY^KB=IC;X5%U&^<ME\'33S/9%BE3EG,,CB^4.Q
M&H#Q&8MJIX8:\U6A:)XN[^3DJ%T56DV:1G #YZPA)?H59Z[6MH35[V8''D_<
M/?3J6*[D& PI"*@BN[4!-5S<;^@!QGUJ8D95(U;P1JE3XR3C"'F^\44)]<+C
M\J(/4MGDXQ=]<=D%C^_$F*R"@@.[;,B0^4/G12L!=<O8-(.NXT 3668?PAU,
M(\QDE@-X<CRM[)IVZ&<;CEJDNM@=V92:UN\?!&_LJ:X,;MZGC*[4]FD+,&Z<
M6>U<UDZ2$VIN;:3L9AI#(\6DTSN+!XBFG\R-G<S#P[XZI.GV'U5_WA9_JZW3
M*P7R$YJ(J(-UC\9A.4%O>2P7@Q3XM]-*:N7"M@0P,.J5SQ(1<')H]VR1CLO?
M*C"=> >IU^*X4%''/2VD_:$0SI"Q @OIS]C=OG$]6#+L2$A5*;]B8R,P_,I*
MY(=R$?<+MAP;X]LVM6.%:NRK2#EL]S&PUD ,_X@3P/N!2@I]%BBBT*T ASOB
M@W'ZF8DE)JV3^J>^7KGV$Z[SPR,ONWB1<.ZZYUQ:6,B>:C=LGFNYI1LGT=)'
MQXN@2@>Z]*-4Z>HL4:3<1GK%^DG7;9?@0-/+"3.&=ZVRKV7 ]+.E[;X*U;X>
M-^-$^_V]T80+>\V3#:,,8#Z,#B9V$\55I[0ZS"EC .L/6A]Y_[Z,E?Y6UY.,
MHQX/VN\BY1\.^::7<E]/*Y]OM.<:Q!P%RPW*&L2H,!\S!.A'$:"NLJ<@>IEA
MHVYC6X/I7^Z73X4J_JS6\FO-EG;Z<CZ)'"\EGRY\X%R[RY'9+3[01[.@T+!'
MVP+!5"QY>T P*<)+ ;"J  $*D-CK=6EHE'#Y8BFWMI(R[E-,_&#6<]YWX+*\
M\S5,"DCHKS)?@/)W'])@N"5#M_H.0H:LZ0D@EO*+7)/_4JLH8H48OZ1Q1I]5
MY_N4#7F_WB#C[CMV(_90WO;FYYS3S%PL*0]1/[H93OTU"&NL[9'!R0Z1\4EW
M/(;(P<41Y(.E]P7&$P2/\;_I:-?"K>; SWRQ.Q'YPB\K[&A7QO-HXUK:,#.K
M2P;SF7A 7WM^<$4PV=BI'/!QRSW4)!BW\VWR)3[>PI_@9B\1>#C+RY1]$_+U
MMN ''=#;3?L0"OS^=TL<65 .'3;=2#NN=;?88T6BS*1LZEK,]3R5$..0@[PE
M3\EX,[#3ZC.?XWWW(;'[D$9BHMX1F<&V\*_IH.+4?ZN/XT1E]NYB?:;0)A5G
MRQS)$WX<"G,CZ3+JYX_J*B6M7YB&/\""6JI7,)JE0G7IZ]1VF34V7ZF5J>(!
MS315Z\Q8<<9G<!Q#<A^3-D=RF!?Y"IV752@H\O;W-ZT$>Q</&(3NM\0W-95D
M341_"U[2U.2(+6+:?VJG\CU+]X;:;DO.DR'C(NO/6P_RC"E<WEY%@@SA%IIE
M'3-9'SXG:#G#D@]B<5 /X0UJR96I,)E+;36=>D]Y1'Y28I7&=:HNV)-TNJ6?
M5,@S/<]#,)AA4/3-@@N:;#^3QB891U+;G2?G*EHGPI%I[H]H^0XQ/"FN!6^H
M;PX?_R<V9<^'EL>,87%BIK%B&"'T52 7EA3:!(LQU00]D]I],U!Z87Y!?V9N
M2GG$^J2>Q0=X_M=3GPOFE5*6IL]#Q!S^/?X]_CW^GPSQ7\C-O[?%&@/B]%NL
M29S,7Z88(QVU,X5EW[Z;:N+1K_4]I"ERVWG[9A/[:B YV I^@E'OJ^-WXF,I
MW148[,=+&=_RH_.@):D"2T6O49EVGA9D9(I>:]H=E$?/CRW12,=#U_%XW[R9
MN32]&_DNBD577/X$LWA.DVIYT(9@RYE@$?<A@FC.Y04[18NQZBZQN<"]*W%'
M3VEL>5.V1FY92&>(7Q&_?.B=/=>:/KH %%G=;L;BMY8%CS B 4\*7_^2+F!"
M&73IF.P(IAJ=*YD<6O2]57$UB):IAK-O:OS3L9:E9GJYR^S)2\%7V&X+4P44
M;EEUDXLZ2&Z)"7L1ZTX9[=Z'B-YH.T=IEC.JC#J^&EA@_=WB.:ZGZ^_%;K)H
M(THCC((L!PDEAY?[N;VP.LJPVT/'].@%^8[6KKRHI59=TSMF4"=T*!/L!O[;
MT8CZ1K![83-,CYH;]E)+W=?=PZI?*+2%>AE5QWPRTKL4D+=<ENQSGCY@/N:;
M8=2-;9EK A9(^&A$8\L[;2'TL5E3E;FKGQEG0N]?J>MLF?9O2??#7<JSM?$,
M#>=(CBNQ"+.R9UVMU]')[!.<WR"/9F(T_MX5!2,]AK(9!U1<O8K".C!KNX8K
M>)YD1X26;SQN?I!,?__JOL:-3D@RZL]Y3/+?6TJ.3IG*LD; =KL[@.5]/X9*
M[4$T1<1K-ZI77%(228TR3[N681V:FKL-\H(Y(A06BCN$5@,VEO'S1LOX7J;M
M(%'<V.GYU>"\$N$);?EF.T.K&'.QPF+FR*;$S-R'85XA.1N_T(KT1+\IYJ-]
M2(AV(K')LR7EMQWTW%3'Z17!Q*6C45QDP0<[V^I;>^* P]&#)XT&]43/#6L8
M"C<HU36;\Q^1)&L#JBHMKQD7P8:9C U#2J->.]_/Y $B>N1DQIYG?=N<$0A>
MU5'Y1WT(\B@C_H4*CGX:2+6GM#"..-#-&:9C+P)_XR4P']M4VFM[I7J&L7ZF
M14%(Q8SX/+YD,=%/A^EC7&ME8@YFG.)?]R'B7<:@'(LB?Z-\BP=CB!!#O1R_
M9G.P^L4H;\]([Z/>)U\B:H+MF'6,ZR7Z8QTR*\CYU#Z6K*D"GJX</_,J*D3\
M"\$UWG[>Y\&8/5?;N"M("G+6]R&_U;SV(41;*X92&Y[)*XG?G1@[V"_^]VLU
MK=I]R-GX;>;O1FR/+9C08\_N[T.B-"$A#O\;YSK4IFZ7?*V:[9FUO&S_\7#V
M;;;OMPHAGY^#-&)9>7H?\MV^<Q_2E9<)V(1C]\2TL=ME3P52U*$L$4\$*YZ/
M2%\+!!MPOLL^Y-G97=:>.V3N_U,S#R$EB1Y#LDZ ^YJT\X)T8PH?U/RCS?_!
MOVQUYWU "?D_.1GZ/_O73$;,&?8_XC/^_X>Y1UI2MVL5=0B ^_IY_LOUUB]\
MPX_<@/^_'\W_Q,RN2!#5GX*0>79['T(JP=4[EU'WM!.%B3<:-MPQ\<O?F]I'
M%>$9>[1E[XS@5M%56]2#2$08'S<MIJP%(EA>43L*.@W]]Q;@IPQ#()XJVF]+
M->R%BOS&'T+?H6PG=C@M!Q/9/WI_6<LGP!*6R-\NY*FO"=1FA4NI_E21Y%VO
M/YEEY$N/V$)68;NMT)&O>RF[-!4X-\#+%V42MH.%HK;//W31'1DA&\D8J;U,
M.O#,T-9XY(JSZXQ>=NKC=Z8YS[M4P;7/LI;P3>5;-LO:*0A>;$AF7.&5ECYL
M#%XD#'V$;'*G^_W:BPUMV>"C<-X/-E:$=_7?#J,6;B#G\-?^SZ"!*,%17+"
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M!&+#9CSOM_:]./<P.M'68[/S>:D/ZEDI'9C3.L)?Q/6H"Y-Z["I>E0 X%:-
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MT[]K6I>EC!$>*[K=9:EL4>=IF*R\S<.4*=%Z/W"46NPD  9#9M(NG;\U_)4
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M#**U'[_?TO36*#M_TGKV@]6TF[^/AWG4ZP84&WF@NG'H.VC:9ZHG6:\GN^_
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MZC1-Z[TL,_"6^J,?ZQ0VCW8#49\8$9"&P&Y<V;\'\K1K^<I!JX:[?'3!J,J
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M0<D4 #5-/1E08\W94Y'C_;1/R>CMM+7<#;D7O]BH,^=RUXX-OB.?>%^=-QU
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MMCLT R'=#H]LYNZD8B=RNU6WUA^7MBL/-.FLKMLVL^W33I79KG9#[GDPD2X
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M,!VE*_:6=@DLTFA<M(10(-M9H-WNH6'Q5KG)9C5(+$_)C2Y)X98/6E4^Q9]
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MJ- NR'4Y8<:FIAH<2E.6>7P@(LG>RY[WFE[.^:4WOL*+B[<9,P'Q;TO@(M4
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M#0@6Z1Y,L;%QW<W+^&L%,+:L>5\#6-!#?O4UG22#DK,#VJ[CH"&D8Q^#)_[
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M>)B A2,CW.ZPK]$D_?QW&GSWT++!*><G,;^T[SF&ADMT%L8KI/@3G^9^0Z;
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M435)']QDG4?-<X5F>,$BU03Z,5@=LJ5;$3H.DUZ_;!DVCVY(/ _-M7NY='A
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M47;EL8Y5 F(&Q@P$$UB*F*&YW9Q\DHRM#A.:R#Z.K)AQ/++#.R?C\0'-?M6
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M9'%KP4GH.T+$4NL3BD+YU0.[VMHRL1%Q_MY"2&F6[.[$>*-3[[QU,6?W8$:
M&J[N&X!3,V<V]IMEX'J?TTP]0\[Y,:NDHZ25L^]QHKQ%Z4+.T;YSR=)\"WC
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MUJ6"Z&XU+'HQ'_J,]/W-G6&MA*M_5$,N9=^,]I'K@E+>,D,X);&[QC""Z#B
MD%%7UI!0G8$47[DV.Q"A:*>./>I_Q2_P_NH^EL?!O9DO^HU9.S!]9''LY6W(
MC'_7?,/T[9B6Y#Y\5;]9NFFIV:65UIYTQ5_.;QZRQQWUJ9\:)*TH9<(O!?-!
M.!W&ECK) ];F"D;9PL;:?F 9F:DXG_@%(&=80$O"F0;5X;T'#-;UE_+Y=%N*
M93ROB*[D.SSJ/E9CMX]_)5WO%V6>*]*P2% .Q\I;0 $YKE "(ZF/I \:+YK?
M@O:J2KXBCV.HHF?/#,0L"P7=8R_<>Y:XKAH(U1E0CESYK4ID1:_,F8#?Z829
M*N8%4-TB]M^=ARW'Y(T>N:DV)]6LBF_&OCUCE.^$F%>?VX@CDH]%HWI&2V6,
MSB0_W -]]IR0Q^5A;J?W-B38*8,,P1BB QBDY#I0SH.#IY[/6(3?_O/-/_<"
ML-H<Y:"W]M,GY\=^-P51R3YJ$,6J<Z<8EI]+F5?^@U5!P\8M8EE:MI6@]Z+U
MT.@W5=V/[ 39YR;73,*'O60F_&1'=W_)USMLS;(HV)-R58&T< U:'D+(;[/G
M41=)QO);/T9<'Z+!=G7(4IV79/#W#']#Y4Q43;+[W<B35R/*6MJ(XS6%<Z?Q
M[R5?2EDP5]?K-.QW]6'+VOCH+>SXA>-2_1*>IO7AQZR;?E*-UP\)E7KND$I\
M$MEWS3@=,EU*.@C^:TQTKPE$LF)7_C4CJX4R]<"G=)A**%F\G.&46ENC.?Z:
M[LS\%G$Y>S)_J2QE%]2"$'V#2==JNG:^03V/DP)?>+45MQ:_.)+&HX:X;'(
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M0V3&@M;T\ U%]#Y0<($@&G[L2:"I@7?WG&QC_9NW+M3T0?U#U>^,/\@7QY=
M!^&4<28*2)ZJ9EGQ<K<K+[?EXIN7-CJ1&7A1M#6AG_&VP[VPQMU2E:&RC#/Y
MM@VAR+H\O>\0*ZWNL73Y6U]4LKVBO>UW\FHXP[M_7H4W42E814M=%#]7 B$)
M$CH*W6KKP&NG&5G'UNEC1P/O:K"_O1RRLOG[\++9WLGA..8%3@':>5$/>V].
MFU.$YG\.IHP!LY05(E>\OI"I=&=IZ(5YC\^E-_H>RE]RGTS?LH(5$KG'@> [
MY(75W3%D653AX+D6ALZJ6Z%OLLQ25Q^2@*5IL:R(N*B_7PYY#]%L-6WF\@@
MF39;U;L- 8]"Z; U!/#>SKMS&R)*#G: [T0M(IK\F*%L)\M2I&5/ $P_Y]05
MM5 KS9[39V@.PKC>^7IBKU,Z'O"=]68^ )M8>WZH:H$Z+[D?HMC'\*X,T6,&
M:YF4PI7783OB]2M;0[T^J4NT]7@<9#U:)OT>M82R-8'I;AI0T,W+)D>K0%>_
M0X8I5QL=4(T,!?/T6T_/VS86VU$S/PIVP(%P<GJ;,=T)U!G)* &XY.";3+Q*
MFR?S8=,;3]&3#A7Y1E0GO@=Y#S=W2ER:9BLE,E3[F0&@ B.<*T1C.:,J1[KQ
MTEQQMLL4TN)4,%VDISG79:QN)E)]RM_HP3+UW5SH+YN+AOD]B>I??Z=VPG9A
MH&SC]B(7$ E4=?O"6MYDO&]I&3712[#-,WY:,ZJ>KP!98!0^8^@QD9QB2^.5
MF]@TS$&V (#(,#70X9ZXF9J&-@C%'L<?Y4SD]@W#-/$/LQTA:$$>P@6"H3K=
MAC-?F21.;5-1Q2A7E>T#?EU$R*/A.;__ROY$73,I%7..6] T?AYT\IJHL\U"
M7J#I%+;S%6D_,$$&3LXGN0L19E;'U!G2-ZN+\G8,%/A.!/CM'UE_EY7'O8JN
MJ?V8A(@#JSN*!1E32=N0W<0LME)%^+&@+\C56?=SZ711PJSEI71W#:*RF_AC
MUE',B)=!%O-Q&7HW$%C17 5)<B$V >WEH7%[+M.T7#.%I(VJ_>J-2OY(\_V5
MX8U^.!\FA^TLW8;(F>!%[%J3)WQW@'G*^5/!0P^4V]G/A EJF9$U@B[RJG32
M7QZ0Z6(^(@0L3;"=IAA!$$$SZYG5Z(F;@X+[:6)FO>>_;5Y9"'4?*.\6S8^N
M#_1OL;UC!>0N[_TT]"S@Y+P-J$>#=F%3JF_@Q3'RJ#@KQ3NE\UE2I^]\O)0\
MVVB_I+[!'^U_M&_Q1]C7.VR!!40*19)WAND[OY_RG[7W/3W>Z'-,ST/FT](C
M6\F7=YPT%S4_[FKZ[ZZWP KQ@$N$L<LK3DUL=?62G\PZWM_T@5_G/>_R8%7J
M8BYC&&6*>82AXNN-,&/%,LU3:$.3PW/[1LNB_#2_7HV[5NSXEA@9[_9-:"_0
M@QN!JK!UP *@_V*N+6,;DOCGN"[J$V'+ITP7W@J?C5HO3UI!3!:K,K1]"@&.
MJ$E0GI?S^:C(D5DWQP,ORI].^T"_D"50X4;O42DDW?.169Y'^T)]$CZLF8U6
M4AIF/<N*"2WDA0<W@RKDDMN0->]KF>99)]_+RV>+OBZOU3[.T,0^(CPBB7#?
MSRMRCZX<_ 3:=A*O?7J;:-F$Y3\5NN-K_H'NKQJL%_F6>5L(0&-A)(7$QS8:
MYRJA+C_6:'+9C(LL.3[9':U9F_W8@N^#]+Z!7I2O+F^H#IKY[N?"7,..S.I@
M7&4KXF::<QQN>1_?$&H)-ZHNMC5](:AX<:*&0C3.B:I?SXD@-J>I)$L[(SX(
M_G[E8JS[(N@R1$&S^&&34X^E"K -R8CQQHFCJD\V3/Q>:6'Z? J3?6%B?""Z
M:;3338'_COEYP2_];*4_-/+,RB)A38\5AY-"A7=R#?U8;N&%^8\Y97[A&.LG
MF\1BUQ[?*\3USR^Z"8(JX3_@H.%TQT;:-D3^7\LAA Q)F3LR)\$=GVJD&NBX
MO09F\_"/#&L;9UT^;(4')MMN"#ZX^N5T28'N'OZW,G\$D\G!Y-N^@M.7&;Q,
M* C";2?6XFX5.8^QC<.1%N8/RR)RCG0?<'U\#JIV[UOX*UY"@"7.$W782O,L
M/[0*4+L-Z<+.Z"W@T[C:8-4J\ TOH U>J#I<7T@]8#FBKJ2]IULJWPAQN5O9
M[N?ZWBNM9'&PN^L:MG/:BYMEEG95=AWYJ4Y/OK;P.W_[1X:RV2[(FX'<=[M\
MGM[8\:G?=!-_%QM,N(V LJ.?LYT N8YMB."W8JTI,VPXF&$'#-<V_6$N?YZ+
M8?1I%F@&K/OG#L. $3@$3M/YUV^-*XWDA7\S:9ZYL88%;2(PD\Q:;C!^^6\"
M>W@;<IB]/OLAV@I6A&^L6H/3<*"V$UOY( ;.G3YVMU6N"YZ-YU]EFY:@N.MR
MX6(:[J_>&A79?X'\/6.EWU]BYGQ([70FJ9:5@ [XB%UXB04<1RBV-)[,VXI:
M+#K"A;6W5V7&B T'$\)^S(?<4N^S>H;4]% 3T2B3%HL3O=P07PHG<C71^J _
M ]<U]E]-8)X*]GII_M0;+@-S;5.VIFP0K</_2D0/=&JDM].<A%#N'<7*#0 V
MD6U<]8UB@]^=TNTP5E-&;&[.C+&C9PI8,R'"$'8A)Q>+)(!FF\Q<3B[:@$=Y
MG5:? 9';$/IDW^/PBA^PG0<P>T)_A?-.?M$C*Z_I+47B8,X"FL>AJJVOC35Z
M!PA]1\C$8L5Y21R(-NN "@]HYU;Z=+,,PI@K99Z?*P>#S*+K3\AW+9WLU?XH
M<_UUCC1?XN8<CG4<O0/8[!DD9!T3[-@0_ 2^YW@@4,TCW8=?A\7QI<@?'^O3
M0F\.*H_]0#1L=/@$]XPL.OHOX.X>^//X@!OM3SA>S&O@^OB.W???CQ;H[Y:_
M^C71"B;('>1J JO_!N*T9EI*7<G'Q6]#A/6ZWD>XT,X6E1V44SKQX:*]@L:K
MV!%GWU,\8$[E-%HJ<=]O0UY7K6%IG<=Q]RSWH306<;U0*6N@V#SS!_'5#+6V
M(]1@PN2!M_G)*V:BQ;Y,B3MC1F68*A[+YXW,"8K*@2N$P':BU?RK>\T=9:N#
M:=4>=2XV'[Y*UO@E*3]Y\N7+% D';';PR([VBT45_HZMX]F$VH?'IJJ#*ZUE
MAKF==W\MN8H=&.WX?$[P#(0MQ2&1PT9F6,Q'O$Q@Q=;@E+(OL'R\P&GZN:I%
M@N"*I3: 2S6-2[(!$R*8K[]Z8 .\S!Y4]49V4"N&?S3^DHYH,&HY\6<;PI8)
M9][CY+3QLZYCWN&;IU/@H60QE%/OM1-TFX\6CO1%(]"I1U4N'*'[0RB2;A.0
MXUZL$6IQXF.:KXLF8A_\6U[J*HUE\=UWSX0E+!3+UZ804?)CNO27ZZ@!VS D
M/X[(UYU6<=>VWI[_9?/RSJ43'ZS16-8-$,9<^ B/R#);-$U=U:*-4+P7T*H0
M19NB!?G8V<,CS@#I^;1JX%2Y0>Q9[[G&U^5[7KA)JJNY2B09/N$39$OU7^)D
M87C*L_,D29O[V5*9TX*10O%6(CF+K>%/8T%WL(\RKIH] ..ZF8&:@0(SP:1X
M[8LY#DFB=BVG=Q\U8*2R)9',9)[?'#&#" &+?V4?.+Q7+6AMT)EFF,G+ZVC7
M6H]P"J$7"O$<UDFO"6HO_J'T:;V2B&U<MV?JRNHS:LXEYO59+H+\+.50K(+E
M43:<4_+'$-2J2B0'/0-6O(O<FR8,QD\CI7[\;,\;+IWY:N.6/O<N(U>_.+"[
M,4732>N$D>'4W&%.,8D/[<#(?LR0HIOQUC>8U*.X_T+92NM\2D3DAKYP\]+/
MH/S#J%<]#QHSI0HA7[<A_OM(\CJK5-H@_@Z^@8L'NKODL.&MP$A2X_".X[IZ
M"4*1RSDB^->VTB<GU_T#6T,\94;K% *4NMV[\-(6KK=8/'G9.:1HV^^$V[H]
MCE%!QX&BI-V >T:LPDXWV6-+M:ONB)GZLZ!=\0E^H_T:0PF-(CGRT/'67C 1
MF*?-]^)$1A9PZ9@=HVB'TED9LV.V]TQ:D!%!>[]$I@<&7%5]+,T'&.)(2MN0
M;FMLYSN$&,:8K4Y*9YT!U0!CER3Z.6*5G28Q9<4Y9UU)3-M3:N\EF6('LN:3
MFC#EQ#?13UGBX'PGI8"MC&6%A1S#INOKM&'Y0 5)BEYC<!!Q?-&S _+E$<5N
MLA_(ARQ,?W/JGD^!BY$D46ZP'>S]8,(ST/\T43_B-Q8:>G#&J\?[A<<S5^L1
MM'@X] SG,3QH5N3B_]/\-T[H^-,EPMW5Q7PAYR3->RORNN\[]IQXMU?"2N5M
MJTV*O;SN\\%#1R#N2PCVGJ(^WSVMO 7BPAW;FB6G_=ZL;P9[&8KTY>^1'_NE
M#83MZHV#A2MV7W82.'?3_8<O\=DWDO;8 32<?EQU^ORKMN32MZ])1$^_XL/R
M^[YU5.]7.2%O.N#%'9ION)65-?78GP5'J2N%?[%N)V9TY8<5"->HG'J.$^>'
M=!_MA/PI@79GF3:):7#%VCCIV+ $>(H$VA9P[X1F'@(+Z(2DL??F7_#6..<I
M@TB*G;*TOWR+\*FLY]ISGUS]$;<P'^8;<>P]5<Q<L I8Q73-\UF*HC;I6G//
MQ*M*JU(P"I[>89:233;V!V(=7F0]NG6PJT3@L_/2DV[)ZZR"=<1NGHCS!C:=
MWHY9\/.4Q)9*!0\OL)1O6R:RHY\!]\T,Q=MLR:,C.R=AR?,0K@ :*K>X0.A$
M"J'@+#?G U6\."*G&L3P\J2=<6K!NRQTGX)%LY/.U&VX!7;A"5F))/FO0^J=
M:>XL0@BC@[8:CT%(@X/]7&&L$.KZUH(!MS&K?+B@*8D3V*7^#J=1FI=NO&SG
MRN>WF;KVE+X-289#MR$!ANF^1\ -V@D""F8/)M3X@/VG=3W"%%T\STQ?NWP]
MKDOS$M2+EX,1*!&N%!+TQ )W0V'  T[J*@*XCPWJ9<XW!,?E?EW[9='VJ^'(
MR)%J2A^N')5J_^9C+.< 9:N/*7CGY_N? OG[Z9=='XPFBI9+[MY[1PR".8T^
M"AYG%'"%#%FVF _1V$X+[-6,C4Q8 ZR?G':X6+D>/$%WM#>-CQ$Q?Q[8DNLV
MNCZ1SU*IV:]?'R&\1T#R;Z7/]X9;+#1:DU/-5>-.;T-$R*$;V1G 3VP*27^J
M36L!FSBG.ADP]L=)3BG!+/UX&"WB\/R*RZ7&0)<I]<MV&LZ:+NN>>K\':=N0
MU6G64;8.PW4CFR2+Y@/<4YK:;8P*4U[S/A*>F?'QV7]43_-57]W"?7'Y8NLP
M:R"7=A&V)QAL@G8;0G72UR,$:D?2"JQOATEV[-KI&-TP% #Q#[WJWP3!F+!5
MP&& T L#@F'WV&:T#=7OQ *2(NB84!D.=%Z7]T XOAQ9HIR9CXV4-XGXDKLL
M4*BM*^LQ&$,&G TEOL&$L0$X4"=UC</@IUD3>_[50Q)I?+O;4C<4-B,1UOSZ
M^Q8YM?9J#M<A3DPY@U](.%]>RL0A+V@7V1/&Q()B.DFUEJKV@$.7 8TEDM+R
M^F-1]XW*#Q2WSUYVM)],#97A?(A4RU;AZ*BE'-L$F+Z[;B% &TF]*8M_YE.3
M$5<Z$[JG-_3@_8C[%KK/Y _2ZH\J*T+ <:8;^.^FL@?(8IT"#R!!'6+'?!+&
MF%&^Q^GY)9#0,0_57XMLDZLL"DUL+?[FI4>QU\]2>4G-MR\W$[^QFNU"EF9?
M 5'P0-C,M->_!W.QG1+;D'#O6D&KR39KF8T>\DR5;[O/A>ZMOMKH!)6FN2*Q
MYCBO^?B?\NQRI<][]J+&!R^P#("&A=1.;&*A8U\2X$2#)K-5_..N!;^M!YH3
M(ZIZ3:IJLN^K[T(R[PT'?,?7XU??EH+KT_1\'.LPN&N\AZDAZZO1#,0^C&.R
M_;^T>-Q-ZU<^6"+>W_VOAQ;J1K?[9&.\R4IU];[*-^-+UX;#-?8&W7O0J6OO
M8GO)E?+_;<V-_]A_[#_V'_O_FT&W9_XO4$L#!!0    ( ":&6U<#S6SGC@0!
M -4W 0 2    97<M,C R,S Y,S!?9S@N:G!G[+MW5!-=W"X:!*0;.E(D(%5I
M2E4I 0M%Q(B%*D2E2\EK0<)K2)#>$100$((B@M*D2TND"Z@(2 M"0E 4!)F(
MA)$4[OB=<^XY=ZV[[KKE_''76=^P]B0AV;/WKSV_YX')SO0.#29^VM;!%L:S
MBP=V!?J![?R$[;'QQ5SS@_G!H(-G9Q9V K:+Y^_Q][SK[\''^_?,S\?'R[>;
M?_?N_Q@"0H+0$-B]6U!$4$CX[P$]$Q41%OW[XN]%_LO47?R\O/S" KL%A/\?
M'SMO8!*"NX[Q_N;EV0_;)<'#*\&STPM#0'OD_X_M\<#^Z\&SBY>/?[< M T1
MZ --XM#V>7FA3?-#.X;>C8+>A_%)\$NJ'K;9+>5\56#_#6G#>UE/!-6.UW7)
MG!\%U(VNW8P1$I:5VRNOH*&II7W@H+&)J=F1H\=.G#QE:V?O</K"Q4LNKF[N
M'CZ^?OX!@4'7;]T.OQ.!C?PW-BX^(3$I.27[P<.<W+Q'^05/2Y^5/2^O>/&R
MOJ&QJ;GE=6M;=T]O7__ V\&AL?%/$Y-3TS.4!?KBEZ]+W[XOKS!^;?S>9&Z!
M?[;_VL4#X^7Y;\?_J5T2D%V[_L9 X*]=/+LB_GY @H]?]?!N21MG@:LWI/8;
MWA.4/I[UI*Y+2,WH/"!S[>:HL*RZ\8(&XZ]I_V'9_SW#8OY?6?:_&_;?[:+
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MC5-3\"ZP5\?T1UFK&X5/52E9B2\T,^9.\]&]!%H=$CBC^!#XW8QN'KE7X\/
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M(;Y0KO=80S?0DJ)IUS^++8F\5B?*<]5X"AV^]A;VBSH[PHQG$/HSP8.);T9
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M9Z:XZB#)Z]HW^_'\G(*AMX?LJZ_ZG]15LQ[Y6N)_I00>!0X#A(61-5Z@L)?
M2]('_?4"NKFZHS7&U7<=\V=<EB:Q[VYJ?E&]OY A;^]W1"6&IR8W!0:&84"S
M$>:>"61 )X+Y#R,@F:3[@V(7OYEJ#I&-%8]OO:P?J521U  ]&=*CWC]W)$1S
MK,Y<7WUB^&5 'G5N:@=&RR7#-FLI/F_(346UF1V$<K!]H3A9,Y,6&6IQ,MNF
MW-U1L:S720D89#87OLLJ*_@RK-.0:W"_#/\0LI< 4-E2A0N(^+^YC^(*B_@P
MM ;.LVTG;\M\;'),3;\V5U4^)GLQ1]=J2*\W6+(Q\(2V^TV1R/C\Y(7;2'!_
MRVHRC4"!]Z&5N>)@"QT336-\970ROD7CQ!B[?S@"ZTGZ;MF_/GN<2#C?5[C_
M@-KY??VF#;R;$](\"X2_?Y<'M1)7(>K/-P&JRKTQF*E'21>):09]W8'%%?9%
M>-R+S,\O/IEB*\OLRT^^BI$^_2V7;\.9.T,%4,A80HM_+2WJPB(JK<,OA+BG
M Q5,1PG.@!B/C"$=2_^Y1UUX^^1BAPMWI,VE>9_N>N<Y#\%$$<F,T&5*DL5_
M1#?*]1 IJ70S*,1)Y['C"\:WX+ 5EV--11W_^N:)#XA]GC_N(5AV]]Y>PV2)
MAU]>OBRY*#4 ;701/"6WUF?&EC:%X-,<G6P$XL"HGPEU&*;!*MKBK''7]5 V
M6>6(V./(]H1%54(!*09R\AV0'YHZ#;JRC-G7P!S&^@+Z[[+_8,OI7X>\P*US
MY(FJGP_.M:=KN.G+RH>*GK,X[CJ]_]*9JZ?KHYOD5O^NV\*!%)Y?9@)9G"0"
MGD=+@)E=9.E-IQ,7&"/Q[- 7 R\HUUU;WM;-?38%8Q-R)"X]-.U)6QLQ^1TN
MS<,06*V#9!P+ D@DV1>9,HF4)"F0>RWMSHZ:$-<((J!(+]>BE03\3,0C<!$N
M3+WXR%),OGI1F>\5I7TK559SQ6:Y<BE'*9I^JK[69JIJ%6_5U#Y+K)W]:QBG
M&$DK1 J3_:@I:$F2$5L=;&<(PR5PETG<CXPY9FDEQ:MZ$W#GBW"0;GY^1#WS
M?52E0A664I7V\J4J)Q])RT<*DGUV8+NP&PO4-ZA4B*3^KD;23=LC:K#I/TU^
MW&W=@36%I1U?VI8/:/9/"#JODG9Q#99[R57XQ^\H:9X-NS=D4'UD-0K081I/
MDFE$%Q("TD0 P3/#-Z^K^/"G^"\NW4$%D;C\2Y*!PV>ZKT0\4$JIE;<=U >O
M0CYM!?5H.@;\8' _09:D@3L)C/2$VL[OP!;6XR"]GJLSASS>VG*^N;XB8_X
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M#MGW;T[G9D;[47<IW'W%?^I@#^P+]T_'>P:=?UD2!8<:H%D)H8N,KK.+LU+
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M1Z/'0X\6=E^:^9B@$__TS3IGU9.IOR0]WDNIAD-"#<2&$?$J.P-[&3S3J5\
M!K?D;!O Z7]AZ"HR30XWU+BCM7I#E03J<MPG;I>/>W_/!XKOH')5-,">&)9/
M[@3DTLY!E ^$U$-'3$8O%OC=&1NWNIZ?5K?M2WC4AM*%&"X@9"[#4@*766K(
M#3B%SRK2O=A/6<Q=Y.N&,L:<LQVHKFBG4"617WT3 ,K//HR8B*0^0BR>OH"<
M<[W)!:S'74:OTGU94H<X=LFQ[,3M^,_,!  ,^+//)%^;>/"O+H-X=M(@<G6?
M3MK3>JHL*PNQ1GQW>W.!O-Y(I/5C&-;JM+)@K+V5C\X%V''9+IRD@.7#( F
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M-W\@\IIJ1X3]=;I!(JEBB-QS"ZG4)'8:XWV:KD<.,#?<<<S( Q=X^Z&JOK$
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M*8B*C+2&9V_O&:!*0GLBE)-Z_3/I1Z^4[ZA-"$OR6TC-<&TM=SC&<Z9T_XQ
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MB6H^P1AAG*PB9>?,A6WJ#4;?.\\[K,DU_L'3[GIZVA<YF^.G0(MB+D^$[4!
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M(,H1Y4"VQ91YJ<\N/: 4:>E/3?47)X05^LC_B#&VN6!C<]! *A&TCIHD4#0
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MC]-D:RL_495KJOJ/V!=TB[G)M,>=I'9S2^Z")C;PVVF&2AX/BCJ@[(B^5A7
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MM[ ,:OOXO?;)EC+'YJRG%H<BS$1"K^<;9"HT[#,"@5C;]V0M&D.89/FPX2D
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M42=/4-[/6V A4Y63;:DB O\XHK+F DB3DDP 'E+/1< ,ASKBE1N;^7+"V*T
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MQB!$NM6-7=!M,H9^8 5#$MD%I8#_O /RL8L!V!G7. G,NG@UT'21T674GPO
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MH\]$9Y/U??DE>73TYR"E$-_D;$5A;=V,&<Q2KTJ"1QJF/W#ZL%54*C\[V\&
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MV N_^)9_CN5@%GZ6'7[[#-3\%F:8JW80'Q\H0,9\UMYVC[SF,OT.I.+7JTD
MOQ9;2)0]$I&P8W1:ZWC7QXBSG"/VSZT-[LS-5T ;^4)\*JQQ>/E O1\81O<8
M>*?:9W4W@ZAX+_JASTO6.5[.:7?KOIRS'D73+WN&DBO]N_S]B,BR63E>G1DM
M_XJ*!W?')J91>NE &9# (';[7ASK(2L#XU^(\4RIB[,_ODSXNIULW_S%&E-?
MCV]BVX4$H=[L'?HFEY[$Z^>8<..OLTO  Y5<5"Y](0\K$TCRZH^O^@:W:FU*
M/5DTX3GA^ 43$1EI<^UU[^?"(KONK;FV:DI]T&P*E*R <O>F]>&5/4-:2PO:
M_"NG7&O.;9E@\G\R#.HCKB.N.ND4RIR)0]NZ1$[.3W*5*NDE Q1PMVCJ'&%Z
MC!W-BJRN=N8< #5@6==;KX&)K@/27WSUCPM?#B"<:/N@0Y4^6IJ>^GE3*MN(
M*SO#GGA/H=]#/G7M15,[7$NA;6"NK2/7)4P4TCR^_"IES8#2<Y]Y0")X>WYA
M^[X*:,4_+3K2'" +K*HW7QE,'23K/QW=FTPU-)>LRO:BM#]'F"9L+;7!S_FJ
M,@93S-'J8/*4%TI1]M,Y8<[;F@?+2/?]7>H//.:5!*0GGV\%_IVK(^[ S)V.
M5W&X$!CP!%NF%_VS7X4M]/S[X/6BL!^@;DH8*R+^M=OG2LGH8Y,1E";UDM:5
MAZ761*%!F^@C:7J'C3.;ZT]S&UX4.2\[UY/N^\:.>_)4QQ"1A&EK]P\#U\-8
M1%<GYPAH;%B4L-<ZY$F1?8T8.<JONOJ[%8[DKUC]@'8D-L+F OU9VPV;R[N_
MON[=F?I=GY5!3N&E($(1,EAU\'8UUV;2W$L;:*5@6L>\WWZNO]F7MN?$;0[%
M>!-'0:O\C,=,%"PMYE)\#.M H->QDR[/AH9O&RR-NB?>O,M^#GPTGQ/!1@9N
MM4#9&^=1CYULGT?;O7TP'YM(#9V9XFG<S]$'YE8O;4S]O85;\ZFT1J6ECL2(
M:MPHLGDXN5/$_"OBHJLRIG3F!,=>U+4X.!::=&C_D.EQ4)<3A1M -%=G!0&$
MI56.)W<_JY44(5,\YPBTY>]%/YG+@S@W[WL]I"2,G1I\@16X+K&S3@^G^6_7
M(4W%=;6OA$_Y\"?5%4P^#G6[ZY'['REI$S9=JKC#&CRH+_@*_7-B<!=%$0?G
MOZ8Z+!DPU4P]>+6:8#W:,OT'5REZQUK^P\QY4V>#F2X!<2E[>2E0 ['W7.'/
MO\V;.-IVF.H^&O5-WU-N@,#F@V'3)(8P?ALV@E$O,>G!.J=$UG+1//Y^9[M)
MKF-PA_&)=4CHLVW'W_=<(\N:_&P^QMIN ^NA .<(&7 =7C[?D#^6S3'% & )
M7><YOA)['O1%Q3ULK62\Z3BD6Z;O8O#VE"OJ%E'NR(N7#C,R5#M(XJ =%L6Q
M% 2./K$K! ^X'(O_@B,'+G93Q+A.0 )?KHR2?W6>U\;6*?9O=BZK\[+M>U08
MY#@1KVAJG/9JAXNXW YB/@WP>BZX]8W2'SVT-D2?Z[1JGSL-TGFVSM-G!M,?
M^W+H.>H"ML\[=.PK$U8T>F[@.WPT<K.+^E>%5WF0Q%X[S$(_A=K*Z5V'*$?@
M@RC)""F' O(N%T8A4Y]G..?C:^KZOOGA[8J,+^RE07W[X)O:!<IS&1[16Q^?
ME;6(8B(D\?0FG!1KLH=44$JF<(PQU%XF8FG.[ W+C7'B;@UJTJ-U1,OT1%MK
MB<G'0R*?Z@:%'V\_]OK*^:/]E;.;V/D*?\>92-"(W'8?UT_>&*A/1^&!$Z0L
M:DF/ZJ*D]; :IMT@P34-@[/.O=FV#G%HNUTTY_;STXA-8?\.2*MP?>OA8CR=
M!&NC+!\ \$R'I>=TU^GKC&:5MC2X ?8"\-T7+$+(]J/@S;E6?G95MH]-MT9G
MC;RRN>6;^8;:_3$).O):_PLZBP:<1,J!EG/$7N34+SL!N9EDE3%U,]#<([KI
M+3!%[=:2BF^M>:>=?OS1J[CS/+C'_MHA?=/@*UU"JH(81,#5CO0@6L8)_0>5
M^O%0-!P&-M%)>9&=!UBPP^.Q>D_JE[ZD;TWY+MDLT43MO'#;M\CBK^IEO>Z=
M,+M32&FPFB]Y1)3 D?LD4 ,7K@%GSV+Y+E DN/88<<8;GW6!T!?G'1Y7?Y':
M;'7\O9;]U%!UZ*OX';->LF:.)F*/443@%%)R$2&$%6&YPY)P^\<$S"UGK><;
M92M9+>PR*NS1XA/V\)6V7<M&D0;WFWT\Y]OCJ>@BY5=4W\K\+GC.?;([**#*
M(B;%R!FR(-C1778"-)"9,)D6D@0EBRL>Y<\,^7-7LX\M\[?\4LKG(\*%'QT^
MOWVW]1KIC>33\(A/OP?S;'P9A$R^[+A-PES$E1GG]S$N5@D\I-N+&UH6Q4\'
M1IW-\C!GCKI?3("$"-G?^Q"KAG <6QAO"?L:$1%Q ?4D,E);?(=QS=ZAMU,2
M%9N=;"#Z<W@504]X<0,9B.D@**AG4+)TENGK2C<K;OA>!.;,].TSRKI^^,JF
MV(9*LPLN9;N\NBP/1PF)J\OWBOQ"@/N%V-4LHVP$/8M_$&SC&*&BP.M=? 0@
M];@1Y+A,SK4Y'[18^_E:6T,,:1(5)=57:/)D-#GKPH>38A\04($O>4AK@/;1
M"DH12S,,?+X++ _K7-5:S3"P]@(&JA\>83IKNZ.;O\5Y%+_W^1XE[WZ)W7CL
M\2-/V8K2U=*_J^RS@#9E@)"!EX;OQ+U'-NHD5V R&3]NA^+40ZWR_Q23H@.*
MIARVEE@TV9?52U:_?+U%:U-YZH[)Y06!"!P!VI("JXYA)(C^MO.'<):3=+")
M^6#D-T7N:VZ$^0.Y'4K9YW.<C'2?;;KQV#E2\3@CX.5.2**K'387<.5+E##1
MBOQ9Q77(4]=E&&<[V,: 9G4Z,ZR)LMC]Y$FNW</OI\"4@4^OWQ)XQ+VUJ$N/
MMK_5<=I7,WWA!FT2:\MKX^N&KF42EO#^M&D<.N<-T'NRY#@K\ U(5E/7SS^M
M)QO?_&)_IZGJFYHBQ[ZROGUU+S7ES+(U[#?]#E3X>U9P^S"![4YB*IDDKDS0
M))LJ>!</GIAO)JF'RF#0?5;LAD=VP7CZ-]UV9Z?E/KVWH[Y%\[)'SQ?6/6:4
M?7;G[041S.'L<E, ,T'>R]46Q*Y&[I8G,NWXLYFG^OQ5 W[=VX0+)Y9L5UZM
MD'Z8 ZSD$%OX+0_X8ZR- <G-.%54^5[6;W5A=>.)^I85A76(_[0G"GJ%?>GI
M38,G5<7Q004G&QY;R]L?+W)HW\>%$O#T1[-RH#%GFPOG/#<:E&02I$./#);@
M))O RVV*JU;I0VWJ)'B)5/O;QT^%BQVWWH^8$7:X9'@E [)&[JQF#"_W<G2X
M2-Y]&SN.'G8O.%^)R1SDRX[BFSN=*T*6M0?9L9320AP[QDWBI?I140/^^:%C
M2>(D2P#!E;?L6XM;'MNH@X"@H-#3?(0HAM(_N^49"Y'RAP %GX9==:\5Z;CY
MO"7>;V+"T] ?TN F9W]FA^/E>YV:]#/&=@)LM,%&8^8D GBW?HM>2UXES#"V
M(Y*$@ KH>V_]>63N1BIUV#>*%!?/&F8'\FZ@X;H8)4;^CRH4T_<R0MGGV_70
MT]\>OZF5TA'+<6V3#"X(N?T@X=+/;HVC@5W:L^H"P3W%0L%!()..%F )P1F^
M=QP14E;W!I^QIM-0:WA3Y94_VF8M<Z9ZVG*ZOVUZ/KOOU-"RX7B^K].E37_L
M%#[CFPC+"BQ-)JT/IL[=#;8 TGBA,)S0L[%1#]]$<U6#B_K/_,ZT-]VRD[.!
M=02\+1S@C-KI=<3_>?W_Z8IG_5]Q<T1N,4UY'3(U7H/_=OSFFAW2$K/(%V>M
M0\2K\UL(@O_T?.18LEOKHA+8Z"4IOD>9/OS=+.93_M20:-3(2;&7-SP^T(!E
MH[5ZY-](_*H+[#\<0V*1P GB7PWO:EZ^VSKDFWE+POPE1%-UUPIX$B[>#L1Q
MM6%4&FK<;W49<?&GQ8\<K>FVA 6>7W0Y;_\"^=]S)?EI?0@>M;'&UWD_NAT1
M7E6Z;VYGX[T+Q/ <$-]-D470BV& GQ&H.Y Z9T0]B(.!.:-H*;M89IG:$;><
ML5. ^\/SR!:1FW>#GP9<L]#ZJ.C8T^IGL?#C^;T,IE+;L^R  KL]7Q>O=0&'
MQ&I(-JS5I52.#M:=//8'D8-H7.TER9[[MF]0NB2*!.KTL);F\D3R-5#W_55J
M('KG()!^",YQ8\T\A5Z.%[B@<!JXRW59FR.,HLFN_!F&G,.>F:C'!T&5,=FW
M/=Q&FQ=?&NZ-] ^_$![<WHHPR:\<>K;'.!GI*[B"."72%SI(;"2FXR\0J;L(
MR60X5_&] 5>;N0[)5->-;?GP,&/ &!V&1ZM>BZ07?]+PW^M3@OMQK-&4M^#O
M'_C0Z\C#;ZU1/C,^?0T^,]W*1[/E+YP]<ZD" A%*$KF,4-I(##<WQ]WF@\6
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M9,;<"H^XN/=R_\7TL_+7)X5*/_Z/Y'GX5_M7^U?[5_O_>X.N3_]?4$L#!!0
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M$NAJF4&XMS3;MP3^:7M4%Z1FY/N$*<NS-9X-=C%8@TX_+-.8.\ZUYKQ$RU0
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MV%DZ= @+\5KE:@.^%FE73%9WNM^7)GUI+I 7W)>:2711^[1O]-5KD7C';0E
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M0]+JY OP#F$ *ON^)LL\UGS0T,>M)0]1;"6D$1P1-7"NYEWCH>'OVUAY,PE
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M?^?5M;G7IP1*K<S=I9QO,!S:8T8;UEW&VI-/8[!@@0AV>= 7A[!T5^1B_V7
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MSI>Z]-"\/W-CW.QWM"P/0V"] 91Q+! @881 6/HL3!JO2!BP=C@W88;;P(H
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M_^[16B;>D?>K;UDO8Z!09T Q^G/]RF5?L1/!>5X51;\T7P2HY=+710XU<NS
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M655K1SPW/<)#;2XFSUK<<LB]D@TSRU5T^2)9_VK"EA\=]/>+)@+8*[X\&"T
M,SH^G-)+VJ<S;=AE1_\(</^@S9!W[RHYF&W@'V<?\+G7>0NI]F D,*M<\&IF
MY4+S>8%AS &PW*#<88PVYQ%;C'4  >JJ\W1$/R=JW.OCQG#6Y[N5TY$:/VL-
M@]IS%2]\/IU*35)0RY+:<ZK30V5N0P3TT1PH-,ZCG8%P!I:Z.221&N.G#CA4
M@0 %R.WT>S0URWE\ME==I:5/!)221FW[3@<.751SOX))!PG]9<YS4/[N0IHL
M-I18#M] R%"V.0PDT']1ZPI?&);$T$A)R_K'S;@-@4]XD'<;S;-O]?!:\D8*
M=[8^XY_AY&/)!8C&\?5HQJ]A6'-]GQ).>81*2+WI,T(-+XVA[BV_*S:1+'%0
M]'57IR%N)0]^_+/+X3O/@^Y''<!G/XNSJF>.<>[CE3"?2'O,C!:&:1)I5A<J
M@0"O?/$6B<2MKU,O"$DG@XE>Y^5"]]_WL^%=AWRY(3%J#'J[91="A]_]9H^C
M2JBBHV::F8<,;Y7ZT.0JK"NFK\1?+=".L(K8*USVA$JP!3NM&><9(7 7DK +
M:2:EF*HH#7=$?\D"%:?9&S,</RJG?QL;,(VVKCI1X4:=#.)3GW^7I:1W^H")
M9NK:F1GX/2RHI?HEXKC:#(^!;B./.2L[6KU2C1!HIHUN=S;-G9#-=Q I>%#1
M#LEG5Q(H>5I9O:C$/SC8IAKL74)@$'K?D%[755,-$(-M!'D;:Q5GQ$SP]%;U
M6Z[)-=WMMKS'(U8ECI\V[A58T07\_4HDV%)M3/L&3IH9?%["?I:K%L;E8X@3
MS.NIU1DPI7,===VF3X2D?](3-">,:\Z<)QOW*CZN4N/XGH9@,&.@Z)L#-[3>
M?*J(3;6ZP^ATGYJO:I^,1F9Z/V06NL8+I7L6O6:\WG_HWX3TG0!F 2>>RX^9
MP<IB)-&7@7Q8:F0++-[& /1,1N\_H8J+"XMFL_/36N\<CYB>'(47?CGZJ6A!
M,WUYYC1$UO4_Y__;>9VDRC4'0I@QP*4:M"\C)@7M\&H^=/;&I_$ "ES\T[68
MQIKKS8F:A_6D?C[]\_@5;^;KMW4GF0*<QBZ04_#S<?+86BP$VXS>6OWLFXVQ
MSX+I>XO+/[ESLN[;<W)QHP>"3P<?EB?6]$0-G3/QG1NZKT3^FG$IV8[^GFNW
M"ZF_HT?# >8QW/-WZ%!N;_$<%Q>M"&$UXL_._/VF:IGP&WI*-M>*;0CP4S<5
MV*I 0/5RV+(94/H,'O;Y1^/1:4-3EL-#>)4W$;U\ZZTL]!!"[=P%@6D"^2E.
ML@M.?\#D!6@,GUX+-[M:5 AY%Y+6XGL Y2.A,H//OVEZ]ODM]0DX!6&,[16W
M40&\H8#%% 4;;V1P(-;"$PBJ&7EIWQ-YW^\RR=EF\W(1[M@3B9=X<RX1Q*B8
M'J,%;^PB;!@JI59" 29JHPTLW"<EE\SK569[0U2*=4S&_ID<:'C&H:E],W90
M(1,6U[W9D71$CQ'1ARR?:B/['2<381B%43'O?C6_O+C6Y#/4.%[IK/6\KK4C
M_E0?7+U-HPIKZ*6@X$ 56-]BA P3Y$ I J6?E8@K,YDV-+2"57'G2$'3?!\<
M.UNGMM[YV YP/E_L+C#SBSO5A7Y&.$4@?\N1N@85QP9C%U@T6%)@J-5IBA&Q
MLZ^0N&]:1UKH-/[)T&$'3?/!T6VB+N\Z,@?7.IYB(XN.II/62^DD"K>"MIE>
M=G#"T&P,+K@J?]]'NZ2\5RW=Y1QWY;9(>$104)*@A&9CZ[1]?^,:9A3;*M^_
M2:Q;'/Q7.^?9-3]E1DK_II1- D.@9V<[G\D19NOF\NXOI14+/0LJ4$I=R/-<
M5$L6SV#(LV4>^,Q@0%8]0&BSR+*ZI&<]G,BVI$B(?7-UO,D,W]OR2T'&>M_G
MN#,.)R9EX)S'[--5*!^N>!7G"1<:ZF;Z+R(#%KPDXSM'R:0$$1IQ+LUMN<,G
MQO@'TH6^BL9^X_T]F:[[9$_ZSUU(.DD5HX6V8=P$;H*\L,DHW>I"Z&O-!/?)
MD"3_8/]1_P\W+.?,7G#GN4?@BM_\Q!AMZX-4K#A4DL3)Z_M^$=\J_#-2_T15
M1$//-UW>I= :+. 4C=V1-<)N5I1SI7T1W"01$FLUE/=J^C"(684>NY"G)[:Y
M.]XPBA:8QM_.=^]"\ 5QYKK_4Q96S0UNC]^8#:>$EQ_2#<YT;(?\/OH>$N7J
M";:BO+5=R&]=OUT(R=F!K=E!X C+$[8G/^X=W/?WPQS#^EW(B:1-SN]F;)\S
MJ%4_/@5U>JP!).+_AVM3+#(V:S]G'V0;W,K2B\SR/LV?\V3E^?_%R9#Y9V!'
M_3][.N?_\/(3L70]Z/\I1/]_7BF^.+@]EUL4B3:(/I!\R$O3S?AX=HO._QIQ
M_%]B;8LB@/_SP_L]VN!6T&G1B31Y-=44A2=BH_]?QSE\#!W#\D&5]$-ED#9R
MP 4FBB&1AES75^_L5/3=>!-:_L#264.EY_K<TR<2UYYU)?00FK&#.7*HCO[^
M8M+Z YJ8^.2/Z\H[+9R!O4J7>O]\.OC!IJSE^V^(Q_ME$U *E*#5Z2EL69T>
M&/W<01M%@-+E1?NNXL8<&Y O4\D;<TA7$O'Z6CA61@OP/7)X?:\LBOO/V5*>
M'7N")3;R(XQZ #F?U#!"MQ@XBV,E@4W])/,%I\I&'#-$VM.R2=2A$5)QY^@K
M]X05WG=WNER/L<INL M'2K.GX/IUN<_$:VB:HKE?_40X^,'Z(1(_>P^G L^#
M2J"<:V>8]ZU\I4R%$VNS-O#59EWA^CNW&KW/? ^OTCRK^5/IQO&4GU]R<Q^B
M<: X%OW^;UTGRQ;3A^"I>X$$'*P\6!ZA,=Y;^'\*M2>I"P%I'#N?EV^L GFG
MA;%L%2FJP4G*^/HX"X8.H==D":1V:;$\4&ZL$QV)5#O=MNG]0X*?D^?;_5BG
M(;%9C%_,!?K7OIQLO!+G 5Z)#9ONBF5<&#RN-=0>1E$Y\%,D<.H62E/*Z27I
MTX?>R,C,FM=/>3X7N!-3YV_[PA?@S#X@EG5I$55_:N*WBW-_V6$@EJKS$?._
ML??F84ULV[YH$ 0!(71*3T1Z$1#I5" !%0$105%ZB$H/ B(B04."]#V"((I*
ML$%0.ND5D="C(M+WTB2HM)$$(12D>\4Z>Y_EVGOM^]8[W[[WOG/?^V/R5?AJ
MSJHY:XS?^(U18\S: \!<5QJF'B-CA/:X"=<'&VN?JF@)DCQH(>DNT-3[FX=V
MU>]&66LW<"B;^IU2D)CO]9J,BT/+$M[QJ/!CNBX,-;CM]7I2?YO;;,[QJ ]H
M['#QU5!>;-,@K K60N(YD69!\5H:?^)71]=\N+^6:C-?<W?ET)S#A=?IQ@:$
MM'<03,X9$Q'(?[&QM3#[,'+9+8AM=)M0'T)XH&/=ZYY24O&U,JB/L.N$BY4\
M?WG["Z&''J_T:@:<Z9^X=%:6Z9(36SD;!8TX0"&M)7"T8 ;?C! &M-ISN6H'
M+@Q?2Q/T[C/"XP<# V11GDV)5RZE<X^T/CYTX8TXS3<1LB$Y;4>Z3YP:MYIA
M03HT *5UDA8-BBHC--Q_-E\74QI3M%@7D3/5/BD3]K7_>WW\CCL?[+X4WW(\
M[Y%)6$E6;<%[6G%B1F"OXNC"3JT@(E@404=9D#;F 2"!\#8<VX+CHCL]FW?H
M66/H,OT2M!FG%ZV[1U<)E]5KNCF6,EB0IS 5S\F8!@99HRF-&Q!MSV%!6E__
M"*RV$D)E?T@Z-QSB,V3>]8Q/U<GAA.!YV=JXS]GNWB]Y+>33&LSET^O&(/0^
MH 5TG$]3[%J0@()2(W9TANK]]M4@4Q7SR56CSR"<P/W\GI,Q4?KZ&&E9@X0>
M10QT!._O%^LD%]_FDCTF.(H9 L6<'@HR<7]@F(9 [:$+4,JBX:+H_4"</T64
M>'X]C0[?/%=[)"N3_ZZ$0I40??URGY4>SL"AQK[C@W;RQ^KU"1$V\E0""^*%
ME6*V39%M61 1;-/1>DGR,I*":,&EX*$EVHB$NY-"?0H#(=*\KOVG_-P*PU,A
M_5\<.WUC.05,Y3J4^5O<A+19D L:HTI$PRG2*&66R9-&Z6[2RQ4=Q*BJWR<L
MQS4(#IX,QYN3/^,"12[Y59^X*#)\YW@V)U_;X_-&P-7W..]>H^TB9XRVHWZ+
MU2I43F,9:5=9D'DMNSJ[&.80;,4)SL6"C*QK,._H0&[F;YWZ:W,;Q;Y?!L'=
M]0Q6RVE7F@<+(O=NF1%F0N\"P?XOB&X:$;G!.\>"K&UB5X7! ?[P\Z])?]HT
M=H/#@@5!5F+GSI?;,\';O7T<OT;38\;\#T= 04%S,UV(?X5H7DYFG\:EXGV6
MN><WBVV'^WRS*_T$4A!F=_O\S#QJWM5-?'/LKJ/N-Y53@>B2\,H7H)@GKT+P
MB=B=]3KD[]AD^%X@X?$(<'+\%+/W-<5DLF3G#?3UFZ&,QZ7BT9?4GNDRQJ\$
MYWQEBF)&D)6F[8&[.Z:A<5C1JLZNZS-6?C1IB6\>574-E6?979S:KL2O'U#Q
MX+2/VC/Y)O">.WM?D4PGT_3FU.9*TD9.&]!-.TH78N1J)TD'SFS%(UIZ?;/Q
M;GU[&W#KFRF?^R8MJ_;MK!7RW]DF9WOAI7WR-E]H-&(74YSNW]V*BX;K]]6;
MYTV-*E<-5OD-Y(JZ7S>U_'A:6MI!G%]<W,%^VXX\_N^),_7&X#5XR05M#'8J
MAB+:U@UU1,VV:5IIQ-7+JA>)4K-6K9M_6NQSFOVD61ST5E3.>SSYZRV7%(B(
MG28E<,:J.3!B4ECF,-!)X3U)GLQ<3W<T#BUR*3Y*_&X37T*T^6FIE1Z=P*Z?
MN\N\>*MNL"JM<2I-S['T/AE'/(TK\I40;JW[GLK;A'V^$5%U@CCD8?Z8GTWY
M<\2AL^<>2D!(<T\2(<I@4VVFL[,@*AP4%H01GV/'3/9=/TG&0UB0C\8&6!;D
MDF(6"!(2$8:_^2)X??QE!A?Q<RVHKBU;[]6]<;R8;JQ 2!J$OI\\E71MJZ"C
MTH(<\VEHR&9!5V/[ZY2C&]G[I-2_QT@;!45>,6((/HF FX!&H(W9BA!$7+:Z
M);.3,K7$@OCX(=H0D3BAU;1X+']Q6<#N2<.S/ZVR;\YWJU($<@UB/)L3W)*"
MSG\QQ?V?!QC_SO;_,?!A2Z(H':6()F*D%YGB9&R\D]E@M?3NA6&+P3N'*]YD
M[#8K$)M5_N:4]F-X)I N.$4M(B\W=H]!"5YTH5 F#R^Y9HJ ;47&8G<:!!.X
M273;O1)6J9_+2KSM;"O&+)0^7%M7\;KY6JKXTQO;ZYGMN'*8.%P6&HW;@3Y/
M<:BZ/F ::Z 77B1MJ+C2U3U:,AFH#!\:<_*<&#GT^<H-NUD]NDBM)2CJ;BQ(
MTQD#I6F-1)PD7!%U]2<A$U=9D%9O\@3X,6R7HD1>6T&BS/-R57959 >)N_"]
M];A_G^BND-C#]1C;=!9_22-E<C<XC"T@.EV[9$C  2>7&]B!!\T-LOWU7%<.
M40+N/SY5P:<V\]4B7>KLCC<'):^\Y#T8-8O;@;U<%@M2 E=<ZE3E;&O:J*)^
M-]\HFI."I2OB=P>LC;K5#E[SJZVHJTAJ>=4L^>FUT]TP"9\!7JRB@N38V8NG
M1=L10HB P)W@[3> /,QDBF3U$L@^C15 K3=OVI%DB;SW/9-L^C'27WR#BX=%
MSR9;"!O&]Q-?I\=?N=.%S_C^%C<^3MT/V)%MF#R[:*K,,2SY].O5*5ZZ)079
MVJ71XJI.[HZ,#K('*AN[>'6?AAE6P603AX9$6! SWE=<<?)U3M/LP51K(.XE
M9F"*'%1 DBQ%51P+S<=T(W>N(G>@A/K<[BTI#'*$AJXKQT7GF,NBDJ.^:^Y]
M?$CL*?4@A;3>A <.U5*?,M+HAAI9!*04_7 O4[$I7TE@=.%CS6Z[_A/O=OUP
M)'C<9D&$3T!]:\EZA"5\N1==2HZ"<Z ,)!2@[*C/@+!GBW"NH8"'"N_::Y\^
M<9J<-QZ'?-D(5!@Y3=&4TS<3P#8AF+ /-&-PD8)!%%L&E#MB%9S*MOF X,$4
M!Y1<HW_4#GV_=?G;H'MM4&NZ<:CWGI\B69Z3; IB$!Y8=4>+1IPKN,)1&0BW
M,E'4L<:Z$UDO@+@FK(#\<-DJ25=9<<#=4OULQ>FYO(_3G4J?1A&:LSD,];*N
MJ?&G;1BQ5V#/%,0E0W5:JZ[UEX)(](TRCEJSTN?^:D,"QH>WCTIIK"?>UDJD
MV5$K&*!7YHD;<2.8 5,T6_JY:C(VYH%M3;^H[=O*UZ]M0@[O56YVZI![2+IT
M>N+ERT^M^S(@< 0H=M-^2!F$)S095CE%WR7<.+53 [,'#0?8BU"15HD8OGZ>
MZHF&1R]&37Q#[@G&V]X\[I#@MGZ\/C,E/QTT!I?28 #X]+=>(G&!-B/R);-K
M<F^J1K2K.& >-,VGNY9O7PT5\;69,KEY15W-^*"3TRAI1](5(=.[=NFB'U7D
MZY#DLSBQ!1+8GYN1@1&CN]=;6$4TR%+XWP01S4N_J-]_B7H^^<&CYW+9%_H#
M@^6#WGN#:_SB;6*]!Z!'@/,T*50@=1]XW<WY/DRS4(I2(UZ$*;XHT4%B(\^:
M761DY4T84?BTK 7*/O@I#*R\+S\!T;]8KZRK%0-AJ/U]/\HR7C*4_FPKA8VZ
MUP>YJ5DT\<\F$[)^4OE)!,^_LZUH[&9.XLN[;Z$M7P!6;;@J1-S^4FTUX\L&
MQT(41G4=#4?W\-X<K^:<_.Q<P?SA(QB[]GXC-MQS13Q 3:$V\MOCT)0L12/N
MY/2(1IF#1WXB$Q$5&J1:8MK(#-6-@J-+LB T.[30;4S/BM/B#6B+U\#S1#5A
MHON1B;:98R\-5Y?D3-2"5+N^"ZT4FPB87W7\ L'T+]0Q8QY[V\&5A]:*+ P/
M?N[]4;HF6925NF./B7I???+1E]NW)PE'< 8G3L.YF2/8"A:$)%GBC J<CNN
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MVE6%DHAMXL;[6O%+J[8,9[NUPA7(EA,UC_(WKN@S7B[85:I*"<[<K+RRR]S
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MJ5RWL&);A=.XT7O&&3_F>UQ-1QM(%E3M2-AI9 J.AP5Q3Y-$'P;$R?=\<S*
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M]G_1]A]0377MNC <1$6E1)#>HM)%P$('B8TF(@("4J.B%!$1$8@2$A3I34!
M0 A2I F1CI1$NH"(=*DAH!0AD%#"@K0O[#/.O]_'Y]G_>??W[<,8:PR2K+G6
M;/<UKWN6ZR8Y0'D8P\A]@[B'3% LA$/7F/25VUBV'+!_[S3JR&WTPY3B_\G^
MS><$4/:M/3@^U;N%S>4$VEU6 UYGV?D%K"JR#\>+E76#DFPQ47@>A$PQD.4
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M_9^ .-,+R(?14L3 5$$6"^[;$J!D('8W(!QF(>+L;2;HSE?(CMY,D*YH=F/
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M,0=&WY=X'H[_4,IW.7,J\&7<:0MX]IU4L:0K/UVEON#<H*'HFO<53-#>KY6
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M%;6WA2SW>5>[+XYO25OUV;<,I;=U^6%5[.Z!]\L5K.%RU^U$0'(>F*_YKRZ
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M#F8=&_-:/?:\W[XP]TXA=Y&QX%S"F36#TKR*764R(523">XV^L5.!]$VA^9
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M?_ON@K+H!UN*W>[76;I7+PH=L4$4P0#4(R(,%_3D#W0W=P*Q]PW[$L('(;-
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MZP1YT(88<^)PO"]4A5]F"W(T0-U<8+S"9=:E_>755*X8&OS%Z)7J9QV;VW.
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MQW0T.U7(KI6W91P].6+C?&K'<=SOV/NA#WW^.%!7[_Z&)L#YOG 5T,X[4^T
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M*V>@*N;I3K7)#25^4N+[+@3QB==5S5^Q4?\@\;IZ =5-GF11='LK!A'GP7[
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M/[ %]._V[_;O]N_V_V/CWYK\'U!+ P04    "  FAEM7-C%EA7]' 0"440T
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M@^X)OW*(46:7ZH>."D.-+EKC86I;L8WRA":4@P!/9"<Q@<ZZ.42K\W>R>I@
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ME:,'"@+B1XX+"?(H1-CU)5.%<AYB%,4^)W& C.K"]_8V-PYKTC%NA3SF(C(
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MW_':L ^ _FO$WC<'E/ED2XI7]YP^IMDJ>ZC\SW'ZTK()81[VJ0>3)(D@\J,
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M?!I01N>D?BP&G9<.-#G9N:E?I>[YZ<B3IP::%IWRA2F_*OE3L?"17)<9<6"
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M5H>G<2="GN9S^O8_Y:#M?\F9VN3'9P._,JH*[L<F)NU.WKH@/.7(\SQ(HT!
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M4'YLY'81J#9HK<PX:/05&)F@7H*O- !DQ4 KLPH>?)TRWHEG&Z?[KS6.(_0
M-I?AS3H!6\-TK!^P_6##>/-Z155](/Z1U_^]7K7;KUORK"PW*83\3;GAK.,<
M77A$I(S'"!*:J:8%"8$X2C/H,10R@>76*K5*11HFQMR8<WM4\50+K5]=4HL-
MECNY[>ARX!*9\>7XP(],F*T"X%VKPF_*"-XNQ6UG*1I%N@$E[ACS/"0=4>9
M(2;ES/. >DV:9XXV\)R<4K[DI4H;T%FAW_A3&]ZOO)/+6VGA\EN2LUM>Z@L6
MB/!(A%$$_3!A<J,:2>KTXQ!R(7>P7N8QCUD=-EE+,#>NU%(V_5NTG_]);EHK
M)2EX4K*#=_(M9L5R2<IJ]S=+2]-^G0S/TL=$?_SS]%9VH&4#'>GK$(PET H
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M%'B(&56&,YQO;@914YOWA<P7=<\ E=C?2 Z4Z+8ECH_C?ISV1D!S9)IS >2
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M+S!/DC ($M>(R<"B;--=#]JV?[T@N,Y9*X*M =5?%#Y@F#Y^75B+#I3L%\V
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M$\)]2#V,(>)RF4](0-0I=D3=$#L.-R*Z["?&U$R$HE:K\P5*5>)M 7XJV8'
M;])])?-W@"L% %_I 1;X%U!Y((8U8OH-FIXW,?Q0#&R*V@H *1Y8J5"/2:4$
MJ+4 :S6J!^^[1L*\X,Q90-JJ1--/B'%+U)P%U%[MFO-:Z[F%7]?*/EG:KCQ6
MVZYF8@K<6%"*!0P2=3_HQAQBZ5E!P863(!<'/#2*;K4FV=2,;;N,?5V#DW36
MZBPWQ3K)?K'.D[10 P^[YD[O(P9SZ.N&O7'LKKE:=A9=M4?O-1CFMO:CUN0:
M=QMK&\Z]W:_U#LX@&U(=%_Q9]BV7FNN,YB]<W<U_RPN>/F4U%PE]?Y02E8K5
MN#IEKOXUKV5E_[XL%THLZ5K>"KE6S5S7HY@F"'*/$(B(Z\'$5<D02$1N$L1!
MB(WJ6 PCYM06BT:3IIX:?0>+C?0 K\7OPW5D?XCUUH*/'[B!%X8Z>VQ+0U"K
M"#XI)7^[ *MA72D*6II6EW$M7<%&V2KC3*TW4F'+_$R##8A-7B?[0H[/!S48
MT =YI(;K[>S]ACKL_?S^98[+LG8E/9X(X0D71K[</* X].4*(7]RF(,\1E@2
M$J,8\XZ^IF;FMWQ)):SR%2MQS_;O]V V]MC/ 6],']P,MW/\Z6.(V/>0]WKZ
M*)_WF,H=7NS15WJS5"U?EG,5B/\[3C-EQIH2 M_F^<\_.'OB]=W<BN@?>RXC
MD0I \'V(J/Q/[(?2G @G8CSP**)&A':&_4_-Q*CC)3ROSA:5^$ Z%I7,IODH
MAJ/@Q3RFL4-AC&,Y"B'#,&8H@"&+(QIS$CEQ:%;=?L!Q&*>VYPK^YQ'@US/V
M T(Z\ +0DKS^K%<>MI3_HBX7HU2H/_6+YO)^B')5_1"TQS%FU/O8?&-]H#G
M/=:KF9Y^JCI>(1U',,T)#-D]@5F3/U^6Y?+E5;U57OUZY:KX]",O7MP9BH.
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M2/Z?0]V9QVA];>Y9OZ4EK7;]:<Z^R=^5,Y(0P5F$ZL4!\8!"XG.A*M=P'XL
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MS.7&AX<1@BAQ?$@X"6 <Q)&/DI@P9A12T-79U'9"C:S@924LX#67E&%44R?
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M0XAB%D&,A>),2QPGYBCDU#&Y2.ON;FI7:"UIS=;H$ZCJK=GVL!K8(+0$;1\
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MS;-= V%L#L_#T9)5["G$J,;Q/*!V;>29K?4SE?=\@66O[ H7F6R^;,J31B+
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MZ/H^=1%Q R]QS;;L9\,ZSC:[!I:OHM/7J Z(M=X"=C9^ Z]$ZX!^*6"]F;D
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MV>_\2;K9RA5+5Z*:!HB>0+C;> Z!V\!V<15/NQ$82(G!6F2PDMDRD*8!N/8
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MZ9Y7!K7%^,ZSI\7SK9#>NPI-Y>E3]J5B=:3OJI3/MWG^\P_.GO@LC%@<8YI
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MB2WF;[I61/VXT03,&U52.2NKTA4@-MR5CO6%Q+%<?"G&,$P2N08[(9)?B)O
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M>I[@F8),;1E8*0.4B*!2!VST 8U"J]P,I9*Z4ZZ4JE[1YJ<];_A..*0C#LK
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M&6[%[\O5G-7[RR1*48R#& 08!0"F!(,L3!# 89)Q0K, ^8DFL^I!XU-SR96
M*FZN%%'[HN<0LY,78&<AX=@N[X%@?NUUB(;VC==9J(QTV26=6-E<56SVB7N/
M?/FXPB]/.?6PFI4*./7YGR5X%37L6L[.\L.]7/<+[\M&E34ME[?_Q"]X\1<K
MUV:=(';>F!V^,=9E6:>LK7NR[F>&%G93%^"*L.NK%*4B[=I(*WI;W9 O%\4G
M+I8K7CWW@'_RXGN^6*[R]5M3>TK:ZOU6E*U>OWWGZR=EIG?Q>1S&V)<F$T1!
MFLI] DP "=,,,!0+(?PLB&EH5B]N--FG9IHKWF52JN>M\4_3$G3C#7H4DB"
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M90)7/_L\A_RWO\ W4A1*G:#E;?_CXI_]>O/2+W-8(%(Z)M_C#R[_=7G'BPF
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M$+>X9SE*7<G 2BZ!F<3=5KJ_\[KU%-]PVG)SX36RZ/>^Q\]^>@I=OE4S+[-
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M2?:+T,'@\J47:PLFR\753VX6V4OHVM1N7+UC9[& Y>)F%?$@K1&&(/Q]::Q
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MKE+)MX^8%!,Q<I[05L?2KY93$B ""2:EJ&AI3]A7?+ &><-6%;QJOK2VLIK
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M=\\72WS=_'J@06DTC?^E4I7'?,HQTS+8N"1*)(_$>5PO%A=,3E2'+&O7J&]
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M_<-/SN$1#ET./B? ;<2@K]M)-"2K,)@3H")&>;KZ[)274]G:,+17!VDM#3:
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M>]]+H<&M2":#4U$%(%Q)3V1@0'R*AF@.420.G$+MZKZG*=K6XGR:GB_._>0
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M0AF*;A.7*0#'G:'V&=ACM&R=!;[WW%5@3I[B+F@825H+(@77I2#0$VLA"AE
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M'T]/N_+G>RO#.Q$Y39JPDNR0"0!=:96(#]YZ:RT/O'9]<%4&&NX#_!+</6X
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M49*DRT1"1)'II(FSQC(;!(]&5$;;$^0,?#VP+PBLO"*XO3[:A=9EABP&5PK
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MI6F&FX, R3SCY>9F3*6BV#-<2I;%+O,@K:)2ANH#&38EMI7CXM=*Y;R.5AN
M[^\P22>S#[Z<*ZW.PU*>HO61:"_1ZF/$12Q5CH O'0LR!VMJ;]7/T?1SY14W
MA,:L1STUC+L1&"6DT)*4^B$BA<3]1!M%##CJ%%-6Y=HU5X_1,BS.ZFI\33B]
M2/S5FB;U8+YB/#\[[TJ)/DWG$&>GT_%_0_I]-BD+LYR3C\H83RD%LJ8U13^#
M2^*2]NC.:ORIT<)4S\!L3NVP^^\@4*RLPH9MWM.<7A1TN,"\<XPX80%C+U D
MH#=,(I-1."<]QF5-@'7M(IS>LCD-@O7%*GPY6-T%6*=P6FCH%:[O_'A^T0TW
ME08A,@#)GOHRD#T2[T4@GF4:(]?&Z=="Y351PZ9R!@'?9@IIP"#N?/7C28G5
MWLWFI1)\A;S0]XC!EM$[,AB45]<U(N+205:Y$CD96WV8U[-4_5S1<)T I+*N
M&D3?W:3GSMELOBPVO-1QOO&+\6(DI)0^&4Z 1TF*U2:.YU!FZBJC+'40:X?"
M+Z5QX'%>E3'R# 2K*JR!8.89_FY<C-_FZ% 4/\-/"L/%%WX#>38O@Q]'!AB7
M3I9V* $7.2OF7R9!,K,F*.^TT]5/]FH0/JQ1'1:Z/:BV?0/[*-/%7;YAV@OC
MH\=-2SN.01Z5D02; DF2 I<\VA#[]@ V(GS8**A1/&^NVB9"HL>E>E< (V6B
MB#HI8CQ'1]P#$!L5)8(9E64VD8?:6<QU:1LV0'IE7%91T,]T0Z8X/WZ:KD/"
M)Z^3A!_E(E$1^KF?7,65=2_2U*.GM_LV/8GL]:_EB!P-@%/$HG-+I.'EOGWB
M1#,.#BPH6?VJ\>M=RWDL^5%>>_G3V[*06E/-O20LEF8\SM#2!<R1$"W^10M0
MKW9LN9K"G^8BSDM0M6[&JH+2&O!O"W?+V=ESW-V.2X]F$WS:Z95$;H0<@LLJ
M:V)"Z< BRR$&M9Z4?&#.6F9'^SCUK$-]F^>D-3"V LX#*/RG@?I'W/,N&3[Y
M!I.O\ 'WRL]W!3(*G N(,9;&Y4!DHI98;Q,)0: RC NY^CS;>M0/#_4A\+?1
M,J@.AI]F&5QR_4_P\Y-OLY//\]GYZ>=WXZ]PEW>1M8F&)<)+#EXR@VQ3B7K
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MNQZZJ U_;,Y"Q.P"6@V18YWRZ"U)**SGF1,?O/;[;%L?OL\0BX/B8P]=;CW
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M$;=R#%=U![[#O>;8#?M.&(LNN9# L+HY2FI16W(DV"QB1!,2=KC]Z!BV=.R
ME4&;DH8HKB<4CK?_I'#,B0)(4YP$E3R#X-&!4<X:R[*-9K06^7_'34F# 'CX
M34D#T' 4FY*D2<*H$B%0# &*T>T7DJ+8U7M43@0Z9>S3WO-_-B7M@HW!FY*&
M**J#@_GA:\DU%RZHD+ERL&H&5UYIB#(:R(K9X!TQ(EMGM3=3TDG2J"LP-M1=
M!PC<9HB:5 6#2+7W4A!+R66(*DHHQ1M1 GJ=1YM"TOTTQ,Z<U29*[ F73\Q;
M,]Z@(L& =?4-T3D-(08#,BGA7%9"C8?+8QZ*. @*.PQ%'**73J'VT^@]855)
M(I-C87T E1G)K*[(X0H3\];'9$9KC#GJH8B#P+#+4,0AFND);4^/2Q-*1LN-
M!)9J$D-G#5Y9!5:P* UY$L6-^#34_U#$SJ[=5JKL":!;32O*)+:ZB :LTJ$N
M6"P0#1/ (H_%)2-E&&U5ZR\S&W$00O::C3A$73UA<<,\*RNSCA2W <^VGOL9
MP8=0!]YSGK7GV?O1DCX[3ACK9#;B(! ,F# V1",]@6O_N^3-;6EJ<(5+)C5P
M)D@&4I I,Z^@H$FF<$T6/=KF@(9\=#+;K*M;?BJ8_%JF\C*<IZOSU9<?%N?G
MOR\N:@''&9.68R:!N.CK<RU%"#%J!@H#H[LQ6U8Z3N%O9JJ3.V$RW(YG2 U
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M^-B5>)<3D:Z.M4<#MDZ75N1B@U.1@_4>75$Z*M=ZXMK^5$^;ENKCF>K NN\
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M:F&>7WU\__[C55RFB]F]^ WS:(.,&]%UB%''8XBPCPY@(4OT'#7D.C96<>_
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MH)MIBRQ>UW$\X?PW/)^1R_?].A^V_(B7E^>8_T^87X6+[P0$<3.V.WJM%%T
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M2;_O?\$N 9 $\;)5LJSX*&5+*DE)=I^F<)6X&0UUR!G%^O?;F)NDT5PX)"C
MB:M2KMBRFXW^&HV^H3'@U8IHV]T]J$"WUO9C\(BC >G(-NF4%(*[-V&-5.Y%
M+W"HI9(IRBE56%J;%=9[$]*/U-P^J.9Y1R@V%6S7$JV(Q-0]VY/HPFTR:9"@
MV"(C>*$U-20WOB^2_UBM[(,JH7^,HM#"39?WQ;2W=7Z_KIL+39$P F)%6+FA
MSTIQ\%X2@BB1::XE)I(6 X? /=@/J[OQ)"X_2@,B\#;G"[JH)M6CF]E53NX6
MZW&O$TX:,TIDP0P!KT9R25!:6(H*H3*4%93R+,529KXCEOT<Q96R^3!%V=85
MX@>U"'1PM8V_+_E?WD$9V?D )G!@,LG<8#AKW5,..2H8QI8QG*3*=Y)\!RMQ
MY61":9T/G*)HD@-'YJ6+ZN1)E.-%2XV;'%9-7K? ?!)-J48BA>#.@KRHDM8-
MRA2HR+!"%EMJ->40\OF^JW8DBW&=W*$4=$A<>RBNG];ZTZH!67ZI*NW&VMV8
M^JE4BX<?1LQF1EMM$,-6H]1(=]-*P#KRA&LFC);:=RYH-S=A^S)C445/:$5A
M+E_VE.N@7DP]G('3<;GP/M:7 M;G@VF^E9.JADCT? )N L2)((.W5!:!ZC<S
MO:]>A9+-B#*=*$4,RJW-P(T7',F$6Z3R+,\YHX7UWNKQ@<L+VT,:R]Z(59^B
M<(47ZWOCS\.Q-N()-IG,<V1ERMQ1I1%WU5[#,LI8IBCQ_G3)+EY:*7'^]U=B
M#TAYS'_Y;98^.[F^.+_X<G-U=CU_H_NEH=<)=+:@7]FY&R4F^G,YGH'$ST0]
M@7W<K$9[=^Z']OMY'RW/ PK$5U?SQK?6/:I$F331C"!,G9=K4XDX<9W\.)%Y
MHH0DB>_H91<OO<OJ&W3GXEXO-*'8&)E@)',W2UD7?+'0(G'S,8151GMOY-['
M4.!*J ]]>%=A]P9 !(?ML>&BYB A+C5B/'/'!2%($*Q1YJ:&XSS-!/$]A7Z(
M-,"':5P/Y>@9V!^#5 2*^(<I[^[AN#B!8UW<F<5H^-5K+N#6-%,X4D"RB\7)
M0B1)SA3X%LQUWX&KP2DG*.%%+A.3%\S[2U!',1BX##^8$@Z'4A1ET*V"&]&,
M$IQ2@YA6N6O'XDCD.<1/*><R58E.J/>!P-L8"5Q6'TRI^DL]2N59^K]K$1DF
M<H/=>,7Y$WVP#%3DF*%<B50RJG7!?&<H#[ 4EY4:Q#GK T($IV+[0W^YT!&'
M"!OK B/+#8B,"SCV*03UPI)40$@.T;[OY.'13,;EHO52D<Y.6A>\HC!S1[H
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MYG[;MV.YO_2A\41O$.)0(B>7Y0I6]PF5L39/A42%5F[JJ,T0SPN)K(13#A;
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M^D%"F>.W8#LI18OG0#"V0J^(%+U(0#N?Z/*IU+/ES;<^0&V0"AN4[9=Y=4@
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MZU[.?#+U\Z5]]ZUWFM#-1VOS@1[;=4EU]9G^U;NM!(.E>(_!Y_5.W2>6T(&
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MG^[RU#6S)R]IEI_^RNB1NZKZ/U!+ P04    "  FAEM7"FYX[10(  "W*@
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M4$L! A0#%     @ )H9;5Z#220E5BP$ ^^,;  \              ( !
M &5W+3(P,C,P.3,P+FAT;5!+ 0(4 Q0    ( ":&6U=[CBJ"I1,  $?(   /
M              "  8*+ 0!E=RTR,#(S,#DS,"YX<V102P$"% ,4    "  F
MAEM7^[D[VO,M  "9U0$ $P              @ %4GP$ 97<M,C R,S Y,S!?
M8V%L+GAM;%!+ 0(4 Q0    ( ":&6U>++C.+9F@  -7#!  3
M  "  7C- 0!E=RTR,#(S,#DS,%]D968N>&UL4$L! A0#%     @ )H9;5RIK
MF'_#L   NN,  !(              ( !#S8" &5W+3(P,C,P.3,P7V<Q+FIP
M9U!+ 0(4 Q0    ( ":&6U<9+R\8V4<  -93   3              "  0+G
M @!E=RTR,#(S,#DS,%]G,3 N:G!G4$L! A0#%     @ )H9;5_*V)ZBG/P
MUTX  !,              ( !#"\# &5W+3(P,C,P.3,P7V<Q,2YJ<&=02P$"
M% ,4    "  FAEM7:*!*=]5/  !^7   $P              @ 'D;@, 97<M
M,C R,S Y,S!?9S$R+FIP9U!+ 0(4 Q0    ( ":&6U>$44KU]HD  */#   2
M              "  >J^ P!E=RTR,#(S,#DS,%]G,BYJ<&=02P$"% ,4
M"  FAEM7H"+0S""_   ="P$ $@              @ $0200 97<M,C R,S Y
M,S!?9S,N:G!G4$L! A0#%     @ )H9;5QFU[,#SJP  9_4  !(
M     ( !8 @% &5W+3(P,C,P.3,P7V<T+FIP9U!+ 0(4 Q0    ( ":&6U=@
M(O("GZH  !?Q   2              "  8.T!0!E=RTR,#(S,#DS,%]G-2YJ
M<&=02P$"% ,4    "  FAEM7N=?_HOZJ  !R\   $@              @ %2
M7P8 97<M,C R,S Y,S!?9S8N:G!G4$L! A0#%     @ )H9;5Y-TWLQ@! $
MOS4! !(              ( !@ H' &5W+3(P,C,P.3,P7V<W+FIP9U!+ 0(4
M Q0    ( ":&6U<#S6SGC@0! -4W 0 2              "  1 /" !E=RTR
M,#(S,#DS,%]G."YJ<&=02P$"% ,4    "  FAEM7/?JJ2\#Z  "N+@$ $@
M            @ '.$PD 97<M,C R,S Y,S!?9SDN:G!G4$L! A0#%     @
M)H9;5S8Q985_1P$ E%$- !,              ( !O@X* &5W+3(P,C,P.3,P
M7VQA8BYX;6Q02P$"% ,4    "  FAEM7C  %%1J[  ",O0@ $P
M    @ %N5@L 97<M,C R,S Y,S!?<')E+GAM;%!+ 0(4 Q0    ( ":&6U>/
M:]MO( @  +$J   4              "  ;D1# !E>"TS,3$Q,'AQ<3,R,#(S
M+FAT;5!+ 0(4 Q0    ( ":&6U<*;GCM% @  +<J   4              "
M 0L:# !E>"TS,3(Q,'AQ<3,R,#(S+FAT;5!+ 0(4 Q0    ( ":&6U?OZD03
M_P0  " 6   3              "  5$B# !E>"TS,C$P>'%Q,S(P,C,N:'1M
64$L%!@     5 !4 1@4  ($G#     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
